data_1xwn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xwn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 CA--C 1.536 0.604 0 N-CA-C 113.446 0.518 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.36 145.93 41.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.738 0.304 . . . . 0.0 110.97 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.31 138.18 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -110.93 104.12 12.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.254 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.29 102.22 14.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.9 83.35 5.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.39 148.65 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 t -58.16 -33.92 69.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -41.27 85.14 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.341 . . . . 0.0 110.569 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.04 154.45 9.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.145 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 tp -80.27 136.24 23.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 111.46 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.1 pt -144.44 137.06 22.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.442 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.84 143.08 12.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mt -124.92 163.68 21.74 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.33 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.11 114.2 20.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.783 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 142.9 27.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.541 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 17.2 m-85 -92.32 97.24 10.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -78.81 14.83 1.21 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -66.51 0.9 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.47 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 2.9 m80 -100.67 -15.38 17.75 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.29 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.667 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.45 1.15 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.667 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 61.7 Cg_exo -39.48 -35.63 0.87 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 122.198 1.932 . . . . 0.0 113.33 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -63.26 1.22 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.773 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -65.65 -36.1 82.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.684 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.2 t -55.22 -50.97 68.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.469 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -58.98 -40.29 84.37 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -51.22 64.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.845 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -43.1 90.8 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.039 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.79 72.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.85 -50.31 69.34 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.146 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -37.83 71.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.0 -31.98 56.88 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -75.57 -48.06 24.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.264 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -28.78 67.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.823 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.06 45.6 1.46 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -102.03 -45.87 5.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.583 0.23 . . . . 0.0 110.667 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -68.25 -30.65 69.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.221 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -59.31 113.36 2.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.059 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 -18.61 26.5 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.987 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.45 175.23 9.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.744 0.307 . . . . 0.0 110.926 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -154.51 173.21 16.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.488 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.49 120.72 26.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.131 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -98.62 -30.48 12.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.498 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.5 123.96 46.39 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.614 0.245 . . . . 0.0 110.627 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.485 ' HA ' HG23 ' A' ' 62' ' ' ILE . 55.5 mt -145.79 100.14 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.448 HG21 HD11 ' A' ' 57' ' ' ILE . 31.0 mt -90.81 118.59 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.586 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.46 123.84 16.11 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.191 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 t70 59.07 50.22 8.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.155 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.73 -84.61 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.78 171.41 18.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.348 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.485 HG23 ' HA ' ' A' ' 56' ' ' ILE . 1.8 pp -141.02 114.59 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.753 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.6 tt0 -93.75 134.79 35.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 111.617 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' A' ' 112' ' ' PHE . . . -94.06 152.33 20.65 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.571 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.165 -179.841 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.878 0.37 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 t -81.18 157.38 25.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.847 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.9 pt -58.44 -36.64 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.372 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.63 -31.41 57.37 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.48 -155.71 27.22 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.567 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -78.36 -55.48 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.674 0.273 . . . . 0.0 110.792 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -135.18 146.15 48.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.808 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -133.14 179.48 6.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -77.91 134.12 37.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.545 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.89 137.09 33.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.281 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.54 40.58 1.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 tp -80.14 133.69 36.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.614 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.39 118.08 3.53 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.694 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.92 101.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.28 -46.02 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.74 177.25 7.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -149.79 150.46 32.04 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -112.99 61.34 0.64 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.226 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -126.11 -46.59 1.66 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -61.98 112.3 4.71 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.89 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -45.32 120.37 2.45 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.64 64.93 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.089 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 94' ' ' GLY . 7.3 mm -133.4 157.05 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.807 0.304 . . . . 0.0 111.382 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 tp -118.89 101.16 7.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.784 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -104.8 141.12 37.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.232 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.46 127.95 32.76 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.854 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -130.48 177.25 7.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -121.83 -51.91 2.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.85 -179.45 34.66 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.473 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -50.96 117.28 3.22 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.643 2.229 . . . . 0.0 112.052 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 61.64 31.13 18.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.993 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -138.26 94.89 2.92 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.458 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.7 150.08 30.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.935 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.08 -146.11 12.15 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 26.45 5.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.671 0.272 . . . . 0.0 111.474 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -90.5 165.44 13.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.422 ' CE1' ' HA3' ' A' ' 64' ' ' GLY . 9.5 p90 -154.25 127.31 8.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.785 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 26.6 p90 -124.55 135.1 52.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.356 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.475 HG11 HG13 ' A' ' 62' ' ' ILE . 10.0 p -108.2 121.58 61.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.727 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.7 p -80.43 119.05 22.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -97.94 -7.87 29.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.826 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.65 148.4 65.44 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.465 0.174 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.82 132.61 50.39 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.889 2.393 . . . . 0.0 112.341 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.428 HG23 ' CZ2' ' A' ' 121' ' ' TRP . 27.0 p -144.98 107.59 4.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 111.418 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -96.67 -30.39 13.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.462 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.428 ' CZ2' HG23 ' A' ' 119' ' ' THR . 22.0 p90 -61.12 -40.87 95.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.687 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.59 0.43 57.43 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.82 81.21 0.02 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 110.885 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.03 -23.68 2.42 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.809 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -57.03 -56.28 23.86 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.58 0.228 . . . . 0.0 111.295 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -98.24 179.14 4.84 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.4 m -107.96 158.67 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.769 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 0.4 OUTLIER -90.29 -179.01 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.511 179.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -177.45 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.35 179.98 25.7 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.817 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -136.9 158.59 44.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.661 0.267 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 t -118.18 84.12 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -77.41 -56.66 4.36 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.423 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -109.01 93.1 4.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.888 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.57 -22.48 0.28 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.233 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.5 tt -46.47 -34.41 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.51 -45.52 96.12 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.404 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -33.77 75.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.72 0.295 . . . . 0.0 110.615 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.1 t -76.22 -35.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.806 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -55.1 -51.55 66.03 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.84 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -57.64 -37.3 73.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.015 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.75 -28.45 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.102 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.63 -30.98 13.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.144 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 mtt -76.62 -24.28 53.37 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.6 m -60.53 176.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.782 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 130.44 37.17 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.5 p -119.83 172.95 7.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -82.97 -171.03 3.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.511 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.1 m -92.17 28.21 1.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.699 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -155.36 -72.14 0.12 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.84 41.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.035 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 123.85 30.36 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.443 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.16 119.65 6.61 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.735 2.29 . . . . 0.0 112.425 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.43 -32.95 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.769 0.319 . . . . 0.0 110.496 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.88 -167.11 1.15 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.552 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.52 112.94 20.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 111.451 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.9 t -133.55 126.5 51.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.341 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.75 174.05 15.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 111.607 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mt -108.08 135.78 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 160' ' ' ILE . 5.0 pt -107.31 -33.32 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.493 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.59 159.32 6.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.71 0.29 . . . . 0.0 110.903 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -148.95 135.24 19.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.95 144.68 16.98 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.59 152.56 22.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.364 2.042 . . . . 0.0 112.162 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 m -63.07 150.94 41.36 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.997 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.375 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.691 0.204 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -112.16 176.84 4.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.048 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.2 t -143.44 129.87 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -93.72 101.5 13.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.704 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.91 90.87 8.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.155 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.17 101.39 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.208 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -110.0 165.18 11.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -33.01 71.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -32.75 69.57 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.5 -145.44 8.02 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.447 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -143.22 130.01 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.228 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 pt -134.26 134.11 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.964 0.412 . . . . 0.0 111.63 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.17 117.22 43.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.1 148.31 23.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -117.13 100.82 7.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.5 mt -83.13 137.54 34.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 26.3 m-85 -71.08 98.15 1.6 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.961 0.41 . . . . 0.0 110.818 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.416 ' CE3' ' CD ' ' A' ' 30' ' ' LYS . 2.2 p-90 -79.05 11.51 2.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.494 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -100.41 -69.36 0.77 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.683 0.278 . . . . 0.0 110.851 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.486 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -100.75 -17.0 17.14 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.655 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -96.87 1.06 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.8 Cg_exo -42.0 -35.57 3.23 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 121.937 1.758 . . . . 0.0 112.875 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -59.27 -59.54 5.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.686 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 p -64.19 -34.38 77.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.569 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.3 t -57.15 -47.61 80.76 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.547 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -61.14 -40.82 95.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -61.37 -41.46 97.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -38.6 74.14 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.71 55.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.815 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -64.94 -32.62 74.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.79 -43.84 73.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.558 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.52 -31.81 32.61 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.199 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -49.14 66.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.4 mtp85 -59.58 -31.92 69.9 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.58 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.09 28.61 3.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.759 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -97.67 -31.25 12.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.607 0.241 . . . . 0.0 110.823 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.77 -57.34 3.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.065 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -63.51 124.9 22.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 110.453 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.75 -29.79 6.99 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.542 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 m -61.94 162.64 8.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.775 0.322 . . . . 0.0 111.256 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -136.54 33.76 2.73 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.069 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 59.86 179.09 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.637 0.256 . . . . 0.0 111.203 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -145.11 -70.96 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.601 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -95.9 130.01 42.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 111.208 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.417 ' HA ' HG22 ' A' ' 62' ' ' ILE . 27.1 mm -133.07 92.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.961 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.3 117.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.149 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -76.05 150.32 37.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 61.89 31.2 18.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -160.41 -88.49 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.088 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.29 170.13 21.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 111.408 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.417 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -140.82 125.45 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.0 mt-30 -94.1 157.0 16.29 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.052 0.454 . . . . 0.0 111.496 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.63 153.44 19.96 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.55 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.478 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.139 -179.654 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.593 0.235 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.2 p -104.88 164.96 11.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.076 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.06 -33.02 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.496 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -75.91 -30.66 58.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.38 -140.68 6.41 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.749 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.24 76.28 1.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.98 0.419 . . . . 0.0 110.475 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 70.8 135.63 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.919 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.41 -175.36 4.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.181 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.83 -179.62 1.21 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.28 141.63 36.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.863 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -78.19 109.76 12.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.156 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tp -156.33 134.24 11.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.407 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.99 -62.39 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.1 151.95 50.31 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.526 2.151 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.03 89.57 1.46 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.702 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.24 -178.29 5.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.149 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.4 155.14 27.95 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.83 83.98 1.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.741 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.5 p -69.52 -34.82 74.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.91 6.17 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.662 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.87 117.23 34.41 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.808 0.304 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.09 59.89 6.52 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.741 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.1 mm -140.32 144.73 27.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.565 0.221 . . . . 0.0 110.78 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.466 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 1.1 mt -116.49 127.4 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -127.64 142.62 51.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.339 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 104.28 10.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.02 179.49 5.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.244 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.86 176.51 12.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.28 14.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.578 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.06 149.94 21.61 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.71 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.67 141.64 34.06 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.883 2.389 . . . . 0.0 112.663 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 63.21 23.22 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.19 80.5 1.25 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 110.673 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.19 113.07 24.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.53 -107.38 0.17 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.241 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 m -149.44 25.43 0.87 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -90.64 163.82 14.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.237 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 7.3 p90 -151.93 175.66 12.26 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.85 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 15.7 p90 -152.7 124.06 7.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 111.43 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.6 t -89.65 111.95 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.058 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 81.9 p -79.68 120.67 24.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.416 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.55 -25.29 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.336 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.77 156.4 40.73 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.095 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.4 130.82 30.36 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.016 2.478 . . . . 0.0 113.043 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.3 p -148.41 62.95 1.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -83.4 -14.7 52.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.73 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -90.77 -25.92 19.73 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.68 0.276 . . . . 0.0 111.29 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.22 1.25 29.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.762 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.76 79.52 0.29 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.23 -37.71 0.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.677 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -67.77 -54.9 15.58 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.664 0.268 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -109.86 138.35 46.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.73 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 t -84.56 157.74 21.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.95 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.72 -179.63 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.724 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.466 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -170.46 -42.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.186 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.72 177.97 25.64 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.728 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.17 153.95 42.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 p -109.71 107.12 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.097 0.475 . . . . 0.0 111.408 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.67 -46.0 7.45 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -123.45 84.27 2.25 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.873 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.62 -23.98 0.1 OUTLIER Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.583 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.8 tt -41.34 -37.34 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.16 -43.7 96.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.602 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 ttp -65.67 -39.56 91.48 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.549 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -61.41 -32.21 72.15 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.909 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -33.56 71.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.964 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.85 -30.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.03 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.7 -31.88 10.79 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.234 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.5 mmt -58.52 -36.01 73.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.511 0.196 . . . . 0.0 111.358 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.2 m -64.23 176.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.563 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.68 172.24 13.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.057 0.456 . . . . 0.0 111.005 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.22 171.49 15.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.29 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.29 -171.1 1.85 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.84 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 p -95.21 30.28 2.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -152.65 32.07 0.51 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.4 t0 55.47 68.76 0.82 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.816 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -150.72 114.48 3.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.737 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.3 152.4 61.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.056 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.89 -37.98 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.41 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.35 80.6 1.52 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.351 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.86 148.25 10.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.59 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.3 t -82.71 141.24 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.147 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -126.15 152.73 45.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 111.384 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.7 mt -115.05 140.85 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 25.1 pt -120.14 -37.8 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.051 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.53 165.1 28.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.962 0.41 . . . . 0.0 111.472 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.53 87.31 1.02 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.673 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -100.86 106.53 44.58 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.166 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.74 93.23 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.656 2.237 . . . . 0.0 112.132 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.5 m -150.65 164.74 35.36 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.206 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.275 -1.291 . . . . 0.0 112.842 179.752 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.535 0.541 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.43 158.64 16.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.707 0.289 . . . . 0.0 111.213 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.7 m -141.24 135.9 32.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.981 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -92.54 113.14 25.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mt -97.86 96.14 8.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.39 113.67 20.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.722 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.7 OUTLIER -125.81 156.16 39.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.949 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.5 t -59.07 -33.55 70.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.07 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.0 tpt -69.97 -30.86 68.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.191 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.13 -161.54 34.03 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 tt -122.3 128.13 75.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 117.105 0.452 . . . . 0.0 111.202 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 pt -129.49 127.59 65.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.047 0.451 . . . . 0.0 111.898 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.49 121.08 51.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.415 ' CD2' HD21 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -127.9 157.96 39.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.222 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.8 150.61 23.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.73 135.75 54.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -76.69 95.04 3.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.725 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -78.86 11.35 2.69 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.32 -61.87 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 122.179 -0.325 . . . . 0.0 110.957 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.485 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 21.0 m170 -100.6 -15.02 17.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.663 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.41 1.31 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 58.8 Cg_exo -38.96 -38.15 1.01 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.353 2.036 . . . . 0.0 113.156 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -61.36 -57.97 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.578 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -35.22 79.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.752 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.2 m -55.2 -51.6 66.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.4 89.48 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.547 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.4 -50.77 72.48 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.745 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.75 -47.96 83.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.555 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.35 86.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.073 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -38.79 92.21 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.453 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -60.42 3.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.586 0.232 . . . . 0.0 111.381 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.35 98.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.679 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -48.6 72.28 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.327 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -61.8 -55.54 28.96 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.49 43.16 0.06 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.243 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -45.75 2.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.781 0.324 . . . . 0.0 110.566 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.06 -24.58 59.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.113 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.88 102.47 4.75 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.55 26.95 4.59 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.4 178.08 6.41 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.04 0.42 . . . . 0.0 110.952 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -157.02 134.8 10.87 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.954 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.437 ' CD1' HG11 ' A' ' 157' ' ' VAL . 28.3 m-85 -69.3 124.09 22.92 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.11 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -100.73 -32.19 10.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.014 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.437 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -119.31 119.8 35.08 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.81 0.338 . . . . 0.0 111.228 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.0 mt -135.13 94.54 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.668 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.3 mt -83.35 108.8 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -63.99 145.34 56.04 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.36 30.77 20.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.321 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.3 -83.3 0.08 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.247 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.45 168.29 25.45 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.471 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 53' ' ' PHE . 3.7 mp -131.91 125.95 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.526 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 1.4 pt20 -112.83 138.83 49.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.289 0.566 . . . . 0.0 112.348 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.48 103.86 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.379 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.333 0.391 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.277 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.639 0.257 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.0 p -129.4 172.81 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.62 -35.45 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.501 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -74.25 -33.59 63.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.247 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.72 -151.7 20.47 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.767 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -83.61 -52.09 6.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.727 0.263 . . . . 0.0 110.612 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -154.46 150.74 28.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.31 174.5 10.48 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.513 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.87 173.76 7.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.8 169.45 11.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.636 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -129.74 47.06 2.55 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 tp -68.68 145.51 53.81 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -162.79 86.7 1.38 Allowed Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.985 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.99 100.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.766 2.311 . . . . 0.0 112.26 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.71 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.939 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 mp -66.94 175.82 2.33 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.734 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -106.91 165.14 11.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.42 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.86 70.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.7 p -57.3 -30.34 64.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.703 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 102.69 -48.1 1.07 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.649 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.0 109.64 18.34 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.296 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.03 63.85 2.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.784 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.5 mm -131.94 152.46 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.751 0.276 . . . . 0.0 111.312 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.415 HD21 ' CD2' ' A' ' 25' ' ' LEU . 4.7 tp -131.28 101.7 5.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.13 144.38 38.83 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.28 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.73 106.69 11.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.33 151.28 23.24 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.548 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -123.09 157.39 32.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.44 63.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.08 179.63 35.49 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.353 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.39 125.95 17.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.582 2.188 . . . . 0.0 112.007 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.1 30.13 19.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.9 m -142.6 91.03 2.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -96.99 155.11 16.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.162 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.32 -151.72 5.48 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.849 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 m -104.16 64.95 0.78 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.492 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -141.42 146.54 36.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -151.08 166.02 32.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.488 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 30.2 p90 -137.76 142.46 40.94 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.3 t -111.23 106.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 p -80.32 134.78 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.552 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.38 -27.6 8.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.47 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.76 151.56 39.35 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.655 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.431 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 66.0 Cg_exo -52.38 130.1 34.5 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.809 2.34 . . . . 0.0 112.484 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.9 t -161.07 77.72 0.57 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 111.197 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.07 -3.73 52.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.422 ' CD1' HD23 ' A' ' 122' ' ' LEU . 36.4 p90 -89.54 -27.22 20.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.079 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 121' ' ' TRP . 0.9 OUTLIER -63.75 -21.16 66.27 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.286 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -66.82 84.75 0.12 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.203 0.525 . . . . 0.0 110.314 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.15 -47.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.035 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -80.17 -35.36 36.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.467 0.175 . . . . 0.0 110.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -122.31 134.51 54.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.802 0.334 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.8 m -80.88 161.12 24.53 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 tt -79.54 -179.24 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.456 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -176.69 -39.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.26 -179.97 26.51 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.85 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -148.81 148.84 30.4 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 122.78 -0.247 . . . . 0.0 110.654 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.4 m -79.13 136.77 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 111.552 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 7.2 t -118.78 -47.06 2.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -142.56 80.93 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.999 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.03 -21.6 0.05 OUTLIER Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.116 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.6 tt -40.85 -38.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.19 93.89 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.555 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.9 ttp -59.78 -41.61 91.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.773 0.32 . . . . 0.0 110.379 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.18 -44.87 84.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.582 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -61.83 -40.84 96.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -56.5 -40.78 75.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.6 t -56.97 -38.29 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.291 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.84 -29.96 16.54 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.625 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 79.1 mmm -66.53 -16.92 64.51 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.2 m -88.2 19.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 165.22 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.4 p -144.18 174.55 10.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.489 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -172.69 3.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.9 m -93.55 33.74 1.24 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.92 31.94 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.478 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 52.7 51.22 16.45 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -123.3 143.49 41.29 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.822 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.21 141.78 32.9 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.68 2.254 . . . . 0.0 112.531 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.4 m -78.89 -35.4 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.888 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.17 11.46 38.25 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.13 138.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.268 0.556 . . . . 0.0 112.295 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.437 HG11 ' CD1' ' A' ' 53' ' ' PHE . 38.4 t -128.74 132.89 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.693 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 159' ' ' ILE . 2.5 tttp -144.17 156.68 44.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.795 0.331 . . . . 0.0 111.408 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 158' ' ' LYS . 7.2 mt -110.82 120.46 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.8 pt -81.67 -43.47 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -175.21 174.31 2.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.78 133.61 15.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -152.29 157.26 33.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.116 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.34 148.86 21.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.261 1.974 . . . . 0.0 112.1 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.5 m -61.94 147.47 46.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.695 -1.059 . . . . 0.0 112.857 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.534 0.514 0 CA-C-O 121.005 0.335 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -126.17 160.16 30.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.7 154.84 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -114.04 111.3 21.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.218 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.26 109.08 20.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 2.9 mm-40 -81.15 112.59 18.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.863 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.77 145.09 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.5 t -56.71 -36.31 69.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.027 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 tpt -65.71 -29.15 69.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.742 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA3' ' HG2' ' A' ' 138' ' ' MET . . . 153.46 150.48 5.46 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.204 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 tt -80.32 139.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.758 0.279 . . . . 0.0 111.031 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.8 pt -145.93 133.47 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.753 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.32 137.71 21.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 mt -129.94 147.82 51.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.77 113.19 26.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.776 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 mt -96.87 119.14 34.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -66.67 102.91 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -80.62 12.34 3.18 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -61.82 1.32 Allowed 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.834 0.35 . . . . 0.0 110.623 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.47 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 62.2 m170 -100.75 -15.5 17.65 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.564 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.665 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.66 0.98 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.0 Cg_exo -40.77 -35.31 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.286 1.99 . . . . 0.0 113.137 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -60.02 3.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.628 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.8 m -67.28 -43.61 81.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.851 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.8 t -54.69 -47.52 73.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -59.17 -48.95 79.73 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.271 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -60.98 -43.41 98.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.125 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.11 -56.42 21.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.999 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.9 94.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.262 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.31 -46.33 83.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -36.8 77.65 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.095 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . . . -66.58 -48.92 68.06 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -35.03 79.54 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.974 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -36.81 84.95 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.232 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.5 41.17 1.65 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.401 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -113.34 -47.49 3.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.463 0.173 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.13 -32.33 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.055 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 112.39 8.3 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.686 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.97 -23.76 11.32 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.099 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.54 178.48 2.02 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.073 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.91 159.6 38.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.161 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.406 ' HB2' HG13 ' A' ' 157' ' ' VAL . 79.0 m-85 -74.06 129.6 38.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -106.63 -36.56 6.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.441 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 119.1 37.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.1 mt -139.4 130.82 34.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.7 mt -114.87 120.53 64.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.039 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.26 142.5 52.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.226 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 29.73 19.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.861 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.39 -85.13 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.877 -0.147 . . . . 0.0 111.306 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.65 173.32 15.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.429 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -133.31 119.97 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.577 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.8 pt20 -106.75 143.96 34.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.83 124.75 2.65 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.71 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.332 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.187 -179.537 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 p -78.26 174.95 10.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.74 -31.4 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -79.67 -69.44 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.451 0.167 . . . . 0.0 110.945 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.08 158.46 30.79 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -33.51 72.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.25 140.96 26.9 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.691 0.282 . . . . 0.0 111.077 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -156.85 172.17 19.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.357 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.13 179.31 0.96 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -101.26 179.84 4.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.996 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -129.74 36.54 4.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.52 146.77 28.86 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.511 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.79 145.68 17.99 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 68.57 5.26 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.614 2.209 . . . . 0.0 112.631 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.46 172.98 11.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.104 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mp 64.38 172.65 0.19 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.658 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 163.64 10.22 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.993 0.425 . . . . 0.0 112.006 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -116.76 87.43 2.69 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.147 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -127.93 -52.45 1.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.609 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.25 7.35 68.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.147 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.02 -169.6 0.2 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.634 0.373 . . . . 0.0 111.191 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.49 47.58 90.44 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.45 154.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.74 0.305 . . . . 0.0 111.089 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tp -124.42 104.03 8.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.036 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -116.57 140.16 49.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.575 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.454 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.56 121.09 24.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.309 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.9 172.2 7.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.378 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -150.7 152.94 34.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.99 78.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.36 176.05 33.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.183 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.47 125.03 15.84 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.537 2.158 . . . . 0.0 111.948 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.23 36.44 17.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -147.54 83.41 1.54 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.908 0.385 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.38 168.65 10.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.41 46.08 0.46 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.901 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t 55.48 37.01 28.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.294 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 161.61 14.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -160.29 173.47 15.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 21.7 p90 -148.24 132.15 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.0 111.399 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -103.06 120.39 52.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.588 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 17.5 p -79.49 129.81 34.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.424 ' CD2' ' HA3' ' A' ' 143' ' ' GLY . 4.1 pp -109.61 -10.7 14.83 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.897 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -136.47 164.33 43.49 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 120.509 0.195 . . . . 0.0 111.298 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.94 119.97 7.07 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.609 2.206 . . . . 0.0 111.434 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 71.9 p -136.43 103.39 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.675 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.536 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -60.09 -41.57 92.79 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.605 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 pp -86.89 0.17 55.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.453 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.85 84.04 0.31 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.825 0.345 . . . . 0.0 110.717 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.54 -29.59 2.25 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.076 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -57.9 11.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.605 0.24 . . . . 0.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -95.77 159.19 15.1 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.7 t -93.59 161.3 14.41 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 3.3 mm -89.04 -178.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.289 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 100' ' ' MET . 2.4 p90 -178.96 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.485 0.183 . . . . 0.0 111.346 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.66 -179.64 19.62 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.48 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.38 162.22 38.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.614 0.245 . . . . 0.0 110.986 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.47 121.27 67.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.825 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.3 t -115.35 -63.81 1.4 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.93 91.5 3.68 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.803 0.335 . . . . 0.0 110.311 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.2 -22.16 0.58 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.193 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.44 HG21 HD12 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -44.88 -36.2 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -53.79 -42.52 68.9 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.707 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.455 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 7.1 tpt -75.17 -43.67 50.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.564 0.221 . . . . 0.0 110.698 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.4 t -54.49 -35.95 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.923 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -61.67 -39.34 91.04 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.911 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -38.21 80.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.015 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.2 t -58.08 -31.15 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.756 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' A' ' 116' ' ' LEU . . . -92.14 -38.49 5.68 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.042 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.2 tpt -53.02 -34.58 57.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.473 0.309 . . . . 0.0 111.692 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 m -59.48 168.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.895 0.379 . . . . 0.0 111.469 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.35 148.01 26.87 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -96.83 165.36 12.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.92 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -136.0 146.75 47.52 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.88 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.26 -46.43 0.13 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.004 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -173.47 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -176.84 38.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.6 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -101.09 123.03 46.48 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.718 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.36 132.41 35.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.803 2.335 . . . . 0.0 112.563 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.23 -42.81 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.709 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.42 115.02 17.84 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.18 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.18 96.17 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.5 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' A' ' 53' ' ' PHE . 12.5 p -90.41 139.42 17.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.98 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 pttt -154.7 155.64 34.97 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.213 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 mt -96.69 145.99 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.889 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.07 -52.12 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 44.4 mtpt -144.43 171.57 14.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . . . -159.35 104.79 1.66 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.086 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.06 154.66 77.67 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.311 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.15 172.24 13.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.618 2.212 . . . . 0.0 112.581 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.25 -33.84 11.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.252 -1.304 . . . . 0.0 112.582 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 CA--C 1.529 0.245 0 CA-C-O 120.858 0.274 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.78 99.93 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.25 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 m -94.37 146.97 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.271 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -121.01 108.72 14.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.242 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.79 104.94 17.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 110.991 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.94 97.06 6.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.625 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 p -106.43 160.18 15.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -63.71 -36.97 85.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.607 179.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.4 tpt -64.66 -32.24 73.82 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.09 -163.91 37.47 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.046 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.8 tt -122.06 118.82 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.003 0.402 . . . . 0.0 111.342 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 pt -116.01 158.19 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.8 t -122.97 120.64 61.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.931 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.01 155.13 27.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -116.21 115.56 26.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.25 120.46 35.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -72.62 104.59 3.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -82.98 23.23 0.86 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 -65.46 0.97 Allowed 'General case' 0 C--O 1.231 0.108 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.437 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.4 m-70 -100.93 -11.49 19.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.646 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.659 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -100.14 1.05 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.2 Cg_exo -40.77 -36.05 1.82 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 122.117 1.878 . . . . 0.0 113.302 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -68.81 -53.52 21.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.943 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -69.32 -36.71 77.25 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.942 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.3 t -58.84 -50.1 75.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.63 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -59.28 -40.24 85.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.408 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -62.36 -43.06 99.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.89 -52.4 65.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.856 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.33 78.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.46 -51.05 71.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.215 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.91 -29.95 69.89 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.429 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.24 -49.22 52.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -76.63 -29.23 56.36 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.573 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -55.12 -32.13 61.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.34 46.64 0.91 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -125.34 -55.0 1.57 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.408 0.147 . . . . 0.0 111.079 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -60.81 -30.35 70.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.337 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -71.7 121.27 18.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.757 0.313 . . . . 0.0 110.469 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.28 -24.26 23.08 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.682 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.85 158.34 13.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 26.74 2.37 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 63.04 -179.43 0.15 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.015 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.41 -92.88 0.28 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.186 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -79.79 121.77 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.706 0.288 . . . . 0.0 110.513 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.465 HG12 HG13 ' A' ' 62' ' ' ILE . 7.8 mt -131.54 125.89 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 mt -129.82 118.0 43.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -56.16 25.53 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.763 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.82 49.46 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.765 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -169.22 -89.02 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.213 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.81 175.73 12.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 0.0 111.407 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.465 HG13 HG12 ' A' ' 56' ' ' ILE . 5.9 tt -139.26 109.55 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.511 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -89.47 156.6 18.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.579 0.704 . . . . 0.0 112.158 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.93 105.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.279 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.572 -179.133 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.618 0.247 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 p -88.58 168.32 12.66 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.2 pt -60.93 -31.44 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.62 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -75.77 -37.13 59.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.32 -151.19 16.87 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -45.02 92.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 110.699 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -161.51 155.36 21.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.95 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -119.17 170.1 9.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.29 178.21 4.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -132.51 171.51 13.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.203 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.23 110.5 9.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.7 tp -100.79 111.07 23.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -130.59 102.52 16.6 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.957 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.03 -14.86 35.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.068 2.512 . . . . 0.0 113.141 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.78 -45.99 20.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.514 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.2 mt -80.2 138.07 36.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.0 178.17 6.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.61 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -137.75 97.64 3.48 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.5 p -81.87 -4.32 56.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.7 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.17 -75.06 1.8 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.979 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.84 107.66 0.32 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.851 0.358 . . . . 0.0 111.802 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.7 61.13 4.56 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.306 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.8 mm -137.39 131.69 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.626 0.25 . . . . 0.0 110.852 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.484 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 7.2 mt -101.63 122.16 43.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.949 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -126.22 134.93 51.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.69 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.94 107.46 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.434 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.99 161.97 18.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.25 140.79 22.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.49 58.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.435 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.01 175.29 35.26 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.552 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.13 121.21 9.25 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.625 2.216 . . . . 0.0 112.185 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 58.52 30.64 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.326 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.6 m -120.77 85.36 2.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.987 0.422 . . . . 0.0 110.493 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.64 120.98 39.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.988 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.63 51.35 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.409 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.7 m 58.89 35.89 24.38 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.75 139.7 33.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.669 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.65 174.97 13.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.036 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.8 p90 -159.55 140.18 12.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.218 0.533 . . . . 0.0 111.876 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 t -98.27 113.77 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.79 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.46 141.94 36.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.91 -28.71 7.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.412 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.74 42.29 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.774 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.09 114.57 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.761 2.307 . . . . 0.0 112.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.3 p -129.37 68.35 1.42 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.065 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -81.11 -39.47 25.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -65.21 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.176 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mt -73.54 -9.31 58.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.664 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.16 84.45 0.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.112 0.482 . . . . 0.0 110.485 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -50.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.465 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.87 -31.58 63.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.635 0.255 . . . . 0.0 111.129 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -119.56 123.22 43.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.084 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.8 t -79.87 163.28 24.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 tt -80.74 -179.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.946 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -176.99 -39.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.856 -0.156 . . . . 0.0 111.287 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.93 179.47 22.04 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.549 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.05 160.91 38.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.22 96.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.017 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.3 -41.54 12.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.502 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -144.5 108.6 4.76 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.894 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.39 -19.64 1.18 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.255 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.433 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.0 tt -50.09 -29.24 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.74 -39.14 90.2 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.427 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 ttp -69.32 -50.51 45.84 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.393 0.14 . . . . 0.0 110.985 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 136' ' ' ILE . 3.6 m -61.89 -20.6 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.418 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.85 -31.72 35.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.593 0.235 . . . . 0.0 110.899 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -56.32 -41.96 76.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.573 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.442 HG11 ' CG2' ' A' ' 56' ' ' ILE . 14.5 p -56.7 -30.66 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.705 0.288 . . . . 0.0 111.361 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.28 -34.91 15.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.966 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.2 mtt -62.09 -28.54 69.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.31 163.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.709 0.29 . . . . 0.0 111.236 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.39 123.07 17.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.192 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.6 p -107.35 178.71 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -79.8 -179.01 6.7 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m -90.15 19.13 5.23 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -151.1 -68.35 0.18 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -174.02 73.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.77 0.319 . . . . 0.0 111.275 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -156.4 96.98 2.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HG3' ' CD1' ' A' ' 56' ' ' ILE . 49.5 Cg_endo -69.46 131.15 21.05 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.733 2.289 . . . . 0.0 112.232 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.64 -44.25 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.647 0.26 . . . . 0.0 110.394 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.62 63.87 0.61 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -52.16 150.5 4.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.648 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.9 t -79.78 101.9 5.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.791 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.4 ' HB3' ' CB ' ' A' ' 19' ' ' SER . 5.7 tttm -84.69 150.51 25.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.6 mt -116.77 128.99 74.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.966 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.4 pt -109.32 -33.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.14 168.02 21.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.07 107.87 2.76 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -144.26 147.08 35.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.432 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.05 174.39 11.56 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.714 2.276 . . . . 0.0 112.516 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.0 p -95.2 -37.38 11.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.309 -1.273 . . . . 0.0 112.868 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 CA--C 1.531 0.366 0 CA-C-O 120.61 0.171 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -130.62 160.75 33.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.702 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 m -125.61 141.22 46.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.178 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.31 105.7 15.21 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.764 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.12 101.64 13.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.062 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.88 108.05 19.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.305 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -113.2 161.98 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.941 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -63.05 -30.0 71.26 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.178 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 tpt -68.79 -32.03 71.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.094 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.64 -148.65 14.19 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.396 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.51 136.49 59.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.764 0.316 . . . . 0.0 111.446 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.32 128.92 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.519 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.3 t -102.53 98.66 7.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.53 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 mp -80.83 148.77 29.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.35 140.33 48.12 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mp -124.11 129.65 51.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.154 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 37.6 m-85 -63.19 99.7 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 110.771 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -78.85 12.63 2.05 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.05 -65.51 0.96 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 110.522 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.474 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.1 m80 -100.73 -15.51 17.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.27 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.75 1.64 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.4 Cg_exo -40.57 -37.74 2.27 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.052 1.835 . . . . 0.0 113.089 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -60.72 -55.8 28.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -34.79 79.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.736 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.6 t -58.35 -45.59 87.89 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.58 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -61.69 -43.53 98.68 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.222 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.42 -39.33 93.63 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -69.07 -43.0 75.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.91 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.02 73.54 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.286 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -48.42 80.52 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.011 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -36.33 78.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.131 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.41 50.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.248 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -76.3 -49.08 17.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -60.08 -40.87 91.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.745 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.93 53.11 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -112.14 -62.84 1.51 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.515 0.198 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -63.3 -51.71 64.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.65 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -67.23 119.75 12.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 110.47 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.22 8.8 10.09 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.088 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -117.74 -172.18 2.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.274 0.537 . . . . 0.0 111.176 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.8 150.19 35.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -64.23 136.9 57.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -109.44 -36.59 5.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.734 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.89 113.65 25.16 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.628 0.251 . . . . 0.0 111.114 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.6 mm -132.71 116.66 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.53 88.28 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.039 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.401 ' HD3' ' HA3' ' A' ' 143' ' ' GLY . 21.8 tptt -58.97 155.53 13.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.09 25.75 4.67 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -166.29 -82.38 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.02 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.53 170.07 21.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 111.516 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -142.66 161.57 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.51 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -146.75 154.59 41.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.924 0.392 . . . . 0.0 111.55 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.68 150.45 17.12 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.562 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.412 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.987 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.0 t -125.4 175.04 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -53.02 -33.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.828 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -92.23 -35.91 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.016 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.9 -143.49 10.34 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.588 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -134.68 27.52 3.65 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 111.193 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.13 -55.72 0.65 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.119 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 61.73 -176.79 0.13 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.63 131.51 48.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.59 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.43 146.25 49.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -131.96 98.85 4.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.236 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.72 110.9 10.71 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.649 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -132.12 172.84 6.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 -173.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.742 2.294 . . . . 0.0 112.174 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.82 179.28 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.9 mt 66.82 165.89 0.21 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.739 0.304 . . . . 0.0 110.887 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 160.38 40.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 111.471 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.31 96.63 5.75 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.972 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.0 p -71.97 -33.61 68.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.2 -26.67 23.03 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.916 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 116.17 31.46 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.069 0.435 . . . . 0.0 111.654 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.35 54.82 21.37 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.213 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.8 mm -129.23 135.53 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.768 0.284 . . . . 0.0 111.203 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.41 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 1.3 mt -105.64 120.44 41.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.833 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -117.81 141.16 48.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.369 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.19 120.02 23.11 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.181 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.72 141.8 36.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.43 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -157.16 117.4 3.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.743 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.47 72.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.71 179.83 17.51 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.48 30.27 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.686 2.258 . . . . 0.0 113.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -176.7 38.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 110.697 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.28 81.95 1.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 110.829 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -106.24 91.47 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.223 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.91 -105.16 0.02 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.358 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -157.5 36.48 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.43 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -118.1 160.3 21.76 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.696 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -159.74 165.66 32.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 6.5 p90 -137.63 136.79 37.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.42 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.8 t -102.72 110.53 29.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.201 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -79.8 130.89 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.71 -15.99 11.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.675 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -108.61 152.35 42.12 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.835 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.99 104.41 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.761 2.308 . . . . 0.0 112.343 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.6 p -138.3 67.53 1.41 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -70.4 -32.96 70.82 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -60.55 -29.13 68.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.296 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mt -73.17 -11.86 60.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.877 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.24 85.44 0.15 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.219 0.533 . . . . 0.0 110.425 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.79 -40.71 0.11 Allowed Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.279 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -74.56 -44.55 50.47 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 110.836 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -112.84 133.9 54.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.3 t -79.91 164.28 23.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.997 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.4 tt -90.4 -179.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.689 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.0 p90 -178.31 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -179.77 23.27 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.779 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.03 150.31 35.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.8 t -106.9 99.75 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.206 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.26 -45.96 5.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -119.84 96.34 5.14 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.829 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.24 -22.23 0.86 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.277 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.2 tt -47.21 -36.41 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.848 0.324 . . . . 0.0 111.807 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.59 96.2 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.482 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 ttp -65.77 -41.99 91.36 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.611 0.243 . . . . 0.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.71 -36.98 63.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.719 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -63.4 -36.15 82.76 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.983 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -60.78 -42.06 96.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.486 0.184 . . . . 0.0 111.028 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.27 -34.03 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.148 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.401 ' HA3' ' HD3' ' A' ' 58' ' ' LYS . . . -89.62 -36.38 7.41 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.12 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -35.77 61.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.46 0.304 . . . . 0.0 111.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 155' ' ' ASP . 18.9 m -63.76 173.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -72.83 -179.93 3.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.062 0.458 . . . . 0.0 111.266 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.0 177.72 9.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.97 -173.11 4.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.03 27.83 2.32 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -147.26 -71.95 0.22 Allowed 'General case' 0 C--O 1.231 0.122 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 178.74 45.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.008 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.04 116.34 28.78 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.33 129.13 33.12 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.953 2.435 . . . . 0.0 112.849 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.4 p -69.78 -35.36 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.12 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.401 ' HB2' HG21 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -75.41 -173.03 1.96 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -127.47 90.95 3.21 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.8 p -102.51 123.43 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.036 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -152.82 126.85 9.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.69 0.281 . . . . 0.0 111.711 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.6 mt -81.42 132.95 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.597 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.19 -33.64 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.295 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -127.51 146.19 50.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.772 0.32 . . . . 0.0 111.114 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.79 82.67 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.825 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -122.67 143.67 40.62 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.32 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.43 150.29 19.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.803 2.335 . . . . 0.0 112.603 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.3 t -171.77 148.72 2.42 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.892 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.036 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.53 0.318 0 N-CA-C 112.658 0.215 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -107.21 170.56 7.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.021 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.2 p -151.89 147.4 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -112.89 135.36 53.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.0 mt -121.63 97.79 5.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 86.28 7.38 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.602 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.94 157.47 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.352 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 t -64.63 -36.39 84.1 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.8 tpt -65.47 -31.49 72.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.37 151.48 6.15 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.058 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -81.05 142.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.715 0.293 . . . . 0.0 111.483 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.5 pt -148.37 146.49 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.786 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.21 130.58 69.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.03 162.91 30.46 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.387 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.55 154.11 25.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.907 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.43 134.12 46.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.769 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -75.15 98.17 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.381 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -82.86 20.4 1.18 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -100.22 -67.29 0.86 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.453 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.81 -13.05 18.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.145 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.66 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.14 0.73 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 85.2 Cg_exo -42.77 -34.98 3.87 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.005 1.804 . . . . 0.0 112.789 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -57.72 -62.73 1.59 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.908 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -66.7 -33.65 76.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.41 -51.32 70.39 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.64 84.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.744 0.307 . . . . 0.0 110.468 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.24 -41.42 94.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.755 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.15 -48.35 68.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.89 83.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.387 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.98 -50.1 74.74 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -33.21 66.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.466 0.174 . . . . 0.0 111.441 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.92 24.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.512 0.196 . . . . 0.0 111.479 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -75.85 -36.79 59.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.449 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -30.33 71.15 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 31.0 3.07 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.927 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -105.03 -41.71 5.51 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.565 0.221 . . . . 0.0 110.663 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -65.58 -51.16 61.81 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.02 123.24 20.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.69 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.91 -29.38 5.39 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.315 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.79 -176.42 3.35 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 111.514 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -155.04 154.8 33.04 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -66.86 169.83 7.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.983 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -135.72 -53.36 0.76 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.665 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -100.53 108.46 20.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.02 99.87 8.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.53 95.54 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.475 ' HB3' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.95 -23.29 65.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.602 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 21.3 3.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.435 ' CD2' ' HG3' ' A' ' 61' ' ' MET . 10.6 t80 -169.98 -81.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.521 -0.112 . . . . 0.0 111.141 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.435 ' HG3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -160.43 175.33 12.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 111.186 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.97 137.06 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -117.47 143.58 45.9 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.138 0.494 . . . . 0.0 112.18 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 125.59 3.66 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.894 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.332 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.027 -179.563 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p -105.96 -175.5 2.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.182 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -66.4 -28.3 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.228 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -97.33 39.19 1.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.825 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -147.38 25.16 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.016 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 -37.3 5.91 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.462 0.172 . . . . 0.0 111.135 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -143.0 158.87 43.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -167.77 169.97 11.23 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.172 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.95 129.86 42.89 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -64.53 168.19 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.633 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -111.49 38.25 2.65 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.172 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.56 135.82 56.38 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.756 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.25 102.28 1.88 Allowed Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.969 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.9 80.71 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.369 . . . . 0.0 111.984 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.33 -49.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.767 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.14 145.69 27.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -97.2 154.51 17.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -113.16 89.33 3.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -57.9 -33.83 69.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.214 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.67 -27.44 17.87 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.846 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.69 106.2 16.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.979 0.389 . . . . 0.0 111.086 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.41 58.46 4.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.958 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.3 mm -133.08 120.41 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.703 0.287 . . . . 0.0 110.817 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.456 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 3.1 mt -96.09 110.02 22.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -117.05 138.69 51.43 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.706 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.89 118.61 21.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.561 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.16 172.08 9.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -148.75 157.87 43.75 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.71 23.94 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.85 174.52 35.87 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.435 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.78 120.26 7.29 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.557 2.171 . . . . 0.0 111.991 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 56.92 42.18 26.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.024 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.6 m -144.6 88.11 1.9 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -107.78 161.93 14.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.14 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.4 -106.16 1.01 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.168 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -147.52 34.68 0.86 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.03 158.1 23.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -160.4 176.46 11.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -145.96 136.69 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.13 109.9 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.129 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.53 132.94 36.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.407 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 pp -114.9 -23.32 9.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.861 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.15 149.03 35.93 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.71 117.3 4.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.862 2.375 . . . . 0.0 112.213 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.411 HG21 ' CZ2' ' A' ' 121' ' ' TRP . 10.2 p -151.91 99.03 2.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.156 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -92.8 -21.89 19.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.411 ' CZ2' HG21 ' A' ' 119' ' ' THR . 2.8 p90 -59.06 -26.18 64.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.3 pp -85.03 -4.59 59.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.78 86.95 0.04 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.182 0.515 . . . . 0.0 110.091 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.73 -32.27 1.46 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.642 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.19 -53.92 21.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.662 0.231 . . . . 0.0 111.219 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -104.61 150.03 25.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.269 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 49.1 m -86.14 155.75 20.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.959 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 tt -86.47 -179.42 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.636 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -175.72 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.62 -179.82 31.89 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.919 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -138.2 166.22 24.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.6 0.238 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.44 102.79 4.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 111.782 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.82 -53.74 4.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.9 84.18 1.89 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.955 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.81 -27.84 0.12 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.844 -0.694 . . . . 0.0 113.437 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.8 tt -46.98 -37.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.73 -38.17 81.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.76 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.446 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -70.45 -35.56 73.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.108 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.59 -30.23 41.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -74.82 -38.04 62.16 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.483 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -67.73 -29.56 68.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.5 t -56.34 -32.71 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.649 0.262 . . . . 0.0 111.015 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 58' ' ' LYS . . . -93.59 -32.19 7.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.506 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 21.2 mmt -60.15 -33.3 71.97 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.524 0.162 . . . . 0.0 111.385 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.1 m -63.75 173.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.18 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 126.07 26.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.976 0.417 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 p -118.58 167.94 11.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -177.29 5.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.83 46.91 1.43 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -174.28 -67.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.56 44.02 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -122.95 104.05 36.15 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.137 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.0 117.06 3.48 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 112.461 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.43 -32.24 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.696 0.284 . . . . 0.0 110.361 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.13 -170.94 1.03 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.382 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.89 114.05 22.65 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.731 0.3 . . . . 0.0 111.617 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.43 113.38 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 174.85 11.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.638 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.14 139.49 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.314 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.13 -30.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.602 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.22 28.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 110.952 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.13 111.14 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.023 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -145.05 158.37 52.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 111.707 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.09 152.38 21.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.274 2.649 . . . . 0.0 112.482 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 140.29 1.85 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.451 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.533 0.439 0 N-CA-C 112.715 0.237 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -125.0 165.74 17.6 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.004 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.58 154.23 21.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -111.5 104.17 12.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.88 96.64 10.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.16 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -80.37 82.48 6.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.187 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.78 161.05 20.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.386 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -64.04 -33.22 75.25 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.054 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.51 -34.16 76.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.945 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.81 -148.36 12.75 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.221 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.28 126.45 55.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 111.279 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 pt -129.99 133.26 64.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.3 109.41 22.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.82 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -105.49 162.42 13.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.28 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -119.89 144.81 47.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.051 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.47 134.29 47.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.401 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 28.0 m-85 -64.42 100.6 0.37 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.014 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -80.8 15.31 1.81 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -100.15 -64.9 1.0 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.772 0.32 . . . . 0.0 110.343 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.447 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -100.76 -13.2 18.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.333 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.666 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.01 1.2 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 77.8 Cg_exo -41.84 -37.52 4.15 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.011 1.807 . . . . 0.0 112.908 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -49.49 71.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.486 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.1 m -67.07 -36.94 83.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.387 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -54.51 -49.13 70.91 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.358 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -64.6 -38.55 91.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.264 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -56.74 -44.09 81.33 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.478 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -67.51 -43.16 81.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.212 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.11 -52.43 55.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.272 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -46.5 89.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -40.73 69.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 -33.77 33.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -47.63 84.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -60.16 -30.23 69.18 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.424 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.87 26.02 5.16 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.908 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -37.13 13.11 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.777 0.288 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -36.39 40.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.179 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -66.99 90.01 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 110.138 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.8 -26.04 2.53 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.772 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.6 p -61.3 151.4 32.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.809 0.305 . . . . 0.0 111.281 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -132.2 159.69 38.29 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.863 0.363 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CD1' HG22 ' A' ' 62' ' ' ILE . 71.0 m-85 -74.13 100.46 3.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.638 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -73.02 -50.2 24.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -102.72 131.09 49.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.0 mt -142.16 105.19 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.018 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mt -90.98 115.06 29.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.735 0.302 . . . . 0.0 110.913 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -63.34 132.2 50.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.188 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 t70 55.39 52.45 11.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.267 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -165.82 -83.83 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.482 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.58 163.6 32.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.819 0.343 . . . . 0.0 111.442 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.402 HG22 ' CD1' ' A' ' 53' ' ' PHE . 4.0 mp -137.99 130.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.721 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.1 pt20 -117.9 154.58 31.64 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 112.004 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.92 106.09 0.48 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.153 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.941 -179.729 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -84.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.684 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.55 -50.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.811 0.339 . . . . 0.0 110.534 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 34.76 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.41 -168.54 13.19 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -119.32 21.69 12.1 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.73 92.82 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 110.632 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -107.76 175.61 5.42 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.251 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.74 140.72 46.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.785 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 157.11 11.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.79 37.31 2.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.651 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 149.13 21.74 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.51 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.28 -62.31 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.73 -174.23 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.758 2.306 . . . . 0.0 112.42 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.94 -61.65 1.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.014 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mp 57.5 -173.85 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.11 173.98 10.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -160.31 38.93 0.17 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.979 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -108.93 -57.74 2.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.811 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.28 122.34 5.26 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.591 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.15 127.21 12.19 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.96 62.38 0.75 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -126.67 140.13 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.767 0.283 . . . . 0.0 111.045 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 3.2 mt -112.41 120.8 42.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -124.52 142.06 51.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.443 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -79.6 114.75 18.76 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.286 179.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.18 26.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.437 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -135.82 157.25 47.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -37.22 14.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.158 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.79 174.46 36.61 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 119.12 5.65 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.579 2.186 . . . . 0.0 112.165 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 59.05 30.75 20.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.185 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.5 m -139.87 88.3 2.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.709 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.02 165.91 12.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.09 -105.7 1.47 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.93 43.94 0.12 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 111.041 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -126.03 157.46 37.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -149.73 160.09 43.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.412 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 7.1 p90 -137.43 130.3 30.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 111.618 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.54 107.1 19.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.228 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.72 125.84 30.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.9 pp -109.29 -4.69 16.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.66 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.95 152.28 53.81 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-O 120.527 0.203 . . . . 0.0 110.839 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.26 100.06 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 112.025 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 79.5 p -122.41 110.4 15.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -94.9 -40.48 9.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -61.81 -33.67 74.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.8 mt -81.91 -3.31 53.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.556 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -82.1 66.56 7.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.004 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.9 -47.38 0.07 OUTLIER Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.651 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -56.08 -47.52 77.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.706 0.289 . . . . 0.0 110.885 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -108.57 139.69 42.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 100' ' ' MET . 11.0 t -79.97 155.8 27.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.788 0.328 . . . . 0.0 111.125 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.2 tt -83.57 -178.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.561 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 1.2 p90 -179.38 -39.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.3 -179.75 17.01 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.113 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -146.85 171.79 14.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.29 . . . . 0.0 110.924 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.3 t -130.64 119.16 44.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.352 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -56.51 2.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.13 92.33 3.86 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.061 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.84 -17.26 0.95 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.274 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -45.87 -36.93 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.89 -47.87 76.46 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.638 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.2 tmm? -58.26 -46.07 86.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 110.403 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.79 -37.98 73.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -63.79 -44.66 92.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.845 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -56.65 -34.3 67.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.175 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.24 -36.03 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.886 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.38 -38.13 18.8 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.563 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 mtp -55.3 -47.69 75.2 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.7 0.25 . . . . 0.0 111.208 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -50.88 136.89 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.52 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -60.75 120.83 10.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.636 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.6 p -86.48 170.39 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -81.96 -166.22 1.18 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.56 34.37 0.76 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -160.12 32.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.627 0.251 . . . . 0.0 110.914 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.34 35.23 13.34 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.088 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -111.71 150.65 42.56 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.943 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.28 120.05 6.84 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.671 2.247 . . . . 0.0 112.495 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.9 t -70.57 -32.22 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.367 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -174.66 4.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.39 79.97 3.14 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.296 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 t -113.93 113.43 43.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.345 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.92 179.81 8.46 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.388 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.2 mt -102.22 125.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.608 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.436 HG22 HD12 ' A' ' 160' ' ' ILE . 24.1 pt -107.12 -32.45 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.553 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -145.1 143.73 30.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.651 0.262 . . . . 0.0 110.864 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.5 94.83 2.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.725 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -119.1 155.98 52.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.329 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.76 167.2 20.79 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.555 2.17 . . . . 0.0 113.003 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.5 t -105.91 163.17 12.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.26 -1.3 . . . . 0.0 112.93 179.789 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 41.5 Cg_endo . . . . . 0 CA--C 1.532 0.413 0 N-CA-C 112.969 0.334 . . . . 0.0 112.969 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.48 142.83 34.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.706 0.289 . . . . 0.0 110.831 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.71 152.59 25.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.448 ' CE1' HG22 ' A' ' 24' ' ' VAL . 4.1 m-85 -113.85 115.09 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.32 104.62 15.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.126 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.16 87.06 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.395 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.96 159.6 20.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.674 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -34.15 74.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.73 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -33.44 64.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.394 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.16 -168.19 40.88 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -119.06 123.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.182 0.491 . . . . 0.0 111.207 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.1 pt -128.1 146.18 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.863 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.448 HG22 ' CE1' ' A' ' 15' ' ' TYR . 13.0 t -105.2 139.3 26.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mt -136.67 159.29 42.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.46 145.29 48.08 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.854 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.36 144.48 44.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.521 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -86.33 102.49 14.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.753 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.406 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 10.9 m95 -76.36 11.99 1.37 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.29 -61.96 1.3 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.546 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.466 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 6.7 p80 -100.79 -15.98 17.45 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.639 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.18 1.38 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 66.8 Cg_exo -40.05 -37.21 1.65 Allowed 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.131 1.887 . . . . 0.0 113.312 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -55.63 13.7 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.061 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.5 m -68.45 -39.49 81.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.3 -50.63 72.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -43.78 86.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.403 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.46 -48.03 83.55 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.78 -45.97 81.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.614 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.59 76.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.55 -42.23 98.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.431 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -52.09 67.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.544 0.211 . . . . 0.0 111.236 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.59 68.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -61.22 -42.53 98.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -38.67 92.08 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.279 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.06 38.96 1.09 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.813 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -32.52 6.55 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.481 0.182 . . . . 0.0 111.011 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -68.59 -36.28 78.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.204 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -65.79 108.7 2.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.27 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.74 -23.15 4.24 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.89 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.0 165.46 8.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 111.502 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.8 143.68 21.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.085 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -66.04 108.48 2.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.88 5.66 47.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.136 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -150.05 114.85 5.31 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.618 0.247 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.47 HG13 HG21 ' A' ' 62' ' ' ILE . 4.0 mp -137.49 107.43 4.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.31 79.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 41.82 -147.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.662 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.08 53.47 2.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.091 0.472 . . . . 0.0 110.311 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -125.13 -66.02 0.99 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.318 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 ptm -156.64 137.3 13.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.747 0.308 . . . . 0.0 111.175 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.47 HG21 HG13 ' A' ' 56' ' ' ILE . 6.4 mt -132.38 115.17 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.0 pt20 -103.08 146.78 27.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.481 . . . . 0.0 112.054 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.78 111.85 0.6 Allowed Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.898 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.945 -179.656 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.662 0.268 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 t -134.94 159.2 42.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.176 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -56.94 -33.6 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.38 -30.81 63.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.94 -160.97 29.12 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.762 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -52.35 60.62 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 110.603 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.65 159.3 38.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -144.41 178.03 8.22 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.97 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.97 130.17 38.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -65.27 161.03 20.29 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.78 139.18 47.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -121.34 127.61 51.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -65.63 135.64 95.74 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.313 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.93 -36.96 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.571 2.181 . . . . 0.0 112.429 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -163.42 106.73 1.01 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.737 0.303 . . . . 0.0 110.827 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.7 mt -149.85 178.76 8.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.31 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -124.66 160.93 27.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.488 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.413 ' CB ' ' HB2' ' A' ' 123' ' ' ASP . 4.2 t80 -135.83 76.43 1.61 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.38 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.3 m -57.09 -27.47 61.79 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.96 -58.52 0.88 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.797 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.26 114.37 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.93 64.01 2.96 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.964 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.7 mm -130.61 158.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.696 0.284 . . . . 0.0 111.139 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.52 97.66 3.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.275 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -105.68 136.05 45.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.509 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -79.74 121.46 25.37 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.87 176.83 4.92 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.457 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -139.76 173.61 11.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.296 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.07 -35.73 12.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.44 167.74 32.52 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.531 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.54 124.07 14.32 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.558 2.172 . . . . 0.0 112.159 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.36 29.07 18.58 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.393 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 m -132.03 89.83 2.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.39 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.58 147.17 25.07 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.625 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.23 -110.72 1.48 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.16 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.5 m -151.55 45.66 0.79 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.986 0.422 . . . . 0.0 111.199 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 148.04 32.71 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.167 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -149.7 132.04 15.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 23.9 p90 -110.08 127.11 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 111.497 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -99.85 119.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.558 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 p -88.81 142.54 27.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.802 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 62' ' ' ILE . 1.3 mm? -113.65 -24.88 8.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.138 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -106.58 162.57 19.27 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.031 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.94 112.31 2.67 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.683 2.255 . . . . 0.0 112.45 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 p -141.34 76.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -76.67 -34.8 58.23 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.153 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -59.69 -28.5 67.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.439 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.0 mt -81.39 -2.35 49.01 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 92' ' ' PHE . 35.8 t0 -82.89 60.22 5.27 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 110.443 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.23 -52.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.778 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -32.61 74.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -119.03 148.83 42.58 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.2 m -99.28 163.7 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.716 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 2.7 mm -79.41 -179.09 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.241 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.509 ' HB3' ' HB2' ' A' ' 100' ' ' MET . 0.1 OUTLIER -176.97 -34.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.82 170.46 31.26 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.575 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.7 159.07 34.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.7 0.286 . . . . 0.0 110.983 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.84 94.53 3.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 6.2 t -92.0 -61.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.277 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -111.74 98.21 7.25 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.03 -21.59 0.51 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.455 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.2 tt -47.88 -35.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.91 92.14 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.037 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.94 -16.45 55.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.566 0.222 . . . . 0.0 110.879 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.57 -42.28 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.558 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.47 -31.03 68.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -53.71 -32.17 50.92 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.9 t -63.41 -36.46 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.644 0.259 . . . . 0.0 111.145 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.02 -29.05 39.2 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.458 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.6 mtp -74.3 -23.51 59.09 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.3 p -84.03 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.39 174.59 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.151 0.5 . . . . 0.0 111.427 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 p -150.78 173.74 13.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.275 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -89.73 -176.37 4.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.852 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -91.4 28.98 1.55 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.608 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -150.4 29.31 0.71 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.296 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.5 44.39 21.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.21 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.3 mtp-105 -115.3 144.47 32.33 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.58 140.57 21.39 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.804 2.336 . . . . 0.0 112.747 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.24 -34.14 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.457 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -171.01 3.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.59 96.64 5.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.275 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.9 p -117.02 111.36 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -145.38 173.63 11.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.3 126.13 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.678 0.275 . . . . 0.0 111.3 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.7 pt -108.14 -33.79 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.638 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -138.8 152.11 47.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.774 0.321 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.48 115.41 3.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -153.5 166.12 16.3 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.84 168.78 18.85 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.045 2.497 . . . . 0.0 112.193 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.38 96.73 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.996 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.799 -1.001 . . . . 0.0 113.031 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 CA--C 1.532 0.402 0 N-CA-C 112.739 0.246 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.23 168.8 8.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.36 126.86 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.019 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.43 95.37 10.14 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.594 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.01 85.75 3.32 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 89.02 6.37 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.274 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -84.36 162.78 19.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.165 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 t -68.62 -34.07 75.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.46 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -33.36 71.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.1 -159.12 27.26 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.387 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.6 tt -122.52 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.877 0.339 . . . . 0.0 111.469 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 pt -139.16 137.8 41.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 131.18 61.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.423 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.403 ' CD2' HD21 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -128.59 144.59 51.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.865 0.365 . . . . 0.0 111.325 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -106.41 116.7 32.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.886 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.442 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 8.9 mp -94.96 129.26 42.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.229 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -63.41 101.5 0.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -82.01 18.34 1.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -100.38 -66.16 0.92 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.743 0.306 . . . . 0.0 110.474 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.475 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 3.0 t60 -100.65 -15.38 17.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.983 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -96.43 0.84 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_exo -42.32 -37.06 4.73 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.987 1.791 . . . . 0.0 112.753 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -54.17 39.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.533 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -35.05 79.81 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 73.9 m -60.11 -47.18 87.0 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.508 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -59.28 -39.71 83.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.495 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -47.24 84.26 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.21 -43.89 98.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.99 63.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.109 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.21 -37.56 87.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.961 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -63.41 -35.73 81.39 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.631 0.253 . . . . 0.0 110.862 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.32 -36.06 24.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.558 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.36 -36.89 63.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.325 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -61.31 -36.58 80.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.525 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.62 30.88 3.37 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.938 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.94 -51.73 3.96 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.599 0.238 . . . . 0.0 110.433 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.407 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 4.0 m-85 -65.55 -29.57 70.2 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.27 101.09 0.88 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.253 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.59 30.02 3.43 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.38 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -111.21 151.33 28.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.976 0.388 . . . . 0.0 110.85 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.57 151.82 48.41 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -60.83 144.3 52.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -113.71 -38.93 4.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.905 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -125.11 118.62 26.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.79 0.328 . . . . 0.0 111.257 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.412 ' CG2' HG12 ' A' ' 62' ' ' ILE . 3.3 mt -130.54 104.35 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -98.28 115.19 37.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 137.19 57.14 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.922 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.65 35.43 19.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.652 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -151.09 -88.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.417 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -160.46 157.36 27.49 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.698 0.285 . . . . 0.0 111.041 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.412 HG12 ' CG2' ' A' ' 56' ' ' ILE . 6.6 mt -130.38 124.93 58.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.346 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.2 pt20 -112.27 148.72 33.55 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.77 109.54 0.59 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.374 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.333 0.394 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.228 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.658 0.266 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -113.1 167.12 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt -56.99 -39.35 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -80.34 -30.98 38.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.42 -167.05 29.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.848 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -63.07 -54.96 29.86 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.598 0.237 . . . . 0.0 110.678 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HG2' ' CG2' ' A' ' 107' ' ' THR . 8.8 mp0 -135.7 139.26 43.53 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.817 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -123.93 172.02 9.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.83 179.2 1.49 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.196 0.522 . . . . 0.0 111.927 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.15 159.95 22.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.416 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.17 75.42 1.16 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.03 141.07 49.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.05 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.407 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -164.06 -63.28 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 87' ' ' HIS . 70.9 Cg_endo -74.19 172.55 15.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.695 2.263 . . . . 0.0 112.956 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.51 95.5 5.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.867 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.9 mp -91.73 172.68 8.32 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 159.21 30.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.037 0.446 . . . . 0.0 111.382 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.4 41.68 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.17 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.7 t -148.11 -47.18 0.16 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.854 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.28 122.09 24.92 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.757 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.45 126.88 8.62 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.91 63.06 0.71 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.281 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.5 mm -130.42 137.79 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 117.056 0.428 . . . . 0.0 110.955 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 25' ' ' LEU . 7.7 tp -111.2 101.91 10.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.107 0.479 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . . . -110.02 146.73 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.31 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.28 133.08 36.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.223 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 142.54 35.17 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -143.22 117.72 9.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.31 75.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.394 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.32 179.5 34.88 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.303 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.85 128.67 23.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.494 2.129 . . . . 0.0 111.934 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 58.79 35.31 24.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.408 ' CG2' ' HG2' ' A' ' 81' ' ' GLN . 85.5 m -143.19 89.33 2.09 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -106.19 155.41 19.49 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.95 -165.63 11.88 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.72 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.31 61.88 1.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.947 0.403 . . . . 0.0 110.888 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.559 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -153.34 155.8 37.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.04 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.16 161.03 43.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.072 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 14.2 p90 -130.79 141.33 50.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.3 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 t -102.74 110.6 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.479 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.89 109.15 15.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.032 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 61' ' ' MET . 0.9 OUTLIER -103.53 -6.82 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.917 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.81 142.85 38.84 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.387 0.136 . . . . 0.0 110.806 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.39 122.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.905 2.403 . . . . 0.0 112.577 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.1 p -128.48 112.56 14.48 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.947 0.404 . . . . 0.0 111.279 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -94.92 -42.74 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.426 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 46.7 p90 -67.74 -31.88 72.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.336 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 12.4 mt -89.36 -2.25 58.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.739 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -68.85 85.53 0.33 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.348 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.02 -25.6 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.72 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -57.01 -53.81 53.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.712 0.256 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -102.3 156.7 17.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 47.6 m -90.32 150.9 21.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.001 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 tt -79.88 -179.62 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.418 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.22 -35.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.88 179.99 29.7 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.828 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 161.9 36.87 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 122.827 -0.219 . . . . 0.0 110.659 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.51 105.32 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.27 0.557 . . . . 0.0 111.528 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.51 -38.42 9.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.28 88.14 2.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.89 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.46 -22.31 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.351 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 tt -43.33 -38.81 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.4 -37.12 86.97 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.909 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -36.0 59.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.789 0.328 . . . . 0.0 110.124 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.7 t -66.76 -56.74 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.32 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -63.26 -24.43 67.87 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.258 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -58.67 -33.77 70.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.547 0.213 . . . . 0.0 110.816 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 26.0 t -63.84 -35.64 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.018 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.71 -39.5 60.07 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.312 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 mmt -53.66 -51.5 62.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -52.2 143.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.691 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -64.75 122.21 16.36 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.3 p -93.06 179.15 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -170.04 2.21 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.75 46.02 1.32 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.646 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -174.61 -76.53 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.835 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.58 30.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.31 118.64 60.85 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-O 120.656 0.265 . . . . 0.0 111.682 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.51 115.25 3.61 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.044 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.21 -31.48 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -171.04 2.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.619 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.26 97.38 6.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.48 108.51 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.875 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 175.22 11.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.361 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mt -103.57 130.48 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.321 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.4 pt -106.73 -29.43 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.914 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.18 108.51 1.9 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.16 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.37 114.37 21.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.187 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -154.1 149.22 20.26 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.03 161.3 23.73 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.514 2.143 . . . . 0.0 112.6 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.8 t -165.38 -62.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.424 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.531 0.37 0 CA-C-O 121.037 0.349 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.36 166.32 11.8 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.019 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.26 46.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.03 96.49 8.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.815 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.3 94.73 9.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.766 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -83.5 118.77 24.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.1 p -135.25 158.02 45.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.522 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -59.04 -36.72 75.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.747 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.0 tpt -67.03 -33.49 75.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.55 143.42 3.67 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.36 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 tt -82.57 126.83 40.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pt -128.56 137.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.86 135.37 35.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.02 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.67 147.56 48.59 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.315 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.24 129.56 38.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.78 131.97 51.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.337 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -76.07 99.65 4.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.0 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -83.03 18.18 1.73 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -67.32 0.86 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.455 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 2.3 m-70 -100.69 -13.28 18.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.666 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.59 1.71 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.2 Cg_exo -40.86 -36.4 2.0 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.062 1.841 . . . . 0.0 112.927 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -47.74 79.38 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.688 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.408 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.7 OUTLIER -78.35 -36.76 45.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.906 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.3 t -57.98 -47.63 82.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.655 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -42.97 75.1 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.197 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -58.89 -53.7 55.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -41.46 70.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.997 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.1 54.65 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.27 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -45.44 93.09 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.176 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -35.4 71.19 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.136 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.21 -36.48 22.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.298 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -47.23 68.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.232 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -58.22 -25.82 62.11 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.757 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.33 13.0 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.817 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.49 -34.74 18.55 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.643 0.259 . . . . 0.0 110.935 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -25.42 55.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -65.08 93.62 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 110.245 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.08 -20.11 3.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.106 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -58.12 157.41 8.19 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.906 0.353 . . . . 0.0 111.508 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -138.92 169.39 17.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.482 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.437 ' CD1' HG11 ' A' ' 157' ' ' VAL . 9.9 m-85 -96.86 83.47 3.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.96 -45.24 78.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -99.77 120.66 40.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.754 0.311 . . . . 0.0 111.026 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.473 ' HB ' ' HG3' ' A' ' 153' ' ' PRO . 19.3 mt -145.68 98.54 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.295 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.11 107.09 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -39.09 93.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.538 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.66 41.3 0.89 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.41 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.986 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.51 171.53 18.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 111.115 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.77 151.67 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.824 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -134.32 161.77 34.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.587 0.708 . . . . 0.0 112.524 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.81 109.33 0.41 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.498 ' HA3' ' CG ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.331 0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.145 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 t -104.51 158.64 16.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.012 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.422 HD12 ' CD2' ' A' ' 78' ' ' TYR . 2.6 pp -57.23 -27.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.298 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.422 ' CD2' HD12 ' A' ' 77' ' ' ILE . 19.3 m-85 -82.28 -33.14 29.23 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.904 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.02 -158.53 27.66 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.33 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.71 -72.71 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.874 0.337 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -133.1 140.75 47.81 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 108' ' ' ASN . 44.0 p90 -130.03 166.93 19.1 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 111.57 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.25 110.0 21.94 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.345 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.06 178.35 4.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 62.9 166.42 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.685 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.38 106.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.587 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -172.11 -61.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.085 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.84 -173.38 1.82 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.652 2.235 . . . . 0.0 112.616 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.58 95.62 5.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.482 ' HG ' ' CG2' ' A' ' 128' ' ' ILE . 2.6 mm? -77.03 -176.33 3.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -70.21 0.47 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.72 70.58 0.63 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.38 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -75.75 -39.08 57.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.93 -42.06 1.83 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.362 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.55 100.22 11.21 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.735 0.302 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.23 55.22 2.13 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.915 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.3 mm -130.61 130.75 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.653 0.264 . . . . 0.0 110.867 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 2.7 mt -102.92 104.27 14.48 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.63 142.42 39.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.32 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.441 ' HG2' ' CD2' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -79.5 123.53 27.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.47 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 143.9 32.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.491 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -154.48 136.34 14.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.69 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.56 179.32 32.49 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.926 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 139.61 63.0 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.398 2.065 . . . . 0.0 112.122 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 59.81 44.91 13.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.308 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.6 m -146.99 85.97 1.63 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 68.3 m-80 -106.56 152.13 24.11 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.51 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 -138.95 3.62 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.808 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.47 60.84 0.73 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.498 ' CG ' ' HA3' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -150.83 146.25 26.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.379 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.441 ' CD2' ' HG2' ' A' ' 100' ' ' MET . 3.8 m-85 -149.72 160.08 43.82 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.391 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 31.4 p90 -134.66 134.37 41.07 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.483 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.1 t -104.04 110.02 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.238 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 45.1 p -80.96 138.27 36.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.977 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 -18.91 11.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.512 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.39 158.29 35.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.84 128.74 9.16 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.848 2.366 . . . . 0.0 112.902 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.8 p -131.94 33.79 3.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -61.64 -37.79 85.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.831 0.348 . . . . 0.0 110.58 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -79.6 -27.78 41.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.136 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.8 mt -75.52 -5.15 43.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.89 84.69 0.08 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.179 0.514 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 163.3 -41.14 0.33 Allowed Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.415 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -59.12 -57.29 13.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.625 0.25 . . . . 0.0 110.783 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -109.53 173.69 6.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.639 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 100' ' ' MET . 28.2 m -106.67 160.14 15.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.482 ' CG2' ' HG ' ' A' ' 90' ' ' LEU . 2.3 tt -87.51 179.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.226 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -176.79 -40.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.397 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.08 -179.8 27.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.276 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -144.08 167.26 22.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.494 0.187 . . . . 0.0 110.837 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG21 ' HB ' ' A' ' 136' ' ' ILE . 30.5 m -125.08 107.21 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -43.99 12.14 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -132.06 90.59 2.84 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.898 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.96 -27.77 0.13 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.341 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.4 ' HB ' HG21 ' A' ' 132' ' ' VAL . 12.3 tt -44.28 -36.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -41.04 75.06 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.694 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' A' ' 141' ' ' ARG . 11.4 tmm? -68.59 -36.55 78.87 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 110.755 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 t -73.62 -35.46 44.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -72.17 -39.39 68.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.192 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 138' ' ' MET . 7.5 ptp180 -62.57 -31.69 72.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.51 -31.0 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.632 0.253 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.85 -22.98 40.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.714 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.5 mmt -76.8 -4.54 44.02 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.27 32.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.646 0.26 . . . . 0.0 111.489 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.79 169.96 0.19 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 111.432 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -152.67 175.84 12.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.399 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 0.6 OUTLIER -79.92 -174.72 4.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.76 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.7 p -89.4 36.59 0.84 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.572 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -166.32 -72.42 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.392 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -174.13 70.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.666 0.269 . . . . 0.0 110.825 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -153.37 99.73 2.65 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.625 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.473 ' HG3' ' HB ' ' A' ' 56' ' ' ILE . 51.0 Cg_exo -53.6 154.35 16.1 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.988 2.459 . . . . 0.0 113.308 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -76.18 -34.11 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.973 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -170.65 2.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.682 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -127.48 110.83 13.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.976 0.417 . . . . 0.0 111.436 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.437 HG11 ' CD1' ' A' ' 53' ' ' PHE . 35.5 t -108.54 121.0 60.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -145.24 152.65 40.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.593 0.235 . . . . 0.0 111.203 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.4 mt -93.21 138.97 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.086 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 160' ' ' ILE . 9.9 pt -109.76 -35.61 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.938 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.66 146.58 4.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -132.17 115.85 16.24 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -133.56 156.19 79.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.68 170.93 16.35 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.676 2.251 . . . . 0.0 112.741 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.55 94.76 6.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.361 -1.244 . . . . 0.0 112.288 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 CA-C-O 120.699 0.208 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -126.36 142.51 51.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.85 153.64 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.286 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -111.34 100.65 9.22 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.4 110.59 19.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -87.39 108.23 18.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.02 156.38 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -61.7 -31.58 71.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.362 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -34.64 71.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.68 -156.22 26.33 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.362 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.2 tt -127.53 128.26 69.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.814 0.307 . . . . 0.0 111.142 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 pt -141.0 138.73 34.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.497 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.46 148.27 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.41 ' HB3' HD13 ' A' ' 98' ' ' LEU . 16.3 mt -123.49 122.83 39.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.367 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.11 94.96 6.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.254 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 mp -82.41 147.26 28.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.976 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.492 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 52.6 m-85 -72.26 102.0 2.99 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -81.16 15.76 1.8 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -69.82 0.75 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 110.277 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.46 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.59 -13.99 18.36 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.164 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.66 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.81 1.58 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 72.3 Cg_exo -41.4 -36.75 2.93 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.065 1.844 . . . . 0.0 112.844 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -52.33 63.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.773 0.321 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -64.97 -40.45 95.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.357 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -56.5 -48.38 77.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.467 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -58.79 -42.88 90.09 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.256 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.2 -51.9 67.61 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.24 -41.63 97.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.92 85.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.05 -42.09 85.36 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.286 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -34.01 76.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.646 0.26 . . . . 0.0 111.153 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.59 -31.73 26.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -84.22 -38.92 19.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.558 0.218 . . . . 0.0 111.474 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -61.4 -58.44 8.2 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.85 65.17 0.04 OUTLIER Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.75 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.39 -62.08 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.584 0.23 . . . . 0.0 110.827 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -60.59 -42.63 97.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.174 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -67.47 101.18 0.94 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.681 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.49 -32.99 2.11 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.437 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.5 t -86.66 -168.59 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.752 0.31 . . . . 0.0 111.391 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -150.31 -174.16 4.66 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.692 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.415 ' HB3' HD11 ' A' ' 56' ' ' ILE . 8.1 m-85 -83.38 122.12 28.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.29 11.88 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.428 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -157.62 111.33 2.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 53' ' ' PHE . 21.6 mm -134.9 120.07 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.78 115.23 49.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.493 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -54.78 124.43 16.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.465 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 58.38 57.4 3.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -165.1 -81.68 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.368 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.71 173.33 15.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 111.617 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.3 pt -142.87 140.51 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.942 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -122.17 153.81 38.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.243 0.544 . . . . 0.0 111.969 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.38 146.42 16.48 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.826 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.343 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.33 -179.428 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.57 0.224 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.0 p -92.26 -52.4 4.7 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.762 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 tp -172.6 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.954 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -102.18 -32.92 9.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.68 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 176.99 179.33 47.33 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.385 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.27 11.42 30.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.1 110.21 0.15 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.606 0.241 . . . . 0.0 110.998 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 34.7 p90 -126.88 161.04 29.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.0 179.78 2.61 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.302 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.3 177.48 5.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -139.17 103.96 4.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.272 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.1 tp -154.17 134.33 13.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.412 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -171.44 -61.3 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.131 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 87' ' ' HIS . 18.4 Cg_endo -60.31 171.33 3.31 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.682 2.255 . . . . 0.0 112.716 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -78.36 107.64 11.13 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.997 0.427 . . . . 0.0 111.195 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.436 ' HG ' HG21 ' A' ' 128' ' ' ILE . 4.0 mm? -109.44 162.32 14.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.932 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -118.31 150.83 38.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.461 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 96.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 15.0 t -175.45 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.627 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.34 120.25 21.11 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.064 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.95 106.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.33 69.95 0.4 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.014 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.1 mm -131.74 139.62 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.569 0.224 . . . . 0.0 111.223 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.452 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 0.8 OUTLIER -106.25 104.94 14.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.622 179.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -109.84 144.09 38.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.49 128.6 33.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.65 167.77 20.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.259 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -159.53 117.53 2.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.773 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.25 -40.28 52.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.142 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.94 160.72 31.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.9 125.84 20.01 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.66 2.24 . . . . 0.0 112.175 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 58.54 30.93 20.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.6 m -142.61 84.4 1.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.992 0.425 . . . . 0.0 110.25 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 2.8 m-20 -123.71 165.9 16.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.582 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.76 -103.33 0.92 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.0 m -151.23 43.26 0.77 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 111.172 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -105.09 154.18 20.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.323 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -155.39 159.31 39.78 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.664 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 15.1 p90 -138.33 139.61 39.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.449 . . . . 0.0 111.611 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -115.56 110.95 33.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.54 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.8 113.7 18.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.8 -16.21 45.49 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.594 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.84 162.54 51.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.473 0.177 . . . . 0.0 110.885 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 93' ' ' THR . 50.6 Cg_exo -53.85 131.51 44.71 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.901 2.401 . . . . 0.0 112.702 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.8 p -143.5 105.07 4.31 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 -43.65 6.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -58.61 -31.84 68.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.148 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.6 -17.94 52.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.529 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -65.66 85.25 0.07 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 110.466 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 153.46 -35.43 0.76 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.363 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -50.53 62.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.692 0.282 . . . . 0.0 110.908 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -112.44 147.61 36.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.454 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.9 t -79.81 170.11 16.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.828 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.3 tt -99.69 -179.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -171.7 -38.41 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.76 -179.41 27.4 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.082 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -135.74 148.12 48.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.83 102.13 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.113 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.45 -63.5 1.28 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.3 82.71 1.76 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.655 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.75 -24.09 0.04 OUTLIER Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.916 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.2 tp -46.75 -34.55 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 117.266 0.533 . . . . 0.0 112.297 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.22 -22.09 54.97 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.868 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -93.44 -39.35 10.95 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.3 t -59.43 -54.28 36.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.065 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -59.07 -33.25 70.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.675 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -38.52 91.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.413 HG11 HD13 ' A' ' 56' ' ' ILE . 20.7 t -57.47 -36.0 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.685 0.279 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.16 -34.43 69.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.397 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.1 mtt -58.59 -40.83 84.26 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.6 t -54.01 119.01 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.26 121.74 12.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.596 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.1 t -89.83 168.73 11.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.134 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -81.8 -170.04 2.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.45 31.24 1.04 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.594 0.235 . . . . 0.0 111.442 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.67 30.37 0.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.65 53.73 10.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.488 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.16 134.6 25.27 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.21 116.69 4.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.592 2.195 . . . . 0.0 112.322 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.09 -35.27 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.625 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.71 -169.26 2.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.567 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.42 101.67 11.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.2 t -130.42 108.27 15.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.238 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -179.97 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.621 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.5 mt -111.57 145.33 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.248 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.64 -35.0 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.898 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.8 149.46 26.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.27 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.48 121.48 10.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.459 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -144.95 155.36 55.54 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.392 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.21 168.18 18.86 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.691 2.26 . . . . 0.0 112.257 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.7 t -142.46 154.21 44.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.148 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.821 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.537 0.654 0 N-CA-C 113.275 0.452 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -89.93 142.95 27.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.649 0.261 . . . . 0.0 111.208 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -131.43 136.59 57.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.164 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.3 108.29 19.85 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.28 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.28 99.53 9.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.99 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -82.16 110.29 17.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.71 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 p -112.31 161.51 16.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 p -62.81 -37.12 85.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.235 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 tpt -68.46 -30.01 68.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.27 -154.33 24.54 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.345 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.86 128.76 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.864 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.85 145.06 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.79 119.12 60.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.549 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.04 155.56 26.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -110.76 115.01 28.82 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.757 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 mt -87.0 147.86 25.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.797 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -84.81 104.58 14.89 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.629 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -82.55 21.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.2 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -69.52 0.77 Allowed 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.474 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.81 18.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.942 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.1 1.27 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.3 Cg_exo -41.43 -38.16 3.68 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.054 1.836 . . . . 0.0 112.819 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -54.15 50.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.321 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -33.62 72.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -55.92 -56.01 25.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -61.24 -39.07 88.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.344 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.97 -38.86 83.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.019 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -46.74 80.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.15 77.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HG3' HD11 ' A' ' 77' ' ' ILE . 1.2 mm-40 -61.03 -50.55 72.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.068 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 mp -57.49 -40.13 77.96 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.992 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.6 67.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.342 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -73.02 -50.83 20.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -60.77 -28.56 68.82 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.847 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.49 28.34 5.47 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.733 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -89.67 -41.32 12.0 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.612 0.206 . . . . 0.0 110.729 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -72.01 -31.13 65.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.281 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.69 102.86 0.21 Allowed 'General case' 0 C--O 1.233 0.202 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.71 11.76 9.13 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.487 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 p -95.55 168.46 10.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.392 0.596 . . . . 0.0 110.827 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -157.55 169.54 24.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.678 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.425 ' HB3' HD13 ' A' ' 56' ' ' ILE . 47.3 m-85 -94.86 100.71 12.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.552 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -88.84 -43.64 11.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.819 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 7.3 mtt180 -90.97 108.61 19.97 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.694 0.283 . . . . 0.0 110.612 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 53' ' ' PHE . 36.1 mm -131.99 140.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.264 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.75 116.84 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.715 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 122.85 14.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.402 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 61.93 51.05 3.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.331 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.88 -80.15 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.234 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.3 ptm -160.6 172.2 17.58 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 111.33 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.86 115.71 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 16.0 pt20 -104.69 138.28 41.24 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 0.0 111.986 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.32 110.5 1.08 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.962 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.323 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.841 -179.747 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.901 0.381 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -74.55 162.25 28.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.406 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.439 HD11 ' HG3' ' A' ' 41' ' ' GLU . 2.8 pt -61.45 -27.24 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.052 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -96.45 30.69 2.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.103 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.18 -146.94 16.68 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.971 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 -25.65 11.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -148.33 139.97 23.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.557 0.217 . . . . 0.0 110.794 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 m-85 -87.38 -174.42 4.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.488 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.17 69.9 1.15 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.733 0.301 . . . . 0.0 111.744 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 66.13 146.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.939 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' O ' HG22 ' A' ' 127' ' ' THR . 6.4 mt-10 -155.38 36.37 0.38 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.13 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tp -65.91 149.9 49.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 111.526 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 11.5 p80 -99.82 152.03 37.68 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.75 -50.42 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.586 2.191 . . . . 0.0 112.24 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.82 146.97 14.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -171.9 173.84 4.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -90.66 160.91 15.62 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.876 0.369 . . . . 0.0 111.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.52 61.14 0.75 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.978 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.34 -36.06 75.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.88 -20.38 46.02 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.238 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.55 112.66 25.68 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.163 0.482 . . . . 0.0 110.959 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.62 56.86 5.76 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.331 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.0 mm -124.15 161.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.483 0.183 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.414 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 3.4 mt -142.08 106.35 4.79 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 110.446 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -114.52 144.04 44.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 110.92 15.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.48 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.71 145.55 31.52 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -124.19 174.75 7.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.26 -45.13 4.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.476 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.96 174.82 36.8 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.778 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.89 141.3 67.04 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.658 2.239 . . . . 0.0 112.152 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 45.2 30.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.914 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -149.93 87.53 1.48 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.78 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.457 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 60.8 m-80 -95.4 172.84 7.84 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.43 -171.43 12.19 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.717 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 m -103.52 45.7 0.95 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.023 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -115.25 168.34 10.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.564 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 24.1 p90 -160.59 171.86 18.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.454 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.0 p90 -152.28 131.56 12.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.851 0.358 . . . . 0.0 111.645 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 34.1 t -96.41 116.78 39.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.358 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.59 127.98 32.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 mt -113.36 -8.4 13.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.561 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.59 161.56 61.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.456 0.17 . . . . 0.0 110.991 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.95 121.77 10.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.873 2.382 . . . . 0.0 112.603 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -143.09 49.02 1.47 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.078 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -31.84 69.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.124 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -65.84 -28.48 69.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.186 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 0.3 OUTLIER -75.89 -7.36 54.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.899 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -66.14 85.57 0.09 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.124 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.68 -41.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.351 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -67.1 -49.56 64.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.548 0.213 . . . . 0.0 111.036 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.32 140.86 48.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 85' ' ' GLU . 97.8 m -85.07 151.4 24.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -79.46 -178.98 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.275 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -169.34 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 -179.51 26.17 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.66 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -143.3 155.59 44.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.525 0.203 . . . . 0.0 110.689 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.0 m -114.39 85.08 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.164 0.507 . . . . 0.0 112.24 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.97 -40.01 40.67 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.05 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -127.52 98.33 5.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.65 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.79 -12.3 1.3 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.622 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.442 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 15.5 tt -50.54 -30.35 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 117.255 0.527 . . . . 0.0 111.938 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.79 -12.13 67.13 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.29 -0.481 . . . . 0.0 113.417 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.05 -30.05 12.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.793 0.296 . . . . 0.0 110.814 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 114' ' ' VAL . 2.5 m -84.61 -34.85 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.434 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -61.52 -28.21 69.16 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.279 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.55 -30.83 47.11 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.855 -0.157 . . . . 0.0 111.298 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.47 -36.88 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.688 0.28 . . . . 0.0 110.738 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.11 -30.27 11.32 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.208 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -65.15 -31.94 73.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.38 176.38 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.98 0.419 . . . . 0.0 111.569 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.38 172.75 12.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -147.79 166.15 28.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -142.74 159.21 42.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 m 85.49 -40.86 0.05 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.508 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 168.36 -37.63 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -169.62 37.25 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.358 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.22 124.99 36.4 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.85 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.403 ' HG3' HG13 ' A' ' 56' ' ' ILE . 51.9 Cg_exo -54.74 109.49 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.71 2.273 . . . . 0.0 112.478 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.1 p -64.13 -30.85 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.922 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.64 -171.67 3.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.719 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.13 117.84 32.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.07 121.88 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.21 178.53 10.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.726 0.298 . . . . 0.0 111.732 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mt -110.84 143.45 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.062 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.38 -40.45 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.38 153.06 17.2 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.669 0.271 . . . . 0.0 111.211 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.88 141.6 22.74 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -154.51 156.45 31.62 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.55 162.94 24.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.448 2.099 . . . . 0.0 112.5 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -85.88 144.51 27.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.076 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 118.684 -1.065 . . . . 0.0 112.954 179.789 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 CA--C 1.529 0.269 0 CA-C-O 120.639 0.183 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -125.05 174.88 7.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.783 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -148.16 130.33 6.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -105.36 106.3 16.73 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 107.15 18.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.498 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -86.61 82.35 7.93 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.354 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.62 165.32 13.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.28 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -67.4 -37.15 82.65 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.9 tpt -62.44 -32.97 73.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.82 -148.53 14.4 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.194 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.8 tt -134.83 130.14 52.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.861 0.331 . . . . 0.0 111.385 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.62 135.58 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.637 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.73 140.24 17.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.599 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 131' ' ' ARG . 2.0 mt -130.87 141.0 50.28 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.588 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.82 107.91 19.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.524 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.49 146.68 27.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -79.86 92.04 5.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -80.69 19.48 0.82 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.01 -72.44 0.67 Allowed 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.45 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -101.1 -12.1 19.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.017 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.665 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.9 1.34 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 71.7 Cg_exo -41.09 -36.38 2.24 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.248 1.966 . . . . 0.0 112.965 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -58.02 -60.37 3.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.353 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -39.31 91.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.337 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.0 t -55.01 -48.68 73.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.446 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -60.61 -37.29 80.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -58.35 -54.22 49.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.767 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -61.13 -45.84 93.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 110.826 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.39 94.02 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.31 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.5 -44.07 58.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.251 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -37.91 70.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.117 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.93 -32.66 34.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.413 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -66.94 -45.95 76.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.124 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -28.42 68.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.736 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.04 36.18 2.79 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.733 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.19 -50.13 5.64 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.637 0.218 . . . . 0.0 110.697 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -62.75 -28.65 70.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.939 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -67.63 113.66 5.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.422 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.6 20.9 7.08 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.359 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.2 p -124.93 154.73 40.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.038 0.419 . . . . 0.0 110.53 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -129.56 169.66 14.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -85.31 99.07 10.9 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.783 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -76.86 -39.4 51.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.169 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -100.98 117.28 34.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.607 0.241 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 62' ' ' ILE . 13.2 mt -141.11 120.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.0 111.379 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 mt -116.22 116.56 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.795 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -60.28 3.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.563 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -88.47 62.38 6.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.605 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 178.25 -86.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.272 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.2 170.94 19.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.809 0.337 . . . . 0.0 111.554 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -127.23 123.09 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.139 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 1.7 pt20 -117.4 155.19 30.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.22 100.63 0.41 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.453 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.332 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.58 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 8.5 t -76.69 171.76 14.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.364 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 tt -73.23 -34.09 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.489 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -100.33 36.75 1.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 111.131 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 76' ' ' SER . . . 89.05 169.07 44.32 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.071 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -52.42 63.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.429 0.157 . . . . 0.0 110.786 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -141.61 143.26 33.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.862 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -138.56 173.57 11.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.525 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.18 173.43 11.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.396 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 4.3 p30 -80.19 178.46 8.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -132.21 72.91 1.51 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 84' ' ' ASP . 3.4 mm? -99.17 104.73 16.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.85 -54.23 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -48.72 149.99 6.79 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.78 2.32 . . . . 0.0 112.703 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.54 94.9 2.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mt -90.16 -174.94 4.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.721 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -69.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.06 61.28 1.37 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.113 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.7 p -57.62 -36.86 72.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.413 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.64 -101.52 0.23 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.613 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.95 135.17 46.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.974 0.416 . . . . 0.0 111.736 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.408 ' CA ' ' HB ' ' A' ' 132' ' ' VAL . . . 77.93 52.65 5.26 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.994 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.1 mm -135.81 138.67 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.427 ' HG ' ' CE2' ' A' ' 129' ' ' PHE . 13.3 tp -115.33 133.75 55.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.8 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 128' ' ' ILE . . . -134.13 151.65 51.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 116.35 19.64 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.36 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.92 158.51 26.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.857 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -121.03 173.45 7.25 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.293 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.24 -43.98 3.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.181 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.95 -179.43 33.78 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.65 113.23 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.05 30.54 20.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.12 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -129.82 90.77 3.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -83.21 162.77 21.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.94 -140.94 4.5 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.57 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 m -138.58 58.49 1.66 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.076 0.465 . . . . 0.0 110.802 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.476 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 3.3 mt-30 -132.78 178.23 7.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.821 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -160.45 158.02 28.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.057 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 41.3 p90 -137.36 133.02 34.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.32 114.66 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.2 p -79.94 113.62 18.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.099 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.71 -23.83 25.4 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.19 165.01 18.33 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.806 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.1 124.64 16.39 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.621 2.214 . . . . 0.0 111.994 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -141.79 48.17 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.211 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -64.47 -35.35 80.65 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.756 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -65.58 -27.9 68.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 mt -78.46 0.11 27.19 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.55 79.91 1.07 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.235 0.54 . . . . 0.0 109.942 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.57 -46.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.203 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.45 -43.28 90.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 110.676 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -123.45 135.8 54.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 63.5 m -80.16 160.83 25.54 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.74 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 99' ' ' ALA . 1.4 tt -79.39 -179.5 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.934 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CE2' ' HG ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -177.13 -38.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.403 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.41 -179.6 17.73 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.848 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 7.6 mtm180 -137.3 168.1 20.29 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 122.819 -0.224 . . . . 0.0 110.778 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.408 ' HB ' ' CA ' ' A' ' 96' ' ' GLY . 11.5 t -131.06 91.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.908 0.385 . . . . 0.0 111.345 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.33 -41.66 9.73 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.535 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 103.83 6.83 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.123 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.12 -19.68 1.57 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.422 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.7 tt -48.17 -36.5 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.996 0.398 . . . . 0.0 112.002 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.23 -24.18 67.04 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.289 -0.481 . . . . 0.0 113.133 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ttp -91.07 -32.37 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.236 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.2 t -73.92 -48.67 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.33 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -65.0 -31.56 72.86 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.155 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -59.98 -34.46 73.34 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.203 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 37.1 t -58.01 -38.69 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.8 -42.61 86.3 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.314 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.6 mmt -49.19 -48.62 45.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -52.73 141.8 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 111.503 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.46 112.69 2.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.764 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.2 p -79.86 165.52 22.62 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.107 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.59 -167.29 1.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.598 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.0 p -88.89 32.78 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.568 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -158.52 31.13 0.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.903 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 57.43 41.8 25.64 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.521 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.09 147.51 37.08 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 120.62 0.247 . . . . 0.0 111.551 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 152.32 31.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.904 2.403 . . . . 0.0 112.636 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.3 p -117.84 23.49 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.283 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.13 24.41 4.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 54.98 85.43 0.06 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.8 t -118.7 111.81 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 175.48 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.22 127.81 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.79 0.328 . . . . 0.0 111.048 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 pt -107.13 -33.62 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.765 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.38 167.94 27.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.285 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.25 159.32 40.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.365 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.23 97.08 26.64 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.207 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.9 95.0 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.827 2.352 . . . . 0.0 112.198 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.6 t -84.48 143.89 29.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.273 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.51 -1.161 . . . . 0.0 112.758 179.741 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 CA--C 1.534 0.52 0 N-CA-C 112.594 0.19 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 8.2 m120 -142.31 175.32 9.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.776 0.322 . . . . 0.0 111.627 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -144.8 147.68 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -91.84 120.31 32.42 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 111.139 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mt -114.05 102.83 10.55 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.303 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 6.5 mt-10 -92.86 103.16 15.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.27 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.427 HG22 HG23 ' A' ' 159' ' ' ILE . 2.1 p -113.56 158.19 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.3 t -60.47 -35.9 76.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.813 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.4 tpt -68.76 -32.34 72.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.329 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.51 -163.74 37.29 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.35 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 tt -124.12 129.95 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.984 0.392 . . . . 0.0 111.185 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.96 156.83 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.683 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -123.32 116.52 48.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' ASN . 3.5 mm? -91.51 158.81 16.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 3.8 tt0 -110.65 105.59 14.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.75 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.97 131.15 37.49 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.392 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -82.41 113.9 20.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -81.96 14.96 2.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.83 -68.46 0.81 Allowed 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.686 0.279 . . . . 0.0 110.378 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.453 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -100.87 -13.94 18.16 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -97.63 0.66 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 98.7 Cg_exo -43.73 -40.56 11.1 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.071 1.847 . . . . 0.0 112.896 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -54.61 27.08 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -64.1 -35.85 82.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.117 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 t -57.01 -51.63 68.48 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.81 -40.47 88.5 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -58.51 -47.23 84.84 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.01 -46.91 78.61 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.739 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 -45.68 70.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.403 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.15 -45.96 91.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.211 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -44.1 93.07 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 110.845 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -35.68 73.14 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.143 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.06 -47.15 60.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -57.41 -31.1 65.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.611 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 33.04 2.53 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.103 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.23 -34.86 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.606 0.203 . . . . 0.0 111.058 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -73.37 -37.2 66.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.645 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.88 151.84 41.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.27 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 18.31 71.0 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.861 -0.609 . . . . 0.0 113.083 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -109.19 161.67 15.01 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.004 0.402 . . . . 0.0 110.465 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -146.54 165.67 28.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -70.64 110.86 5.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -77.18 -45.23 27.34 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.851 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -112.11 130.1 56.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.41 ' HA ' HG21 ' A' ' 62' ' ' ILE . 51.9 mt -143.05 97.48 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.792 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.54 110.11 21.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -62.51 141.06 58.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.187 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.6 45.74 7.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.524 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -168.71 -89.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.942 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 175.23 12.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 56' ' ' ILE . 1.8 pp -144.04 156.34 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.015 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 6.0 pt20 -132.73 142.53 49.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 111.568 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.03 156.43 16.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.704 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.441 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.973 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.618 0.247 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.26 177.74 8.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 pp -56.19 -31.44 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.747 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.53 40.39 1.11 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.96 179.69 33.37 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.956 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.75 76.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.529 0.204 . . . . 0.0 110.931 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -155.91 146.28 21.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.908 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -126.9 177.21 6.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.22 140.53 38.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.59 157.19 14.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.465 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.63 40.6 3.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.541 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.94 145.98 42.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.695 0.283 . . . . 0.0 110.916 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -164.46 153.51 11.57 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.87 -166.48 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.396 2.064 . . . . 0.0 112.08 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.53 33.46 10.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 111.152 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.7 mt -122.03 -178.45 3.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.882 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.424 ' HE2' ' HB ' ' A' ' 93' ' ' THR . 17.0 tttt -128.08 157.29 41.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.088 0.47 . . . . 0.0 111.659 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.39 48.36 0.89 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.919 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.424 ' HB ' ' HE2' ' A' ' 91' ' ' LYS . 1.7 t -58.8 -23.83 60.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.8 -7.31 81.6 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.78 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.64 96.87 5.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.951 0.876 . . . . 0.0 111.383 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.23 61.64 1.89 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.302 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 4.4 mp -138.75 154.46 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.717 0.258 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.99 111.94 15.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.907 0.384 . . . . 0.0 110.454 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.22 137.04 46.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.34 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.437 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.64 104.88 10.54 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 164.89 22.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.475 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 172.68 12.62 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.32 -36.03 10.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.733 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.74 -179.84 32.93 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.614 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -61.87 124.21 14.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.696 2.264 . . . . 0.0 112.149 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.26 28.49 17.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.051 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.5 m -136.57 84.53 2.08 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.269 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.11 129.41 34.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.769 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.02 -164.06 24.88 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.953 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 m -110.25 68.43 0.67 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.063 0.458 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -148.67 152.47 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -147.17 156.68 43.18 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.755 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 22.8 p90 -137.77 126.15 23.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.968 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 11.7 p -98.47 120.14 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.356 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 p -84.18 129.36 34.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.761 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.45 -19.47 12.93 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.64 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.14 160.34 47.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.61 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.56 127.82 23.87 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.043 2.495 . . . . 0.0 112.802 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.5 p -147.42 42.9 1.1 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -59.19 -30.99 68.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.414 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 32.6 p90 -60.95 -29.2 69.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.273 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.414 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 14.6 mt -81.25 -2.06 47.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.78 85.63 0.21 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.153 0.501 . . . . 0.0 110.386 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.21 -31.58 0.54 Allowed Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.697 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -72.59 -62.94 1.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.708 0.254 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -95.63 172.13 8.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 t -114.06 156.73 23.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.522 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mm -80.01 -179.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.283 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 100' ' ' MET . 0.1 OUTLIER -178.22 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.393 0.277 . . . . 0.0 110.696 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 26' ' ' GLU . . . -145.44 -179.63 21.86 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.213 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 160.6 42.31 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.577 0.227 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.8 t -106.73 93.61 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.8 m -84.12 -42.58 15.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.475 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 107.25 8.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.09 -10.31 4.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.607 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.4 tt -48.78 -33.82 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.55 91.68 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.609 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -66.59 -46.49 75.79 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 0.0 110.471 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.75 -38.1 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.787 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.13 -40.81 77.87 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.62 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -62.09 -37.32 84.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.917 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.408 ' CG1' HD11 ' A' ' 56' ' ' ILE . 38.2 t -57.5 -41.04 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.946 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.09 -13.13 58.05 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.6 tpt -84.11 -35.64 23.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.977 0.388 . . . . 0.0 111.507 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 m -51.85 154.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.985 0.422 . . . . 0.0 111.684 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.17 95.49 0.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.672 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.3 p -79.95 170.52 16.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.371 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.31 179.46 7.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 29.59 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.387 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -156.1 33.52 0.34 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 54.3 61.88 2.83 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.34 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.0 114.38 13.89 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.114 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.99 117.41 4.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.849 2.366 . . . . 0.0 112.575 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.3 m -68.03 -34.26 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.334 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.3 179.54 7.43 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -105.79 80.66 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.6 t -98.94 115.62 39.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.96 175.14 11.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.553 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 18' ' ' THR . 3.9 mt -109.8 148.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.69 -40.93 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.845 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 11.0 mttt -139.25 161.73 36.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.77 0.319 . . . . 0.0 111.298 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.57 110.14 2.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -128.69 166.84 21.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.93 174.71 11.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.905 2.403 . . . . 0.0 111.916 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.2 t -129.18 103.53 7.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.719 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.473 -179.851 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 CA--C 1.533 0.449 0 CA-C-O 121.05 0.354 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.69 161.46 13.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.331 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.08 131.47 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.104 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -91.25 96.97 10.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.09 98.59 10.18 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.218 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' CB ' ' HB2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -87.34 122.23 30.83 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.225 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.61 163.6 24.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.156 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.8 t -68.18 -34.75 76.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.196 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -30.81 70.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' HA3' ' HG3' ' A' ' 138' ' ' MET . . . 168.16 -143.46 8.16 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.253 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.2 mt -140.86 135.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.854 0.327 . . . . 0.0 111.036 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.6 pt -137.78 147.95 25.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.764 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.1 t -120.04 123.64 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.021 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.406 ' HG ' ' CD1' ' A' ' 98' ' ' LEU . 1.4 mm? -116.26 159.14 22.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.217 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -125.71 106.76 9.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.05 158.61 19.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -102.86 102.5 12.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.236 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -81.25 23.25 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.14 -68.07 0.83 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.493 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.65 -14.11 18.27 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 178.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -97.29 1.39 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.7 Cg_exo -40.71 -37.46 2.28 Favored 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 121.952 1.768 . . . . 0.0 112.893 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -55.15 38.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.487 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -71.93 -34.97 69.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.797 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.1 m -56.97 -50.94 71.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.66 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -42.33 99.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -65.07 -48.23 74.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.206 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.39 -46.38 86.51 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.946 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.15 83.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.42 -43.97 97.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.058 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -41.17 83.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.01 77.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.902 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -68.48 -41.22 80.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -28.55 68.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.554 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.25 28.88 4.47 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.775 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -51.14 5.35 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.573 0.225 . . . . 0.0 110.425 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -77.3 -41.52 40.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.444 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -70.3 93.38 0.85 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.96 3.5 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.091 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 74.0 p -61.78 166.55 4.3 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.006 0.403 . . . . 0.0 112.004 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -137.01 25.77 3.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.939 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 57.23 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 0.0 111.659 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -149.37 -65.84 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -91.34 122.25 33.79 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.399 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.516 HG13 ' HB3' ' A' ' 153' ' ' PRO . 23.9 mm -131.21 84.3 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.102 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.1 mt -89.86 88.94 2.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -24.23 60.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.744 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -91.43 25.59 2.55 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.85 -77.67 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 O-C-N 122.452 -0.155 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.423 ' HB3' ' HA ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -160.32 178.79 9.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.631 0.253 . . . . 0.0 111.123 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 pt -135.46 149.19 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -133.06 154.17 50.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 112.161 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.82 103.43 0.47 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.025 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.334 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.776 -179.673 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.605 0.241 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p -99.82 172.71 7.08 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 pt -57.4 -38.22 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.646 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -74.55 -46.19 40.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.6 -153.91 21.95 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.757 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -34.54 7.08 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.58 109.87 5.92 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.675 0.274 . . . . 0.0 111.037 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -118.34 176.19 5.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.09 -177.91 0.41 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -113.86 176.94 4.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.463 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -130.75 110.31 11.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.369 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.02 129.09 9.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.78 -53.51 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -61.94 171.82 4.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.659 2.239 . . . . 0.0 112.11 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.19 -75.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.35 151.43 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -137.4 167.07 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.556 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -133.24 87.83 2.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.053 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.1 p -71.34 -27.78 63.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.82 -67.99 0.89 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.85 104.92 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.7 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.76 63.05 2.39 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.435 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.9 mm -142.4 123.34 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.778 0.289 . . . . 0.0 110.559 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 3.0 mt -98.93 117.51 33.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 111.251 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -119.63 143.69 47.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.496 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.65 116.48 19.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.387 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.12 168.28 19.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.477 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -151.95 170.92 18.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -101.71 -49.07 4.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.649 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.02 -179.65 34.95 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.29 122.06 10.54 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.704 2.269 . . . . 0.0 111.908 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.32 31.33 17.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.188 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.12 85.44 2.07 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.731 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -107.49 140.83 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.36 -152.14 16.02 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.781 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 p -117.73 38.78 3.52 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -111.25 150.71 29.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.154 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.12 146.14 42.48 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.675 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 31.9 p90 -129.27 130.36 46.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.406 ' HB ' HD22 ' A' ' 98' ' ' LEU . 12.1 p -109.77 121.2 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.898 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 1.1 p -79.59 139.38 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.525 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -108.82 -31.16 7.8 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.663 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.1 153.89 37.73 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.036 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.48 122.71 10.71 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.681 2.254 . . . . 0.0 112.029 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.489 HG23 ' CZ2' ' A' ' 121' ' ' TRP . 75.1 p -145.97 92.61 2.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.85 -4.51 52.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.717 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.489 ' CZ2' HG23 ' A' ' 119' ' ' THR . 22.9 p90 -82.18 -32.63 29.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.286 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 pp -83.49 0.53 45.98 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -60.32 87.09 0.01 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.354 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.12 -23.3 2.74 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.966 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -61.6 -65.8 0.64 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.917 0.359 . . . . 0.0 110.951 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -97.5 172.61 7.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.795 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 46.5 m -92.13 155.15 18.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.95 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.4 tt -98.97 -179.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.778 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -172.77 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.8 -179.78 19.82 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.928 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -136.17 172.59 12.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.711 0.291 . . . . 0.0 110.969 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.66 121.09 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.218 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 29.1 m -123.25 -59.0 1.6 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -113.91 93.7 4.49 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.44 -17.43 1.3 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.386 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.2 tt -44.7 -34.75 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.008 0.404 . . . . 0.0 111.92 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.33 -42.23 82.22 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.769 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . 0.401 ' HG3' ' HA3' ' A' ' 21' ' ' GLY . 1.4 ttp -60.79 -40.23 91.83 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.75 0.309 . . . . 0.0 110.476 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.9 t -70.53 -35.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.0 -46.43 74.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -58.4 -35.31 71.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.524 0.202 . . . . 0.0 111.262 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 33.4 t -58.42 -40.04 76.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.638 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.68 -37.97 38.46 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.464 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 mmt -60.76 -38.47 85.32 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.554 0.216 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.64 166.65 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.366 -0.379 . . . . 0.0 112.015 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -66.68 171.3 5.3 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.283 0.563 . . . . 0.0 110.968 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 p -149.13 174.73 12.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.271 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -95.48 -176.33 3.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.6 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.9 m -92.76 35.09 1.05 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 111.279 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.27 37.12 0.12 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.459 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.16 41.84 31.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.215 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.93 126.06 29.84 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.056 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.516 ' HB3' HG13 ' A' ' 56' ' ' ILE . 33.8 Cg_endo -64.5 154.24 72.88 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.813 2.342 . . . . 0.0 112.776 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.93 -28.24 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.889 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.66 17.65 11.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 33.81 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.0 t -80.24 97.52 3.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.0 tttp -102.4 130.56 49.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.422 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.68 135.59 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.647 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.26 2.48 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 22.3 mttt -154.37 131.99 11.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.643 0.258 . . . . 0.0 111.183 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.43 81.74 1.04 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.063 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -144.67 156.81 56.11 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.368 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.93 177.83 7.91 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.098 2.532 . . . . 0.0 112.195 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.43 119.36 17.4 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.112 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.514 179.841 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 CA-C-O 120.631 0.18 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -128.49 177.47 6.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.786 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.79 129.93 66.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.687 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.83 93.01 9.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.92 89.26 7.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.937 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 89.56 6.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.445 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -95.21 164.11 12.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.147 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -66.89 -40.92 87.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.609 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 tpt -62.11 -30.91 71.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.21 -168.71 41.03 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.951 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.17 129.13 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.932 0.366 . . . . 0.0 111.075 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 pt -138.52 128.34 33.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.584 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.85 111.28 32.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.391 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.4 154.44 19.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.196 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -112.2 133.37 54.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 4.5 mt -97.23 149.84 21.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.408 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 20.0 m-85 -92.24 90.66 7.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -80.47 23.6 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -100.44 -71.95 0.69 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.505 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.94 -13.67 18.21 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.664 178.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.658 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -100.15 1.36 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 43.5 Cg_exo -36.83 -37.39 0.31 Allowed 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.467 2.111 . . . . 0.0 113.375 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -60.67 3.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.781 0.324 . . . . 0.0 110.532 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.2 p -67.0 -34.69 78.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 96.6 m -58.94 -50.57 73.55 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -57.3 -40.31 77.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.284 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -63.25 -53.09 58.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.568 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -56.76 -44.04 81.38 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.5 99.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.982 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.7 -38.0 89.5 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.933 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.02 -39.55 94.34 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.971 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.88 74.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.115 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -72.83 -52.83 13.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.151 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.428 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.29 32.07 3.85 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.591 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -53.08 8.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.629 0.252 . . . . 0.0 110.386 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -64.81 -41.0 96.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.644 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -61.19 127.44 31.54 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.473 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 -32.02 8.03 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.604 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 170.12 15.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HB3' ' CB ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.46 159.23 43.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.925 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CD1' HG12 ' A' ' 62' ' ' ILE . 58.6 m-85 -67.45 117.24 9.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.681 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.25 -61.57 1.67 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.289 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -88.97 123.37 33.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.072 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.438 HG12 HG13 ' A' ' 62' ' ' ILE . 7.1 mt -142.07 112.29 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.297 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.89 121.02 44.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.065 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.23 123.7 18.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.13 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 t70 59.17 58.02 3.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.537 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.463 ' CE1' HG22 ' A' ' 119' ' ' THR . 15.6 t80 -166.66 -74.68 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.976 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.11 177.46 10.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.224 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.469 HG12 ' CD1' ' A' ' 53' ' ' PHE . 11.2 tt -151.15 101.91 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.9 tt0 -87.36 132.54 33.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.13 150.47 17.76 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.419 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.38 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.023 -179.744 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 p -101.28 169.79 8.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 pt -67.96 -29.95 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.866 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -81.65 -42.87 19.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.301 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.2 -138.56 2.65 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.725 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -61.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -160.72 161.16 32.13 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.731 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -137.03 177.36 7.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.21 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -87.11 176.94 7.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.092 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -92.74 179.25 5.54 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.0 136.02 39.98 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.252 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.05 129.37 9.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -62.48 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.68 -14.48 44.09 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.755 2.303 . . . . 0.0 113.076 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 72.2 -67.99 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.477 0.311 . . . . 0.0 111.144 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 89' ' ' ASP . 1.7 mp 66.27 157.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.855 0.36 . . . . 0.0 111.57 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -58.72 145.67 39.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.379 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.6 29.16 0.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.618 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.5 t -137.43 -46.57 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.5 122.95 30.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.778 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.16 131.6 10.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.636 0.255 . . . . 0.0 111.671 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.81 59.93 0.81 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.868 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.6 mm -128.56 132.56 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.73 0.265 . . . . 0.0 111.039 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.468 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 2.1 mt -109.67 103.65 12.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.48 140.21 46.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.398 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.7 108.72 13.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.81 151.99 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.754 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -130.66 147.5 52.34 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.718 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.05 -73.68 0.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.252 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.61 176.14 19.91 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.435 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.3 135.93 38.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.359 2.04 . . . . 0.0 111.879 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.35 30.41 19.79 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.336 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.78 87.05 2.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.776 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -83.25 129.7 35.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.472 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.43 -116.84 4.25 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.832 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -154.22 32.06 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 111.463 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -95.33 163.16 13.37 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -159.03 124.29 4.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.3 p90 -110.97 135.1 51.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.88 105.53 17.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.881 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.39 125.58 31.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.283 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.24 -1.22 12.42 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.695 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -121.16 140.07 30.5 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -52.12 112.53 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.761 2.307 . . . . 0.0 112.212 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.463 HG22 ' CE1' ' A' ' 60' ' ' PHE . 69.5 p -128.79 97.73 4.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.92 -32.06 15.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.332 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.6 p90 -60.02 -39.16 84.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.417 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 4.2 pp -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -63.83 85.52 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.42 -32.08 1.99 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.701 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -44.69 96.65 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.634 0.254 . . . . 0.0 111.128 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -104.02 150.15 24.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.2 m -89.37 151.74 21.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.9 -179.33 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.498 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -172.09 -42.26 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.04 173.35 30.55 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.855 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -140.84 148.64 40.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.592 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.7 m -89.98 114.01 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.671 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 27.0 m -95.48 -36.2 11.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -150.52 94.91 2.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.634 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 162.03 -19.24 0.18 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.828 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.5 tt -44.39 -34.61 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.457 0.628 . . . . 0.0 111.903 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.9 -25.15 52.35 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.024 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 ttp -86.11 -36.03 19.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.754 0.311 . . . . 0.0 110.329 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.42 -54.26 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.437 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -58.56 -30.69 67.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.575 0.226 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.56 -39.23 90.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.532 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.8 t -65.87 -27.03 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.35 -30.78 24.01 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.158 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.31 -34.56 78.26 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.137 0.175 . . . . 0.0 111.45 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.4 174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.828 0.347 . . . . 0.0 111.413 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.15 131.16 44.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.5 p -94.61 172.14 8.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.19 142.68 47.5 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.853 0.359 . . . . 0.0 111.646 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.19 -47.76 0.14 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.989 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 176.35 -32.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.593 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -169.54 36.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.478 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 116.05 65.57 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.78 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.82 111.28 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.596 2.197 . . . . 0.0 112.191 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.56 -33.86 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -168.25 1.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.587 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.09 100.04 7.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.748 0.309 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.6 p -118.7 115.17 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.708 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -154.4 176.21 12.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.318 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.2 mt -110.45 130.0 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.6 pt -110.41 -34.35 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.506 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -147.04 140.11 25.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.76 0.314 . . . . 0.0 110.767 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.41 117.14 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.83 147.93 31.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.246 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.83 146.44 18.6 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.668 2.245 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.89 174.22 7.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.042 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.545 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 CA--C 1.529 0.259 0 CA-C-O 120.654 0.189 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -118.98 167.3 11.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.1 m -144.28 137.42 23.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.207 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -118.57 102.26 8.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.777 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mt -84.06 104.9 14.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.12 90.66 8.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -114.06 166.55 11.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -35.86 79.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.211 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.4 tpt -62.7 -28.23 69.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.115 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 152.45 5.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.954 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 tp -79.64 122.75 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 117.078 0.439 . . . . 0.0 111.358 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.62 124.09 67.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.66 120.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.976 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.61 147.73 33.64 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -102.37 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.519 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.35 132.18 35.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.468 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 79.0 m-85 -68.28 99.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -77.9 11.23 2.3 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 -69.18 0.78 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.701 0.286 . . . . 0.0 110.527 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.442 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 14.7 m-70 -100.82 -15.93 17.45 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.652 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.55 1.48 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 81.6 Cg_exo -42.81 -36.5 5.16 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.079 1.853 . . . . 0.0 113.081 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -62.91 -57.13 11.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.853 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -61.92 -36.98 82.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.03 -48.49 73.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -56.37 -39.08 72.35 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.465 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.81 -44.17 64.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -61.76 -45.38 94.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.63 80.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.59 -43.15 97.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.52 -35.39 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.069 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.64 81.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.528 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -92.6 -31.9 15.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.616 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -57.2 -31.69 65.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.6 26.13 4.92 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.982 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.2 -44.82 7.11 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -82.25 -33.23 29.31 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.922 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.0 105.91 0.37 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.733 0.301 . . . . 0.0 110.501 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 21.96 6.19 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.895 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -98.55 173.44 6.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.144 0.472 . . . . 0.0 111.097 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.66 38.17 0.23 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.713 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 56.45 -177.58 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.413 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -151.11 -48.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.706 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.21 111.26 19.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.69 0.281 . . . . 0.0 110.624 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.419 HG13 ' HG3' ' A' ' 153' ' ' PRO . 32.6 mm -115.7 116.02 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.486 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.0 mt -122.74 94.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.361 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.73 -27.5 59.34 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.517 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.37 31.47 2.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.734 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.74 -78.36 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.21 178.13 9.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 111.601 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -132.81 104.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 11.1 tt0 -93.44 130.8 39.13 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.643 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.92 145.54 17.84 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.737 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.395 -179.005 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.717 0.294 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.3 p -96.24 -179.24 4.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -61.52 -28.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.484 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -83.97 -43.71 14.92 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.87 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.81 -169.47 42.54 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.745 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -63.52 -45.38 90.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.559 0.219 . . . . 0.0 111.213 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.17 127.74 10.07 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.79 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -116.37 157.05 25.66 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.936 0.398 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -65.95 179.16 0.94 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -95.64 146.57 24.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.32 102.09 11.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.601 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tp -134.73 144.88 47.99 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.426 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 m-70 -158.3 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 87' ' ' HIS . 72.6 Cg_endo -74.43 158.1 44.61 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.676 2.251 . . . . 0.0 112.507 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.66 -49.03 43.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.238 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.2 -170.92 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.41 ' CD1' HD12 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -159.7 35.97 0.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.556 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -126.97 -46.54 1.53 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.79 117.08 9.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.864 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -45.35 134.24 6.76 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.62 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.38 60.32 0.91 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.726 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 11.0 mm -128.36 160.23 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.568 0.184 . . . . 0.0 110.643 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 10.2 mt -133.96 115.95 14.99 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.947 0.403 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.14 139.95 50.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.335 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.416 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.82 113.56 18.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.406 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.64 170.37 10.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -142.66 151.44 41.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.82 -33.81 75.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.72 179.99 34.91 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.467 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.99 131.9 44.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.541 2.16 . . . . 0.0 111.72 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 p30 44.15 30.0 0.4 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.688 0.618 . . . . 0.0 112.0 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.2 m -136.59 85.81 2.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -83.89 162.17 20.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.63 -105.35 1.15 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.035 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m -155.89 40.55 0.38 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -109.41 161.27 15.46 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.187 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 7.6 p90 -159.98 125.91 4.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 50.5 p90 -112.85 133.76 54.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.281 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 40.6 t -94.81 111.29 25.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.63 103.42 9.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 pp -95.23 -5.33 44.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.743 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.23 151.01 50.35 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.58 0.228 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 109.21 2.31 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.778 2.319 . . . . 0.0 111.931 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 72.1 p -133.91 100.96 4.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.23 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.1 -27.04 16.47 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.419 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -58.8 -27.33 64.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.54 0.21 . . . . 0.0 111.505 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.41 HD12 ' CD1' ' A' ' 92' ' ' PHE . 4.4 pp -98.03 0.2 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.85 84.56 0.03 OUTLIER 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 151.11 -30.95 0.98 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.837 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -67.41 -57.65 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.685 0.279 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -93.88 144.38 25.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.897 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.3 t -88.22 152.69 21.79 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.821 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.16 -179.32 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.406 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -173.26 -44.19 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.445 0.164 . . . . 0.0 111.179 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.0 179.7 20.36 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.729 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.96 153.65 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -101.69 87.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.32 -51.37 8.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.711 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 103.04 7.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.18 -23.75 0.52 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.196 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.0 tt -47.49 -34.77 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -44.44 97.91 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.537 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.8 tpt -76.52 -46.41 26.68 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.555 0.217 . . . . 0.0 110.769 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.9 t -56.49 -34.8 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.191 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -67.24 -39.64 86.22 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.674 0.273 . . . . 0.0 110.788 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -60.94 -28.64 69.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.198 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.445 ' O ' HG21 ' A' ' 145' ' ' VAL . 17.2 t -58.36 -25.42 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.736 0.303 . . . . 0.0 111.03 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.66 -23.3 39.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.804 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -63.57 -27.01 68.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.772 0.286 . . . . 0.0 111.359 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 142' ' ' VAL . 0.2 OUTLIER -64.53 173.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.478 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -86.58 133.72 33.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.57 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -100.81 178.07 4.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.656 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.55 29.03 8.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.376 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.21 24.53 8.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 111.198 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.93 33.83 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.184 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 58.33 44.15 18.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.389 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.52 90.33 37.65 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.419 ' HG3' HG13 ' A' ' 56' ' ' ILE . 36.8 Cg_endo -66.25 139.68 55.93 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.693 2.262 . . . . 0.0 112.437 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.84 -50.42 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.83 67.45 1.98 Allowed 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -51.32 156.31 1.22 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.757 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.83 138.15 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.096 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.86 119.31 16.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 111.266 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.0 mt -92.62 148.33 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.206 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -38.33 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.856 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -154.63 170.42 21.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.88 0.371 . . . . 0.0 111.343 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -132.7 134.57 44.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.639 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.85 93.72 11.14 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.71 104.74 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.468 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.2 t -71.49 78.94 0.78 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.397 -1.224 . . . . 0.0 112.459 -179.925 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 CA--C 1.53 0.323 0 N-CA-C 112.755 0.252 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -126.77 154.64 43.97 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.998 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.29 143.88 38.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.29 117.36 34.58 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 99.77 10.97 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 105.24 17.45 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.392 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.92 167.74 10.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -21.48 52.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.644 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.6 28.2 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.995 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.03 -156.59 15.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.284 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -146.43 139.07 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.919 0.36 . . . . 0.0 111.021 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 pt -139.34 133.69 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 111.642 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 t -108.13 113.77 44.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 mp -112.57 138.41 49.38 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -103.64 130.15 51.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.869 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.426 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -97.51 131.8 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.593 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 22.9 m-85 -64.83 99.4 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.788 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -79.46 14.77 1.47 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -70.67 0.73 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.463 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 10.2 m-70 -100.88 -14.46 17.94 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.14 1.12 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.8 Cg_exo -40.79 -37.19 2.24 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.154 1.903 . . . . 0.0 112.974 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -55.3 36.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 110.442 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -64.9 -35.12 80.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 27' ' ' LEU . 55.8 m -56.15 -50.2 71.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.299 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -61.11 -39.32 89.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -62.4 -59.06 5.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.929 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -40.84 84.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.53 67.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -64.22 -36.12 83.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.11 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -49.49 77.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.656 0.265 . . . . 0.0 110.657 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.95 64.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.23 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -46.09 50.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.312 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -60.14 -54.07 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.51 52.36 0.03 OUTLIER Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.788 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -125.63 -49.67 1.63 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.544 0.211 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -45.29 62.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.177 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -56.17 118.64 4.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.23 32.37 20.27 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.697 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -100.23 -175.27 2.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -163.39 137.27 5.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.428 ' CD1' ' HB ' ' A' ' 157' ' ' VAL . 39.9 m-85 -64.93 150.28 48.16 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.852 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -142.76 19.26 2.0 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.07 104.69 1.91 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.584 0.23 . . . . 0.0 111.155 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.445 HG12 ' CG1' ' A' ' 142' ' ' VAL . 2.7 mp -136.18 113.59 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.26 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.85 100.11 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 1.1 ttmt -59.12 145.23 43.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.68 36.09 2.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.092 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -169.53 -94.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.892 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -160.41 169.61 22.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.24 150.33 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.753 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 4.6 pm0 -126.26 145.61 50.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 111.324 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.57 159.79 13.62 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.604 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.411 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.896 -179.867 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.698 0.285 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.6 t -108.37 170.92 7.71 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.429 HG13 ' CD2' ' A' ' 78' ' ' TYR . 19.5 pt -48.5 -45.05 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.429 ' CD2' HG13 ' A' ' 77' ' ' ILE . 4.1 p90 -131.07 14.85 5.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.158 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.459 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -86.27 -136.57 4.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.372 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.84 -63.49 0.37 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.137 0.494 . . . . 0.0 110.364 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.59 100.91 2.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.508 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.459 ' CD1' ' HA2' ' A' ' 79' ' ' GLY . 27.9 p90 -154.31 179.4 9.02 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -101.87 115.54 30.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.848 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.21 165.92 16.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.136 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.15 128.56 38.04 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.357 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.2 136.68 49.92 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.045 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -140.6 99.91 6.87 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.008 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.79 156.16 67.04 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 60.71 76.12 0.38 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.24 80.37 1.61 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.754 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.39 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.219 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.59 34.13 2.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.718 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -71.59 -36.27 70.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.344 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA2' HG21 ' A' ' 115' ' ' THR . . . 115.05 160.34 12.74 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.3 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.99 94.74 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.866 0.365 . . . . 0.0 111.689 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.06 44.95 7.84 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.781 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.6 mm -124.57 116.11 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.579 0.228 . . . . 0.0 110.855 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.1 tp -96.51 114.78 26.47 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.933 0.397 . . . . 0.0 111.097 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . 0.404 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . . . -114.07 150.38 34.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.319 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.45 125.27 29.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.592 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.54 151.77 28.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.71 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -130.16 146.71 51.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.403 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.17 -53.9 4.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.794 0.33 . . . . 0.0 110.592 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.12 179.99 35.29 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.502 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.63 116.85 3.57 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.475 2.117 . . . . 0.0 111.881 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.89 26.82 15.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.31 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.5 m -146.23 83.77 1.63 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.834 0.35 . . . . 0.0 110.889 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -101.18 156.29 17.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.354 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.65 -109.78 3.38 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.14 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.0 38.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 111.258 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -100.46 170.92 8.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -150.45 160.03 44.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 25.2 p90 -152.8 138.83 18.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.6 m -103.69 134.7 44.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.444 HG21 ' HA2' ' A' ' 94' ' ' GLY . 3.2 m -79.61 117.94 20.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.858 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -5.48 42.43 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.477 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.98 156.8 30.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.356 0.122 . . . . 0.0 111.147 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -51.38 120.23 6.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.911 2.407 . . . . 0.0 112.736 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 122' ' ' LEU . 45.8 p -135.02 53.44 1.99 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.364 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -59.48 -35.75 74.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -66.62 -24.7 66.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.534 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 2.4 mt -76.11 -2.78 32.6 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.55 85.36 0.07 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.095 0.474 . . . . 0.0 110.348 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.39 -44.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.736 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -64.63 -53.56 45.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.678 0.275 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -125.63 131.66 52.62 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.4 t -79.92 167.42 20.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.804 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 tt -79.56 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.699 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.8 -44.07 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.16 179.96 16.23 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.801 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.38 165.59 30.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.523 0.202 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.99 103.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.3 t -98.06 -51.24 4.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.798 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -123.3 98.39 5.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.9 -17.72 1.08 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.386 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.435 HD13 HG22 ' A' ' 136' ' ' ILE . 12.9 tt -46.57 -33.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.65 88.66 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.308 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -40.48 90.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.761 0.315 . . . . 0.0 110.274 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.68 -41.43 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.901 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.92 -41.98 83.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -59.63 -33.89 72.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.128 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . 0.445 ' CG1' HG12 ' A' ' 56' ' ' ILE . 10.6 t -60.25 -30.85 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.068 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . -89.05 -41.86 5.77 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.355 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.7 mmt -51.78 -34.69 40.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.4 m -62.26 171.26 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.543 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.25 177.69 8.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.897 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -133.1 176.46 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -111.22 -165.52 1.0 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.68 36.73 0.9 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.77 29.34 0.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.866 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.43 39.2 23.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -121.77 146.06 44.83 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.785 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . 0.44 ' HG3' ' CD1' ' A' ' 56' ' ' ILE . 66.6 Cg_endo -73.67 140.14 29.01 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.759 2.306 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.3 m -58.85 -33.93 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.049 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.4 77.68 1.19 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.263 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.58 138.11 47.51 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.354 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 21.7 t -80.05 126.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 114.27 23.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.01 144.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.441 HG23 HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -133.73 8.57 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -157.57 140.83 15.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 111.304 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -153.91 101.08 2.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.941 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -151.33 155.93 34.76 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.479 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.11 149.17 19.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.862 2.375 . . . . 0.0 112.829 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -149.21 93.22 2.05 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.263 -1.299 . . . . 0.0 112.851 -179.869 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 29' ' ' TRP . 61.3 Cg_endo . . . . . 0 CA--C 1.534 0.499 0 N-CA-C 112.96 0.331 . . . . 0.0 112.96 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -87.8 146.37 25.65 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 m -134.43 149.84 30.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.56 123.53 50.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.356 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.43 94.01 4.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 109.59 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.546 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.3 p -118.29 156.83 28.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.632 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.6 t -57.93 -35.06 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.567 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.873 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.87 -159.4 31.5 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.358 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -125.93 124.48 66.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.922 0.361 . . . . 0.0 111.003 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.2 pt -123.74 130.89 73.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.72 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -92.87 121.97 43.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.23 154.87 38.18 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.303 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 130.32 56.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.465 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 92.3 mt -103.79 134.1 47.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.769 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.18 98.46 5.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.613 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 39.9 p-90 -82.26 20.42 1.05 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -100.27 -68.98 0.79 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.469 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.34 18.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.139 179.347 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.661 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.76 1.01 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.6 Cg_exo -40.26 -40.02 2.81 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.296 1.998 . . . . 0.0 113.226 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.85 -53.75 54.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.561 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 m -70.81 -35.48 72.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.831 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 68.5 m -56.69 -53.59 56.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.539 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -44.02 96.46 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.369 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -55.47 -44.83 76.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -60.51 -58.05 10.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.239 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.77 96.63 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.609 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.86 -47.11 81.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.346 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -39.02 88.56 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.7 -28.14 36.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.636 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -50.11 55.75 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.557 0.217 . . . . 0.0 111.171 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -60.68 -33.78 73.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.31 52.44 0.45 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.667 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.18 -54.27 1.91 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.383 0.135 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -47.26 62.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -60.36 114.71 3.07 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.35 -26.86 3.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.675 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -72.67 -175.58 1.71 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.558 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -165.75 144.9 6.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.723 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -61.92 112.94 2.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.719 0.295 . . . . 0.0 110.716 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -88.29 -55.07 3.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.357 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 113.43 22.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.219 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.2 mm -120.21 84.89 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -91.76 90.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -62.8 153.08 34.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 t0 68.27 26.79 6.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.165 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -163.59 -85.27 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.24 169.59 22.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.421 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 pt -143.12 132.9 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 2.7 pt20 -118.19 150.46 39.37 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.325 0.583 . . . . 0.0 112.245 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.47 115.9 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.462 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.359 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.293 -179.115 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 t -84.01 -175.69 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.2 pt -71.8 -38.43 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.505 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -81.31 -31.22 33.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.196 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.27 -152.79 23.98 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -92.9 -45.52 7.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.324 . . . . 0.0 110.482 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.5 162.7 30.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.734 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.64 164.95 19.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.015 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -68.44 -178.12 1.05 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.28 156.64 24.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.423 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.77 97.09 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.29 145.12 47.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -154.44 122.99 3.02 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.503 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.95 87.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.059 2.506 . . . . 0.0 112.867 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -160.5 33.16 0.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.968 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mp -143.02 -176.25 4.83 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.325 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptt -120.16 148.24 43.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.851 0.358 . . . . 0.0 111.512 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.434 ' CE2' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -136.9 79.82 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 179.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -31.01 49.19 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.323 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 115' ' ' THR . . . 112.77 -64.75 0.27 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.46 101.96 0.64 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.629 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.416 ' CA ' ' HB ' ' A' ' 132' ' ' VAL . . . 83.25 69.92 1.37 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.977 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.1 mm -132.62 137.09 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.654 0.227 . . . . 0.0 111.149 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tp -112.73 94.93 5.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.58 144.16 41.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.203 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 122.68 26.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.342 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.0 166.08 21.14 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.402 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -146.88 142.28 27.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.324 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.48 -40.99 18.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.394 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.55 179.79 34.9 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.619 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.73 122.57 11.21 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.552 2.168 . . . . 0.0 111.821 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.99 28.77 18.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.937 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.1 m -137.22 80.09 1.79 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 110.632 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -102.71 163.06 12.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.642 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.4 -127.46 2.77 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.6 m -135.71 41.3 2.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.953 0.406 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -108.48 161.31 15.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.74 161.35 42.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 24.3 p90 -137.52 130.45 30.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 111.298 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.2 107.77 22.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.085 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -79.78 138.94 37.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.522 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 pp -114.77 -17.88 11.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.553 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -112.99 162.96 19.3 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.483 0.182 . . . . 0.0 111.02 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.405 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 52.5 Cg_endo -68.52 122.64 9.63 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 112.762 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 122' ' ' LEU . 77.9 p -147.15 70.23 1.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.827 0.346 . . . . 0.0 111.465 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.77 -38.81 92.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.903 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -62.47 -26.62 68.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.399 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 2.1 mt -64.53 -16.44 62.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.586 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.89 81.98 0.2 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 110.0 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 169.6 -45.19 0.21 Allowed Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.358 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -70.73 -45.65 64.49 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.512 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -114.6 136.4 53.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.0 t -80.12 162.6 24.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.915 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.434 HD12 ' CE2' ' A' ' 92' ' ' PHE . 1.1 tt -87.85 -179.44 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.673 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.78 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.79 -179.71 27.67 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.76 161.72 33.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.822 0.344 . . . . 0.0 111.062 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . 0.416 ' HB ' ' CA ' ' A' ' 96' ' ' GLY . 13.9 t -114.89 87.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.7 t -84.97 -36.4 21.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.52 101.27 3.85 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.016 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.81 -21.96 0.31 Allowed Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.343 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.442 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.7 tt -50.72 -30.88 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.988 0.394 . . . . 0.0 111.503 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.32 -13.83 63.24 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.8 ttp -97.35 -32.65 11.77 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.919 0.36 . . . . 0.0 111.077 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' A' ' 136' ' ' ILE . 3.0 m -81.03 -30.74 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -79.29 -33.82 42.98 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.394 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -64.78 -29.56 70.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.8 t -56.91 -34.94 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.705 0.288 . . . . 0.0 110.895 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.23 -30.82 24.26 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.565 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.1 mtt -61.43 -27.38 68.51 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.2 p -82.82 33.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 62.38 171.36 0.13 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.018 0.437 . . . . 0.0 111.529 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -147.33 172.4 13.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 1.4 m-20 -85.06 -176.48 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.8 p -90.52 34.46 0.89 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.409 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -164.53 36.83 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.897 0.379 . . . . 0.0 110.774 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.61 57.83 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.088 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.421 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.2 OUTLIER -126.66 133.74 25.33 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 133.84 23.28 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.518 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.57 -35.26 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.809 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 -173.4 4.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.6 104.4 13.09 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.228 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.8 122.13 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -156.3 162.54 40.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.243 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.3 mt -97.26 129.36 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.803 0.335 . . . . 0.0 111.245 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 26.7 pt -111.94 -36.53 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.042 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -145.24 150.52 36.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.51 88.71 1.01 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.122 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -126.3 153.76 74.63 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.851 0.358 . . . . 0.0 111.621 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.22 140.65 14.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 112.382 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.86 152.78 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.072 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.536 179.584 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.561 0.219 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.72 92.53 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.679 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -110.01 132.02 54.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.96 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.426 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 1.3 pt -94.63 99.41 4.01 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.769 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 4' ' ' ILE . 1.9 Cg_endo -45.06 -55.21 3.58 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.867 2.378 . . . . 0.0 112.849 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.417 ' HD3' ' HG2' ' A' ' 5' ' ' PRO . 58.5 Cg_endo -71.07 162.38 42.85 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.185 1.923 . . . . 0.0 112.111 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.59 169.03 19.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.112 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 p -139.16 126.71 21.77 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -99.08 -60.64 1.49 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 63.1 109.21 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.214 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.53 110.69 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.622 2.215 . . . . 0.0 112.198 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.84 12.78 2.93 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.748 2.298 . . . . 0.0 113.446 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.36 145.93 41.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.738 0.304 . . . . 0.0 110.97 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.31 138.18 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -110.93 104.12 12.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.254 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.29 102.22 14.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.9 83.35 5.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.39 148.65 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 t -58.16 -33.92 69.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.42 -41.27 85.14 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.341 . . . . 0.0 110.569 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.04 154.45 9.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.145 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.7 tp -80.27 136.24 23.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 111.46 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.1 pt -144.44 137.06 22.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.442 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.84 143.08 12.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mt -124.92 163.68 21.74 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.33 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.11 114.2 20.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.783 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 142.9 27.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.541 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.465 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 17.2 m-85 -92.32 97.24 10.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -78.81 14.83 1.21 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -66.51 0.9 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.47 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 2.9 m80 -100.67 -15.38 17.75 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.29 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.667 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.45 1.15 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.667 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 61.7 Cg_exo -39.48 -35.63 0.87 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 122.198 1.932 . . . . 0.0 113.33 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -63.26 1.22 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.773 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 t -65.65 -36.1 82.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.684 179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.2 t -55.22 -50.97 68.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.469 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -58.98 -40.29 84.37 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -51.22 64.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.845 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -43.1 90.8 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.039 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.79 72.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.85 -50.31 69.34 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.146 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -37.83 71.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.0 -31.98 56.88 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -75.57 -48.06 24.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.264 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -28.78 67.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.823 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.06 45.6 1.46 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -102.03 -45.87 5.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.583 0.23 . . . . 0.0 110.667 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -68.25 -30.65 69.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.221 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -59.31 113.36 2.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.059 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 -18.61 26.5 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.987 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.45 175.23 9.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.744 0.307 . . . . 0.0 110.926 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.4 pttt -154.51 173.21 16.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.488 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.49 120.72 26.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.131 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -98.62 -30.48 12.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.498 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.5 123.96 46.39 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.614 0.245 . . . . 0.0 110.627 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.485 ' HA ' HG23 ' A' ' 62' ' ' ILE . 55.5 mt -145.79 100.14 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.448 HG21 HD11 ' A' ' 57' ' ' ILE . 31.0 mt -90.81 118.59 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.586 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -56.46 123.84 16.11 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.191 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.5 t70 59.07 50.22 8.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.155 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.73 -84.61 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.78 171.41 18.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.348 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.485 HG23 ' HA ' ' A' ' 56' ' ' ILE . 1.8 pp -141.02 114.59 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.753 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.6 tt0 -93.75 134.79 35.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 111.617 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.422 ' HA3' ' CE1' ' A' ' 112' ' ' PHE . . . -94.06 152.33 20.65 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.571 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.89 178.54 53.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.165 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.563 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 5.0 t0 -174.87 -58.54 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.995 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 73.6 Cg_endo -76.26 63.72 7.05 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.412 2.074 . . . . 0.0 111.781 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.4 m 65.5 12.62 8.31 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.535 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.83 13.75 14.09 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 121.209 -0.52 . . . . 0.0 113.777 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.9 p -156.31 22.24 0.36 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.196 0.498 . . . . 0.0 111.731 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.9 30.76 45.91 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.222 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -55.0 4.26 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.692 0.282 . . . . 0.0 110.7 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.18 94.43 0.19 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.176 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.45 132.13 4.49 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.587 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.09 142.8 24.62 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.878 0.37 . . . . 0.0 111.463 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 t -81.18 157.38 25.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.847 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.9 pt -58.44 -36.64 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.372 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.63 -31.41 57.37 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.48 -155.71 27.22 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.567 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -78.36 -55.48 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.674 0.273 . . . . 0.0 110.792 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -135.18 146.15 48.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.808 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -133.14 179.48 6.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -77.91 134.12 37.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.545 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.89 137.09 33.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.281 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.54 40.58 1.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.8 tp -80.14 133.69 36.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.614 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.39 118.08 3.53 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.694 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.92 101.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.28 -46.02 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.74 177.25 7.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -149.79 150.46 32.04 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -112.99 61.34 0.64 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.226 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -126.11 -46.59 1.66 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -61.98 112.3 4.71 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.89 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -45.32 120.37 2.45 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.64 64.93 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.089 179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.42 HG12 ' O ' ' A' ' 94' ' ' GLY . 7.3 mm -133.4 157.05 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.807 0.304 . . . . 0.0 111.382 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 tp -118.89 101.16 7.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.784 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.473 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -104.8 141.12 37.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.232 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.46 127.95 32.76 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.854 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -130.48 177.25 7.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -121.83 -51.91 2.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.85 -179.45 34.66 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.473 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -50.96 117.28 3.22 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.643 2.229 . . . . 0.0 112.052 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 61.64 31.13 18.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.993 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -138.26 94.89 2.92 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.458 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.7 150.08 30.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.935 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.08 -146.11 12.15 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 26.45 5.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.671 0.272 . . . . 0.0 111.474 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -90.5 165.44 13.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.422 ' CE1' ' HA3' ' A' ' 64' ' ' GLY . 9.5 p90 -154.25 127.31 8.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.785 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.415 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 26.6 p90 -124.55 135.1 52.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.356 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.475 HG11 HG13 ' A' ' 62' ' ' ILE . 10.0 p -108.2 121.58 61.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.727 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.7 p -80.43 119.05 22.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -97.94 -7.87 29.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.826 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.65 148.4 65.44 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.465 0.174 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.82 132.61 50.39 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.889 2.393 . . . . 0.0 112.341 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.428 HG23 ' CZ2' ' A' ' 121' ' ' TRP . 27.0 p -144.98 107.59 4.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 111.418 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -96.67 -30.39 13.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.462 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.428 ' CZ2' HG23 ' A' ' 119' ' ' THR . 22.0 p90 -61.12 -40.87 95.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.687 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.59 0.43 57.43 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.82 81.21 0.02 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 110.885 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.03 -23.68 2.42 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.809 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -57.03 -56.28 23.86 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.58 0.228 . . . . 0.0 111.295 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -98.24 179.14 4.84 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 25.4 m -107.96 158.67 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.769 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 0.4 OUTLIER -90.29 -179.01 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.511 179.376 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -177.45 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.35 179.98 25.7 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.817 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -136.9 158.59 44.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.661 0.267 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.5 t -118.18 84.12 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -77.41 -56.66 4.36 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.423 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -109.01 93.1 4.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.888 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.57 -22.48 0.28 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.233 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.5 tt -46.47 -34.41 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.51 -45.52 96.12 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.404 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.31 -33.77 75.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.72 0.295 . . . . 0.0 110.615 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.1 t -76.22 -35.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.806 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -55.1 -51.55 66.03 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.84 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.8 ptp180 -57.64 -37.3 73.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.015 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 38.0 t -59.75 -28.45 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.102 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.63 -30.98 13.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.144 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 mtt -76.62 -24.28 53.37 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 33.6 m -60.53 176.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.782 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 130.44 37.17 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.5 p -119.83 172.95 7.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -82.97 -171.03 3.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.511 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.1 m -92.17 28.21 1.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.699 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -155.36 -72.14 0.12 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.84 41.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.035 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.18 123.85 30.36 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.443 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.16 119.65 6.61 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.735 2.29 . . . . 0.0 112.425 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.43 -32.95 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.769 0.319 . . . . 0.0 110.496 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.88 -167.11 1.15 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.552 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.52 112.94 20.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 111.451 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.9 t -133.55 126.5 51.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.341 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.75 174.05 15.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 111.607 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mt -108.08 135.78 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 160' ' ' ILE . 5.0 pt -107.31 -33.32 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.493 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -170.59 159.32 6.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.71 0.29 . . . . 0.0 110.903 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -148.95 135.24 19.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.95 144.68 16.98 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.59 152.56 22.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.364 2.042 . . . . 0.0 112.162 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 m -63.07 150.94 41.36 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.997 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.375 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.594 0.235 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.03 145.73 49.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.201 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.69 14.51 7.28 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.031 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.43 HD12 HG22 ' A' ' 4' ' ' ILE . 21.2 mt -149.13 63.94 7.07 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.522 0.201 . . . . 0.0 110.666 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.63 107.58 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.659 2.24 . . . . 0.0 112.328 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.05 95.65 0.96 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.772 2.315 . . . . 0.0 112.553 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t70 69.47 152.94 0.1 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.324 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -117.22 134.92 54.22 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.847 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -166.36 118.48 1.02 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.143 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -135.26 92.82 17.44 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.693 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.86 104.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.914 2.409 . . . . 0.0 112.534 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.45 -51.56 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.954 2.436 . . . . 0.0 112.406 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -112.16 176.84 4.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.048 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 39.2 t -143.44 129.87 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -93.72 101.5 13.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.704 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.91 90.87 8.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.155 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.17 101.39 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.208 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -110.0 165.18 11.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -33.01 71.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -32.75 69.57 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.5 -145.44 8.02 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.447 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -143.22 130.01 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.228 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 33.4 pt -134.26 134.11 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.964 0.412 . . . . 0.0 111.63 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.17 117.22 43.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.1 mp -98.1 148.31 23.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -117.13 100.82 7.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.5 mt -83.13 137.54 34.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.493 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.481 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 26.3 m-85 -71.08 98.15 1.6 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.961 0.41 . . . . 0.0 110.818 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.416 ' CE3' ' CD ' ' A' ' 30' ' ' LYS . 2.2 p-90 -79.05 11.51 2.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.494 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' A' ' 30' ' ' LYS . 0.3 OUTLIER -100.41 -69.36 0.77 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.683 0.278 . . . . 0.0 110.851 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.486 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -100.75 -17.0 17.14 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.655 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -96.87 1.06 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.8 Cg_exo -42.0 -35.57 3.23 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 121.937 1.758 . . . . 0.0 112.875 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -59.27 -59.54 5.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.686 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 p -64.19 -34.38 77.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.569 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.3 t -57.15 -47.61 80.76 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.547 179.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -61.14 -40.82 95.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -61.37 -41.46 97.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -38.6 74.14 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.71 55.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.815 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -64.94 -32.62 74.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.79 -43.84 73.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.558 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.52 -31.81 32.61 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.199 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -49.14 66.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 36.4 mtp85 -59.58 -31.92 69.9 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.58 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.09 28.61 3.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.759 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -97.67 -31.25 12.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.607 0.241 . . . . 0.0 110.823 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -81.77 -57.34 3.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.065 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -63.51 124.9 22.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 110.453 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.75 -29.79 6.99 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.542 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.6 m -61.94 162.64 8.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.775 0.322 . . . . 0.0 111.256 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -136.54 33.76 2.73 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.069 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 59.86 179.09 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.637 0.256 . . . . 0.0 111.203 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -145.11 -70.96 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.601 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -95.9 130.01 42.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 111.208 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.417 ' HA ' HG22 ' A' ' 62' ' ' ILE . 27.1 mm -133.07 92.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.961 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.3 117.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.149 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -76.05 150.32 37.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 61.89 31.2 18.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -160.41 -88.49 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.088 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.29 170.13 21.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 111.408 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.417 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -140.82 125.45 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.0 mt-30 -94.1 157.0 16.29 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.052 0.454 . . . . 0.0 111.496 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.63 153.44 19.96 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.55 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.62 171.07 49.04 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.139 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.436 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -160.6 -64.71 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.274 . . . . 0.0 110.714 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' CD ' ' CB ' ' A' ' 66' ' ' ASP . 86.4 Cg_endo -77.8 163.26 29.02 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.448 2.098 . . . . 0.0 112.888 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.6 m 57.29 37.59 28.24 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.244 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.2 -32.91 77.9 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.614 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 p -85.68 -34.09 21.38 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.606 0.241 . . . . 0.0 111.233 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 94.89 60.35 1.08 Allowed Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.328 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.21 -52.23 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.485 0.183 . . . . 0.0 111.147 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.56 140.79 16.3 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.734 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.11 87.16 0.33 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.554 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.73 156.7 41.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.593 0.235 . . . . 0.0 111.222 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.2 p -104.88 164.96 11.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.076 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.5 pp -66.06 -33.02 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.496 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -75.91 -30.66 58.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.38 -140.68 6.41 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.749 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.24 76.28 1.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.98 0.419 . . . . 0.0 110.475 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 54.9 mm-40 70.8 135.63 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.919 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.41 -175.36 4.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.181 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.83 -179.62 1.21 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.28 141.63 36.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.863 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -78.19 109.76 12.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.156 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tp -156.33 134.24 11.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.407 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.99 -62.39 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.1 151.95 50.31 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.526 2.151 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.03 89.57 1.46 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.702 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.24 -178.29 5.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.149 -179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.4 155.14 27.95 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.83 83.98 1.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.741 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.5 p -69.52 -34.82 74.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.91 6.17 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.662 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.87 117.23 34.41 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.808 0.304 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.09 59.89 6.52 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.741 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.1 mm -140.32 144.73 27.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.565 0.221 . . . . 0.0 110.78 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.466 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 1.1 mt -116.49 127.4 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -127.64 142.62 51.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.339 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 104.28 10.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.02 179.49 5.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.244 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.86 176.51 12.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.28 14.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.578 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.06 149.94 21.61 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.71 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.67 141.64 34.06 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.883 2.389 . . . . 0.0 112.663 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 63.21 23.22 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.19 80.5 1.25 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 110.673 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.19 113.07 24.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.53 -107.38 0.17 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.241 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 1.6 m -149.44 25.43 0.87 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -90.64 163.82 14.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.237 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 7.3 p90 -151.93 175.66 12.26 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.85 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 15.7 p90 -152.7 124.06 7.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 111.43 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.6 t -89.65 111.95 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.058 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 81.9 p -79.68 120.67 24.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.416 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.55 -25.29 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.336 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.77 156.4 40.73 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.095 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.4 130.82 30.36 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.016 2.478 . . . . 0.0 113.043 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.3 p -148.41 62.95 1.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -83.4 -14.7 52.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.73 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -90.77 -25.92 19.73 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.68 0.276 . . . . 0.0 111.29 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.22 1.25 29.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.762 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.76 79.52 0.29 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.23 -37.71 0.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.677 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -67.77 -54.9 15.58 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.664 0.268 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -109.86 138.35 46.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.73 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 3.6 t -84.56 157.74 21.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.95 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.72 -179.63 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.724 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.466 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -170.46 -42.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.186 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.72 177.97 25.64 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.728 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.17 153.95 42.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.8 p -109.71 107.12 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.097 0.475 . . . . 0.0 111.408 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.67 -46.0 7.45 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -123.45 84.27 2.25 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.873 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.62 -23.98 0.1 OUTLIER Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.583 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.8 tt -41.34 -37.34 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.16 -43.7 96.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.602 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 ttp -65.67 -39.56 91.48 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.549 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -61.41 -32.21 72.15 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.909 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -33.56 71.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.964 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.85 -30.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.03 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.7 -31.88 10.79 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.234 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.5 mmt -58.52 -36.01 73.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.511 0.196 . . . . 0.0 111.358 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 30.2 m -64.23 176.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.563 179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.68 172.24 13.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.057 0.456 . . . . 0.0 111.005 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.22 171.49 15.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.29 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.29 -171.1 1.85 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.84 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 p -95.21 30.28 2.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -152.65 32.07 0.51 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.4 t0 55.47 68.76 0.82 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.816 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -150.72 114.48 3.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.737 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.3 152.4 61.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.056 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 36.2 t -69.89 -37.98 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.41 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.35 80.6 1.52 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.351 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.86 148.25 10.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.59 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 8.3 t -82.71 141.24 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.147 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -126.15 152.73 45.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 111.384 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 6.7 mt -115.05 140.85 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 25.1 pt -120.14 -37.8 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.051 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.53 165.1 28.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.962 0.41 . . . . 0.0 111.472 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.53 87.31 1.02 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.673 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -100.86 106.53 44.58 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.166 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.74 93.23 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.656 2.237 . . . . 0.0 112.132 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.5 m -150.65 164.74 35.36 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.206 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.275 -1.291 . . . . 0.0 112.842 179.752 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.658 0.266 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.03 155.57 21.05 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.63 62.77 0.72 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.366 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 tt -173.66 87.85 0.37 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 120.992 0.425 . . . . 0.0 111.576 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 44.2 Cg_exo -55.36 -49.0 17.68 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.662 2.241 . . . . 0.0 113.042 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 5' ' ' PRO . 94.9 Cg_endo -79.98 133.05 9.86 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.473 2.115 . . . . 0.0 112.404 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -119.83 169.78 9.83 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.348 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.82 157.06 17.58 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.081 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -129.89 -51.29 1.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.277 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.63 143.54 30.79 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.719 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.66 109.55 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.817 2.345 . . . . 0.0 112.569 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.42 -17.23 30.65 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.623 2.216 . . . . 0.0 112.841 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.43 158.64 16.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.707 0.289 . . . . 0.0 111.213 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 23.7 m -141.24 135.9 32.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.981 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -92.54 113.14 25.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 mt -97.86 96.14 8.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.39 113.67 20.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.722 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.437 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.7 OUTLIER -125.81 156.16 39.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.949 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.5 t -59.07 -33.55 70.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.07 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.0 tpt -69.97 -30.86 68.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.191 179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.13 -161.54 34.03 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 tt -122.3 128.13 75.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 117.105 0.452 . . . . 0.0 111.202 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.3 pt -129.49 127.59 65.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.047 0.451 . . . . 0.0 111.898 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.49 121.08 51.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.415 ' CD2' HD21 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -127.9 157.96 39.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.222 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.8 150.61 23.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.73 135.75 54.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 44.6 m-85 -76.69 95.04 3.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.725 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -78.86 11.35 2.69 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.32 -61.87 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 122.179 -0.325 . . . . 0.0 110.957 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.485 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 21.0 m170 -100.6 -15.02 17.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.663 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.41 1.31 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 58.8 Cg_exo -38.96 -38.15 1.01 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.353 2.036 . . . . 0.0 113.156 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -61.36 -57.97 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.578 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.2 -35.22 79.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.752 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.2 m -55.2 -51.6 66.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.4 89.48 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.547 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.4 -50.77 72.48 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.745 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.75 -47.96 83.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.555 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.35 86.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.073 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -38.79 92.21 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.453 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -60.42 3.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.586 0.232 . . . . 0.0 111.381 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.35 98.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.679 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -48.6 72.28 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.327 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -61.8 -55.54 28.96 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.49 43.16 0.06 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.243 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -45.75 2.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.781 0.324 . . . . 0.0 110.566 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.06 -24.58 59.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.113 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.88 102.47 4.75 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.55 26.95 4.59 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.4 178.08 6.41 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.04 0.42 . . . . 0.0 110.952 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -157.02 134.8 10.87 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.954 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.437 ' CD1' HG11 ' A' ' 157' ' ' VAL . 28.3 m-85 -69.3 124.09 22.92 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.11 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -100.73 -32.19 10.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.014 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.437 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -119.31 119.8 35.08 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.81 0.338 . . . . 0.0 111.228 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.0 mt -135.13 94.54 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.668 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.3 mt -83.35 108.8 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -63.99 145.34 56.04 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.36 30.77 20.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.321 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.3 -83.3 0.08 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.247 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.45 168.29 25.45 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.471 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.427 HG22 ' CD2' ' A' ' 53' ' ' PHE . 3.7 mp -131.91 125.95 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.526 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.502 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 1.4 pt20 -112.83 138.83 49.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.289 0.566 . . . . 0.0 112.348 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.48 103.86 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.379 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.492 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . -129.26 -179.75 16.17 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.277 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -114.85 73.53 3.12 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.858 0.361 . . . . 0.0 110.815 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.26 -1.44 11.61 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.788 2.325 . . . . 0.0 113.425 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.4 m 60.01 33.18 21.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.717 0.294 . . . . 0.0 111.148 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.41 24.81 59.71 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.574 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.4 p -125.97 -45.53 1.72 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.029 0.414 . . . . 0.0 111.315 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.45 38.19 13.0 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.195 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -177.76 -46.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.622 0.248 . . . . 0.0 110.881 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.67 97.3 2.31 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.545 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.69 162.53 27.0 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.698 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.41 155.55 48.39 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.639 0.257 . . . . 0.0 111.497 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.0 p -129.4 172.81 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.62 -35.45 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.501 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -74.25 -33.59 63.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.247 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.72 -151.7 20.47 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.767 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -83.61 -52.09 6.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.727 0.263 . . . . 0.0 110.612 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -154.46 150.74 28.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.31 174.5 10.48 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.513 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.87 173.76 7.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.8 169.45 11.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.636 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -129.74 47.06 2.55 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 tp -68.68 145.51 53.81 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -162.79 86.7 1.38 Allowed Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.985 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.99 100.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.766 2.311 . . . . 0.0 112.26 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.71 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.939 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 mp -66.94 175.82 2.33 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.734 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -106.91 165.14 11.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.42 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.86 70.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.7 p -57.3 -30.34 64.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.703 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 102.69 -48.1 1.07 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.649 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.0 109.64 18.34 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.296 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.03 63.85 2.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.784 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.5 mm -131.94 152.46 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.751 0.276 . . . . 0.0 111.312 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.415 HD21 ' CD2' ' A' ' 25' ' ' LEU . 4.7 tp -131.28 101.7 5.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -110.13 144.38 38.83 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.28 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.73 106.69 11.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.33 151.28 23.24 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.548 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -123.09 157.39 32.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.44 63.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.08 179.63 35.49 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.353 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.39 125.95 17.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.582 2.188 . . . . 0.0 112.007 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.1 30.13 19.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.9 m -142.6 91.03 2.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -96.99 155.11 16.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.162 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.32 -151.72 5.48 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.849 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 m -104.16 64.95 0.78 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.492 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -141.42 146.54 36.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -151.08 166.02 32.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.488 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.502 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 30.2 p90 -137.76 142.46 40.94 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.3 t -111.23 106.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 p -80.32 134.78 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.552 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.38 -27.6 8.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.47 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.76 151.56 39.35 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.655 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.431 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 66.0 Cg_exo -52.38 130.1 34.5 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.809 2.34 . . . . 0.0 112.484 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.9 t -161.07 77.72 0.57 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 111.197 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.07 -3.73 52.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.422 ' CD1' HD23 ' A' ' 122' ' ' LEU . 36.4 p90 -89.54 -27.22 20.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.079 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 121' ' ' TRP . 0.9 OUTLIER -63.75 -21.16 66.27 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.286 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -66.82 84.75 0.12 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.203 0.525 . . . . 0.0 110.314 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.15 -47.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.035 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -80.17 -35.36 36.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.467 0.175 . . . . 0.0 110.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -122.31 134.51 54.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.802 0.334 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 31.8 m -80.88 161.12 24.53 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 tt -79.54 -179.24 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.456 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -176.69 -39.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.26 -179.97 26.51 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.85 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -148.81 148.84 30.4 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 122.78 -0.247 . . . . 0.0 110.654 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.4 m -79.13 136.77 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 111.552 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 7.2 t -118.78 -47.06 2.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -142.56 80.93 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.999 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 176.03 -21.6 0.05 OUTLIER Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.116 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 14.6 tt -40.85 -38.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.19 93.89 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.555 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.9 ttp -59.78 -41.61 91.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.773 0.32 . . . . 0.0 110.379 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.18 -44.87 84.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.582 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -61.83 -40.84 96.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -56.5 -40.78 75.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.6 t -56.97 -38.29 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.291 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.84 -29.96 16.54 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.625 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 79.1 mmm -66.53 -16.92 64.51 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 16.2 m -88.2 19.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 165.22 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.4 p -144.18 174.55 10.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.489 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -172.69 3.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.9 m -93.55 33.74 1.24 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.92 31.94 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.478 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 52.7 51.22 16.45 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -123.3 143.49 41.29 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.822 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.21 141.78 32.9 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.68 2.254 . . . . 0.0 112.531 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 6.4 m -78.89 -35.4 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.888 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.17 11.46 38.25 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.13 138.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.268 0.556 . . . . 0.0 112.295 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.437 HG11 ' CD1' ' A' ' 53' ' ' PHE . 38.4 t -128.74 132.89 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.693 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 159' ' ' ILE . 2.5 tttp -144.17 156.68 44.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.795 0.331 . . . . 0.0 111.408 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.471 ' N ' ' HG2' ' A' ' 158' ' ' LYS . 7.2 mt -110.82 120.46 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 31.8 pt -81.67 -43.47 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -175.21 174.31 2.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.78 133.61 15.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -152.29 157.26 33.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.116 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -79.34 148.86 21.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.261 1.974 . . . . 0.0 112.1 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.5 m -61.94 147.47 46.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.695 -1.059 . . . . 0.0 112.857 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.407 0.146 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.16 -75.33 0.26 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.192 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.57 131.58 4.21 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.72 0.295 . . . . 0.0 111.253 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.456 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 11.5 mm -79.59 -49.79 1.34 Allowed Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.506 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 97.9 Cg_endo -81.55 128.34 6.07 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.354 2.036 . . . . 0.0 112.784 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.93 -174.12 1.81 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.666 2.244 . . . . 0.0 112.494 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.6 104.13 6.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.84 0.352 . . . . 0.0 111.344 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 p -74.61 -35.42 62.93 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 69.73 154.06 0.12 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.527 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.25 139.25 84.27 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.975 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.37 157.22 29.27 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.551 2.167 . . . . 0.0 112.368 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.41 62.1 3.52 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.225 2.617 . . . . 0.0 112.155 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -126.17 160.16 30.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.7 154.84 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -114.04 111.3 21.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.218 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.26 109.08 20.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 2.9 mm-40 -81.15 112.59 18.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.863 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.77 145.09 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.5 t -56.71 -36.31 69.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.027 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 tpt -65.71 -29.15 69.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.742 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' HA3' ' HG2' ' A' ' 138' ' ' MET . . . 153.46 150.48 5.46 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.204 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 tt -80.32 139.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.758 0.279 . . . . 0.0 111.031 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.8 pt -145.93 133.47 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.753 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.32 137.71 21.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 mt -129.94 147.82 51.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.77 113.19 26.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.776 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 mt -96.87 119.14 34.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -66.67 102.91 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -80.62 12.34 3.18 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -61.82 1.32 Allowed 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.834 0.35 . . . . 0.0 110.623 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.47 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 62.2 m170 -100.75 -15.5 17.65 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.564 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.665 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.66 0.98 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.0 Cg_exo -40.77 -35.31 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.286 1.99 . . . . 0.0 113.137 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -60.02 3.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.628 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.8 m -67.28 -43.61 81.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.851 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.8 t -54.69 -47.52 73.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -59.17 -48.95 79.73 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.271 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -60.98 -43.41 98.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.125 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.11 -56.42 21.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.999 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.9 94.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.262 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.31 -46.33 83.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -36.8 77.65 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.095 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 162' ' ' ALA . . . -66.58 -48.92 68.06 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.74 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -35.03 79.54 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.974 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -36.81 84.95 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.232 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.5 41.17 1.65 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.401 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -113.34 -47.49 3.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.463 0.173 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.13 -32.33 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.055 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 112.39 8.3 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.686 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.97 -23.76 11.32 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.099 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.54 178.48 2.02 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.073 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -156.91 159.6 38.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.161 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.406 ' HB2' HG13 ' A' ' 157' ' ' VAL . 79.0 m-85 -74.06 129.6 38.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -106.63 -36.56 6.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.441 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 119.1 37.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 22.1 mt -139.4 130.82 34.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.17 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.7 mt -114.87 120.53 64.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.039 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.26 142.5 52.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.226 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 29.73 19.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.861 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.39 -85.13 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.877 -0.147 . . . . 0.0 111.306 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.65 173.32 15.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.429 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.7 mp -133.31 119.97 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.577 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.8 pt20 -106.75 143.96 34.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.83 124.75 2.65 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.71 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.39 -179.63 35.29 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.187 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.11 55.94 0.56 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 111.641 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -79.22 58.76 7.1 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.717 2.278 . . . . 0.0 112.227 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.8 p -120.02 -71.44 0.74 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.25 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.97 27.78 69.29 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.823 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -89.93 -36.3 15.08 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.653 0.227 . . . . 0.0 111.505 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.14 -37.57 3.65 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.459 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -62.32 1.44 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.514 0.197 . . . . 0.0 111.128 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.29 173.58 36.91 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.707 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -138.91 107.8 0.58 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.616 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.91 144.4 31.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 p -78.26 174.95 10.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.74 -31.4 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -79.67 -69.44 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.451 0.167 . . . . 0.0 110.945 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.08 158.46 30.79 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -33.51 72.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.25 140.96 26.9 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.691 0.282 . . . . 0.0 111.077 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -156.85 172.17 19.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.357 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.13 179.31 0.96 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -101.26 179.84 4.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.996 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -129.74 36.54 4.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mt -57.52 146.77 28.86 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.511 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.79 145.68 17.99 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 68.57 5.26 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.614 2.209 . . . . 0.0 112.631 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -165.46 172.98 11.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.104 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mp 64.38 172.65 0.19 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.658 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 163.64 10.22 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.993 0.425 . . . . 0.0 112.006 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -116.76 87.43 2.69 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.147 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -127.93 -52.45 1.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.609 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.25 7.35 68.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.147 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.02 -169.6 0.2 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.634 0.373 . . . . 0.0 111.191 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.49 47.58 90.44 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.5 mm -120.45 154.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.74 0.305 . . . . 0.0 111.089 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tp -124.42 104.03 8.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.036 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.522 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -116.57 140.16 49.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.575 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.454 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.56 121.09 24.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.309 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -110.9 172.2 7.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.378 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -150.7 152.94 34.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.99 78.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.36 176.05 33.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.183 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.47 125.03 15.84 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.537 2.158 . . . . 0.0 111.948 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.23 36.44 17.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -147.54 83.41 1.54 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.908 0.385 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.38 168.65 10.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.41 46.08 0.46 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.901 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t 55.48 37.01 28.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.294 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 161.61 14.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -160.29 173.47 15.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 21.7 p90 -148.24 132.15 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.0 111.399 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.1 p -103.06 120.39 52.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.588 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 17.5 p -79.49 129.81 34.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.424 ' CD2' ' HA3' ' A' ' 143' ' ' GLY . 4.1 pp -109.61 -10.7 14.83 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.897 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -136.47 164.33 43.49 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 120.509 0.195 . . . . 0.0 111.298 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.94 119.97 7.07 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.609 2.206 . . . . 0.0 111.434 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 71.9 p -136.43 103.39 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.675 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.536 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -60.09 -41.57 92.79 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.605 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.6 pp -86.89 0.17 55.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.453 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.85 84.04 0.31 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.825 0.345 . . . . 0.0 110.717 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.54 -29.59 2.25 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.076 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -57.9 11.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.605 0.24 . . . . 0.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -95.77 159.19 15.1 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 6.7 t -93.59 161.3 14.41 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.522 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 3.3 mm -89.04 -178.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.289 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.454 ' HB3' ' HB2' ' A' ' 100' ' ' MET . 2.4 p90 -178.96 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.485 0.183 . . . . 0.0 111.346 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.66 -179.64 19.62 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.48 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.38 162.22 38.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.614 0.245 . . . . 0.0 110.986 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.0 t -116.47 121.27 67.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.825 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.3 t -115.35 -63.81 1.4 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.93 91.5 3.68 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.803 0.335 . . . . 0.0 110.311 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.2 -22.16 0.58 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.193 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.44 HG21 HD12 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -44.88 -36.2 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -53.79 -42.52 68.9 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.707 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.455 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 7.1 tpt -75.17 -43.67 50.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.564 0.221 . . . . 0.0 110.698 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.4 t -54.49 -35.95 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.923 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -61.67 -39.34 91.04 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.911 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -38.21 80.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.015 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.2 t -58.08 -31.15 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.756 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.424 ' HA3' ' CD2' ' A' ' 116' ' ' LEU . . . -92.14 -38.49 5.68 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.042 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.2 tpt -53.02 -34.58 57.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.473 0.309 . . . . 0.0 111.692 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 m -59.48 168.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.895 0.379 . . . . 0.0 111.469 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -104.35 148.01 26.87 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -96.83 165.36 12.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.92 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -136.0 146.75 47.52 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.88 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.26 -46.43 0.13 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.004 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -173.47 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -176.84 38.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.6 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -101.09 123.03 46.48 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.718 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.36 132.41 35.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.803 2.335 . . . . 0.0 112.563 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 41.3 t -70.23 -42.81 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.709 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.42 115.02 17.84 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.18 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.18 96.17 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.5 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.406 HG13 ' HB2' ' A' ' 53' ' ' PHE . 12.5 p -90.41 139.42 17.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.98 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 18.2 pttt -154.7 155.64 34.97 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.213 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 mt -96.69 145.99 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.889 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.07 -52.12 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.441 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 44.4 mtpt -144.43 171.57 14.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.415 ' HB2' ' HB2' ' A' ' 43' ' ' ALA . . . -159.35 104.79 1.66 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.086 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.06 154.66 77.67 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.311 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.15 172.24 13.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.618 2.212 . . . . 0.0 112.581 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.25 -33.84 11.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.252 -1.304 . . . . 0.0 112.582 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.522 0.201 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.62 92.89 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.452 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.09 -50.66 0.23 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.314 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 mt -111.01 93.0 16.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.03 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.17 155.47 69.32 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.695 2.264 . . . . 0.0 112.349 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.43 -31.51 34.25 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.52 2.147 . . . . 0.0 112.247 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -116.7 175.98 5.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 110.919 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.39 -55.22 2.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER 64.67 162.05 0.12 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.28 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -132.29 81.08 61.89 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.218 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.452 ' HB2' ' HD3' ' A' ' 12' ' ' PRO . 45.4 Cg_exo -54.7 -47.84 24.54 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.686 2.257 . . . . 0.0 113.055 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 11' ' ' PRO . 84.7 Cg_endo -81.26 80.99 2.8 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.486 2.124 . . . . 0.0 112.327 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.78 99.93 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.25 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 m -94.37 146.97 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.271 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -121.01 108.72 14.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.242 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.79 104.94 17.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 110.991 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.94 97.06 6.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.625 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 p -106.43 160.18 15.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.4 ' CB ' ' HB3' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -63.71 -36.97 85.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.607 179.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.4 tpt -64.66 -32.24 73.82 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.09 -163.91 37.47 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.046 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.8 tt -122.06 118.82 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.003 0.402 . . . . 0.0 111.342 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 pt -116.01 158.19 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.8 t -122.97 120.64 61.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.931 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 mt -115.01 155.13 27.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -116.21 115.56 26.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.25 120.46 35.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.717 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -72.62 104.59 3.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -82.98 23.23 0.86 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 -65.46 0.97 Allowed 'General case' 0 C--O 1.231 0.108 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.437 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.4 m-70 -100.93 -11.49 19.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.646 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.659 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -100.14 1.05 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.2 Cg_exo -40.77 -36.05 1.82 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 122.117 1.878 . . . . 0.0 113.302 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -68.81 -53.52 21.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.943 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -69.32 -36.71 77.25 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.942 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.3 t -58.84 -50.1 75.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.63 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -59.28 -40.24 85.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.408 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -62.36 -43.06 99.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.89 -52.4 65.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.856 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.33 78.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.46 -51.05 71.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.215 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.91 -29.95 69.89 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.429 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.24 -49.22 52.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -76.63 -29.23 56.36 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.573 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -55.12 -32.13 61.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.34 46.64 0.91 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -125.34 -55.0 1.57 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.408 0.147 . . . . 0.0 111.079 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -60.81 -30.35 70.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.337 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -71.7 121.27 18.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.757 0.313 . . . . 0.0 110.469 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.28 -24.26 23.08 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.682 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.85 158.34 13.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 26.74 2.37 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 63.04 -179.43 0.15 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.015 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.41 -92.88 0.28 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.186 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -79.79 121.77 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.706 0.288 . . . . 0.0 110.513 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.465 HG12 HG13 ' A' ' 62' ' ' ILE . 7.8 mt -131.54 125.89 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 mt -129.82 118.0 43.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -56.16 25.53 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.763 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.82 49.46 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.765 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -169.22 -89.02 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.213 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.81 175.73 12.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 0.0 111.407 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.465 HG13 HG12 ' A' ' 56' ' ' ILE . 5.9 tt -139.26 109.55 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.511 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -89.47 156.6 18.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.579 0.704 . . . . 0.0 112.158 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.93 105.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.279 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.81 179.62 33.41 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.572 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 42.94 63.83 7.05 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 121.523 0.678 . . . . 0.0 111.247 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.77 56.99 6.13 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.914 2.409 . . . . 0.0 111.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.7 p -114.74 -68.0 0.96 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.184 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.65 22.31 7.78 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.215 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.33 -37.75 4.9 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.033 0.417 . . . . 0.0 111.492 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.64 30.08 76.57 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.503 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -49.27 0.11 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.564 0.221 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.06 80.09 0.26 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.484 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.39 125.37 5.9 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.579 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.1 166.99 31.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.618 0.247 . . . . 0.0 111.211 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 p -88.58 168.32 12.66 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 5.2 pt -60.93 -31.44 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.62 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -75.77 -37.13 59.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.32 -151.19 16.87 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -45.02 92.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 110.699 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -161.51 155.36 21.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.95 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -119.17 170.1 9.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.29 178.21 4.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -132.51 171.51 13.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.203 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.23 110.5 9.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.7 tp -100.79 111.07 23.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -130.59 102.52 16.6 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.957 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.03 -14.86 35.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.068 2.512 . . . . 0.0 113.141 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.78 -45.99 20.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.514 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.2 mt -80.2 138.07 36.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.0 178.17 6.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.61 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -137.75 97.64 3.48 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 21.5 p -81.87 -4.32 56.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.7 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.17 -75.06 1.8 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.979 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.84 107.66 0.32 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.851 0.358 . . . . 0.0 111.802 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.7 61.13 4.56 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.306 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 26.8 mm -137.39 131.69 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.626 0.25 . . . . 0.0 110.852 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.484 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 7.2 mt -101.63 122.16 43.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.949 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -126.22 134.93 51.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.69 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.94 107.46 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.434 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -85.99 161.97 18.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.476 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.25 140.79 22.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.49 58.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.435 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.01 175.29 35.26 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.552 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.13 121.21 9.25 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.625 2.216 . . . . 0.0 112.185 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 58.52 30.64 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.326 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.6 m -120.77 85.36 2.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.987 0.422 . . . . 0.0 110.493 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.64 120.98 39.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.988 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.63 51.35 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.409 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.7 m 58.89 35.89 24.38 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.75 139.7 33.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.669 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.65 174.97 13.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.036 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.8 p90 -159.55 140.18 12.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.218 0.533 . . . . 0.0 111.876 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.9 t -98.27 113.77 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.79 178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.46 141.94 36.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.91 -28.71 7.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.412 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.74 42.29 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.774 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.09 114.57 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.761 2.307 . . . . 0.0 112.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.3 p -129.37 68.35 1.42 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.065 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -81.11 -39.47 25.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -65.21 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.176 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mt -73.54 -9.31 58.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.664 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.16 84.45 0.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.112 0.482 . . . . 0.0 110.485 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -50.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.465 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.87 -31.58 63.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.635 0.255 . . . . 0.0 111.129 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -119.56 123.22 43.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.084 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 14.8 t -79.87 163.28 24.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 tt -80.74 -179.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.946 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.484 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -176.99 -39.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.856 -0.156 . . . . 0.0 111.287 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.93 179.47 22.04 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.549 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.05 160.91 38.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.22 96.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.017 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.3 -41.54 12.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.502 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -144.5 108.6 4.76 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.894 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.39 -19.64 1.18 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.255 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.433 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.0 tt -50.09 -29.24 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.74 -39.14 90.2 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.427 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.4 ttp -69.32 -50.51 45.84 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.393 0.14 . . . . 0.0 110.985 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.433 ' CG2' ' HA ' ' A' ' 136' ' ' ILE . 3.6 m -61.89 -20.6 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.418 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.85 -31.72 35.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.593 0.235 . . . . 0.0 110.899 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -56.32 -41.96 76.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.573 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.442 HG11 ' CG2' ' A' ' 56' ' ' ILE . 14.5 p -56.7 -30.66 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.705 0.288 . . . . 0.0 111.361 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.28 -34.91 15.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.966 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.2 mtt -62.09 -28.54 69.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.31 163.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.709 0.29 . . . . 0.0 111.236 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.39 123.07 17.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.192 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.6 p -107.35 178.71 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -79.8 -179.01 6.7 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m -90.15 19.13 5.23 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -151.1 -68.35 0.18 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -174.02 73.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.77 0.319 . . . . 0.0 111.275 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -156.4 96.98 2.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.422 ' HG3' ' CD1' ' A' ' 56' ' ' ILE . 49.5 Cg_endo -69.46 131.15 21.05 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.733 2.289 . . . . 0.0 112.232 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.64 -44.25 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.647 0.26 . . . . 0.0 110.394 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.62 63.87 0.61 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -52.16 150.5 4.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.648 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 3.9 t -79.78 101.9 5.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.791 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.4 ' HB3' ' CB ' ' A' ' 19' ' ' SER . 5.7 tttm -84.69 150.51 25.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 17.6 mt -116.77 128.99 74.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.966 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.4 pt -109.32 -33.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.14 168.02 21.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.07 107.87 2.76 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -144.26 147.08 35.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.432 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.05 174.39 11.56 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.714 2.276 . . . . 0.0 112.516 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 25.0 p -95.2 -37.38 11.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.309 -1.273 . . . . 0.0 112.868 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.65 146.3 50.9 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.093 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.55 81.55 0.17 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.138 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.12 134.39 90.45 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -74.18 143.58 32.24 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.656 2.237 . . . . 0.0 112.192 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.01 111.97 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.706 2.271 . . . . 0.0 112.432 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -62.62 114.89 3.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.416 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 p -69.15 -72.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.585 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -74.48 155.49 37.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.972 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -178.53 -61.81 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.015 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.79 109.71 2.79 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.613 2.209 . . . . 0.0 112.535 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -69.35 -44.07 2.59 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.545 2.163 . . . . 0.0 112.49 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -130.62 160.75 33.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.702 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 m -125.61 141.22 46.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.178 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.31 105.7 15.21 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.764 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.12 101.64 13.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.062 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.88 108.05 19.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.305 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -113.2 161.98 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.941 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 m -63.05 -30.0 71.26 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.178 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.7 tpt -68.79 -32.03 71.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.094 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.64 -148.65 14.19 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.396 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.51 136.49 59.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.764 0.316 . . . . 0.0 111.446 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 pt -144.32 128.92 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.519 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.3 t -102.53 98.66 7.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.53 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.5 mp -80.83 148.77 29.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.35 140.33 48.12 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mp -124.11 129.65 51.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.154 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.525 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 37.6 m-85 -63.19 99.7 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 110.771 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -78.85 12.63 2.05 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.05 -65.51 0.96 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 110.522 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.474 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.1 m80 -100.73 -15.51 17.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.27 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.75 1.64 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.4 Cg_exo -40.57 -37.74 2.27 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.052 1.835 . . . . 0.0 113.089 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -60.72 -55.8 28.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -34.79 79.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.736 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.6 t -58.35 -45.59 87.89 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.58 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -61.69 -43.53 98.68 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.222 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.42 -39.33 93.63 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -69.07 -43.0 75.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.91 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.02 73.54 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.286 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -48.42 80.52 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.011 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -36.33 78.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.131 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.41 50.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.248 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -76.3 -49.08 17.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -60.08 -40.87 91.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.745 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.93 53.11 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -112.14 -62.84 1.51 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.515 0.198 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 12.9 m-85 -63.3 -51.71 64.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.65 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -67.23 119.75 12.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 110.47 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.22 8.8 10.09 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.088 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 t -117.74 -172.18 2.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.274 0.537 . . . . 0.0 111.176 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.8 150.19 35.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -64.23 136.9 57.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.187 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -109.44 -36.59 5.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.734 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -113.89 113.65 25.16 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.628 0.251 . . . . 0.0 111.114 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 29.6 mm -132.71 116.66 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.53 88.28 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.039 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.401 ' HD3' ' HA3' ' A' ' 143' ' ' GLY . 21.8 tptt -58.97 155.53 13.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.09 25.75 4.67 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -166.29 -82.38 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.02 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.53 170.07 21.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 111.516 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -142.66 161.57 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.51 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -146.75 154.59 41.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.924 0.392 . . . . 0.0 111.55 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.68 150.45 17.12 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.562 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.89 -179.55 38.77 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.987 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.653 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 15.1 t70 -156.3 -63.05 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.942 -0.129 . . . . 0.0 111.198 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 73.6 Cg_endo -76.0 -176.81 3.23 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.279 1.986 . . . . 0.0 112.677 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 6.7 t -56.69 -35.92 69.03 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.979 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.73 29.59 47.19 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.431 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.2 p -133.74 -46.19 0.8 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.852 0.326 . . . . 0.0 111.06 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.99 31.3 2.1 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.477 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -105.72 -45.04 4.5 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.586 0.232 . . . . 0.0 110.69 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.46 80.15 0.2 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.43 80.62 0.32 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.326 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.04 155.72 28.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.0 t -125.4 175.04 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -53.02 -33.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.828 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -92.23 -35.91 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.016 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.9 -143.49 10.34 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.588 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -134.68 27.52 3.65 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 111.193 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.13 -55.72 0.65 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.119 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 61.73 -176.79 0.13 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.63 131.51 48.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.59 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.43 146.25 49.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -131.96 98.85 4.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.236 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.72 110.9 10.71 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.649 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -132.12 172.84 6.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 -173.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.742 2.294 . . . . 0.0 112.174 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.82 179.28 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.9 mt 66.82 165.89 0.21 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.739 0.304 . . . . 0.0 110.887 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 160.38 40.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 111.471 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.31 96.63 5.75 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.972 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.0 p -71.97 -33.61 68.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.2 -26.67 23.03 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.916 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 116.17 31.46 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.069 0.435 . . . . 0.0 111.654 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.35 54.82 21.37 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.213 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 19.8 mm -129.23 135.53 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.768 0.284 . . . . 0.0 111.203 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.41 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 1.3 mt -105.64 120.44 41.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.833 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -117.81 141.16 48.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.369 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.19 120.02 23.11 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.181 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.72 141.8 36.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.43 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -157.16 117.4 3.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.743 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.47 72.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.71 179.83 17.51 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.48 30.27 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.686 2.258 . . . . 0.0 113.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -176.7 38.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 110.697 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.28 81.95 1.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 110.829 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -106.24 91.47 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.223 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.91 -105.16 0.02 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.358 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.438 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 67.3 m -157.5 36.48 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.43 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -118.1 160.3 21.76 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.696 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -159.74 165.66 32.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 6.5 p90 -137.63 136.79 37.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.42 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 4.8 t -102.72 110.53 29.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.201 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -79.8 130.89 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.71 -15.99 11.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.675 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -108.61 152.35 42.12 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.835 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.99 104.41 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.761 2.308 . . . . 0.0 112.343 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.6 p -138.3 67.53 1.41 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -70.4 -32.96 70.82 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -60.55 -29.13 68.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.296 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mt -73.17 -11.86 60.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.877 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.24 85.44 0.15 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.219 0.533 . . . . 0.0 110.425 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.79 -40.71 0.11 Allowed Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.279 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.7 mttt -74.56 -44.55 50.47 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 110.836 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -112.84 133.9 54.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 15.3 t -79.91 164.28 23.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.997 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.4 tt -90.4 -179.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.689 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.0 p90 -178.31 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -179.77 23.27 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.779 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.03 150.31 35.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.8 t -106.9 99.75 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.206 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.26 -45.96 5.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -119.84 96.34 5.14 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.829 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.24 -22.23 0.86 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.277 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.2 tt -47.21 -36.41 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.848 0.324 . . . . 0.0 111.807 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.59 96.2 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.482 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 ttp -65.77 -41.99 91.36 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.611 0.243 . . . . 0.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.71 -36.98 63.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.719 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -63.4 -36.15 82.76 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.983 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -60.78 -42.06 96.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.486 0.184 . . . . 0.0 111.028 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 12.1 t -58.27 -34.03 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.148 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.401 ' HA3' ' HD3' ' A' ' 58' ' ' LYS . . . -89.62 -36.38 7.41 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.12 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -35.77 61.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.46 0.304 . . . . 0.0 111.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.401 HG21 ' HB2' ' A' ' 155' ' ' ASP . 18.9 m -63.76 173.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -72.83 -179.93 3.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.062 0.458 . . . . 0.0 111.266 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.0 177.72 9.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.97 -173.11 4.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.03 27.83 2.32 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -147.26 -71.95 0.22 Allowed 'General case' 0 C--O 1.231 0.122 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 178.74 45.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.008 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.04 116.34 28.78 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.33 129.13 33.12 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.953 2.435 . . . . 0.0 112.849 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 11.4 p -69.78 -35.36 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.12 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.401 ' HB2' HG21 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -75.41 -173.03 1.96 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -127.47 90.95 3.21 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.8 p -102.51 123.43 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.036 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -152.82 126.85 9.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.69 0.281 . . . . 0.0 111.711 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.407 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 4.6 mt -81.42 132.95 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.597 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.19 -33.64 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.295 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -127.51 146.19 50.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.772 0.32 . . . . 0.0 111.114 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.79 82.67 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.825 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -122.67 143.67 40.62 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.32 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.43 150.29 19.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.803 2.335 . . . . 0.0 112.603 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.3 t -171.77 148.72 2.42 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.892 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.036 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.794 0.33 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.97 -36.88 9.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.231 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.01 82.64 0.18 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.062 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 mm 59.56 73.51 0.66 Allowed Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.034 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.05 109.37 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.842 2.361 . . . . 0.0 112.645 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.56 163.95 36.18 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.774 2.316 . . . . 0.0 112.957 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -130.0 -49.2 1.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.055 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.5 p -164.13 169.19 18.09 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.649 0.261 . . . . 0.0 111.359 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -132.24 -48.32 0.92 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.432 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -99.8 104.22 26.9 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.826 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.18 116.24 4.4 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.54 2.16 . . . . 0.0 112.478 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.38 -35.95 17.0 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.644 2.229 . . . . 0.0 112.658 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -107.21 170.56 7.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.021 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.2 p -151.89 147.4 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -112.89 135.36 53.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 18.0 mt -121.63 97.79 5.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 86.28 7.38 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.602 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.94 157.47 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.352 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 t -64.63 -36.39 84.1 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.8 tpt -65.47 -31.49 72.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.37 151.48 6.15 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.058 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -81.05 142.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.715 0.293 . . . . 0.0 111.483 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 19.5 pt -148.37 146.49 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.786 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.21 130.58 69.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.03 162.91 30.46 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.387 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.55 154.11 25.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.907 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.43 134.12 46.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.769 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -75.15 98.17 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.381 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -82.86 20.4 1.18 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -100.22 -67.29 0.86 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.453 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.81 -13.05 18.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.145 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.66 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.14 0.73 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 85.2 Cg_exo -42.77 -34.98 3.87 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.005 1.804 . . . . 0.0 112.789 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -57.72 -62.73 1.59 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.908 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -66.7 -33.65 76.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.41 -51.32 70.39 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.64 84.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.744 0.307 . . . . 0.0 110.468 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.24 -41.42 94.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.755 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.15 -48.35 68.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.89 83.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.387 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.98 -50.1 74.74 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -33.21 66.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.466 0.174 . . . . 0.0 111.441 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.92 24.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.512 0.196 . . . . 0.0 111.479 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -75.85 -36.79 59.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.449 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -30.33 71.15 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 31.0 3.07 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.927 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -105.03 -41.71 5.51 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.565 0.221 . . . . 0.0 110.663 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -65.58 -51.16 61.81 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.02 123.24 20.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.69 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.91 -29.38 5.39 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.315 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.79 -176.42 3.35 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 111.514 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -155.04 154.8 33.04 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -66.86 169.83 7.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.983 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -135.72 -53.36 0.76 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.665 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.2 mtt-85 -100.53 108.46 20.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mp -120.02 99.87 8.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.53 95.54 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.475 ' HB3' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.95 -23.29 65.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.602 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 21.3 3.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.435 ' CD2' ' HG3' ' A' ' 61' ' ' MET . 10.6 t80 -169.98 -81.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.521 -0.112 . . . . 0.0 111.141 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.435 ' HG3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -160.43 175.33 12.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 111.186 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.4 pp -133.97 137.06 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -117.47 143.58 45.9 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.138 0.494 . . . . 0.0 112.18 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 125.59 3.66 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.894 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.11 -179.9 34.27 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.027 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.4 t70 71.28 56.21 0.41 Allowed Pre-proline 0 N--CA 1.464 0.268 0 C-N-CA 122.564 0.346 . . . . 0.0 111.789 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -79.18 62.8 8.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.564 2.176 . . . . 0.0 111.994 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 70.5 p -134.45 -61.22 0.78 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.305 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.69 30.29 62.12 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.727 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 m -100.97 -47.14 4.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.638 0.219 . . . . 0.0 111.203 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.42 -36.42 4.01 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.228 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -110.03 27.2 9.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.32 125.14 1.42 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.869 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.13 80.64 0.21 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.613 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.34 150.91 32.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.293 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p -105.96 -175.5 2.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.182 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -66.4 -28.3 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.228 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -97.33 39.19 1.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.825 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -147.38 25.16 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.016 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 -37.3 5.91 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.462 0.172 . . . . 0.0 111.135 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -143.0 158.87 43.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -167.77 169.97 11.23 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.172 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.95 129.86 42.89 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -64.53 168.19 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.633 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -111.49 38.25 2.65 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.172 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.56 135.82 56.38 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.756 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.25 102.28 1.88 Allowed Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.969 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.9 80.71 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.369 . . . . 0.0 111.984 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.33 -49.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.767 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.14 145.69 27.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -97.2 154.51 17.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -113.16 89.33 3.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -57.9 -33.83 69.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.214 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.67 -27.44 17.87 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.846 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.69 106.2 16.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.979 0.389 . . . . 0.0 111.086 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.41 58.46 4.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.958 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.3 mm -133.08 120.41 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.703 0.287 . . . . 0.0 110.817 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.456 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 3.1 mt -96.09 110.02 22.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -117.05 138.69 51.43 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.706 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.407 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.89 118.61 21.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.561 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.16 172.08 9.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -148.75 157.87 43.75 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.71 23.94 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.85 174.52 35.87 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.435 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.78 120.26 7.29 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.557 2.171 . . . . 0.0 111.991 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 56.92 42.18 26.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.024 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.6 m -144.6 88.11 1.9 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -107.78 161.93 14.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.14 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.4 -106.16 1.01 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.168 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -147.52 34.68 0.86 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.03 158.1 23.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -160.4 176.46 11.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -145.96 136.69 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.0 t -102.13 109.9 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.129 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.53 132.94 36.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.407 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 pp -114.9 -23.32 9.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.861 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.15 149.03 35.93 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.71 117.3 4.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.862 2.375 . . . . 0.0 112.213 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.411 HG21 ' CZ2' ' A' ' 121' ' ' TRP . 10.2 p -151.91 99.03 2.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.156 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -92.8 -21.89 19.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.411 ' CZ2' HG21 ' A' ' 119' ' ' THR . 2.8 p90 -59.06 -26.18 64.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.3 pp -85.03 -4.59 59.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.78 86.95 0.04 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.182 0.515 . . . . 0.0 110.091 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.73 -32.27 1.46 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.642 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.19 -53.92 21.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.662 0.231 . . . . 0.0 111.219 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -104.61 150.03 25.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.269 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 49.1 m -86.14 155.75 20.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.959 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 tt -86.47 -179.42 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.636 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.456 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -175.72 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.62 -179.82 31.89 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.919 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -138.2 166.22 24.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.6 0.238 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.0 m -134.44 102.79 4.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 111.782 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.82 -53.74 4.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.9 84.18 1.89 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.955 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.81 -27.84 0.12 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.844 -0.694 . . . . 0.0 113.437 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 7.8 tt -46.98 -37.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.73 -38.17 81.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.76 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.446 ' O ' ' HG3' ' A' ' 141' ' ' ARG . 0.0 OUTLIER -70.45 -35.56 73.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.108 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.59 -30.23 41.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -74.82 -38.04 62.16 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.483 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -67.73 -29.56 68.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.5 t -56.34 -32.71 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.649 0.262 . . . . 0.0 111.015 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.475 ' HA3' ' HB3' ' A' ' 58' ' ' LYS . . . -93.59 -32.19 7.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.506 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 21.2 mmt -60.15 -33.3 71.97 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.524 0.162 . . . . 0.0 111.385 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.1 m -63.75 173.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.18 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 126.07 26.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.976 0.417 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 p -118.58 167.94 11.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -177.29 5.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.83 46.91 1.43 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -174.28 -67.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.56 44.02 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -122.95 104.05 36.15 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.137 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.0 117.06 3.48 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 112.461 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.43 -32.24 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.696 0.284 . . . . 0.0 110.361 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.13 -170.94 1.03 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.382 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.89 114.05 22.65 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.731 0.3 . . . . 0.0 111.617 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.43 113.38 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 174.85 11.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.638 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.14 139.49 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.314 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.13 -30.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.602 179.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.22 28.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 110.952 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.13 111.14 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.023 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -145.05 158.37 52.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 111.707 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -80.09 152.38 21.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.274 2.649 . . . . 0.0 112.482 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 140.29 1.85 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.451 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.671 0.272 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.32 29.75 15.59 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.67 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.91 76.41 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.888 0.375 . . . . 0.0 110.795 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 mt -107.04 92.53 7.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.749 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.34 145.58 60.03 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.516 2.144 . . . . 0.0 112.118 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.64 58.37 6.77 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.856 2.37 . . . . 0.0 111.929 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.03 23.85 5.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.869 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -161.49 163.62 30.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.62 0.248 . . . . 0.0 111.0 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -108.5 -27.44 9.9 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.5 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.18 76.52 3.58 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.883 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HG3' ' CB ' ' A' ' 164' ' ' PRO . 73.7 Cg_endo -76.16 151.0 33.99 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.892 2.394 . . . . 0.0 112.667 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.0 -37.51 3.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.745 2.297 . . . . 0.0 112.715 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -125.0 165.74 17.6 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.004 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.58 154.23 21.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -111.5 104.17 12.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.88 96.64 10.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.16 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -80.37 82.48 6.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.187 179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.78 161.05 20.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.386 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -64.04 -33.22 75.25 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.054 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 15.3 tpt -67.51 -34.16 76.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.945 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.81 -148.36 12.75 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.221 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -132.28 126.45 55.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 111.279 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.7 pt -129.99 133.26 64.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.3 109.41 22.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.82 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.4 mt -105.49 162.42 13.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.28 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -119.89 144.81 47.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.051 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -129.47 134.29 47.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.401 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 28.0 m-85 -64.42 100.6 0.37 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.014 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -80.8 15.31 1.81 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -100.15 -64.9 1.0 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.772 0.32 . . . . 0.0 110.343 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.447 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -100.76 -13.2 18.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.333 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.666 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.01 1.2 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 77.8 Cg_exo -41.84 -37.52 4.15 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.011 1.807 . . . . 0.0 112.908 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -49.49 71.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.486 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.1 m -67.07 -36.94 83.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.387 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -54.51 -49.13 70.91 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.358 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -64.6 -38.55 91.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.264 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -56.74 -44.09 81.33 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.478 179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -67.51 -43.16 81.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.212 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.11 -52.43 55.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.272 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -46.5 89.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -40.73 69.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 -33.77 33.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -47.63 84.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -60.16 -30.23 69.18 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.424 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.87 26.02 5.16 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.908 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -37.13 13.11 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.777 0.288 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -36.39 40.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.179 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -66.99 90.01 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 110.138 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.8 -26.04 2.53 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.772 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.6 p -61.3 151.4 32.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.809 0.305 . . . . 0.0 111.281 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -132.2 159.69 38.29 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.863 0.363 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' CD1' HG22 ' A' ' 62' ' ' ILE . 71.0 m-85 -74.13 100.46 3.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.638 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -73.02 -50.2 24.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -102.72 131.09 49.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 27.0 mt -142.16 105.19 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.018 -179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mt -90.98 115.06 29.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.735 0.302 . . . . 0.0 110.913 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.0 tmtt? -63.34 132.2 50.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.188 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.5 t70 55.39 52.45 11.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.267 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -165.82 -83.83 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.482 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.58 163.6 32.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.819 0.343 . . . . 0.0 111.442 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.402 HG22 ' CD1' ' A' ' 53' ' ' PHE . 4.0 mp -137.99 130.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.721 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.1 pt20 -117.9 154.58 31.64 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 112.004 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.92 106.09 0.48 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.153 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.25 -179.99 35.4 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.941 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.0 76.46 0.34 Allowed Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 111.068 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.22 -34.02 6.6 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.759 2.306 . . . . 0.0 112.697 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -87.07 -41.04 14.14 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.304 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.93 52.35 14.85 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.529 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 p -112.29 -42.89 3.61 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 115.83 -68.04 0.28 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.119 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -33.39 18.62 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.656 0.228 . . . . 0.0 111.39 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.57 84.09 1.6 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.816 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.39 97.69 0.18 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.728 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.48 135.13 55.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 0.0 111.221 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -84.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.684 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.3 mp -142.55 -50.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.811 0.339 . . . . 0.0 110.534 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 34.76 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.41 -168.54 13.19 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -119.32 21.69 12.1 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.73 92.82 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 110.632 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -107.76 175.61 5.42 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.251 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.74 140.72 46.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.785 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 157.11 11.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.79 37.31 2.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.651 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 149.13 21.74 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.51 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.28 -62.31 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -75.73 -174.23 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.758 2.306 . . . . 0.0 112.42 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.94 -61.65 1.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.014 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mp 57.5 -173.85 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.11 173.98 10.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -160.31 38.93 0.17 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.979 -179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -108.93 -57.74 2.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.811 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.28 122.34 5.26 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.591 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.15 127.21 12.19 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 101.96 62.38 0.75 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -126.67 140.13 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.767 0.283 . . . . 0.0 111.045 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 3.2 mt -112.41 120.8 42.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -124.52 142.06 51.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.443 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.4 ' N ' ' O ' ' A' ' 127' ' ' THR . 0.0 OUTLIER -79.6 114.75 18.76 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.286 179.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.18 26.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.437 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -135.82 157.25 47.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -37.22 14.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.158 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.79 174.46 36.61 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 119.12 5.65 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.579 2.186 . . . . 0.0 112.165 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 59.05 30.75 20.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.185 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 10.5 m -139.87 88.3 2.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.709 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.02 165.91 12.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.09 -105.7 1.47 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.93 43.94 0.12 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 111.041 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -126.03 157.46 37.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -149.73 160.09 43.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.412 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 7.1 p90 -137.43 130.3 30.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 111.618 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.54 107.1 19.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.228 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.72 125.84 30.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.9 pp -109.29 -4.69 16.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.66 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.95 152.28 53.81 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-O 120.527 0.203 . . . . 0.0 110.839 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.26 100.06 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 112.025 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 79.5 p -122.41 110.4 15.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -94.9 -40.48 9.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -61.81 -33.67 74.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 12.8 mt -81.91 -3.31 53.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.556 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -82.1 66.56 7.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.004 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.9 -47.38 0.07 OUTLIER Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.651 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -56.08 -47.52 77.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.706 0.289 . . . . 0.0 110.885 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -108.57 139.69 42.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 100' ' ' MET . 11.0 t -79.97 155.8 27.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.788 0.328 . . . . 0.0 111.125 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.2 tt -83.57 -178.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.561 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 1.2 p90 -179.38 -39.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.3 -179.75 17.01 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.113 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -146.85 171.79 14.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.29 . . . . 0.0 110.924 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.3 t -130.64 119.16 44.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.352 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -56.51 2.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.13 92.33 3.86 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.061 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.84 -17.26 0.95 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.274 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -45.87 -36.93 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.89 -47.87 76.46 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.638 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.2 tmm? -58.26 -46.07 86.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 110.403 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.5 t -59.79 -37.98 73.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -63.79 -44.66 92.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.845 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -56.65 -34.3 67.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.175 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 21.8 t -58.24 -36.03 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.886 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.38 -38.13 18.8 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.563 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 mtp -55.3 -47.69 75.2 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.7 0.25 . . . . 0.0 111.208 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -50.88 136.89 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.52 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -60.75 120.83 10.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.636 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.6 p -86.48 170.39 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -81.96 -166.22 1.18 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.56 34.37 0.76 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -160.12 32.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.627 0.251 . . . . 0.0 110.914 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.34 35.23 13.34 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.088 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 -111.71 150.65 42.56 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.943 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.28 120.05 6.84 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.671 2.247 . . . . 0.0 112.495 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.9 t -70.57 -32.22 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.367 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -174.66 4.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.39 79.97 3.14 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.296 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 t -113.93 113.43 43.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.345 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.92 179.81 8.46 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.388 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.2 mt -102.22 125.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.608 179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.436 HG22 HD12 ' A' ' 160' ' ' ILE . 24.1 pt -107.12 -32.45 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.553 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -145.1 143.73 30.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.651 0.262 . . . . 0.0 110.864 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.5 94.83 2.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.725 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -119.1 155.98 52.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.329 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.411 ' CB ' ' HG3' ' A' ' 11' ' ' PRO . 94.0 Cg_endo -79.76 167.2 20.79 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.555 2.17 . . . . 0.0 113.003 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 3.5 t -105.91 163.17 12.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.26 -1.3 . . . . 0.0 112.93 179.789 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.42 177.08 4.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.614 0.245 . . . . 0.0 110.926 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.45 149.61 50.16 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.41 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.18 71.43 70.15 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.16 108.7 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.803 2.335 . . . . 0.0 112.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.42 147.71 84.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.043 2.495 . . . . 0.0 112.962 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.48 43.37 0.67 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.135 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 p -92.53 90.75 7.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.809 0.337 . . . . 0.0 111.097 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -155.64 117.81 4.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.99 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -84.8 160.11 56.39 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.634 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.09 108.01 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.802 2.335 . . . . 0.0 112.643 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 41.5 Cg_endo -67.79 -27.99 37.07 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.732 2.288 . . . . 0.0 112.969 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.48 142.83 34.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.706 0.289 . . . . 0.0 110.831 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.71 152.59 25.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.448 ' CE1' HG22 ' A' ' 24' ' ' VAL . 4.1 m-85 -113.85 115.09 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.32 104.62 15.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.126 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.16 87.06 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.395 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.96 159.6 20.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.674 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.78 -34.15 74.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.73 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.51 -33.44 64.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.394 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.16 -168.19 40.88 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.494 HG21 HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -119.06 123.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.182 0.491 . . . . 0.0 111.207 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.1 pt -128.1 146.18 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.863 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.448 HG22 ' CE1' ' A' ' 15' ' ' TYR . 13.0 t -105.2 139.3 26.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.864 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mt -136.67 159.29 42.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.46 145.29 48.08 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.854 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -116.36 144.48 44.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.521 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -86.33 102.49 14.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.753 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.406 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 10.9 m95 -76.36 11.99 1.37 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.29 -61.96 1.3 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.546 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.466 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 6.7 p80 -100.79 -15.98 17.45 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.639 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.18 1.38 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 66.8 Cg_exo -40.05 -37.21 1.65 Allowed 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.131 1.887 . . . . 0.0 113.312 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -55.63 13.7 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.061 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.5 m -68.45 -39.49 81.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.3 -50.63 72.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -43.78 86.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.403 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.46 -48.03 83.55 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.78 -45.97 81.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.614 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.59 76.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.55 -42.23 98.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.431 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -52.09 67.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.544 0.211 . . . . 0.0 111.236 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.59 68.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -61.22 -42.53 98.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -38.67 92.08 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.279 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.06 38.96 1.09 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.813 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -32.52 6.55 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.481 0.182 . . . . 0.0 111.011 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -68.59 -36.28 78.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.204 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -65.79 108.7 2.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.27 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.74 -23.15 4.24 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.89 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.443 ' OG1' ' HB3' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -64.0 165.46 8.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 111.502 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -153.8 143.68 21.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.085 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -66.04 108.48 2.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.88 5.66 47.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.136 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -150.05 114.85 5.31 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.618 0.247 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.47 HG13 HG21 ' A' ' 62' ' ' ILE . 4.0 mp -137.49 107.43 4.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.31 79.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 41.82 -147.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.662 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.08 53.47 2.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.091 0.472 . . . . 0.0 110.311 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -125.13 -66.02 0.99 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.318 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 ptm -156.64 137.3 13.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.747 0.308 . . . . 0.0 111.175 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.47 HG21 HG13 ' A' ' 56' ' ' ILE . 6.4 mt -132.38 115.17 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.0 pt20 -103.08 146.78 27.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.481 . . . . 0.0 112.054 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.78 111.85 0.6 Allowed Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.898 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.44 -179.93 35.53 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.945 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.65 65.54 0.75 Allowed Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 111.23 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.443 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 90.9 Cg_endo -81.78 58.7 6.87 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.84 2.36 . . . . 0.0 112.063 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -118.22 -59.42 1.9 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.171 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.4 30.5 5.29 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.895 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 t -114.79 -41.29 3.4 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.716 0.258 . . . . 0.0 111.084 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.84 -60.19 0.67 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.44 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.42 37.17 4.47 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.674 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.66 97.33 0.61 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.677 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.33 99.94 0.59 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.425 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.73 159.31 16.09 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.662 0.268 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 t -134.94 159.2 42.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.176 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -56.94 -33.6 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.38 -30.81 63.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.94 -160.97 29.12 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.762 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -52.35 60.62 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 110.603 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.65 159.3 38.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -144.41 178.03 8.22 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.97 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.97 130.17 38.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -65.27 161.03 20.29 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.78 139.18 47.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -121.34 127.61 51.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -65.63 135.64 95.74 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.313 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.93 -36.96 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.571 2.181 . . . . 0.0 112.429 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -163.42 106.73 1.01 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.737 0.303 . . . . 0.0 110.827 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.7 mt -149.85 178.76 8.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.31 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -124.66 160.93 27.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.488 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.413 ' CB ' ' HB2' ' A' ' 123' ' ' ASP . 4.2 t80 -135.83 76.43 1.61 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.38 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.3 m -57.09 -27.47 61.79 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 98.96 -58.52 0.88 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.797 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.26 114.37 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 70.93 64.01 2.96 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.964 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.7 mm -130.61 158.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.696 0.284 . . . . 0.0 111.139 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 mt -137.52 97.66 3.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.275 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -105.68 136.05 45.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.509 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -79.74 121.46 25.37 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.87 176.83 4.92 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.457 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -139.76 173.61 11.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.296 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.07 -35.73 12.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.44 167.74 32.52 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.531 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.54 124.07 14.32 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.558 2.172 . . . . 0.0 112.159 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.36 29.07 18.58 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.393 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 m -132.03 89.83 2.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.39 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.58 147.17 25.07 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.625 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.23 -110.72 1.48 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.16 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.5 m -151.55 45.66 0.79 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.986 0.422 . . . . 0.0 111.199 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 148.04 32.71 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.167 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -149.7 132.04 15.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 23.9 p90 -110.08 127.11 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 111.497 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 29.2 m -99.85 119.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.558 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 p -88.81 142.54 27.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.802 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 62' ' ' ILE . 1.3 mm? -113.65 -24.88 8.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.138 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -106.58 162.57 19.27 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.031 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -67.94 112.31 2.67 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.683 2.255 . . . . 0.0 112.45 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 p -141.34 76.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -76.67 -34.8 58.23 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.153 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -59.69 -28.5 67.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.439 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.0 mt -81.39 -2.35 49.01 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.413 ' HB2' ' CB ' ' A' ' 92' ' ' PHE . 35.8 t0 -82.89 60.22 5.27 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 110.443 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.23 -52.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.778 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -32.61 74.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -119.03 148.83 42.58 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.2 m -99.28 163.7 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.716 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 2.7 mm -79.41 -179.09 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.241 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.509 ' HB3' ' HB2' ' A' ' 100' ' ' MET . 0.1 OUTLIER -176.97 -34.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.82 170.46 31.26 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.575 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.7 159.07 34.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.7 0.286 . . . . 0.0 110.983 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.84 94.53 3.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 6.2 t -92.0 -61.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.277 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -111.74 98.21 7.25 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.03 -21.59 0.51 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.455 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.2 tt -47.88 -35.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.91 92.14 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.037 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.94 -16.45 55.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.566 0.222 . . . . 0.0 110.879 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 t -88.57 -42.28 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.558 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.47 -31.03 68.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -53.71 -32.17 50.92 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 20.9 t -63.41 -36.46 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.644 0.259 . . . . 0.0 111.145 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.02 -29.05 39.2 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.458 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.6 mtp -74.3 -23.51 59.09 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.3 p -84.03 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.39 174.59 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.151 0.5 . . . . 0.0 111.427 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 p -150.78 173.74 13.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.275 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -89.73 -176.37 4.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.852 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -91.4 28.98 1.55 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.608 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -150.4 29.31 0.71 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.296 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.5 44.39 21.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.21 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.3 mtp-105 -115.3 144.47 32.33 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.58 140.57 21.39 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.804 2.336 . . . . 0.0 112.747 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.24 -34.14 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.457 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -171.01 3.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.59 96.64 5.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.275 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.9 p -117.02 111.36 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.9 pttt -145.38 173.63 11.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.3 126.13 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.678 0.275 . . . . 0.0 111.3 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 42.7 pt -108.14 -33.79 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.638 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -138.8 152.11 47.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.774 0.321 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.48 115.41 3.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -153.5 166.12 16.3 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.84 168.78 18.85 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.045 2.497 . . . . 0.0 112.193 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.38 96.73 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.996 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.799 -1.001 . . . . 0.0 113.031 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.607 0.241 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.0 101.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.09 96.14 8.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.396 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.541 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 2.0 mt -83.0 -49.0 0.76 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.525 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.541 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 52.9 Cg_exo -53.68 -49.83 15.91 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.444 2.096 . . . . 0.0 113.337 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 5' ' ' PRO . 87.6 Cg_endo -81.51 129.33 6.5 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.473 2.116 . . . . 0.0 112.432 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -92.77 119.59 32.29 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -137.17 153.12 50.52 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.24 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 62.27 86.75 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -120.52 147.88 46.51 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.402 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.407 ' CG ' ' HB2' ' A' ' 164' ' ' PRO . 58.1 Cg_endo -71.84 122.37 8.45 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.776 2.318 . . . . 0.0 112.664 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.23 -40.0 5.03 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.73 2.287 . . . . 0.0 112.739 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.23 168.8 8.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -128.36 126.86 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.019 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.43 95.37 10.14 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.594 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.01 85.75 3.32 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 89.02 6.37 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.274 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -84.36 162.78 19.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.165 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.3 t -68.62 -34.07 75.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.46 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -33.36 71.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.1 -159.12 27.26 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.387 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 11.6 tt -122.52 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.877 0.339 . . . . 0.0 111.469 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.3 pt -139.16 137.8 41.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 131.18 61.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.423 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.403 ' CD2' HD21 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -128.59 144.59 51.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.865 0.365 . . . . 0.0 111.325 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -106.41 116.7 32.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.886 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.442 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 8.9 mp -94.96 129.26 42.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.229 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -63.41 101.5 0.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -82.01 18.34 1.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -100.38 -66.16 0.92 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.743 0.306 . . . . 0.0 110.474 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.475 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 3.0 t60 -100.65 -15.38 17.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.983 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -96.43 0.84 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_exo -42.32 -37.06 4.73 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.987 1.791 . . . . 0.0 112.753 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -54.17 39.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.533 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -35.05 79.81 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 73.9 m -60.11 -47.18 87.0 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.508 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -59.28 -39.71 83.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.495 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -47.24 84.26 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.21 -43.89 98.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.99 63.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.109 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.21 -37.56 87.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.961 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -63.41 -35.73 81.39 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.631 0.253 . . . . 0.0 110.862 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.32 -36.06 24.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.558 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.36 -36.89 63.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.325 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -61.31 -36.58 80.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.525 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.62 30.88 3.37 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.938 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.94 -51.73 3.96 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.599 0.238 . . . . 0.0 110.433 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.407 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 4.0 m-85 -65.55 -29.57 70.2 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.27 101.09 0.88 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.253 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.59 30.02 3.43 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.38 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -111.21 151.33 28.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.976 0.388 . . . . 0.0 110.85 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.57 151.82 48.41 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -60.83 144.3 52.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -113.71 -38.93 4.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.905 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -125.11 118.62 26.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.79 0.328 . . . . 0.0 111.257 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.412 ' CG2' HG12 ' A' ' 62' ' ' ILE . 3.3 mt -130.54 104.35 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mp -98.28 115.19 37.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 137.19 57.14 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.922 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.65 35.43 19.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.652 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -151.09 -88.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.417 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -160.46 157.36 27.49 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.698 0.285 . . . . 0.0 111.041 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.412 HG12 ' CG2' ' A' ' 56' ' ' ILE . 6.6 mt -130.38 124.93 58.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.346 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.2 pt20 -112.27 148.72 33.55 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.77 109.54 0.59 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.374 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.559 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . -160.9 -179.63 35.77 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.228 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.27 61.21 5.74 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 120.805 0.335 . . . . 0.0 110.732 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.17 -53.71 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.387 2.058 . . . . 0.0 112.097 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -167.81 41.1 0.04 OUTLIER 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.981 0.42 . . . . 0.0 110.645 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.49 64.47 3.23 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.264 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.7 t -175.28 -42.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.622 0.248 . . . . 0.0 111.055 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.83 91.05 0.71 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.069 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.86 37.71 18.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 111.053 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.37 90.86 0.41 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.404 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.32 102.9 0.23 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.447 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.31 136.17 32.96 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.658 0.266 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -113.1 167.12 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt -56.99 -39.35 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -80.34 -30.98 38.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.42 -167.05 29.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.848 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -63.07 -54.96 29.86 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.598 0.237 . . . . 0.0 110.678 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.408 ' HG2' ' CG2' ' A' ' 107' ' ' THR . 8.8 mp0 -135.7 139.26 43.53 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.817 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -123.93 172.02 9.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.83 179.2 1.49 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.196 0.522 . . . . 0.0 111.927 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.15 159.95 22.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.416 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.17 75.42 1.16 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.03 141.07 49.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.05 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.407 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -164.06 -63.28 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.407 ' CD ' ' CB ' ' A' ' 87' ' ' HIS . 70.9 Cg_endo -74.19 172.55 15.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.695 2.263 . . . . 0.0 112.956 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.51 95.5 5.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.867 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.9 mp -91.73 172.68 8.32 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 159.21 30.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.037 0.446 . . . . 0.0 111.382 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.4 41.68 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.17 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.7 t -148.11 -47.18 0.16 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.854 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -55.28 122.09 24.92 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.757 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.45 126.88 8.62 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.91 63.06 0.71 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.281 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.5 mm -130.42 137.79 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 117.056 0.428 . . . . 0.0 110.955 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.403 HD21 ' CD2' ' A' ' 25' ' ' LEU . 7.7 tp -111.2 101.91 10.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.107 0.479 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . . . -110.02 146.73 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.31 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.28 133.08 36.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.223 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 142.54 35.17 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -143.22 117.72 9.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.31 75.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.394 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.32 179.5 34.88 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.303 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.85 128.67 23.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.494 2.129 . . . . 0.0 111.934 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 58.79 35.31 24.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.408 ' CG2' ' HG2' ' A' ' 81' ' ' GLN . 85.5 m -143.19 89.33 2.09 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -106.19 155.41 19.49 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.95 -165.63 11.88 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.72 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.31 61.88 1.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.947 0.403 . . . . 0.0 110.888 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.559 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -153.34 155.8 37.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.04 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.16 161.03 43.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.072 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 14.2 p90 -130.79 141.33 50.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.3 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.4 t -102.74 110.6 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.479 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.89 109.15 15.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.032 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 61' ' ' MET . 0.9 OUTLIER -103.53 -6.82 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.917 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.81 142.85 38.84 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.387 0.136 . . . . 0.0 110.806 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.39 122.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.905 2.403 . . . . 0.0 112.577 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.1 p -128.48 112.56 14.48 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.947 0.404 . . . . 0.0 111.279 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -94.92 -42.74 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.426 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 46.7 p90 -67.74 -31.88 72.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.336 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 12.4 mt -89.36 -2.25 58.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.739 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -68.85 85.53 0.33 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.348 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.02 -25.6 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.72 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -57.01 -53.81 53.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.712 0.256 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -102.3 156.7 17.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 47.6 m -90.32 150.9 21.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.001 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 tt -79.88 -179.62 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.418 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.22 -35.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.88 179.99 29.7 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.828 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 161.9 36.87 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 122.827 -0.219 . . . . 0.0 110.659 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.6 p -124.51 105.32 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.27 0.557 . . . . 0.0 111.528 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.51 -38.42 9.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.28 88.14 2.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.89 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 159.46 -22.31 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.351 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 tt -43.33 -38.81 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.4 -37.12 86.97 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.909 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -36.0 59.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.789 0.328 . . . . 0.0 110.124 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 23.7 t -66.76 -56.74 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.32 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -63.26 -24.43 67.87 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.258 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -58.67 -33.77 70.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.547 0.213 . . . . 0.0 110.816 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 26.0 t -63.84 -35.64 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.018 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.71 -39.5 60.07 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.312 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 mmt -53.66 -51.5 62.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -52.2 143.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.691 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -64.75 122.21 16.36 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.3 p -93.06 179.15 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -170.04 2.21 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.75 46.02 1.32 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.646 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -174.61 -76.53 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.835 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.58 30.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.31 118.64 60.85 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-O 120.656 0.265 . . . . 0.0 111.682 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.51 115.25 3.61 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.044 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.21 -31.48 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -171.04 2.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.619 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.26 97.38 6.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.48 108.51 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.875 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 175.22 11.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.361 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.6 mt -103.57 130.48 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.321 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 17.4 pt -106.73 -29.43 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.914 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.18 108.51 1.9 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.16 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -120.37 114.37 21.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.187 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -154.1 149.22 20.26 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.407 ' HB2' ' CG ' ' A' ' 11' ' ' PRO . 97.5 Cg_endo -80.03 161.3 23.73 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.514 2.143 . . . . 0.0 112.6 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.8 t -165.38 -62.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.424 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ttm . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.675 0.274 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.24 73.02 1.34 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.76 86.54 2.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.249 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.5 tt -129.68 54.69 15.16 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.2 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' HG2' ' HD3' ' A' ' 6' ' ' PRO . 1.6 Cg_endo -46.2 -54.33 4.83 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.78 2.32 . . . . 0.0 112.661 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.437 ' HD3' ' HG2' ' A' ' 5' ' ' PRO . 62.5 Cg_endo -71.9 -170.18 0.52 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.206 1.937 . . . . 0.0 112.099 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.37 97.03 0.06 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 t -123.46 173.42 8.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.313 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.9 34.87 1.02 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.123 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.36 -60.45 3.32 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.323 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.85 112.71 3.34 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.516 2.144 . . . . 0.0 112.522 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.18 55.28 4.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.829 2.353 . . . . 0.0 112.069 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.36 166.32 11.8 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.019 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.26 46.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.03 96.49 8.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.815 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.3 94.73 9.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.766 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -83.5 118.77 24.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 8.1 p -135.25 158.02 45.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.522 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -59.04 -36.72 75.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.747 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.0 tpt -67.03 -33.49 75.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.55 143.42 3.67 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.36 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.7 tt -82.57 126.83 40.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 pt -128.56 137.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.86 135.37 35.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.02 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.67 147.56 48.59 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.315 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.24 129.56 38.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -104.78 131.97 51.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.337 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -76.07 99.65 4.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.0 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -83.03 18.18 1.73 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -67.32 0.86 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.455 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 2.3 m-70 -100.69 -13.28 18.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.666 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.59 1.71 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.2 Cg_exo -40.86 -36.4 2.0 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.062 1.841 . . . . 0.0 112.927 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -47.74 79.38 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.688 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.408 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.7 OUTLIER -78.35 -36.76 45.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.906 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.3 t -57.98 -47.63 82.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.655 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -42.97 75.1 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.197 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -58.89 -53.7 55.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -41.46 70.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.997 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.1 54.65 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.27 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -45.44 93.09 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.176 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -35.4 71.19 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.136 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -84.21 -36.48 22.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.298 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -47.23 68.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.232 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -58.22 -25.82 62.11 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.757 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.33 13.0 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.817 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.49 -34.74 18.55 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.643 0.259 . . . . 0.0 110.935 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.15 -25.42 55.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -65.08 93.62 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 110.245 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.08 -20.11 3.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.106 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.2 m -58.12 157.41 8.19 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.906 0.353 . . . . 0.0 111.508 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -138.92 169.39 17.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.482 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.437 ' CD1' HG11 ' A' ' 157' ' ' VAL . 9.9 m-85 -96.86 83.47 3.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.96 -45.24 78.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -99.77 120.66 40.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.754 0.311 . . . . 0.0 111.026 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.473 ' HB ' ' HG3' ' A' ' 153' ' ' PRO . 19.3 mt -145.68 98.54 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.295 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.11 107.09 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -39.09 93.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.538 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.66 41.3 0.89 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.41 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.986 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.51 171.53 18.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 111.115 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.77 151.67 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.824 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -134.32 161.77 34.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.587 0.708 . . . . 0.0 112.524 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.81 109.33 0.41 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.498 ' HA3' ' CG ' ' A' ' 111' ' ' GLN . . . -160.2 -179.25 34.85 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.145 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.4 76.34 3.74 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 110.75 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.36 143.49 19.67 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.646 2.231 . . . . 0.0 112.58 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.8 p -98.4 29.5 3.59 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.442 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.82 -27.25 63.08 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.454 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -112.38 -30.11 7.28 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.27 22.87 5.69 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.943 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.28 16.67 13.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.847 0.324 . . . . 0.0 111.236 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.98 150.19 17.12 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.411 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.04 168.82 28.95 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.14 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.09 175.47 8.53 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.213 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 t -104.51 158.64 16.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.012 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.422 HD12 ' CD2' ' A' ' 78' ' ' TYR . 2.6 pp -57.23 -27.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.298 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.422 ' CD2' HD12 ' A' ' 77' ' ' ILE . 19.3 m-85 -82.28 -33.14 29.23 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.904 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.02 -158.53 27.66 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.33 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.71 -72.71 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.874 0.337 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -133.1 140.75 47.81 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.404 ' CZ ' ' HB2' ' A' ' 108' ' ' ASN . 44.0 p90 -130.03 166.93 19.1 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 111.57 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.25 110.0 21.94 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.345 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.06 178.35 4.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 62.9 166.42 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.685 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.38 106.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.587 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -172.11 -61.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.085 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -80.84 -173.38 1.82 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.652 2.235 . . . . 0.0 112.616 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.58 95.62 5.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.482 ' HG ' ' CG2' ' A' ' 128' ' ' ILE . 2.6 mm? -77.03 -176.33 3.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -70.21 0.47 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.72 70.58 0.63 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.38 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -75.75 -39.08 57.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 119.93 -42.06 1.83 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.362 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.55 100.22 11.21 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.735 0.302 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.23 55.22 2.13 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.915 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.3 mm -130.61 130.75 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.653 0.264 . . . . 0.0 110.867 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.474 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 2.7 mt -102.92 104.27 14.48 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.63 142.42 39.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.32 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.441 ' HG2' ' CD2' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -79.5 123.53 27.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.47 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 143.9 32.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.491 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -154.48 136.34 14.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.69 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.56 179.32 32.49 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.926 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 139.61 63.0 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.398 2.065 . . . . 0.0 112.122 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 59.81 44.91 13.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.308 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.6 m -146.99 85.97 1.63 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 68.3 m-80 -106.56 152.13 24.11 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.51 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 -138.95 3.62 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.808 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.47 60.84 0.73 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.498 ' CG ' ' HA3' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -150.83 146.25 26.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.379 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.441 ' CD2' ' HG2' ' A' ' 100' ' ' MET . 3.8 m-85 -149.72 160.08 43.82 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.391 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.479 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 31.4 p90 -134.66 134.37 41.07 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.483 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 24.1 t -104.04 110.02 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.238 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 45.1 p -80.96 138.27 36.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.977 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 -18.91 11.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.512 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.39 158.29 35.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.84 128.74 9.16 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.848 2.366 . . . . 0.0 112.902 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 22.8 p -131.94 33.79 3.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -61.64 -37.79 85.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.831 0.348 . . . . 0.0 110.58 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -79.6 -27.78 41.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.136 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 19.8 mt -75.52 -5.15 43.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.89 84.69 0.08 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.179 0.514 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 163.3 -41.14 0.33 Allowed Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.415 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -59.12 -57.29 13.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.625 0.25 . . . . 0.0 110.783 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -109.53 173.69 6.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.639 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.421 ' O ' ' N ' ' A' ' 100' ' ' MET . 28.2 m -106.67 160.14 15.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.482 ' CG2' ' HG ' ' A' ' 90' ' ' LEU . 2.3 tt -87.51 179.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.226 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -176.79 -40.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.397 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.08 -179.8 27.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.276 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -144.08 167.26 22.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.494 0.187 . . . . 0.0 110.837 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG21 ' HB ' ' A' ' 136' ' ' ILE . 30.5 m -125.08 107.21 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -43.99 12.14 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -132.06 90.59 2.84 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.898 179.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 168.96 -27.77 0.13 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.341 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.4 ' HB ' HG21 ' A' ' 132' ' ' VAL . 12.3 tt -44.28 -36.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -41.04 75.06 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.694 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' A' ' 141' ' ' ARG . 11.4 tmm? -68.59 -36.55 78.87 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 110.755 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.1 t -73.62 -35.46 44.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -72.17 -39.39 68.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.192 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 138' ' ' MET . 7.5 ptp180 -62.57 -31.69 72.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 22.0 t -56.51 -31.0 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.632 0.253 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.85 -22.98 40.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.714 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.5 mmt -76.8 -4.54 44.02 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.27 32.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.646 0.26 . . . . 0.0 111.489 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.79 169.96 0.19 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 111.432 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -152.67 175.84 12.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.399 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 0.6 OUTLIER -79.92 -174.72 4.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.76 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.7 p -89.4 36.59 0.84 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.572 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -166.32 -72.42 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.392 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -174.13 70.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.666 0.269 . . . . 0.0 110.825 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.426 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -153.37 99.73 2.65 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.625 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.473 ' HG3' ' HB ' ' A' ' 56' ' ' ILE . 51.0 Cg_exo -53.6 154.35 16.1 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.988 2.459 . . . . 0.0 113.308 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -76.18 -34.11 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.973 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -170.65 2.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.682 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -127.48 110.83 13.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.976 0.417 . . . . 0.0 111.436 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.437 HG11 ' CD1' ' A' ' 53' ' ' PHE . 35.5 t -108.54 121.0 60.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.0 pttt -145.24 152.65 40.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.593 0.235 . . . . 0.0 111.203 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 30.4 mt -93.21 138.97 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.086 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.457 HD13 HG22 ' A' ' 160' ' ' ILE . 9.9 pt -109.76 -35.61 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.938 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.66 146.58 4.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -132.17 115.85 16.24 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -133.56 156.19 79.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.68 170.93 16.35 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.676 2.251 . . . . 0.0 112.741 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.55 94.76 6.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.361 -1.244 . . . . 0.0 112.288 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptt? . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.93 154.36 17.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.513 0.197 . . . . 0.0 111.064 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 71.13 138.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.95 98.01 32.2 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.924 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -51.95 160.29 3.14 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.987 2.458 . . . . 0.0 112.536 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.74 120.58 6.72 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.903 2.402 . . . . 0.0 112.777 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -125.33 125.94 44.28 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.856 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m 64.0 174.32 0.18 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.401 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.73 159.84 19.15 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.526 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -83.26 135.82 43.94 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.96 116.02 4.14 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.707 2.271 . . . . 0.0 112.358 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.4 -33.99 28.04 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.689 2.259 . . . . 0.0 112.441 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -126.36 142.51 51.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.5 m -126.85 153.64 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.286 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -111.34 100.65 9.22 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.4 110.59 19.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -87.39 108.23 18.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.02 156.38 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -61.7 -31.58 71.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.362 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -34.64 71.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.68 -156.22 26.33 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.362 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.2 tt -127.53 128.26 69.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.814 0.307 . . . . 0.0 111.142 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 pt -141.0 138.73 34.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.497 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 m -97.46 148.27 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.41 ' HB3' HD13 ' A' ' 98' ' ' LEU . 16.3 mt -123.49 122.83 39.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.367 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.11 94.96 6.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.254 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.8 mp -82.41 147.26 28.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.976 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.492 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 52.6 m-85 -72.26 102.0 2.99 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -81.16 15.76 1.8 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -69.82 0.75 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 110.277 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.46 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.59 -13.99 18.36 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.164 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.66 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.81 1.58 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 72.3 Cg_exo -41.4 -36.75 2.93 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.065 1.844 . . . . 0.0 112.844 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -52.33 63.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.773 0.321 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -64.97 -40.45 95.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.357 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -56.5 -48.38 77.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.467 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -58.79 -42.88 90.09 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.256 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.2 -51.9 67.61 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.24 -41.63 97.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.92 85.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.05 -42.09 85.36 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.286 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -34.01 76.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.646 0.26 . . . . 0.0 111.153 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.59 -31.73 26.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -84.22 -38.92 19.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.558 0.218 . . . . 0.0 111.474 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -61.4 -58.44 8.2 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.85 65.17 0.04 OUTLIER Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.75 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.39 -62.08 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.584 0.23 . . . . 0.0 110.827 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -60.59 -42.63 97.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.174 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -67.47 101.18 0.94 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.681 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.49 -32.99 2.11 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.437 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.5 t -86.66 -168.59 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.752 0.31 . . . . 0.0 111.391 -179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -150.31 -174.16 4.66 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.692 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.415 ' HB3' HD11 ' A' ' 56' ' ' ILE . 8.1 m-85 -83.38 122.12 28.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.29 11.88 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.428 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -157.62 111.33 2.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 53' ' ' PHE . 21.6 mm -134.9 120.07 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.7 mp -109.78 115.23 49.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.493 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -54.78 124.43 16.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.465 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 58.38 57.4 3.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -165.1 -81.68 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.368 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.71 173.33 15.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 111.617 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 42.3 pt -142.87 140.51 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.942 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.446 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -122.17 153.81 38.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.243 0.544 . . . . 0.0 111.969 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.38 146.42 16.48 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.826 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -110.85 139.32 15.46 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.33 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.435 ' N ' ' HD3' ' A' ' 67' ' ' PRO . 4.9 t70 -158.92 53.52 0.59 Allowed Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 120.836 0.35 . . . . 0.0 111.079 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' A' ' 66' ' ' ASP . 60.9 Cg_endo -85.88 -177.84 2.68 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.992 2.461 . . . . 0.0 113.137 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 73' ' ' GLY . 1.3 p -155.79 31.17 0.36 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.784 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.32 59.73 1.92 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.574 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 p -112.32 28.78 8.47 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 111.043 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.42 32.3 83.75 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.691 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.87 -70.47 0.77 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.471 0.177 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' O ' ' HB ' ' A' ' 68' ' ' THR . . . -160.45 158.83 30.29 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.34 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.4 104.53 0.47 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.782 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -160.4 121.21 2.97 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.57 0.224 . . . . 0.0 111.395 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.0 p -92.26 -52.4 4.7 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.762 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 tp -172.6 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.954 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -102.18 -32.92 9.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.68 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 176.99 179.33 47.33 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.385 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.27 11.42 30.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.1 110.21 0.15 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.606 0.241 . . . . 0.0 110.998 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 34.7 p90 -126.88 161.04 29.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.0 179.78 2.61 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.302 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.3 177.48 5.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -139.17 103.96 4.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.272 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.1 tp -154.17 134.33 13.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.412 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -171.44 -61.3 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.131 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 87' ' ' HIS . 18.4 Cg_endo -60.31 171.33 3.31 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.682 2.255 . . . . 0.0 112.716 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -78.36 107.64 11.13 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.997 0.427 . . . . 0.0 111.195 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.436 ' HG ' HG21 ' A' ' 128' ' ' ILE . 4.0 mm? -109.44 162.32 14.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.932 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -118.31 150.83 38.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.461 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 96.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 15.0 t -175.45 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.627 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.34 120.25 21.11 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.064 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -49.95 106.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 117.33 69.95 0.4 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.014 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.1 mm -131.74 139.62 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.569 0.224 . . . . 0.0 111.223 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.452 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 0.8 OUTLIER -106.25 104.94 14.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.622 179.245 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -109.84 144.09 38.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.49 128.6 33.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.65 167.77 20.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.259 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -159.53 117.53 2.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.773 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.25 -40.28 52.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.142 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.94 160.72 31.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.9 125.84 20.01 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.66 2.24 . . . . 0.0 112.175 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 58.54 30.93 20.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.6 m -142.61 84.4 1.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.992 0.425 . . . . 0.0 110.25 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.424 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 2.8 m-20 -123.71 165.9 16.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.582 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.76 -103.33 0.92 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.434 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 38.0 m -151.23 43.26 0.77 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 111.172 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -105.09 154.18 20.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.323 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -155.39 159.31 39.78 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.664 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 15.1 p90 -138.33 139.61 39.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.449 . . . . 0.0 111.611 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 16.9 t -115.56 110.95 33.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.54 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.8 113.7 18.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.8 -16.21 45.49 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.594 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.84 162.54 51.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.473 0.177 . . . . 0.0 110.885 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 93' ' ' THR . 50.6 Cg_exo -53.85 131.51 44.71 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.901 2.401 . . . . 0.0 112.702 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.8 p -143.5 105.07 4.31 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 -43.65 6.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -58.61 -31.84 68.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.148 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.6 -17.94 52.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.529 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -65.66 85.25 0.07 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 110.466 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 153.46 -35.43 0.76 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.363 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -50.53 62.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.692 0.282 . . . . 0.0 110.908 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -112.44 147.61 36.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.454 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.9 t -79.81 170.11 16.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.828 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.464 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.3 tt -99.69 -179.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.452 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -171.7 -38.41 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.76 -179.41 27.4 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.082 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.8 ttm105 -135.74 148.12 48.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.83 102.13 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.113 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.45 -63.5 1.28 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.3 82.71 1.76 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.655 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -178.75 -24.09 0.04 OUTLIER Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.916 -179.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.2 tp -46.75 -34.55 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 117.266 0.533 . . . . 0.0 112.297 -179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.22 -22.09 54.97 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.868 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 8.8 tmm? -93.44 -39.35 10.95 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 32.3 t -59.43 -54.28 36.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.065 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.5 p30 -59.07 -33.25 70.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.675 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -38.52 91.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.413 HG11 HD13 ' A' ' 56' ' ' ILE . 20.7 t -57.47 -36.0 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.685 0.279 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.16 -34.43 69.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.397 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.1 mtt -58.59 -40.83 84.26 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.6 t -54.01 119.01 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.26 121.74 12.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.596 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.1 t -89.83 168.73 11.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.134 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -81.8 -170.04 2.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.45 31.24 1.04 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.594 0.235 . . . . 0.0 111.442 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.67 30.37 0.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.65 53.73 10.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.488 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.16 134.6 25.27 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.21 116.69 4.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.592 2.195 . . . . 0.0 112.322 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.09 -35.27 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.625 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.71 -169.26 2.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.567 179.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.42 101.67 11.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.2 t -130.42 108.27 15.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.238 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -179.97 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.621 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 1.5 mt -111.57 145.33 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.248 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.64 -35.0 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.898 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.8 149.46 26.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.27 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -145.48 121.48 10.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.459 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -144.95 155.36 55.54 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.392 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.21 168.18 18.86 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.691 2.26 . . . . 0.0 112.257 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.7 t -142.46 154.21 44.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.148 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.821 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.458 0.17 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.4 -59.2 1.96 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.962 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -111.97 132.28 54.87 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.951 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 tp -118.77 70.04 9.38 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 121.349 0.595 . . . . 0.0 110.692 179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.33 173.58 13.53 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.75 2.3 . . . . 0.0 111.856 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.61 -26.36 36.98 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.644 2.229 . . . . 0.0 112.741 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 61.45 58.61 2.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 111.131 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.66 137.16 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.47 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -160.69 129.28 4.66 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.595 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -169.83 -62.0 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.859 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.85 118.36 5.65 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.494 2.13 . . . . 0.0 112.56 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.31 -2.48 12.68 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.808 2.339 . . . . 0.0 113.275 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -89.93 142.95 27.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.649 0.261 . . . . 0.0 111.208 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -131.43 136.59 57.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.164 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.3 108.29 19.85 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.28 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.28 99.53 9.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.99 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -82.16 110.29 17.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.71 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.3 p -112.31 161.51 16.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 p -62.81 -37.12 85.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.235 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.3 tpt -68.46 -30.01 68.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.27 -154.33 24.54 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.345 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.86 128.76 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.864 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.85 145.06 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.79 119.12 60.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.549 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.04 155.56 26.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -110.76 115.01 28.82 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.757 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 mt -87.0 147.86 25.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.797 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -84.81 104.58 14.89 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.629 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -82.55 21.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.2 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -69.52 0.77 Allowed 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.474 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.81 18.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.942 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.1 1.27 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.3 Cg_exo -41.43 -38.16 3.68 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.054 1.836 . . . . 0.0 112.819 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -54.15 50.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.321 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.68 -33.62 72.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -55.92 -56.01 25.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -61.24 -39.07 88.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.344 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.97 -38.86 83.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.019 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -46.74 80.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.15 77.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.439 ' HG3' HD11 ' A' ' 77' ' ' ILE . 1.2 mm-40 -61.03 -50.55 72.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.068 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 mp -57.49 -40.13 77.96 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.992 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.6 67.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.342 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -73.02 -50.83 20.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -60.77 -28.56 68.82 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.847 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.49 28.34 5.47 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.733 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -89.67 -41.32 12.0 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.612 0.206 . . . . 0.0 110.729 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -72.01 -31.13 65.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.281 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.69 102.86 0.21 Allowed 'General case' 0 C--O 1.233 0.202 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.71 11.76 9.13 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.487 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.472 ' CG2' ' HB3' ' A' ' 67' ' ' PRO . 20.3 p -95.55 168.46 10.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.392 0.596 . . . . 0.0 110.827 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -157.55 169.54 24.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.678 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.425 ' HB3' HD13 ' A' ' 56' ' ' ILE . 47.3 m-85 -94.86 100.71 12.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.552 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -88.84 -43.64 11.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.819 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 63' ' ' GLN . 7.3 mtt180 -90.97 108.61 19.97 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.694 0.283 . . . . 0.0 110.612 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.425 HD13 ' HB3' ' A' ' 53' ' ' PHE . 36.1 mm -131.99 140.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.264 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.75 116.84 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.715 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 122.85 14.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.402 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 61.93 51.05 3.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.331 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.88 -80.15 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.234 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.3 ptm -160.6 172.2 17.58 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 111.33 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.2 pp -132.86 115.71 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 16.0 pt20 -104.69 138.28 41.24 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 0.0 111.986 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.32 110.5 1.08 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.962 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.36 179.44 35.87 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.841 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.68 69.53 0.61 Allowed Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 121.144 0.497 . . . . 0.0 110.628 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.472 ' HB3' ' CG2' ' A' ' 51' ' ' THR . 25.4 Cg_endo -62.56 -71.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.909 2.406 . . . . 0.0 112.542 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 46.04 47.2 12.83 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.94 -32.27 66.18 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.775 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.6 t -83.28 -31.43 26.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.508 0.194 . . . . 0.0 111.258 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.18 32.49 35.22 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.465 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -150.54 -62.71 0.2 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.678 0.275 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.43 121.14 3.94 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.485 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.08 79.67 0.21 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.266 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.82 158.87 17.71 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.901 0.381 . . . . 0.0 111.119 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -74.55 162.25 28.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.406 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.439 HD11 ' HG3' ' A' ' 41' ' ' GLU . 2.8 pt -61.45 -27.24 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.052 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -96.45 30.69 2.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.103 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.18 -146.94 16.68 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.971 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 -25.65 11.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -148.33 139.97 23.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.557 0.217 . . . . 0.0 110.794 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 m-85 -87.38 -174.42 4.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.488 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.17 69.9 1.15 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.733 0.301 . . . . 0.0 111.744 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 66.13 146.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.939 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' O ' HG22 ' A' ' 127' ' ' THR . 6.4 mt-10 -155.38 36.37 0.38 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.13 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tp -65.91 149.9 49.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 111.526 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.432 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 11.5 p80 -99.82 152.03 37.68 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.75 -50.42 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.586 2.191 . . . . 0.0 112.24 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.82 146.97 14.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.432 ' HB2' ' CE1' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -171.9 173.84 4.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -90.66 160.91 15.62 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.876 0.369 . . . . 0.0 111.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.52 61.14 0.75 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.978 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.34 -36.06 75.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.88 -20.38 46.02 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.238 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.55 112.66 25.68 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.163 0.482 . . . . 0.0 110.959 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.62 56.86 5.76 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.331 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.0 mm -124.15 161.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.483 0.183 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.414 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 3.4 mt -142.08 106.35 4.79 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 110.446 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -114.52 144.04 44.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 110.92 15.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.48 179.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.71 145.55 31.52 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -124.19 174.75 7.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.26 -45.13 4.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.476 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.96 174.82 36.8 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.778 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.89 141.3 67.04 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.658 2.239 . . . . 0.0 112.152 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 45.2 30.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.914 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -149.93 87.53 1.48 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.78 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.457 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 60.8 m-80 -95.4 172.84 7.84 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.43 -171.43 12.19 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.717 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 m -103.52 45.7 0.95 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.023 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -115.25 168.34 10.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.564 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 24.1 p90 -160.59 171.86 18.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.454 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.0 p90 -152.28 131.56 12.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.851 0.358 . . . . 0.0 111.645 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 34.1 t -96.41 116.78 39.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.358 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.59 127.98 32.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.2 mt -113.36 -8.4 13.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.561 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.59 161.56 61.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.456 0.17 . . . . 0.0 110.991 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.95 121.77 10.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.873 2.382 . . . . 0.0 112.603 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.423 ' HB ' ' HB2' ' A' ' 122' ' ' LEU . 0.9 OUTLIER -143.09 49.02 1.47 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.078 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -31.84 69.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.124 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -65.84 -28.48 69.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.186 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 0.3 OUTLIER -75.89 -7.36 54.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.899 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -66.14 85.57 0.09 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.124 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.68 -41.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.351 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.5 mttt -67.1 -49.56 64.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.548 0.213 . . . . 0.0 111.036 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.32 140.86 48.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.46 HG22 ' O ' ' A' ' 85' ' ' GLU . 97.8 m -85.07 151.4 24.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 0.6 OUTLIER -79.46 -178.98 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.275 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -169.34 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 -179.51 26.17 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.66 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -143.3 155.59 44.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.525 0.203 . . . . 0.0 110.689 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.0 m -114.39 85.08 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.164 0.507 . . . . 0.0 112.24 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.97 -40.01 40.67 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.05 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -127.52 98.33 5.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.65 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.79 -12.3 1.3 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.622 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.442 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 15.5 tt -50.54 -30.35 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 117.255 0.527 . . . . 0.0 111.938 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.79 -12.13 67.13 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.29 -0.481 . . . . 0.0 113.417 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.05 -30.05 12.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.793 0.296 . . . . 0.0 110.814 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.448 HG22 HG12 ' A' ' 114' ' ' VAL . 2.5 m -84.61 -34.85 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.434 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.7 p30 -61.52 -28.21 69.16 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.279 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.55 -30.83 47.11 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.855 -0.157 . . . . 0.0 111.298 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 39.3 t -57.47 -36.88 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.688 0.28 . . . . 0.0 110.738 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.11 -30.27 11.32 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.208 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -65.15 -31.94 73.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 27.1 m -61.38 176.38 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.98 0.419 . . . . 0.0 111.569 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.38 172.75 12.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -147.79 166.15 28.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -142.74 159.21 42.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 m 85.49 -40.86 0.05 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.508 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 168.36 -37.63 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -169.62 37.25 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.358 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.22 124.99 36.4 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.85 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.403 ' HG3' HG13 ' A' ' 56' ' ' ILE . 51.9 Cg_exo -54.74 109.49 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.71 2.273 . . . . 0.0 112.478 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.1 p -64.13 -30.85 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.922 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.64 -171.67 3.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.719 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.13 117.84 32.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.6 t -142.07 121.88 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.21 178.53 10.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.726 0.298 . . . . 0.0 111.732 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.3 mt -110.84 143.45 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.062 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.38 -40.45 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.38 153.06 17.2 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.669 0.271 . . . . 0.0 111.211 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -150.88 141.6 22.74 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -154.51 156.45 31.62 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.55 162.94 24.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.448 2.099 . . . . 0.0 112.5 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -85.88 144.51 27.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.076 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 118.684 -1.065 . . . . 0.0 112.954 179.789 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtm . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.901 0.381 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.01 111.28 0.28 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.54 -60.21 0.94 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.262 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -65.35 130.1 94.61 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.996 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.53 112.8 3.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.733 2.289 . . . . 0.0 112.468 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.66 161.02 29.94 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.944 2.429 . . . . 0.0 112.97 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.2 33.54 1.52 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.287 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.81 134.74 7.94 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.684 0.278 . . . . 0.0 111.168 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -111.21 128.29 55.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.52 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.07 81.56 2.19 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.78 107.85 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.882 2.388 . . . . 0.0 112.823 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.57 -42.87 2.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.951 2.434 . . . . 0.0 111.912 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -125.05 174.88 7.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.783 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.5 p -148.16 130.33 6.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -105.36 106.3 16.73 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 107.15 18.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.498 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -86.61 82.35 7.93 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.354 179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.62 165.32 13.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.28 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -67.4 -37.15 82.65 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 12.9 tpt -62.44 -32.97 73.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.82 -148.53 14.4 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.194 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.8 tt -134.83 130.14 52.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.861 0.331 . . . . 0.0 111.385 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.5 pt -137.62 135.58 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.637 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.73 140.24 17.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.599 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 131' ' ' ARG . 2.0 mt -130.87 141.0 50.28 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.588 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.82 107.91 19.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.524 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.49 146.68 27.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 23.0 m-85 -79.86 92.04 5.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -80.69 19.48 0.82 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.01 -72.44 0.67 Allowed 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.45 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -101.1 -12.1 19.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.017 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.665 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.9 1.34 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 71.7 Cg_exo -41.09 -36.38 2.24 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.248 1.966 . . . . 0.0 112.965 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -58.02 -60.37 3.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.353 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -39.31 91.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.337 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.0 t -55.01 -48.68 73.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.446 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -60.61 -37.29 80.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -58.35 -54.22 49.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.767 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -61.13 -45.84 93.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 110.826 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.39 94.02 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.31 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.5 -44.07 58.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.251 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -37.91 70.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.117 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.93 -32.66 34.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.413 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -66.94 -45.95 76.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.124 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -28.42 68.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.736 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.04 36.18 2.79 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.733 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.19 -50.13 5.64 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.637 0.218 . . . . 0.0 110.697 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -62.75 -28.65 70.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.939 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -67.63 113.66 5.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.422 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.6 20.9 7.08 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.359 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.2 p -124.93 154.73 40.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.038 0.419 . . . . 0.0 110.53 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -129.56 169.66 14.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -85.31 99.07 10.9 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.783 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -76.86 -39.4 51.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.169 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -100.98 117.28 34.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.607 0.241 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 62' ' ' ILE . 13.2 mt -141.11 120.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.0 111.379 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 mt -116.22 116.56 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.795 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.59 -60.28 3.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.563 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -88.47 62.38 6.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.605 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 178.25 -86.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.272 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.2 170.94 19.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.809 0.337 . . . . 0.0 111.554 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.449 HG12 HG12 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -127.23 123.09 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.139 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 1.7 pt20 -117.4 155.19 30.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.22 100.63 0.41 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.453 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.476 ' HA2' ' HB3' ' A' ' 111' ' ' GLN . . . -107.22 175.89 20.73 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.58 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -143.6 67.33 16.15 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 120.952 0.406 . . . . 0.0 110.57 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.17 163.61 22.42 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.79 2.327 . . . . 0.0 112.715 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -114.61 43.85 1.85 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.921 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.44 23.41 30.24 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.613 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.75 -30.89 9.62 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.438 0.161 . . . . 0.0 111.395 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.85 28.99 7.94 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.585 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.12 32.65 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.19 157.62 15.23 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.544 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.04 174.13 27.28 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.131 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.04 157.08 18.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.365 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.411 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 8.5 t -76.69 171.76 14.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.364 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 tt -73.23 -34.09 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.489 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -100.33 36.75 1.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 111.131 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 76' ' ' SER . . . 89.05 169.07 44.32 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.071 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -52.42 63.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.429 0.157 . . . . 0.0 110.786 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -141.61 143.26 33.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.862 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -138.56 173.57 11.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.525 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.18 173.43 11.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.396 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.415 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 4.3 p30 -80.19 178.46 8.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -132.21 72.91 1.51 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' CD2' ' HB2' ' A' ' 84' ' ' ASP . 3.4 mm? -99.17 104.73 16.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.85 -54.23 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -48.72 149.99 6.79 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.78 2.32 . . . . 0.0 112.703 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.54 94.9 2.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 mt -90.16 -174.94 4.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.721 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -69.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 62.06 61.28 1.37 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.113 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.7 p -57.62 -36.86 72.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.413 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 147.64 -101.52 0.23 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.613 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.95 135.17 46.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.974 0.416 . . . . 0.0 111.736 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.408 ' CA ' ' HB ' ' A' ' 132' ' ' VAL . . . 77.93 52.65 5.26 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.994 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 17.1 mm -135.81 138.67 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.427 ' HG ' ' CE2' ' A' ' 129' ' ' PHE . 13.3 tp -115.33 133.75 55.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.8 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.417 ' HB2' ' HA ' ' A' ' 128' ' ' ILE . . . -134.13 151.65 51.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 116.35 19.64 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.36 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.92 158.51 26.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.857 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -121.03 173.45 7.25 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.293 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.24 -43.98 3.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.181 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.95 -179.43 33.78 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.65 113.23 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.05 30.54 20.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.12 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -129.82 90.77 3.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -83.21 162.77 21.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.94 -140.94 4.5 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.57 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 m -138.58 58.49 1.66 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.076 0.465 . . . . 0.0 110.802 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.476 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 3.3 mt-30 -132.78 178.23 7.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.821 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -160.45 158.02 28.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.057 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 41.3 p90 -137.36 133.02 34.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.32 114.66 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.2 p -79.94 113.62 18.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.099 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -86.71 -23.83 25.4 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.19 165.01 18.33 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.806 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.1 124.64 16.39 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.621 2.214 . . . . 0.0 111.994 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -141.79 48.17 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.211 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -64.47 -35.35 80.65 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.756 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -65.58 -27.9 68.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.5 mt -78.46 0.11 27.19 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.55 79.91 1.07 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.235 0.54 . . . . 0.0 109.942 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.57 -46.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.203 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.45 -43.28 90.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 110.676 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -123.45 135.8 54.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 63.5 m -80.16 160.83 25.54 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.74 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.417 ' HA ' ' HB2' ' A' ' 99' ' ' ALA . 1.4 tt -79.39 -179.5 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.934 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CE2' ' HG ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -177.13 -38.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.403 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.41 -179.6 17.73 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.848 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 7.6 mtm180 -137.3 168.1 20.29 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 122.819 -0.224 . . . . 0.0 110.778 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.408 ' HB ' ' CA ' ' A' ' 96' ' ' GLY . 11.5 t -131.06 91.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.908 0.385 . . . . 0.0 111.345 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.33 -41.66 9.73 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.535 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 103.83 6.83 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.123 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.12 -19.68 1.57 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.422 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.7 tt -48.17 -36.5 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.996 0.398 . . . . 0.0 112.002 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.23 -24.18 67.04 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.289 -0.481 . . . . 0.0 113.133 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ttp -91.07 -32.37 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.236 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 20.2 t -73.92 -48.67 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.33 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -65.0 -31.56 72.86 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.155 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -59.98 -34.46 73.34 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.203 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 37.1 t -58.01 -38.69 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.8 -42.61 86.3 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.314 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.6 mmt -49.19 -48.62 45.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -52.73 141.8 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 111.503 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.46 112.69 2.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.764 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.2 p -79.86 165.52 22.62 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.107 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.59 -167.29 1.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.598 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.0 p -88.89 32.78 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.568 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -158.52 31.13 0.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.903 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 57.43 41.8 25.64 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.521 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.09 147.51 37.08 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 120.62 0.247 . . . . 0.0 111.551 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 152.32 31.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.904 2.403 . . . . 0.0 112.636 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 8.3 p -117.84 23.49 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.283 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.13 24.41 4.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 54.98 85.43 0.06 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 22.8 t -118.7 111.81 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 175.48 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.22 127.81 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.79 0.328 . . . . 0.0 111.048 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 pt -107.13 -33.62 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.765 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.38 167.94 27.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.285 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.25 159.32 40.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.365 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -129.23 97.08 26.64 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.207 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.9 95.0 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.827 2.352 . . . . 0.0 112.198 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.6 t -84.48 143.89 29.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.273 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.51 -1.161 . . . . 0.0 112.758 179.741 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.775 0.322 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.02 80.79 0.22 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.08 -25.77 66.39 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.551 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.51 83.2 13.17 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.757 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.29 149.69 63.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.705 2.27 . . . . 0.0 112.48 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.92 143.41 36.62 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.779 2.319 . . . . 0.0 112.662 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -143.62 131.99 22.12 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.39 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.28 92.78 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.614 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -179.87 1.42 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.441 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -132.67 88.71 37.54 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.044 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.417 ' N ' ' CD ' ' A' ' 12' ' ' PRO . 52.7 Cg_exo -53.1 -44.11 51.58 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.08 2.52 . . . . 0.0 113.728 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 11' ' ' PRO . 13.8 Cg_exo -70.27 54.74 1.41 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.548 2.165 . . . . 0.0 112.594 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 25' ' ' LEU . 8.2 m120 -142.31 175.32 9.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.776 0.322 . . . . 0.0 111.627 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -144.8 147.68 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -91.84 120.31 32.42 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 111.139 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.2 mt -114.05 102.83 10.55 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.303 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 6.5 mt-10 -92.86 103.16 15.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.27 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.427 HG22 HG23 ' A' ' 159' ' ' ILE . 2.1 p -113.56 158.19 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.3 t -60.47 -35.9 76.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.813 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.4 tpt -68.76 -32.34 72.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.329 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.51 -163.74 37.29 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.35 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 tt -124.12 129.95 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.984 0.392 . . . . 0.0 111.185 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.3 pt -136.96 156.83 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.683 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.3 t -123.32 116.52 48.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 13' ' ' ASN . 3.5 mm? -91.51 158.81 16.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.417 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 3.8 tt0 -110.65 105.59 14.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.75 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.97 131.15 37.49 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.392 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -82.41 113.9 20.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -81.96 14.96 2.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.83 -68.46 0.81 Allowed 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.686 0.279 . . . . 0.0 110.378 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.453 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -100.87 -13.94 18.16 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -97.63 0.66 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 98.7 Cg_exo -43.73 -40.56 11.1 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.071 1.847 . . . . 0.0 112.896 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -54.61 27.08 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.8 m -64.1 -35.85 82.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.117 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 t -57.01 -51.63 68.48 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.81 -40.47 88.5 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -58.51 -47.23 84.84 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.01 -46.91 78.61 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.739 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 -45.68 70.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.403 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.15 -45.96 91.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.211 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -44.1 93.07 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 110.845 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.59 -35.68 73.14 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.143 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.06 -47.15 60.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -57.41 -31.1 65.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.611 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 33.04 2.53 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.103 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.23 -34.86 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.606 0.203 . . . . 0.0 111.058 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -73.37 -37.2 66.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.645 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.88 151.84 41.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.27 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 18.31 71.0 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.861 -0.609 . . . . 0.0 113.083 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -109.19 161.67 15.01 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.004 0.402 . . . . 0.0 110.465 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -146.54 165.67 28.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -70.64 110.86 5.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -77.18 -45.23 27.34 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.851 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -112.11 130.1 56.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.41 ' HA ' HG21 ' A' ' 62' ' ' ILE . 51.9 mt -143.05 97.48 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.792 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.54 110.11 21.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -62.51 141.06 58.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.187 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.6 45.74 7.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.524 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -168.71 -89.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.942 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 175.23 12.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.41 HG21 ' HA ' ' A' ' 56' ' ' ILE . 1.8 pp -144.04 156.34 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.015 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 6.0 pt20 -132.73 142.53 49.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 111.568 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.03 156.43 16.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.704 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.98 -179.65 47.26 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.973 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -155.76 -64.54 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.94 -0.13 . . . . 0.0 111.128 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 66' ' ' ASP . 71.6 Cg_endo -76.46 -161.78 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.445 2.097 . . . . 0.0 111.832 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.6 t -51.95 -34.57 42.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.404 0.145 . . . . 0.0 111.285 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.06 47.53 72.66 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.771 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.8 p -136.32 40.52 2.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.812 0.339 . . . . 0.0 111.074 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.16 24.01 62.66 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.827 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.9 ttt-85 -175.06 77.45 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.722 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.31 158.85 34.76 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.008 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.8 178.39 53.8 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.804 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.85 131.68 35.26 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.618 0.247 . . . . 0.0 111.152 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.26 177.74 8.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 pp -56.19 -31.44 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.747 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.53 40.39 1.11 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.96 179.69 33.37 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.956 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.75 76.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.529 0.204 . . . . 0.0 110.931 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -155.91 146.28 21.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.908 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -126.9 177.21 6.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.22 140.53 38.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.59 157.19 14.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.465 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.63 40.6 3.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.541 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.94 145.98 42.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.695 0.283 . . . . 0.0 110.916 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -164.46 153.51 11.57 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.87 -166.48 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.396 2.064 . . . . 0.0 112.08 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.53 33.46 10.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 111.152 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 84.7 mt -122.03 -178.45 3.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.882 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.424 ' HE2' ' HB ' ' A' ' 93' ' ' THR . 17.0 tttt -128.08 157.29 41.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.088 0.47 . . . . 0.0 111.659 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.39 48.36 0.89 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.919 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.424 ' HB ' ' HE2' ' A' ' 91' ' ' LYS . 1.7 t -58.8 -23.83 60.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.8 -7.31 81.6 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.78 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.64 96.87 5.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.951 0.876 . . . . 0.0 111.383 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 83.23 61.64 1.89 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.302 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 4.4 mp -138.75 154.46 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.717 0.258 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -125.99 111.94 15.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.907 0.384 . . . . 0.0 110.454 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -108.22 137.04 46.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.34 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.437 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.64 104.88 10.54 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 164.89 22.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.475 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 172.68 12.62 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.32 -36.03 10.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.733 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.74 -179.84 32.93 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.614 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -61.87 124.21 14.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.696 2.264 . . . . 0.0 112.149 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.26 28.49 17.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.051 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.5 m -136.57 84.53 2.08 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.269 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.11 129.41 34.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.769 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.02 -164.06 24.88 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.953 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 m -110.25 68.43 0.67 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.063 0.458 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -148.67 152.47 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -147.17 156.68 43.18 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.755 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 22.8 p90 -137.77 126.15 23.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.968 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 11.7 p -98.47 120.14 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.356 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 p -84.18 129.36 34.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.761 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.45 -19.47 12.93 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.64 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.14 160.34 47.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.61 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.56 127.82 23.87 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.043 2.495 . . . . 0.0 112.802 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.5 p -147.42 42.9 1.1 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -59.19 -30.99 68.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.414 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 32.6 p90 -60.95 -29.2 69.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.273 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.414 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 14.6 mt -81.25 -2.06 47.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.78 85.63 0.21 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.153 0.501 . . . . 0.0 110.386 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.21 -31.58 0.54 Allowed Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.697 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -72.59 -62.94 1.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.708 0.254 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -95.63 172.13 8.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.3 t -114.06 156.73 23.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.522 179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mm -80.01 -179.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.283 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.437 ' HB3' ' HB2' ' A' ' 100' ' ' MET . 0.1 OUTLIER -178.22 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.393 0.277 . . . . 0.0 110.696 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 26' ' ' GLU . . . -145.44 -179.63 21.86 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.213 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 160.6 42.31 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.577 0.227 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.8 t -106.73 93.61 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.8 m -84.12 -42.58 15.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.475 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 107.25 8.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 136.09 -10.31 4.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.607 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.4 tt -48.78 -33.82 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.55 91.68 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.609 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -66.59 -46.49 75.79 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 0.0 110.471 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.75 -38.1 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.787 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.13 -40.81 77.87 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.62 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -62.09 -37.32 84.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.917 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.408 ' CG1' HD11 ' A' ' 56' ' ' ILE . 38.2 t -57.5 -41.04 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.946 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.09 -13.13 58.05 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.6 tpt -84.11 -35.64 23.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.977 0.388 . . . . 0.0 111.507 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 m -51.85 154.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.985 0.422 . . . . 0.0 111.684 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.17 95.49 0.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.672 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.3 p -79.95 170.52 16.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.371 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.31 179.46 7.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 29.59 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.387 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -156.1 33.52 0.34 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 54.3 61.88 2.83 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.34 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.0 114.38 13.89 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.114 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.99 117.41 4.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.849 2.366 . . . . 0.0 112.575 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.3 m -68.03 -34.26 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.334 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.3 179.54 7.43 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -105.79 80.66 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.6 t -98.94 115.62 39.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.658 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -149.96 175.14 11.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.553 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.427 HG23 HG22 ' A' ' 18' ' ' THR . 3.9 mt -109.8 148.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.69 -40.93 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.845 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.446 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 11.0 mttt -139.25 161.73 36.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.77 0.319 . . . . 0.0 111.298 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.57 110.14 2.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -128.69 166.84 21.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.93 174.71 11.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.905 2.403 . . . . 0.0 111.916 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.2 t -129.18 103.53 7.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.719 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.473 -179.851 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.708 0.29 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.46 171.4 8.19 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.382 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.43 -55.81 12.16 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.968 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.01 94.2 18.81 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.95 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.12 163.47 3.28 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.04 2.494 . . . . 0.0 112.793 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.49 125.2 13.01 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.755 2.304 . . . . 0.0 112.683 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -118.54 153.0 34.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.753 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -80.4 58.3 3.09 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.079 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 67.37 143.84 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.378 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -129.74 123.82 21.36 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.06 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.57 109.83 0.96 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.543 2.162 . . . . 0.0 111.769 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.43 63.0 5.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.093 2.528 . . . . 0.0 112.178 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.69 161.46 13.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.331 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 22.0 t -134.08 131.47 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.104 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -91.25 96.97 10.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.09 98.59 10.18 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.218 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' CB ' ' HB2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -87.34 122.23 30.83 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.225 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.61 163.6 24.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.156 -179.279 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.8 t -68.18 -34.75 76.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.196 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.72 -30.81 70.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' HA3' ' HG3' ' A' ' 138' ' ' MET . . . 168.16 -143.46 8.16 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.253 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.2 mt -140.86 135.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.854 0.327 . . . . 0.0 111.036 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 16.6 pt -137.78 147.95 25.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.764 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.1 t -120.04 123.64 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.021 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.406 ' HG ' ' CD1' ' A' ' 98' ' ' LEU . 1.4 mm? -116.26 159.14 22.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.217 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -125.71 106.76 9.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.05 158.61 19.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -102.86 102.5 12.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.236 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -81.25 23.25 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.14 -68.07 0.83 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.493 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.65 -14.11 18.27 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 178.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -97.29 1.39 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.7 Cg_exo -40.71 -37.46 2.28 Favored 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 121.952 1.768 . . . . 0.0 112.893 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -55.15 38.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.487 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.9 t -71.93 -34.97 69.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.797 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.1 m -56.97 -50.94 71.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.66 179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -42.33 99.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -65.07 -48.23 74.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.206 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.39 -46.38 86.51 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.946 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.15 83.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.42 -43.97 97.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.058 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.26 -41.17 83.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.01 77.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.902 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -68.48 -41.22 80.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -28.55 68.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.554 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.25 28.88 4.47 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.775 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -51.14 5.35 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.573 0.225 . . . . 0.0 110.425 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -77.3 -41.52 40.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.444 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -70.3 93.38 0.85 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.96 3.5 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.091 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 67' ' ' PRO . 74.0 p -61.78 166.55 4.3 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.006 0.403 . . . . 0.0 112.004 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -137.01 25.77 3.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.939 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 57.23 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 0.0 111.659 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -149.37 -65.84 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.8 mtt180 -91.34 122.25 33.79 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.399 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.516 HG13 ' HB3' ' A' ' 153' ' ' PRO . 23.9 mm -131.21 84.3 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.102 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 26.1 mt -89.86 88.94 2.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -24.23 60.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.744 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -91.43 25.59 2.55 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.85 -77.67 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 O-C-N 122.452 -0.155 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.423 ' HB3' ' HA ' ' A' ' 115' ' ' THR . 0.0 OUTLIER -160.32 178.79 9.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.631 0.253 . . . . 0.0 111.123 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 4.0 pt -135.46 149.19 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -133.06 154.17 50.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 112.161 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.82 103.43 0.47 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.025 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.06 167.74 35.53 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.776 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t70 63.04 70.68 0.72 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 111.078 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.426 ' HB3' HG22 ' A' ' 51' ' ' THR . 57.1 Cg_endo -72.09 -40.72 2.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.8 59.27 3.9 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.426 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.32 -29.59 73.62 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.706 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.7 p -88.28 -30.0 19.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.75 0.275 . . . . 0.0 111.349 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.35 0.38 40.67 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.805 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.88 41.75 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.915 0.358 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.78 123.72 1.77 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.66 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.33 87.46 0.17 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.521 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.72 152.71 31.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.605 0.241 . . . . 0.0 111.311 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p -99.82 172.71 7.08 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.4 pt -57.4 -38.22 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.646 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -74.55 -46.19 40.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.6 -153.91 21.95 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.757 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -34.54 7.08 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.58 109.87 5.92 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.675 0.274 . . . . 0.0 111.037 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -118.34 176.19 5.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.09 -177.91 0.41 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -113.86 176.94 4.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.463 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -130.75 110.31 11.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.369 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.02 129.09 9.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.78 -53.51 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -61.94 171.82 4.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.659 2.239 . . . . 0.0 112.11 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.19 -75.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.35 151.43 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -137.4 167.07 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.556 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -133.24 87.83 2.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.053 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.1 p -71.34 -27.78 63.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.82 -67.99 0.89 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.85 104.92 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.7 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.76 63.05 2.39 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.435 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.9 mm -142.4 123.34 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.778 0.289 . . . . 0.0 110.559 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 3.0 mt -98.93 117.51 33.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 111.251 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 128' ' ' ILE . . . -119.63 143.69 47.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.496 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.65 116.48 19.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.387 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.12 168.28 19.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.477 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -151.95 170.92 18.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -101.71 -49.07 4.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.649 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.02 -179.65 34.95 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.29 122.06 10.54 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.704 2.269 . . . . 0.0 111.908 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.32 31.33 17.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.188 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -139.12 85.44 2.07 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.731 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -107.49 140.83 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.36 -152.14 16.02 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.781 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 p -117.73 38.78 3.52 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -111.25 150.71 29.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.154 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.12 146.14 42.48 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.675 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 31.9 p90 -129.27 130.36 46.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.406 ' HB ' HD22 ' A' ' 98' ' ' LEU . 12.1 p -109.77 121.2 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.898 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.423 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 1.1 p -79.59 139.38 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.525 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -108.82 -31.16 7.8 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.663 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.1 153.89 37.73 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.036 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.48 122.71 10.71 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.681 2.254 . . . . 0.0 112.029 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.489 HG23 ' CZ2' ' A' ' 121' ' ' TRP . 75.1 p -145.97 92.61 2.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.85 -4.51 52.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.717 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.489 ' CZ2' HG23 ' A' ' 119' ' ' THR . 22.9 p90 -82.18 -32.63 29.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.286 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 pp -83.49 0.53 45.98 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -60.32 87.09 0.01 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.354 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.12 -23.3 2.74 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.966 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -61.6 -65.8 0.64 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.917 0.359 . . . . 0.0 110.951 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -97.5 172.61 7.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.795 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 46.5 m -92.13 155.15 18.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.95 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.4 tt -98.97 -179.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.778 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -172.77 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.8 -179.78 19.82 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.928 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -136.17 172.59 12.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.711 0.291 . . . . 0.0 110.969 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.66 121.09 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.218 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 29.1 m -123.25 -59.0 1.6 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -113.91 93.7 4.49 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 148.44 -17.43 1.3 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.386 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.2 tt -44.7 -34.75 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.008 0.404 . . . . 0.0 111.92 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.33 -42.23 82.22 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.769 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.401 ' HG3' ' HA3' ' A' ' 21' ' ' GLY . 1.4 ttp -60.79 -40.23 91.83 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.75 0.309 . . . . 0.0 110.476 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 22.9 t -70.53 -35.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.0 -46.43 74.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -58.4 -35.31 71.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.524 0.202 . . . . 0.0 111.262 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 33.4 t -58.42 -40.04 76.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.638 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.68 -37.97 38.46 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.464 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 mmt -60.76 -38.47 85.32 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.554 0.216 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.64 166.65 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.366 -0.379 . . . . 0.0 112.015 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -66.68 171.3 5.3 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.283 0.563 . . . . 0.0 110.968 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 p -149.13 174.73 12.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.271 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -95.48 -176.33 3.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.6 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.9 m -92.76 35.09 1.05 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 111.279 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.27 37.12 0.12 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.459 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.16 41.84 31.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.215 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.93 126.06 29.84 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.056 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.516 ' HB3' HG13 ' A' ' 56' ' ' ILE . 33.8 Cg_endo -64.5 154.24 72.88 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.813 2.342 . . . . 0.0 112.776 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 40.0 t -103.93 -28.24 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.889 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.66 17.65 11.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 33.81 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 11.0 t -80.24 97.52 3.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.0 tttp -102.4 130.56 49.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.422 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.0 mt -104.68 135.59 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.647 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.26 2.48 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.434 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 22.3 mttt -154.37 131.99 11.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.643 0.258 . . . . 0.0 111.183 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.43 81.74 1.04 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.063 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -144.67 156.81 56.11 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.368 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.93 177.83 7.91 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.098 2.532 . . . . 0.0 112.195 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.43 119.36 17.4 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.112 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.514 179.841 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mtm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.668 0.271 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.82 159.04 40.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.35 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.02 158.06 15.91 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.415 ' HB ' ' HD2' ' A' ' 6' ' ' PRO . 1.1 pt -61.96 144.53 93.76 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.294 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 43.8 Cg_exo -54.99 -49.49 16.46 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.597 2.198 . . . . 0.0 112.572 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 5' ' ' PRO . 35.6 Cg_exo -58.87 161.74 14.78 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.216 1.944 . . . . 0.0 112.512 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.7 t0 62.04 98.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.606 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.0 p -155.94 -73.22 0.11 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.87 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 64.85 118.78 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.046 0.45 . . . . 0.0 111.5 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.03 164.37 42.73 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.575 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.93 106.4 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.014 2.476 . . . . 0.0 112.248 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.94 -47.9 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.276 1.984 . . . . 0.0 112.359 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -128.49 177.47 6.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.786 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.79 129.93 66.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.687 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.83 93.01 9.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.92 89.26 7.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.937 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 89.56 6.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.445 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.2 p -95.21 164.11 12.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.147 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -66.89 -40.92 87.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.609 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.5 tpt -62.11 -30.91 71.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.21 -168.71 41.03 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.951 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.17 129.13 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.932 0.366 . . . . 0.0 111.075 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.6 pt -138.52 128.34 33.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.584 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.85 111.28 32.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.391 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.4 154.44 19.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.196 -179.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -112.2 133.37 54.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 4.5 mt -97.23 149.84 21.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.408 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.404 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 20.0 m-85 -92.24 90.66 7.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -80.47 23.6 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -100.44 -71.95 0.69 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.505 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.94 -13.67 18.21 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.664 178.81 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.658 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -100.15 1.36 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 43.5 Cg_exo -36.83 -37.39 0.31 Allowed 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.467 2.111 . . . . 0.0 113.375 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -60.67 3.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.781 0.324 . . . . 0.0 110.532 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.2 p -67.0 -34.69 78.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 96.6 m -58.94 -50.57 73.55 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -57.3 -40.31 77.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.284 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -63.25 -53.09 58.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.568 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -56.76 -44.04 81.38 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.5 99.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.982 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -64.7 -38.0 89.5 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.933 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.2 mt -64.02 -39.55 94.34 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.971 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.88 74.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.115 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -72.83 -52.83 13.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.151 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.428 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.29 32.07 3.85 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.591 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -53.08 8.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.629 0.252 . . . . 0.0 110.386 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -64.81 -41.0 96.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.644 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -61.19 127.44 31.54 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.473 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 -32.02 8.03 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.604 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 170.12 15.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.409 ' HB3' ' CB ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.46 159.23 43.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.925 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.469 ' CD1' HG12 ' A' ' 62' ' ' ILE . 58.6 m-85 -67.45 117.24 9.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.681 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.25 -61.57 1.67 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.289 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -88.97 123.37 33.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.072 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.438 HG12 HG13 ' A' ' 62' ' ' ILE . 7.1 mt -142.07 112.29 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.297 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.8 mp -93.89 121.02 44.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.065 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.23 123.7 18.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.13 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 t70 59.17 58.02 3.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.537 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.463 ' CE1' HG22 ' A' ' 119' ' ' THR . 15.6 t80 -166.66 -74.68 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.976 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -160.11 177.46 10.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.224 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.469 HG12 ' CD1' ' A' ' 53' ' ' PHE . 11.2 tt -151.15 101.91 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.9 tt0 -87.36 132.54 33.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.13 150.47 17.76 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.419 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.79 171.24 52.38 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.023 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.479 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 2.8 t0 179.21 -55.02 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 96.7 Cg_endo -80.45 47.12 2.45 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.601 2.201 . . . . 0.0 112.978 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.3 40.9 0.36 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.803 0.335 . . . . 0.0 110.976 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.42 31.28 6.26 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.952 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 t -128.39 -41.5 1.55 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.709 0.255 . . . . 0.0 111.455 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.51 40.66 2.71 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.629 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.23 -58.95 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.45 0.167 . . . . 0.0 111.097 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.26 149.79 19.44 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.765 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.28 101.74 2.78 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.763 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.34 160.96 14.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.275 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 p -101.28 169.79 8.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.9 pt -67.96 -29.95 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.866 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -81.65 -42.87 19.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.301 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.2 -138.56 2.65 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.725 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -61.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -160.72 161.16 32.13 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.731 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -137.03 177.36 7.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.21 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -87.11 176.94 7.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.092 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -92.74 179.25 5.54 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -136.0 136.02 39.98 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.252 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.05 129.37 9.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -62.48 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.68 -14.48 44.09 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.755 2.303 . . . . 0.0 113.076 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 72.2 -67.99 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.477 0.311 . . . . 0.0 111.144 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 89' ' ' ASP . 1.7 mp 66.27 157.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.855 0.36 . . . . 0.0 111.57 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -58.72 145.67 39.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.379 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.6 29.16 0.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.618 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.5 t -137.43 -46.57 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.5 122.95 30.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.778 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.16 131.6 10.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.636 0.255 . . . . 0.0 111.671 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 100.81 59.93 0.81 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.868 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.6 mm -128.56 132.56 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.73 0.265 . . . . 0.0 111.039 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.468 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 2.1 mt -109.67 103.65 12.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.48 140.21 46.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.398 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.7 108.72 13.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.81 151.99 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.754 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -130.66 147.5 52.34 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.718 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.05 -73.68 0.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.252 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.61 176.14 19.91 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.435 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.3 135.93 38.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.359 2.04 . . . . 0.0 111.879 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.35 30.41 19.79 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.336 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.78 87.05 2.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.776 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -83.25 129.7 35.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.472 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.43 -116.84 4.25 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.832 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.401 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 67.4 m -154.22 32.06 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 111.463 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -95.33 163.16 13.37 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -159.03 124.29 4.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.528 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.3 p90 -110.97 135.1 51.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.5 t -100.88 105.53 17.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.881 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.39 125.58 31.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.283 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.24 -1.22 12.42 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.695 179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -121.16 140.07 30.5 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -52.12 112.53 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.761 2.307 . . . . 0.0 112.212 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.463 HG22 ' CE1' ' A' ' 60' ' ' PHE . 69.5 p -128.79 97.73 4.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.92 -32.06 15.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.332 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.6 p90 -60.02 -39.16 84.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.417 ' HG ' ' HB ' ' A' ' 119' ' ' THR . 4.2 pp -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -63.83 85.52 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.42 -32.08 1.99 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.701 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -44.69 96.65 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.634 0.254 . . . . 0.0 111.128 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -104.02 150.15 24.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 87.2 m -89.37 151.74 21.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -80.9 -179.33 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.498 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -172.09 -42.26 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.04 173.35 30.55 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.855 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 7.6 tpp180 -140.84 148.64 40.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.592 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.7 m -89.98 114.01 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.671 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 27.0 m -95.48 -36.2 11.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -150.52 94.91 2.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.634 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 162.03 -19.24 0.18 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.828 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.5 tt -44.39 -34.61 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.457 0.628 . . . . 0.0 111.903 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.9 -25.15 52.35 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.024 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.6 ttp -86.11 -36.03 19.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.754 0.311 . . . . 0.0 110.329 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 t -72.42 -54.26 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.437 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -58.56 -30.69 67.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.575 0.226 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.56 -39.23 90.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.532 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.8 t -65.87 -27.03 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.35 -30.78 24.01 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.158 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.31 -34.56 78.26 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.137 0.175 . . . . 0.0 111.45 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 29.6 m -63.4 174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.828 0.347 . . . . 0.0 111.413 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.15 131.16 44.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.5 p -94.61 172.14 8.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.19 142.68 47.5 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.853 0.359 . . . . 0.0 111.646 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.19 -47.76 0.14 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.989 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 176.35 -32.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.593 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -169.54 36.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.478 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 116.05 65.57 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.78 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -64.82 111.28 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.596 2.197 . . . . 0.0 112.191 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.56 -33.86 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -168.25 1.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.587 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.09 100.04 7.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.748 0.309 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.6 p -118.7 115.17 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.708 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -154.4 176.21 12.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.318 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 3.2 mt -110.45 130.0 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.6 pt -110.41 -34.35 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.506 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -147.04 140.11 25.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.76 0.314 . . . . 0.0 110.767 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.41 117.14 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.83 147.93 31.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.246 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.83 146.44 18.6 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.668 2.245 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.89 174.22 7.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.042 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.545 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.086 0.47 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.37 104.13 15.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.233 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.36 125.6 17.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.7 mt 59.99 56.08 4.44 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.159 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.22 145.29 30.53 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.71 2.273 . . . . 0.0 112.378 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -57.95 170.86 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.825 2.35 . . . . 0.0 112.659 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 64.14 72.63 0.45 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.579 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.6 m -120.44 166.64 13.3 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.506 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.521 ' O ' ' HB3' ' A' ' 10' ' ' GLN . 18.9 m95 -68.63 177.81 2.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.473 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.521 ' HB3' ' O ' ' A' ' 9' ' ' TRP . 1.1 tm0? 74.58 131.1 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 123.254 0.346 . . . . 0.0 110.623 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' A' ' 10' ' ' GLN . 35.1 Cg_endo -65.36 108.73 1.23 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.579 2.186 . . . . 0.0 111.936 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 10' ' ' GLN . 32.3 Cg_exo -58.0 -41.08 72.03 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.673 2.249 . . . . 0.0 112.298 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -118.98 167.3 11.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.1 m -144.28 137.42 23.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.207 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -118.57 102.26 8.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.777 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mt -84.06 104.9 14.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.12 90.66 8.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -114.06 166.55 11.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -35.86 79.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.211 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.4 tpt -62.7 -28.23 69.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.115 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 152.45 5.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.954 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 tp -79.64 122.75 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 117.078 0.439 . . . . 0.0 111.358 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.62 124.09 67.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 20.8 t -98.66 120.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.976 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.61 147.73 33.64 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -102.37 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.519 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -81.35 132.18 35.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.468 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.518 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 79.0 m-85 -68.28 99.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -77.9 11.23 2.3 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 -69.18 0.78 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.701 0.286 . . . . 0.0 110.527 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.442 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 14.7 m-70 -100.82 -15.93 17.45 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.652 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.55 1.48 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 81.6 Cg_exo -42.81 -36.5 5.16 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.079 1.853 . . . . 0.0 113.081 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -62.91 -57.13 11.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.853 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -61.92 -36.98 82.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.03 -48.49 73.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -56.37 -39.08 72.35 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.465 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.81 -44.17 64.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -61.76 -45.38 94.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.63 80.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.59 -43.15 97.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.52 -35.39 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.069 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.64 81.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.528 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -92.6 -31.9 15.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.616 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -57.2 -31.69 65.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.6 26.13 4.92 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.982 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.2 -44.82 7.11 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -82.25 -33.23 29.31 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.922 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.0 105.91 0.37 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.733 0.301 . . . . 0.0 110.501 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 21.96 6.19 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.895 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.6 t -98.55 173.44 6.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.144 0.472 . . . . 0.0 111.097 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.66 38.17 0.23 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.713 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 56.45 -177.58 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.413 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -151.11 -48.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.706 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.21 111.26 19.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.69 0.281 . . . . 0.0 110.624 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.419 HG13 ' HG3' ' A' ' 153' ' ' PRO . 32.6 mm -115.7 116.02 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.486 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 33.0 mt -122.74 94.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.361 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.73 -27.5 59.34 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.517 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.37 31.47 2.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.734 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.74 -78.36 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.21 178.13 9.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 111.601 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.423 HD13 HG22 ' A' ' 62' ' ' ILE . 0.1 OUTLIER -132.81 104.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 11.1 tt0 -93.44 130.8 39.13 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.643 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.92 145.54 17.84 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.737 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.48 168.46 29.45 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.395 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.88 68.38 6.77 Favored Pre-proline 0 C--O 1.235 0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 111.08 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.67 -177.07 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.716 2.278 . . . . 0.0 112.234 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.69 -50.5 1.73 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.566 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.53 44.39 0.32 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.45 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -149.38 -44.88 0.14 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.504 0.192 . . . . 0.0 111.263 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.9 28.66 17.71 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.551 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -177.27 -42.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.57 0.224 . . . . 0.0 111.165 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.28 101.39 1.98 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.647 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -126.41 110.06 1.21 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.433 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.29 138.9 22.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.717 0.294 . . . . 0.0 111.207 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.3 p -96.24 -179.24 4.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -61.52 -28.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.484 179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -83.97 -43.71 14.92 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.87 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.81 -169.47 42.54 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.745 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -63.52 -45.38 90.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.559 0.219 . . . . 0.0 111.213 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -152.17 127.74 10.07 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.79 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -116.37 157.05 25.66 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.936 0.398 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -65.95 179.16 0.94 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -95.64 146.57 24.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.32 102.09 11.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.601 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tp -134.73 144.88 47.99 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.426 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 m-70 -158.3 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 87' ' ' HIS . 72.6 Cg_endo -74.43 158.1 44.61 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.676 2.251 . . . . 0.0 112.507 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.66 -49.03 43.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.238 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 56.2 -170.92 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.41 ' CD1' HD12 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -159.7 35.97 0.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.556 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -126.97 -46.54 1.53 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.79 117.08 9.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.864 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -45.35 134.24 6.76 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.62 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.38 60.32 0.91 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.726 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 11.0 mm -128.36 160.23 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.568 0.184 . . . . 0.0 110.643 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 129' ' ' PHE . 10.2 mt -133.96 115.95 14.99 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.947 0.403 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -118.14 139.95 50.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.335 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.416 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.82 113.56 18.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.406 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.64 170.37 10.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -142.66 151.44 41.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.82 -33.81 75.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.72 179.99 34.91 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.467 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.99 131.9 44.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.541 2.16 . . . . 0.0 111.72 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 p30 44.15 30.0 0.4 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.688 0.618 . . . . 0.0 112.0 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 50.2 m -136.59 85.81 2.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -83.89 162.17 20.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.63 -105.35 1.15 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.035 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m -155.89 40.55 0.38 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -109.41 161.27 15.46 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.187 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.438 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 7.6 p90 -159.98 125.91 4.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 50.5 p90 -112.85 133.76 54.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.281 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 40.6 t -94.81 111.29 25.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.63 103.42 9.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.1 pp -95.23 -5.33 44.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.743 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.23 151.01 50.35 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.58 0.228 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 109.21 2.31 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.778 2.319 . . . . 0.0 111.931 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 72.1 p -133.91 100.96 4.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.23 -179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.1 -27.04 16.47 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.419 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -58.8 -27.33 64.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.54 0.21 . . . . 0.0 111.505 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.41 HD12 ' CD1' ' A' ' 92' ' ' PHE . 4.4 pp -98.03 0.2 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.85 84.56 0.03 OUTLIER 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 151.11 -30.95 0.98 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.837 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -67.41 -57.65 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.685 0.279 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -93.88 144.38 25.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.897 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 12.3 t -88.22 152.69 21.79 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.821 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.3 mm -80.16 -179.32 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.406 179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -173.26 -44.19 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.445 0.164 . . . . 0.0 111.179 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.0 179.7 20.36 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.729 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.96 153.65 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -101.69 87.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.32 -51.37 8.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.711 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 103.04 7.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.18 -23.75 0.52 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.196 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 15.0 tt -47.49 -34.77 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -44.44 97.91 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.537 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.8 tpt -76.52 -46.41 26.68 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.555 0.217 . . . . 0.0 110.769 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 19.9 t -56.49 -34.8 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.191 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -67.24 -39.64 86.22 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.674 0.273 . . . . 0.0 110.788 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -60.94 -28.64 69.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.198 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.445 ' O ' HG21 ' A' ' 145' ' ' VAL . 17.2 t -58.36 -25.42 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.736 0.303 . . . . 0.0 111.03 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.66 -23.3 39.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.804 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -63.57 -27.01 68.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.772 0.286 . . . . 0.0 111.359 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 142' ' ' VAL . 0.2 OUTLIER -64.53 173.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.478 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -86.58 133.72 33.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.57 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -100.81 178.07 4.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.656 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.55 29.03 8.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.376 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.21 24.53 8.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 111.198 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.93 33.83 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.184 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 58.33 44.15 18.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.389 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.52 90.33 37.65 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.419 ' HG3' HG13 ' A' ' 56' ' ' ILE . 36.8 Cg_endo -66.25 139.68 55.93 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.693 2.262 . . . . 0.0 112.437 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.84 -50.42 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.83 67.45 1.98 Allowed 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -51.32 156.31 1.22 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.757 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.83 138.15 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.096 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.86 119.31 16.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 111.266 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 12.0 mt -92.62 148.33 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.206 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -38.33 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.856 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -154.63 170.42 21.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.88 0.371 . . . . 0.0 111.343 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -132.7 134.57 44.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.639 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.85 93.72 11.14 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.71 104.74 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.468 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.2 t -71.49 78.94 0.78 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.397 -1.224 . . . . 0.0 112.459 -179.925 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.548 0.213 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.5 -53.62 0.1 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.32 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.84 -65.78 0.54 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.293 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 pt -143.32 101.43 5.18 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.416 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.445 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 50.3 Cg_exo -52.97 -48.39 22.41 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.381 2.054 . . . . 0.0 112.797 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.445 ' HD3' ' HB2' ' A' ' 5' ' ' PRO . 97.8 Cg_endo -78.26 139.04 16.43 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.426 2.084 . . . . 0.0 113.014 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -132.93 127.64 34.74 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 t 61.58 -169.81 0.17 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.816 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -81.46 179.47 7.83 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -108.44 101.13 41.35 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.71 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.48 110.36 2.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.806 2.338 . . . . 0.0 112.414 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 -32.78 17.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.661 2.241 . . . . 0.0 112.755 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -126.77 154.64 43.97 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.998 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.29 143.88 38.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.29 117.36 34.58 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 99.77 10.97 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 105.24 17.45 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.392 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.92 167.74 10.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -21.48 52.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.644 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.6 28.2 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.995 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 119.03 -156.59 15.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.284 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -146.43 139.07 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.919 0.36 . . . . 0.0 111.021 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 pt -139.34 133.69 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 111.642 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 t -108.13 113.77 44.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 mp -112.57 138.41 49.38 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -103.64 130.15 51.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.869 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.426 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -97.51 131.8 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.593 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.455 ' HB2' ' HB3' ' A' ' 32' ' ' ALA . 22.9 m-85 -64.83 99.4 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.788 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -79.46 14.77 1.47 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -70.67 0.73 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.463 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 10.2 m-70 -100.88 -14.46 17.94 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.14 1.12 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.8 Cg_exo -40.79 -37.19 2.24 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.154 1.903 . . . . 0.0 112.974 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -55.3 36.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 110.442 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -64.9 -35.12 80.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.426 ' SG ' HD13 ' A' ' 27' ' ' LEU . 55.8 m -56.15 -50.2 71.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.299 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -61.11 -39.32 89.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -62.4 -59.06 5.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.929 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -40.84 84.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.53 67.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -64.22 -36.12 83.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.11 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -49.49 77.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.656 0.265 . . . . 0.0 110.657 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.95 64.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.23 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -46.09 50.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.312 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -60.14 -54.07 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.51 52.36 0.03 OUTLIER Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.788 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -125.63 -49.67 1.63 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.544 0.211 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.65 -45.29 62.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.177 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -56.17 118.64 4.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.23 32.37 20.27 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.697 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -100.23 -175.27 2.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -163.39 137.27 5.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.428 ' CD1' ' HB ' ' A' ' 157' ' ' VAL . 39.9 m-85 -64.93 150.28 48.16 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.852 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -142.76 19.26 2.0 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -158.07 104.69 1.91 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.584 0.23 . . . . 0.0 111.155 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.445 HG12 ' CG1' ' A' ' 142' ' ' VAL . 2.7 mp -136.18 113.59 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.26 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.85 100.11 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 1.1 ttmt -59.12 145.23 43.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.68 36.09 2.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.092 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -169.53 -94.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.892 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -160.41 169.61 22.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 33.9 pt -137.24 150.33 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.753 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 4.6 pm0 -126.26 145.61 50.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 111.324 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.57 159.79 13.62 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.604 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -89.9 160.22 28.47 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.896 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.5 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -148.29 -65.07 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.957 -0.121 . . . . 0.0 111.214 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.5 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 71.8 Cg_endo -77.27 97.82 1.17 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.433 2.089 . . . . 0.0 112.208 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.7 67.78 0.76 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.981 0.42 . . . . 0.0 110.759 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.24 -11.52 75.57 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.168 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.3 t -130.67 -43.27 1.12 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.884 0.342 . . . . 0.0 111.362 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 135.69 -35.46 2.15 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.501 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.32 -20.14 13.37 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -123.79 131.61 8.1 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.835 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.56 125.49 6.44 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.813 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.43 146.15 28.31 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.698 0.285 . . . . 0.0 111.135 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.6 t -108.37 170.92 7.71 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.429 HG13 ' CD2' ' A' ' 78' ' ' TYR . 19.5 pt -48.5 -45.05 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.429 ' CD2' HG13 ' A' ' 77' ' ' ILE . 4.1 p90 -131.07 14.85 5.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.158 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.459 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -86.27 -136.57 4.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.372 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.84 -63.49 0.37 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.137 0.494 . . . . 0.0 110.364 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.59 100.91 2.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.508 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.459 ' CD1' ' HA2' ' A' ' 79' ' ' GLY . 27.9 p90 -154.31 179.4 9.02 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -101.87 115.54 30.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.848 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.21 165.92 16.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.136 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.15 128.56 38.04 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.357 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.2 136.68 49.92 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.045 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.5 m80 -140.6 99.91 6.87 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.008 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.79 156.16 67.04 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 60.71 76.12 0.38 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -145.24 80.37 1.61 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.754 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.39 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.219 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.59 34.13 2.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.718 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -71.59 -36.27 70.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.344 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.444 ' HA2' HG21 ' A' ' 115' ' ' THR . . . 115.05 160.34 12.74 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.3 -179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.99 94.74 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.866 0.365 . . . . 0.0 111.689 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.06 44.95 7.84 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.781 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.6 mm -124.57 116.11 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.579 0.228 . . . . 0.0 110.855 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.1 tp -96.51 114.78 26.47 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.933 0.397 . . . . 0.0 111.097 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . 0.404 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . . . -114.07 150.38 34.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.319 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -79.45 125.27 29.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.592 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.54 151.77 28.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.71 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -130.16 146.71 51.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.403 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -91.17 -53.9 4.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.794 0.33 . . . . 0.0 110.592 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.12 179.99 35.29 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.502 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.63 116.85 3.57 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.475 2.117 . . . . 0.0 111.881 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.89 26.82 15.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.31 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.5 m -146.23 83.77 1.63 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.834 0.35 . . . . 0.0 110.889 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -101.18 156.29 17.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.354 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.65 -109.78 3.38 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.14 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.427 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -169.0 38.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 111.258 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -100.46 170.92 8.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -150.45 160.03 44.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 25.2 p90 -152.8 138.83 18.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 17.6 m -103.69 134.7 44.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.444 HG21 ' HA2' ' A' ' 94' ' ' GLY . 3.2 m -79.61 117.94 20.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.858 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -5.48 42.43 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.477 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -155.98 156.8 30.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.356 0.122 . . . . 0.0 111.147 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -51.38 120.23 6.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.911 2.407 . . . . 0.0 112.736 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.418 ' HB ' ' HB2' ' A' ' 122' ' ' LEU . 45.8 p -135.02 53.44 1.99 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.364 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -59.48 -35.75 74.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -66.62 -24.7 66.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.534 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 2.4 mt -76.11 -2.78 32.6 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.55 85.36 0.07 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.095 0.474 . . . . 0.0 110.348 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.39 -44.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.736 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -64.63 -53.56 45.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.678 0.275 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -125.63 131.66 52.62 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 13.4 t -79.92 167.42 20.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.804 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 tt -79.56 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.699 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.8 -44.07 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.16 179.96 16.23 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.801 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.38 165.59 30.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.523 0.202 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.99 103.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.3 t -98.06 -51.24 4.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.798 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -123.3 98.39 5.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.9 -17.72 1.08 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.386 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.435 HD13 HG22 ' A' ' 136' ' ' ILE . 12.9 tt -46.57 -33.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.65 88.66 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.308 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.17 -40.48 90.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.761 0.315 . . . . 0.0 110.274 179.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.68 -41.43 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.901 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.92 -41.98 83.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -59.63 -33.89 72.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.128 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.445 ' CG1' HG12 ' A' ' 56' ' ' ILE . 10.6 t -60.25 -30.85 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.068 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.445 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . -89.05 -41.86 5.77 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.355 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.7 mmt -51.78 -34.69 40.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 32.4 m -62.26 171.26 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.543 179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -84.25 177.69 8.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.897 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -133.1 176.46 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -111.22 -165.52 1.0 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.68 36.73 0.9 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.77 29.34 0.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.866 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.43 39.2 23.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -121.77 146.06 44.83 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.785 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . 0.44 ' HG3' ' CD1' ' A' ' 56' ' ' ILE . 66.6 Cg_endo -73.67 140.14 29.01 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.759 2.306 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 4.3 m -58.85 -33.93 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.049 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.4 77.68 1.19 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.263 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.58 138.11 47.51 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.354 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.428 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 21.7 t -80.05 126.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 114.27 23.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 8.5 mt -91.01 144.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.441 HG23 HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -133.73 8.57 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -157.57 140.83 15.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 111.304 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -153.91 101.08 2.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.941 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -151.33 155.93 34.76 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.479 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.11 149.17 19.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.862 2.375 . . . . 0.0 112.829 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -149.21 93.22 2.05 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.263 -1.299 . . . . 0.0 112.851 -179.869 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.78 0.324 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.71 163.36 13.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.318 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.22 167.79 0.26 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.592 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp -98.11 131.25 26.81 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.06 121.04 6.89 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.831 2.354 . . . . 0.0 112.47 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.08 -173.56 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.745 2.297 . . . . 0.0 112.471 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 t70 63.83 27.39 14.55 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.785 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.5 m -151.55 130.8 12.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.747 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -134.78 -45.56 0.73 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.437 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.4 114.23 53.61 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.528 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.59 121.49 9.96 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.556 2.171 . . . . 0.0 112.517 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.445 ' HB3' ' CD1' ' A' ' 29' ' ' TRP . 61.3 Cg_endo -72.85 -18.93 24.22 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.866 2.378 . . . . 0.0 112.96 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -87.8 146.37 25.65 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 m -134.43 149.84 30.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.56 123.53 50.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.356 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.43 94.01 4.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 109.59 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.546 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.3 p -118.29 156.83 28.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.632 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.6 t -57.93 -35.06 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.567 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.873 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.87 -159.4 31.5 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.358 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -125.93 124.48 66.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.922 0.361 . . . . 0.0 111.003 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.2 pt -123.74 130.89 73.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.72 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -92.87 121.97 43.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -123.23 154.87 38.18 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.303 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 130.32 56.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.465 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 92.3 mt -103.79 134.1 47.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.769 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -77.18 98.46 5.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.613 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TRP . . . . . 0.445 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 39.9 p-90 -82.26 20.42 1.05 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -100.27 -68.98 0.79 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.469 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.34 18.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.139 179.347 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.661 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.76 1.01 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.6 Cg_exo -40.26 -40.02 2.81 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.296 1.998 . . . . 0.0 113.226 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.85 -53.75 54.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.561 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 m -70.81 -35.48 72.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.831 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 68.5 m -56.69 -53.59 56.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.539 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -44.02 96.46 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.369 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -55.47 -44.83 76.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -60.51 -58.05 10.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.239 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.77 96.63 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.609 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.86 -47.11 81.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.346 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -39.02 88.56 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.7 -28.14 36.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.636 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -50.11 55.75 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.557 0.217 . . . . 0.0 111.171 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -60.68 -33.78 73.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.31 52.44 0.45 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.667 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.18 -54.27 1.91 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.383 0.135 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -47.26 62.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -60.36 114.71 3.07 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.35 -26.86 3.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.675 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -72.67 -175.58 1.71 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.558 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -165.75 144.9 6.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.723 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -61.92 112.94 2.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.719 0.295 . . . . 0.0 110.716 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -88.29 -55.07 3.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.357 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 113.43 22.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.219 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 13.2 mm -120.21 84.89 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -91.76 90.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -62.8 153.08 34.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 t0 68.27 26.79 6.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.165 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -163.59 -85.27 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.24 169.59 22.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.421 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 pt -143.12 132.9 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 2.7 pt20 -118.19 150.46 39.37 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.325 0.583 . . . . 0.0 112.245 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.47 115.9 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.462 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.19 -179.42 34.96 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.293 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t0 70.93 69.81 0.34 Allowed Pre-proline 0 N--CA 1.463 0.193 0 CA-C-O 120.858 0.361 . . . . 0.0 111.146 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -89.23 45.91 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.151 2.568 . . . . 0.0 112.087 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -178.07 -38.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.595 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.12 66.82 1.18 Allowed Glycine 0 C--N 1.338 0.661 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.972 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.2 m -93.04 -24.53 18.29 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.593 0.235 . . . . 0.0 110.944 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.31 -33.62 0.13 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.68 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -69.97 0.39 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.608 0.204 . . . . 0.0 110.99 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.15 165.73 34.91 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.824 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.09 101.48 0.21 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.511 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.64 133.56 36.38 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 t -84.01 -175.69 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.2 pt -71.8 -38.43 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.505 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -81.31 -31.22 33.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.196 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.27 -152.79 23.98 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -92.9 -45.52 7.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.324 . . . . 0.0 110.482 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.5 162.7 30.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.734 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.64 164.95 19.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.015 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -68.44 -178.12 1.05 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -114.28 156.64 24.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.423 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.77 97.09 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.29 145.12 47.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -154.44 122.99 3.02 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.503 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.95 87.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.059 2.506 . . . . 0.0 112.867 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -160.5 33.16 0.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.968 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.2 mp -143.02 -176.25 4.83 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.325 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptt -120.16 148.24 43.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.851 0.358 . . . . 0.0 111.512 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.434 ' CE2' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -136.9 79.82 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 179.671 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -31.01 49.19 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.323 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 115' ' ' THR . . . 112.77 -64.75 0.27 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.46 101.96 0.64 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.629 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.416 ' CA ' ' HB ' ' A' ' 132' ' ' VAL . . . 83.25 69.92 1.37 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.977 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 27.1 mm -132.62 137.09 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.654 0.227 . . . . 0.0 111.149 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tp -112.73 94.93 5.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -111.58 144.16 41.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.203 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 122.68 26.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.342 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.0 166.08 21.14 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.402 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -146.88 142.28 27.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.324 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.48 -40.99 18.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.394 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.55 179.79 34.9 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.619 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.73 122.57 11.21 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.552 2.168 . . . . 0.0 111.821 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.99 28.77 18.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.937 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.1 m -137.22 80.09 1.79 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 110.632 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -102.71 163.06 12.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.642 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.4 -127.46 2.77 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.6 m -135.71 41.3 2.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.953 0.406 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -108.48 161.31 15.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.74 161.35 42.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 24.3 p90 -137.52 130.45 30.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 111.298 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 10.9 t -101.2 107.77 22.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.085 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER -79.78 138.94 37.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.522 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 pp -114.77 -17.88 11.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.553 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -112.99 162.96 19.3 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.483 0.182 . . . . 0.0 111.02 179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.405 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 52.5 Cg_endo -68.52 122.64 9.63 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 112.762 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 122' ' ' LEU . 77.9 p -147.15 70.23 1.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.827 0.346 . . . . 0.0 111.465 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.77 -38.81 92.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.903 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -62.47 -26.62 68.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.399 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.411 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 2.1 mt -64.53 -16.44 62.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.586 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.89 81.98 0.2 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 110.0 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 169.6 -45.19 0.21 Allowed Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.358 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -70.73 -45.65 64.49 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.512 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -114.6 136.4 53.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 11.0 t -80.12 162.6 24.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.915 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.434 HD12 ' CE2' ' A' ' 92' ' ' PHE . 1.1 tt -87.85 -179.44 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.673 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -178.78 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.79 -179.71 27.67 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.76 161.72 33.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.822 0.344 . . . . 0.0 111.062 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.416 ' HB ' ' CA ' ' A' ' 96' ' ' GLY . 13.9 t -114.89 87.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.7 t -84.97 -36.4 21.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.52 101.27 3.85 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.016 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.81 -21.96 0.31 Allowed Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.343 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.442 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.7 tt -50.72 -30.88 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.988 0.394 . . . . 0.0 111.503 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.32 -13.83 63.24 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.8 ttp -97.35 -32.65 11.77 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.919 0.36 . . . . 0.0 111.077 179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.442 ' CG2' ' HA ' ' A' ' 136' ' ' ILE . 3.0 m -81.03 -30.74 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -79.29 -33.82 42.98 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.394 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -64.78 -29.56 70.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 19.8 t -56.91 -34.94 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.705 0.288 . . . . 0.0 110.895 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.23 -30.82 24.26 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.565 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.1 mtt -61.43 -27.38 68.51 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.2 p -82.82 33.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 62.38 171.36 0.13 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.018 0.437 . . . . 0.0 111.529 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -147.33 172.4 13.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 1.4 m-20 -85.06 -176.48 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.8 p -90.52 34.46 0.89 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.409 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -164.53 36.83 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.897 0.379 . . . . 0.0 110.774 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.61 57.83 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.088 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.421 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.2 OUTLIER -126.66 133.74 25.33 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 133.84 23.28 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.518 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.57 -35.26 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.809 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 -173.4 4.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.6 104.4 13.09 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.228 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 9.2 p -119.8 122.13 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -156.3 162.54 40.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.243 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 24.3 mt -97.26 129.36 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.803 0.335 . . . . 0.0 111.245 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 26.7 pt -111.94 -36.53 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.042 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -145.24 150.52 36.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -157.51 88.71 1.01 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.122 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -126.3 153.76 74.63 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.851 0.358 . . . . 0.0 111.621 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.22 140.65 14.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 112.382 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.86 152.78 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.072 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.536 179.584 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 CA--C 1.536 0.604 0 N-CA-C 113.446 0.518 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.36 145.93 41.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.738 0.304 . . . . 0.0 110.97 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.31 138.18 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.4 ' CE1' HG22 ' A' ' 24' ' ' VAL . 2.2 m-85 -110.93 104.12 12.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.254 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.461 HD12 ' CD1' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -93.29 102.22 14.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.642 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HG2' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -79.9 83.35 5.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.39 148.65 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 t -58.16 -33.92 69.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.519 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.42 -41.27 85.14 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.341 . . . . 0.0 110.569 179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.04 154.45 9.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.145 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.436 HD13 ' HG2' ' A' ' 17' ' ' GLU . 5.7 tp -80.27 136.24 23.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 111.46 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.624 HG22 ' HA2' ' A' ' 135' ' ' GLY . 9.1 pt -144.44 137.06 22.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.442 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 15' ' ' TYR . 16.6 t -94.84 143.08 12.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.84 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.62 HD22 HD22 ' A' ' 98' ' ' LEU . 2.0 mt -124.92 163.68 21.74 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.33 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.11 114.2 20.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.783 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 142.9 27.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.541 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 17.2 m-85 -92.32 97.24 10.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -78.81 14.83 1.21 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -66.51 0.9 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.501 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 8.8 m170 -100.67 -15.38 17.75 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.29 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.45 1.15 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.667 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 61.7 Cg_exo -39.48 -35.63 0.87 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 122.198 1.932 . . . . 0.0 113.33 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -63.26 1.22 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.773 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 129' ' ' PHE . 5.9 t -65.65 -36.1 82.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.684 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.2 t -55.22 -50.97 68.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.469 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -58.98 -40.29 84.37 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -51.22 64.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.845 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -43.1 90.8 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.039 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.79 72.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.85 -50.31 69.34 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.146 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -37.83 71.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.0 -31.98 56.88 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -75.57 -48.06 24.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.264 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -28.78 67.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.823 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.06 45.6 1.46 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -102.03 -45.87 5.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.583 0.23 . . . . 0.0 110.667 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -68.25 -30.65 69.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.221 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -59.31 113.36 2.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.059 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 -18.61 26.5 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.987 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -83.45 175.23 9.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.744 0.307 . . . . 0.0 110.926 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.442 ' H ' HG22 ' A' ' 51' ' ' THR . 33.4 pttt -154.51 173.21 16.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.488 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.49 120.72 26.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.131 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -98.62 -30.48 12.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.498 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.5 123.96 46.39 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.614 0.245 . . . . 0.0 110.627 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.923 HD12 ' HB3' ' A' ' 153' ' ' PRO . 55.5 mt -145.79 100.14 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.0 mt -90.81 118.59 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.586 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -56.46 123.84 16.11 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.191 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 6.5 t70 59.07 50.22 8.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.155 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.73 -84.61 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.78 171.41 18.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.348 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.699 HG22 HG23 ' A' ' 56' ' ' ILE . 1.8 pp -141.02 114.59 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.753 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.6 tt0 -93.75 134.79 35.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 111.617 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 112' ' ' PHE . . . -94.06 152.33 20.65 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.571 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.165 -179.841 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.878 0.37 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 t -81.18 157.38 25.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.847 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.9 pt -58.44 -36.64 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.372 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.63 -31.41 57.37 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.48 -155.71 27.22 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.567 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -78.36 -55.48 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.674 0.273 . . . . 0.0 110.792 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -135.18 146.15 48.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.808 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -133.14 179.48 6.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -77.91 134.12 37.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.545 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.89 137.09 33.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.281 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.54 40.58 1.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.59 ' HA ' HG23 ' A' ' 127' ' ' THR . 4.8 tp -80.14 133.69 36.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.614 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.39 118.08 3.53 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.694 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.92 101.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.28 -46.02 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.931 ' HB3' HD13 ' A' ' 128' ' ' ILE . 2.8 mm? -86.74 177.25 7.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 93' ' ' THR . 6.2 tttt -149.79 150.46 32.04 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -112.99 61.34 0.64 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.226 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.412 HG22 ' HG2' ' A' ' 91' ' ' LYS . 15.0 t -126.11 -46.59 1.66 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -61.98 112.3 4.71 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.89 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 136' ' ' ILE . . . -45.32 120.37 2.45 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.561 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 105.64 64.93 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.089 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 114' ' ' VAL . 7.3 mm -133.4 157.05 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.807 0.304 . . . . 0.0 111.382 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.62 HD22 HD22 ' A' ' 25' ' ' LEU . 1.6 tp -118.89 101.16 7.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.784 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.662 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -104.8 141.12 37.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.232 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.46 127.95 32.76 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.854 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -130.48 177.25 7.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -121.83 -51.91 2.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.85 -179.45 34.66 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.473 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -50.96 117.28 3.22 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.643 2.229 . . . . 0.0 112.052 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 61.64 31.13 18.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.993 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -138.26 94.89 2.92 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.458 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.7 150.08 30.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.935 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.08 -146.11 12.15 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 26.45 5.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.671 0.272 . . . . 0.0 111.474 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -90.5 165.44 13.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CE1' ' HA3' ' A' ' 64' ' ' GLY . 9.5 p90 -154.25 127.31 8.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.785 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 26.6 p90 -124.55 135.1 52.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.356 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 97' ' ' ILE . 10.0 p -108.2 121.58 61.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.727 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.7 p -80.43 119.05 22.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 116' ' ' LEU . 4.6 pp -97.94 -7.87 29.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.826 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.65 148.4 65.44 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.465 0.174 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.82 132.61 50.39 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.889 2.393 . . . . 0.0 112.341 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.446 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.0 p -144.98 107.59 4.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 111.418 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -96.67 -30.39 13.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.462 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.446 ' CZ2' HG22 ' A' ' 119' ' ' THR . 22.0 p90 -61.12 -40.87 95.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.687 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.59 0.43 57.43 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.82 81.21 0.02 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 110.885 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.03 -23.68 2.42 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.809 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -57.03 -56.28 23.86 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.58 0.228 . . . . 0.0 111.295 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -98.24 179.14 4.84 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.662 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 25.4 m -107.96 158.67 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.769 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.931 HD13 ' HB3' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -90.29 -179.01 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.511 179.376 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.483 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -177.45 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.35 179.98 25.7 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.817 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -136.9 158.59 44.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.661 0.267 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.512 ' CG2' HD13 ' A' ' 98' ' ' LEU . 19.5 t -118.18 84.12 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -77.41 -56.66 4.36 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.423 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -109.01 93.1 4.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.888 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 159.57 -22.48 0.28 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.233 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 95' ' ' ALA . 10.5 tt -46.47 -34.41 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.51 -45.52 96.12 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.404 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.588 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -62.31 -33.77 75.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.72 0.295 . . . . 0.0 110.615 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.464 HG11 ' CG1' ' A' ' 114' ' ' VAL . 21.1 t -76.22 -35.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.806 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -55.1 -51.55 66.03 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.84 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.805 ' O ' HG13 ' A' ' 145' ' ' VAL . 16.8 ptp180 -57.64 -37.3 73.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.015 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 145' ' ' VAL . 38.0 t -59.75 -28.45 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.102 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.63 -30.98 13.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.144 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 mtt -76.62 -24.28 53.37 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 141' ' ' ARG . 33.6 m -60.53 176.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.782 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 130.44 37.17 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.5 p -119.83 172.95 7.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 3.8 t-20 -82.97 -171.03 3.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.511 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.1 m -92.17 28.21 1.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.699 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -155.36 -72.14 0.12 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.84 41.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.035 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.418 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -116.18 123.85 30.36 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.443 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.923 ' HB3' HD12 ' A' ' 56' ' ' ILE . 41.8 Cg_endo -69.16 119.65 6.61 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.735 2.29 . . . . 0.0 112.425 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.43 -32.95 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.769 0.319 . . . . 0.0 110.496 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.88 -167.11 1.15 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.552 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.52 112.94 20.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 111.451 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.519 HG13 ' HB2' ' A' ' 20' ' ' MET . 36.9 t -133.55 126.5 51.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.341 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.75 174.05 15.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 111.607 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mt -108.08 135.78 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.0 pt -107.31 -33.32 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.493 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -170.59 159.32 6.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.71 0.29 . . . . 0.0 110.903 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -148.95 135.24 19.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.95 144.68 16.98 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.59 152.56 22.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.364 2.042 . . . . 0.0 112.162 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 m -63.07 150.94 41.36 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.997 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.375 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.691 0.204 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -112.16 176.84 4.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.048 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 164' ' ' PRO . 39.2 t -143.44 129.87 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -93.72 101.5 13.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.704 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.566 HD21 ' CE2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -87.91 90.87 8.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.155 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.17 101.39 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.208 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 159' ' ' ILE . 1.2 p -110.0 165.18 11.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -33.01 71.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.666 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.04 -32.75 69.57 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.5 -145.44 8.02 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.447 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -143.22 130.01 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.228 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.511 HG22 ' CA ' ' A' ' 135' ' ' GLY . 33.4 pt -134.26 134.11 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.964 0.412 . . . . 0.0 111.63 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.17 117.22 43.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.504 HD13 HD12 ' A' ' 16' ' ' LEU . 7.1 mp -98.1 148.31 23.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -117.13 100.82 7.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.554 HD13 ' SG ' ' A' ' 36' ' ' CYS . 37.5 mt -83.13 137.54 34.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.493 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 26.3 m-85 -71.08 98.15 1.6 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.961 0.41 . . . . 0.0 110.818 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.431 ' CE3' ' HD2' ' A' ' 30' ' ' LYS . 2.2 p-90 -79.05 11.51 2.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.494 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' CE3' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -100.41 -69.36 0.77 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.683 0.278 . . . . 0.0 110.851 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.516 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -100.75 -17.0 17.14 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.655 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -96.87 1.06 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.8 Cg_exo -42.0 -35.57 3.23 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 121.937 1.758 . . . . 0.0 112.875 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -59.27 -59.54 5.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.686 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 p -64.19 -34.38 77.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.569 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.554 ' SG ' HD13 ' A' ' 27' ' ' LEU . 19.3 t -57.15 -47.61 80.76 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -61.14 -40.82 95.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -61.37 -41.46 97.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -38.6 74.14 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.71 55.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.815 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' HG21 ' A' ' 77' ' ' ILE . 27.4 mt-10 -64.94 -32.62 74.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -54.79 -43.84 73.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.558 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -81.52 -31.81 32.61 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.199 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -49.14 66.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.558 ' HD2' HG22 ' A' ' 77' ' ' ILE . 36.4 mtp85 -59.58 -31.92 69.9 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.58 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.09 28.61 3.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.759 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -97.67 -31.25 12.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.607 0.241 . . . . 0.0 110.823 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.566 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -81.77 -57.34 3.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.065 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -63.51 124.9 22.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 110.453 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.75 -29.79 6.99 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.542 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.607 ' HB ' HD12 ' A' ' 159' ' ' ILE . 1.6 m -61.94 162.64 8.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.775 0.322 . . . . 0.0 111.256 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -136.54 33.76 2.73 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.069 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.609 ' HE2' HD12 ' A' ' 62' ' ' ILE . 9.2 m-85 59.86 179.09 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.637 0.256 . . . . 0.0 111.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -145.11 -70.96 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.601 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.528 ' O ' HD13 ' A' ' 56' ' ' ILE . 3.8 tpt180 -95.9 130.01 42.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 111.208 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.759 HG21 HG12 ' A' ' 142' ' ' VAL . 27.1 mm -133.07 92.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.961 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.554 HD12 ' HE2' ' A' ' 61' ' ' MET . 7.3 mt -95.3 117.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.149 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -76.05 150.32 37.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 61.89 31.2 18.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -160.41 -88.49 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.088 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.554 ' HE2' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.29 170.13 21.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 111.408 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.655 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -140.82 125.45 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.524 ' HG3' ' HE3' ' A' ' 61' ' ' MET . 3.0 mt-30 -94.1 157.0 16.29 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.052 0.454 . . . . 0.0 111.496 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.63 153.44 19.96 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.55 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.478 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.139 -179.654 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.593 0.235 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.2 p -104.88 164.96 11.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.076 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.558 HG22 ' HD2' ' A' ' 45' ' ' ARG . 2.5 pp -66.06 -33.02 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.496 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -75.91 -30.66 58.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.38 -140.68 6.41 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.749 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.24 76.28 1.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.98 0.419 . . . . 0.0 110.475 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HB3' HG22 ' A' ' 107' ' ' THR . 54.9 mm-40 70.8 135.63 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.41 -175.36 4.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.181 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.83 -179.62 1.21 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.28 141.63 36.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.863 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -78.19 109.76 12.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.156 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tp -156.33 134.24 11.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.407 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.99 -62.39 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.1 151.95 50.31 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.526 2.151 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.03 89.57 1.46 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.702 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.656 HD13 HG22 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -78.24 -178.29 5.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.149 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.4 155.14 27.95 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.83 83.98 1.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.741 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.5 p -69.52 -34.82 74.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.91 6.17 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.662 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.87 117.23 34.41 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.808 0.304 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.781 ' HA3' HD12 ' A' ' 136' ' ' ILE . . . 67.09 59.89 6.52 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.741 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 96' ' ' GLY . 19.1 mm -140.32 144.73 27.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.565 0.221 . . . . 0.0 110.78 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.747 HD23 HG22 ' A' ' 114' ' ' VAL . 1.1 mt -116.49 127.4 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.798 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -127.64 142.62 51.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.339 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 104.28 10.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.02 179.49 5.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.244 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.86 176.51 12.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.28 14.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.578 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.06 149.94 21.61 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.71 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.67 141.64 34.06 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.883 2.389 . . . . 0.0 112.663 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 63.21 23.22 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 81' ' ' GLN . 0.2 OUTLIER -152.19 80.5 1.25 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 110.673 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -98.19 113.07 24.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.53 -107.38 0.17 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.241 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 m -149.44 25.43 0.87 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -90.64 163.82 14.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.237 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -151.93 175.66 12.26 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.798 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 15.7 p90 -152.7 124.06 7.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 111.43 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.747 HG22 HD23 ' A' ' 98' ' ' LEU . 5.6 t -89.65 111.95 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.058 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.4 ' OG1' ' HB ' ' A' ' 97' ' ' ILE . 81.9 p -79.68 120.67 24.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.416 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.55 -25.29 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.336 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.77 156.4 40.73 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.095 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.4 130.82 30.36 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.016 2.478 . . . . 0.0 113.043 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.3 p -148.41 62.95 1.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -83.4 -14.7 52.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.73 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -90.77 -25.92 19.73 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.68 0.276 . . . . 0.0 111.29 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.22 1.25 29.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.762 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.76 79.52 0.29 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.23 -37.71 0.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.677 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -67.77 -54.9 15.58 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.664 0.268 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -109.86 138.35 46.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.73 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.749 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 3.6 t -84.56 157.74 21.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.95 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.656 HG22 HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -79.72 -179.63 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.724 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.512 ' HE1' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -170.46 -42.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.186 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.72 177.97 25.64 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.728 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.17 153.95 42.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 132' ' ' VAL . 13.8 p -109.71 107.12 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.097 0.475 . . . . 0.0 111.408 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.67 -46.0 7.45 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -123.45 84.27 2.25 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.873 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.511 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 169.62 -23.98 0.1 OUTLIER Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.583 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.781 HD12 ' HA3' ' A' ' 96' ' ' GLY . 15.8 tt -41.34 -37.34 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.16 -43.7 96.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.602 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 ttp -65.67 -39.56 91.48 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.549 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.414 HG11 HG11 ' A' ' 114' ' ' VAL . 21.5 t -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -61.41 -32.21 72.15 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.909 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -33.56 71.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.964 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.759 HG12 HG21 ' A' ' 56' ' ' ILE . 19.8 t -57.85 -30.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.7 -31.88 10.79 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.234 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.5 mmt -58.52 -36.01 73.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.511 0.196 . . . . 0.0 111.358 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 142' ' ' VAL . 30.2 m -64.23 176.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.563 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -81.68 172.24 13.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.057 0.456 . . . . 0.0 111.005 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.22 171.49 15.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.29 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.29 -171.1 1.85 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.84 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 p -95.21 30.28 2.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -152.65 32.07 0.51 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.4 t0 55.47 68.76 0.82 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.816 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -150.72 114.48 3.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.737 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.403 ' HG3' HG13 ' A' ' 56' ' ' ILE . 56.0 Cg_endo -71.3 152.4 61.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.056 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 146' ' ' GLU . 36.2 t -69.89 -37.98 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.41 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.35 80.6 1.52 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.351 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.86 148.25 10.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.59 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.666 HG13 ' HB2' ' A' ' 20' ' ' MET . 8.3 t -82.71 141.24 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.147 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -126.15 152.73 45.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 111.384 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.607 HD12 ' HB ' ' A' ' 51' ' ' THR . 6.7 mt -115.05 140.85 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 25.1 pt -120.14 -37.8 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.051 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.53 165.1 28.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.962 0.41 . . . . 0.0 111.472 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.452 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -156.53 87.31 1.02 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.673 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -100.86 106.53 44.58 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.166 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.615 ' HA ' HG13 ' A' ' 14' ' ' VAL . 72.3 Cg_endo -79.74 93.23 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.656 2.237 . . . . 0.0 112.132 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.5 m -150.65 164.74 35.36 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.206 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.275 -1.291 . . . . 0.0 112.842 179.752 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.535 0.541 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.43 158.64 16.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.707 0.289 . . . . 0.0 111.213 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 164' ' ' PRO . 23.7 m -141.24 135.9 32.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.981 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -92.54 113.14 25.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.62 HD12 HD13 ' A' ' 25' ' ' LEU . 3.2 mt -97.86 96.14 8.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.647 ' HG2' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.39 113.67 20.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.722 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.755 ' CG2' HG23 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -125.81 156.16 39.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.949 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.5 t -59.07 -33.55 70.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.07 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.628 ' HB2' HG13 ' A' ' 157' ' ' VAL . 8.0 tpt -69.97 -30.86 68.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.191 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.13 -161.54 34.03 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.647 HD12 ' HG2' ' A' ' 17' ' ' GLU . 2.1 tt -122.3 128.13 75.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 117.105 0.452 . . . . 0.0 111.202 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.442 HG22 ' CA ' ' A' ' 135' ' ' GLY . 16.3 pt -129.49 127.59 65.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.047 0.451 . . . . 0.0 111.898 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.49 121.08 51.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD22 HD22 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -127.9 157.96 39.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.222 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.8 150.61 23.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.73 135.75 54.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.775 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 44.6 m-85 -76.69 95.04 3.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.725 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -78.86 11.35 2.69 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.32 -61.87 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 122.179 -0.325 . . . . 0.0 110.957 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.515 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 21.0 m170 -100.6 -15.02 17.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.775 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.41 1.31 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 58.8 Cg_exo -38.96 -38.15 1.01 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.353 2.036 . . . . 0.0 113.156 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -61.36 -57.97 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.578 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.49 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -67.2 -35.22 79.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.752 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.2 m -55.2 -51.6 66.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.4 89.48 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.547 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.4 -50.77 72.48 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.745 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.75 -47.96 83.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.555 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.35 86.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.073 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -38.79 92.21 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.453 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -60.42 3.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.586 0.232 . . . . 0.0 111.381 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.35 98.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.679 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -48.6 72.28 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.327 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -61.8 -55.54 28.96 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.49 43.16 0.06 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.243 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -45.75 2.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.781 0.324 . . . . 0.0 110.566 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.06 -24.58 59.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.113 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.88 102.47 4.75 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.55 26.95 4.59 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.487 ' OG1' HD12 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -89.4 178.08 6.41 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.04 0.42 . . . . 0.0 110.952 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -157.02 134.8 10.87 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.954 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CD2' HG22 ' A' ' 62' ' ' ILE . 28.3 m-85 -69.3 124.09 22.92 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.11 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -100.73 -32.19 10.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.014 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.31 119.8 35.08 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.81 0.338 . . . . 0.0 111.228 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.609 HG12 HG23 ' A' ' 62' ' ' ILE . 29.0 mt -135.13 94.54 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.668 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.3 mt -83.35 108.8 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -63.99 145.34 56.04 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.36 30.77 20.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.321 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.3 -83.3 0.08 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.247 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.412 ' HB3' ' HA ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -160.45 168.29 25.45 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.471 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.609 HG23 HG12 ' A' ' 56' ' ' ILE . 3.7 mp -131.91 125.95 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.526 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 2.1 pt20 -112.83 138.83 49.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.289 0.566 . . . . 0.0 112.348 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.48 103.86 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.379 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.333 0.391 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.277 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.639 0.257 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.0 p -129.4 172.81 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.62 -35.45 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.501 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -74.25 -33.59 63.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.247 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.72 -151.7 20.47 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.767 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -83.61 -52.09 6.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.727 0.263 . . . . 0.0 110.612 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -154.46 150.74 28.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.31 174.5 10.48 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.513 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.87 173.76 7.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.8 169.45 11.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.636 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -129.74 47.06 2.55 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 tp -68.68 145.51 53.81 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -162.79 86.7 1.38 Allowed Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.985 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.99 100.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.766 2.311 . . . . 0.0 112.26 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.71 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.939 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.762 HD22 HG21 ' A' ' 128' ' ' ILE . 4.9 mp -66.94 175.82 2.33 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.734 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -106.91 165.14 11.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.42 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.86 70.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 97' ' ' ILE . 25.7 p -57.3 -30.34 64.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.703 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 102.69 -48.1 1.07 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.649 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.0 109.64 18.34 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.296 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.553 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 79.03 63.85 2.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.784 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 96' ' ' GLY . 10.5 mm -131.94 152.46 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.751 0.276 . . . . 0.0 111.312 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.729 HD22 HD22 ' A' ' 25' ' ' LEU . 4.7 tp -131.28 101.7 5.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.702 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -110.13 144.38 38.83 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.28 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.49 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.73 106.69 11.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.632 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.33 151.28 23.24 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.548 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -123.09 157.39 32.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.44 63.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.08 179.63 35.49 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.353 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.39 125.95 17.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.582 2.188 . . . . 0.0 112.007 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.1 30.13 19.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.9 m -142.6 91.03 2.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -96.99 155.11 16.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.162 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.32 -151.72 5.48 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.849 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 m -104.16 64.95 0.78 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.521 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -141.42 146.54 36.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -151.08 166.02 32.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.488 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.677 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 30.2 p90 -137.76 142.46 40.94 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.689 HG22 ' CD1' ' A' ' 98' ' ' LEU . 5.3 t -111.23 106.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 3.3 p -80.32 134.78 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.552 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.38 -27.6 8.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.47 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.76 151.56 39.35 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.655 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 66.0 Cg_exo -52.38 130.1 34.5 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.809 2.34 . . . . 0.0 112.484 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.9 t -161.07 77.72 0.57 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 111.197 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.07 -3.73 52.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -89.54 -27.22 20.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.079 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -21.16 66.27 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.286 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -66.82 84.75 0.12 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.203 0.525 . . . . 0.0 110.314 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.15 -47.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.035 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -80.17 -35.36 36.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.467 0.175 . . . . 0.0 110.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -122.31 134.51 54.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.802 0.334 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.702 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 31.8 m -80.88 161.12 24.53 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.762 HG21 HD22 ' A' ' 90' ' ' LEU . 1.5 tt -79.54 -179.24 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.456 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.549 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -176.69 -39.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.26 -179.97 26.51 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.85 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -148.81 148.84 30.4 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 122.78 -0.247 . . . . 0.0 110.654 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.531 HG21 ' HB ' ' A' ' 136' ' ' ILE . 10.4 m -79.13 136.77 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 111.552 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 7.2 t -118.78 -47.06 2.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -142.56 80.93 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.999 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.442 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 176.03 -21.6 0.05 OUTLIER Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.116 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.531 ' HB ' HG21 ' A' ' 132' ' ' VAL . 14.6 tt -40.85 -38.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.19 93.89 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.555 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.424 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.9 ttp -59.78 -41.61 91.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.773 0.32 . . . . 0.0 110.379 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.18 -44.87 84.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.582 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -61.83 -40.84 96.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -56.5 -40.78 75.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 20' ' ' MET . 17.6 t -56.97 -38.29 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.291 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.84 -29.96 16.54 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.625 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 79.1 mmm -66.53 -16.92 64.51 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.456 ' O ' HG21 ' A' ' 154' ' ' VAL . 16.2 m -88.2 19.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 165.22 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.4 p -144.18 174.55 10.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.489 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -172.69 3.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.9 m -93.55 33.74 1.24 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.92 31.94 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.478 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 52.7 51.22 16.45 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -123.3 143.49 41.29 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.822 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.503 ' CB ' HG23 ' A' ' 157' ' ' VAL . 60.6 Cg_endo -73.21 141.78 32.9 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.68 2.254 . . . . 0.0 112.531 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 145' ' ' VAL . 6.4 m -78.89 -35.4 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.888 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.17 11.46 38.25 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.13 138.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.268 0.556 . . . . 0.0 112.295 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 20' ' ' MET . 38.4 t -128.74 132.89 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.693 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' HG2' ' N ' ' A' ' 159' ' ' ILE . 2.5 tttp -144.17 156.68 44.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.795 0.331 . . . . 0.0 111.408 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.755 HG23 ' CG2' ' A' ' 18' ' ' THR . 7.2 mt -110.82 120.46 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.436 HD11 ' CD ' ' A' ' 17' ' ' GLU . 31.8 pt -81.67 -43.47 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -175.21 174.31 2.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.511 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -150.78 133.61 15.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -152.29 157.26 33.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.116 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.437 ' HA ' HG12 ' A' ' 14' ' ' VAL . 72.1 Cg_endo -79.34 148.86 21.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.261 1.974 . . . . 0.0 112.1 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.5 m -61.94 147.47 46.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.695 -1.059 . . . . 0.0 112.857 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.534 0.514 0 CA-C-O 121.005 0.335 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -126.17 160.16 30.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.7 154.84 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -114.04 111.3 21.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.218 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -92.26 109.08 20.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 2.9 mm-40 -81.15 112.59 18.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.863 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.77 145.09 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.5 t -56.71 -36.31 69.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.027 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.899 ' HB2' HG23 ' A' ' 157' ' ' VAL . 1.2 tpt -65.71 -29.15 69.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.742 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' HA3' ' HG2' ' A' ' 138' ' ' MET . . . 153.46 150.48 5.46 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.204 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 tt -80.32 139.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.758 0.279 . . . . 0.0 111.031 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.572 HG22 ' CA ' ' A' ' 135' ' ' GLY . 10.8 pt -145.93 133.47 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.753 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.32 137.71 21.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 16' ' ' LEU . 3.2 mt -129.94 147.82 51.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.77 113.19 26.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.776 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 mt -96.87 119.14 34.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.787 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 29.4 m-85 -66.67 102.91 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -80.62 12.34 3.18 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -61.82 1.32 Allowed 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.834 0.35 . . . . 0.0 110.623 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.502 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 62.2 m170 -100.75 -15.5 17.65 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.564 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.66 0.98 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.0 Cg_exo -40.77 -35.31 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.286 1.99 . . . . 0.0 113.137 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -60.02 3.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.628 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.67 HG21 ' HG3' ' A' ' 100' ' ' MET . 26.8 m -67.28 -43.61 81.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.851 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.8 t -54.69 -47.52 73.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -59.17 -48.95 79.73 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.271 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -60.98 -43.41 98.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.125 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.11 -56.42 21.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.999 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.9 94.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.262 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.31 -46.33 83.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -36.8 77.65 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.095 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.58 -48.92 68.06 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.74 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -35.03 79.54 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.974 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -36.81 84.95 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.232 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.5 41.17 1.65 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.401 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -113.34 -47.49 3.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.463 0.173 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.13 -32.33 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.055 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 112.39 8.3 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.686 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.97 -23.76 11.32 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.099 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.54 178.48 2.02 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.073 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 157' ' ' VAL . 0.3 OUTLIER -156.91 159.6 38.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.161 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -74.06 129.6 38.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -106.63 -36.56 6.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.441 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 119.1 37.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.574 HG12 HG23 ' A' ' 62' ' ' ILE . 22.1 mt -139.4 130.82 34.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.17 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.452 HD12 ' CE ' ' A' ' 61' ' ' MET . 17.7 mt -114.87 120.53 64.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.039 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.26 142.5 52.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.226 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 29.73 19.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.861 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.39 -85.13 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.877 -0.147 . . . . 0.0 111.306 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.452 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.65 173.32 15.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.429 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.574 HG23 HG12 ' A' ' 56' ' ' ILE . 3.7 mp -133.31 119.97 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.577 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.8 pt20 -106.75 143.96 34.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.83 124.75 2.65 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.71 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.332 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.187 -179.537 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 p -78.26 174.95 10.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.74 -31.4 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -79.67 -69.44 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.451 0.167 . . . . 0.0 110.945 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.08 158.46 30.79 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -33.51 72.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.25 140.96 26.9 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.691 0.282 . . . . 0.0 111.077 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -156.85 172.17 19.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.357 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.13 179.31 0.96 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.443 ' OD1' HD12 ' A' ' 86' ' ' LEU . 2.5 p30 -101.26 179.84 4.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.996 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -129.74 36.54 4.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.443 HD12 ' OD1' ' A' ' 84' ' ' ASP . 6.6 mt -57.52 146.77 28.86 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.511 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.79 145.68 17.99 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 68.57 5.26 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.614 2.209 . . . . 0.0 112.631 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.601 ' HB3' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -165.46 172.98 11.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.104 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 1.042 HD22 HG21 ' A' ' 128' ' ' ILE . 3.9 mp 64.38 172.65 0.19 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.658 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 163.64 10.22 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.993 0.425 . . . . 0.0 112.006 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HE2' ' HB2' ' A' ' 99' ' ' ALA . 1.2 m-85 -116.76 87.43 2.69 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.147 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -127.93 -52.45 1.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.609 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.25 7.35 68.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.147 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.02 -169.6 0.2 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.634 0.373 . . . . 0.0 111.191 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.49 47.58 90.44 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 30.5 mm -120.45 154.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.74 0.305 . . . . 0.0 111.089 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.508 HD13 HD22 ' A' ' 25' ' ' LEU . 1.1 tp -124.42 104.03 8.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.036 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -116.57 140.16 49.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.575 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.67 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.56 121.09 24.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.309 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 113' ' ' PHE . . . -110.9 172.2 7.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.378 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -150.7 152.94 34.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.99 78.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.36 176.05 33.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.183 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.47 125.03 15.84 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.537 2.158 . . . . 0.0 111.948 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.23 36.44 17.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -147.54 83.41 1.54 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.908 0.385 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.38 168.65 10.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.41 46.08 0.46 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.901 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t 55.48 37.01 28.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.294 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 161.61 14.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -160.29 173.47 15.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.638 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 21.7 p90 -148.24 132.15 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.0 111.399 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.618 HG21 HG11 ' A' ' 139' ' ' VAL . 14.1 p -103.06 120.39 52.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.588 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 92' ' ' PHE . 17.5 p -79.49 129.81 34.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.501 ' C ' HD12 ' A' ' 116' ' ' LEU . 4.1 pp -109.61 -10.7 14.83 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.897 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -136.47 164.33 43.49 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 120.509 0.195 . . . . 0.0 111.298 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 36.7 Cg_endo -65.94 119.97 7.07 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.609 2.206 . . . . 0.0 111.434 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 71.9 p -136.43 103.39 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.675 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.536 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -60.09 -41.57 92.79 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.605 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.6 pp -86.89 0.17 55.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.453 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.85 84.04 0.31 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.825 0.345 . . . . 0.0 110.717 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.54 -29.59 2.25 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.076 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -57.9 11.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.605 0.24 . . . . 0.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -95.77 159.19 15.1 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.737 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 6.7 t -93.59 161.3 14.41 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.042 HG21 HD22 ' A' ' 90' ' ' LEU . 3.3 mm -89.04 -178.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.289 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.7 ' H ' HG22 ' A' ' 128' ' ' ILE . 2.4 p90 -178.96 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.485 0.183 . . . . 0.0 111.346 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.66 -179.64 19.62 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.48 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.38 162.22 38.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.614 0.245 . . . . 0.0 110.986 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 25' ' ' LEU . 13.0 t -116.47 121.27 67.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.825 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.3 t -115.35 -63.81 1.4 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.93 91.5 3.68 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.803 0.335 . . . . 0.0 110.311 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.572 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 155.2 -22.16 0.58 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.193 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.519 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -44.88 -36.2 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -53.79 -42.52 68.9 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.707 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.464 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 7.1 tpt -75.17 -43.67 50.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.564 0.221 . . . . 0.0 110.698 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.618 HG11 HG21 ' A' ' 114' ' ' VAL . 15.4 t -54.49 -35.95 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.923 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -61.67 -39.34 91.04 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.911 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HB2' ' HE3' ' A' ' 138' ' ' MET . 0.5 OUTLIER -59.55 -38.21 80.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.015 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.421 HG22 ' HG2' ' A' ' 20' ' ' MET . 19.2 t -58.08 -31.15 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.756 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.466 ' HA3' HD22 ' A' ' 116' ' ' LEU . . . -92.14 -38.49 5.68 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.042 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.2 tpt -53.02 -34.58 57.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.473 0.309 . . . . 0.0 111.692 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 m -59.48 168.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.895 0.379 . . . . 0.0 111.469 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.679 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -104.35 148.01 26.87 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -96.83 165.36 12.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.92 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 6.9 m120 -136.0 146.75 47.52 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.88 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.26 -46.43 0.13 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.004 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -173.47 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -176.84 38.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.6 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 148' ' ' ASN . 6.9 mtt180 -101.09 123.03 46.48 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.718 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 56' ' ' ILE . 29.4 Cg_endo -63.36 132.41 35.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.803 2.335 . . . . 0.0 112.563 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 146' ' ' GLU . 41.3 t -70.23 -42.81 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.709 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.42 115.02 17.84 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.18 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.18 96.17 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.5 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.899 HG23 ' HB2' ' A' ' 20' ' ' MET . 12.5 p -90.41 139.42 17.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.98 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 52' ' ' LYS . 18.2 pttt -154.7 155.64 34.97 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.213 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 mt -96.69 145.99 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.889 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.07 -52.12 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 44.4 mtpt -144.43 171.57 14.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.35 104.79 1.66 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.086 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.06 154.66 77.67 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.311 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.15 172.24 13.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.618 2.212 . . . . 0.0 112.581 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.25 -33.84 11.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.252 -1.304 . . . . 0.0 112.582 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 CA--C 1.529 0.245 0 CA-C-O 120.858 0.274 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.78 99.93 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.25 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 m -94.37 146.97 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.271 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.495 ' HE1' ' HG ' ' A' ' 165' ' ' SER . 6.6 m-85 -121.01 108.72 14.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.242 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.79 104.94 17.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 110.991 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CB ' ' HG2' ' A' ' 161' ' ' LYS . 0.5 OUTLIER -79.94 97.06 6.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.625 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.53 HG22 HG12 ' A' ' 159' ' ' ILE . 1.9 p -106.43 160.18 15.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -63.71 -36.97 85.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.607 179.298 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.655 ' CB ' HG13 ' A' ' 157' ' ' VAL . 9.4 tpt -64.66 -32.24 73.82 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.09 -163.91 37.47 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.046 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 22' ' ' ILE . 10.8 tt -122.06 118.82 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.003 0.402 . . . . 0.0 111.342 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.478 HG23 ' SD ' ' A' ' 138' ' ' MET . 26.9 pt -116.01 158.19 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 15' ' ' TYR . 18.8 t -122.97 120.64 61.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.931 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 98' ' ' LEU . 5.2 mt -115.01 155.13 27.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -116.21 115.56 26.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD21 ' HE1' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -95.25 120.46 35.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.717 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.825 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 87.1 m-85 -72.62 104.59 3.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -82.98 23.23 0.86 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 -65.46 0.97 Allowed 'General case' 0 C--O 1.231 0.108 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.469 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.4 m-70 -100.93 -11.49 19.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.646 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -100.14 1.05 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.2 Cg_exo -40.77 -36.05 1.82 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 122.117 1.878 . . . . 0.0 113.302 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -68.81 -53.52 21.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.943 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -69.32 -36.71 77.25 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.942 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.3 t -58.84 -50.1 75.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.63 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -59.28 -40.24 85.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.408 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -62.36 -43.06 99.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.89 -52.4 65.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.856 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.33 78.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HB3' HD13 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -60.46 -51.05 71.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.215 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.542 HD22 ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -60.91 -29.95 69.89 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.429 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . . . -70.24 -49.22 52.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -76.63 -29.23 56.36 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.573 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -55.12 -32.13 61.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.34 46.64 0.91 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -125.34 -55.0 1.57 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.408 0.147 . . . . 0.0 111.079 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.542 ' CE1' HD22 ' A' ' 42' ' ' LEU . 13.8 m-85 -60.81 -30.35 70.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.337 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -71.7 121.27 18.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.757 0.313 . . . . 0.0 110.469 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.28 -24.26 23.08 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.682 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.854 ' HB ' HD12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -60.85 158.34 13.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 26.74 2.37 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 63.04 -179.43 0.15 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.015 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 -92.88 0.28 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.186 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -79.79 121.77 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.706 0.288 . . . . 0.0 110.513 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.833 HD12 ' HG3' ' A' ' 153' ' ' PRO . 7.8 mt -131.54 125.89 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 mt -129.82 118.0 43.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -56.16 25.53 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.763 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.82 49.46 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.765 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -169.22 -89.02 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.213 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.81 175.73 12.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 0.0 111.407 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.686 HD12 HG11 ' A' ' 142' ' ' VAL . 5.9 tt -139.26 109.55 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.511 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -89.47 156.6 18.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.579 0.704 . . . . 0.0 112.158 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.93 105.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.279 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.572 -179.133 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.618 0.247 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 p -88.58 168.32 12.66 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 41' ' ' GLU . 5.2 pt -60.93 -31.44 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.62 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -75.77 -37.13 59.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.32 -151.19 16.87 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -45.02 92.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 110.699 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -161.51 155.36 21.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.95 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -119.17 170.1 9.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.29 178.21 4.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -132.51 171.51 13.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.203 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.23 110.5 9.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.7 tp -100.79 111.07 23.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -130.59 102.52 16.6 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.957 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.03 -14.86 35.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.068 2.512 . . . . 0.0 113.141 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.78 -45.99 20.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.514 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' HD13 ' A' ' 128' ' ' ILE . 6.2 mt -80.2 138.07 36.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.0 178.17 6.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.61 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.621 ' HE2' ' HB2' ' A' ' 99' ' ' ALA . 10.4 m-85 -137.75 97.64 3.48 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.6 ' OG1' HD11 ' A' ' 97' ' ' ILE . 21.5 p -81.87 -4.32 56.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.7 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.17 -75.06 1.8 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.979 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.84 107.66 0.32 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.851 0.358 . . . . 0.0 111.802 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 69.7 61.13 4.56 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.306 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.6 HD11 ' OG1' ' A' ' 93' ' ' THR . 26.8 mm -137.39 131.69 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.626 0.25 . . . . 0.0 110.852 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.616 HD11 HD22 ' A' ' 25' ' ' LEU . 7.2 mt -101.63 122.16 43.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.949 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.621 ' HB2' ' HE2' ' A' ' 92' ' ' PHE . . . -126.22 134.93 51.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.69 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.467 ' HE3' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -79.94 107.46 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.434 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.476 ' HB3' ' OE1' ' A' ' 111' ' ' GLN . . . -85.99 161.97 18.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.476 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.25 140.79 22.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.49 58.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.435 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.01 175.29 35.26 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.552 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.13 121.21 9.25 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.625 2.216 . . . . 0.0 112.185 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 58.52 30.64 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.326 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.6 m -120.77 85.36 2.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.987 0.422 . . . . 0.0 110.493 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.64 120.98 39.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.988 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.63 51.35 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.409 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.496 ' OG ' HD13 ' A' ' 42' ' ' LEU . 16.7 m 58.89 35.89 24.38 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -97.75 139.7 33.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.669 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.65 174.97 13.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.036 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.8 p90 -159.55 140.18 12.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.218 0.533 . . . . 0.0 111.876 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.574 HG22 ' CD2' ' A' ' 98' ' ' LEU . 4.9 t -98.27 113.77 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.79 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.46 141.94 36.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.91 -28.71 7.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.412 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.74 42.29 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.774 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.09 114.57 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.761 2.307 . . . . 0.0 112.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.3 p -129.37 68.35 1.42 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.065 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -81.11 -39.47 25.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -65.21 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.176 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mt -73.54 -9.31 58.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.664 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.16 84.45 0.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.112 0.482 . . . . 0.0 110.485 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -50.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.465 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.87 -31.58 63.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.635 0.255 . . . . 0.0 111.129 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -119.56 123.22 43.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.084 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.552 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 14.8 t -79.87 163.28 24.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.599 HD12 ' CE1' ' A' ' 92' ' ' PHE . 1.3 tt -80.74 -179.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.946 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.542 ' HE1' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -176.99 -39.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.856 -0.156 . . . . 0.0 111.287 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.93 179.47 22.04 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.549 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.467 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -138.05 160.91 38.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.22 96.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.017 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.3 -41.54 12.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.502 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -144.5 108.6 4.76 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.894 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.39 -19.64 1.18 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.255 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.448 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.0 tt -50.09 -29.24 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.74 -39.14 90.2 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.427 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.478 ' SD ' HG23 ' A' ' 23' ' ' ILE . 3.4 ttp -69.32 -50.51 45.84 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.393 0.14 . . . . 0.0 110.985 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.646 ' O ' HG12 ' A' ' 142' ' ' VAL . 3.6 m -61.89 -20.6 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.418 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.85 -31.72 35.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.593 0.235 . . . . 0.0 110.899 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -56.32 -41.96 76.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.573 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 62' ' ' ILE . 14.5 p -56.7 -30.66 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.705 0.288 . . . . 0.0 111.361 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.28 -34.91 15.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.966 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.2 mtt -62.09 -28.54 69.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.31 163.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.709 0.29 . . . . 0.0 111.236 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.4 tt0 -62.39 123.07 17.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.192 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.6 p -107.35 178.71 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -79.8 -179.01 6.7 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m -90.15 19.13 5.23 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -151.1 -68.35 0.18 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -174.02 73.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.77 0.319 . . . . 0.0 111.275 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -156.4 96.98 2.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.833 ' HG3' HD12 ' A' ' 56' ' ' ILE . 49.5 Cg_endo -69.46 131.15 21.05 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.733 2.289 . . . . 0.0 112.232 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 146' ' ' GLU . 60.5 t -58.64 -44.25 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.647 0.26 . . . . 0.0 110.394 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.62 63.87 0.61 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -52.16 150.5 4.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.648 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.655 HG13 ' CB ' ' A' ' 20' ' ' MET . 3.9 t -79.78 101.9 5.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.791 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' SER . 5.7 tttm -84.69 150.51 25.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.854 HD12 ' HB ' ' A' ' 51' ' ' THR . 17.6 mt -116.77 128.99 74.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.4 pt -109.32 -33.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.424 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -163.14 168.02 21.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.07 107.87 2.76 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -144.26 147.08 35.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.432 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.05 174.39 11.56 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.714 2.276 . . . . 0.0 112.516 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.495 ' HG ' ' HE1' ' A' ' 15' ' ' TYR . 25.0 p -95.2 -37.38 11.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.309 -1.273 . . . . 0.0 112.868 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 CA--C 1.531 0.366 0 CA-C-O 120.61 0.171 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.474 HD22 HG12 ' A' ' 24' ' ' VAL . 2.4 m120 -130.62 160.75 33.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.702 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 27' ' ' LEU . 25.2 m -125.61 141.22 46.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.178 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.31 105.7 15.21 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.764 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.414 ' CD1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -97.12 101.64 13.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.062 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.88 108.05 19.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.305 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -113.2 161.98 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.941 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.409 ' N ' HD11 ' A' ' 160' ' ' ILE . 1.4 m -63.05 -30.0 71.26 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.178 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.85 ' HG2' HG22 ' A' ' 142' ' ' VAL . 8.7 tpt -68.79 -32.03 71.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.094 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.64 -148.65 14.19 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.396 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.51 136.49 59.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.764 0.316 . . . . 0.0 111.446 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.56 HG22 ' CA ' ' A' ' 135' ' ' GLY . 20.7 pt -144.32 128.92 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.519 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.474 HG12 HD22 ' A' ' 13' ' ' ASN . 18.3 t -102.53 98.66 7.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.53 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.69 ' HG ' HD11 ' A' ' 98' ' ' LEU . 9.5 mp -80.83 148.77 29.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.35 140.33 48.12 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 14' ' ' VAL . 3.0 mp -124.11 129.65 51.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.154 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 37.6 m-85 -63.19 99.7 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 110.771 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -78.85 12.63 2.05 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.05 -65.51 0.96 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 110.522 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.503 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.1 m80 -100.73 -15.51 17.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.27 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.75 1.64 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.4 Cg_exo -40.57 -37.74 2.27 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.052 1.835 . . . . 0.0 113.089 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -60.72 -55.8 28.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -34.79 79.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.736 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.6 t -58.35 -45.59 87.89 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.58 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -61.69 -43.53 98.68 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.222 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.42 -39.33 93.63 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -69.07 -43.0 75.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.91 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.02 73.54 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.286 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -48.42 80.52 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.011 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -36.33 78.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.131 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.41 50.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.248 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -76.3 -49.08 17.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -60.08 -40.87 91.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.745 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.93 53.11 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -112.14 -62.84 1.51 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.515 0.198 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.615 ' O ' HG22 ' A' ' 51' ' ' THR . 12.9 m-85 -63.3 -51.71 64.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.65 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -67.23 119.75 12.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 110.47 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.22 8.8 10.09 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.088 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 48' ' ' TYR . 15.1 t -117.74 -172.18 2.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.274 0.537 . . . . 0.0 111.176 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.8 150.19 35.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.759 ' HB3' HD11 ' A' ' 56' ' ' ILE . 59.8 m-85 -64.23 136.9 57.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.187 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -109.44 -36.59 5.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.734 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.472 ' O ' HD13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -113.89 113.65 25.16 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.628 0.251 . . . . 0.0 111.114 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.759 HD11 ' HB3' ' A' ' 53' ' ' PHE . 29.6 mm -132.71 116.66 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.53 88.28 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.039 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HD3' ' HA3' ' A' ' 143' ' ' GLY . 21.8 tptt -58.97 155.53 13.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.09 25.75 4.67 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -166.29 -82.38 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.02 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.605 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -160.53 170.07 21.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 111.516 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -142.66 161.57 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.51 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -146.75 154.59 41.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.924 0.392 . . . . 0.0 111.55 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.68 150.45 17.12 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.562 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.412 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.987 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.0 t -125.4 175.04 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -53.02 -33.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.828 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.403 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 29.1 m-85 -92.23 -35.91 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.016 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.9 -143.49 10.34 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.588 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -134.68 27.52 3.65 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 111.193 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.13 -55.72 0.65 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.119 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 78' ' ' TYR . 15.5 m-85 61.73 -176.79 0.13 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.63 131.51 48.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.59 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.43 146.25 49.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -131.96 98.85 4.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.236 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.72 110.9 10.71 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.649 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -132.12 172.84 6.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 -173.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.742 2.294 . . . . 0.0 112.174 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.82 179.28 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.9 mt 66.82 165.89 0.21 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.739 0.304 . . . . 0.0 110.887 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 160.38 40.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 111.471 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.31 96.63 5.75 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.972 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.426 ' OG1' HD11 ' A' ' 97' ' ' ILE . 17.0 p -71.97 -33.61 68.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.2 -26.67 23.03 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.916 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 116.17 31.46 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.069 0.435 . . . . 0.0 111.654 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 66.35 54.82 21.37 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.213 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 96' ' ' GLY . 19.8 mm -129.23 135.53 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.768 0.284 . . . . 0.0 111.203 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.781 HD23 HG22 ' A' ' 114' ' ' VAL . 1.3 mt -105.64 120.44 41.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.833 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.758 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -117.81 141.16 48.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.369 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.19 120.02 23.11 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.181 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.72 141.8 36.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.43 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -157.16 117.4 3.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.743 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.47 72.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.71 179.83 17.51 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.48 30.27 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.686 2.258 . . . . 0.0 113.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -176.7 38.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 110.697 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.28 81.95 1.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 110.829 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -106.24 91.47 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.223 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.91 -105.16 0.02 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.358 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -157.5 36.48 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.43 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -118.1 160.3 21.76 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.696 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -159.74 165.66 32.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.758 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 6.5 p90 -137.63 136.79 37.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.42 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.781 HG22 HD23 ' A' ' 98' ' ' LEU . 4.8 t -102.72 110.53 29.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.201 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -79.8 130.89 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 61' ' ' MET . 0.6 OUTLIER -114.71 -15.99 11.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.675 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -108.61 152.35 42.12 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.835 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.99 104.41 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.761 2.308 . . . . 0.0 112.343 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.6 p -138.3 67.53 1.41 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -70.4 -32.96 70.82 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -60.55 -29.13 68.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.296 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.419 HD23 ' HD2' ' A' ' 125' ' ' LYS . 4.4 mt -73.17 -11.86 60.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.877 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.24 85.44 0.15 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.219 0.533 . . . . 0.0 110.425 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.79 -40.71 0.11 Allowed Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.279 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.419 ' HD2' HD23 ' A' ' 122' ' ' LEU . 30.7 mttt -74.56 -44.55 50.47 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 110.836 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -112.84 133.9 54.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.651 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 15.3 t -79.91 164.28 23.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.997 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.4 tt -90.4 -179.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.689 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.0 p90 -178.31 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -179.77 23.27 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.779 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.589 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -146.03 150.31 35.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.8 t -106.9 99.75 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.206 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.26 -45.96 5.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -119.84 96.34 5.14 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.829 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.56 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 152.24 -22.23 0.86 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.277 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.2 tt -47.21 -36.41 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.848 0.324 . . . . 0.0 111.807 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.59 96.2 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.482 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 ttp -65.77 -41.99 91.36 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.611 0.243 . . . . 0.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.71 -36.98 63.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.719 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -63.4 -36.15 82.76 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.983 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -60.78 -42.06 96.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.486 0.184 . . . . 0.0 111.028 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.85 HG22 ' HG2' ' A' ' 20' ' ' MET . 12.1 t -58.27 -34.03 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.148 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 58' ' ' LYS . . . -89.62 -36.38 7.41 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.12 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -35.77 61.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.46 0.304 . . . . 0.0 111.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 155' ' ' ASP . 18.9 m -63.76 173.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.612 ' O ' HG12 ' A' ' 154' ' ' VAL . 3.6 mm-40 -72.83 -179.93 3.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.062 0.458 . . . . 0.0 111.266 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.0 177.72 9.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.97 -173.11 4.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.03 27.83 2.32 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -147.26 -71.95 0.22 Allowed 'General case' 0 C--O 1.231 0.122 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 178.74 45.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.008 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.04 116.34 28.78 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.33 129.13 33.12 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.953 2.435 . . . . 0.0 112.849 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 146' ' ' GLU . 11.4 p -69.78 -35.36 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.12 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.567 ' HB2' HG21 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -75.41 -173.03 1.96 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -127.47 90.95 3.21 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 20' ' ' MET . 7.8 p -102.51 123.43 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.036 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -152.82 126.85 9.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.69 0.281 . . . . 0.0 111.711 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.437 ' HA ' ' HB ' ' A' ' 18' ' ' THR . 4.6 mt -81.42 132.95 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.597 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 19' ' ' SER . 0.3 OUTLIER -114.19 -33.64 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.295 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -127.51 146.19 50.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.772 0.32 . . . . 0.0 111.114 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.79 82.67 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.825 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -122.67 143.67 40.62 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.32 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.43 150.29 19.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.803 2.335 . . . . 0.0 112.603 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.3 t -171.77 148.72 2.42 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.892 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.036 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.53 0.318 0 N-CA-C 112.658 0.215 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -107.21 170.56 7.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.021 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.435 HG13 ' HG ' ' A' ' 25' ' ' LEU . 14.2 p -151.89 147.4 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -112.89 135.36 53.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.828 HD12 HD21 ' A' ' 25' ' ' LEU . 18.0 mt -121.63 97.79 5.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 86.28 7.38 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.602 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.7 OUTLIER -98.94 157.47 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.352 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 t -64.63 -36.39 84.1 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.847 ' HB2' HG23 ' A' ' 157' ' ' VAL . 9.8 tpt -65.47 -31.49 72.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.37 151.48 6.15 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.058 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -81.05 142.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.715 0.293 . . . . 0.0 111.483 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.713 HG22 ' HA2' ' A' ' 135' ' ' GLY . 19.5 pt -148.37 146.49 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.786 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.21 130.58 69.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.828 HD21 HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -133.03 162.91 30.46 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.387 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.55 154.11 25.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.907 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.43 134.12 46.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.769 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.769 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 74.3 m-85 -75.15 98.17 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.381 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -82.86 20.4 1.18 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -100.22 -67.29 0.86 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.482 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.81 -13.05 18.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.145 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.14 0.73 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 85.2 Cg_exo -42.77 -34.98 3.87 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.005 1.804 . . . . 0.0 112.789 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -57.72 -62.73 1.59 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.908 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -66.7 -33.65 76.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.41 -51.32 70.39 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.64 84.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.744 0.307 . . . . 0.0 110.468 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.24 -41.42 94.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.755 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.15 -48.35 68.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.89 83.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.387 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.98 -50.1 74.74 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -33.21 66.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.466 0.174 . . . . 0.0 111.441 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.92 24.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.512 0.196 . . . . 0.0 111.479 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -75.85 -36.79 59.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.449 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -30.33 71.15 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 31.0 3.07 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.927 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -105.03 -41.71 5.51 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.565 0.221 . . . . 0.0 110.663 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -65.58 -51.16 61.81 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.02 123.24 20.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.69 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.91 -29.38 5.39 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.315 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.79 -176.42 3.35 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 111.514 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -155.04 154.8 33.04 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.766 ' HB3' HD11 ' A' ' 56' ' ' ILE . 54.8 m-85 -66.86 169.83 7.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.983 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -135.72 -53.36 0.76 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.665 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.625 ' C ' HD12 ' A' ' 56' ' ' ILE . 6.2 mtt-85 -100.53 108.46 20.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.766 HD11 ' HB3' ' A' ' 53' ' ' PHE . 1.7 mp -120.02 99.87 8.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.53 95.54 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.95 -23.29 65.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.602 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 21.3 3.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CD2' ' HG3' ' A' ' 61' ' ' MET . 10.6 t80 -169.98 -81.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.521 -0.112 . . . . 0.0 111.141 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.457 ' HG3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -160.43 175.33 12.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 111.186 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.4 pp -133.97 137.06 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -117.47 143.58 45.9 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.138 0.494 . . . . 0.0 112.18 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 125.59 3.66 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.894 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.332 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.027 -179.563 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p -105.96 -175.5 2.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.182 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -66.4 -28.3 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.228 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -97.33 39.19 1.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.825 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -147.38 25.16 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.016 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 -37.3 5.91 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.462 0.172 . . . . 0.0 111.135 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -143.0 158.87 43.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -167.77 169.97 11.23 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.172 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.95 129.86 42.89 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -64.53 168.19 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.633 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -111.49 38.25 2.65 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.172 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.596 ' HA ' HG23 ' A' ' 127' ' ' THR . 0.1 OUTLIER -64.56 135.82 56.38 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.756 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.25 102.28 1.88 Allowed Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.969 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.9 80.71 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.369 . . . . 0.0 111.984 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.33 -49.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.767 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.466 HD13 HG21 ' A' ' 128' ' ' ILE . 4.8 mp -85.14 145.69 27.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -97.2 154.51 17.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -113.16 89.33 3.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -57.9 -33.83 69.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.214 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.67 -27.44 17.87 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.846 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.69 106.2 16.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.979 0.389 . . . . 0.0 111.086 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.572 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 74.41 58.46 4.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.958 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 96' ' ' GLY . 25.3 mm -133.08 120.41 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.703 0.287 . . . . 0.0 110.817 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.613 HD12 HG13 ' A' ' 132' ' ' VAL . 3.1 mt -96.09 110.02 22.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -117.05 138.69 51.43 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.706 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.419 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.89 118.61 21.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.561 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.16 172.08 9.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -148.75 157.87 43.75 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.71 23.94 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.85 174.52 35.87 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.435 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.78 120.26 7.29 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.557 2.171 . . . . 0.0 111.991 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 56.92 42.18 26.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.024 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.6 m -144.6 88.11 1.9 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -107.78 161.93 14.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.14 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.4 -106.16 1.01 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.168 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -147.52 34.68 0.86 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.03 158.1 23.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -160.4 176.46 11.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -145.96 136.69 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.56 HG22 ' CD2' ' A' ' 98' ' ' LEU . 22.0 t -102.13 109.9 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.129 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.53 132.94 36.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.407 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 pp -114.9 -23.32 9.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.861 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.15 149.03 35.93 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.71 117.3 4.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.862 2.375 . . . . 0.0 112.213 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.842 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 10.2 p -151.91 99.03 2.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.156 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -92.8 -21.89 19.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.842 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.8 p90 -59.06 -26.18 64.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.3 pp -85.03 -4.59 59.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.78 86.95 0.04 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.182 0.515 . . . . 0.0 110.091 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.73 -32.27 1.46 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.642 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.19 -53.92 21.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.662 0.231 . . . . 0.0 111.219 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -104.61 150.03 25.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.269 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.665 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 49.1 m -86.14 155.75 20.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.959 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 90' ' ' LEU . 1.3 tt -86.47 -179.42 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.636 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -175.72 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.62 -179.82 31.89 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.919 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -138.2 166.22 24.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.6 0.238 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.662 HG12 ' HB3' ' A' ' 25' ' ' LEU . 3.0 m -134.44 102.79 4.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 111.782 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.82 -53.74 4.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.9 84.18 1.89 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.955 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.713 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 169.81 -27.84 0.12 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.844 -0.694 . . . . 0.0 113.437 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 96' ' ' GLY . 7.8 tt -46.98 -37.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.73 -38.17 81.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.76 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -70.45 -35.56 73.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.108 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.59 -30.23 41.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -74.82 -38.04 62.16 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.483 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -67.73 -29.56 68.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.685 HG22 ' HG2' ' A' ' 20' ' ' MET . 21.5 t -56.34 -32.71 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.649 0.262 . . . . 0.0 111.015 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 58' ' ' LYS . . . -93.59 -32.19 7.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.506 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 21.2 mmt -60.15 -33.3 71.97 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.524 0.162 . . . . 0.0 111.385 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.1 m -63.75 173.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.18 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 126.07 26.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.976 0.417 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 p -118.58 167.94 11.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -177.29 5.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.83 46.91 1.43 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -174.28 -67.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.56 44.02 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -122.95 104.05 36.15 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.137 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.0 117.06 3.48 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 112.461 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.43 -32.24 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.696 0.284 . . . . 0.0 110.361 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.13 -170.94 1.03 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.382 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.89 114.05 22.65 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.731 0.3 . . . . 0.0 111.617 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 20' ' ' MET . 7.1 p -125.43 113.38 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 174.85 11.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.638 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.435 ' HA ' HG22 ' A' ' 18' ' ' THR . 2.4 mt -115.14 139.49 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.314 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.55 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -116.13 -30.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.602 179.037 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.22 28.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 110.952 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.13 111.14 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.023 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 36.6 p90 -145.05 158.37 52.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 111.707 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.4 Cg_exo -80.09 152.38 21.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.274 2.649 . . . . 0.0 112.482 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 140.29 1.85 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.451 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.533 0.439 0 N-CA-C 112.715 0.237 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -125.0 165.74 17.6 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.004 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.672 HG22 HD11 ' A' ' 27' ' ' LEU . 30.5 m -140.58 154.23 21.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.467 ' CE1' HG22 ' A' ' 24' ' ' VAL . 4.1 m-85 -111.5 104.17 12.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -87.88 96.64 10.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.16 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 161' ' ' LYS . 1.3 tm-20 -80.37 82.48 6.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.187 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.668 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.8 OUTLIER -84.78 161.05 20.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.386 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -64.04 -33.22 75.25 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.054 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.923 ' HB2' HG13 ' A' ' 157' ' ' VAL . 15.3 tpt -67.51 -34.16 76.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.945 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.81 -148.36 12.75 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.221 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.427 HD11 ' CD1' ' A' ' 15' ' ' TYR . 17.2 tt -132.28 126.45 55.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 111.279 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 25' ' ' LEU . 29.7 pt -129.99 133.26 64.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.467 HG22 ' CE1' ' A' ' 15' ' ' TYR . 18.4 t -94.3 109.41 22.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.82 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 132' ' ' VAL . 7.4 mt -105.49 162.42 13.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.28 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -119.89 144.81 47.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.051 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.672 HD11 HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -129.47 134.29 47.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.81 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 28.0 m-85 -64.42 100.6 0.37 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.014 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -80.8 15.31 1.81 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -100.15 -64.9 1.0 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.772 0.32 . . . . 0.0 110.343 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.478 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -100.76 -13.2 18.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.333 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.01 1.2 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 77.8 Cg_exo -41.84 -37.52 4.15 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.011 1.807 . . . . 0.0 112.908 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -49.49 71.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.486 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.1 m -67.07 -36.94 83.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.387 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -54.51 -49.13 70.91 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.358 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -64.6 -38.55 91.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.264 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.409 ' CG ' HD13 ' A' ' 77' ' ' ILE . 1.5 t30 -56.74 -44.09 81.33 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.478 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -67.51 -43.16 81.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.212 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.11 -52.43 55.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.272 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -46.5 89.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -40.73 69.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 -33.77 33.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -47.63 84.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -60.16 -30.23 69.18 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.424 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.87 26.02 5.16 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.908 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -37.13 13.11 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.777 0.288 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -36.39 40.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.179 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -66.99 90.01 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 110.138 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.8 -26.04 2.53 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.772 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.6 p -61.3 151.4 32.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.809 0.305 . . . . 0.0 111.281 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -132.2 159.69 38.29 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.863 0.363 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -74.13 100.46 3.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.638 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -73.02 -50.2 24.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -102.72 131.09 49.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.725 HG23 HG12 ' A' ' 62' ' ' ILE . 27.0 mt -142.16 105.19 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.018 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mt -90.98 115.06 29.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.735 0.302 . . . . 0.0 110.913 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 2.0 tmtt? -63.34 132.2 50.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.188 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 2.5 t70 55.39 52.45 11.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.267 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.449 ' N ' HD11 ' A' ' 116' ' ' LEU . 16.4 t80 -165.82 -83.83 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.482 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.58 163.6 32.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.819 0.343 . . . . 0.0 111.442 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 56' ' ' ILE . 4.0 mp -137.99 130.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.721 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 15.6 pt20 -117.9 154.58 31.64 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 112.004 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.92 106.09 0.48 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.153 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.941 -179.729 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.668 ' HB2' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -80.35 -84.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.684 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 76' ' ' SER . 4.3 mp -142.55 -50.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.811 0.339 . . . . 0.0 110.534 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 34.76 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.41 -168.54 13.19 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -119.32 21.69 12.1 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.66 ' HB3' HG23 ' A' ' 107' ' ' THR . 0.0 OUTLIER -177.73 92.82 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 110.632 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -107.76 175.61 5.42 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.251 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.74 140.72 46.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.785 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 157.11 11.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.79 37.31 2.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.651 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 149.13 21.74 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.51 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.28 -62.31 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.526 ' HG2' HD13 ' A' ' 90' ' ' LEU . 78.2 Cg_endo -75.73 -174.23 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.758 2.306 . . . . 0.0 112.42 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.94 -61.65 1.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.014 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.577 HD22 HG21 ' A' ' 128' ' ' ILE . 7.6 mp 57.5 -173.85 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.11 173.98 10.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' A' ' 99' ' ' ALA . 8.2 t80 -160.31 38.93 0.17 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.979 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -108.93 -57.74 2.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.811 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.28 122.34 5.26 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.591 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.15 127.21 12.19 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 101.96 62.38 0.75 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 96' ' ' GLY . 14.8 mm -126.67 140.13 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.767 0.283 . . . . 0.0 111.045 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.524 HD22 ' HE1' ' A' ' 129' ' ' PHE . 3.2 mt -112.41 120.8 42.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.676 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -124.52 142.06 51.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.443 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -79.6 114.75 18.76 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.286 179.279 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.18 26.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.437 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -135.82 157.25 47.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -37.22 14.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.158 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.79 174.46 36.61 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 119.12 5.65 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.579 2.186 . . . . 0.0 112.165 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 59.05 30.75 20.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.185 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 81' ' ' GLN . 10.5 m -139.87 88.3 2.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.709 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.02 165.91 12.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.09 -105.7 1.47 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.93 43.94 0.12 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 111.041 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -126.03 157.46 37.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 100' ' ' MET . 2.4 m-85 -149.73 160.09 43.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.412 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.676 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 7.1 p90 -137.43 130.3 30.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 111.618 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 139' ' ' VAL . 21.4 t -98.54 107.1 19.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.228 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.41 HG21 ' CE2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -79.72 125.84 30.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 60' ' ' PHE . 1.9 pp -109.29 -4.69 16.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.66 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.432 ' N ' HD12 ' A' ' 116' ' ' LEU . . . -119.95 152.28 53.81 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-O 120.527 0.203 . . . . 0.0 110.839 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.26 100.06 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 112.025 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 79.5 p -122.41 110.4 15.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -94.9 -40.48 9.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -61.81 -33.67 74.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 122' ' ' LEU . 12.8 mt -81.91 -3.31 53.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.556 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -82.1 66.56 7.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.004 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.9 -47.38 0.07 OUTLIER Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.651 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -56.08 -47.52 77.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.706 0.289 . . . . 0.0 110.885 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -108.57 139.69 42.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.606 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 11.0 t -79.97 155.8 27.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.788 0.328 . . . . 0.0 111.125 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.577 HG21 HD22 ' A' ' 90' ' ' LEU . 1.2 tt -83.57 -178.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.561 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.524 ' HE1' HD22 ' A' ' 98' ' ' LEU . 1.2 p90 -179.38 -39.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.3 -179.75 17.01 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.113 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -146.85 171.79 14.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.29 . . . . 0.0 110.924 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 25' ' ' LEU . 16.3 t -130.64 119.16 44.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.352 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -56.51 2.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.13 92.33 3.86 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.061 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.84 -17.26 0.95 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.274 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.568 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -45.87 -36.93 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.89 -47.87 76.46 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.638 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.423 ' O ' HG23 ' A' ' 142' ' ' VAL . 7.2 tmm? -58.26 -46.07 86.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 110.403 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 114' ' ' VAL . 19.5 t -59.79 -37.98 73.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -63.79 -44.66 92.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.845 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -56.65 -34.3 67.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.175 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 138' ' ' MET . 21.8 t -58.24 -36.03 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.886 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.38 -38.13 18.8 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.563 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 mtp -55.3 -47.69 75.2 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.7 0.25 . . . . 0.0 111.208 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -50.88 136.89 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.52 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -60.75 120.83 10.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.636 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.6 p -86.48 170.39 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.407 ' CB ' ' HG3' ' A' ' 152' ' ' ARG . 1.4 t-20 -81.96 -166.22 1.18 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.56 34.37 0.76 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -160.12 32.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.627 0.251 . . . . 0.0 110.914 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.34 35.23 13.34 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.088 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.407 ' HG3' ' CB ' ' A' ' 148' ' ' ASN . 2.6 ptp180 -111.71 150.65 42.56 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.943 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.28 120.05 6.84 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.671 2.247 . . . . 0.0 112.495 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.9 t -70.57 -32.22 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.367 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -174.66 4.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.39 79.97 3.14 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.296 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.923 HG13 ' HB2' ' A' ' 20' ' ' MET . 30.3 t -113.93 113.43 43.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.345 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.92 179.81 8.46 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.388 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.668 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.2 mt -102.22 125.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.608 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.1 pt -107.12 -32.45 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.553 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . 3.3 tttt -145.1 143.73 30.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.651 0.262 . . . . 0.0 110.864 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.5 94.83 2.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.725 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -119.1 155.98 52.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.329 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.76 167.2 20.79 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.555 2.17 . . . . 0.0 113.003 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' SER . . . . . 0.412 ' HG ' ' HE2' ' A' ' 15' ' ' TYR . 3.5 t -105.91 163.17 12.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.26 -1.3 . . . . 0.0 112.93 179.789 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 41.5 Cg_endo . . . . . 0 CA--C 1.532 0.413 0 N-CA-C 112.969 0.334 . . . . 0.0 112.969 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.48 142.83 34.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.706 0.289 . . . . 0.0 110.831 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.71 152.59 25.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -113.85 115.09 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.537 HD21 ' HE2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -101.32 104.62 15.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.126 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.16 87.06 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.395 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.6 OUTLIER -84.96 159.6 20.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.674 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 160' ' ' ILE . 0.3 OUTLIER -60.78 -34.15 74.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.73 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -73.51 -33.44 64.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.394 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.16 -168.19 40.88 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.52 ' C ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -119.06 123.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.182 0.491 . . . . 0.0 111.207 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.645 HG22 ' HA2' ' A' ' 135' ' ' GLY . 23.1 pt -128.1 146.18 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.863 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.0 t -105.2 139.3 26.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.522 HD21 HD12 ' A' ' 23' ' ' ILE . 3.4 mt -136.67 159.29 42.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' C ' HD22 ' A' ' 27' ' ' LEU . 15.8 pt-20 -121.46 145.29 48.08 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.854 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 ' C ' ' A' ' 26' ' ' GLU . 3.7 mm? -116.36 144.48 44.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.521 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.706 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 49.2 m-85 -86.33 102.49 14.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.753 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 10.9 m95 -76.36 11.99 1.37 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.29 -61.96 1.3 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.546 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.751 ' NE2' HD11 ' A' ' 90' ' ' LEU . 6.7 p80 -100.79 -15.98 17.45 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.18 1.38 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 66.8 Cg_exo -40.05 -37.21 1.65 Allowed 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.131 1.887 . . . . 0.0 113.312 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -55.63 13.7 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.061 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.616 HG21 ' HG3' ' A' ' 100' ' ' MET . 52.5 m -68.45 -39.49 81.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.3 -50.63 72.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -43.78 86.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.403 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.46 -48.03 83.55 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.78 -45.97 81.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.614 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.59 76.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.55 -42.23 98.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.431 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -52.09 67.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.544 0.211 . . . . 0.0 111.236 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.59 68.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -61.22 -42.53 98.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -38.67 92.08 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.279 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.06 38.96 1.09 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.813 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -32.52 6.55 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.481 0.182 . . . . 0.0 111.011 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HE2' HD21 ' A' ' 16' ' ' LEU . 1.5 t80 -68.59 -36.28 78.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.204 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -65.79 108.7 2.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.27 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.74 -23.15 4.24 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.89 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.537 ' HB ' HD12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -64.0 165.46 8.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 111.502 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 158' ' ' LYS . 0.4 OUTLIER -153.8 143.68 21.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.085 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CD1' HG22 ' A' ' 62' ' ' ILE . 42.3 m-85 -66.04 108.48 2.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.88 5.66 47.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.136 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -150.05 114.85 5.31 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.618 0.247 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.862 HG23 HG12 ' A' ' 62' ' ' ILE . 4.0 mp -137.49 107.43 4.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.31 79.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 41.82 -147.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.662 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.08 53.47 2.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.091 0.472 . . . . 0.0 110.311 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -125.13 -66.02 0.99 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.318 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 ptm -156.64 137.3 13.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.747 0.308 . . . . 0.0 111.175 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.862 HG12 HG23 ' A' ' 56' ' ' ILE . 6.4 mt -132.38 115.17 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.0 pt20 -103.08 146.78 27.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.481 . . . . 0.0 112.054 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.78 111.85 0.6 Allowed Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.898 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.945 -179.656 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.662 0.268 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 t -134.94 159.2 42.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.176 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -56.94 -33.6 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.38 -30.81 63.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.94 -160.97 29.12 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.762 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -52.35 60.62 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 110.603 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.65 159.3 38.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -144.41 178.03 8.22 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.97 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.97 130.17 38.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -65.27 161.03 20.29 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.78 139.18 47.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -121.34 127.61 51.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.584 ' HB2' HD12 ' A' ' 90' ' ' LEU . 17.7 p80 -65.63 135.64 95.74 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.313 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.93 -36.96 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.571 2.181 . . . . 0.0 112.429 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -163.42 106.73 1.01 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.737 0.303 . . . . 0.0 110.827 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.751 HD11 ' NE2' ' A' ' 31' ' ' HIS . 11.7 mt -149.85 178.76 8.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.31 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -124.66 160.93 27.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.488 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.414 ' CB ' ' HB2' ' A' ' 123' ' ' ASP . 4.2 t80 -135.83 76.43 1.61 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.38 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.3 m -57.09 -27.47 61.79 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 98.96 -58.52 0.88 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.797 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.26 114.37 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 70.93 64.01 2.96 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.964 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 96' ' ' GLY . 12.7 mm -130.61 158.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.696 0.284 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.821 ' HG ' HG12 ' A' ' 114' ' ' VAL . 1.1 mt -137.52 97.66 3.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.275 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -105.68 136.05 45.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.616 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -79.74 121.46 25.37 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.87 176.83 4.92 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.457 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -139.76 173.61 11.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.296 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.07 -35.73 12.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.44 167.74 32.52 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.531 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.54 124.07 14.32 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.558 2.172 . . . . 0.0 112.159 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.36 29.07 18.58 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.393 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 m -132.03 89.83 2.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.39 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.58 147.17 25.07 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.625 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.23 -110.72 1.48 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.16 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.5 m -151.55 45.66 0.79 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.986 0.422 . . . . 0.0 111.199 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 148.04 32.71 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.167 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -149.7 132.04 15.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 23.9 p90 -110.08 127.11 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 111.497 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.821 HG12 ' HG ' ' A' ' 98' ' ' LEU . 29.2 m -99.85 119.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.558 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 p -88.81 142.54 27.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.802 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.565 ' N ' HD22 ' A' ' 116' ' ' LEU . 1.3 mm? -113.65 -24.88 8.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.138 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -106.58 162.57 19.27 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.031 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 46.4 Cg_endo -67.94 112.31 2.67 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.683 2.255 . . . . 0.0 112.45 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 p -141.34 76.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 92' ' ' PHE . 36.2 mt-30 -76.67 -34.8 58.23 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.153 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -59.69 -28.5 67.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.439 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 122' ' ' LEU . 11.0 mt -81.39 -2.35 49.01 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 92' ' ' PHE . 35.8 t0 -82.89 60.22 5.27 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 110.443 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.23 -52.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.778 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -32.61 74.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -119.03 148.83 42.58 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.623 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 95.2 m -99.28 163.7 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.716 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.694 HG22 ' H ' ' A' ' 129' ' ' PHE . 2.7 mm -79.41 -179.09 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.241 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.694 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -176.97 -34.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.82 170.46 31.26 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.575 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.401 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -126.7 159.07 34.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.7 0.286 . . . . 0.0 110.983 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.84 94.53 3.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 6.2 t -92.0 -61.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.277 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -111.74 98.21 7.25 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.645 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 156.03 -21.59 0.51 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.455 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.2 tt -47.88 -35.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.91 92.14 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.037 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.94 -16.45 55.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.566 0.222 . . . . 0.0 110.879 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.64 HG11 HG21 ' A' ' 114' ' ' VAL . 21.9 t -88.57 -42.28 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.558 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.47 -31.03 68.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -53.71 -32.17 50.92 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.581 HG12 HG21 ' A' ' 56' ' ' ILE . 20.9 t -63.41 -36.46 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.644 0.259 . . . . 0.0 111.145 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.02 -29.05 39.2 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.458 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.6 mtp -74.3 -23.51 59.09 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 145' ' ' VAL . 13.3 p -84.03 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.39 174.59 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.151 0.5 . . . . 0.0 111.427 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 p -150.78 173.74 13.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.275 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -89.73 -176.37 4.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.852 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -91.4 28.98 1.55 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.608 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -150.4 29.31 0.71 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.296 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.5 44.39 21.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.21 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.3 mtp-105 -115.3 144.47 32.33 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.733 ' HB3' HD13 ' A' ' 56' ' ' ILE . 74.1 Cg_endo -76.58 140.57 21.39 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.804 2.336 . . . . 0.0 112.747 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.24 -34.14 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.457 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -171.01 3.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.59 96.64 5.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.275 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 157' ' ' VAL . 10.9 p -117.02 111.36 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 52' ' ' LYS . 5.9 pttt -145.38 173.63 11.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.722 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.1 mt -106.3 126.13 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.678 0.275 . . . . 0.0 111.3 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.411 HG23 ' HB2' ' A' ' 19' ' ' SER . 42.7 pt -108.14 -33.79 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.638 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -138.8 152.11 47.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.774 0.321 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.48 115.41 3.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -153.5 166.12 16.3 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.84 168.78 18.85 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.045 2.497 . . . . 0.0 112.193 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.38 96.73 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.996 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.799 -1.001 . . . . 0.0 113.031 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 CA--C 1.532 0.402 0 N-CA-C 112.739 0.246 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.23 168.8 8.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.462 HG23 HD13 ' A' ' 27' ' ' LEU . 21.3 t -128.36 126.86 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.019 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.429 ' CE1' HD11 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -90.43 95.37 10.14 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.594 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.01 85.75 3.32 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 89.02 6.37 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.274 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.541 HG22 ' CG1' ' A' ' 159' ' ' ILE . 1.1 p -84.36 162.78 19.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.165 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 160' ' ' ILE . 2.3 t -68.62 -34.07 75.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.46 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.514 ' CB ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -70.06 -33.36 71.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.1 -159.12 27.26 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.387 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.429 HD11 ' CE1' ' A' ' 15' ' ' TYR . 11.6 tt -122.52 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.877 0.339 . . . . 0.0 111.469 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG22 ' CA ' ' A' ' 135' ' ' GLY . 17.3 pt -139.16 137.8 41.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 131.18 61.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.423 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -128.59 144.59 51.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.865 0.365 . . . . 0.0 111.325 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -106.41 116.7 32.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.886 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 14' ' ' VAL . 8.9 mp -94.96 129.26 42.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.229 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.791 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 69.9 m-85 -63.41 101.5 0.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -82.01 18.34 1.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -100.38 -66.16 0.92 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.743 0.306 . . . . 0.0 110.474 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.5 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 3.0 t60 -100.65 -15.38 17.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.983 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.791 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -96.43 0.84 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_exo -42.32 -37.06 4.73 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.987 1.791 . . . . 0.0 112.753 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -54.17 39.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.533 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -35.05 79.81 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 73.9 m -60.11 -47.18 87.0 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.508 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -59.28 -39.71 83.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.495 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -47.24 84.26 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.21 -43.89 98.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.99 63.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.109 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.21 -37.56 87.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.961 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -63.41 -35.73 81.39 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.631 0.253 . . . . 0.0 110.862 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 162' ' ' ALA . . . -83.32 -36.06 24.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.558 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.36 -36.89 63.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.325 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -61.31 -36.58 80.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.525 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.62 30.88 3.37 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.938 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.94 -51.73 3.96 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.599 0.238 . . . . 0.0 110.433 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.422 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 4.0 m-85 -65.55 -29.57 70.2 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.27 101.09 0.88 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.253 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.59 30.02 3.43 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.38 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -111.21 151.33 28.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.976 0.388 . . . . 0.0 110.85 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.57 151.82 48.41 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -60.83 144.3 52.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 63' ' ' GLN . 16.5 p80 -113.71 -38.93 4.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.905 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.442 ' CD ' HD11 ' A' ' 57' ' ' ILE . 5.7 ttt180 -125.11 118.62 26.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.79 0.328 . . . . 0.0 111.257 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.903 HG23 HG12 ' A' ' 62' ' ' ILE . 3.3 mt -130.54 104.35 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.442 HD11 ' CD ' ' A' ' 55' ' ' ARG . 4.1 mp -98.28 115.19 37.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.976 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 137.19 57.14 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.922 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.65 35.43 19.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.652 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -151.09 -88.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.432 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -160.46 157.36 27.49 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.698 0.285 . . . . 0.0 111.041 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.903 HG12 HG23 ' A' ' 56' ' ' ILE . 6.6 mt -130.38 124.93 58.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.346 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.2 pt20 -112.27 148.72 33.55 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.77 109.54 0.59 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.374 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.333 0.394 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.228 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.658 0.266 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -113.1 167.12 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt -56.99 -39.35 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -80.34 -30.98 38.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.42 -167.05 29.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.848 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -63.07 -54.96 29.86 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.598 0.237 . . . . 0.0 110.678 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.775 ' HG2' HG23 ' A' ' 107' ' ' THR . 8.8 mp0 -135.7 139.26 43.53 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.817 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -123.93 172.02 9.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.83 179.2 1.49 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.196 0.522 . . . . 0.0 111.927 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.15 159.95 22.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.416 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.17 75.42 1.16 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.403 HD12 ' OG1' ' A' ' 127' ' ' THR . 0.4 OUTLIER -119.03 141.07 49.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.05 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.407 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -164.06 -63.28 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.55 ' HG2' HD11 ' A' ' 90' ' ' LEU . 70.9 Cg_endo -74.19 172.55 15.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.695 2.263 . . . . 0.0 112.956 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.51 95.5 5.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.867 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 1.005 HD22 HG21 ' A' ' 128' ' ' ILE . 5.9 mp -91.73 172.68 8.32 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 159.21 30.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.037 0.446 . . . . 0.0 111.382 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.4 41.68 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.17 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 94' ' ' GLY . 11.7 t -148.11 -47.18 0.16 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.854 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 93' ' ' THR . . . -55.28 122.09 24.92 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.757 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.45 126.88 8.62 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.616 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 102.91 63.06 0.71 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.281 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.616 HD13 ' O ' ' A' ' 96' ' ' GLY . 9.5 mm -130.42 137.79 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 117.056 0.428 . . . . 0.0 110.955 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 25' ' ' LEU . 7.7 tp -111.2 101.91 10.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.107 0.479 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -110.02 146.73 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.31 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.28 133.08 36.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.223 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 142.54 35.17 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -143.22 117.72 9.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.31 75.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.394 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.32 179.5 34.88 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.303 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.85 128.67 23.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.494 2.129 . . . . 0.0 111.934 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 58.79 35.31 24.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.775 HG23 ' HG2' ' A' ' 81' ' ' GLN . 85.5 m -143.19 89.33 2.09 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -106.19 155.41 19.49 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.95 -165.63 11.88 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.72 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.31 61.88 1.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.947 0.403 . . . . 0.0 110.888 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.57 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -153.34 155.8 37.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.04 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.16 161.03 43.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.072 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 14.2 p90 -130.79 141.33 50.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.3 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.697 HG11 HG11 ' A' ' 139' ' ' VAL . 11.4 t -102.74 110.6 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.479 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.89 109.15 15.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.032 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 61' ' ' MET . 0.9 OUTLIER -103.53 -6.82 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.917 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 119' ' ' THR . . . -122.81 142.85 38.84 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.387 0.136 . . . . 0.0 110.806 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.39 122.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.905 2.403 . . . . 0.0 112.577 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 117' ' ' ALA . 31.1 p -128.48 112.56 14.48 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.947 0.404 . . . . 0.0 111.279 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -94.92 -42.74 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.438 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 46.7 p90 -67.74 -31.88 72.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.336 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 122' ' ' LEU . 12.4 mt -89.36 -2.25 58.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.739 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -68.85 85.53 0.33 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.348 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.02 -25.6 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.72 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -57.01 -53.81 53.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.712 0.256 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -102.3 156.7 17.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.64 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 47.6 m -90.32 150.9 21.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.001 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 1.005 HG21 HD22 ' A' ' 90' ' ' LEU . 1.1 tt -79.88 -179.62 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.418 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.453 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -177.22 -35.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.88 179.99 29.7 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.828 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 161.9 36.87 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 122.827 -0.219 . . . . 0.0 110.659 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 132' ' ' VAL . 11.6 p -124.51 105.32 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.27 0.557 . . . . 0.0 111.528 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.51 -38.42 9.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.28 88.14 2.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.89 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.475 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 159.46 -22.31 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.351 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 tt -43.33 -38.81 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.4 -37.12 86.97 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.909 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -36.0 59.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.789 0.328 . . . . 0.0 110.124 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.697 HG11 HG11 ' A' ' 114' ' ' VAL . 23.7 t -66.76 -56.74 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.32 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -63.26 -24.43 67.87 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.258 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -58.67 -33.77 70.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.547 0.213 . . . . 0.0 110.816 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.775 HG12 HG21 ' A' ' 56' ' ' ILE . 26.0 t -63.84 -35.64 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.018 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.71 -39.5 60.07 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.312 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 mmt -53.66 -51.5 62.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -52.2 143.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.691 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -64.75 122.21 16.36 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.3 p -93.06 179.15 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -170.04 2.21 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.75 46.02 1.32 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.646 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -174.61 -76.53 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.835 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.58 30.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.31 118.64 60.85 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-O 120.656 0.265 . . . . 0.0 111.682 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HB3' HD13 ' A' ' 56' ' ' ILE . 38.1 Cg_endo -67.51 115.25 3.61 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.044 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.21 -31.48 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -171.04 2.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.619 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.26 97.38 6.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 157' ' ' VAL . 9.1 p -123.48 108.51 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.875 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 175.22 11.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.361 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.541 ' CG1' HG22 ' A' ' 18' ' ' THR . 3.6 mt -103.57 130.48 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.321 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 19' ' ' SER . 17.4 pt -106.73 -29.43 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.914 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.18 108.51 1.9 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.16 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.496 ' O ' ' HB1' ' A' ' 43' ' ' ALA . . . -120.37 114.37 21.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.187 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -154.1 149.22 20.26 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.03 161.3 23.73 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.514 2.143 . . . . 0.0 112.6 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.8 t -165.38 -62.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.424 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.531 0.37 0 CA-C-O 121.037 0.349 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.36 166.32 11.8 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.019 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.26 46.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.03 96.49 8.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.815 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -86.3 94.73 9.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.766 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.554 ' HG2' HD11 ' A' ' 160' ' ' ILE . 4.3 tt0 -83.5 118.77 24.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.54 HG22 HG23 ' A' ' 159' ' ' ILE . 8.1 p -135.25 158.02 45.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.522 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -59.04 -36.72 75.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.747 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.736 ' CB ' HG13 ' A' ' 157' ' ' VAL . 8.0 tpt -67.03 -33.49 75.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.55 143.42 3.67 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.36 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.502 HD12 ' CB ' ' A' ' 17' ' ' GLU . 1.7 tt -82.57 126.83 40.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.471 HG22 ' HA2' ' A' ' 135' ' ' GLY . 2.7 pt -128.56 137.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' HB ' ' CG ' ' A' ' 134' ' ' GLN . 20.6 t -99.86 135.37 35.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.02 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -135.67 147.56 48.59 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.315 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.24 129.56 38.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.6 HD21 HD12 ' A' ' 25' ' ' LEU . 4.5 mm? -104.78 131.97 51.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.337 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.808 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 22.8 m-85 -76.07 99.65 4.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.0 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -83.03 18.18 1.73 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -67.32 0.86 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.489 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 2.3 m-70 -100.69 -13.28 18.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.59 1.71 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.2 Cg_exo -40.86 -36.4 2.0 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.062 1.841 . . . . 0.0 112.927 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -47.74 79.38 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.688 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.613 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.7 OUTLIER -78.35 -36.76 45.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.906 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.3 t -57.98 -47.63 82.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.655 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -42.97 75.1 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.197 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -58.89 -53.7 55.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -41.46 70.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.997 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.1 54.65 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.27 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -45.44 93.09 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.176 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -35.4 71.19 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.136 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -84.21 -36.48 22.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.298 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -47.23 68.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.232 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -58.22 -25.82 62.11 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.757 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.33 13.0 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.817 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.49 -34.74 18.55 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.643 0.259 . . . . 0.0 110.935 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.429 ' HE2' HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -76.15 -25.42 55.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -65.08 93.62 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 110.245 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.08 -20.11 3.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.106 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.817 ' HB ' HD12 ' A' ' 159' ' ' ILE . 2.2 m -58.12 157.41 8.19 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.906 0.353 . . . . 0.0 111.508 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -138.92 169.39 17.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.482 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' HB3' HD11 ' A' ' 56' ' ' ILE . 9.9 m-85 -96.86 83.47 3.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.96 -45.24 78.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -99.77 120.66 40.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.754 0.311 . . . . 0.0 111.026 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.867 HD12 ' HG2' ' A' ' 153' ' ' PRO . 19.3 mt -145.68 98.54 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.295 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.11 107.09 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -39.09 93.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.538 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.66 41.3 0.89 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.41 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.986 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.51 171.53 18.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 111.115 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.726 HG21 HG23 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -131.77 151.67 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.824 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -134.32 161.77 34.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.587 0.708 . . . . 0.0 112.524 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.81 109.33 0.41 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.331 0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.145 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 t -104.51 158.64 16.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.012 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 78' ' ' TYR . 2.6 pp -57.23 -27.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.298 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.751 ' N ' HD12 ' A' ' 77' ' ' ILE . 19.3 m-85 -82.28 -33.14 29.23 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.904 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.02 -158.53 27.66 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.33 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.71 -72.71 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.874 0.337 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.416 ' HB3' HG23 ' A' ' 107' ' ' THR . 15.8 mm100 -133.1 140.75 47.81 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 108' ' ' ASN . 44.0 p90 -130.03 166.93 19.1 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 111.57 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.25 110.0 21.94 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.345 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.06 178.35 4.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.485 ' HB3' HG21 ' A' ' 127' ' ' THR . 2.0 mm-40 62.9 166.42 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.685 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.38 106.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.587 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.411 ' CB ' ' HD3' ' A' ' 88' ' ' PRO . 1.2 m80 -172.11 -61.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.085 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 87' ' ' HIS . 87.9 Cg_endo -80.84 -173.38 1.82 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.652 2.235 . . . . 0.0 112.616 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.58 95.62 5.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.949 ' HG ' HG21 ' A' ' 128' ' ' ILE . 2.6 mm? -77.03 -176.33 3.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -70.21 0.47 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.72 70.58 0.63 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.38 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -75.75 -39.08 57.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 119.93 -42.06 1.83 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.362 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.55 100.22 11.21 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.735 0.302 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.585 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 89.23 55.22 2.13 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.915 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 96' ' ' GLY . 37.3 mm -130.61 130.75 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.653 0.264 . . . . 0.0 110.867 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 129' ' ' PHE . 2.7 mt -102.92 104.27 14.48 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.738 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -108.63 142.42 39.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.32 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.613 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.5 123.53 27.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.47 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 143.9 32.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.491 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.48 136.34 14.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.69 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.56 179.32 32.49 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.926 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 139.61 63.0 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.398 2.065 . . . . 0.0 112.122 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 59.81 44.91 13.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.308 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 81' ' ' GLN . 87.6 m -146.99 85.97 1.63 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 68.3 m-80 -106.56 152.13 24.11 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.51 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 -138.95 3.62 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.808 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.47 60.84 0.73 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.505 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -150.83 146.25 26.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.379 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CD2' ' HG2' ' A' ' 100' ' ' MET . 3.8 m-85 -149.72 160.08 43.82 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.391 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.738 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 31.4 p90 -134.66 134.37 41.07 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.483 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 98' ' ' LEU . 24.1 t -104.04 110.02 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.238 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.498 HG21 HG21 ' A' ' 119' ' ' THR . 45.1 p -80.96 138.27 36.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.977 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 -18.91 11.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.512 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.39 158.29 35.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.464 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 85.4 Cg_exo -44.84 128.74 9.16 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.848 2.366 . . . . 0.0 112.902 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.806 HG22 HD12 ' A' ' 122' ' ' LEU . 22.8 p -131.94 33.79 3.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -61.64 -37.79 85.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.831 0.348 . . . . 0.0 110.58 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -79.6 -27.78 41.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.136 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.806 HD12 HG22 ' A' ' 119' ' ' THR . 19.8 mt -75.52 -5.15 43.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.89 84.69 0.08 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.179 0.514 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 163.3 -41.14 0.33 Allowed Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.415 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -59.12 -57.29 13.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.625 0.25 . . . . 0.0 110.783 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -109.53 173.69 6.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.639 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 28.2 m -106.67 160.14 15.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.949 HG21 ' HG ' ' A' ' 90' ' ' LEU . 2.3 tt -87.51 179.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.226 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.568 ' HE1' HD11 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -176.79 -40.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.397 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.08 -179.8 27.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.276 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -144.08 167.26 22.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.494 0.187 . . . . 0.0 110.837 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 132' ' ' VAL . 30.5 m -125.08 107.21 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -43.99 12.14 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.403 ' CG ' ' HB ' ' A' ' 24' ' ' VAL . 7.2 pt20 -132.06 90.59 2.84 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.898 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 168.96 -27.77 0.13 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.341 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.507 HD12 ' CA ' ' A' ' 96' ' ' GLY . 12.3 tt -44.28 -36.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -41.04 75.06 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.694 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.679 ' O ' HG23 ' A' ' 142' ' ' VAL . 11.4 tmm? -68.59 -36.55 78.87 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 110.755 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.449 HG13 HD11 ' A' ' 62' ' ' ILE . 35.1 t -73.62 -35.46 44.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -72.17 -39.39 68.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.192 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 138' ' ' MET . 7.5 ptp180 -62.57 -31.69 72.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.727 HG11 HD13 ' A' ' 56' ' ' ILE . 22.0 t -56.51 -31.0 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.632 0.253 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.85 -22.98 40.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.714 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.5 mmt -76.8 -4.54 44.02 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.27 32.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.646 0.26 . . . . 0.0 111.489 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.79 169.96 0.19 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 111.432 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -152.67 175.84 12.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.399 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 0.6 OUTLIER -79.92 -174.72 4.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.76 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.7 p -89.4 36.59 0.84 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.572 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -166.32 -72.42 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.392 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -174.13 70.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.666 0.269 . . . . 0.0 110.825 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -153.37 99.73 2.65 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.625 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.867 ' HG2' HD12 ' A' ' 56' ' ' ILE . 51.0 Cg_exo -53.6 154.35 16.1 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.988 2.459 . . . . 0.0 113.308 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -76.18 -34.11 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.973 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -170.65 2.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.682 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -127.48 110.83 13.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.976 0.417 . . . . 0.0 111.436 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.736 HG13 ' CB ' ' A' ' 20' ' ' MET . 35.5 t -108.54 121.0 60.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 18' ' ' THR . 3.0 pttt -145.24 152.65 40.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.593 0.235 . . . . 0.0 111.203 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.817 HD12 ' HB ' ' A' ' 51' ' ' THR . 30.4 mt -93.21 138.97 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.086 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 17' ' ' GLU . 9.9 pt -109.76 -35.61 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.938 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.66 146.58 4.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.499 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -132.17 115.85 16.24 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -133.56 156.19 79.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.68 170.93 16.35 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.676 2.251 . . . . 0.0 112.741 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.55 94.76 6.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.361 -1.244 . . . . 0.0 112.288 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 CA-C-O 120.699 0.208 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -126.36 142.51 51.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 164' ' ' PRO . 27.5 m -126.85 153.64 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.286 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -111.34 100.65 9.22 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.4 110.59 19.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -87.39 108.23 18.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.558 HG22 ' CG1' ' A' ' 159' ' ' ILE . 1.0 OUTLIER -114.02 156.38 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -61.7 -31.58 71.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.362 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.792 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -71.12 -34.64 71.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.68 -156.22 26.33 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.362 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.2 tt -127.53 128.26 69.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.814 0.307 . . . . 0.0 111.142 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.637 HG22 ' HA2' ' A' ' 135' ' ' GLY . 11.6 pt -141.0 138.73 34.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.497 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.502 ' O ' HD23 ' A' ' 25' ' ' LEU . 22.3 m -97.46 148.27 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 24' ' ' VAL . 16.3 mt -123.49 122.83 39.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.367 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.11 94.96 6.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.254 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 36' ' ' CYS . 8.8 mp -82.41 147.26 28.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.976 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.699 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 52.6 m-85 -72.26 102.0 2.99 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -81.16 15.76 1.8 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -69.82 0.75 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 110.277 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.491 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.59 -13.99 18.36 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.164 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.81 1.58 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 72.3 Cg_exo -41.4 -36.75 2.93 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.065 1.844 . . . . 0.0 112.844 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -52.33 63.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.773 0.321 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -64.97 -40.45 95.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.357 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.73 ' HA ' HD23 ' A' ' 27' ' ' LEU . 46.2 t -56.5 -48.38 77.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.467 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -58.79 -42.88 90.09 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.256 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.2 -51.9 67.61 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HE1' ' HH ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -61.24 -41.63 97.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.92 85.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.697 ' HB3' HD13 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -67.05 -42.09 85.36 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.286 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 76' ' ' SER . 0.1 OUTLIER -62.57 -34.01 76.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.646 0.26 . . . . 0.0 111.153 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -83.59 -31.73 26.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -84.22 -38.92 19.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.558 0.218 . . . . 0.0 111.474 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -61.4 -58.44 8.2 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.85 65.17 0.04 OUTLIER Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.75 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.39 -62.08 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.584 0.23 . . . . 0.0 110.827 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' HH ' ' HE1' ' A' ' 39' ' ' PHE . 3.9 m-85 -60.59 -42.63 97.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.174 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -67.47 101.18 0.94 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.681 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.49 -32.99 2.11 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.437 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 65' ' ' GLY . 14.5 t -86.66 -168.59 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.752 0.31 . . . . 0.0 111.391 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -150.31 -174.16 4.66 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.692 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.617 ' HB3' HD11 ' A' ' 56' ' ' ILE . 8.1 m-85 -83.38 122.12 28.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.414 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -103.29 11.88 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.524 ' O ' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -157.62 111.33 2.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.853 HG23 HG22 ' A' ' 62' ' ' ILE . 21.6 mm -134.9 120.07 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.7 mp -109.78 115.23 49.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.493 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -54.78 124.43 16.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.465 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 58.38 57.4 3.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -165.1 -81.68 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.368 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.496 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -160.71 173.33 15.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 111.617 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.853 HG22 HG23 ' A' ' 56' ' ' ILE . 42.3 pt -142.87 140.51 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.942 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -122.17 153.81 38.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.243 0.544 . . . . 0.0 111.969 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.38 146.42 16.48 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.826 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.561 ' O ' HG21 ' A' ' 51' ' ' THR . . . . . . . . 0 C--N 1.332 0.343 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.33 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.57 0.224 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.561 ' HB2' HD11 ' A' ' 42' ' ' LEU . 13.0 p -92.26 -52.4 4.7 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.762 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 41' ' ' GLU . 1.1 tp -172.6 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.954 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.435 ' N ' HG23 ' A' ' 77' ' ' ILE . 25.1 m-85 -102.18 -32.92 9.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.68 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 176.99 179.33 47.33 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.385 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.27 11.42 30.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.1 110.21 0.15 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.606 0.241 . . . . 0.0 110.998 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 34.7 p90 -126.88 161.04 29.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.0 179.78 2.61 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.302 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.3 177.48 5.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -139.17 103.96 4.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.272 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.1 tp -154.17 134.33 13.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.425 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -171.44 -61.3 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.131 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 87' ' ' HIS . 18.4 Cg_endo -60.31 171.33 3.31 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.682 2.255 . . . . 0.0 112.716 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -78.36 107.64 11.13 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.997 0.427 . . . . 0.0 111.195 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.468 ' CD1' HG21 ' A' ' 128' ' ' ILE . 4.0 mm? -109.44 162.32 14.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.932 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -118.31 150.83 38.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.461 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 96.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 15.0 t -175.45 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.627 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.34 120.25 21.11 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.064 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 116' ' ' LEU . . . -49.95 106.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.624 ' CA ' HD13 ' A' ' 136' ' ' ILE . . . 117.33 69.95 0.4 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.014 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 96' ' ' GLY . 10.1 mm -131.74 139.62 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.569 0.224 . . . . 0.0 111.223 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 114' ' ' VAL . 0.8 OUTLIER -106.25 104.94 14.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.622 179.245 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -109.84 144.09 38.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.49 128.6 33.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.65 167.77 20.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.259 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' A' ' 126' ' ' HIS . 3.5 p-10 -159.53 117.53 2.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.773 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.25 -40.28 52.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.142 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.94 160.72 31.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.9 125.84 20.01 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.66 2.24 . . . . 0.0 112.175 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 58.54 30.93 20.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.6 m -142.61 84.4 1.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.992 0.425 . . . . 0.0 110.25 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.448 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 2.8 m-20 -123.71 165.9 16.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.582 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.76 -103.33 0.92 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.0 m -151.23 43.26 0.77 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 111.172 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -105.09 154.18 20.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.323 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -155.39 159.31 39.78 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.664 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 15.1 p90 -138.33 139.61 39.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.449 . . . . 0.0 111.611 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.742 HG22 HD23 ' A' ' 98' ' ' LEU . 16.9 t -115.56 110.95 33.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.54 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.448 HG21 ' OG1' ' A' ' 119' ' ' THR . 0.3 OUTLIER -79.8 113.7 18.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.551 ' O ' ' HB1' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -83.8 -16.21 45.49 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.594 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.84 162.54 51.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.473 0.177 . . . . 0.0 110.885 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 93' ' ' THR . 50.6 Cg_exo -53.85 131.51 44.71 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.901 2.401 . . . . 0.0 112.702 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.448 ' OG1' HG21 ' A' ' 115' ' ' THR . 1.8 p -143.5 105.07 4.31 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 -43.65 6.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -58.61 -31.84 68.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.148 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.6 -17.94 52.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.529 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -65.66 85.25 0.07 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 110.466 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 153.46 -35.43 0.76 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.363 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -50.53 62.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.692 0.282 . . . . 0.0 110.908 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.404 ' HA ' ' OD1' ' A' ' 102' ' ' ASN . 24.9 m-70 -112.44 147.61 36.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.454 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.753 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 12.9 t -79.81 170.11 16.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.828 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.3 tt -99.69 -179.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -171.7 -38.41 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 27' ' ' LEU . . . -151.76 -179.41 27.4 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.082 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.449 ' C ' HD12 ' A' ' 98' ' ' LEU . 1.8 ttm105 -135.74 148.12 48.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.83 102.13 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.113 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.45 -63.5 1.28 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.495 ' O ' HG22 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -114.3 82.71 1.76 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.655 178.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.637 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . -178.75 -24.09 0.04 OUTLIER Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.916 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.624 HD13 ' CA ' ' A' ' 96' ' ' GLY . 9.2 tp -46.75 -34.55 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 117.266 0.533 . . . . 0.0 112.297 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.22 -22.09 54.97 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.868 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.652 ' O ' HG23 ' A' ' 142' ' ' VAL . 8.8 tmm? -93.44 -39.35 10.95 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.644 HG13 HD11 ' A' ' 62' ' ' ILE . 32.3 t -59.43 -54.28 36.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.065 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.401 ' HA ' HD13 ' A' ' 116' ' ' LEU . 28.5 p30 -59.07 -33.25 70.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.675 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -38.52 91.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 138' ' ' MET . 20.7 t -57.47 -36.0 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.685 0.279 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.16 -34.43 69.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.397 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.1 mtt -58.59 -40.83 84.26 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 155' ' ' ASP . 1.6 t -54.01 119.01 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.26 121.74 12.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.596 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.1 t -89.83 168.73 11.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.134 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -81.8 -170.04 2.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.45 31.24 1.04 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.594 0.235 . . . . 0.0 111.442 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.67 30.37 0.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.65 53.73 10.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.488 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.16 134.6 25.27 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.21 116.69 4.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.592 2.195 . . . . 0.0 112.322 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.09 -35.27 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.625 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.43 ' HB2' HG11 ' A' ' 145' ' ' VAL . 0.8 OUTLIER -82.71 -169.26 2.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.567 179.25 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.42 101.67 11.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 20' ' ' MET . 26.2 t -130.42 108.27 15.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.238 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -179.97 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.621 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.558 ' CG1' HG22 ' A' ' 18' ' ' THR . 1.5 mt -111.57 145.33 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.248 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.494 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -121.64 -35.0 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.898 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.8 149.46 26.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.27 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.428 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -145.48 121.48 10.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.459 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -144.95 155.36 55.54 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.392 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.403 ' HB3' HG12 ' A' ' 14' ' ' VAL . 95.4 Cg_endo -80.21 168.18 18.86 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.691 2.26 . . . . 0.0 112.257 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.7 t -142.46 154.21 44.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.148 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.821 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.537 0.654 0 N-CA-C 113.275 0.452 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -89.93 142.95 27.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.649 0.261 . . . . 0.0 111.208 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -131.43 136.59 57.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.164 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.3 108.29 19.85 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.28 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.427 ' HG ' ' HB1' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -107.28 99.53 9.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.99 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -82.16 110.29 17.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.71 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.648 HG22 ' CG1' ' A' ' 159' ' ' ILE . 2.3 p -112.31 161.51 16.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 p -62.81 -37.12 85.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.235 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.741 ' HB2' HG13 ' A' ' 157' ' ' VAL . 1.3 tpt -68.46 -30.01 68.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.27 -154.33 24.54 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.345 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.86 128.76 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.864 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.85 145.06 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.79 119.12 60.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.549 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.511 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -115.04 155.56 26.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -110.76 115.01 28.82 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.757 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 mt -87.0 147.86 25.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.797 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.763 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 35.1 m-85 -84.81 104.58 14.89 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.629 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -82.55 21.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.2 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -69.52 0.77 Allowed 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.505 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.81 18.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.942 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.1 1.27 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.3 Cg_exo -41.43 -38.16 3.68 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.054 1.836 . . . . 0.0 112.819 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -54.15 50.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.321 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.833 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -69.68 -33.62 72.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -55.92 -56.01 25.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -61.24 -39.07 88.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.344 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.458 ' ND2' HG12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -59.97 -38.86 83.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.019 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -46.74 80.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.15 77.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.537 ' HB3' HG21 ' A' ' 77' ' ' ILE . 1.2 mm-40 -61.03 -50.55 72.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.068 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 1.4 mp -57.49 -40.13 77.96 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.992 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.6 67.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.342 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -73.02 -50.83 20.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -60.77 -28.56 68.82 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.847 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.49 28.34 5.47 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.733 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -89.67 -41.32 12.0 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.612 0.206 . . . . 0.0 110.729 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 5.5 m-85 -72.01 -31.13 65.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.281 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.69 102.86 0.21 Allowed 'General case' 0 C--O 1.233 0.202 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.71 11.76 9.13 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.487 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 p -95.55 168.46 10.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.392 0.596 . . . . 0.0 110.827 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -157.55 169.54 24.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.678 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.859 ' HB3' HD11 ' A' ' 56' ' ' ILE . 47.3 m-85 -94.86 100.71 12.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.552 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -88.84 -43.64 11.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.819 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.555 ' O ' HD13 ' A' ' 56' ' ' ILE . 7.3 mtt180 -90.97 108.61 19.97 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.694 0.283 . . . . 0.0 110.612 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 1.046 HG23 HG22 ' A' ' 62' ' ' ILE . 36.1 mm -131.99 140.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.264 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.421 HD13 ' HG3' ' A' ' 61' ' ' MET . 4.3 mp -116.75 116.84 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.715 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 122.85 14.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.402 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 61.93 51.05 3.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.331 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.88 -80.15 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.234 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.421 ' HG3' HD13 ' A' ' 57' ' ' ILE . 1.3 ptm -160.6 172.2 17.58 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 111.33 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.046 HG22 HG23 ' A' ' 56' ' ' ILE . 1.2 pp -132.86 115.71 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 16.0 pt20 -104.69 138.28 41.24 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 0.0 111.986 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.32 110.5 1.08 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.962 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.323 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.841 -179.747 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.901 0.381 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -74.55 162.25 28.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.406 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 41' ' ' GLU . 2.8 pt -61.45 -27.24 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.052 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -96.45 30.69 2.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.103 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.18 -146.94 16.68 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.971 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 -25.65 11.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -148.33 139.97 23.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.557 0.217 . . . . 0.0 110.794 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 m-85 -87.38 -174.42 4.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.488 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.17 69.9 1.15 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.733 0.301 . . . . 0.0 111.744 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 66.13 146.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.939 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.616 ' O ' HG21 ' A' ' 127' ' ' THR . 6.4 mt-10 -155.38 36.37 0.38 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.13 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tp -65.91 149.9 49.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 111.526 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 11.5 p80 -99.82 152.03 37.68 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.75 -50.42 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.586 2.191 . . . . 0.0 112.24 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.82 146.97 14.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -171.9 173.84 4.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -90.66 160.91 15.62 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.876 0.369 . . . . 0.0 111.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.52 61.14 0.75 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.978 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.34 -36.06 75.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.88 -20.38 46.02 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.238 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.55 112.66 25.68 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.163 0.482 . . . . 0.0 110.959 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.459 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 72.62 56.86 5.76 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.331 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.0 mm -124.15 161.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.483 0.183 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 132' ' ' VAL . 3.4 mt -142.08 106.35 4.79 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 110.446 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.752 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -114.52 144.04 44.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.833 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.83 110.92 15.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.48 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.71 145.55 31.52 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -124.19 174.75 7.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.26 -45.13 4.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.476 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.96 174.82 36.8 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.778 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.89 141.3 67.04 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.658 2.239 . . . . 0.0 112.152 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 45.2 30.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.914 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -149.93 87.53 1.48 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.78 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.48 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 60.8 m-80 -95.4 172.84 7.84 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.43 -171.43 12.19 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.717 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 m -103.52 45.7 0.95 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.023 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -115.25 168.34 10.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.564 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 24.1 p90 -160.59 171.86 18.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.454 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.752 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 42.0 p90 -152.28 131.56 12.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.851 0.358 . . . . 0.0 111.645 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 139' ' ' VAL . 34.1 t -96.41 116.78 39.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.358 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.482 HG21 ' OG1' ' A' ' 119' ' ' THR . 0.2 OUTLIER -79.59 127.98 32.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.704 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.63 HD22 ' HA ' ' A' ' 140' ' ' ASN . 3.2 mt -113.36 -8.4 13.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.561 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -131.59 161.56 61.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.456 0.17 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 20.3 Cg_endo -59.95 121.77 10.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.873 2.382 . . . . 0.0 112.603 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.482 ' OG1' HG21 ' A' ' 115' ' ' THR . 0.9 OUTLIER -143.09 49.02 1.47 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.078 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -31.84 69.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.124 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -65.84 -28.48 69.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.186 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.552 HD23 ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -75.89 -7.36 54.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.899 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -66.14 85.57 0.09 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.124 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.68 -41.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.351 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB2' HD23 ' A' ' 122' ' ' LEU . 20.5 mttt -67.1 -49.56 64.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.548 0.213 . . . . 0.0 111.036 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.32 140.86 48.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.664 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 97.8 m -85.07 151.4 24.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 129' ' ' PHE . 0.6 OUTLIER -79.46 -178.98 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.275 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.659 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.7 OUTLIER -169.34 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 -179.51 26.17 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.66 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -143.3 155.59 44.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.525 0.203 . . . . 0.0 110.689 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.526 HG13 HD12 ' A' ' 98' ' ' LEU . 16.0 m -114.39 85.08 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.164 0.507 . . . . 0.0 112.24 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.97 -40.01 40.67 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.05 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -127.52 98.33 5.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.65 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.79 -12.3 1.3 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.622 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.452 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 15.5 tt -50.54 -30.35 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 117.255 0.527 . . . . 0.0 111.938 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.79 -12.13 67.13 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.29 -0.481 . . . . 0.0 113.417 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.05 -30.05 12.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.793 0.296 . . . . 0.0 110.814 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 114' ' ' VAL . 2.5 m -84.61 -34.85 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.434 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.63 ' HA ' HD22 ' A' ' 116' ' ' LEU . 53.7 p30 -61.52 -28.21 69.16 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.279 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ARG . . . . . 0.635 ' O ' HG13 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -78.55 -30.83 47.11 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.855 -0.157 . . . . 0.0 111.298 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.482 ' HB ' HG21 ' A' ' 62' ' ' ILE . 39.3 t -57.47 -36.88 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.688 0.28 . . . . 0.0 110.738 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.11 -30.27 11.32 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.208 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -65.15 -31.94 73.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 141' ' ' ARG . 27.1 m -61.38 176.38 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.98 0.419 . . . . 0.0 111.569 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.38 172.75 12.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -147.79 166.15 28.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -142.74 159.21 42.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 m 85.49 -40.86 0.05 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.508 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 168.36 -37.63 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -169.62 37.25 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.358 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.22 124.99 36.4 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.85 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.462 ' HG3' HG13 ' A' ' 56' ' ' ILE . 51.9 Cg_exo -54.74 109.49 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.71 2.273 . . . . 0.0 112.478 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.1 p -64.13 -30.85 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.922 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.64 -171.67 3.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.719 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.13 117.84 32.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.741 HG13 ' HB2' ' A' ' 20' ' ' MET . 21.6 t -142.07 121.88 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.21 178.53 10.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.726 0.298 . . . . 0.0 111.732 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.648 ' CG1' HG22 ' A' ' 18' ' ' THR . 3.3 mt -110.84 143.45 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.062 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.38 -40.45 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.38 153.06 17.2 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.669 0.271 . . . . 0.0 111.211 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.427 ' HB1' ' HG ' ' A' ' 16' ' ' LEU . . . -150.88 141.6 22.74 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -154.51 156.45 31.62 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.55 162.94 24.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.448 2.099 . . . . 0.0 112.5 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -85.88 144.51 27.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.076 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 118.684 -1.065 . . . . 0.0 112.954 179.789 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 CA--C 1.529 0.269 0 CA-C-O 120.639 0.183 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -125.05 174.88 7.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.783 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' A' ' 27' ' ' LEU . 9.5 p -148.16 130.33 6.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.404 ' HB2' ' CB ' ' A' ' 163' ' ' TYR . 10.4 m-85 -105.36 106.3 16.73 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 107.15 18.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.498 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HG2' HD12 ' A' ' 22' ' ' ILE . 11.2 mt-10 -86.61 82.35 7.93 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.354 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.65 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.8 OUTLIER -91.62 165.32 13.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.28 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -67.4 -37.15 82.65 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.729 ' HB2' HG13 ' A' ' 157' ' ' VAL . 12.9 tpt -62.44 -32.97 73.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.82 -148.53 14.4 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.194 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.475 HD12 ' HG2' ' A' ' 17' ' ' GLU . 4.8 tt -134.83 130.14 52.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.861 0.331 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.647 HG22 ' CA ' ' A' ' 135' ' ' GLY . 15.5 pt -137.62 135.58 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.637 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.73 140.24 17.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.599 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 98' ' ' LEU . 2.0 mt -130.87 141.0 50.28 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.588 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.82 107.91 19.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.524 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.433 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -84.49 146.68 27.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.665 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 23.0 m-85 -79.86 92.04 5.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -80.69 19.48 0.82 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.01 -72.44 0.67 Allowed 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.48 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -101.1 -12.1 19.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.017 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.9 1.34 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 71.7 Cg_exo -41.09 -36.38 2.24 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.248 1.966 . . . . 0.0 112.965 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -58.02 -60.37 3.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.353 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -39.31 91.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.337 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 27' ' ' LEU . 14.0 t -55.01 -48.68 73.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.446 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -60.61 -37.29 80.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -58.35 -54.22 49.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.767 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -61.13 -45.84 93.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 110.826 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.39 94.02 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.31 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.5 -44.07 58.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.251 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -37.91 70.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.117 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -80.93 -32.66 34.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.413 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -66.94 -45.95 76.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.124 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -28.42 68.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.736 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.04 36.18 2.79 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.733 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.19 -50.13 5.64 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.637 0.218 . . . . 0.0 110.697 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -62.75 -28.65 70.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.939 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -67.63 113.66 5.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.422 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.6 20.9 7.08 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.359 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.2 p -124.93 154.73 40.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.038 0.419 . . . . 0.0 110.53 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -129.56 169.66 14.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CD1' HG12 ' A' ' 157' ' ' VAL . 34.1 m-85 -85.31 99.07 10.9 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.783 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -76.86 -39.4 51.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.169 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -100.98 117.28 34.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.607 0.241 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.62 HG23 ' CG1' ' A' ' 62' ' ' ILE . 13.2 mt -141.11 120.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.0 111.379 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 mt -116.22 116.56 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.795 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -56.59 -60.28 3.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.563 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -88.47 62.38 6.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.605 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 178.25 -86.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.272 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.413 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -161.2 170.94 19.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.809 0.337 . . . . 0.0 111.554 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.62 ' CG1' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -127.23 123.09 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.139 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 1.7 pt20 -117.4 155.19 30.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.22 100.63 0.41 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.453 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.332 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.58 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 8.5 t -76.69 171.76 14.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.364 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 tt -73.23 -34.09 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.489 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -100.33 36.75 1.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 111.131 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 76' ' ' SER . . . 89.05 169.07 44.32 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.071 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -52.42 63.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.429 0.157 . . . . 0.0 110.786 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -141.61 143.26 33.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.862 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -138.56 173.57 11.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.525 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.18 173.43 11.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.396 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 4.3 p30 -80.19 178.46 8.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -132.21 72.91 1.51 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.467 ' N ' HD22 ' A' ' 86' ' ' LEU . 3.4 mm? -99.17 104.73 16.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.85 -54.23 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HB2' HD21 ' A' ' 90' ' ' LEU . 71.4 Cg_exo -48.72 149.99 6.79 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.78 2.32 . . . . 0.0 112.703 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.54 94.9 2.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.508 HD22 ' CG2' ' A' ' 128' ' ' ILE . 3.0 mt -90.16 -174.94 4.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.721 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -69.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.638 ' HD1' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER 62.06 61.28 1.37 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.113 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.7 p -57.62 -36.86 72.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.413 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 118' ' ' PRO . . . 147.64 -101.52 0.23 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.613 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' A' ' 136' ' ' ILE . . . -71.95 135.17 46.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.974 0.416 . . . . 0.0 111.736 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 77.93 52.65 5.26 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.994 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 96' ' ' GLY . 17.1 mm -135.81 138.67 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.94 HD13 HG22 ' A' ' 114' ' ' VAL . 13.3 tp -115.33 133.75 55.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.8 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -134.13 151.65 51.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 116.35 19.64 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.36 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.92 158.51 26.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.857 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -121.03 173.45 7.25 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.293 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.24 -43.98 3.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.181 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.95 -179.43 33.78 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.65 113.23 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.05 30.54 20.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.12 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -129.82 90.77 3.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -83.21 162.77 21.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.94 -140.94 4.5 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.57 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 m -138.58 58.49 1.66 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.076 0.465 . . . . 0.0 110.802 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 3.3 mt-30 -132.78 178.23 7.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.821 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -160.45 158.02 28.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.057 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.72 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 41.3 p90 -137.36 133.02 34.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.94 HG22 HD13 ' A' ' 98' ' ' LEU . 22.1 t -101.32 114.66 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.2 p -79.94 113.62 18.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.099 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 58' ' ' LYS . 0.8 OUTLIER -86.71 -23.83 25.4 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -119.19 165.01 18.33 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.806 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 18.6 Cg_endo -58.1 124.64 16.39 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.621 2.214 . . . . 0.0 111.994 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 122' ' ' LEU . 2.7 p -141.79 48.17 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.211 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -64.47 -35.35 80.65 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.756 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -65.58 -27.9 68.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 2.5 mt -78.46 0.11 27.19 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.55 79.91 1.07 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.235 0.54 . . . . 0.0 109.942 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.57 -46.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.203 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.45 -43.28 90.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 110.676 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -123.45 135.8 54.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.747 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 63.5 m -80.16 160.83 25.54 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.74 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.638 HD12 ' HD1' ' A' ' 92' ' ' PHE . 1.4 tt -79.39 -179.5 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.934 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.424 ' CE2' ' HG ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -177.13 -38.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.403 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.41 -179.6 17.73 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.848 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 7.6 mtm180 -137.3 168.1 20.29 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 122.819 -0.224 . . . . 0.0 110.778 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.563 HG21 HG13 ' A' ' 114' ' ' VAL . 11.5 t -131.06 91.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.908 0.385 . . . . 0.0 111.345 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.33 -41.66 9.73 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.535 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 103.83 6.83 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.123 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.647 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 147.12 -19.68 1.57 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.422 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' A' ' 95' ' ' ALA . 12.7 tt -48.17 -36.5 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.996 0.398 . . . . 0.0 112.002 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.23 -24.18 67.04 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.289 -0.481 . . . . 0.0 113.133 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ttp -91.07 -32.37 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.236 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.584 HG11 ' CG1' ' A' ' 114' ' ' VAL . 20.2 t -73.92 -48.67 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.33 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -65.0 -31.56 72.86 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.155 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -59.98 -34.46 73.34 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.203 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.617 HG13 HG21 ' A' ' 157' ' ' VAL . 37.1 t -58.01 -38.69 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.8 -42.61 86.3 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.314 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.6 mmt -49.19 -48.62 45.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -52.73 141.8 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 111.503 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.46 112.69 2.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.764 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.2 p -79.86 165.52 22.62 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.107 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.59 -167.29 1.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.598 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.0 p -88.89 32.78 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.568 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -158.52 31.13 0.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.903 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 57.43 41.8 25.64 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.521 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.09 147.51 37.08 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 120.62 0.247 . . . . 0.0 111.551 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 152.32 31.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.904 2.403 . . . . 0.0 112.636 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 154' ' ' VAL . 8.3 p -117.84 23.49 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.283 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.13 24.41 4.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 54.98 85.43 0.06 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 20' ' ' MET . 22.8 t -118.7 111.81 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 175.48 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.65 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.0 mt -105.22 127.81 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.79 0.328 . . . . 0.0 111.048 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 pt -107.13 -33.62 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.765 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.416 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -159.38 167.94 27.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.285 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.426 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -133.25 159.32 40.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.365 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.404 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -129.23 97.08 26.64 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.207 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.9 95.0 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.827 2.352 . . . . 0.0 112.198 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.6 t -84.48 143.89 29.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.273 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.51 -1.161 . . . . 0.0 112.758 179.741 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 CA--C 1.534 0.52 0 N-CA-C 112.594 0.19 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.481 ' HB3' HG12 ' A' ' 24' ' ' VAL . 8.2 m120 -142.31 175.32 9.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.776 0.322 . . . . 0.0 111.627 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -144.8 147.68 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -91.84 120.31 32.42 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 111.139 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.802 HD21 ' HE2' ' A' ' 48' ' ' TYR . 2.2 mt -114.05 102.83 10.55 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.303 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 6.5 mt-10 -92.86 103.16 15.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.27 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 159' ' ' ILE . 2.1 p -113.56 158.19 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.3 t -60.47 -35.9 76.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.813 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.782 ' HB2' HG13 ' A' ' 157' ' ' VAL . 11.4 tpt -68.76 -32.34 72.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.329 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.51 -163.74 37.29 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.35 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 tt -124.12 129.95 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.984 0.392 . . . . 0.0 111.185 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.559 HG22 ' CA ' ' A' ' 135' ' ' GLY . 8.3 pt -136.96 156.83 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.683 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 13' ' ' ASN . 20.3 t -123.32 116.52 48.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.717 HD23 HD12 ' A' ' 16' ' ' LEU . 3.5 mm? -91.51 158.81 16.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 3.8 tt0 -110.65 105.59 14.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.75 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.97 131.15 37.49 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.392 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.738 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 24.5 m-85 -82.41 113.9 20.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -81.96 14.96 2.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.83 -68.46 0.81 Allowed 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.686 0.279 . . . . 0.0 110.378 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.481 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -100.87 -13.94 18.16 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -97.63 0.66 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 98.7 Cg_exo -43.73 -40.56 11.1 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.071 1.847 . . . . 0.0 112.896 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -54.61 27.08 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.746 HG21 ' HG3' ' A' ' 100' ' ' MET . 4.8 m -64.1 -35.85 82.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.117 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 t -57.01 -51.63 68.48 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.81 -40.47 88.5 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -58.51 -47.23 84.84 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.01 -46.91 78.61 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.739 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 -45.68 70.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.403 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.15 -45.96 91.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.211 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -44.1 93.07 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 110.845 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -70.59 -35.68 73.14 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.143 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.06 -47.15 60.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -57.41 -31.1 65.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.611 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 33.04 2.53 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.103 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.23 -34.86 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.606 0.203 . . . . 0.0 111.058 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.802 ' HE2' HD21 ' A' ' 16' ' ' LEU . 1.4 t80 -73.37 -37.2 66.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.645 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.88 151.84 41.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.27 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 18.31 71.0 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.861 -0.609 . . . . 0.0 113.083 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -109.19 161.67 15.01 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.004 0.402 . . . . 0.0 110.465 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HB3' ' CB ' ' A' ' 158' ' ' LYS . 44.3 pttt -146.54 165.67 28.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -70.64 110.86 5.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -77.18 -45.23 27.34 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.851 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -112.11 130.1 56.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.726 HD12 ' HG3' ' A' ' 153' ' ' PRO . 51.9 mt -143.05 97.48 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.792 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.54 110.11 21.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -62.51 141.06 58.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.187 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.6 45.74 7.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.524 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -168.71 -89.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.942 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 175.23 12.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.651 ' CG2' HG23 ' A' ' 56' ' ' ILE . 1.8 pp -144.04 156.34 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.015 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 6.0 pt20 -132.73 142.53 49.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 111.568 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.03 156.43 16.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.704 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.441 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.973 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.618 0.247 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.26 177.74 8.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 pp -56.19 -31.44 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.747 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.53 40.39 1.11 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.96 179.69 33.37 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.956 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.75 76.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.529 0.204 . . . . 0.0 110.931 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -155.91 146.28 21.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.908 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -126.9 177.21 6.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.22 140.53 38.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.59 157.19 14.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.465 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.63 40.6 3.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.541 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.94 145.98 42.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.695 0.283 . . . . 0.0 110.916 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -164.46 153.51 11.57 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.87 -166.48 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.396 2.064 . . . . 0.0 112.08 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.53 33.46 10.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 111.152 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.658 HD13 ' CG1' ' A' ' 128' ' ' ILE . 84.7 mt -122.03 -178.45 3.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.882 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HE2' ' HB ' ' A' ' 93' ' ' THR . 17.0 tttt -128.08 157.29 41.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.088 0.47 . . . . 0.0 111.659 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.39 48.36 0.89 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.919 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.696 HG23 HD11 ' A' ' 97' ' ' ILE . 1.7 t -58.8 -23.83 60.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.8 -7.31 81.6 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.78 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.64 96.87 5.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.951 0.876 . . . . 0.0 111.383 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' C ' HD12 ' A' ' 97' ' ' ILE . . . 83.23 61.64 1.89 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.302 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.696 HD11 HG23 ' A' ' 93' ' ' THR . 4.4 mp -138.75 154.46 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.717 0.258 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.756 HD12 ' HE2' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -125.99 111.94 15.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.907 0.384 . . . . 0.0 110.454 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.614 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -108.22 137.04 46.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.34 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.746 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.64 104.88 10.54 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 164.89 22.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.475 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 172.68 12.62 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.32 -36.03 10.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.733 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.74 -179.84 32.93 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.614 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -61.87 124.21 14.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.696 2.264 . . . . 0.0 112.149 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.26 28.49 17.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.051 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.5 m -136.57 84.53 2.08 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.269 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.11 129.41 34.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.769 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.02 -164.06 24.88 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.953 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 m -110.25 68.43 0.67 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.063 0.458 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -148.67 152.47 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -147.17 156.68 43.18 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.755 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.614 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 22.8 p90 -137.77 126.15 23.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.968 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 11.7 p -98.47 120.14 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.356 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 p -84.18 129.36 34.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.761 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.45 -19.47 12.93 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.64 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -122.14 160.34 47.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.61 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 9.5 Cg_endo -51.56 127.82 23.87 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.043 2.495 . . . . 0.0 112.802 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.5 p -147.42 42.9 1.1 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -59.19 -30.99 68.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.426 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 32.6 p90 -60.95 -29.2 69.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.273 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 14.6 mt -81.25 -2.06 47.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.78 85.63 0.21 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.153 0.501 . . . . 0.0 110.386 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.21 -31.58 0.54 Allowed Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.697 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -72.59 -62.94 1.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.708 0.254 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -95.63 172.13 8.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.558 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 13.3 t -114.06 156.73 23.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.522 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 129' ' ' PHE . 4.2 mm -80.01 -179.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.283 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.756 ' HE2' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -178.22 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.393 0.277 . . . . 0.0 110.696 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 26' ' ' GLU . . . -145.44 -179.63 21.86 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.213 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 160.6 42.31 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.577 0.227 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 25' ' ' LEU . 17.8 t -106.73 93.61 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.8 m -84.12 -42.58 15.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.475 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 107.25 8.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 136.09 -10.31 4.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.607 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.417 ' HA ' HG11 ' A' ' 132' ' ' VAL . 13.4 tt -48.78 -33.82 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.55 91.68 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.609 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -66.59 -46.49 75.79 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 0.0 110.471 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.75 -38.1 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.787 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.13 -40.81 77.87 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.62 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -62.09 -37.32 84.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.917 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.648 ' CG1' HD13 ' A' ' 56' ' ' ILE . 38.2 t -57.5 -41.04 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.946 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.09 -13.13 58.05 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.6 tpt -84.11 -35.64 23.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.977 0.388 . . . . 0.0 111.507 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 m -51.85 154.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.985 0.422 . . . . 0.0 111.684 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.17 95.49 0.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.672 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.3 p -79.95 170.52 16.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.371 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.31 179.46 7.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 29.59 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.387 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -156.1 33.52 0.34 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 54.3 61.88 2.83 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.34 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.0 114.38 13.89 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.114 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.726 ' HG3' HD12 ' A' ' 56' ' ' ILE . 32.2 Cg_exo -61.99 117.41 4.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.849 2.366 . . . . 0.0 112.575 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.3 m -68.03 -34.26 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.334 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.3 179.54 7.43 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -105.79 80.66 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 20' ' ' MET . 32.6 t -98.94 115.62 39.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.658 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.415 ' CB ' ' HB3' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -149.96 175.14 11.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.553 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.64 ' HA ' HG22 ' A' ' 18' ' ' THR . 3.9 mt -109.8 148.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.69 -40.93 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.845 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 11.0 mttt -139.25 161.73 36.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.77 0.319 . . . . 0.0 111.298 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.53 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -156.57 110.14 2.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -128.69 166.84 21.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.93 174.71 11.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.905 2.403 . . . . 0.0 111.916 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.2 t -129.18 103.53 7.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.719 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.473 -179.851 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 CA--C 1.533 0.449 0 CA-C-O 121.05 0.354 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.69 161.46 13.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.331 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 27' ' ' LEU . 22.0 t -134.08 131.47 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.104 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -91.25 96.97 10.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.09 98.59 10.18 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.218 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -87.34 122.23 30.83 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.225 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -128.61 163.6 24.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.156 -179.279 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.8 t -68.18 -34.75 76.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.196 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.702 ' HG3' HG22 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.72 -30.81 70.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 18' ' ' THR . . . 168.16 -143.46 8.16 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.253 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.2 mt -140.86 135.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.854 0.327 . . . . 0.0 111.036 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 135' ' ' GLY . 16.6 pt -137.78 147.95 25.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.764 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.1 t -120.04 123.64 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.021 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.4 mm? -116.26 159.14 22.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.217 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -125.71 106.76 9.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 14' ' ' VAL . 5.3 mp -87.05 158.61 19.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.778 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 33.2 m-85 -102.86 102.5 12.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.236 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -81.25 23.25 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.14 -68.07 0.83 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.525 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.65 -14.11 18.27 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 178.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -97.29 1.39 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.7 Cg_exo -40.71 -37.46 2.28 Favored 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 121.952 1.768 . . . . 0.0 112.893 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -55.15 38.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.487 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.456 ' CG2' ' HB1' ' A' ' 32' ' ' ALA . 3.9 t -71.93 -34.97 69.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.797 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 2.1 m -56.97 -50.94 71.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.66 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -42.33 99.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -65.07 -48.23 74.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.206 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.39 -46.38 86.51 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.946 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.15 83.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.562 ' CB ' HD13 ' A' ' 77' ' ' ILE . 3.4 mm-40 -62.42 -43.97 97.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.058 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -58.26 -41.17 83.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.01 77.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.902 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -68.48 -41.22 80.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -28.55 68.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.554 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.25 28.88 4.47 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.775 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -51.14 5.35 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.573 0.225 . . . . 0.0 110.425 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 15.1 m-85 -77.3 -41.52 40.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.444 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -70.3 93.38 0.85 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.96 3.5 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.091 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.576 ' OG1' HD12 ' A' ' 159' ' ' ILE . 74.0 p -61.78 166.55 4.3 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.006 0.403 . . . . 0.0 112.004 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -137.01 25.77 3.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.939 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 159' ' ' ILE . 10.0 m-85 57.23 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 0.0 111.659 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -149.37 -65.84 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 56' ' ' ILE . 2.8 mtt180 -91.34 122.25 33.79 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.399 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.726 ' HA ' HG22 ' A' ' 62' ' ' ILE . 23.9 mm -131.21 84.3 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.102 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.555 HD12 ' CE ' ' A' ' 61' ' ' MET . 26.1 mt -89.86 88.94 2.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -24.23 60.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.744 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -91.43 25.59 2.55 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.85 -77.67 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 O-C-N 122.452 -0.155 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.555 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.32 178.79 9.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.631 0.253 . . . . 0.0 111.123 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 56' ' ' ILE . 4.0 pt -135.46 149.19 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -133.06 154.17 50.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 112.161 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.82 103.43 0.47 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.025 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.334 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.776 -179.673 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.605 0.241 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p -99.82 172.71 7.08 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.562 HD13 ' CB ' ' A' ' 41' ' ' GLU . 34.4 pt -57.4 -38.22 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.646 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -74.55 -46.19 40.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.6 -153.91 21.95 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.757 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -34.54 7.08 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.455 ' CB ' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER -141.58 109.87 5.92 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.675 0.274 . . . . 0.0 111.037 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -118.34 176.19 5.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.09 -177.91 0.41 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -113.86 176.94 4.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.463 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -130.75 110.31 11.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.369 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.02 129.09 9.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.417 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 0.7 OUTLIER -178.78 -53.51 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 87' ' ' HIS . 27.1 Cg_exo -61.94 171.82 4.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.659 2.239 . . . . 0.0 112.11 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.19 -75.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.75 HD22 HG21 ' A' ' 128' ' ' ILE . 0.4 OUTLIER 65.35 151.43 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -137.4 167.07 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.556 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -133.24 87.83 2.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.053 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.1 p -71.34 -27.78 63.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.82 -67.99 0.89 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.85 104.92 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.7 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.522 ' HA3' HD12 ' A' ' 136' ' ' ILE . . . 76.76 63.05 2.39 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.435 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 96' ' ' GLY . 33.9 mm -142.4 123.34 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.778 0.289 . . . . 0.0 110.559 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.616 HD22 ' HE2' ' A' ' 129' ' ' PHE . 3.0 mt -98.93 117.51 33.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 111.251 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -119.63 143.69 47.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.496 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.65 116.48 19.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.387 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB2' ' HD1' ' A' ' 113' ' ' PHE . . . -80.12 168.28 19.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.477 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -151.95 170.92 18.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -101.71 -49.07 4.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.649 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.02 -179.65 34.95 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.29 122.06 10.54 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.704 2.269 . . . . 0.0 111.908 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.32 31.33 17.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.188 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.455 HG23 ' CB ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -139.12 85.44 2.07 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.731 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -107.49 140.83 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.36 -152.14 16.02 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.781 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 p -117.73 38.78 3.52 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -111.25 150.71 29.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.154 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.12 146.14 42.48 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.675 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.659 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 31.9 p90 -129.27 130.36 46.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 114' ' ' VAL . 12.1 p -109.77 121.2 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.898 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 61' ' ' MET . 1.1 p -79.59 139.38 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.525 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -108.82 -31.16 7.8 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.663 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.1 153.89 37.73 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.036 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.48 122.71 10.71 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.681 2.254 . . . . 0.0 112.029 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.681 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 75.1 p -145.97 92.61 2.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.85 -4.51 52.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.717 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.681 ' CZ2' HG22 ' A' ' 119' ' ' THR . 22.9 p90 -82.18 -32.63 29.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.286 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.4 pp -83.49 0.53 45.98 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -60.32 87.09 0.01 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.354 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.12 -23.3 2.74 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.966 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -61.6 -65.8 0.64 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.917 0.359 . . . . 0.0 110.951 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -97.5 172.61 7.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.795 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.74 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 46.5 m -92.13 155.15 18.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.95 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.75 HG21 HD22 ' A' ' 90' ' ' LEU . 1.4 tt -98.97 -179.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.778 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.616 ' HE2' HD22 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -172.77 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.8 -179.78 19.82 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.928 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -136.17 172.59 12.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.711 0.291 . . . . 0.0 110.969 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.66 121.09 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.218 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 29.1 m -123.25 -59.0 1.6 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -113.91 93.7 4.49 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.532 ' O ' HG22 ' A' ' 23' ' ' ILE . . . 148.44 -17.43 1.3 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.386 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.522 HD12 ' HA3' ' A' ' 96' ' ' GLY . 15.2 tt -44.7 -34.75 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.008 0.404 . . . . 0.0 111.92 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.33 -42.23 82.22 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.769 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.75 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.4 ttp -60.79 -40.23 91.83 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.75 0.309 . . . . 0.0 110.476 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.645 HG13 HD11 ' A' ' 62' ' ' ILE . 22.9 t -70.53 -35.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.0 -46.43 74.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -58.4 -35.31 71.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.524 0.202 . . . . 0.0 111.262 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 138' ' ' MET . 33.4 t -58.42 -40.04 76.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.638 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.68 -37.97 38.46 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.464 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 mmt -60.76 -38.47 85.32 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.554 0.216 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.4 OUTLIER -62.64 166.65 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.366 -0.379 . . . . 0.0 112.015 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 145' ' ' VAL . 1.9 mt-10 -66.68 171.3 5.3 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.283 0.563 . . . . 0.0 110.968 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 154' ' ' VAL . 3.0 p -149.13 174.73 12.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.271 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -95.48 -176.33 3.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.6 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.9 m -92.76 35.09 1.05 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 111.279 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.27 37.12 0.12 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.459 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.16 41.84 31.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.215 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.93 126.06 29.84 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.056 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.534 ' HB3' HG13 ' A' ' 56' ' ' ILE . 33.8 Cg_endo -64.5 154.24 72.88 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.813 2.342 . . . . 0.0 112.776 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 147' ' ' THR . 40.0 t -103.93 -28.24 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.889 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.66 17.65 11.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 33.81 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.702 HG22 ' HG3' ' A' ' 20' ' ' MET . 11.0 t -80.24 97.52 3.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.0 tttp -102.4 130.56 49.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.422 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.576 HD12 ' OG1' ' A' ' 51' ' ' THR . 13.0 mt -104.68 135.59 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.647 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.56 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -134.26 2.48 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 22.3 mttt -154.37 131.99 11.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.643 0.258 . . . . 0.0 111.183 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.43 81.74 1.04 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.063 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -144.67 156.81 56.11 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.368 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.93 177.83 7.91 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.098 2.532 . . . . 0.0 112.195 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.43 119.36 17.4 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.112 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.514 179.841 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 CA-C-O 120.631 0.18 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -128.49 177.47 6.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.786 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.79 129.93 66.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.687 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.83 93.01 9.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.92 89.26 7.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.937 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 89.56 6.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.445 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 159' ' ' ILE . 1.2 p -95.21 164.11 12.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.147 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -66.89 -40.92 87.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.609 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.715 ' HB2' HG23 ' A' ' 157' ' ' VAL . 4.5 tpt -62.11 -30.91 71.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.21 -168.71 41.03 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.951 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.17 129.13 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.932 0.366 . . . . 0.0 111.075 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.605 HG22 ' CA ' ' A' ' 135' ' ' GLY . 11.6 pt -138.52 128.34 33.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.584 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.85 111.28 32.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.391 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.875 HD12 HG12 ' A' ' 132' ' ' VAL . 0.8 OUTLIER -103.4 154.44 19.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.196 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -112.2 133.37 54.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 4.5 mt -97.23 149.84 21.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.408 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.66 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 20.0 m-85 -92.24 90.66 7.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -80.47 23.6 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -100.44 -71.95 0.69 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.536 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.94 -13.67 18.21 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.664 178.81 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -100.15 1.36 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 43.5 Cg_exo -36.83 -37.39 0.31 Allowed 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.467 2.111 . . . . 0.0 113.375 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -60.67 3.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.781 0.324 . . . . 0.0 110.532 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.2 p -67.0 -34.69 78.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 96.6 m -58.94 -50.57 73.55 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -57.3 -40.31 77.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.284 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.451 ' OD1' HD11 ' A' ' 42' ' ' LEU . 14.9 t-20 -63.25 -53.09 58.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.568 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.725 ' HA ' HD12 ' A' ' 42' ' ' LEU . 20.5 t80 -56.76 -44.04 81.38 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.5 99.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.982 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.664 ' HB3' HG21 ' A' ' 77' ' ' ILE . 1.8 tt0 -64.7 -38.0 89.5 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.933 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 39' ' ' PHE . 9.2 mt -64.02 -39.55 94.34 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.971 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.88 74.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.115 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -72.83 -52.83 13.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.151 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.428 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.29 32.07 3.85 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.591 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -53.08 8.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.629 0.252 . . . . 0.0 110.386 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -64.81 -41.0 96.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.644 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -61.19 127.44 31.54 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.473 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 -32.02 8.03 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.604 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 170.12 15.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HB3' ' CB ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.46 159.23 43.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.925 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.472 ' CD1' HG12 ' A' ' 62' ' ' ILE . 58.6 m-85 -67.45 117.24 9.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.681 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.25 -61.57 1.67 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.289 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -88.97 123.37 33.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.072 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 153' ' ' PRO . 7.1 mt -142.07 112.29 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.297 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -93.89 121.02 44.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.065 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.23 123.7 18.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.13 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 t70 59.17 58.02 3.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.537 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.417 ' H ' HD21 ' A' ' 116' ' ' LEU . 15.6 t80 -166.66 -74.68 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.976 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.402 ' SD ' HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -160.11 177.46 10.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.224 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 62' ' ' ILE . 11.2 tt -151.15 101.91 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.544 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.9 tt0 -87.36 132.54 33.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.13 150.47 17.76 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.419 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.38 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.023 -179.744 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 p -101.28 169.79 8.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.664 HG21 ' HB3' ' A' ' 41' ' ' GLU . 3.9 pt -67.96 -29.95 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.866 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -81.65 -42.87 19.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.301 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.2 -138.56 2.65 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.725 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -61.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -160.72 161.16 32.13 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.731 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -137.03 177.36 7.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.21 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -87.11 176.94 7.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.092 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -92.74 179.25 5.54 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 127' ' ' THR . 0.4 OUTLIER -136.0 136.02 39.98 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.252 -179.674 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.05 129.37 9.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -62.48 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.47 ' HB2' HD12 ' A' ' 90' ' ' LEU . 41.1 Cg_endo -66.68 -14.48 44.09 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.755 2.303 . . . . 0.0 113.076 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 72.2 -67.99 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.477 0.311 . . . . 0.0 111.144 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HB3' HD13 ' A' ' 128' ' ' ILE . 1.7 mp 66.27 157.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.855 0.36 . . . . 0.0 111.57 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -58.72 145.67 39.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.379 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.6 29.16 0.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.618 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.5 t -137.43 -46.57 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.5 122.95 30.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.778 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.16 131.6 10.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.636 0.255 . . . . 0.0 111.671 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.582 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 100.81 59.93 0.81 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.868 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.706 HD12 HH11 ' A' ' 131' ' ' ARG . 14.6 mm -128.56 132.56 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.73 0.265 . . . . 0.0 111.039 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 114' ' ' VAL . 2.1 mt -109.67 103.65 12.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -111.48 140.21 46.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.398 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.7 108.72 13.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 113' ' ' PHE . . . -88.81 151.99 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.754 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -130.66 147.5 52.34 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.718 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.05 -73.68 0.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.252 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.61 176.14 19.91 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.435 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.3 135.93 38.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.359 2.04 . . . . 0.0 111.879 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.35 30.41 19.79 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.336 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.78 87.05 2.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.776 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -83.25 129.7 35.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.472 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.43 -116.84 4.25 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.832 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -154.22 32.06 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 111.463 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -95.33 163.16 13.37 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 2.6 p90 -159.03 124.29 4.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.3 p90 -110.97 135.1 51.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.809 ' CG1' HG11 ' A' ' 139' ' ' VAL . 3.5 t -100.88 105.53 17.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.881 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.39 125.58 31.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.283 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.627 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -116.24 -1.22 12.42 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.695 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.688 ' O ' HG23 ' A' ' 119' ' ' THR . . . -121.16 140.07 30.5 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -52.12 112.53 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.761 2.307 . . . . 0.0 112.212 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' ALA . 69.5 p -128.79 97.73 4.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.92 -32.06 15.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.332 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.6 p90 -60.02 -39.16 84.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.2 pp -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -63.83 85.52 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.42 -32.08 1.99 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.701 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -44.69 96.65 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.634 0.254 . . . . 0.0 111.128 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -104.02 150.15 24.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.625 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 87.2 m -89.37 151.74 21.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 90' ' ' LEU . 1.0 OUTLIER -80.9 -179.33 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.498 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -172.09 -42.26 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.04 173.35 30.55 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.855 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.706 HH11 HD12 ' A' ' 97' ' ' ILE . 7.6 tpp180 -140.84 148.64 40.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.592 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.875 HG12 HD12 ' A' ' 25' ' ' LEU . 17.7 m -89.98 114.01 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.671 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 27.0 m -95.48 -36.2 11.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -150.52 94.91 2.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.634 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.605 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 162.03 -19.24 0.18 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.828 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.532 ' HB ' HG21 ' A' ' 132' ' ' VAL . 10.5 tt -44.39 -34.61 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.457 0.628 . . . . 0.0 111.903 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.9 -25.15 52.35 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.024 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.488 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.6 ttp -86.11 -36.03 19.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.754 0.311 . . . . 0.0 110.329 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.809 HG11 ' CG1' ' A' ' 114' ' ' VAL . 21.9 t -72.42 -54.26 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.437 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -58.56 -30.69 67.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.575 0.226 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.56 -39.23 90.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.532 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.547 ' O ' HG22 ' A' ' 145' ' ' VAL . 17.8 t -65.87 -27.03 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.35 -30.78 24.01 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.158 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.31 -34.56 78.26 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.137 0.175 . . . . 0.0 111.45 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 142' ' ' VAL . 29.6 m -63.4 174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.828 0.347 . . . . 0.0 111.413 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.15 131.16 44.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.5 p -94.61 172.14 8.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.19 142.68 47.5 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.853 0.359 . . . . 0.0 111.646 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.19 -47.76 0.14 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.989 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 176.35 -32.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.593 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -169.54 36.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.478 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 116.05 65.57 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.78 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 56' ' ' ILE . 31.3 Cg_endo -64.82 111.28 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.596 2.197 . . . . 0.0 112.191 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.56 -33.86 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -168.25 1.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.587 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.09 100.04 7.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.748 0.309 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 20' ' ' MET . 9.6 p -118.7 115.17 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.708 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.432 ' CB ' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -154.4 176.21 12.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.318 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.574 ' HA ' HG22 ' A' ' 18' ' ' THR . 3.2 mt -110.45 130.0 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.6 pt -110.41 -34.35 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.506 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -147.04 140.11 25.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.76 0.314 . . . . 0.0 110.767 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.41 117.14 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.83 147.93 31.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.246 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.83 146.44 18.6 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.668 2.245 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.89 174.22 7.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.042 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.545 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 CA--C 1.529 0.259 0 CA-C-O 120.654 0.189 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -118.98 167.3 11.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.1 m -144.28 137.42 23.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.207 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CD2' HG22 ' A' ' 24' ' ' VAL . 18.9 m-85 -118.57 102.26 8.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.777 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mt -84.06 104.9 14.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -87.12 90.66 8.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.474 ' HB ' HG23 ' A' ' 159' ' ' ILE . 1.4 t -114.06 166.55 11.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -35.86 79.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.211 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.931 ' HB2' HG13 ' A' ' 157' ' ' VAL . 7.4 tpt -62.7 -28.23 69.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.115 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 152.45 5.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.954 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 17' ' ' GLU . 1.4 tp -79.64 122.75 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 117.078 0.439 . . . . 0.0 111.358 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -124.62 124.09 67.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 15' ' ' TYR . 20.8 t -98.66 120.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.976 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -110.61 147.73 33.64 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -102.37 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.519 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.548 HD11 ' CE1' ' A' ' 129' ' ' PHE . 3.8 mm? -81.35 132.18 35.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.468 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 79.0 m-85 -68.28 99.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -77.9 11.23 2.3 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 -69.18 0.78 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.701 0.286 . . . . 0.0 110.527 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 14.7 m-70 -100.82 -15.93 17.45 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.652 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.55 1.48 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 81.6 Cg_exo -42.81 -36.5 5.16 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.079 1.853 . . . . 0.0 113.081 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -62.91 -57.13 11.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.853 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -61.92 -36.98 82.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.03 -48.49 73.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -56.37 -39.08 72.35 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.465 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.81 -44.17 64.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -61.76 -45.38 94.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.63 80.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.59 -43.15 97.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.52 -35.39 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.069 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.64 81.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.528 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -92.6 -31.9 15.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.616 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -57.2 -31.69 65.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.6 26.13 4.92 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.982 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.2 -44.82 7.11 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.585 ' O ' HG22 ' A' ' 51' ' ' THR . 10.7 m-85 -82.25 -33.23 29.31 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.922 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.0 105.91 0.37 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.733 0.301 . . . . 0.0 110.501 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 21.96 6.19 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.895 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.69 ' CG2' HD12 ' A' ' 159' ' ' ILE . 7.6 t -98.55 173.44 6.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.144 0.472 . . . . 0.0 111.097 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.66 38.17 0.23 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.713 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.445 ' HB3' HD11 ' A' ' 56' ' ' ILE . 31.0 m-85 56.45 -177.58 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.413 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -151.11 -48.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.706 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.21 111.26 19.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.69 0.281 . . . . 0.0 110.624 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.803 HG23 HG22 ' A' ' 62' ' ' ILE . 32.6 mm -115.7 116.02 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.486 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.47 HD12 ' CE ' ' A' ' 61' ' ' MET . 33.0 mt -122.74 94.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.361 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -56.73 -27.5 59.34 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.517 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.37 31.47 2.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.734 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.74 -78.36 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.47 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.21 178.13 9.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 111.601 -179.345 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.803 HG22 HG23 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -132.81 104.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.311 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 11.1 tt0 -93.44 130.8 39.13 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.643 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.92 145.54 17.84 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.737 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.395 -179.005 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.717 0.294 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.3 p -96.24 -179.24 4.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.527 HD11 ' CZ ' ' A' ' 78' ' ' TYR . 1.2 pt -61.52 -28.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.484 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.527 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 62.8 m-85 -83.97 -43.71 14.92 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.87 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.81 -169.47 42.54 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.745 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -63.52 -45.38 90.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.559 0.219 . . . . 0.0 111.213 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.837 ' CB ' HG23 ' A' ' 107' ' ' THR . 2.9 pt20 -152.17 127.74 10.07 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.79 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -116.37 157.05 25.66 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.936 0.398 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -65.95 179.16 0.94 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -95.64 146.57 24.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.32 102.09 11.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.601 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tp -134.73 144.88 47.99 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.426 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 m-70 -158.3 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HB2' HD12 ' A' ' 90' ' ' LEU . 72.6 Cg_endo -74.43 158.1 44.61 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.676 2.251 . . . . 0.0 112.507 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.66 -49.03 43.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.238 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.665 HD22 HG13 ' A' ' 128' ' ' ILE . 0.2 OUTLIER 56.2 -170.92 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -159.7 35.97 0.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.556 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -126.97 -46.54 1.53 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.79 117.08 9.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.864 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 136' ' ' ILE . . . -45.35 134.24 6.76 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.62 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.523 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 98.38 60.32 0.91 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.726 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 96' ' ' GLY . 11.0 mm -128.36 160.23 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.568 0.184 . . . . 0.0 110.643 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.604 HD21 HG22 ' A' ' 114' ' ' VAL . 10.2 mt -133.96 115.95 14.99 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.947 0.403 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -118.14 139.95 50.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.335 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.431 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.82 113.56 18.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.406 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.64 170.37 10.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -142.66 151.44 41.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.82 -33.81 75.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.72 179.99 34.91 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.467 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.99 131.9 44.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.541 2.16 . . . . 0.0 111.72 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 p30 44.15 30.0 0.4 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.688 0.618 . . . . 0.0 112.0 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.837 HG23 ' CB ' ' A' ' 81' ' ' GLN . 50.2 m -136.59 85.81 2.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -83.89 162.17 20.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.63 -105.35 1.15 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.035 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m -155.89 40.55 0.38 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -109.41 161.27 15.46 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.187 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 7.6 p90 -159.98 125.91 4.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 50.5 p90 -112.85 133.76 54.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.281 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.604 HG22 HD21 ' A' ' 98' ' ' LEU . 40.6 t -94.81 111.29 25.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.63 103.42 9.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 58' ' ' LYS . 1.1 pp -95.23 -5.33 44.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.743 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.23 151.01 50.35 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.58 0.228 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 109.21 2.31 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.778 2.319 . . . . 0.0 111.931 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.441 ' OG1' HD21 ' A' ' 122' ' ' LEU . 72.1 p -133.91 100.96 4.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.23 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.1 -27.04 16.47 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.419 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -58.8 -27.33 64.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.54 0.21 . . . . 0.0 111.505 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.497 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.4 pp -98.03 0.2 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.85 84.56 0.03 OUTLIER 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 151.11 -30.95 0.98 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.837 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -67.41 -57.65 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.685 0.279 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -93.88 144.38 25.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.897 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.617 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 12.3 t -88.22 152.69 21.79 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.821 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 129' ' ' PHE . 3.3 mm -80.16 -179.32 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.406 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.71 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -173.26 -44.19 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.445 0.164 . . . . 0.0 111.179 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.0 179.7 20.36 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.729 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.96 153.65 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -101.69 87.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.32 -51.37 8.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.711 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 103.04 7.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 156.18 -23.75 0.52 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.196 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 95' ' ' ALA . 15.0 tt -47.49 -34.77 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -44.44 97.91 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.537 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.8 tpt -76.52 -46.41 26.68 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.555 0.217 . . . . 0.0 110.769 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 135' ' ' GLY . 19.9 t -56.49 -34.8 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.191 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -67.24 -39.64 86.22 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.674 0.273 . . . . 0.0 110.788 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -60.94 -28.64 69.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.198 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.2 t -58.36 -25.42 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.736 0.303 . . . . 0.0 111.03 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.66 -23.3 39.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.804 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -63.57 -27.01 68.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.772 0.286 . . . . 0.0 111.359 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER -64.53 173.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.478 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -86.58 133.72 33.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.57 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -100.81 178.07 4.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.656 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.55 29.03 8.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.376 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.21 24.53 8.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 111.198 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.93 33.83 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.184 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 58.33 44.15 18.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.389 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.52 90.33 37.65 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.458 ' HG3' HG13 ' A' ' 56' ' ' ILE . 36.8 Cg_endo -66.25 139.68 55.93 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.693 2.262 . . . . 0.0 112.437 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.84 -50.42 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.83 67.45 1.98 Allowed 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -51.32 156.31 1.22 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.757 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.931 HG13 ' HB2' ' A' ' 20' ' ' MET . 25.9 t -79.83 138.15 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.096 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.86 119.31 16.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 111.266 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.69 HD12 ' CG2' ' A' ' 51' ' ' THR . 12.0 mt -92.62 148.33 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.206 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -38.33 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.856 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -154.63 170.42 21.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.88 0.371 . . . . 0.0 111.343 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -132.7 134.57 44.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.639 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -107.85 93.72 11.14 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.71 104.74 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.468 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.2 t -71.49 78.94 0.78 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.397 -1.224 . . . . 0.0 112.459 -179.925 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 CA--C 1.53 0.323 0 N-CA-C 112.755 0.252 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -126.77 154.64 43.97 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.998 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.29 143.88 38.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.29 117.36 34.58 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.53 HD12 HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -98.47 99.77 10.97 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 105.24 17.45 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.392 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.56 ' HB ' HG23 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -114.92 167.74 10.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -21.48 52.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.644 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.807 ' HB3' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -95.6 28.2 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.995 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 18' ' ' THR . . . 119.03 -156.59 15.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.284 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -146.43 139.07 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.919 0.36 . . . . 0.0 111.021 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 25' ' ' LEU . 8.4 pt -139.34 133.69 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 111.642 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 t -108.13 113.77 44.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 23' ' ' ILE . 2.2 mp -112.57 138.41 49.38 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -103.64 130.15 51.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.869 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.724 HD12 ' SG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -97.51 131.8 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.593 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.608 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 22.9 m-85 -64.83 99.4 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.788 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -79.46 14.77 1.47 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -70.67 0.73 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.493 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 10.2 m-70 -100.88 -14.46 17.94 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.14 1.12 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.8 Cg_exo -40.79 -37.19 2.24 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.154 1.903 . . . . 0.0 112.974 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -55.3 36.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 110.442 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -64.9 -35.12 80.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.724 ' SG ' HD12 ' A' ' 27' ' ' LEU . 55.8 m -56.15 -50.2 71.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.299 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -61.11 -39.32 89.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -62.4 -59.06 5.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.929 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -40.84 84.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.53 67.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -64.22 -36.12 83.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.11 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -49.49 77.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.656 0.265 . . . . 0.0 110.657 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.95 64.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.23 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -46.09 50.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.312 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -60.14 -54.07 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.51 52.36 0.03 OUTLIER Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.788 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -125.63 -49.67 1.63 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.544 0.211 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.477 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -71.65 -45.29 62.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.177 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -56.17 118.64 4.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.23 32.37 20.27 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.697 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -100.23 -175.27 2.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -163.39 137.27 5.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HB3' HD11 ' A' ' 56' ' ' ILE . 39.9 m-85 -64.93 150.28 48.16 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.852 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -142.76 19.26 2.0 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.619 ' C ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -158.07 104.69 1.91 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.584 0.23 . . . . 0.0 111.155 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.949 HD13 ' HG3' ' A' ' 153' ' ' PRO . 2.7 mp -136.18 113.59 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.26 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.85 100.11 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 1.1 ttmt -59.12 145.23 43.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.68 36.09 2.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.092 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -169.53 -94.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.892 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -160.41 169.61 22.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 56' ' ' ILE . 33.9 pt -137.24 150.33 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.753 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 4.6 pm0 -126.26 145.61 50.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 111.324 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.57 159.79 13.62 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.604 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.411 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.896 -179.867 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.698 0.285 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.6 t -108.37 170.92 7.71 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 78' ' ' TYR . 19.5 pt -48.5 -45.05 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CD2' HG13 ' A' ' 77' ' ' ILE . 4.1 p90 -131.07 14.85 5.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.158 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -86.27 -136.57 4.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.372 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.84 -63.49 0.37 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.137 0.494 . . . . 0.0 110.364 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.59 100.91 2.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.508 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD1' ' HA2' ' A' ' 79' ' ' GLY . 27.9 p90 -154.31 179.4 9.02 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -101.87 115.54 30.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.848 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.21 165.92 16.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.136 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.15 128.56 38.04 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.357 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.2 136.68 49.92 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.045 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . 0.419 ' HB3' HD12 ' A' ' 90' ' ' LEU . 25.5 m80 -140.6 99.91 6.87 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.008 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.79 156.16 67.04 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 60.71 76.12 0.38 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -145.24 80.37 1.61 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.754 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.39 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.219 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.59 34.13 2.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.718 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -71.59 -36.27 70.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.344 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.05 160.34 12.74 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.3 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.99 94.74 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.866 0.365 . . . . 0.0 111.689 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 81.06 44.95 7.84 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.781 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 96' ' ' GLY . 33.6 mm -124.57 116.11 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.579 0.228 . . . . 0.0 110.855 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.557 HD22 HD22 ' A' ' 25' ' ' LEU . 25.1 tp -96.51 114.78 26.47 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.933 0.397 . . . . 0.0 111.097 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -114.07 150.38 34.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.319 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.403 ' HG3' ' CG ' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -79.45 125.27 29.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.592 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.54 151.77 28.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.71 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -130.16 146.71 51.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.403 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 107' ' ' THR . . . -91.17 -53.9 4.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.794 0.33 . . . . 0.0 110.592 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.12 179.99 35.29 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.502 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.63 116.85 3.57 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.475 2.117 . . . . 0.0 111.881 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.89 26.82 15.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.31 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 27.5 m -146.23 83.77 1.63 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.834 0.35 . . . . 0.0 110.889 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -101.18 156.29 17.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.354 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.65 -109.78 3.38 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.14 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.0 38.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 111.258 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -100.46 170.92 8.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -150.45 160.03 44.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 25.2 p90 -152.8 138.83 18.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 98' ' ' LEU . 17.6 m -103.69 134.7 44.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 117' ' ' ALA . 3.2 m -79.61 117.94 20.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.858 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -5.48 42.43 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.477 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 119' ' ' THR . . . -155.98 156.8 30.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.356 0.122 . . . . 0.0 111.147 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -51.38 120.23 6.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.911 2.407 . . . . 0.0 112.736 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.63 ' HB ' HD12 ' A' ' 122' ' ' LEU . 45.8 p -135.02 53.44 1.99 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.364 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -59.48 -35.75 74.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -66.62 -24.7 66.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.534 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.63 HD12 ' HB ' ' A' ' 119' ' ' THR . 2.4 mt -76.11 -2.78 32.6 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.55 85.36 0.07 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.095 0.474 . . . . 0.0 110.348 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.39 -44.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.736 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -64.63 -53.56 45.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.678 0.275 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -125.63 131.66 52.62 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.647 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 13.4 t -79.92 167.42 20.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.804 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.676 HG21 HD22 ' A' ' 90' ' ' LEU . 1.4 tt -79.56 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.699 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.581 ' CD1' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -177.8 -44.07 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.16 179.96 16.23 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.801 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.38 165.59 30.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.523 0.202 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.99 103.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.3 t -98.06 -51.24 4.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.798 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -123.3 98.39 5.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 23' ' ' ILE . . . 149.9 -17.72 1.08 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.386 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.9 tt -46.57 -33.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.65 88.66 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.308 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.419 ' HG3' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -60.17 -40.48 90.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.761 0.315 . . . . 0.0 110.274 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 114' ' ' VAL . 25.2 t -64.68 -41.43 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.901 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.92 -41.98 83.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -59.63 -33.89 72.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.128 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.569 HG12 HG12 ' A' ' 56' ' ' ILE . 10.6 t -60.25 -30.85 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.068 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . -89.05 -41.86 5.77 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.355 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.7 mmt -51.78 -34.69 40.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 142' ' ' VAL . 32.4 m -62.26 171.26 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.543 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 154' ' ' VAL . 1.1 tt0 -84.25 177.69 8.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.897 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -133.1 176.46 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -111.22 -165.52 1.0 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.68 36.73 0.9 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.77 29.34 0.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.866 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.43 39.2 23.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -121.77 146.06 44.83 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.785 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.949 ' HG3' HD13 ' A' ' 56' ' ' ILE . 66.6 Cg_endo -73.67 140.14 29.01 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.759 2.306 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 146' ' ' GLU . 4.3 m -58.85 -33.93 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.049 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.4 77.68 1.19 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.263 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.58 138.11 47.51 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.354 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' A' ' 20' ' ' MET . 21.7 t -80.05 126.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 114.27 23.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' HB ' ' A' ' 18' ' ' THR . 8.5 mt -91.01 144.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -133.73 8.57 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -157.57 140.83 15.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 111.304 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -153.91 101.08 2.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.941 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -151.33 155.93 34.76 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.479 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.11 149.17 19.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.862 2.375 . . . . 0.0 112.829 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -149.21 93.22 2.05 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.263 -1.299 . . . . 0.0 112.851 -179.869 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 29' ' ' TRP . 61.3 Cg_endo . . . . . 0 CA--C 1.534 0.499 0 N-CA-C 112.96 0.331 . . . . 0.0 112.96 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -87.8 146.37 25.65 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 m -134.43 149.84 30.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.56 123.53 50.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.356 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.767 HD12 ' CD1' ' A' ' 25' ' ' LEU . 1.3 mt -106.43 94.01 4.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 109.59 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.546 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 159' ' ' ILE . 31.3 p -118.29 156.83 28.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.632 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.6 t -57.93 -35.06 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.567 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.778 ' HB2' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.873 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.87 -159.4 31.5 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.358 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -125.93 124.48 66.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.922 0.361 . . . . 0.0 111.003 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.603 HG22 ' HA2' ' A' ' 135' ' ' GLY . 24.2 pt -123.74 130.89 73.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.72 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -92.87 121.97 43.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.767 ' CD1' HD12 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -123.23 154.87 38.18 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.303 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 130.32 56.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 92.3 mt -103.79 134.1 47.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.769 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.721 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 82.7 m-85 -77.18 98.46 5.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.613 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 39.9 p-90 -82.26 20.42 1.05 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -100.27 -68.98 0.79 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.5 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.34 18.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.139 179.347 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.76 1.01 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.6 Cg_exo -40.26 -40.02 2.81 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.296 1.998 . . . . 0.0 113.226 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.85 -53.75 54.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.561 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 m -70.81 -35.48 72.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.831 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 68.5 m -56.69 -53.59 56.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.539 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -44.02 96.46 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.369 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -55.47 -44.83 76.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -60.51 -58.05 10.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.239 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.77 96.63 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.609 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.625 ' HG2' HG21 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -56.86 -47.11 81.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.346 -179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -39.02 88.56 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.7 -28.14 36.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.636 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -50.11 55.75 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.557 0.217 . . . . 0.0 111.171 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.457 HH11 HG22 ' A' ' 77' ' ' ILE . 12.7 ptm180 -60.68 -33.78 73.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.31 52.44 0.45 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.667 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.18 -54.27 1.91 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.383 0.135 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -47.26 62.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -60.36 114.71 3.07 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.35 -26.86 3.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.675 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.674 HG23 HD12 ' A' ' 159' ' ' ILE . 14.2 t -72.67 -175.58 1.71 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.558 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -165.75 144.9 6.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.723 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -61.92 112.94 2.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.719 0.295 . . . . 0.0 110.716 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -88.29 -55.07 3.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.357 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 113.43 22.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.219 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.666 ' HA ' HG22 ' A' ' 62' ' ' ILE . 13.2 mm -120.21 84.89 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -91.76 90.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -62.8 153.08 34.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 t0 68.27 26.79 6.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.165 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -163.59 -85.27 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.507 ' HB3' HG23 ' A' ' 115' ' ' THR . 0.0 OUTLIER -160.24 169.59 22.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.421 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.666 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.9 pt -143.12 132.9 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.4 pt20 -118.19 150.46 39.37 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.325 0.583 . . . . 0.0 112.245 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.47 115.9 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.462 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.359 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.293 -179.115 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 t -84.01 -175.69 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.625 HG21 ' HG2' ' A' ' 41' ' ' GLU . 42.2 pt -71.8 -38.43 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.505 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -81.31 -31.22 33.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.196 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.27 -152.79 23.98 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -92.9 -45.52 7.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.324 . . . . 0.0 110.482 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.5 162.7 30.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.734 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.64 164.95 19.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.015 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -68.44 -178.12 1.05 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.434 ' OD1' HG21 ' A' ' 127' ' ' THR . 1.4 t70 -114.28 156.64 24.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.423 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.77 97.09 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.29 145.12 47.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -154.44 122.99 3.02 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.503 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.95 87.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.059 2.506 . . . . 0.0 112.867 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . 1.1 t70 -160.5 33.16 0.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.968 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD22 HG21 ' A' ' 128' ' ' ILE . 1.2 mp -143.02 -176.25 4.83 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.325 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptt -120.16 148.24 43.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.851 0.358 . . . . 0.0 111.512 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.524 ' CE2' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -136.9 79.82 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 179.671 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -31.01 49.19 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.323 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 112.77 -64.75 0.27 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.46 101.96 0.64 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.629 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.439 ' N ' HD12 ' A' ' 136' ' ' ILE . . . 83.25 69.92 1.37 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.977 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 96' ' ' GLY . 27.1 mm -132.62 137.09 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.654 0.227 . . . . 0.0 111.149 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.5 HD13 HG22 ' A' ' 132' ' ' VAL . 1.7 tp -112.73 94.93 5.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . 0.774 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -111.58 144.16 41.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.203 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 122.68 26.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.342 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.0 166.08 21.14 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.402 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -146.88 142.28 27.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.324 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.48 -40.99 18.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.394 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.55 179.79 34.9 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.619 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.73 122.57 11.21 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.552 2.168 . . . . 0.0 111.821 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.99 28.77 18.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.937 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.1 m -137.22 80.09 1.79 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 110.632 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -102.71 163.06 12.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.642 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.4 -127.46 2.77 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.6 m -135.71 41.3 2.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.953 0.406 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -108.48 161.31 15.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.74 161.35 42.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.774 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 24.3 p90 -137.52 130.45 30.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 111.298 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.521 HG13 HG21 ' A' ' 132' ' ' VAL . 10.9 t -101.2 107.77 22.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.085 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -79.78 138.94 37.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.522 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 pp -114.77 -17.88 11.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.553 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.602 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -112.99 162.96 19.3 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.483 0.182 . . . . 0.0 111.02 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.602 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 52.5 Cg_endo -68.52 122.64 9.63 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 112.762 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.537 ' CB ' HD12 ' A' ' 122' ' ' LEU . 77.9 p -147.15 70.23 1.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.827 0.346 . . . . 0.0 111.465 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.77 -38.81 92.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.903 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -62.47 -26.62 68.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.399 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.537 HD12 ' CB ' ' A' ' 119' ' ' THR . 2.1 mt -64.53 -16.44 62.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.586 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.89 81.98 0.2 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 110.0 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 169.6 -45.19 0.21 Allowed Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.358 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -70.73 -45.65 64.49 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.512 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -114.6 136.4 53.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.734 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 11.0 t -80.12 162.6 24.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.915 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.585 HG21 HD22 ' A' ' 90' ' ' LEU . 1.1 tt -87.85 -179.44 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.673 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -178.78 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.79 -179.71 27.67 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.76 161.72 33.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.822 0.344 . . . . 0.0 111.062 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.521 HG21 HG13 ' A' ' 114' ' ' VAL . 13.9 t -114.89 87.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.7 t -84.97 -36.4 21.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.52 101.27 3.85 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.016 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 158.81 -21.96 0.31 Allowed Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.343 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.7 tt -50.72 -30.88 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.988 0.394 . . . . 0.0 111.503 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.32 -13.83 63.24 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . 0.471 ' O ' HG23 ' A' ' 142' ' ' VAL . 4.8 ttp -97.35 -32.65 11.77 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.919 0.36 . . . . 0.0 111.077 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.503 HG21 HG11 ' A' ' 114' ' ' VAL . 3.0 m -81.03 -30.74 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -79.29 -33.82 42.98 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.394 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -64.78 -29.56 70.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 145' ' ' VAL . 19.8 t -56.91 -34.94 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.705 0.288 . . . . 0.0 110.895 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.23 -30.82 24.26 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.565 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.1 mtt -61.43 -27.38 68.51 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 145' ' ' VAL . 13.2 p -82.82 33.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 62.38 171.36 0.13 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.018 0.437 . . . . 0.0 111.529 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -147.33 172.4 13.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 1.4 m-20 -85.06 -176.48 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.8 p -90.52 34.46 0.89 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.409 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -164.53 36.83 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.897 0.379 . . . . 0.0 110.774 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.61 57.83 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.088 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.2 OUTLIER -126.66 133.74 25.33 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 133.84 23.28 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.518 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.57 -35.26 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.809 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 -173.4 4.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.6 104.4 13.09 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.228 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' A' ' 20' ' ' MET . 9.2 p -119.8 122.13 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -156.3 162.54 40.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.243 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.68 ' HA ' HG22 ' A' ' 18' ' ' THR . 24.3 mt -97.26 129.36 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.803 0.335 . . . . 0.0 111.245 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 26.7 pt -111.94 -36.53 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.042 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -145.24 150.52 36.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -157.51 88.71 1.01 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.122 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -126.3 153.76 74.63 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.851 0.358 . . . . 0.0 111.621 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.22 140.65 14.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 112.382 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.86 152.78 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.072 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.536 179.584 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.561 0.219 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.72 92.53 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.679 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -110.01 132.02 54.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.96 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 1.3 pt -94.63 99.41 4.01 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.769 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 4' ' ' ILE . 1.9 Cg_endo -45.06 -55.21 3.58 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.867 2.378 . . . . 0.0 112.849 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD3' ' HG2' ' A' ' 5' ' ' PRO . 58.5 Cg_endo -71.07 162.38 42.85 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.185 1.923 . . . . 0.0 112.111 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.59 169.03 19.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.112 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 p -139.16 126.71 21.77 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -99.08 -60.64 1.49 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 63.1 109.21 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.214 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.53 110.69 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.622 2.215 . . . . 0.0 112.198 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.84 12.78 2.93 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.748 2.298 . . . . 0.0 113.446 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.36 145.93 41.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.738 0.304 . . . . 0.0 110.97 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.31 138.18 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.4 ' CE1' HG22 ' A' ' 24' ' ' VAL . 2.2 m-85 -110.93 104.12 12.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.254 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.461 HD12 ' CD1' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -93.29 102.22 14.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.642 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HG2' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -79.9 83.35 5.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.39 148.65 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 t -58.16 -33.92 69.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.519 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.42 -41.27 85.14 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.341 . . . . 0.0 110.569 179.298 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.04 154.45 9.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.145 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.436 HD13 ' HG2' ' A' ' 17' ' ' GLU . 5.7 tp -80.27 136.24 23.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 111.46 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.624 HG22 ' HA2' ' A' ' 135' ' ' GLY . 9.1 pt -144.44 137.06 22.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.442 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 15' ' ' TYR . 16.6 t -94.84 143.08 12.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.84 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.62 HD22 HD22 ' A' ' 98' ' ' LEU . 2.0 mt -124.92 163.68 21.74 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.33 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.11 114.2 20.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.783 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 142.9 27.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.541 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 17.2 m-85 -92.32 97.24 10.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -78.81 14.83 1.21 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -66.51 0.9 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.501 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 8.8 m170 -100.67 -15.38 17.75 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.29 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.45 1.15 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.667 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 61.7 Cg_exo -39.48 -35.63 0.87 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 122.198 1.932 . . . . 0.0 113.33 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -63.26 1.22 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.773 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 129' ' ' PHE . 5.9 t -65.65 -36.1 82.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.684 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.2 t -55.22 -50.97 68.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.469 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -58.98 -40.29 84.37 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -51.22 64.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.845 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -43.1 90.8 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.039 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.79 72.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.85 -50.31 69.34 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.146 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -37.83 71.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.0 -31.98 56.88 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -75.57 -48.06 24.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.264 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -28.78 67.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.823 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.06 45.6 1.46 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -102.03 -45.87 5.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.583 0.23 . . . . 0.0 110.667 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -68.25 -30.65 69.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.221 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -59.31 113.36 2.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.059 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 -18.61 26.5 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.987 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -83.45 175.23 9.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.744 0.307 . . . . 0.0 110.926 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.442 ' H ' HG22 ' A' ' 51' ' ' THR . 33.4 pttt -154.51 173.21 16.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.488 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.49 120.72 26.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.131 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -98.62 -30.48 12.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.498 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.5 123.96 46.39 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.614 0.245 . . . . 0.0 110.627 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.923 HD12 ' HB3' ' A' ' 153' ' ' PRO . 55.5 mt -145.79 100.14 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.0 mt -90.81 118.59 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.586 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -56.46 123.84 16.11 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.191 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 6.5 t70 59.07 50.22 8.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.155 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.73 -84.61 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.78 171.41 18.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.348 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.699 HG22 HG23 ' A' ' 56' ' ' ILE . 1.8 pp -141.02 114.59 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.753 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.6 tt0 -93.75 134.79 35.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 111.617 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 112' ' ' PHE . . . -94.06 152.33 20.65 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.571 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.89 178.54 53.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.165 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 5.0 t0 -174.87 -58.54 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.995 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 73.6 Cg_endo -76.26 63.72 7.05 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.412 2.074 . . . . 0.0 111.781 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.475 ' O ' HG22 ' A' ' 68' ' ' THR . 12.4 m 65.5 12.62 8.31 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.535 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 70' ' ' THR . . . 57.83 13.75 14.09 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 121.209 -0.52 . . . . 0.0 113.777 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 69' ' ' GLY . 5.9 p -156.31 22.24 0.36 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.196 0.498 . . . . 0.0 111.731 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.9 30.76 45.91 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.222 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -55.0 4.26 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.692 0.282 . . . . 0.0 110.7 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.18 94.43 0.19 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.176 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.45 132.13 4.49 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.587 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.09 142.8 24.62 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.878 0.37 . . . . 0.0 111.463 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 t -81.18 157.38 25.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.847 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.9 pt -58.44 -36.64 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.372 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.63 -31.41 57.37 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.48 -155.71 27.22 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.567 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -78.36 -55.48 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.674 0.273 . . . . 0.0 110.792 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -135.18 146.15 48.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.808 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -133.14 179.48 6.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -77.91 134.12 37.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.545 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.89 137.09 33.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.281 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.54 40.58 1.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.59 ' HA ' HG23 ' A' ' 127' ' ' THR . 4.8 tp -80.14 133.69 36.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.614 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.39 118.08 3.53 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.694 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.92 101.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.28 -46.02 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.931 ' HB3' HD13 ' A' ' 128' ' ' ILE . 2.8 mm? -86.74 177.25 7.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 93' ' ' THR . 6.2 tttt -149.79 150.46 32.04 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -112.99 61.34 0.64 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.226 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.412 HG22 ' HG2' ' A' ' 91' ' ' LYS . 15.0 t -126.11 -46.59 1.66 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -61.98 112.3 4.71 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.89 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 136' ' ' ILE . . . -45.32 120.37 2.45 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.561 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 105.64 64.93 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.089 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 114' ' ' VAL . 7.3 mm -133.4 157.05 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.807 0.304 . . . . 0.0 111.382 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.62 HD22 HD22 ' A' ' 25' ' ' LEU . 1.6 tp -118.89 101.16 7.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.784 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.662 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -104.8 141.12 37.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.232 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.46 127.95 32.76 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.854 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -130.48 177.25 7.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -121.83 -51.91 2.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.85 -179.45 34.66 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.473 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -50.96 117.28 3.22 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.643 2.229 . . . . 0.0 112.052 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 61.64 31.13 18.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.993 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -138.26 94.89 2.92 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.458 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.7 150.08 30.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.935 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.08 -146.11 12.15 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 26.45 5.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.671 0.272 . . . . 0.0 111.474 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -90.5 165.44 13.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CE1' ' HA3' ' A' ' 64' ' ' GLY . 9.5 p90 -154.25 127.31 8.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.785 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 26.6 p90 -124.55 135.1 52.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.356 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 97' ' ' ILE . 10.0 p -108.2 121.58 61.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.727 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.7 p -80.43 119.05 22.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 116' ' ' LEU . 4.6 pp -97.94 -7.87 29.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.826 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.65 148.4 65.44 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.465 0.174 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.82 132.61 50.39 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.889 2.393 . . . . 0.0 112.341 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.446 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.0 p -144.98 107.59 4.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 111.418 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -96.67 -30.39 13.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.462 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.446 ' CZ2' HG22 ' A' ' 119' ' ' THR . 22.0 p90 -61.12 -40.87 95.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.687 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.59 0.43 57.43 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.82 81.21 0.02 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 110.885 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.03 -23.68 2.42 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.809 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -57.03 -56.28 23.86 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.58 0.228 . . . . 0.0 111.295 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -98.24 179.14 4.84 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.662 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 25.4 m -107.96 158.67 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.769 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.931 HD13 ' HB3' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -90.29 -179.01 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.511 179.376 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.483 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -177.45 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.35 179.98 25.7 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.817 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -136.9 158.59 44.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.661 0.267 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.512 ' CG2' HD13 ' A' ' 98' ' ' LEU . 19.5 t -118.18 84.12 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -77.41 -56.66 4.36 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.423 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -109.01 93.1 4.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.888 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 159.57 -22.48 0.28 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.233 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 95' ' ' ALA . 10.5 tt -46.47 -34.41 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.51 -45.52 96.12 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.404 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.588 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -62.31 -33.77 75.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.72 0.295 . . . . 0.0 110.615 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.464 HG11 ' CG1' ' A' ' 114' ' ' VAL . 21.1 t -76.22 -35.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.806 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -55.1 -51.55 66.03 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.84 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.805 ' O ' HG13 ' A' ' 145' ' ' VAL . 16.8 ptp180 -57.64 -37.3 73.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.015 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 145' ' ' VAL . 38.0 t -59.75 -28.45 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.102 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.63 -30.98 13.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.144 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 mtt -76.62 -24.28 53.37 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 141' ' ' ARG . 33.6 m -60.53 176.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.782 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 130.44 37.17 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.5 p -119.83 172.95 7.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 3.8 t-20 -82.97 -171.03 3.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.511 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.1 m -92.17 28.21 1.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.699 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -155.36 -72.14 0.12 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.84 41.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.035 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.418 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -116.18 123.85 30.36 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.443 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.923 ' HB3' HD12 ' A' ' 56' ' ' ILE . 41.8 Cg_endo -69.16 119.65 6.61 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.735 2.29 . . . . 0.0 112.425 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.43 -32.95 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.769 0.319 . . . . 0.0 110.496 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.88 -167.11 1.15 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.552 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.52 112.94 20.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 111.451 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.519 HG13 ' HB2' ' A' ' 20' ' ' MET . 36.9 t -133.55 126.5 51.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.341 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.75 174.05 15.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 111.607 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mt -108.08 135.78 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.0 pt -107.31 -33.32 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.493 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -170.59 159.32 6.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.71 0.29 . . . . 0.0 110.903 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -148.95 135.24 19.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.95 144.68 16.98 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.59 152.56 22.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.364 2.042 . . . . 0.0 112.162 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 m -63.07 150.94 41.36 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.997 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.375 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.594 0.235 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.03 145.73 49.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.201 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.69 14.51 7.28 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.031 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 mt -149.13 63.94 7.07 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.522 0.201 . . . . 0.0 110.666 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.63 107.58 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.659 2.24 . . . . 0.0 112.328 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.05 95.65 0.96 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.772 2.315 . . . . 0.0 112.553 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t70 69.47 152.94 0.1 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.324 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -117.22 134.92 54.22 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.847 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -166.36 118.48 1.02 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.143 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -135.26 92.82 17.44 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.693 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.86 104.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.914 2.409 . . . . 0.0 112.534 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.45 -51.56 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.954 2.436 . . . . 0.0 112.406 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -112.16 176.84 4.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.048 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 164' ' ' PRO . 39.2 t -143.44 129.87 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -93.72 101.5 13.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.704 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.566 HD21 ' CE2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -87.91 90.87 8.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.155 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.17 101.39 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.208 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 159' ' ' ILE . 1.2 p -110.0 165.18 11.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -33.01 71.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.666 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.04 -32.75 69.57 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.5 -145.44 8.02 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.447 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -143.22 130.01 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.228 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.511 HG22 ' CA ' ' A' ' 135' ' ' GLY . 33.4 pt -134.26 134.11 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.964 0.412 . . . . 0.0 111.63 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.17 117.22 43.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.504 HD13 HD12 ' A' ' 16' ' ' LEU . 7.1 mp -98.1 148.31 23.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -117.13 100.82 7.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.554 HD13 ' SG ' ' A' ' 36' ' ' CYS . 37.5 mt -83.13 137.54 34.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.493 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 26.3 m-85 -71.08 98.15 1.6 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.961 0.41 . . . . 0.0 110.818 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.431 ' CE3' ' HD2' ' A' ' 30' ' ' LYS . 2.2 p-90 -79.05 11.51 2.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.494 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' CE3' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -100.41 -69.36 0.77 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.683 0.278 . . . . 0.0 110.851 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.516 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -100.75 -17.0 17.14 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.655 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -96.87 1.06 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.8 Cg_exo -42.0 -35.57 3.23 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 121.937 1.758 . . . . 0.0 112.875 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -59.27 -59.54 5.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.686 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 p -64.19 -34.38 77.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.569 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.554 ' SG ' HD13 ' A' ' 27' ' ' LEU . 19.3 t -57.15 -47.61 80.76 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -61.14 -40.82 95.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -61.37 -41.46 97.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -38.6 74.14 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.71 55.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.815 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' HG21 ' A' ' 77' ' ' ILE . 27.4 mt-10 -64.94 -32.62 74.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD12 ' OD1' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -54.79 -43.84 73.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.558 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -81.52 -31.81 32.61 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.199 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -49.14 66.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.558 ' HD2' HG22 ' A' ' 77' ' ' ILE . 36.4 mtp85 -59.58 -31.92 69.9 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.58 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.09 28.61 3.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.759 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -97.67 -31.25 12.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.607 0.241 . . . . 0.0 110.823 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.566 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -81.77 -57.34 3.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.065 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -63.51 124.9 22.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 110.453 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.75 -29.79 6.99 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.542 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.607 ' HB ' HD12 ' A' ' 159' ' ' ILE . 1.6 m -61.94 162.64 8.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.775 0.322 . . . . 0.0 111.256 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -136.54 33.76 2.73 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.069 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.609 ' HE2' HD12 ' A' ' 62' ' ' ILE . 9.2 m-85 59.86 179.09 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.637 0.256 . . . . 0.0 111.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -145.11 -70.96 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.601 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.528 ' O ' HD13 ' A' ' 56' ' ' ILE . 3.8 tpt180 -95.9 130.01 42.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 111.208 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.759 HG21 HG12 ' A' ' 142' ' ' VAL . 27.1 mm -133.07 92.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.961 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.554 HD12 ' HE2' ' A' ' 61' ' ' MET . 7.3 mt -95.3 117.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.149 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -76.05 150.32 37.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 61.89 31.2 18.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -160.41 -88.49 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.088 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.554 ' HE2' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.29 170.13 21.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 111.408 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.655 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -140.82 125.45 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.524 ' HG3' ' HE3' ' A' ' 61' ' ' MET . 3.0 mt-30 -94.1 157.0 16.29 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.052 0.454 . . . . 0.0 111.496 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.63 153.44 19.96 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.55 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.62 171.07 49.04 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.139 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.491 ' OD1' HD12 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -160.6 -64.71 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.274 . . . . 0.0 110.714 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 66' ' ' ASP . 86.4 Cg_endo -77.8 163.26 29.02 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.448 2.098 . . . . 0.0 112.888 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.442 HG22 ' HA2' ' A' ' 71' ' ' GLY . 4.6 m 57.29 37.59 28.24 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.244 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.2 -32.91 77.9 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.614 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 p -85.68 -34.09 21.38 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.606 0.241 . . . . 0.0 111.233 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 94.89 60.35 1.08 Allowed Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.328 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.21 -52.23 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.485 0.183 . . . . 0.0 111.147 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.56 140.79 16.3 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.734 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.11 87.16 0.33 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.554 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.73 156.7 41.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.593 0.235 . . . . 0.0 111.222 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.2 p -104.88 164.96 11.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.076 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.558 HG22 ' HD2' ' A' ' 45' ' ' ARG . 2.5 pp -66.06 -33.02 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.496 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -75.91 -30.66 58.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.38 -140.68 6.41 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.749 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.24 76.28 1.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.98 0.419 . . . . 0.0 110.475 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HB3' HG22 ' A' ' 107' ' ' THR . 54.9 mm-40 70.8 135.63 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.41 -175.36 4.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.181 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.83 -179.62 1.21 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.28 141.63 36.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.863 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -78.19 109.76 12.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.156 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tp -156.33 134.24 11.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.407 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.99 -62.39 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.1 151.95 50.31 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.526 2.151 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.03 89.57 1.46 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.702 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.656 HD13 HG22 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -78.24 -178.29 5.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.149 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.4 155.14 27.95 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.83 83.98 1.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.741 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.5 p -69.52 -34.82 74.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.91 6.17 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.662 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.87 117.23 34.41 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.808 0.304 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.781 ' HA3' HD12 ' A' ' 136' ' ' ILE . . . 67.09 59.89 6.52 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.741 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 96' ' ' GLY . 19.1 mm -140.32 144.73 27.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.565 0.221 . . . . 0.0 110.78 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.747 HD23 HG22 ' A' ' 114' ' ' VAL . 1.1 mt -116.49 127.4 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.798 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -127.64 142.62 51.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.339 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 104.28 10.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.02 179.49 5.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.244 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.86 176.51 12.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.28 14.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.578 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.06 149.94 21.61 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.71 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.67 141.64 34.06 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.883 2.389 . . . . 0.0 112.663 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 63.21 23.22 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 81' ' ' GLN . 0.2 OUTLIER -152.19 80.5 1.25 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 110.673 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -98.19 113.07 24.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.53 -107.38 0.17 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.241 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 1.6 m -149.44 25.43 0.87 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -90.64 163.82 14.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.237 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -151.93 175.66 12.26 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.798 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 15.7 p90 -152.7 124.06 7.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 111.43 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.747 HG22 HD23 ' A' ' 98' ' ' LEU . 5.6 t -89.65 111.95 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.058 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.4 ' OG1' ' HB ' ' A' ' 97' ' ' ILE . 81.9 p -79.68 120.67 24.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.416 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.55 -25.29 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.336 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.77 156.4 40.73 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.095 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.4 130.82 30.36 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.016 2.478 . . . . 0.0 113.043 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.3 p -148.41 62.95 1.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -83.4 -14.7 52.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.73 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -90.77 -25.92 19.73 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.68 0.276 . . . . 0.0 111.29 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.22 1.25 29.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.762 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.76 79.52 0.29 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.23 -37.71 0.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.677 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -67.77 -54.9 15.58 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.664 0.268 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -109.86 138.35 46.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.73 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.749 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 3.6 t -84.56 157.74 21.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.95 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.656 HG22 HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -79.72 -179.63 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.724 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.512 ' HE1' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -170.46 -42.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.186 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.72 177.97 25.64 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.728 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.17 153.95 42.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 132' ' ' VAL . 13.8 p -109.71 107.12 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.097 0.475 . . . . 0.0 111.408 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.67 -46.0 7.45 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -123.45 84.27 2.25 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.873 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.511 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 169.62 -23.98 0.1 OUTLIER Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.583 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.781 HD12 ' HA3' ' A' ' 96' ' ' GLY . 15.8 tt -41.34 -37.34 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.16 -43.7 96.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.602 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 ttp -65.67 -39.56 91.48 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.549 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.414 HG11 HG11 ' A' ' 114' ' ' VAL . 21.5 t -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -61.41 -32.21 72.15 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.909 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -33.56 71.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.964 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.759 HG12 HG21 ' A' ' 56' ' ' ILE . 19.8 t -57.85 -30.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.7 -31.88 10.79 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.234 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.5 mmt -58.52 -36.01 73.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.511 0.196 . . . . 0.0 111.358 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 142' ' ' VAL . 30.2 m -64.23 176.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.563 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -81.68 172.24 13.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.057 0.456 . . . . 0.0 111.005 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.22 171.49 15.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.29 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.29 -171.1 1.85 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.84 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 p -95.21 30.28 2.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -152.65 32.07 0.51 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.4 t0 55.47 68.76 0.82 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.816 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -150.72 114.48 3.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.737 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.403 ' HG3' HG13 ' A' ' 56' ' ' ILE . 56.0 Cg_endo -71.3 152.4 61.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.056 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 146' ' ' GLU . 36.2 t -69.89 -37.98 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.41 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.35 80.6 1.52 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.351 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.86 148.25 10.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.59 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.666 HG13 ' HB2' ' A' ' 20' ' ' MET . 8.3 t -82.71 141.24 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.147 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -126.15 152.73 45.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 111.384 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.607 HD12 ' HB ' ' A' ' 51' ' ' THR . 6.7 mt -115.05 140.85 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 25.1 pt -120.14 -37.8 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.051 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.53 165.1 28.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.962 0.41 . . . . 0.0 111.472 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.452 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -156.53 87.31 1.02 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.673 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -100.86 106.53 44.58 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.166 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.615 ' HA ' HG13 ' A' ' 14' ' ' VAL . 72.3 Cg_endo -79.74 93.23 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.656 2.237 . . . . 0.0 112.132 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.5 m -150.65 164.74 35.36 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.206 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.275 -1.291 . . . . 0.0 112.842 179.752 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.658 0.266 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.03 155.57 21.05 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.63 62.77 0.72 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.366 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 4' ' ' ILE . 2.2 tt -173.66 87.85 0.37 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 120.992 0.425 . . . . 0.0 111.576 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.472 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 44.2 Cg_exo -55.36 -49.0 17.68 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.662 2.241 . . . . 0.0 113.042 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 5' ' ' PRO . 94.9 Cg_endo -79.98 133.05 9.86 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.473 2.115 . . . . 0.0 112.404 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -119.83 169.78 9.83 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.348 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.82 157.06 17.58 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.081 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -129.89 -51.29 1.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.277 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.63 143.54 30.79 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.719 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.66 109.55 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.817 2.345 . . . . 0.0 112.569 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.42 -17.23 30.65 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.623 2.216 . . . . 0.0 112.841 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.43 158.64 16.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.707 0.289 . . . . 0.0 111.213 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 164' ' ' PRO . 23.7 m -141.24 135.9 32.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.981 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -92.54 113.14 25.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.62 HD12 HD13 ' A' ' 25' ' ' LEU . 3.2 mt -97.86 96.14 8.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.647 ' HG2' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.39 113.67 20.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.722 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.755 ' CG2' HG23 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -125.81 156.16 39.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.949 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.5 t -59.07 -33.55 70.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.07 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.628 ' HB2' HG13 ' A' ' 157' ' ' VAL . 8.0 tpt -69.97 -30.86 68.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.191 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.13 -161.54 34.03 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.647 HD12 ' HG2' ' A' ' 17' ' ' GLU . 2.1 tt -122.3 128.13 75.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 117.105 0.452 . . . . 0.0 111.202 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.442 HG22 ' CA ' ' A' ' 135' ' ' GLY . 16.3 pt -129.49 127.59 65.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.047 0.451 . . . . 0.0 111.898 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.49 121.08 51.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD22 HD22 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -127.9 157.96 39.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.222 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.8 150.61 23.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.73 135.75 54.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.775 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 44.6 m-85 -76.69 95.04 3.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.725 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -78.86 11.35 2.69 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.32 -61.87 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 122.179 -0.325 . . . . 0.0 110.957 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.515 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 21.0 m170 -100.6 -15.02 17.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.775 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.41 1.31 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 58.8 Cg_exo -38.96 -38.15 1.01 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.353 2.036 . . . . 0.0 113.156 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -61.36 -57.97 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.578 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.49 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -67.2 -35.22 79.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.752 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.2 m -55.2 -51.6 66.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.4 89.48 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.547 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.4 -50.77 72.48 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.745 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.75 -47.96 83.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.555 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.35 86.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.073 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -38.79 92.21 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.453 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -60.42 3.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.586 0.232 . . . . 0.0 111.381 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.35 98.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.679 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -48.6 72.28 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.327 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -61.8 -55.54 28.96 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.49 43.16 0.06 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.243 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -45.75 2.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.781 0.324 . . . . 0.0 110.566 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.06 -24.58 59.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.113 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.88 102.47 4.75 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.55 26.95 4.59 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.487 ' OG1' HD12 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -89.4 178.08 6.41 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.04 0.42 . . . . 0.0 110.952 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -157.02 134.8 10.87 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.954 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CD2' HG22 ' A' ' 62' ' ' ILE . 28.3 m-85 -69.3 124.09 22.92 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.11 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -100.73 -32.19 10.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.014 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -119.31 119.8 35.08 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.81 0.338 . . . . 0.0 111.228 -179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.609 HG12 HG23 ' A' ' 62' ' ' ILE . 29.0 mt -135.13 94.54 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.668 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.3 mt -83.35 108.8 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -63.99 145.34 56.04 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.36 30.77 20.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.321 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.3 -83.3 0.08 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.247 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.412 ' HB3' ' HA ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -160.45 168.29 25.45 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.471 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.609 HG23 HG12 ' A' ' 56' ' ' ILE . 3.7 mp -131.91 125.95 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.526 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 2.1 pt20 -112.83 138.83 49.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.289 0.566 . . . . 0.0 112.348 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.48 103.86 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.379 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . -129.26 -179.75 16.17 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.277 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -114.85 73.53 3.12 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.858 0.361 . . . . 0.0 110.815 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.26 -1.44 11.61 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.788 2.325 . . . . 0.0 113.425 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.4 m 60.01 33.18 21.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.717 0.294 . . . . 0.0 111.148 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.41 24.81 59.71 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.574 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.4 p -125.97 -45.53 1.72 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.029 0.414 . . . . 0.0 111.315 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.45 38.19 13.0 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.195 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -177.76 -46.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.622 0.248 . . . . 0.0 110.881 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.67 97.3 2.31 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.545 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.69 162.53 27.0 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.698 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.41 155.55 48.39 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.639 0.257 . . . . 0.0 111.497 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.0 p -129.4 172.81 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.62 -35.45 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.501 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -74.25 -33.59 63.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.247 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.72 -151.7 20.47 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.767 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -83.61 -52.09 6.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.727 0.263 . . . . 0.0 110.612 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -154.46 150.74 28.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.31 174.5 10.48 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.513 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.87 173.76 7.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.8 169.45 11.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.636 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -129.74 47.06 2.55 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 tp -68.68 145.51 53.81 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -162.79 86.7 1.38 Allowed Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.985 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.99 100.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.766 2.311 . . . . 0.0 112.26 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.71 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.939 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.762 HD22 HG21 ' A' ' 128' ' ' ILE . 4.9 mp -66.94 175.82 2.33 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.734 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -106.91 165.14 11.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.42 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.86 70.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 97' ' ' ILE . 25.7 p -57.3 -30.34 64.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.703 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 102.69 -48.1 1.07 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.649 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.0 109.64 18.34 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.296 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.553 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 79.03 63.85 2.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.784 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 96' ' ' GLY . 10.5 mm -131.94 152.46 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.751 0.276 . . . . 0.0 111.312 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.729 HD22 HD22 ' A' ' 25' ' ' LEU . 4.7 tp -131.28 101.7 5.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.702 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -110.13 144.38 38.83 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.28 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.49 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.73 106.69 11.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.632 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.33 151.28 23.24 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.548 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -123.09 157.39 32.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.44 63.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.08 179.63 35.49 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.353 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.39 125.95 17.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.582 2.188 . . . . 0.0 112.007 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.1 30.13 19.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.9 m -142.6 91.03 2.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -96.99 155.11 16.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.162 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.32 -151.72 5.48 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.849 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 m -104.16 64.95 0.78 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.521 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -141.42 146.54 36.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -151.08 166.02 32.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.488 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.677 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 30.2 p90 -137.76 142.46 40.94 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.689 HG22 ' CD1' ' A' ' 98' ' ' LEU . 5.3 t -111.23 106.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 3.3 p -80.32 134.78 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.552 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.38 -27.6 8.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.47 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.76 151.56 39.35 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.655 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 66.0 Cg_exo -52.38 130.1 34.5 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.809 2.34 . . . . 0.0 112.484 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.9 t -161.07 77.72 0.57 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 111.197 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.07 -3.73 52.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -89.54 -27.22 20.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.079 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -21.16 66.27 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.286 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -66.82 84.75 0.12 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.203 0.525 . . . . 0.0 110.314 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.15 -47.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.035 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -80.17 -35.36 36.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.467 0.175 . . . . 0.0 110.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -122.31 134.51 54.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.802 0.334 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.702 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 31.8 m -80.88 161.12 24.53 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.762 HG21 HD22 ' A' ' 90' ' ' LEU . 1.5 tt -79.54 -179.24 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.456 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.549 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -176.69 -39.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.26 -179.97 26.51 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.85 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -148.81 148.84 30.4 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 122.78 -0.247 . . . . 0.0 110.654 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.531 HG21 ' HB ' ' A' ' 136' ' ' ILE . 10.4 m -79.13 136.77 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 111.552 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 7.2 t -118.78 -47.06 2.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -142.56 80.93 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.999 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.442 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 176.03 -21.6 0.05 OUTLIER Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.116 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.531 ' HB ' HG21 ' A' ' 132' ' ' VAL . 14.6 tt -40.85 -38.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.19 93.89 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.555 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.424 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.9 ttp -59.78 -41.61 91.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.773 0.32 . . . . 0.0 110.379 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.18 -44.87 84.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.582 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -61.83 -40.84 96.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -56.5 -40.78 75.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 20' ' ' MET . 17.6 t -56.97 -38.29 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.291 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.84 -29.96 16.54 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.625 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 79.1 mmm -66.53 -16.92 64.51 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.456 ' O ' HG21 ' A' ' 154' ' ' VAL . 16.2 m -88.2 19.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 165.22 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.4 p -144.18 174.55 10.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.489 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -172.69 3.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.9 m -93.55 33.74 1.24 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.92 31.94 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.478 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 52.7 51.22 16.45 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -123.3 143.49 41.29 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.822 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.503 ' CB ' HG23 ' A' ' 157' ' ' VAL . 60.6 Cg_endo -73.21 141.78 32.9 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.68 2.254 . . . . 0.0 112.531 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 145' ' ' VAL . 6.4 m -78.89 -35.4 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.888 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.17 11.46 38.25 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.13 138.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.268 0.556 . . . . 0.0 112.295 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 20' ' ' MET . 38.4 t -128.74 132.89 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.693 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' HG2' ' N ' ' A' ' 159' ' ' ILE . 2.5 tttp -144.17 156.68 44.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.795 0.331 . . . . 0.0 111.408 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.755 HG23 ' CG2' ' A' ' 18' ' ' THR . 7.2 mt -110.82 120.46 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.436 HD11 ' CD ' ' A' ' 17' ' ' GLU . 31.8 pt -81.67 -43.47 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -175.21 174.31 2.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.511 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -150.78 133.61 15.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -152.29 157.26 33.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.116 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.437 ' HA ' HG12 ' A' ' 14' ' ' VAL . 72.1 Cg_endo -79.34 148.86 21.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.261 1.974 . . . . 0.0 112.1 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.5 m -61.94 147.47 46.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.695 -1.059 . . . . 0.0 112.857 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.407 0.146 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.16 -75.33 0.26 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.192 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.57 131.58 4.21 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.72 0.295 . . . . 0.0 111.253 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.482 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 11.5 mm -79.59 -49.79 1.34 Allowed Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.506 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 97.9 Cg_endo -81.55 128.34 6.07 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.354 2.036 . . . . 0.0 112.784 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.93 -174.12 1.81 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.666 2.244 . . . . 0.0 112.494 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.6 104.13 6.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.84 0.352 . . . . 0.0 111.344 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 p -74.61 -35.42 62.93 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 69.73 154.06 0.12 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.527 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.25 139.25 84.27 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.975 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.37 157.22 29.27 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.551 2.167 . . . . 0.0 112.368 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.41 62.1 3.52 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.225 2.617 . . . . 0.0 112.155 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -126.17 160.16 30.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.7 154.84 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -114.04 111.3 21.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.218 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -92.26 109.08 20.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 2.9 mm-40 -81.15 112.59 18.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.863 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.77 145.09 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.5 t -56.71 -36.31 69.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.027 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.899 ' HB2' HG23 ' A' ' 157' ' ' VAL . 1.2 tpt -65.71 -29.15 69.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.742 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' HA3' ' HG2' ' A' ' 138' ' ' MET . . . 153.46 150.48 5.46 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.204 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 tt -80.32 139.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.758 0.279 . . . . 0.0 111.031 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.572 HG22 ' CA ' ' A' ' 135' ' ' GLY . 10.8 pt -145.93 133.47 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.753 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.32 137.71 21.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 16' ' ' LEU . 3.2 mt -129.94 147.82 51.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.77 113.19 26.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.776 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 mt -96.87 119.14 34.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.787 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 29.4 m-85 -66.67 102.91 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -80.62 12.34 3.18 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -61.82 1.32 Allowed 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.834 0.35 . . . . 0.0 110.623 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.502 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 62.2 m170 -100.75 -15.5 17.65 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.564 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.66 0.98 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.0 Cg_exo -40.77 -35.31 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.286 1.99 . . . . 0.0 113.137 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -60.02 3.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.628 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.67 HG21 ' HG3' ' A' ' 100' ' ' MET . 26.8 m -67.28 -43.61 81.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.851 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.8 t -54.69 -47.52 73.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -59.17 -48.95 79.73 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.271 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -60.98 -43.41 98.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.125 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.11 -56.42 21.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.999 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.9 94.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.262 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.31 -46.33 83.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -36.8 77.65 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.095 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.58 -48.92 68.06 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.74 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -35.03 79.54 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.974 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -36.81 84.95 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.232 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.5 41.17 1.65 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.401 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -113.34 -47.49 3.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.463 0.173 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.13 -32.33 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.055 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 112.39 8.3 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.686 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.97 -23.76 11.32 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.099 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -68.54 178.48 2.02 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.073 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 157' ' ' VAL . 0.3 OUTLIER -156.91 159.6 38.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.161 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -74.06 129.6 38.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -106.63 -36.56 6.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.441 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 119.1 37.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.574 HG12 HG23 ' A' ' 62' ' ' ILE . 22.1 mt -139.4 130.82 34.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.17 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.452 HD12 ' CE ' ' A' ' 61' ' ' MET . 17.7 mt -114.87 120.53 64.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.039 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.26 142.5 52.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.226 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 29.73 19.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.861 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.39 -85.13 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.877 -0.147 . . . . 0.0 111.306 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.452 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.65 173.32 15.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.429 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.574 HG23 HG12 ' A' ' 56' ' ' ILE . 3.7 mp -133.31 119.97 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.577 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.8 pt20 -106.75 143.96 34.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.83 124.75 2.65 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.71 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.39 -179.63 35.29 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.187 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.11 55.94 0.56 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 111.641 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' HA ' HG21 ' A' ' 51' ' ' THR . 90.1 Cg_endo -79.22 58.76 7.1 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.717 2.278 . . . . 0.0 112.227 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.596 HG21 ' HA2' ' A' ' 74' ' ' GLY . 61.8 p -120.02 -71.44 0.74 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.25 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.97 27.78 69.29 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.823 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -89.93 -36.3 15.08 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.653 0.227 . . . . 0.0 111.505 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.14 -37.57 3.65 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.459 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -62.32 1.44 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.514 0.197 . . . . 0.0 111.128 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.29 173.58 36.91 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.707 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.596 ' HA2' HG21 ' A' ' 68' ' ' THR . . . -138.91 107.8 0.58 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.616 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.91 144.4 31.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 p -78.26 174.95 10.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.74 -31.4 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -79.67 -69.44 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.451 0.167 . . . . 0.0 110.945 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.08 158.46 30.79 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -33.51 72.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.25 140.96 26.9 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.691 0.282 . . . . 0.0 111.077 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -156.85 172.17 19.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.357 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.13 179.31 0.96 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.443 ' OD1' HD12 ' A' ' 86' ' ' LEU . 2.5 p30 -101.26 179.84 4.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.996 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -129.74 36.54 4.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.443 HD12 ' OD1' ' A' ' 84' ' ' ASP . 6.6 mt -57.52 146.77 28.86 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.511 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.79 145.68 17.99 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 68.57 5.26 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.614 2.209 . . . . 0.0 112.631 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.601 ' HB3' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -165.46 172.98 11.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.104 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 1.042 HD22 HG21 ' A' ' 128' ' ' ILE . 3.9 mp 64.38 172.65 0.19 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.658 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 163.64 10.22 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.993 0.425 . . . . 0.0 112.006 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HE2' ' HB2' ' A' ' 99' ' ' ALA . 1.2 m-85 -116.76 87.43 2.69 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.147 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -127.93 -52.45 1.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.609 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.25 7.35 68.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.147 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.02 -169.6 0.2 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.634 0.373 . . . . 0.0 111.191 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.49 47.58 90.44 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 30.5 mm -120.45 154.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.74 0.305 . . . . 0.0 111.089 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.508 HD13 HD22 ' A' ' 25' ' ' LEU . 1.1 tp -124.42 104.03 8.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.036 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -116.57 140.16 49.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.575 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.67 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.56 121.09 24.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.309 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 113' ' ' PHE . . . -110.9 172.2 7.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.378 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -150.7 152.94 34.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.99 78.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.36 176.05 33.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.183 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.47 125.03 15.84 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.537 2.158 . . . . 0.0 111.948 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.23 36.44 17.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -147.54 83.41 1.54 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.908 0.385 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.38 168.65 10.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.41 46.08 0.46 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.901 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t 55.48 37.01 28.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.294 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 161.61 14.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -160.29 173.47 15.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.638 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 21.7 p90 -148.24 132.15 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.0 111.399 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.618 HG21 HG11 ' A' ' 139' ' ' VAL . 14.1 p -103.06 120.39 52.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.588 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 92' ' ' PHE . 17.5 p -79.49 129.81 34.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.501 ' C ' HD12 ' A' ' 116' ' ' LEU . 4.1 pp -109.61 -10.7 14.83 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.897 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -136.47 164.33 43.49 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 120.509 0.195 . . . . 0.0 111.298 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 36.7 Cg_endo -65.94 119.97 7.07 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.609 2.206 . . . . 0.0 111.434 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 71.9 p -136.43 103.39 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.675 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.536 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -60.09 -41.57 92.79 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.605 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.6 pp -86.89 0.17 55.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.453 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.85 84.04 0.31 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.825 0.345 . . . . 0.0 110.717 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.54 -29.59 2.25 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.076 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -57.9 11.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.605 0.24 . . . . 0.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -95.77 159.19 15.1 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.737 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 6.7 t -93.59 161.3 14.41 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.042 HG21 HD22 ' A' ' 90' ' ' LEU . 3.3 mm -89.04 -178.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.289 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.7 ' H ' HG22 ' A' ' 128' ' ' ILE . 2.4 p90 -178.96 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.485 0.183 . . . . 0.0 111.346 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.66 -179.64 19.62 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.48 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.38 162.22 38.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.614 0.245 . . . . 0.0 110.986 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 25' ' ' LEU . 13.0 t -116.47 121.27 67.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.825 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.3 t -115.35 -63.81 1.4 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.93 91.5 3.68 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.803 0.335 . . . . 0.0 110.311 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.572 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 155.2 -22.16 0.58 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.193 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.519 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -44.88 -36.2 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -53.79 -42.52 68.9 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.707 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.464 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 7.1 tpt -75.17 -43.67 50.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.564 0.221 . . . . 0.0 110.698 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.618 HG11 HG21 ' A' ' 114' ' ' VAL . 15.4 t -54.49 -35.95 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.923 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -61.67 -39.34 91.04 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.911 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HB2' ' HE3' ' A' ' 138' ' ' MET . 0.5 OUTLIER -59.55 -38.21 80.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.015 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.421 HG22 ' HG2' ' A' ' 20' ' ' MET . 19.2 t -58.08 -31.15 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.756 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.466 ' HA3' HD22 ' A' ' 116' ' ' LEU . . . -92.14 -38.49 5.68 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.042 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.2 tpt -53.02 -34.58 57.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.473 0.309 . . . . 0.0 111.692 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 m -59.48 168.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.895 0.379 . . . . 0.0 111.469 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.679 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -104.35 148.01 26.87 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -96.83 165.36 12.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.92 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 6.9 m120 -136.0 146.75 47.52 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.88 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.26 -46.43 0.13 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.004 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -173.47 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -176.84 38.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.6 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 148' ' ' ASN . 6.9 mtt180 -101.09 123.03 46.48 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.718 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 56' ' ' ILE . 29.4 Cg_endo -63.36 132.41 35.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.803 2.335 . . . . 0.0 112.563 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 146' ' ' GLU . 41.3 t -70.23 -42.81 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.709 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.42 115.02 17.84 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.18 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.18 96.17 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.5 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.899 HG23 ' HB2' ' A' ' 20' ' ' MET . 12.5 p -90.41 139.42 17.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.98 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 52' ' ' LYS . 18.2 pttt -154.7 155.64 34.97 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.213 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 mt -96.69 145.99 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.889 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.07 -52.12 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 44.4 mtpt -144.43 171.57 14.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.35 104.79 1.66 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.086 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.06 154.66 77.67 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.311 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.15 172.24 13.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.618 2.212 . . . . 0.0 112.581 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.25 -33.84 11.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.252 -1.304 . . . . 0.0 112.582 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.522 0.201 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.62 92.89 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.452 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.09 -50.66 0.23 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.314 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 mt -111.01 93.0 16.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.03 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.17 155.47 69.32 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.695 2.264 . . . . 0.0 112.349 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.43 -31.51 34.25 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.52 2.147 . . . . 0.0 112.247 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -116.7 175.98 5.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 110.919 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.39 -55.22 2.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER 64.67 162.05 0.12 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.28 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -132.29 81.08 61.89 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.218 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HB2' ' HD3' ' A' ' 12' ' ' PRO . 45.4 Cg_exo -54.7 -47.84 24.54 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.686 2.257 . . . . 0.0 113.055 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 11' ' ' PRO . 84.7 Cg_endo -81.26 80.99 2.8 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.486 2.124 . . . . 0.0 112.327 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.78 99.93 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.25 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 m -94.37 146.97 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.271 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.495 ' HE1' ' HG ' ' A' ' 165' ' ' SER . 6.6 m-85 -121.01 108.72 14.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.242 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.79 104.94 17.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 110.991 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CB ' ' HG2' ' A' ' 161' ' ' LYS . 0.5 OUTLIER -79.94 97.06 6.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.625 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.53 HG22 HG12 ' A' ' 159' ' ' ILE . 1.9 p -106.43 160.18 15.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -63.71 -36.97 85.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.607 179.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.655 ' CB ' HG13 ' A' ' 157' ' ' VAL . 9.4 tpt -64.66 -32.24 73.82 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.09 -163.91 37.47 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.046 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 22' ' ' ILE . 10.8 tt -122.06 118.82 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.003 0.402 . . . . 0.0 111.342 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.478 HG23 ' SD ' ' A' ' 138' ' ' MET . 26.9 pt -116.01 158.19 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 15' ' ' TYR . 18.8 t -122.97 120.64 61.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.931 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 98' ' ' LEU . 5.2 mt -115.01 155.13 27.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -116.21 115.56 26.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD21 ' HE1' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -95.25 120.46 35.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.717 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.825 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 87.1 m-85 -72.62 104.59 3.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -82.98 23.23 0.86 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 -65.46 0.97 Allowed 'General case' 0 C--O 1.231 0.108 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.469 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.4 m-70 -100.93 -11.49 19.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.646 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -100.14 1.05 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.2 Cg_exo -40.77 -36.05 1.82 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 122.117 1.878 . . . . 0.0 113.302 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -68.81 -53.52 21.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.943 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -69.32 -36.71 77.25 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.942 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.3 t -58.84 -50.1 75.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.63 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -59.28 -40.24 85.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.408 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -62.36 -43.06 99.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.89 -52.4 65.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.856 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.33 78.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HB3' HD13 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -60.46 -51.05 71.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.215 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.542 HD22 ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -60.91 -29.95 69.89 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.429 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . . . -70.24 -49.22 52.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -76.63 -29.23 56.36 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.573 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -55.12 -32.13 61.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.34 46.64 0.91 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -125.34 -55.0 1.57 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.408 0.147 . . . . 0.0 111.079 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.542 ' CE1' HD22 ' A' ' 42' ' ' LEU . 13.8 m-85 -60.81 -30.35 70.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.337 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -71.7 121.27 18.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.757 0.313 . . . . 0.0 110.469 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.28 -24.26 23.08 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.682 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.854 ' HB ' HD12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -60.85 158.34 13.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 26.74 2.37 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 63.04 -179.43 0.15 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.015 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.41 -92.88 0.28 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.186 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -79.79 121.77 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.706 0.288 . . . . 0.0 110.513 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.833 HD12 ' HG3' ' A' ' 153' ' ' PRO . 7.8 mt -131.54 125.89 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 mt -129.82 118.0 43.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -56.16 25.53 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.763 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.82 49.46 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.765 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -169.22 -89.02 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.213 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.81 175.73 12.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 0.0 111.407 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.686 HD12 HG11 ' A' ' 142' ' ' VAL . 5.9 tt -139.26 109.55 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.511 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -89.47 156.6 18.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.579 0.704 . . . . 0.0 112.158 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.93 105.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.279 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.81 179.62 33.41 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.572 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 42.94 63.83 7.05 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 121.523 0.678 . . . . 0.0 111.247 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.77 56.99 6.13 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.914 2.409 . . . . 0.0 111.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.7 p -114.74 -68.0 0.96 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.184 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.65 22.31 7.78 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.215 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.33 -37.75 4.9 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.033 0.417 . . . . 0.0 111.492 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.64 30.08 76.57 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.503 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -49.27 0.11 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.564 0.221 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.06 80.09 0.26 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.484 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.39 125.37 5.9 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.579 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.1 166.99 31.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.618 0.247 . . . . 0.0 111.211 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 p -88.58 168.32 12.66 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 41' ' ' GLU . 5.2 pt -60.93 -31.44 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.62 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -75.77 -37.13 59.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.32 -151.19 16.87 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -45.02 92.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 110.699 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -161.51 155.36 21.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.95 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -119.17 170.1 9.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.29 178.21 4.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -132.51 171.51 13.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.203 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.23 110.5 9.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.7 tp -100.79 111.07 23.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -130.59 102.52 16.6 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.957 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.03 -14.86 35.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.068 2.512 . . . . 0.0 113.141 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.78 -45.99 20.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.514 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' HD13 ' A' ' 128' ' ' ILE . 6.2 mt -80.2 138.07 36.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.0 178.17 6.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.61 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.621 ' HE2' ' HB2' ' A' ' 99' ' ' ALA . 10.4 m-85 -137.75 97.64 3.48 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.6 ' OG1' HD11 ' A' ' 97' ' ' ILE . 21.5 p -81.87 -4.32 56.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.7 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.17 -75.06 1.8 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.979 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.84 107.66 0.32 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.851 0.358 . . . . 0.0 111.802 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 69.7 61.13 4.56 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.306 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.6 HD11 ' OG1' ' A' ' 93' ' ' THR . 26.8 mm -137.39 131.69 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.626 0.25 . . . . 0.0 110.852 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.616 HD11 HD22 ' A' ' 25' ' ' LEU . 7.2 mt -101.63 122.16 43.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.949 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.621 ' HB2' ' HE2' ' A' ' 92' ' ' PHE . . . -126.22 134.93 51.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.69 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.467 ' HE3' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -79.94 107.46 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.434 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.476 ' HB3' ' OE1' ' A' ' 111' ' ' GLN . . . -85.99 161.97 18.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.476 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.25 140.79 22.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.49 58.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.435 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.01 175.29 35.26 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.552 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.13 121.21 9.25 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.625 2.216 . . . . 0.0 112.185 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 58.52 30.64 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.326 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.6 m -120.77 85.36 2.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.987 0.422 . . . . 0.0 110.493 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.64 120.98 39.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.988 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.63 51.35 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.409 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.496 ' OG ' HD13 ' A' ' 42' ' ' LEU . 16.7 m 58.89 35.89 24.38 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -97.75 139.7 33.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.669 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.65 174.97 13.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.036 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.8 p90 -159.55 140.18 12.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.218 0.533 . . . . 0.0 111.876 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.574 HG22 ' CD2' ' A' ' 98' ' ' LEU . 4.9 t -98.27 113.77 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.79 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.46 141.94 36.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.91 -28.71 7.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.412 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.74 42.29 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.774 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.09 114.57 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.761 2.307 . . . . 0.0 112.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.3 p -129.37 68.35 1.42 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.065 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -81.11 -39.47 25.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -65.21 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.176 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mt -73.54 -9.31 58.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.664 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.16 84.45 0.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.112 0.482 . . . . 0.0 110.485 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -50.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.465 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.87 -31.58 63.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.635 0.255 . . . . 0.0 111.129 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -119.56 123.22 43.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.084 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.552 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 14.8 t -79.87 163.28 24.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.599 HD12 ' CE1' ' A' ' 92' ' ' PHE . 1.3 tt -80.74 -179.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.946 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.542 ' HE1' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -176.99 -39.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.856 -0.156 . . . . 0.0 111.287 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.93 179.47 22.04 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.549 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.467 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -138.05 160.91 38.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.22 96.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.017 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.3 -41.54 12.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.502 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -144.5 108.6 4.76 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.894 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.39 -19.64 1.18 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.255 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.448 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.0 tt -50.09 -29.24 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.74 -39.14 90.2 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.427 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.478 ' SD ' HG23 ' A' ' 23' ' ' ILE . 3.4 ttp -69.32 -50.51 45.84 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.393 0.14 . . . . 0.0 110.985 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.646 ' O ' HG12 ' A' ' 142' ' ' VAL . 3.6 m -61.89 -20.6 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.418 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.85 -31.72 35.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.593 0.235 . . . . 0.0 110.899 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -56.32 -41.96 76.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.573 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 62' ' ' ILE . 14.5 p -56.7 -30.66 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.705 0.288 . . . . 0.0 111.361 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.28 -34.91 15.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.966 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.2 mtt -62.09 -28.54 69.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.31 163.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.709 0.29 . . . . 0.0 111.236 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.4 tt0 -62.39 123.07 17.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.192 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.6 p -107.35 178.71 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -79.8 -179.01 6.7 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m -90.15 19.13 5.23 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -151.1 -68.35 0.18 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -174.02 73.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.77 0.319 . . . . 0.0 111.275 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -156.4 96.98 2.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.833 ' HG3' HD12 ' A' ' 56' ' ' ILE . 49.5 Cg_endo -69.46 131.15 21.05 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.733 2.289 . . . . 0.0 112.232 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 146' ' ' GLU . 60.5 t -58.64 -44.25 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.647 0.26 . . . . 0.0 110.394 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.62 63.87 0.61 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -52.16 150.5 4.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.648 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.655 HG13 ' CB ' ' A' ' 20' ' ' MET . 3.9 t -79.78 101.9 5.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.791 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' SER . 5.7 tttm -84.69 150.51 25.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.854 HD12 ' HB ' ' A' ' 51' ' ' THR . 17.6 mt -116.77 128.99 74.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.4 pt -109.32 -33.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.424 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -163.14 168.02 21.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.07 107.87 2.76 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -144.26 147.08 35.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.432 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.05 174.39 11.56 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.714 2.276 . . . . 0.0 112.516 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.495 ' HG ' ' HE1' ' A' ' 15' ' ' TYR . 25.0 p -95.2 -37.38 11.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.309 -1.273 . . . . 0.0 112.868 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.65 146.3 50.9 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.093 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.55 81.55 0.17 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.138 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.12 134.39 90.45 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 62.0 Cg_endo -74.18 143.58 32.24 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.656 2.237 . . . . 0.0 112.192 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 50.8 Cg_exo -55.01 111.97 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.706 2.271 . . . . 0.0 112.432 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -62.62 114.89 3.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.416 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 p -69.15 -72.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.585 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -74.48 155.49 37.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.972 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.405 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.5 mt-30 -178.53 -61.81 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 72.2 Cg_endo -77.79 109.71 2.79 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.613 2.209 . . . . 0.0 112.535 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 11' ' ' PRO . 45.3 Cg_endo -69.35 -44.07 2.59 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.545 2.163 . . . . 0.0 112.49 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.474 HD22 HG12 ' A' ' 24' ' ' VAL . 2.4 m120 -130.62 160.75 33.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.702 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 27' ' ' LEU . 25.2 m -125.61 141.22 46.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.178 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.31 105.7 15.21 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.764 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.414 ' CD1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -97.12 101.64 13.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.062 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.88 108.05 19.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.305 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -113.2 161.98 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.941 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.409 ' N ' HD11 ' A' ' 160' ' ' ILE . 1.4 m -63.05 -30.0 71.26 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.178 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.85 ' HG2' HG22 ' A' ' 142' ' ' VAL . 8.7 tpt -68.79 -32.03 71.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.094 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.64 -148.65 14.19 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.396 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.51 136.49 59.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.764 0.316 . . . . 0.0 111.446 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.56 HG22 ' CA ' ' A' ' 135' ' ' GLY . 20.7 pt -144.32 128.92 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.519 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.474 HG12 HD22 ' A' ' 13' ' ' ASN . 18.3 t -102.53 98.66 7.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.53 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.69 ' HG ' HD11 ' A' ' 98' ' ' LEU . 9.5 mp -80.83 148.77 29.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.35 140.33 48.12 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 14' ' ' VAL . 3.0 mp -124.11 129.65 51.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.154 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 37.6 m-85 -63.19 99.7 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 110.771 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -78.85 12.63 2.05 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.05 -65.51 0.96 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 110.522 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.503 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.1 m80 -100.73 -15.51 17.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.27 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.75 1.64 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.4 Cg_exo -40.57 -37.74 2.27 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.052 1.835 . . . . 0.0 113.089 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -60.72 -55.8 28.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -34.79 79.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.736 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.6 t -58.35 -45.59 87.89 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.58 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -61.69 -43.53 98.68 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.222 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.42 -39.33 93.63 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -69.07 -43.0 75.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.91 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.02 73.54 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.286 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -48.42 80.52 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.011 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -36.33 78.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.131 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.41 50.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.248 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -76.3 -49.08 17.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -60.08 -40.87 91.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.745 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.93 53.11 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -112.14 -62.84 1.51 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.515 0.198 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.615 ' O ' HG22 ' A' ' 51' ' ' THR . 12.9 m-85 -63.3 -51.71 64.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.65 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -67.23 119.75 12.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 110.47 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.22 8.8 10.09 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.088 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 48' ' ' TYR . 15.1 t -117.74 -172.18 2.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.274 0.537 . . . . 0.0 111.176 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.8 150.19 35.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.759 ' HB3' HD11 ' A' ' 56' ' ' ILE . 59.8 m-85 -64.23 136.9 57.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.187 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -109.44 -36.59 5.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.734 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.472 ' O ' HD13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -113.89 113.65 25.16 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.628 0.251 . . . . 0.0 111.114 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.759 HD11 ' HB3' ' A' ' 53' ' ' PHE . 29.6 mm -132.71 116.66 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.53 88.28 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.039 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HD3' ' HA3' ' A' ' 143' ' ' GLY . 21.8 tptt -58.97 155.53 13.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.09 25.75 4.67 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -166.29 -82.38 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.02 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.605 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -160.53 170.07 21.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 111.516 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -142.66 161.57 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.51 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -146.75 154.59 41.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.924 0.392 . . . . 0.0 111.55 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.68 150.45 17.12 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.562 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.89 -179.55 38.77 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.987 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.676 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 15.1 t70 -156.3 -63.05 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.942 -0.129 . . . . 0.0 111.198 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 73.6 Cg_endo -76.0 -176.81 3.23 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.279 1.986 . . . . 0.0 112.677 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 70' ' ' THR . 6.7 t -56.69 -35.92 69.03 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.979 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.73 29.59 47.19 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.431 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 68' ' ' THR . 1.2 p -133.74 -46.19 0.8 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.852 0.326 . . . . 0.0 111.06 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.99 31.3 2.1 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.477 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -105.72 -45.04 4.5 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.586 0.232 . . . . 0.0 110.69 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.46 80.15 0.2 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.43 80.62 0.32 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.326 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.04 155.72 28.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.0 t -125.4 175.04 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -53.02 -33.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.828 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.403 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 29.1 m-85 -92.23 -35.91 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.016 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.9 -143.49 10.34 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.588 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -134.68 27.52 3.65 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 111.193 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.13 -55.72 0.65 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.119 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 78' ' ' TYR . 15.5 m-85 61.73 -176.79 0.13 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.63 131.51 48.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.59 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.43 146.25 49.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -131.96 98.85 4.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.236 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.72 110.9 10.71 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.649 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -132.12 172.84 6.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 -173.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.742 2.294 . . . . 0.0 112.174 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.82 179.28 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.9 mt 66.82 165.89 0.21 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.739 0.304 . . . . 0.0 110.887 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 160.38 40.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 111.471 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.31 96.63 5.75 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.972 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.426 ' OG1' HD11 ' A' ' 97' ' ' ILE . 17.0 p -71.97 -33.61 68.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.2 -26.67 23.03 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.916 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 116.17 31.46 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.069 0.435 . . . . 0.0 111.654 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 66.35 54.82 21.37 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.213 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 96' ' ' GLY . 19.8 mm -129.23 135.53 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.768 0.284 . . . . 0.0 111.203 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.781 HD23 HG22 ' A' ' 114' ' ' VAL . 1.3 mt -105.64 120.44 41.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.833 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.758 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -117.81 141.16 48.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.369 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.19 120.02 23.11 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.181 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.72 141.8 36.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.43 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -157.16 117.4 3.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.743 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.47 72.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.71 179.83 17.51 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.48 30.27 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.686 2.258 . . . . 0.0 113.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -176.7 38.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 110.697 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.28 81.95 1.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 110.829 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -106.24 91.47 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.223 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.91 -105.16 0.02 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.358 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.466 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 67.3 m -157.5 36.48 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.43 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -118.1 160.3 21.76 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.696 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -159.74 165.66 32.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.758 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 6.5 p90 -137.63 136.79 37.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.42 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.781 HG22 HD23 ' A' ' 98' ' ' LEU . 4.8 t -102.72 110.53 29.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.201 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -79.8 130.89 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 61' ' ' MET . 0.6 OUTLIER -114.71 -15.99 11.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.675 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -108.61 152.35 42.12 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.835 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.99 104.41 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.761 2.308 . . . . 0.0 112.343 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.6 p -138.3 67.53 1.41 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -70.4 -32.96 70.82 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -60.55 -29.13 68.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.296 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.419 HD23 ' HD2' ' A' ' 125' ' ' LYS . 4.4 mt -73.17 -11.86 60.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.877 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.24 85.44 0.15 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.219 0.533 . . . . 0.0 110.425 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.79 -40.71 0.11 Allowed Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.279 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' HD2' HD23 ' A' ' 122' ' ' LEU . 30.7 mttt -74.56 -44.55 50.47 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 110.836 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -112.84 133.9 54.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.651 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 15.3 t -79.91 164.28 23.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.997 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.4 tt -90.4 -179.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.689 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.0 p90 -178.31 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -179.77 23.27 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.779 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.589 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -146.03 150.31 35.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.8 t -106.9 99.75 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.206 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.26 -45.96 5.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -119.84 96.34 5.14 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.829 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.56 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 152.24 -22.23 0.86 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.277 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.2 tt -47.21 -36.41 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.848 0.324 . . . . 0.0 111.807 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.59 96.2 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.482 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 ttp -65.77 -41.99 91.36 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.611 0.243 . . . . 0.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.71 -36.98 63.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.719 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -63.4 -36.15 82.76 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.983 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -60.78 -42.06 96.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.486 0.184 . . . . 0.0 111.028 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.85 HG22 ' HG2' ' A' ' 20' ' ' MET . 12.1 t -58.27 -34.03 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.148 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 58' ' ' LYS . . . -89.62 -36.38 7.41 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.12 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -35.77 61.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.46 0.304 . . . . 0.0 111.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 155' ' ' ASP . 18.9 m -63.76 173.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.612 ' O ' HG12 ' A' ' 154' ' ' VAL . 3.6 mm-40 -72.83 -179.93 3.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.062 0.458 . . . . 0.0 111.266 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.0 177.72 9.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.97 -173.11 4.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.03 27.83 2.32 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -147.26 -71.95 0.22 Allowed 'General case' 0 C--O 1.231 0.122 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 178.74 45.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.008 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.04 116.34 28.78 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.33 129.13 33.12 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.953 2.435 . . . . 0.0 112.849 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 146' ' ' GLU . 11.4 p -69.78 -35.36 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.12 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.567 ' HB2' HG21 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -75.41 -173.03 1.96 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -127.47 90.95 3.21 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 20' ' ' MET . 7.8 p -102.51 123.43 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.036 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -152.82 126.85 9.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.69 0.281 . . . . 0.0 111.711 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.437 ' HA ' ' HB ' ' A' ' 18' ' ' THR . 4.6 mt -81.42 132.95 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.597 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 19' ' ' SER . 0.3 OUTLIER -114.19 -33.64 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.295 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -127.51 146.19 50.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.772 0.32 . . . . 0.0 111.114 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.79 82.67 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.825 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -122.67 143.67 40.62 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.32 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . 94.6 Cg_endo -80.43 150.29 19.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.803 2.335 . . . . 0.0 112.603 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.3 t -171.77 148.72 2.42 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.892 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.036 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.794 0.33 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.97 -36.88 9.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.231 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.01 82.64 0.18 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.062 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 mm 59.56 73.51 0.66 Allowed Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.034 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.05 109.37 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.842 2.361 . . . . 0.0 112.645 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.56 163.95 36.18 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.774 2.316 . . . . 0.0 112.957 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -130.0 -49.2 1.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.055 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.5 p -164.13 169.19 18.09 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.649 0.261 . . . . 0.0 111.359 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -132.24 -48.32 0.92 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.432 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -99.8 104.22 26.9 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.826 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.18 116.24 4.4 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.54 2.16 . . . . 0.0 112.478 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.38 -35.95 17.0 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.644 2.229 . . . . 0.0 112.658 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -107.21 170.56 7.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.021 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG13 ' HG ' ' A' ' 25' ' ' LEU . 14.2 p -151.89 147.4 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -112.89 135.36 53.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.828 HD12 HD21 ' A' ' 25' ' ' LEU . 18.0 mt -121.63 97.79 5.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 86.28 7.38 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.602 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.7 OUTLIER -98.94 157.47 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.352 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 t -64.63 -36.39 84.1 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.847 ' HB2' HG23 ' A' ' 157' ' ' VAL . 9.8 tpt -65.47 -31.49 72.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.37 151.48 6.15 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.058 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -81.05 142.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.715 0.293 . . . . 0.0 111.483 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.713 HG22 ' HA2' ' A' ' 135' ' ' GLY . 19.5 pt -148.37 146.49 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.786 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.21 130.58 69.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.828 HD21 HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -133.03 162.91 30.46 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.387 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.55 154.11 25.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.907 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.43 134.12 46.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.769 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.769 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 74.3 m-85 -75.15 98.17 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.381 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -82.86 20.4 1.18 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -100.22 -67.29 0.86 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.482 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.81 -13.05 18.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.145 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.14 0.73 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 85.2 Cg_exo -42.77 -34.98 3.87 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.005 1.804 . . . . 0.0 112.789 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -57.72 -62.73 1.59 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.908 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -66.7 -33.65 76.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.41 -51.32 70.39 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.64 84.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.744 0.307 . . . . 0.0 110.468 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.24 -41.42 94.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.755 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.15 -48.35 68.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.89 83.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.387 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.98 -50.1 74.74 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.424 HD23 ' HG2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -56.79 -33.21 66.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.466 0.174 . . . . 0.0 111.441 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.92 24.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.512 0.196 . . . . 0.0 111.479 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -75.85 -36.79 59.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.449 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -30.33 71.15 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 31.0 3.07 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.927 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.533 ' CE2' HG22 ' A' ' 68' ' ' THR . 1.1 m-85 -105.03 -41.71 5.51 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.565 0.221 . . . . 0.0 110.663 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -65.58 -51.16 61.81 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.02 123.24 20.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.69 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.91 -29.38 5.39 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.315 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -75.79 -176.42 3.35 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 111.514 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -155.04 154.8 33.04 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.766 ' HB3' HD11 ' A' ' 56' ' ' ILE . 54.8 m-85 -66.86 169.83 7.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.983 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -135.72 -53.36 0.76 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.665 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.625 ' C ' HD12 ' A' ' 56' ' ' ILE . 6.2 mtt-85 -100.53 108.46 20.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.766 HD11 ' HB3' ' A' ' 53' ' ' PHE . 1.7 mp -120.02 99.87 8.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.53 95.54 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.95 -23.29 65.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.602 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 21.3 3.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CD2' ' HG3' ' A' ' 61' ' ' MET . 10.6 t80 -169.98 -81.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.521 -0.112 . . . . 0.0 111.141 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.457 ' HG3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -160.43 175.33 12.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 111.186 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.4 pp -133.97 137.06 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -117.47 143.58 45.9 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.138 0.494 . . . . 0.0 112.18 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 125.59 3.66 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.894 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.11 -179.9 34.27 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.027 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.4 t70 71.28 56.21 0.41 Allowed Pre-proline 0 N--CA 1.464 0.268 0 C-N-CA 122.564 0.346 . . . . 0.0 111.789 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.53 ' HA ' HG21 ' A' ' 51' ' ' THR . 91.2 Cg_endo -79.18 62.8 8.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.564 2.176 . . . . 0.0 111.994 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.533 HG22 ' CE2' ' A' ' 47' ' ' TYR . 70.5 p -134.45 -61.22 0.78 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.305 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.69 30.29 62.12 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.727 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 m -100.97 -47.14 4.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.638 0.219 . . . . 0.0 111.203 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.42 -36.42 4.01 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.228 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -110.03 27.2 9.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.32 125.14 1.42 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.869 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.13 80.64 0.21 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.613 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.34 150.91 32.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.293 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p -105.96 -175.5 2.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.182 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -66.4 -28.3 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.228 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -97.33 39.19 1.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.825 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -147.38 25.16 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.016 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 -37.3 5.91 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.462 0.172 . . . . 0.0 111.135 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -143.0 158.87 43.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -167.77 169.97 11.23 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.172 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.95 129.86 42.89 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -64.53 168.19 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.633 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -111.49 38.25 2.65 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.172 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.596 ' HA ' HG23 ' A' ' 127' ' ' THR . 0.1 OUTLIER -64.56 135.82 56.38 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.756 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.25 102.28 1.88 Allowed Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.969 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.9 80.71 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.369 . . . . 0.0 111.984 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.33 -49.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.767 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.466 HD13 HG21 ' A' ' 128' ' ' ILE . 4.8 mp -85.14 145.69 27.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -97.2 154.51 17.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -113.16 89.33 3.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -57.9 -33.83 69.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.214 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.67 -27.44 17.87 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.846 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.69 106.2 16.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.979 0.389 . . . . 0.0 111.086 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.572 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 74.41 58.46 4.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.958 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 96' ' ' GLY . 25.3 mm -133.08 120.41 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.703 0.287 . . . . 0.0 110.817 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.613 HD12 HG13 ' A' ' 132' ' ' VAL . 3.1 mt -96.09 110.02 22.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -117.05 138.69 51.43 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.706 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.419 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.89 118.61 21.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.561 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.16 172.08 9.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -148.75 157.87 43.75 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.71 23.94 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.85 174.52 35.87 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.435 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.78 120.26 7.29 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.557 2.171 . . . . 0.0 111.991 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 56.92 42.18 26.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.024 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.6 m -144.6 88.11 1.9 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -107.78 161.93 14.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.14 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.4 -106.16 1.01 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.168 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -147.52 34.68 0.86 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.03 158.1 23.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -160.4 176.46 11.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -145.96 136.69 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.56 HG22 ' CD2' ' A' ' 98' ' ' LEU . 22.0 t -102.13 109.9 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.129 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.53 132.94 36.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.407 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 pp -114.9 -23.32 9.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.861 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.15 149.03 35.93 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.71 117.3 4.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.862 2.375 . . . . 0.0 112.213 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.842 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 10.2 p -151.91 99.03 2.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.156 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -92.8 -21.89 19.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.842 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.8 p90 -59.06 -26.18 64.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.3 pp -85.03 -4.59 59.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.78 86.95 0.04 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.182 0.515 . . . . 0.0 110.091 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.73 -32.27 1.46 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.642 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.19 -53.92 21.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.662 0.231 . . . . 0.0 111.219 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -104.61 150.03 25.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.269 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.665 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 49.1 m -86.14 155.75 20.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.959 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 90' ' ' LEU . 1.3 tt -86.47 -179.42 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.636 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -175.72 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.62 -179.82 31.89 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.919 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -138.2 166.22 24.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.6 0.238 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.662 HG12 ' HB3' ' A' ' 25' ' ' LEU . 3.0 m -134.44 102.79 4.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 111.782 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.82 -53.74 4.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.9 84.18 1.89 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.955 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.713 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 169.81 -27.84 0.12 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.844 -0.694 . . . . 0.0 113.437 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 96' ' ' GLY . 7.8 tt -46.98 -37.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.73 -38.17 81.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.76 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -70.45 -35.56 73.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.108 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.59 -30.23 41.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -74.82 -38.04 62.16 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.483 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -67.73 -29.56 68.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.685 HG22 ' HG2' ' A' ' 20' ' ' MET . 21.5 t -56.34 -32.71 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.649 0.262 . . . . 0.0 111.015 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 58' ' ' LYS . . . -93.59 -32.19 7.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.506 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 21.2 mmt -60.15 -33.3 71.97 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.524 0.162 . . . . 0.0 111.385 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.1 m -63.75 173.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.18 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 126.07 26.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.976 0.417 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 p -118.58 167.94 11.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -177.29 5.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.83 46.91 1.43 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -174.28 -67.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.56 44.02 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -122.95 104.05 36.15 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.137 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.0 117.06 3.48 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 112.461 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.43 -32.24 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.696 0.284 . . . . 0.0 110.361 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.13 -170.94 1.03 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.382 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.89 114.05 22.65 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.731 0.3 . . . . 0.0 111.617 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 20' ' ' MET . 7.1 p -125.43 113.38 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 174.85 11.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.638 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.435 ' HA ' HG22 ' A' ' 18' ' ' THR . 2.4 mt -115.14 139.49 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.314 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.55 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -116.13 -30.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.602 179.037 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.22 28.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 110.952 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.13 111.14 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.023 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 36.6 p90 -145.05 158.37 52.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 111.707 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.4 Cg_exo -80.09 152.38 21.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.274 2.649 . . . . 0.0 112.482 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 140.29 1.85 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.451 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.671 0.272 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.32 29.75 15.59 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.67 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.91 76.41 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.888 0.375 . . . . 0.0 110.795 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 mt -107.04 92.53 7.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.749 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.34 145.58 60.03 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.516 2.144 . . . . 0.0 112.118 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . 92.5 Cg_endo -78.64 58.37 6.77 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.856 2.37 . . . . 0.0 111.929 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.03 23.85 5.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.869 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -161.49 163.62 30.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.62 0.248 . . . . 0.0 111.0 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -108.5 -27.44 9.9 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.5 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.18 76.52 3.58 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.883 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HG3' ' CB ' ' A' ' 164' ' ' PRO . 73.7 Cg_endo -76.16 151.0 33.99 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.892 2.394 . . . . 0.0 112.667 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.0 -37.51 3.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.745 2.297 . . . . 0.0 112.715 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -125.0 165.74 17.6 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.004 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.672 HG22 HD11 ' A' ' 27' ' ' LEU . 30.5 m -140.58 154.23 21.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.467 ' CE1' HG22 ' A' ' 24' ' ' VAL . 4.1 m-85 -111.5 104.17 12.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -87.88 96.64 10.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.16 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 161' ' ' LYS . 1.3 tm-20 -80.37 82.48 6.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.187 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.668 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.8 OUTLIER -84.78 161.05 20.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.386 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -64.04 -33.22 75.25 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.054 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.923 ' HB2' HG13 ' A' ' 157' ' ' VAL . 15.3 tpt -67.51 -34.16 76.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.945 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.81 -148.36 12.75 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.221 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.427 HD11 ' CD1' ' A' ' 15' ' ' TYR . 17.2 tt -132.28 126.45 55.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 111.279 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 25' ' ' LEU . 29.7 pt -129.99 133.26 64.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.467 HG22 ' CE1' ' A' ' 15' ' ' TYR . 18.4 t -94.3 109.41 22.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.82 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 132' ' ' VAL . 7.4 mt -105.49 162.42 13.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.28 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -119.89 144.81 47.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.051 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.672 HD11 HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -129.47 134.29 47.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.81 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 28.0 m-85 -64.42 100.6 0.37 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.014 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -80.8 15.31 1.81 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -100.15 -64.9 1.0 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.772 0.32 . . . . 0.0 110.343 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.478 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -100.76 -13.2 18.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.333 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.01 1.2 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 77.8 Cg_exo -41.84 -37.52 4.15 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.011 1.807 . . . . 0.0 112.908 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -49.49 71.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.486 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.1 m -67.07 -36.94 83.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.387 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -54.51 -49.13 70.91 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.358 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -64.6 -38.55 91.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.264 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.409 ' CG ' HD13 ' A' ' 77' ' ' ILE . 1.5 t30 -56.74 -44.09 81.33 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.478 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -67.51 -43.16 81.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.212 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.11 -52.43 55.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.272 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -46.5 89.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -40.73 69.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 -33.77 33.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -47.63 84.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -60.16 -30.23 69.18 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.424 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.87 26.02 5.16 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.908 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -37.13 13.11 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.777 0.288 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -36.39 40.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.179 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -66.99 90.01 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 110.138 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.8 -26.04 2.53 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.772 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.6 p -61.3 151.4 32.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.809 0.305 . . . . 0.0 111.281 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -132.2 159.69 38.29 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.863 0.363 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -74.13 100.46 3.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.638 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -73.02 -50.2 24.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -102.72 131.09 49.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.725 HG23 HG12 ' A' ' 62' ' ' ILE . 27.0 mt -142.16 105.19 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.018 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mt -90.98 115.06 29.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.735 0.302 . . . . 0.0 110.913 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 2.0 tmtt? -63.34 132.2 50.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.188 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 2.5 t70 55.39 52.45 11.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.267 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.449 ' N ' HD11 ' A' ' 116' ' ' LEU . 16.4 t80 -165.82 -83.83 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.482 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.58 163.6 32.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.819 0.343 . . . . 0.0 111.442 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 56' ' ' ILE . 4.0 mp -137.99 130.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.721 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 15.6 pt20 -117.9 154.58 31.64 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 112.004 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.92 106.09 0.48 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.153 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.25 -179.99 35.4 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.941 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.0 76.46 0.34 Allowed Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 111.068 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.22 -34.02 6.6 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.759 2.306 . . . . 0.0 112.697 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -87.07 -41.04 14.14 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.304 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.93 52.35 14.85 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.529 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 p -112.29 -42.89 3.61 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 115.83 -68.04 0.28 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.119 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -33.39 18.62 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.656 0.228 . . . . 0.0 111.39 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.57 84.09 1.6 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.816 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.39 97.69 0.18 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.728 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.48 135.13 55.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 0.0 111.221 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.668 ' HB2' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -80.35 -84.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.684 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 76' ' ' SER . 4.3 mp -142.55 -50.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.811 0.339 . . . . 0.0 110.534 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 34.76 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.41 -168.54 13.19 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -119.32 21.69 12.1 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.66 ' HB3' HG23 ' A' ' 107' ' ' THR . 0.0 OUTLIER -177.73 92.82 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 110.632 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -107.76 175.61 5.42 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.251 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.74 140.72 46.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.785 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 157.11 11.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.79 37.31 2.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.651 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 149.13 21.74 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.51 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.28 -62.31 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.526 ' HG2' HD13 ' A' ' 90' ' ' LEU . 78.2 Cg_endo -75.73 -174.23 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.758 2.306 . . . . 0.0 112.42 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.94 -61.65 1.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.014 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.577 HD22 HG21 ' A' ' 128' ' ' ILE . 7.6 mp 57.5 -173.85 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.11 173.98 10.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' A' ' 99' ' ' ALA . 8.2 t80 -160.31 38.93 0.17 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.979 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -108.93 -57.74 2.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.811 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.28 122.34 5.26 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.591 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.15 127.21 12.19 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 101.96 62.38 0.75 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 96' ' ' GLY . 14.8 mm -126.67 140.13 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.767 0.283 . . . . 0.0 111.045 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.524 HD22 ' HE1' ' A' ' 129' ' ' PHE . 3.2 mt -112.41 120.8 42.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.676 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -124.52 142.06 51.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.443 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -79.6 114.75 18.76 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.286 179.279 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.18 26.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.437 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -135.82 157.25 47.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -37.22 14.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.158 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.79 174.46 36.61 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 119.12 5.65 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.579 2.186 . . . . 0.0 112.165 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 59.05 30.75 20.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.185 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 81' ' ' GLN . 10.5 m -139.87 88.3 2.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.709 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.02 165.91 12.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.09 -105.7 1.47 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.93 43.94 0.12 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 111.041 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -126.03 157.46 37.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 100' ' ' MET . 2.4 m-85 -149.73 160.09 43.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.412 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.676 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 7.1 p90 -137.43 130.3 30.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 111.618 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 139' ' ' VAL . 21.4 t -98.54 107.1 19.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.228 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.41 HG21 ' CE2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -79.72 125.84 30.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 60' ' ' PHE . 1.9 pp -109.29 -4.69 16.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.66 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.432 ' N ' HD12 ' A' ' 116' ' ' LEU . . . -119.95 152.28 53.81 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-O 120.527 0.203 . . . . 0.0 110.839 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.26 100.06 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 112.025 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 79.5 p -122.41 110.4 15.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -94.9 -40.48 9.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -61.81 -33.67 74.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 122' ' ' LEU . 12.8 mt -81.91 -3.31 53.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.556 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -82.1 66.56 7.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.004 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.9 -47.38 0.07 OUTLIER Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.651 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -56.08 -47.52 77.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.706 0.289 . . . . 0.0 110.885 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -108.57 139.69 42.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.606 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 11.0 t -79.97 155.8 27.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.788 0.328 . . . . 0.0 111.125 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.577 HG21 HD22 ' A' ' 90' ' ' LEU . 1.2 tt -83.57 -178.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.561 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.524 ' HE1' HD22 ' A' ' 98' ' ' LEU . 1.2 p90 -179.38 -39.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.3 -179.75 17.01 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.113 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -146.85 171.79 14.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.29 . . . . 0.0 110.924 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 25' ' ' LEU . 16.3 t -130.64 119.16 44.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.352 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -56.51 2.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.13 92.33 3.86 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.061 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.84 -17.26 0.95 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.274 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.568 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -45.87 -36.93 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.89 -47.87 76.46 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.638 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.423 ' O ' HG23 ' A' ' 142' ' ' VAL . 7.2 tmm? -58.26 -46.07 86.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 110.403 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 114' ' ' VAL . 19.5 t -59.79 -37.98 73.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -63.79 -44.66 92.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.845 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -56.65 -34.3 67.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.175 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 138' ' ' MET . 21.8 t -58.24 -36.03 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.886 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.38 -38.13 18.8 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.563 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 mtp -55.3 -47.69 75.2 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.7 0.25 . . . . 0.0 111.208 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -50.88 136.89 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.52 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -60.75 120.83 10.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.636 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.6 p -86.48 170.39 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.407 ' CB ' ' HG3' ' A' ' 152' ' ' ARG . 1.4 t-20 -81.96 -166.22 1.18 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.56 34.37 0.76 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -160.12 32.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.627 0.251 . . . . 0.0 110.914 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.34 35.23 13.34 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.088 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.407 ' HG3' ' CB ' ' A' ' 148' ' ' ASN . 2.6 ptp180 -111.71 150.65 42.56 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.943 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.28 120.05 6.84 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.671 2.247 . . . . 0.0 112.495 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.9 t -70.57 -32.22 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.367 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -174.66 4.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.39 79.97 3.14 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.296 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.923 HG13 ' HB2' ' A' ' 20' ' ' MET . 30.3 t -113.93 113.43 43.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.345 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.92 179.81 8.46 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.388 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.668 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.2 mt -102.22 125.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.608 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.1 pt -107.12 -32.45 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.553 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . 3.3 tttt -145.1 143.73 30.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.651 0.262 . . . . 0.0 110.864 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.5 94.83 2.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.725 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -119.1 155.98 52.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.329 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.434 ' CB ' ' HG3' ' A' ' 11' ' ' PRO . 94.0 Cg_endo -79.76 167.2 20.79 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.555 2.17 . . . . 0.0 113.003 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . 0.412 ' HG ' ' HE2' ' A' ' 15' ' ' TYR . 3.5 t -105.91 163.17 12.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 6' ' ' PRO . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.26 -1.3 . . . . 0.0 112.93 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.42 177.08 4.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.614 0.245 . . . . 0.0 110.926 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.45 149.61 50.16 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.41 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.18 71.43 70.15 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.16 108.7 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.803 2.335 . . . . 0.0 112.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.42 147.71 84.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.043 2.495 . . . . 0.0 112.962 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.48 43.37 0.67 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.135 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 p -92.53 90.75 7.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.809 0.337 . . . . 0.0 111.097 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -155.64 117.81 4.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.99 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -84.8 160.11 56.39 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.634 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 71.7 Cg_exo -49.09 108.01 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.802 2.335 . . . . 0.0 112.643 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 41.5 Cg_endo -67.79 -27.99 37.07 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.732 2.288 . . . . 0.0 112.969 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.48 142.83 34.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.706 0.289 . . . . 0.0 110.831 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.71 152.59 25.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -113.85 115.09 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.537 HD21 ' HE2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -101.32 104.62 15.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.126 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.16 87.06 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.395 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.6 OUTLIER -84.96 159.6 20.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.674 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 160' ' ' ILE . 0.3 OUTLIER -60.78 -34.15 74.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.73 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -73.51 -33.44 64.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.394 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.16 -168.19 40.88 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.52 ' C ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -119.06 123.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.182 0.491 . . . . 0.0 111.207 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.645 HG22 ' HA2' ' A' ' 135' ' ' GLY . 23.1 pt -128.1 146.18 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.863 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.0 t -105.2 139.3 26.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.522 HD21 HD12 ' A' ' 23' ' ' ILE . 3.4 mt -136.67 159.29 42.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.494 ' C ' HD22 ' A' ' 27' ' ' LEU . 15.8 pt-20 -121.46 145.29 48.08 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.854 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 ' C ' ' A' ' 26' ' ' GLU . 3.7 mm? -116.36 144.48 44.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.521 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.706 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 49.2 m-85 -86.33 102.49 14.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.753 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 10.9 m95 -76.36 11.99 1.37 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.29 -61.96 1.3 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.546 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.751 ' NE2' HD11 ' A' ' 90' ' ' LEU . 6.7 p80 -100.79 -15.98 17.45 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.18 1.38 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 66.8 Cg_exo -40.05 -37.21 1.65 Allowed 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.131 1.887 . . . . 0.0 113.312 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -55.63 13.7 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.061 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.616 HG21 ' HG3' ' A' ' 100' ' ' MET . 52.5 m -68.45 -39.49 81.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.3 -50.63 72.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -43.78 86.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.403 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.46 -48.03 83.55 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.78 -45.97 81.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.614 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.59 76.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.55 -42.23 98.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.431 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -52.09 67.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.544 0.211 . . . . 0.0 111.236 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.59 68.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -61.22 -42.53 98.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -38.67 92.08 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.279 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.06 38.96 1.09 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.813 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -32.52 6.55 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.481 0.182 . . . . 0.0 111.011 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HE2' HD21 ' A' ' 16' ' ' LEU . 1.5 t80 -68.59 -36.28 78.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.204 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -65.79 108.7 2.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.27 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.74 -23.15 4.24 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.89 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.537 ' HB ' HD12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -64.0 165.46 8.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 111.502 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 158' ' ' LYS . 0.4 OUTLIER -153.8 143.68 21.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.085 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CD1' HG22 ' A' ' 62' ' ' ILE . 42.3 m-85 -66.04 108.48 2.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.88 5.66 47.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.136 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -150.05 114.85 5.31 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.618 0.247 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.862 HG23 HG12 ' A' ' 62' ' ' ILE . 4.0 mp -137.49 107.43 4.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.31 79.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 41.82 -147.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.662 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.08 53.47 2.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.091 0.472 . . . . 0.0 110.311 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -125.13 -66.02 0.99 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.318 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 ptm -156.64 137.3 13.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.747 0.308 . . . . 0.0 111.175 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.862 HG12 HG23 ' A' ' 56' ' ' ILE . 6.4 mt -132.38 115.17 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.0 pt20 -103.08 146.78 27.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.481 . . . . 0.0 112.054 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.78 111.85 0.6 Allowed Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.898 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.44 -179.93 35.53 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.945 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.65 65.54 0.75 Allowed Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 111.23 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.466 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 90.9 Cg_endo -81.78 58.7 6.87 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.84 2.36 . . . . 0.0 112.063 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -118.22 -59.42 1.9 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.171 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.4 30.5 5.29 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.895 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 t -114.79 -41.29 3.4 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.716 0.258 . . . . 0.0 111.084 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.84 -60.19 0.67 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.44 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.42 37.17 4.47 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.674 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.66 97.33 0.61 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.677 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.33 99.94 0.59 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.425 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.73 159.31 16.09 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.662 0.268 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 t -134.94 159.2 42.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.176 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -56.94 -33.6 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.38 -30.81 63.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.94 -160.97 29.12 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.762 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -52.35 60.62 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 110.603 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.65 159.3 38.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -144.41 178.03 8.22 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.97 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.97 130.17 38.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -65.27 161.03 20.29 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.78 139.18 47.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -121.34 127.61 51.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.584 ' HB2' HD12 ' A' ' 90' ' ' LEU . 17.7 p80 -65.63 135.64 95.74 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.313 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.93 -36.96 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.571 2.181 . . . . 0.0 112.429 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -163.42 106.73 1.01 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.737 0.303 . . . . 0.0 110.827 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.751 HD11 ' NE2' ' A' ' 31' ' ' HIS . 11.7 mt -149.85 178.76 8.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.31 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -124.66 160.93 27.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.488 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.414 ' CB ' ' HB2' ' A' ' 123' ' ' ASP . 4.2 t80 -135.83 76.43 1.61 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.38 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.3 m -57.09 -27.47 61.79 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 98.96 -58.52 0.88 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.797 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.26 114.37 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 70.93 64.01 2.96 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.964 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 96' ' ' GLY . 12.7 mm -130.61 158.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.696 0.284 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.821 ' HG ' HG12 ' A' ' 114' ' ' VAL . 1.1 mt -137.52 97.66 3.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.275 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -105.68 136.05 45.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.616 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -79.74 121.46 25.37 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.87 176.83 4.92 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.457 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -139.76 173.61 11.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.296 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.07 -35.73 12.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.44 167.74 32.52 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.531 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.54 124.07 14.32 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.558 2.172 . . . . 0.0 112.159 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.36 29.07 18.58 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.393 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 m -132.03 89.83 2.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.39 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.58 147.17 25.07 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.625 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.23 -110.72 1.48 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.16 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.5 m -151.55 45.66 0.79 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.986 0.422 . . . . 0.0 111.199 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 148.04 32.71 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.167 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -149.7 132.04 15.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 23.9 p90 -110.08 127.11 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 111.497 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.821 HG12 ' HG ' ' A' ' 98' ' ' LEU . 29.2 m -99.85 119.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.558 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 p -88.81 142.54 27.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.802 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.565 ' N ' HD22 ' A' ' 116' ' ' LEU . 1.3 mm? -113.65 -24.88 8.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.138 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -106.58 162.57 19.27 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.031 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 46.4 Cg_endo -67.94 112.31 2.67 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.683 2.255 . . . . 0.0 112.45 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 p -141.34 76.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 92' ' ' PHE . 36.2 mt-30 -76.67 -34.8 58.23 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.153 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -59.69 -28.5 67.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.439 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 122' ' ' LEU . 11.0 mt -81.39 -2.35 49.01 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 92' ' ' PHE . 35.8 t0 -82.89 60.22 5.27 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 110.443 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.23 -52.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.778 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -32.61 74.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -119.03 148.83 42.58 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.623 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 95.2 m -99.28 163.7 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.716 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.694 HG22 ' H ' ' A' ' 129' ' ' PHE . 2.7 mm -79.41 -179.09 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.241 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.694 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -176.97 -34.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.82 170.46 31.26 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.575 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.401 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -126.7 159.07 34.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.7 0.286 . . . . 0.0 110.983 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.84 94.53 3.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 6.2 t -92.0 -61.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.277 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -111.74 98.21 7.25 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.645 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 156.03 -21.59 0.51 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.455 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.2 tt -47.88 -35.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.91 92.14 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.037 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.94 -16.45 55.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.566 0.222 . . . . 0.0 110.879 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.64 HG11 HG21 ' A' ' 114' ' ' VAL . 21.9 t -88.57 -42.28 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.558 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.47 -31.03 68.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -53.71 -32.17 50.92 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.581 HG12 HG21 ' A' ' 56' ' ' ILE . 20.9 t -63.41 -36.46 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.644 0.259 . . . . 0.0 111.145 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.02 -29.05 39.2 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.458 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.6 mtp -74.3 -23.51 59.09 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 145' ' ' VAL . 13.3 p -84.03 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.39 174.59 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.151 0.5 . . . . 0.0 111.427 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 p -150.78 173.74 13.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.275 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -89.73 -176.37 4.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.852 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -91.4 28.98 1.55 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.608 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -150.4 29.31 0.71 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.296 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.5 44.39 21.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.21 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.3 mtp-105 -115.3 144.47 32.33 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.733 ' HB3' HD13 ' A' ' 56' ' ' ILE . 74.1 Cg_endo -76.58 140.57 21.39 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.804 2.336 . . . . 0.0 112.747 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.24 -34.14 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.457 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -171.01 3.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.59 96.64 5.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.275 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 157' ' ' VAL . 10.9 p -117.02 111.36 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 52' ' ' LYS . 5.9 pttt -145.38 173.63 11.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.722 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.1 mt -106.3 126.13 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.678 0.275 . . . . 0.0 111.3 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.411 HG23 ' HB2' ' A' ' 19' ' ' SER . 42.7 pt -108.14 -33.79 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.638 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -138.8 152.11 47.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.774 0.321 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.48 115.41 3.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -153.5 166.12 16.3 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.84 168.78 18.85 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.045 2.497 . . . . 0.0 112.193 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.38 96.73 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.996 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.799 -1.001 . . . . 0.0 113.031 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.607 0.241 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.0 101.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.751 ' HB1' ' HG2' ' A' ' 6' ' ' PRO . . . -96.09 96.14 8.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.396 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.549 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 2.0 mt -83.0 -49.0 0.76 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.525 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 52.9 Cg_exo -53.68 -49.83 15.91 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.444 2.096 . . . . 0.0 113.337 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.751 ' HG2' ' HB1' ' A' ' 3' ' ' ALA . 87.6 Cg_endo -81.51 129.33 6.5 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.473 2.116 . . . . 0.0 112.432 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -92.77 119.59 32.29 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -137.17 153.12 50.52 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.24 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 62.27 86.75 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -120.52 147.88 46.51 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.402 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.44 ' CG ' ' HB2' ' A' ' 164' ' ' PRO . 58.1 Cg_endo -71.84 122.37 8.45 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.776 2.318 . . . . 0.0 112.664 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.23 -40.0 5.03 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.73 2.287 . . . . 0.0 112.739 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.23 168.8 8.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.462 HG23 HD13 ' A' ' 27' ' ' LEU . 21.3 t -128.36 126.86 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.019 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.429 ' CE1' HD11 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -90.43 95.37 10.14 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.594 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.01 85.75 3.32 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 89.02 6.37 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.274 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.541 HG22 ' CG1' ' A' ' 159' ' ' ILE . 1.1 p -84.36 162.78 19.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.165 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 160' ' ' ILE . 2.3 t -68.62 -34.07 75.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.46 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.514 ' CB ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -70.06 -33.36 71.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.1 -159.12 27.26 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.387 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.429 HD11 ' CE1' ' A' ' 15' ' ' TYR . 11.6 tt -122.52 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.877 0.339 . . . . 0.0 111.469 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG22 ' CA ' ' A' ' 135' ' ' GLY . 17.3 pt -139.16 137.8 41.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 131.18 61.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.423 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -128.59 144.59 51.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.865 0.365 . . . . 0.0 111.325 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -106.41 116.7 32.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.886 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 14' ' ' VAL . 8.9 mp -94.96 129.26 42.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.229 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.791 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 69.9 m-85 -63.41 101.5 0.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -82.01 18.34 1.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -100.38 -66.16 0.92 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.743 0.306 . . . . 0.0 110.474 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.5 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 3.0 t60 -100.65 -15.38 17.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.983 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.791 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -96.43 0.84 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_exo -42.32 -37.06 4.73 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.987 1.791 . . . . 0.0 112.753 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -54.17 39.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.533 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -35.05 79.81 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 73.9 m -60.11 -47.18 87.0 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.508 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -59.28 -39.71 83.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.495 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -47.24 84.26 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.21 -43.89 98.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.99 63.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.109 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.21 -37.56 87.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.961 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -63.41 -35.73 81.39 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.631 0.253 . . . . 0.0 110.862 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 162' ' ' ALA . . . -83.32 -36.06 24.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.558 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.36 -36.89 63.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.325 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -61.31 -36.58 80.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.525 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.62 30.88 3.37 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.938 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.94 -51.73 3.96 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.599 0.238 . . . . 0.0 110.433 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.422 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 4.0 m-85 -65.55 -29.57 70.2 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.27 101.09 0.88 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.253 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.59 30.02 3.43 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.38 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -111.21 151.33 28.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.976 0.388 . . . . 0.0 110.85 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.57 151.82 48.41 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -60.83 144.3 52.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 63' ' ' GLN . 16.5 p80 -113.71 -38.93 4.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.905 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.442 ' CD ' HD11 ' A' ' 57' ' ' ILE . 5.7 ttt180 -125.11 118.62 26.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.79 0.328 . . . . 0.0 111.257 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.903 HG23 HG12 ' A' ' 62' ' ' ILE . 3.3 mt -130.54 104.35 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.442 HD11 ' CD ' ' A' ' 55' ' ' ARG . 4.1 mp -98.28 115.19 37.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.976 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 137.19 57.14 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.922 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.65 35.43 19.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.652 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -151.09 -88.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.432 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -160.46 157.36 27.49 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.698 0.285 . . . . 0.0 111.041 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.903 HG12 HG23 ' A' ' 56' ' ' ILE . 6.6 mt -130.38 124.93 58.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.346 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.2 pt20 -112.27 148.72 33.55 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.77 109.54 0.59 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.374 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . -160.9 -179.63 35.77 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.228 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.27 61.21 5.74 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 120.805 0.335 . . . . 0.0 110.732 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.52 ' O ' HG23 ' A' ' 68' ' ' THR . 29.9 Cg_endo -64.17 -53.71 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.387 2.058 . . . . 0.0 112.097 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -167.81 41.1 0.04 OUTLIER 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.981 0.42 . . . . 0.0 110.645 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.49 64.47 3.23 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.264 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.7 t -175.28 -42.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.622 0.248 . . . . 0.0 111.055 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.83 91.05 0.71 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.069 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.86 37.71 18.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 111.053 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.37 90.86 0.41 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.404 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.32 102.9 0.23 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.447 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.31 136.17 32.96 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.658 0.266 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -113.1 167.12 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt -56.99 -39.35 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -80.34 -30.98 38.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.42 -167.05 29.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.848 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -63.07 -54.96 29.86 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.598 0.237 . . . . 0.0 110.678 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.775 ' HG2' HG23 ' A' ' 107' ' ' THR . 8.8 mp0 -135.7 139.26 43.53 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.817 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -123.93 172.02 9.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.83 179.2 1.49 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.196 0.522 . . . . 0.0 111.927 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.15 159.95 22.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.416 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.17 75.42 1.16 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.403 HD12 ' OG1' ' A' ' 127' ' ' THR . 0.4 OUTLIER -119.03 141.07 49.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.05 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.407 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -164.06 -63.28 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.55 ' HG2' HD11 ' A' ' 90' ' ' LEU . 70.9 Cg_endo -74.19 172.55 15.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.695 2.263 . . . . 0.0 112.956 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.51 95.5 5.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.867 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 1.005 HD22 HG21 ' A' ' 128' ' ' ILE . 5.9 mp -91.73 172.68 8.32 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 159.21 30.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.037 0.446 . . . . 0.0 111.382 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.4 41.68 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.17 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 94' ' ' GLY . 11.7 t -148.11 -47.18 0.16 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.854 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 93' ' ' THR . . . -55.28 122.09 24.92 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.757 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.45 126.88 8.62 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.616 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 102.91 63.06 0.71 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.281 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.616 HD13 ' O ' ' A' ' 96' ' ' GLY . 9.5 mm -130.42 137.79 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 117.056 0.428 . . . . 0.0 110.955 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 25' ' ' LEU . 7.7 tp -111.2 101.91 10.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.107 0.479 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -110.02 146.73 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.31 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.28 133.08 36.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.223 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 142.54 35.17 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -143.22 117.72 9.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.31 75.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.394 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.32 179.5 34.88 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.303 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.85 128.67 23.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.494 2.129 . . . . 0.0 111.934 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 58.79 35.31 24.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.775 HG23 ' HG2' ' A' ' 81' ' ' GLN . 85.5 m -143.19 89.33 2.09 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -106.19 155.41 19.49 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.95 -165.63 11.88 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.72 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.31 61.88 1.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.947 0.403 . . . . 0.0 110.888 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.57 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -153.34 155.8 37.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.04 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.16 161.03 43.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.072 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 14.2 p90 -130.79 141.33 50.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.3 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.697 HG11 HG11 ' A' ' 139' ' ' VAL . 11.4 t -102.74 110.6 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.479 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.89 109.15 15.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.032 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 61' ' ' MET . 0.9 OUTLIER -103.53 -6.82 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.917 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 119' ' ' THR . . . -122.81 142.85 38.84 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.387 0.136 . . . . 0.0 110.806 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.39 122.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.905 2.403 . . . . 0.0 112.577 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 117' ' ' ALA . 31.1 p -128.48 112.56 14.48 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.947 0.404 . . . . 0.0 111.279 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -94.92 -42.74 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.438 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 46.7 p90 -67.74 -31.88 72.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.336 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 122' ' ' LEU . 12.4 mt -89.36 -2.25 58.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.739 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -68.85 85.53 0.33 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.348 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.02 -25.6 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.72 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -57.01 -53.81 53.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.712 0.256 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -102.3 156.7 17.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.64 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 47.6 m -90.32 150.9 21.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.001 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 1.005 HG21 HD22 ' A' ' 90' ' ' LEU . 1.1 tt -79.88 -179.62 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.418 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.453 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -177.22 -35.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.88 179.99 29.7 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.828 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 161.9 36.87 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 122.827 -0.219 . . . . 0.0 110.659 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 132' ' ' VAL . 11.6 p -124.51 105.32 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.27 0.557 . . . . 0.0 111.528 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.51 -38.42 9.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.28 88.14 2.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.89 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.475 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 159.46 -22.31 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.351 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 tt -43.33 -38.81 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.4 -37.12 86.97 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.909 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -36.0 59.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.789 0.328 . . . . 0.0 110.124 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.697 HG11 HG11 ' A' ' 114' ' ' VAL . 23.7 t -66.76 -56.74 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.32 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -63.26 -24.43 67.87 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.258 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -58.67 -33.77 70.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.547 0.213 . . . . 0.0 110.816 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.775 HG12 HG21 ' A' ' 56' ' ' ILE . 26.0 t -63.84 -35.64 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.018 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.71 -39.5 60.07 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.312 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 mmt -53.66 -51.5 62.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -52.2 143.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.691 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -64.75 122.21 16.36 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.3 p -93.06 179.15 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -170.04 2.21 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.75 46.02 1.32 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.646 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -174.61 -76.53 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.835 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.58 30.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.31 118.64 60.85 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-O 120.656 0.265 . . . . 0.0 111.682 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HB3' HD13 ' A' ' 56' ' ' ILE . 38.1 Cg_endo -67.51 115.25 3.61 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.044 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.21 -31.48 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -171.04 2.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.619 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.26 97.38 6.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 157' ' ' VAL . 9.1 p -123.48 108.51 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.875 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 175.22 11.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.361 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.541 ' CG1' HG22 ' A' ' 18' ' ' THR . 3.6 mt -103.57 130.48 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.321 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 19' ' ' SER . 17.4 pt -106.73 -29.43 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.914 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.18 108.51 1.9 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.16 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.496 ' O ' ' HB1' ' A' ' 43' ' ' ALA . . . -120.37 114.37 21.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.187 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -154.1 149.22 20.26 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.44 ' HB2' ' CG ' ' A' ' 11' ' ' PRO . 97.5 Cg_endo -80.03 161.3 23.73 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.514 2.143 . . . . 0.0 112.6 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.8 t -165.38 -62.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.424 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ttm . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.675 0.274 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.24 73.02 1.34 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.76 86.54 2.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.249 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.5 tt -129.68 54.69 15.16 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.2 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HG2' ' HD3' ' A' ' 6' ' ' PRO . 1.6 Cg_endo -46.2 -54.33 4.83 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.78 2.32 . . . . 0.0 112.661 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HD3' ' HG2' ' A' ' 5' ' ' PRO . 62.5 Cg_endo -71.9 -170.18 0.52 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.206 1.937 . . . . 0.0 112.099 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.37 97.03 0.06 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 t -123.46 173.42 8.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.313 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.9 34.87 1.02 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.123 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.36 -60.45 3.32 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.323 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.85 112.71 3.34 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.516 2.144 . . . . 0.0 112.522 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.18 55.28 4.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.829 2.353 . . . . 0.0 112.069 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.36 166.32 11.8 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.019 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.26 46.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.03 96.49 8.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.815 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -86.3 94.73 9.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.766 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.554 ' HG2' HD11 ' A' ' 160' ' ' ILE . 4.3 tt0 -83.5 118.77 24.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.54 HG22 HG23 ' A' ' 159' ' ' ILE . 8.1 p -135.25 158.02 45.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.522 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -59.04 -36.72 75.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.747 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.736 ' CB ' HG13 ' A' ' 157' ' ' VAL . 8.0 tpt -67.03 -33.49 75.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.55 143.42 3.67 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.36 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.502 HD12 ' CB ' ' A' ' 17' ' ' GLU . 1.7 tt -82.57 126.83 40.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.471 HG22 ' HA2' ' A' ' 135' ' ' GLY . 2.7 pt -128.56 137.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' HB ' ' CG ' ' A' ' 134' ' ' GLN . 20.6 t -99.86 135.37 35.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.02 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -135.67 147.56 48.59 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.315 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.24 129.56 38.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.6 HD21 HD12 ' A' ' 25' ' ' LEU . 4.5 mm? -104.78 131.97 51.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.337 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.808 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 22.8 m-85 -76.07 99.65 4.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.0 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -83.03 18.18 1.73 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -67.32 0.86 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.489 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 2.3 m-70 -100.69 -13.28 18.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.59 1.71 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.2 Cg_exo -40.86 -36.4 2.0 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.062 1.841 . . . . 0.0 112.927 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -47.74 79.38 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.688 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.613 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.7 OUTLIER -78.35 -36.76 45.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.906 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.3 t -57.98 -47.63 82.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.655 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -42.97 75.1 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.197 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -58.89 -53.7 55.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -41.46 70.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.997 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.1 54.65 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.27 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -45.44 93.09 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.176 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -35.4 71.19 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.136 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -84.21 -36.48 22.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.298 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -47.23 68.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.232 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -58.22 -25.82 62.11 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.757 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.33 13.0 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.817 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.49 -34.74 18.55 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.643 0.259 . . . . 0.0 110.935 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.429 ' HE2' HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -76.15 -25.42 55.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -65.08 93.62 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 110.245 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.08 -20.11 3.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.106 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.817 ' HB ' HD12 ' A' ' 159' ' ' ILE . 2.2 m -58.12 157.41 8.19 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.906 0.353 . . . . 0.0 111.508 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -138.92 169.39 17.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.482 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' HB3' HD11 ' A' ' 56' ' ' ILE . 9.9 m-85 -96.86 83.47 3.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.96 -45.24 78.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -99.77 120.66 40.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.754 0.311 . . . . 0.0 111.026 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.867 HD12 ' HG2' ' A' ' 153' ' ' PRO . 19.3 mt -145.68 98.54 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.295 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.11 107.09 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -39.09 93.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.538 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.66 41.3 0.89 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.41 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.986 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.51 171.53 18.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 111.115 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.726 HG21 HG23 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -131.77 151.67 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.824 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -134.32 161.77 34.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.587 0.708 . . . . 0.0 112.524 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.81 109.33 0.41 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 111' ' ' GLN . . . -160.2 -179.25 34.85 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.145 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.4 76.34 3.74 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 110.75 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.36 143.49 19.67 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.646 2.231 . . . . 0.0 112.58 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.8 p -98.4 29.5 3.59 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.442 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.82 -27.25 63.08 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.454 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -112.38 -30.11 7.28 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.27 22.87 5.69 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.943 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.28 16.67 13.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.847 0.324 . . . . 0.0 111.236 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.98 150.19 17.12 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.411 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.04 168.82 28.95 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.14 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.09 175.47 8.53 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.213 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 t -104.51 158.64 16.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.012 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 78' ' ' TYR . 2.6 pp -57.23 -27.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.298 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.751 ' N ' HD12 ' A' ' 77' ' ' ILE . 19.3 m-85 -82.28 -33.14 29.23 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.904 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.02 -158.53 27.66 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.33 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.71 -72.71 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.874 0.337 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.416 ' HB3' HG23 ' A' ' 107' ' ' THR . 15.8 mm100 -133.1 140.75 47.81 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 108' ' ' ASN . 44.0 p90 -130.03 166.93 19.1 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 111.57 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.25 110.0 21.94 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.345 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.06 178.35 4.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.485 ' HB3' HG21 ' A' ' 127' ' ' THR . 2.0 mm-40 62.9 166.42 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.685 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.38 106.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.587 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.411 ' CB ' ' HD3' ' A' ' 88' ' ' PRO . 1.2 m80 -172.11 -61.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.085 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 87' ' ' HIS . 87.9 Cg_endo -80.84 -173.38 1.82 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.652 2.235 . . . . 0.0 112.616 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.58 95.62 5.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.949 ' HG ' HG21 ' A' ' 128' ' ' ILE . 2.6 mm? -77.03 -176.33 3.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -70.21 0.47 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.72 70.58 0.63 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.38 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -75.75 -39.08 57.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 119.93 -42.06 1.83 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.362 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.55 100.22 11.21 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.735 0.302 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.585 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 89.23 55.22 2.13 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.915 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 96' ' ' GLY . 37.3 mm -130.61 130.75 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.653 0.264 . . . . 0.0 110.867 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 129' ' ' PHE . 2.7 mt -102.92 104.27 14.48 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.738 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -108.63 142.42 39.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.32 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.613 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.5 123.53 27.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.47 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 143.9 32.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.491 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.48 136.34 14.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.69 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.56 179.32 32.49 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.926 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 139.61 63.0 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.398 2.065 . . . . 0.0 112.122 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 59.81 44.91 13.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.308 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 81' ' ' GLN . 87.6 m -146.99 85.97 1.63 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 68.3 m-80 -106.56 152.13 24.11 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.51 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 -138.95 3.62 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.808 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.47 60.84 0.73 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.505 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -150.83 146.25 26.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.379 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CD2' ' HG2' ' A' ' 100' ' ' MET . 3.8 m-85 -149.72 160.08 43.82 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.391 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.738 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 31.4 p90 -134.66 134.37 41.07 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.483 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 98' ' ' LEU . 24.1 t -104.04 110.02 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.238 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.498 HG21 HG21 ' A' ' 119' ' ' THR . 45.1 p -80.96 138.27 36.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.977 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 -18.91 11.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.512 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.39 158.29 35.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.464 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 85.4 Cg_exo -44.84 128.74 9.16 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.848 2.366 . . . . 0.0 112.902 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.806 HG22 HD12 ' A' ' 122' ' ' LEU . 22.8 p -131.94 33.79 3.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -61.64 -37.79 85.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.831 0.348 . . . . 0.0 110.58 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -79.6 -27.78 41.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.136 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.806 HD12 HG22 ' A' ' 119' ' ' THR . 19.8 mt -75.52 -5.15 43.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.89 84.69 0.08 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.179 0.514 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 163.3 -41.14 0.33 Allowed Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.415 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -59.12 -57.29 13.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.625 0.25 . . . . 0.0 110.783 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -109.53 173.69 6.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.639 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 28.2 m -106.67 160.14 15.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.949 HG21 ' HG ' ' A' ' 90' ' ' LEU . 2.3 tt -87.51 179.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.226 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.568 ' HE1' HD11 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -176.79 -40.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.397 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.08 -179.8 27.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.276 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -144.08 167.26 22.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.494 0.187 . . . . 0.0 110.837 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 132' ' ' VAL . 30.5 m -125.08 107.21 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -43.99 12.14 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.403 ' CG ' ' HB ' ' A' ' 24' ' ' VAL . 7.2 pt20 -132.06 90.59 2.84 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.898 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 168.96 -27.77 0.13 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.341 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.507 HD12 ' CA ' ' A' ' 96' ' ' GLY . 12.3 tt -44.28 -36.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -41.04 75.06 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.694 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.679 ' O ' HG23 ' A' ' 142' ' ' VAL . 11.4 tmm? -68.59 -36.55 78.87 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 110.755 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.449 HG13 HD11 ' A' ' 62' ' ' ILE . 35.1 t -73.62 -35.46 44.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -72.17 -39.39 68.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.192 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 138' ' ' MET . 7.5 ptp180 -62.57 -31.69 72.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.727 HG11 HD13 ' A' ' 56' ' ' ILE . 22.0 t -56.51 -31.0 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.632 0.253 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.85 -22.98 40.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.714 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.5 mmt -76.8 -4.54 44.02 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.27 32.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.646 0.26 . . . . 0.0 111.489 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.79 169.96 0.19 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 111.432 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -152.67 175.84 12.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.399 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 0.6 OUTLIER -79.92 -174.72 4.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.76 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.7 p -89.4 36.59 0.84 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.572 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -166.32 -72.42 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.392 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -174.13 70.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.666 0.269 . . . . 0.0 110.825 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -153.37 99.73 2.65 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.625 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.867 ' HG2' HD12 ' A' ' 56' ' ' ILE . 51.0 Cg_exo -53.6 154.35 16.1 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.988 2.459 . . . . 0.0 113.308 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -76.18 -34.11 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.973 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -170.65 2.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.682 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -127.48 110.83 13.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.976 0.417 . . . . 0.0 111.436 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.736 HG13 ' CB ' ' A' ' 20' ' ' MET . 35.5 t -108.54 121.0 60.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 18' ' ' THR . 3.0 pttt -145.24 152.65 40.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.593 0.235 . . . . 0.0 111.203 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.817 HD12 ' HB ' ' A' ' 51' ' ' THR . 30.4 mt -93.21 138.97 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.086 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 17' ' ' GLU . 9.9 pt -109.76 -35.61 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.938 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.66 146.58 4.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.499 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -132.17 115.85 16.24 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -133.56 156.19 79.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.68 170.93 16.35 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.676 2.251 . . . . 0.0 112.741 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.55 94.76 6.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.361 -1.244 . . . . 0.0 112.288 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptt? . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -97.93 154.36 17.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.513 0.197 . . . . 0.0 111.064 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 71.13 138.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.95 98.01 32.2 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.924 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -51.95 160.29 3.14 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.987 2.458 . . . . 0.0 112.536 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.74 120.58 6.72 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.903 2.402 . . . . 0.0 112.777 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -125.33 125.94 44.28 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.856 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m 64.0 174.32 0.18 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.401 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.73 159.84 19.15 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.526 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -83.26 135.82 43.94 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.96 116.02 4.14 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.707 2.271 . . . . 0.0 112.358 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.4 -33.99 28.04 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.689 2.259 . . . . 0.0 112.441 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -126.36 142.51 51.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 164' ' ' PRO . 27.5 m -126.85 153.64 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.286 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -111.34 100.65 9.22 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.4 110.59 19.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -87.39 108.23 18.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.558 HG22 ' CG1' ' A' ' 159' ' ' ILE . 1.0 OUTLIER -114.02 156.38 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -61.7 -31.58 71.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.362 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.792 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -71.12 -34.64 71.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.68 -156.22 26.33 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.362 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.2 tt -127.53 128.26 69.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.814 0.307 . . . . 0.0 111.142 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.637 HG22 ' HA2' ' A' ' 135' ' ' GLY . 11.6 pt -141.0 138.73 34.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.497 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.502 ' O ' HD23 ' A' ' 25' ' ' LEU . 22.3 m -97.46 148.27 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 24' ' ' VAL . 16.3 mt -123.49 122.83 39.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.367 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.11 94.96 6.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.254 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 36' ' ' CYS . 8.8 mp -82.41 147.26 28.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.976 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.699 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 52.6 m-85 -72.26 102.0 2.99 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -81.16 15.76 1.8 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -69.82 0.75 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 110.277 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.491 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.59 -13.99 18.36 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.164 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.81 1.58 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 72.3 Cg_exo -41.4 -36.75 2.93 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.065 1.844 . . . . 0.0 112.844 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -52.33 63.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.773 0.321 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -64.97 -40.45 95.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.357 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.73 ' HA ' HD23 ' A' ' 27' ' ' LEU . 46.2 t -56.5 -48.38 77.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.467 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -58.79 -42.88 90.09 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.256 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -60.2 -51.9 67.61 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HE1' ' HH ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -61.24 -41.63 97.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.92 85.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.697 ' HB3' HD13 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -67.05 -42.09 85.36 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.286 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 76' ' ' SER . 0.1 OUTLIER -62.57 -34.01 76.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.646 0.26 . . . . 0.0 111.153 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -83.59 -31.73 26.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -84.22 -38.92 19.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.558 0.218 . . . . 0.0 111.474 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -61.4 -58.44 8.2 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.85 65.17 0.04 OUTLIER Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.75 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.39 -62.08 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.584 0.23 . . . . 0.0 110.827 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' HH ' ' HE1' ' A' ' 39' ' ' PHE . 3.9 m-85 -60.59 -42.63 97.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.174 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -67.47 101.18 0.94 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.681 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.49 -32.99 2.11 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.437 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 65' ' ' GLY . 14.5 t -86.66 -168.59 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.752 0.31 . . . . 0.0 111.391 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -150.31 -174.16 4.66 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.692 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.617 ' HB3' HD11 ' A' ' 56' ' ' ILE . 8.1 m-85 -83.38 122.12 28.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.414 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -103.29 11.88 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.524 ' O ' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -157.62 111.33 2.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.853 HG23 HG22 ' A' ' 62' ' ' ILE . 21.6 mm -134.9 120.07 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.7 mp -109.78 115.23 49.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.493 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -54.78 124.43 16.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.465 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 58.38 57.4 3.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -165.1 -81.68 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.368 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.496 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -160.71 173.33 15.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 111.617 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.853 HG22 HG23 ' A' ' 56' ' ' ILE . 42.3 pt -142.87 140.51 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.942 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -122.17 153.81 38.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.243 0.544 . . . . 0.0 111.969 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.38 146.42 16.48 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.826 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.561 ' O ' HG21 ' A' ' 51' ' ' THR . . . -110.85 139.32 15.46 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.33 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 110' ' ' SER . 4.9 t70 -158.92 53.52 0.59 Allowed Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 120.836 0.35 . . . . 0.0 111.079 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 66' ' ' ASP . 60.9 Cg_endo -85.88 -177.84 2.68 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.992 2.461 . . . . 0.0 113.137 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 73' ' ' GLY . 1.3 p -155.79 31.17 0.36 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.784 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.32 59.73 1.92 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.574 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 p -112.32 28.78 8.47 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 111.043 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.42 32.3 83.75 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.691 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.87 -70.47 0.77 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.471 0.177 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 68' ' ' THR . . . -160.45 158.83 30.29 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.34 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.4 104.53 0.47 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.782 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -160.4 121.21 2.97 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.57 0.224 . . . . 0.0 111.395 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.561 ' HB2' HD11 ' A' ' 42' ' ' LEU . 13.0 p -92.26 -52.4 4.7 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.762 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 41' ' ' GLU . 1.1 tp -172.6 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.954 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.435 ' N ' HG23 ' A' ' 77' ' ' ILE . 25.1 m-85 -102.18 -32.92 9.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.68 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 176.99 179.33 47.33 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.385 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.27 11.42 30.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.1 110.21 0.15 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.606 0.241 . . . . 0.0 110.998 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 34.7 p90 -126.88 161.04 29.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.0 179.78 2.61 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.302 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.3 177.48 5.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -139.17 103.96 4.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.272 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.1 tp -154.17 134.33 13.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.425 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -171.44 -61.3 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.131 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 87' ' ' HIS . 18.4 Cg_endo -60.31 171.33 3.31 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.682 2.255 . . . . 0.0 112.716 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -78.36 107.64 11.13 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.997 0.427 . . . . 0.0 111.195 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.468 ' CD1' HG21 ' A' ' 128' ' ' ILE . 4.0 mm? -109.44 162.32 14.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.932 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -118.31 150.83 38.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.461 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 96.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 15.0 t -175.45 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.627 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.34 120.25 21.11 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.064 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 116' ' ' LEU . . . -49.95 106.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.624 ' CA ' HD13 ' A' ' 136' ' ' ILE . . . 117.33 69.95 0.4 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.014 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 96' ' ' GLY . 10.1 mm -131.74 139.62 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.569 0.224 . . . . 0.0 111.223 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 114' ' ' VAL . 0.8 OUTLIER -106.25 104.94 14.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.622 179.245 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -109.84 144.09 38.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.49 128.6 33.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.65 167.77 20.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.259 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' A' ' 126' ' ' HIS . 3.5 p-10 -159.53 117.53 2.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.773 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.25 -40.28 52.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.142 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.94 160.72 31.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.9 125.84 20.01 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.66 2.24 . . . . 0.0 112.175 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 58.54 30.93 20.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.6 m -142.61 84.4 1.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.992 0.425 . . . . 0.0 110.25 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.448 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 2.8 m-20 -123.71 165.9 16.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.582 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.76 -103.33 0.92 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 38.0 m -151.23 43.26 0.77 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 111.172 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -105.09 154.18 20.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.323 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -155.39 159.31 39.78 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.664 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 15.1 p90 -138.33 139.61 39.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.449 . . . . 0.0 111.611 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.742 HG22 HD23 ' A' ' 98' ' ' LEU . 16.9 t -115.56 110.95 33.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.54 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.448 HG21 ' OG1' ' A' ' 119' ' ' THR . 0.3 OUTLIER -79.8 113.7 18.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.551 ' O ' ' HB1' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -83.8 -16.21 45.49 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.594 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.84 162.54 51.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.473 0.177 . . . . 0.0 110.885 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 93' ' ' THR . 50.6 Cg_exo -53.85 131.51 44.71 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.901 2.401 . . . . 0.0 112.702 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.448 ' OG1' HG21 ' A' ' 115' ' ' THR . 1.8 p -143.5 105.07 4.31 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 -43.65 6.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -58.61 -31.84 68.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.148 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.6 -17.94 52.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.529 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -65.66 85.25 0.07 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 110.466 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 153.46 -35.43 0.76 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.363 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -50.53 62.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.692 0.282 . . . . 0.0 110.908 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' HA ' ' OD1' ' A' ' 102' ' ' ASN . 24.9 m-70 -112.44 147.61 36.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.454 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.753 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 12.9 t -79.81 170.11 16.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.828 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.3 tt -99.69 -179.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -171.7 -38.41 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 27' ' ' LEU . . . -151.76 -179.41 27.4 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.082 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.449 ' C ' HD12 ' A' ' 98' ' ' LEU . 1.8 ttm105 -135.74 148.12 48.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.83 102.13 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.113 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.45 -63.5 1.28 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.495 ' O ' HG22 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -114.3 82.71 1.76 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.655 178.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.637 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . -178.75 -24.09 0.04 OUTLIER Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.916 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.624 HD13 ' CA ' ' A' ' 96' ' ' GLY . 9.2 tp -46.75 -34.55 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 117.266 0.533 . . . . 0.0 112.297 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.22 -22.09 54.97 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.868 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.652 ' O ' HG23 ' A' ' 142' ' ' VAL . 8.8 tmm? -93.44 -39.35 10.95 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.644 HG13 HD11 ' A' ' 62' ' ' ILE . 32.3 t -59.43 -54.28 36.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.065 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.401 ' HA ' HD13 ' A' ' 116' ' ' LEU . 28.5 p30 -59.07 -33.25 70.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.675 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -38.52 91.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 138' ' ' MET . 20.7 t -57.47 -36.0 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.685 0.279 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.16 -34.43 69.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.397 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.1 mtt -58.59 -40.83 84.26 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 155' ' ' ASP . 1.6 t -54.01 119.01 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.26 121.74 12.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.596 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.1 t -89.83 168.73 11.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.134 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -81.8 -170.04 2.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.45 31.24 1.04 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.594 0.235 . . . . 0.0 111.442 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.67 30.37 0.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.65 53.73 10.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.488 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.16 134.6 25.27 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.21 116.69 4.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.592 2.195 . . . . 0.0 112.322 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.09 -35.27 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.625 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.43 ' HB2' HG11 ' A' ' 145' ' ' VAL . 0.8 OUTLIER -82.71 -169.26 2.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.567 179.25 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.42 101.67 11.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 20' ' ' MET . 26.2 t -130.42 108.27 15.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.238 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -179.97 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.621 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.558 ' CG1' HG22 ' A' ' 18' ' ' THR . 1.5 mt -111.57 145.33 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.248 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.494 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -121.64 -35.0 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.898 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.8 149.46 26.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.27 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.428 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -145.48 121.48 10.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.459 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -144.95 155.36 55.54 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.392 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.403 ' HB3' HG12 ' A' ' 14' ' ' VAL . 95.4 Cg_endo -80.21 168.18 18.86 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.691 2.26 . . . . 0.0 112.257 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.7 t -142.46 154.21 44.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.148 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.821 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.458 0.17 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.4 -59.2 1.96 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.962 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -111.97 132.28 54.87 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.951 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 4' ' ' ILE . 5.9 tp -118.77 70.04 9.38 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 121.349 0.595 . . . . 0.0 110.692 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.33 173.58 13.53 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.75 2.3 . . . . 0.0 111.856 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.61 -26.36 36.98 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.644 2.229 . . . . 0.0 112.741 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 61.45 58.61 2.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 111.131 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.66 137.16 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.47 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -160.69 129.28 4.66 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.595 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -169.83 -62.0 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.859 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.85 118.36 5.65 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.494 2.13 . . . . 0.0 112.56 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.31 -2.48 12.68 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.808 2.339 . . . . 0.0 113.275 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -89.93 142.95 27.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.649 0.261 . . . . 0.0 111.208 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -131.43 136.59 57.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.164 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.3 108.29 19.85 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.28 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.427 ' HG ' ' HB1' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -107.28 99.53 9.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.99 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -82.16 110.29 17.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.71 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.648 HG22 ' CG1' ' A' ' 159' ' ' ILE . 2.3 p -112.31 161.51 16.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 p -62.81 -37.12 85.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.235 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.741 ' HB2' HG13 ' A' ' 157' ' ' VAL . 1.3 tpt -68.46 -30.01 68.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.27 -154.33 24.54 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.345 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.86 128.76 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.864 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.85 145.06 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.79 119.12 60.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.549 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -115.04 155.56 26.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -110.76 115.01 28.82 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.757 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 mt -87.0 147.86 25.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.797 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.763 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 35.1 m-85 -84.81 104.58 14.89 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.629 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -82.55 21.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.2 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -69.52 0.77 Allowed 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.505 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.81 18.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.942 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.1 1.27 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.3 Cg_exo -41.43 -38.16 3.68 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.054 1.836 . . . . 0.0 112.819 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -54.15 50.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.321 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.833 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -69.68 -33.62 72.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -55.92 -56.01 25.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -61.24 -39.07 88.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.344 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.458 ' ND2' HG12 ' A' ' 77' ' ' ILE . 0.1 OUTLIER -59.97 -38.86 83.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.019 179.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -46.74 80.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.15 77.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.537 ' HB3' HG21 ' A' ' 77' ' ' ILE . 1.2 mm-40 -61.03 -50.55 72.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.068 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 1.4 mp -57.49 -40.13 77.96 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.992 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.6 67.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.342 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -73.02 -50.83 20.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -60.77 -28.56 68.82 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.847 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.49 28.34 5.47 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.733 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -89.67 -41.32 12.0 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.612 0.206 . . . . 0.0 110.729 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 5.5 m-85 -72.01 -31.13 65.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.281 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.69 102.86 0.21 Allowed 'General case' 0 C--O 1.233 0.202 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.71 11.76 9.13 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.487 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 67' ' ' PRO . 20.3 p -95.55 168.46 10.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.392 0.596 . . . . 0.0 110.827 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -157.55 169.54 24.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.678 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.859 ' HB3' HD11 ' A' ' 56' ' ' ILE . 47.3 m-85 -94.86 100.71 12.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.552 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -88.84 -43.64 11.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.819 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.555 ' O ' HD13 ' A' ' 56' ' ' ILE . 7.3 mtt180 -90.97 108.61 19.97 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.694 0.283 . . . . 0.0 110.612 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 1.046 HG23 HG22 ' A' ' 62' ' ' ILE . 36.1 mm -131.99 140.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.264 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.421 HD13 ' HG3' ' A' ' 61' ' ' MET . 4.3 mp -116.75 116.84 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.715 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 122.85 14.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.402 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 61.93 51.05 3.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.331 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.88 -80.15 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.234 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.421 ' HG3' HD13 ' A' ' 57' ' ' ILE . 1.3 ptm -160.6 172.2 17.58 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 111.33 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.046 HG22 HG23 ' A' ' 56' ' ' ILE . 1.2 pp -132.86 115.71 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 16.0 pt20 -104.69 138.28 41.24 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 0.0 111.986 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.32 110.5 1.08 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.962 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.36 179.44 35.87 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.841 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.68 69.53 0.61 Allowed Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 121.144 0.497 . . . . 0.0 110.628 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.473 ' HB3' ' CG2' ' A' ' 51' ' ' THR . 25.4 Cg_endo -62.56 -71.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.909 2.406 . . . . 0.0 112.542 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.478 HG22 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER 46.04 47.2 12.83 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.94 -32.27 66.18 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.775 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.6 t -83.28 -31.43 26.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.508 0.194 . . . . 0.0 111.258 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 80.18 32.49 35.22 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.465 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -150.54 -62.71 0.2 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.678 0.275 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.43 121.14 3.94 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.485 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.08 79.67 0.21 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.266 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.82 158.87 17.71 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.901 0.381 . . . . 0.0 111.119 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -74.55 162.25 28.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.406 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 41' ' ' GLU . 2.8 pt -61.45 -27.24 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.052 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -96.45 30.69 2.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.103 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.18 -146.94 16.68 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.971 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 -25.65 11.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -148.33 139.97 23.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.557 0.217 . . . . 0.0 110.794 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 m-85 -87.38 -174.42 4.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.488 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.17 69.9 1.15 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.733 0.301 . . . . 0.0 111.744 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 66.13 146.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.939 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.616 ' O ' HG21 ' A' ' 127' ' ' THR . 6.4 mt-10 -155.38 36.37 0.38 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.13 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tp -65.91 149.9 49.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 111.526 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 11.5 p80 -99.82 152.03 37.68 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.75 -50.42 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.586 2.191 . . . . 0.0 112.24 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.82 146.97 14.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -171.9 173.84 4.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -90.66 160.91 15.62 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.876 0.369 . . . . 0.0 111.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.52 61.14 0.75 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.978 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.34 -36.06 75.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.88 -20.38 46.02 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.238 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.55 112.66 25.68 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.163 0.482 . . . . 0.0 110.959 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.459 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 72.62 56.86 5.76 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.331 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.0 mm -124.15 161.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.483 0.183 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 132' ' ' VAL . 3.4 mt -142.08 106.35 4.79 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 110.446 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.752 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -114.52 144.04 44.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.833 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.83 110.92 15.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.48 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.71 145.55 31.52 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -124.19 174.75 7.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.26 -45.13 4.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.476 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.96 174.82 36.8 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.778 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.89 141.3 67.04 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.658 2.239 . . . . 0.0 112.152 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 45.2 30.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.914 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -149.93 87.53 1.48 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.78 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.48 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 60.8 m-80 -95.4 172.84 7.84 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.43 -171.43 12.19 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.717 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 m -103.52 45.7 0.95 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.023 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -115.25 168.34 10.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.564 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 24.1 p90 -160.59 171.86 18.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.454 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.752 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 42.0 p90 -152.28 131.56 12.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.851 0.358 . . . . 0.0 111.645 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 139' ' ' VAL . 34.1 t -96.41 116.78 39.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.358 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.482 HG21 ' OG1' ' A' ' 119' ' ' THR . 0.2 OUTLIER -79.59 127.98 32.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.704 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.63 HD22 ' HA ' ' A' ' 140' ' ' ASN . 3.2 mt -113.36 -8.4 13.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.561 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -131.59 161.56 61.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.456 0.17 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 20.3 Cg_endo -59.95 121.77 10.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.873 2.382 . . . . 0.0 112.603 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.482 ' OG1' HG21 ' A' ' 115' ' ' THR . 0.9 OUTLIER -143.09 49.02 1.47 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.078 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -31.84 69.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.124 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -65.84 -28.48 69.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.186 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.552 HD23 ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -75.89 -7.36 54.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.899 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -66.14 85.57 0.09 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.124 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.68 -41.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.351 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB2' HD23 ' A' ' 122' ' ' LEU . 20.5 mttt -67.1 -49.56 64.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.548 0.213 . . . . 0.0 111.036 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.32 140.86 48.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.664 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 97.8 m -85.07 151.4 24.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 129' ' ' PHE . 0.6 OUTLIER -79.46 -178.98 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.275 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.659 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.7 OUTLIER -169.34 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 -179.51 26.17 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.66 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -143.3 155.59 44.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.525 0.203 . . . . 0.0 110.689 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.526 HG13 HD12 ' A' ' 98' ' ' LEU . 16.0 m -114.39 85.08 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.164 0.507 . . . . 0.0 112.24 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.97 -40.01 40.67 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.05 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -127.52 98.33 5.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.65 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.79 -12.3 1.3 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.622 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.452 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 15.5 tt -50.54 -30.35 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 117.255 0.527 . . . . 0.0 111.938 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.79 -12.13 67.13 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.29 -0.481 . . . . 0.0 113.417 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.05 -30.05 12.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.793 0.296 . . . . 0.0 110.814 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 114' ' ' VAL . 2.5 m -84.61 -34.85 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.434 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.63 ' HA ' HD22 ' A' ' 116' ' ' LEU . 53.7 p30 -61.52 -28.21 69.16 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.279 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.635 ' O ' HG13 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -78.55 -30.83 47.11 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.855 -0.157 . . . . 0.0 111.298 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.482 ' HB ' HG21 ' A' ' 62' ' ' ILE . 39.3 t -57.47 -36.88 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.688 0.28 . . . . 0.0 110.738 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.11 -30.27 11.32 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.208 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -65.15 -31.94 73.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 141' ' ' ARG . 27.1 m -61.38 176.38 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.98 0.419 . . . . 0.0 111.569 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.38 172.75 12.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -147.79 166.15 28.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -142.74 159.21 42.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 m 85.49 -40.86 0.05 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.508 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 168.36 -37.63 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -169.62 37.25 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.358 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.22 124.99 36.4 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.85 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.462 ' HG3' HG13 ' A' ' 56' ' ' ILE . 51.9 Cg_exo -54.74 109.49 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.71 2.273 . . . . 0.0 112.478 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.1 p -64.13 -30.85 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.922 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.64 -171.67 3.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.719 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.13 117.84 32.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.741 HG13 ' HB2' ' A' ' 20' ' ' MET . 21.6 t -142.07 121.88 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.21 178.53 10.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.726 0.298 . . . . 0.0 111.732 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.648 ' CG1' HG22 ' A' ' 18' ' ' THR . 3.3 mt -110.84 143.45 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.062 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.38 -40.45 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.38 153.06 17.2 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.669 0.271 . . . . 0.0 111.211 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.427 ' HB1' ' HG ' ' A' ' 16' ' ' LEU . . . -150.88 141.6 22.74 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -154.51 156.45 31.62 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.55 162.94 24.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.448 2.099 . . . . 0.0 112.5 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -85.88 144.51 27.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.076 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 118.684 -1.065 . . . . 0.0 112.954 179.789 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtm . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.901 0.381 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.01 111.28 0.28 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.54 -60.21 0.94 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.262 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -65.35 130.1 94.61 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.996 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.53 112.8 3.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.733 2.289 . . . . 0.0 112.468 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.66 161.02 29.94 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.944 2.429 . . . . 0.0 112.97 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.2 33.54 1.52 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.287 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.81 134.74 7.94 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.684 0.278 . . . . 0.0 111.168 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -111.21 128.29 55.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.52 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.07 81.56 2.19 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.78 107.85 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.882 2.388 . . . . 0.0 112.823 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.57 -42.87 2.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.951 2.434 . . . . 0.0 111.912 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -125.05 174.88 7.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.783 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' A' ' 27' ' ' LEU . 9.5 p -148.16 130.33 6.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.404 ' HB2' ' CB ' ' A' ' 163' ' ' TYR . 10.4 m-85 -105.36 106.3 16.73 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 107.15 18.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.498 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HG2' HD12 ' A' ' 22' ' ' ILE . 11.2 mt-10 -86.61 82.35 7.93 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.354 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.65 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.8 OUTLIER -91.62 165.32 13.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.28 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -67.4 -37.15 82.65 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.729 ' HB2' HG13 ' A' ' 157' ' ' VAL . 12.9 tpt -62.44 -32.97 73.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.82 -148.53 14.4 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.194 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.475 HD12 ' HG2' ' A' ' 17' ' ' GLU . 4.8 tt -134.83 130.14 52.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.861 0.331 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.647 HG22 ' CA ' ' A' ' 135' ' ' GLY . 15.5 pt -137.62 135.58 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.637 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.73 140.24 17.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.599 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 98' ' ' LEU . 2.0 mt -130.87 141.0 50.28 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.588 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.82 107.91 19.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.524 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.433 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -84.49 146.68 27.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.665 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 23.0 m-85 -79.86 92.04 5.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -80.69 19.48 0.82 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.01 -72.44 0.67 Allowed 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.48 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -101.1 -12.1 19.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.017 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.9 1.34 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 71.7 Cg_exo -41.09 -36.38 2.24 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.248 1.966 . . . . 0.0 112.965 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -58.02 -60.37 3.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.353 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -39.31 91.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.337 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 27' ' ' LEU . 14.0 t -55.01 -48.68 73.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.446 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -60.61 -37.29 80.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -58.35 -54.22 49.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.767 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -61.13 -45.84 93.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 110.826 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.39 94.02 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.31 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.5 -44.07 58.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.251 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -37.91 70.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.117 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -80.93 -32.66 34.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.413 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -66.94 -45.95 76.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.124 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -28.42 68.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.736 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.04 36.18 2.79 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.733 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.19 -50.13 5.64 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.637 0.218 . . . . 0.0 110.697 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -62.75 -28.65 70.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.939 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -67.63 113.66 5.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.422 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.6 20.9 7.08 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.359 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.2 p -124.93 154.73 40.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.038 0.419 . . . . 0.0 110.53 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -129.56 169.66 14.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CD1' HG12 ' A' ' 157' ' ' VAL . 34.1 m-85 -85.31 99.07 10.9 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.783 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -76.86 -39.4 51.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.169 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -100.98 117.28 34.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.607 0.241 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.62 HG23 ' CG1' ' A' ' 62' ' ' ILE . 13.2 mt -141.11 120.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.0 111.379 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 mt -116.22 116.56 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.795 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -56.59 -60.28 3.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.563 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -88.47 62.38 6.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.605 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 178.25 -86.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.272 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.413 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -161.2 170.94 19.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.809 0.337 . . . . 0.0 111.554 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.62 ' CG1' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -127.23 123.09 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.139 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 1.7 pt20 -117.4 155.19 30.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.22 100.63 0.41 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.453 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 111' ' ' GLN . . . -107.22 175.89 20.73 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.58 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -143.6 67.33 16.15 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 120.952 0.406 . . . . 0.0 110.57 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.17 163.61 22.42 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.79 2.327 . . . . 0.0 112.715 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.747 HG23 ' HA3' ' A' ' 73' ' ' GLY . 2.9 m -114.61 43.85 1.85 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.921 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.44 23.41 30.24 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.613 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.75 -30.89 9.62 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.438 0.161 . . . . 0.0 111.395 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.85 28.99 7.94 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.585 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.12 32.65 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.747 ' HA3' HG23 ' A' ' 68' ' ' THR . . . -108.19 157.62 15.23 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.544 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.04 174.13 27.28 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.131 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.04 157.08 18.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.365 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 8.5 t -76.69 171.76 14.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.364 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 tt -73.23 -34.09 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.489 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -100.33 36.75 1.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 111.131 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 76' ' ' SER . . . 89.05 169.07 44.32 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.071 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -52.42 63.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.429 0.157 . . . . 0.0 110.786 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -141.61 143.26 33.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.862 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -138.56 173.57 11.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.525 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.18 173.43 11.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.396 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 4.3 p30 -80.19 178.46 8.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -132.21 72.91 1.51 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.467 ' N ' HD22 ' A' ' 86' ' ' LEU . 3.4 mm? -99.17 104.73 16.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.85 -54.23 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HB2' HD21 ' A' ' 90' ' ' LEU . 71.4 Cg_exo -48.72 149.99 6.79 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.78 2.32 . . . . 0.0 112.703 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.54 94.9 2.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.508 HD22 ' CG2' ' A' ' 128' ' ' ILE . 3.0 mt -90.16 -174.94 4.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.721 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -69.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.638 ' HD1' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER 62.06 61.28 1.37 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.113 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.7 p -57.62 -36.86 72.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.413 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 118' ' ' PRO . . . 147.64 -101.52 0.23 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.613 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' A' ' 136' ' ' ILE . . . -71.95 135.17 46.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.974 0.416 . . . . 0.0 111.736 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 77.93 52.65 5.26 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.994 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 96' ' ' GLY . 17.1 mm -135.81 138.67 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.94 HD13 HG22 ' A' ' 114' ' ' VAL . 13.3 tp -115.33 133.75 55.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.8 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -134.13 151.65 51.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 116.35 19.64 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.36 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.92 158.51 26.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.857 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -121.03 173.45 7.25 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.293 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.24 -43.98 3.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.181 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.95 -179.43 33.78 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.65 113.23 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.05 30.54 20.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.12 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -129.82 90.77 3.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -83.21 162.77 21.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.94 -140.94 4.5 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.57 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 m -138.58 58.49 1.66 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.076 0.465 . . . . 0.0 110.802 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 3.3 mt-30 -132.78 178.23 7.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.821 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -160.45 158.02 28.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.057 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.72 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 41.3 p90 -137.36 133.02 34.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.94 HG22 HD13 ' A' ' 98' ' ' LEU . 22.1 t -101.32 114.66 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.2 p -79.94 113.62 18.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.099 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 58' ' ' LYS . 0.8 OUTLIER -86.71 -23.83 25.4 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -119.19 165.01 18.33 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.806 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 18.6 Cg_endo -58.1 124.64 16.39 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.621 2.214 . . . . 0.0 111.994 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 122' ' ' LEU . 2.7 p -141.79 48.17 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.211 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -64.47 -35.35 80.65 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.756 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -65.58 -27.9 68.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 2.5 mt -78.46 0.11 27.19 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.55 79.91 1.07 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.235 0.54 . . . . 0.0 109.942 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.57 -46.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.203 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.45 -43.28 90.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 110.676 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -123.45 135.8 54.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.747 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 63.5 m -80.16 160.83 25.54 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.74 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.638 HD12 ' HD1' ' A' ' 92' ' ' PHE . 1.4 tt -79.39 -179.5 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.934 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.424 ' CE2' ' HG ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -177.13 -38.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.403 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.41 -179.6 17.73 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.848 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 7.6 mtm180 -137.3 168.1 20.29 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 122.819 -0.224 . . . . 0.0 110.778 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.563 HG21 HG13 ' A' ' 114' ' ' VAL . 11.5 t -131.06 91.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.908 0.385 . . . . 0.0 111.345 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.33 -41.66 9.73 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.535 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 103.83 6.83 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.123 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.647 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 147.12 -19.68 1.57 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.422 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' A' ' 95' ' ' ALA . 12.7 tt -48.17 -36.5 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.996 0.398 . . . . 0.0 112.002 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.23 -24.18 67.04 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.289 -0.481 . . . . 0.0 113.133 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ttp -91.07 -32.37 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.236 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.584 HG11 ' CG1' ' A' ' 114' ' ' VAL . 20.2 t -73.92 -48.67 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.33 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -65.0 -31.56 72.86 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.155 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -59.98 -34.46 73.34 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.203 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.617 HG13 HG21 ' A' ' 157' ' ' VAL . 37.1 t -58.01 -38.69 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.8 -42.61 86.3 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.314 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.6 mmt -49.19 -48.62 45.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -52.73 141.8 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 111.503 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.46 112.69 2.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.764 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.2 p -79.86 165.52 22.62 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.107 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.59 -167.29 1.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.598 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.0 p -88.89 32.78 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.568 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -158.52 31.13 0.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.903 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 57.43 41.8 25.64 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.521 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.09 147.51 37.08 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 120.62 0.247 . . . . 0.0 111.551 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 152.32 31.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.904 2.403 . . . . 0.0 112.636 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 154' ' ' VAL . 8.3 p -117.84 23.49 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.283 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.13 24.41 4.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 54.98 85.43 0.06 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 20' ' ' MET . 22.8 t -118.7 111.81 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 175.48 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.65 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.0 mt -105.22 127.81 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.79 0.328 . . . . 0.0 111.048 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 pt -107.13 -33.62 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.765 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.416 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -159.38 167.94 27.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.285 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.426 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -133.25 159.32 40.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.365 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.404 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -129.23 97.08 26.64 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.207 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.9 95.0 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.827 2.352 . . . . 0.0 112.198 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.6 t -84.48 143.89 29.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.273 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.51 -1.161 . . . . 0.0 112.758 179.741 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.775 0.322 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.02 80.79 0.22 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.08 -25.77 66.39 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.551 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.51 83.2 13.17 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.757 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.29 149.69 63.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.705 2.27 . . . . 0.0 112.48 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.92 143.41 36.62 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.779 2.319 . . . . 0.0 112.662 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -143.62 131.99 22.12 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.39 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.28 92.78 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.614 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -179.87 1.42 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.441 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -132.67 88.71 37.54 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.044 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.417 ' CD ' ' HD3' ' A' ' 12' ' ' PRO . 52.7 Cg_exo -53.1 -44.11 51.58 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.08 2.52 . . . . 0.0 113.728 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' CD ' ' A' ' 11' ' ' PRO . 13.8 Cg_exo -70.27 54.74 1.41 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.548 2.165 . . . . 0.0 112.594 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.481 ' HB3' HG12 ' A' ' 24' ' ' VAL . 8.2 m120 -142.31 175.32 9.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.776 0.322 . . . . 0.0 111.627 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -144.8 147.68 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -91.84 120.31 32.42 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 111.139 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.802 HD21 ' HE2' ' A' ' 48' ' ' TYR . 2.2 mt -114.05 102.83 10.55 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.303 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 6.5 mt-10 -92.86 103.16 15.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.27 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 159' ' ' ILE . 2.1 p -113.56 158.19 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.3 t -60.47 -35.9 76.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.813 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.782 ' HB2' HG13 ' A' ' 157' ' ' VAL . 11.4 tpt -68.76 -32.34 72.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.329 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.51 -163.74 37.29 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.35 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 tt -124.12 129.95 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.984 0.392 . . . . 0.0 111.185 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.559 HG22 ' CA ' ' A' ' 135' ' ' GLY . 8.3 pt -136.96 156.83 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.683 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 13' ' ' ASN . 20.3 t -123.32 116.52 48.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.717 HD23 HD12 ' A' ' 16' ' ' LEU . 3.5 mm? -91.51 158.81 16.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 3.8 tt0 -110.65 105.59 14.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.75 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.97 131.15 37.49 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.392 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.738 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 24.5 m-85 -82.41 113.9 20.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -81.96 14.96 2.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.83 -68.46 0.81 Allowed 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.686 0.279 . . . . 0.0 110.378 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.481 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -100.87 -13.94 18.16 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -97.63 0.66 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 98.7 Cg_exo -43.73 -40.56 11.1 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.071 1.847 . . . . 0.0 112.896 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -54.61 27.08 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.746 HG21 ' HG3' ' A' ' 100' ' ' MET . 4.8 m -64.1 -35.85 82.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.117 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 t -57.01 -51.63 68.48 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.81 -40.47 88.5 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -58.51 -47.23 84.84 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.01 -46.91 78.61 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.739 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 -45.68 70.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.403 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.15 -45.96 91.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.211 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -44.1 93.07 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 110.845 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -70.59 -35.68 73.14 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.143 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.06 -47.15 60.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -57.41 -31.1 65.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.611 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 33.04 2.53 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.103 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.23 -34.86 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.606 0.203 . . . . 0.0 111.058 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.802 ' HE2' HD21 ' A' ' 16' ' ' LEU . 1.4 t80 -73.37 -37.2 66.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.645 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.88 151.84 41.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.27 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 18.31 71.0 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.861 -0.609 . . . . 0.0 113.083 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -109.19 161.67 15.01 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.004 0.402 . . . . 0.0 110.465 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HB3' ' CB ' ' A' ' 158' ' ' LYS . 44.3 pttt -146.54 165.67 28.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -70.64 110.86 5.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -77.18 -45.23 27.34 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.851 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -112.11 130.1 56.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.726 HD12 ' HG3' ' A' ' 153' ' ' PRO . 51.9 mt -143.05 97.48 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.792 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.54 110.11 21.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -62.51 141.06 58.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.187 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.6 45.74 7.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.524 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -168.71 -89.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.942 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 175.23 12.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.651 ' CG2' HG23 ' A' ' 56' ' ' ILE . 1.8 pp -144.04 156.34 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.015 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 6.0 pt20 -132.73 142.53 49.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 111.568 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.03 156.43 16.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.704 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.98 -179.65 47.26 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.973 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -155.76 -64.54 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.94 -0.13 . . . . 0.0 111.128 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 66' ' ' ASP . 71.6 Cg_endo -76.46 -161.78 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.445 2.097 . . . . 0.0 111.832 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.684 HG22 ' HA2' ' A' ' 73' ' ' GLY . 9.6 t -51.95 -34.57 42.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.404 0.145 . . . . 0.0 111.285 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.06 47.53 72.66 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.771 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.8 p -136.32 40.52 2.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.812 0.339 . . . . 0.0 111.074 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.16 24.01 62.66 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.827 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.9 ttt-85 -175.06 77.45 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.722 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.684 ' HA2' HG22 ' A' ' 68' ' ' THR . . . -84.31 158.85 34.76 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.008 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.8 178.39 53.8 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.804 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.85 131.68 35.26 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.618 0.247 . . . . 0.0 111.152 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.26 177.74 8.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 pp -56.19 -31.44 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.747 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.53 40.39 1.11 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.96 179.69 33.37 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.956 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.75 76.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.529 0.204 . . . . 0.0 110.931 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -155.91 146.28 21.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.908 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -126.9 177.21 6.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.22 140.53 38.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.59 157.19 14.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.465 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.63 40.6 3.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.541 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.94 145.98 42.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.695 0.283 . . . . 0.0 110.916 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -164.46 153.51 11.57 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.87 -166.48 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.396 2.064 . . . . 0.0 112.08 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.53 33.46 10.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 111.152 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.658 HD13 ' CG1' ' A' ' 128' ' ' ILE . 84.7 mt -122.03 -178.45 3.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.882 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HE2' ' HB ' ' A' ' 93' ' ' THR . 17.0 tttt -128.08 157.29 41.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.088 0.47 . . . . 0.0 111.659 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.39 48.36 0.89 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.919 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.696 HG23 HD11 ' A' ' 97' ' ' ILE . 1.7 t -58.8 -23.83 60.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.8 -7.31 81.6 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.78 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.64 96.87 5.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.951 0.876 . . . . 0.0 111.383 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' C ' HD12 ' A' ' 97' ' ' ILE . . . 83.23 61.64 1.89 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.302 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.696 HD11 HG23 ' A' ' 93' ' ' THR . 4.4 mp -138.75 154.46 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.717 0.258 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.756 HD12 ' HE2' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -125.99 111.94 15.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.907 0.384 . . . . 0.0 110.454 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.614 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -108.22 137.04 46.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.34 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.746 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.64 104.88 10.54 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 164.89 22.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.475 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 172.68 12.62 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.32 -36.03 10.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.733 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.74 -179.84 32.93 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.614 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -61.87 124.21 14.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.696 2.264 . . . . 0.0 112.149 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.26 28.49 17.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.051 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.5 m -136.57 84.53 2.08 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.269 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.11 129.41 34.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.769 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.02 -164.06 24.88 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.953 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 m -110.25 68.43 0.67 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.063 0.458 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -148.67 152.47 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -147.17 156.68 43.18 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.755 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.614 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 22.8 p90 -137.77 126.15 23.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.968 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 11.7 p -98.47 120.14 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.356 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 p -84.18 129.36 34.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.761 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.45 -19.47 12.93 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.64 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -122.14 160.34 47.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.61 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 9.5 Cg_endo -51.56 127.82 23.87 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.043 2.495 . . . . 0.0 112.802 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.5 p -147.42 42.9 1.1 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -59.19 -30.99 68.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.426 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 32.6 p90 -60.95 -29.2 69.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.273 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 14.6 mt -81.25 -2.06 47.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.78 85.63 0.21 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.153 0.501 . . . . 0.0 110.386 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.21 -31.58 0.54 Allowed Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.697 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -72.59 -62.94 1.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.708 0.254 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -95.63 172.13 8.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.558 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 13.3 t -114.06 156.73 23.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.522 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 129' ' ' PHE . 4.2 mm -80.01 -179.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.283 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.756 ' HE2' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -178.22 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.393 0.277 . . . . 0.0 110.696 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 26' ' ' GLU . . . -145.44 -179.63 21.86 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.213 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 160.6 42.31 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.577 0.227 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 25' ' ' LEU . 17.8 t -106.73 93.61 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.8 m -84.12 -42.58 15.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.475 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 107.25 8.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 136.09 -10.31 4.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.607 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.417 ' HA ' HG11 ' A' ' 132' ' ' VAL . 13.4 tt -48.78 -33.82 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.55 91.68 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.609 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -66.59 -46.49 75.79 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 0.0 110.471 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.75 -38.1 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.787 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.13 -40.81 77.87 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.62 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -62.09 -37.32 84.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.917 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.648 ' CG1' HD13 ' A' ' 56' ' ' ILE . 38.2 t -57.5 -41.04 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.946 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.09 -13.13 58.05 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.6 tpt -84.11 -35.64 23.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.977 0.388 . . . . 0.0 111.507 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 m -51.85 154.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.985 0.422 . . . . 0.0 111.684 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.17 95.49 0.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.672 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.3 p -79.95 170.52 16.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.371 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.31 179.46 7.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 29.59 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.387 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -156.1 33.52 0.34 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 54.3 61.88 2.83 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.34 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.0 114.38 13.89 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.114 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.726 ' HG3' HD12 ' A' ' 56' ' ' ILE . 32.2 Cg_exo -61.99 117.41 4.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.849 2.366 . . . . 0.0 112.575 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.3 m -68.03 -34.26 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.334 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.3 179.54 7.43 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -105.79 80.66 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 20' ' ' MET . 32.6 t -98.94 115.62 39.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.658 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.415 ' CB ' ' HB3' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -149.96 175.14 11.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.553 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.64 ' HA ' HG22 ' A' ' 18' ' ' THR . 3.9 mt -109.8 148.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.69 -40.93 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.845 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 11.0 mttt -139.25 161.73 36.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.77 0.319 . . . . 0.0 111.298 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.53 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -156.57 110.14 2.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -128.69 166.84 21.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.93 174.71 11.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.905 2.403 . . . . 0.0 111.916 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.2 t -129.18 103.53 7.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.719 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.473 -179.851 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.708 0.29 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.46 171.4 8.19 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.382 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.43 -55.81 12.16 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.968 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.01 94.2 18.81 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.95 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.12 163.47 3.28 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.04 2.494 . . . . 0.0 112.793 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.49 125.2 13.01 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.755 2.304 . . . . 0.0 112.683 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -118.54 153.0 34.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.753 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -80.4 58.3 3.09 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.079 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 67.37 143.84 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.378 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -129.74 123.82 21.36 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.06 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 27.2 Cg_endo -62.57 109.83 0.96 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.543 2.162 . . . . 0.0 111.769 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 6.6 Cg_exo -74.43 63.0 5.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.093 2.528 . . . . 0.0 112.178 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.69 161.46 13.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.331 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 27' ' ' LEU . 22.0 t -134.08 131.47 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.104 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -91.25 96.97 10.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.09 98.59 10.18 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.218 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -87.34 122.23 30.83 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.225 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -128.61 163.6 24.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.156 -179.279 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.8 t -68.18 -34.75 76.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.196 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.702 ' HG3' HG22 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.72 -30.81 70.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 18' ' ' THR . . . 168.16 -143.46 8.16 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.253 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.2 mt -140.86 135.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.854 0.327 . . . . 0.0 111.036 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 135' ' ' GLY . 16.6 pt -137.78 147.95 25.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.764 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.1 t -120.04 123.64 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.021 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.4 mm? -116.26 159.14 22.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.217 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -125.71 106.76 9.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 14' ' ' VAL . 5.3 mp -87.05 158.61 19.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.778 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 33.2 m-85 -102.86 102.5 12.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.236 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -81.25 23.25 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.14 -68.07 0.83 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.525 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.65 -14.11 18.27 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 178.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -97.29 1.39 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.7 Cg_exo -40.71 -37.46 2.28 Favored 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 121.952 1.768 . . . . 0.0 112.893 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -55.15 38.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.487 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.456 ' CG2' ' HB1' ' A' ' 32' ' ' ALA . 3.9 t -71.93 -34.97 69.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.797 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 2.1 m -56.97 -50.94 71.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.66 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -42.33 99.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -65.07 -48.23 74.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.206 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.39 -46.38 86.51 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.946 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.15 83.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.562 ' CB ' HD13 ' A' ' 77' ' ' ILE . 3.4 mm-40 -62.42 -43.97 97.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.058 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -58.26 -41.17 83.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.01 77.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.902 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -68.48 -41.22 80.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -28.55 68.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.554 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.25 28.88 4.47 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.775 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -51.14 5.35 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.573 0.225 . . . . 0.0 110.425 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 15.1 m-85 -77.3 -41.52 40.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.444 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -70.3 93.38 0.85 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.96 3.5 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.091 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.851 HG22 ' HB3' ' A' ' 67' ' ' PRO . 74.0 p -61.78 166.55 4.3 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.006 0.403 . . . . 0.0 112.004 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -137.01 25.77 3.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.939 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 159' ' ' ILE . 10.0 m-85 57.23 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 0.0 111.659 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.0 m80 -149.37 -65.84 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 56' ' ' ILE . 2.8 mtt180 -91.34 122.25 33.79 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.399 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.726 ' HA ' HG22 ' A' ' 62' ' ' ILE . 23.9 mm -131.21 84.3 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.102 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.555 HD12 ' CE ' ' A' ' 61' ' ' MET . 26.1 mt -89.86 88.94 2.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -24.23 60.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.744 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -91.43 25.59 2.55 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.85 -77.67 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 O-C-N 122.452 -0.155 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.555 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.32 178.79 9.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.631 0.253 . . . . 0.0 111.123 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 56' ' ' ILE . 4.0 pt -135.46 149.19 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -133.06 154.17 50.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 112.161 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.82 103.43 0.47 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.025 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.06 167.74 35.53 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.776 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t70 63.04 70.68 0.72 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 111.078 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.851 ' HB3' HG22 ' A' ' 51' ' ' THR . 57.1 Cg_endo -72.09 -40.72 2.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.8 59.27 3.9 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.426 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.32 -29.59 73.62 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.706 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.7 p -88.28 -30.0 19.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.75 0.275 . . . . 0.0 111.349 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.35 0.38 40.67 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.805 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.88 41.75 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.915 0.358 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.78 123.72 1.77 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.66 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.33 87.46 0.17 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.521 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.72 152.71 31.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.605 0.241 . . . . 0.0 111.311 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p -99.82 172.71 7.08 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.562 HD13 ' CB ' ' A' ' 41' ' ' GLU . 34.4 pt -57.4 -38.22 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.646 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -74.55 -46.19 40.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.6 -153.91 21.95 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.757 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -34.54 7.08 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.455 ' CB ' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER -141.58 109.87 5.92 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.675 0.274 . . . . 0.0 111.037 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -118.34 176.19 5.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.09 -177.91 0.41 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -113.86 176.94 4.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.463 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -130.75 110.31 11.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.369 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.02 129.09 9.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.417 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 0.7 OUTLIER -178.78 -53.51 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 87' ' ' HIS . 27.1 Cg_exo -61.94 171.82 4.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.659 2.239 . . . . 0.0 112.11 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.19 -75.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.75 HD22 HG21 ' A' ' 128' ' ' ILE . 0.4 OUTLIER 65.35 151.43 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -137.4 167.07 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.556 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -133.24 87.83 2.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.053 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.1 p -71.34 -27.78 63.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.82 -67.99 0.89 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.85 104.92 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.7 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.522 ' HA3' HD12 ' A' ' 136' ' ' ILE . . . 76.76 63.05 2.39 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.435 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 96' ' ' GLY . 33.9 mm -142.4 123.34 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.778 0.289 . . . . 0.0 110.559 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.616 HD22 ' HE2' ' A' ' 129' ' ' PHE . 3.0 mt -98.93 117.51 33.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 111.251 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -119.63 143.69 47.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.496 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.65 116.48 19.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.387 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB2' ' HD1' ' A' ' 113' ' ' PHE . . . -80.12 168.28 19.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.477 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -151.95 170.92 18.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -101.71 -49.07 4.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.649 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.02 -179.65 34.95 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.29 122.06 10.54 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.704 2.269 . . . . 0.0 111.908 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.32 31.33 17.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.188 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.455 HG23 ' CB ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -139.12 85.44 2.07 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.731 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -107.49 140.83 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.36 -152.14 16.02 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.781 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 p -117.73 38.78 3.52 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -111.25 150.71 29.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.154 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.12 146.14 42.48 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.675 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.659 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 31.9 p90 -129.27 130.36 46.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 114' ' ' VAL . 12.1 p -109.77 121.2 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.898 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 61' ' ' MET . 1.1 p -79.59 139.38 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.525 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -108.82 -31.16 7.8 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.663 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.1 153.89 37.73 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.036 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.48 122.71 10.71 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.681 2.254 . . . . 0.0 112.029 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.681 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 75.1 p -145.97 92.61 2.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.85 -4.51 52.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.717 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.681 ' CZ2' HG22 ' A' ' 119' ' ' THR . 22.9 p90 -82.18 -32.63 29.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.286 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.4 pp -83.49 0.53 45.98 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -60.32 87.09 0.01 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.354 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.12 -23.3 2.74 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.966 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -61.6 -65.8 0.64 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.917 0.359 . . . . 0.0 110.951 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -97.5 172.61 7.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.795 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.74 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 46.5 m -92.13 155.15 18.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.95 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.75 HG21 HD22 ' A' ' 90' ' ' LEU . 1.4 tt -98.97 -179.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.778 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.616 ' HE2' HD22 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -172.77 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.8 -179.78 19.82 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.928 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -136.17 172.59 12.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.711 0.291 . . . . 0.0 110.969 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.66 121.09 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.218 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 29.1 m -123.25 -59.0 1.6 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 22.5 tt0 -113.91 93.7 4.49 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.532 ' O ' HG22 ' A' ' 23' ' ' ILE . . . 148.44 -17.43 1.3 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.386 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.522 HD12 ' HA3' ' A' ' 96' ' ' GLY . 15.2 tt -44.7 -34.75 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.008 0.404 . . . . 0.0 111.92 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.33 -42.23 82.22 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.769 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.75 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.4 ttp -60.79 -40.23 91.83 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.75 0.309 . . . . 0.0 110.476 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.645 HG13 HD11 ' A' ' 62' ' ' ILE . 22.9 t -70.53 -35.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.0 -46.43 74.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -58.4 -35.31 71.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.524 0.202 . . . . 0.0 111.262 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 138' ' ' MET . 33.4 t -58.42 -40.04 76.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.638 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.68 -37.97 38.46 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.464 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 mmt -60.76 -38.47 85.32 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.554 0.216 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.4 OUTLIER -62.64 166.65 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.366 -0.379 . . . . 0.0 112.015 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 145' ' ' VAL . 1.9 mt-10 -66.68 171.3 5.3 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.283 0.563 . . . . 0.0 110.968 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 154' ' ' VAL . 3.0 p -149.13 174.73 12.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.271 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -95.48 -176.33 3.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.6 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.9 m -92.76 35.09 1.05 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 111.279 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.27 37.12 0.12 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.459 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.16 41.84 31.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.215 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.93 126.06 29.84 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.056 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.534 ' HB3' HG13 ' A' ' 56' ' ' ILE . 33.8 Cg_endo -64.5 154.24 72.88 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.813 2.342 . . . . 0.0 112.776 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 147' ' ' THR . 40.0 t -103.93 -28.24 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.889 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.66 17.65 11.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 33.81 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.702 HG22 ' HG3' ' A' ' 20' ' ' MET . 11.0 t -80.24 97.52 3.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.0 tttp -102.4 130.56 49.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.422 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.576 HD12 ' OG1' ' A' ' 51' ' ' THR . 13.0 mt -104.68 135.59 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.647 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.56 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -134.26 2.48 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 22.3 mttt -154.37 131.99 11.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.643 0.258 . . . . 0.0 111.183 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.43 81.74 1.04 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.063 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -144.67 156.81 56.11 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.368 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.93 177.83 7.91 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.098 2.532 . . . . 0.0 112.195 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.43 119.36 17.4 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.112 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.514 179.841 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mtm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.668 0.271 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.82 159.04 40.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.35 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.02 158.06 15.91 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.495 HD12 ' HD2' ' A' ' 6' ' ' PRO . 1.1 pt -61.96 144.53 93.76 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.294 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.52 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 43.8 Cg_exo -54.99 -49.49 16.46 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.597 2.198 . . . . 0.0 112.572 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' A' ' 5' ' ' PRO . 35.6 Cg_exo -58.87 161.74 14.78 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.216 1.944 . . . . 0.0 112.512 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.7 t0 62.04 98.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.606 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.0 p -155.94 -73.22 0.11 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.87 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 64.85 118.78 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.046 0.45 . . . . 0.0 111.5 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.03 164.37 42.73 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.575 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.93 106.4 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.014 2.476 . . . . 0.0 112.248 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.94 -47.9 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.276 1.984 . . . . 0.0 112.359 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -128.49 177.47 6.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.786 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.79 129.93 66.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.687 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.83 93.01 9.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.92 89.26 7.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.937 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 89.56 6.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.445 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 159' ' ' ILE . 1.2 p -95.21 164.11 12.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.147 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -66.89 -40.92 87.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.609 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.715 ' HB2' HG23 ' A' ' 157' ' ' VAL . 4.5 tpt -62.11 -30.91 71.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.21 -168.71 41.03 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.951 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.17 129.13 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.932 0.366 . . . . 0.0 111.075 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.605 HG22 ' CA ' ' A' ' 135' ' ' GLY . 11.6 pt -138.52 128.34 33.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.584 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.85 111.28 32.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.391 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.875 HD12 HG12 ' A' ' 132' ' ' VAL . 0.8 OUTLIER -103.4 154.44 19.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.196 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -112.2 133.37 54.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 4.5 mt -97.23 149.84 21.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.408 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.66 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 20.0 m-85 -92.24 90.66 7.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -80.47 23.6 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -100.44 -71.95 0.69 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.536 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.94 -13.67 18.21 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.664 178.81 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -100.15 1.36 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 43.5 Cg_exo -36.83 -37.39 0.31 Allowed 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.467 2.111 . . . . 0.0 113.375 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -60.67 3.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.781 0.324 . . . . 0.0 110.532 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.2 p -67.0 -34.69 78.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 96.6 m -58.94 -50.57 73.55 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -57.3 -40.31 77.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.284 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.451 ' OD1' HD11 ' A' ' 42' ' ' LEU . 14.9 t-20 -63.25 -53.09 58.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.568 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.725 ' HA ' HD12 ' A' ' 42' ' ' LEU . 20.5 t80 -56.76 -44.04 81.38 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.5 99.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.982 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.664 ' HB3' HG21 ' A' ' 77' ' ' ILE . 1.8 tt0 -64.7 -38.0 89.5 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.933 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 39' ' ' PHE . 9.2 mt -64.02 -39.55 94.34 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.971 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.88 74.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.115 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -72.83 -52.83 13.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.151 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.428 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.29 32.07 3.85 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.591 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -53.08 8.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.629 0.252 . . . . 0.0 110.386 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -64.81 -41.0 96.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.644 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -61.19 127.44 31.54 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.473 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 -32.02 8.03 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.604 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 170.12 15.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HB3' ' CB ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.46 159.23 43.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.925 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.472 ' CD1' HG12 ' A' ' 62' ' ' ILE . 58.6 m-85 -67.45 117.24 9.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.681 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.25 -61.57 1.67 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.289 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -88.97 123.37 33.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.072 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 153' ' ' PRO . 7.1 mt -142.07 112.29 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.297 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -93.89 121.02 44.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.065 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.23 123.7 18.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.13 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 t70 59.17 58.02 3.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.537 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.417 ' H ' HD21 ' A' ' 116' ' ' LEU . 15.6 t80 -166.66 -74.68 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.976 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.402 ' SD ' HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -160.11 177.46 10.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.224 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 62' ' ' ILE . 11.2 tt -151.15 101.91 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.544 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.9 tt0 -87.36 132.54 33.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.13 150.47 17.76 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.419 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.79 171.24 52.38 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.023 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.503 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 2.8 t0 179.21 -55.02 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 96.7 Cg_endo -80.45 47.12 2.45 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.601 2.201 . . . . 0.0 112.978 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.3 40.9 0.36 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.803 0.335 . . . . 0.0 110.976 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.42 31.28 6.26 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.952 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 t -128.39 -41.5 1.55 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.709 0.255 . . . . 0.0 111.455 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.51 40.66 2.71 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.629 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.23 -58.95 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.45 0.167 . . . . 0.0 111.097 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.26 149.79 19.44 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.765 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.28 101.74 2.78 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.763 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.34 160.96 14.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.275 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 p -101.28 169.79 8.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.664 HG21 ' HB3' ' A' ' 41' ' ' GLU . 3.9 pt -67.96 -29.95 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.866 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -81.65 -42.87 19.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.301 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.2 -138.56 2.65 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.725 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -61.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -160.72 161.16 32.13 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.731 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -137.03 177.36 7.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.21 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -87.11 176.94 7.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.092 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -92.74 179.25 5.54 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 127' ' ' THR . 0.4 OUTLIER -136.0 136.02 39.98 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.252 -179.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.05 129.37 9.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -62.48 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.47 ' HB2' HD12 ' A' ' 90' ' ' LEU . 41.1 Cg_endo -66.68 -14.48 44.09 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.755 2.303 . . . . 0.0 113.076 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 72.2 -67.99 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.477 0.311 . . . . 0.0 111.144 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HB3' HD13 ' A' ' 128' ' ' ILE . 1.7 mp 66.27 157.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.855 0.36 . . . . 0.0 111.57 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -58.72 145.67 39.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.379 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.6 29.16 0.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.618 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.5 t -137.43 -46.57 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.5 122.95 30.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.778 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.16 131.6 10.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.636 0.255 . . . . 0.0 111.671 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.582 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 100.81 59.93 0.81 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.868 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.706 HD12 HH11 ' A' ' 131' ' ' ARG . 14.6 mm -128.56 132.56 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.73 0.265 . . . . 0.0 111.039 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 114' ' ' VAL . 2.1 mt -109.67 103.65 12.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -111.48 140.21 46.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.398 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.7 108.72 13.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 113' ' ' PHE . . . -88.81 151.99 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.754 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -130.66 147.5 52.34 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.718 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.05 -73.68 0.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.252 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.61 176.14 19.91 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.435 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.3 135.93 38.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.359 2.04 . . . . 0.0 111.879 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.35 30.41 19.79 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.336 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.78 87.05 2.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.776 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -83.25 129.7 35.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.472 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.43 -116.84 4.25 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.832 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.406 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 67.4 m -154.22 32.06 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 111.463 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -95.33 163.16 13.37 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 2.6 p90 -159.03 124.29 4.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.3 p90 -110.97 135.1 51.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.809 ' CG1' HG11 ' A' ' 139' ' ' VAL . 3.5 t -100.88 105.53 17.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.881 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.39 125.58 31.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.283 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.627 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -116.24 -1.22 12.42 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.695 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.688 ' O ' HG23 ' A' ' 119' ' ' THR . . . -121.16 140.07 30.5 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -52.12 112.53 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.761 2.307 . . . . 0.0 112.212 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' ALA . 69.5 p -128.79 97.73 4.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.92 -32.06 15.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.332 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.6 p90 -60.02 -39.16 84.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.2 pp -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -63.83 85.52 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.42 -32.08 1.99 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.701 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -44.69 96.65 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.634 0.254 . . . . 0.0 111.128 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.0 m170 -104.02 150.15 24.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.625 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 87.2 m -89.37 151.74 21.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 90' ' ' LEU . 1.0 OUTLIER -80.9 -179.33 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.498 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -172.09 -42.26 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.04 173.35 30.55 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.855 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.706 HH11 HD12 ' A' ' 97' ' ' ILE . 7.6 tpp180 -140.84 148.64 40.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.592 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.875 HG12 HD12 ' A' ' 25' ' ' LEU . 17.7 m -89.98 114.01 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.671 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 27.0 m -95.48 -36.2 11.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -150.52 94.91 2.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.634 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.605 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 162.03 -19.24 0.18 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.828 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.532 ' HB ' HG21 ' A' ' 132' ' ' VAL . 10.5 tt -44.39 -34.61 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.457 0.628 . . . . 0.0 111.903 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.9 -25.15 52.35 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.024 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.488 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.6 ttp -86.11 -36.03 19.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.754 0.311 . . . . 0.0 110.329 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.809 HG11 ' CG1' ' A' ' 114' ' ' VAL . 21.9 t -72.42 -54.26 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.437 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -58.56 -30.69 67.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.575 0.226 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.56 -39.23 90.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.532 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.547 ' O ' HG22 ' A' ' 145' ' ' VAL . 17.8 t -65.87 -27.03 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.35 -30.78 24.01 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.158 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.31 -34.56 78.26 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.137 0.175 . . . . 0.0 111.45 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 142' ' ' VAL . 29.6 m -63.4 174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.828 0.347 . . . . 0.0 111.413 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.15 131.16 44.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.5 p -94.61 172.14 8.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.19 142.68 47.5 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.853 0.359 . . . . 0.0 111.646 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.19 -47.76 0.14 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.989 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 176.35 -32.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.593 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -169.54 36.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.478 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 116.05 65.57 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.78 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 56' ' ' ILE . 31.3 Cg_endo -64.82 111.28 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.596 2.197 . . . . 0.0 112.191 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.56 -33.86 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -168.25 1.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.587 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.09 100.04 7.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.748 0.309 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 20' ' ' MET . 9.6 p -118.7 115.17 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.708 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.432 ' CB ' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -154.4 176.21 12.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.318 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.574 ' HA ' HG22 ' A' ' 18' ' ' THR . 3.2 mt -110.45 130.0 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.6 pt -110.41 -34.35 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.506 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -147.04 140.11 25.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.76 0.314 . . . . 0.0 110.767 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.41 117.14 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.83 147.93 31.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.246 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.83 146.44 18.6 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.668 2.245 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.89 174.22 7.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.042 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.545 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.086 0.47 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.37 104.13 15.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.233 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.36 125.6 17.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 4' ' ' ILE . 3.7 mt 59.99 56.08 4.44 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.159 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 73.4 Cg_endo -75.22 145.29 30.53 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.71 2.273 . . . . 0.0 112.378 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 33.1 Cg_exo -57.95 170.86 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.825 2.35 . . . . 0.0 112.659 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 64.14 72.63 0.45 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.579 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.6 m -120.44 166.64 13.3 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.506 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.536 ' O ' ' HB3' ' A' ' 10' ' ' GLN . 18.9 m95 -68.63 177.81 2.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.473 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 9' ' ' TRP . 1.1 tm0? 74.58 131.1 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 123.254 0.346 . . . . 0.0 110.623 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' A' ' 10' ' ' GLN . 35.1 Cg_endo -65.36 108.73 1.23 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.579 2.186 . . . . 0.0 111.936 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.0 -41.08 72.03 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.673 2.249 . . . . 0.0 112.298 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -118.98 167.3 11.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.1 m -144.28 137.42 23.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.207 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CD2' HG22 ' A' ' 24' ' ' VAL . 18.9 m-85 -118.57 102.26 8.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.777 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mt -84.06 104.9 14.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -87.12 90.66 8.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.474 ' HB ' HG23 ' A' ' 159' ' ' ILE . 1.4 t -114.06 166.55 11.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -35.86 79.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.211 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.931 ' HB2' HG13 ' A' ' 157' ' ' VAL . 7.4 tpt -62.7 -28.23 69.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.115 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 152.45 5.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.954 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 17' ' ' GLU . 1.4 tp -79.64 122.75 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 117.078 0.439 . . . . 0.0 111.358 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -124.62 124.09 67.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 15' ' ' TYR . 20.8 t -98.66 120.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.976 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -110.61 147.73 33.64 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -102.37 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.519 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.548 HD11 ' CE1' ' A' ' 129' ' ' PHE . 3.8 mm? -81.35 132.18 35.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.468 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 79.0 m-85 -68.28 99.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -77.9 11.23 2.3 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 -69.18 0.78 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.701 0.286 . . . . 0.0 110.527 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 14.7 m-70 -100.82 -15.93 17.45 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.652 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.55 1.48 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 81.6 Cg_exo -42.81 -36.5 5.16 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.079 1.853 . . . . 0.0 113.081 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -62.91 -57.13 11.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.853 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -61.92 -36.98 82.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.03 -48.49 73.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -56.37 -39.08 72.35 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.465 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.81 -44.17 64.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -61.76 -45.38 94.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.63 80.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.59 -43.15 97.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.52 -35.39 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.069 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.64 81.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.528 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -92.6 -31.9 15.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.616 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -57.2 -31.69 65.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.6 26.13 4.92 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.982 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.2 -44.82 7.11 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.585 ' O ' HG22 ' A' ' 51' ' ' THR . 10.7 m-85 -82.25 -33.23 29.31 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.922 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.0 105.91 0.37 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.733 0.301 . . . . 0.0 110.501 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 21.96 6.19 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.895 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.69 ' CG2' HD12 ' A' ' 159' ' ' ILE . 7.6 t -98.55 173.44 6.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.144 0.472 . . . . 0.0 111.097 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.66 38.17 0.23 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.713 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.445 ' HB3' HD11 ' A' ' 56' ' ' ILE . 31.0 m-85 56.45 -177.58 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.413 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -151.11 -48.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.706 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.21 111.26 19.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.69 0.281 . . . . 0.0 110.624 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.803 HG23 HG22 ' A' ' 62' ' ' ILE . 32.6 mm -115.7 116.02 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.486 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.47 HD12 ' CE ' ' A' ' 61' ' ' MET . 33.0 mt -122.74 94.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.361 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -56.73 -27.5 59.34 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.517 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.37 31.47 2.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.734 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.74 -78.36 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.47 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.21 178.13 9.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 111.601 -179.345 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.803 HG22 HG23 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -132.81 104.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.311 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 11.1 tt0 -93.44 130.8 39.13 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.643 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.92 145.54 17.84 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.737 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.48 168.46 29.45 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.395 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.88 68.38 6.77 Favored Pre-proline 0 C--O 1.235 0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 111.08 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.67 -177.07 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.716 2.278 . . . . 0.0 112.234 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.69 -50.5 1.73 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.566 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.53 44.39 0.32 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.45 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -149.38 -44.88 0.14 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.504 0.192 . . . . 0.0 111.263 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.9 28.66 17.71 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.551 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -177.27 -42.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.57 0.224 . . . . 0.0 111.165 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.28 101.39 1.98 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.647 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -126.41 110.06 1.21 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.433 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.29 138.9 22.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.717 0.294 . . . . 0.0 111.207 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.3 p -96.24 -179.24 4.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.527 HD11 ' CZ ' ' A' ' 78' ' ' TYR . 1.2 pt -61.52 -28.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.484 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.527 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 62.8 m-85 -83.97 -43.71 14.92 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.87 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.81 -169.47 42.54 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.745 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -63.52 -45.38 90.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.559 0.219 . . . . 0.0 111.213 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.837 ' CB ' HG23 ' A' ' 107' ' ' THR . 2.9 pt20 -152.17 127.74 10.07 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.79 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -116.37 157.05 25.66 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.936 0.398 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -65.95 179.16 0.94 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -95.64 146.57 24.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.32 102.09 11.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.601 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tp -134.73 144.88 47.99 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.426 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 m-70 -158.3 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HB2' HD12 ' A' ' 90' ' ' LEU . 72.6 Cg_endo -74.43 158.1 44.61 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.676 2.251 . . . . 0.0 112.507 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.66 -49.03 43.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.238 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.665 HD22 HG13 ' A' ' 128' ' ' ILE . 0.2 OUTLIER 56.2 -170.92 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -159.7 35.97 0.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.556 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -126.97 -46.54 1.53 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.79 117.08 9.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.864 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 136' ' ' ILE . . . -45.35 134.24 6.76 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.62 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.523 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 98.38 60.32 0.91 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.726 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 96' ' ' GLY . 11.0 mm -128.36 160.23 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.568 0.184 . . . . 0.0 110.643 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.604 HD21 HG22 ' A' ' 114' ' ' VAL . 10.2 mt -133.96 115.95 14.99 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.947 0.403 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -118.14 139.95 50.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.335 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.431 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.82 113.56 18.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.406 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.64 170.37 10.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -142.66 151.44 41.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.82 -33.81 75.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.72 179.99 34.91 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.467 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.99 131.9 44.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.541 2.16 . . . . 0.0 111.72 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 p30 44.15 30.0 0.4 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.688 0.618 . . . . 0.0 112.0 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.837 HG23 ' CB ' ' A' ' 81' ' ' GLN . 50.2 m -136.59 85.81 2.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -83.89 162.17 20.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.63 -105.35 1.15 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.035 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m -155.89 40.55 0.38 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -109.41 161.27 15.46 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.187 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 7.6 p90 -159.98 125.91 4.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 50.5 p90 -112.85 133.76 54.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.281 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.604 HG22 HD21 ' A' ' 98' ' ' LEU . 40.6 t -94.81 111.29 25.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.63 103.42 9.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 58' ' ' LYS . 1.1 pp -95.23 -5.33 44.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.743 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.23 151.01 50.35 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.58 0.228 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 109.21 2.31 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.778 2.319 . . . . 0.0 111.931 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.441 ' OG1' HD21 ' A' ' 122' ' ' LEU . 72.1 p -133.91 100.96 4.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.23 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -94.1 -27.04 16.47 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.419 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -58.8 -27.33 64.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.54 0.21 . . . . 0.0 111.505 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.497 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.4 pp -98.03 0.2 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.85 84.56 0.03 OUTLIER 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 151.11 -30.95 0.98 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.837 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -67.41 -57.65 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.685 0.279 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -93.88 144.38 25.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.897 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.617 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 12.3 t -88.22 152.69 21.79 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.821 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 129' ' ' PHE . 3.3 mm -80.16 -179.32 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.406 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.71 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -173.26 -44.19 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.445 0.164 . . . . 0.0 111.179 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.0 179.7 20.36 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.729 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.96 153.65 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -101.69 87.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.32 -51.37 8.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.711 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 103.04 7.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 156.18 -23.75 0.52 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.196 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 95' ' ' ALA . 15.0 tt -47.49 -34.77 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -44.44 97.91 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.537 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.8 tpt -76.52 -46.41 26.68 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.555 0.217 . . . . 0.0 110.769 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 135' ' ' GLY . 19.9 t -56.49 -34.8 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.191 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -67.24 -39.64 86.22 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.674 0.273 . . . . 0.0 110.788 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -60.94 -28.64 69.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.198 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.2 t -58.36 -25.42 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.736 0.303 . . . . 0.0 111.03 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.66 -23.3 39.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.804 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -63.57 -27.01 68.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.772 0.286 . . . . 0.0 111.359 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER -64.53 173.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.478 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -86.58 133.72 33.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.57 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -100.81 178.07 4.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.656 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.55 29.03 8.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.376 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.21 24.53 8.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 111.198 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.93 33.83 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.184 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 58.33 44.15 18.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.389 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.52 90.33 37.65 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.458 ' HG3' HG13 ' A' ' 56' ' ' ILE . 36.8 Cg_endo -66.25 139.68 55.93 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.693 2.262 . . . . 0.0 112.437 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.84 -50.42 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.83 67.45 1.98 Allowed 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -51.32 156.31 1.22 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.757 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.931 HG13 ' HB2' ' A' ' 20' ' ' MET . 25.9 t -79.83 138.15 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.096 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.86 119.31 16.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 111.266 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.69 HD12 ' CG2' ' A' ' 51' ' ' THR . 12.0 mt -92.62 148.33 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.206 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -38.33 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.856 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -154.63 170.42 21.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.88 0.371 . . . . 0.0 111.343 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -132.7 134.57 44.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.639 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -107.85 93.72 11.14 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.71 104.74 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.468 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.2 t -71.49 78.94 0.78 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.397 -1.224 . . . . 0.0 112.459 -179.925 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.548 0.213 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.5 -53.62 0.1 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.32 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.84 -65.78 0.54 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.293 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 pt -143.32 101.43 5.18 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.416 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 50.3 Cg_exo -52.97 -48.39 22.41 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.381 2.054 . . . . 0.0 112.797 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 5' ' ' PRO . 97.8 Cg_endo -78.26 139.04 16.43 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.426 2.084 . . . . 0.0 113.014 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -132.93 127.64 34.74 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 t 61.58 -169.81 0.17 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.816 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -81.46 179.47 7.83 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -108.44 101.13 41.35 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.71 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.48 110.36 2.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.806 2.338 . . . . 0.0 112.414 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 -32.78 17.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.661 2.241 . . . . 0.0 112.755 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -126.77 154.64 43.97 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.998 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.29 143.88 38.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.29 117.36 34.58 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.53 HD12 HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -98.47 99.77 10.97 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 105.24 17.45 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.392 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.56 ' HB ' HG23 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -114.92 167.74 10.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -21.48 52.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.644 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.807 ' HB3' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -95.6 28.2 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.995 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 18' ' ' THR . . . 119.03 -156.59 15.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.284 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -146.43 139.07 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.919 0.36 . . . . 0.0 111.021 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 25' ' ' LEU . 8.4 pt -139.34 133.69 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 111.642 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 t -108.13 113.77 44.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 23' ' ' ILE . 2.2 mp -112.57 138.41 49.38 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -103.64 130.15 51.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.869 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.724 HD12 ' SG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -97.51 131.8 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.593 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.608 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 22.9 m-85 -64.83 99.4 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.788 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -79.46 14.77 1.47 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -70.67 0.73 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.493 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 10.2 m-70 -100.88 -14.46 17.94 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.14 1.12 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.8 Cg_exo -40.79 -37.19 2.24 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.154 1.903 . . . . 0.0 112.974 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -55.3 36.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 110.442 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -64.9 -35.12 80.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.724 ' SG ' HD12 ' A' ' 27' ' ' LEU . 55.8 m -56.15 -50.2 71.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.299 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -61.11 -39.32 89.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -62.4 -59.06 5.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.929 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -40.84 84.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.53 67.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -64.22 -36.12 83.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.11 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -49.49 77.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.656 0.265 . . . . 0.0 110.657 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.95 64.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.23 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -46.09 50.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.312 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -60.14 -54.07 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.51 52.36 0.03 OUTLIER Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.788 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -125.63 -49.67 1.63 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.544 0.211 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.477 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -71.65 -45.29 62.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.177 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -56.17 118.64 4.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.23 32.37 20.27 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.697 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -100.23 -175.27 2.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -163.39 137.27 5.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HB3' HD11 ' A' ' 56' ' ' ILE . 39.9 m-85 -64.93 150.28 48.16 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.852 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -142.76 19.26 2.0 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.619 ' C ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -158.07 104.69 1.91 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.584 0.23 . . . . 0.0 111.155 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.949 HD13 ' HG3' ' A' ' 153' ' ' PRO . 2.7 mp -136.18 113.59 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.26 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.85 100.11 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 1.1 ttmt -59.12 145.23 43.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.68 36.09 2.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.092 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -169.53 -94.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.892 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -160.41 169.61 22.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 56' ' ' ILE . 33.9 pt -137.24 150.33 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.753 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 4.6 pm0 -126.26 145.61 50.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 111.324 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.57 159.79 13.62 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.604 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -89.9 160.22 28.47 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.896 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.529 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -148.29 -65.07 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.957 -0.121 . . . . 0.0 111.214 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 71.8 Cg_endo -77.27 97.82 1.17 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.433 2.089 . . . . 0.0 112.208 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.473 HG22 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -153.7 67.78 0.76 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.981 0.42 . . . . 0.0 110.759 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.24 -11.52 75.57 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.168 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 73' ' ' GLY . 2.3 t -130.67 -43.27 1.12 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.884 0.342 . . . . 0.0 111.362 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 135.69 -35.46 2.15 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.501 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.32 -20.14 13.37 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.412 ' H ' HG23 ' A' ' 70' ' ' THR . . . -123.79 131.61 8.1 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.835 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.56 125.49 6.44 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.813 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.43 146.15 28.31 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.698 0.285 . . . . 0.0 111.135 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.6 t -108.37 170.92 7.71 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 78' ' ' TYR . 19.5 pt -48.5 -45.05 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CD2' HG13 ' A' ' 77' ' ' ILE . 4.1 p90 -131.07 14.85 5.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.158 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -86.27 -136.57 4.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.372 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.84 -63.49 0.37 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.137 0.494 . . . . 0.0 110.364 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.59 100.91 2.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.508 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD1' ' HA2' ' A' ' 79' ' ' GLY . 27.9 p90 -154.31 179.4 9.02 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -101.87 115.54 30.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.848 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.21 165.92 16.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.136 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.15 128.56 38.04 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.357 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.2 136.68 49.92 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.045 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.419 ' HB3' HD12 ' A' ' 90' ' ' LEU . 25.5 m80 -140.6 99.91 6.87 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.008 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.79 156.16 67.04 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 60.71 76.12 0.38 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -145.24 80.37 1.61 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.754 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.39 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.219 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.59 34.13 2.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.718 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -71.59 -36.27 70.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.344 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.05 160.34 12.74 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.3 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.99 94.74 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.866 0.365 . . . . 0.0 111.689 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 81.06 44.95 7.84 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.781 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 96' ' ' GLY . 33.6 mm -124.57 116.11 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.579 0.228 . . . . 0.0 110.855 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.557 HD22 HD22 ' A' ' 25' ' ' LEU . 25.1 tp -96.51 114.78 26.47 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.933 0.397 . . . . 0.0 111.097 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -114.07 150.38 34.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.319 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.403 ' HG3' ' CG ' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -79.45 125.27 29.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.592 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.54 151.77 28.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.71 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -130.16 146.71 51.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.403 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 107' ' ' THR . . . -91.17 -53.9 4.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.794 0.33 . . . . 0.0 110.592 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.12 179.99 35.29 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.502 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.63 116.85 3.57 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.475 2.117 . . . . 0.0 111.881 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.89 26.82 15.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.31 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 27.5 m -146.23 83.77 1.63 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.834 0.35 . . . . 0.0 110.889 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -101.18 156.29 17.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.354 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.65 -109.78 3.38 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.14 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.411 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -169.0 38.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 111.258 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -100.46 170.92 8.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -150.45 160.03 44.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 25.2 p90 -152.8 138.83 18.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 98' ' ' LEU . 17.6 m -103.69 134.7 44.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 117' ' ' ALA . 3.2 m -79.61 117.94 20.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.858 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -5.48 42.43 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.477 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 119' ' ' THR . . . -155.98 156.8 30.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.356 0.122 . . . . 0.0 111.147 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -51.38 120.23 6.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.911 2.407 . . . . 0.0 112.736 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.63 ' HB ' HD12 ' A' ' 122' ' ' LEU . 45.8 p -135.02 53.44 1.99 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.364 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -59.48 -35.75 74.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -66.62 -24.7 66.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.534 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.63 HD12 ' HB ' ' A' ' 119' ' ' THR . 2.4 mt -76.11 -2.78 32.6 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.55 85.36 0.07 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.095 0.474 . . . . 0.0 110.348 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.39 -44.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.736 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -64.63 -53.56 45.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.678 0.275 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -125.63 131.66 52.62 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.647 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 13.4 t -79.92 167.42 20.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.804 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.676 HG21 HD22 ' A' ' 90' ' ' LEU . 1.4 tt -79.56 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.699 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.581 ' CD1' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -177.8 -44.07 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.16 179.96 16.23 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.801 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.38 165.59 30.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.523 0.202 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.99 103.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.3 t -98.06 -51.24 4.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.798 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -123.3 98.39 5.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 23' ' ' ILE . . . 149.9 -17.72 1.08 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.386 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.9 tt -46.57 -33.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.65 88.66 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.308 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.419 ' HG3' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -60.17 -40.48 90.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.761 0.315 . . . . 0.0 110.274 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 114' ' ' VAL . 25.2 t -64.68 -41.43 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.901 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.92 -41.98 83.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -59.63 -33.89 72.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.128 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.569 HG12 HG12 ' A' ' 56' ' ' ILE . 10.6 t -60.25 -30.85 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.068 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . -89.05 -41.86 5.77 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.355 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.7 mmt -51.78 -34.69 40.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 142' ' ' VAL . 32.4 m -62.26 171.26 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.543 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 154' ' ' VAL . 1.1 tt0 -84.25 177.69 8.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.897 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -133.1 176.46 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -111.22 -165.52 1.0 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.68 36.73 0.9 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.77 29.34 0.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.866 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.43 39.2 23.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -121.77 146.06 44.83 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.785 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.949 ' HG3' HD13 ' A' ' 56' ' ' ILE . 66.6 Cg_endo -73.67 140.14 29.01 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.759 2.306 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 146' ' ' GLU . 4.3 m -58.85 -33.93 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.049 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.4 77.68 1.19 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.263 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.58 138.11 47.51 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.354 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' A' ' 20' ' ' MET . 21.7 t -80.05 126.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 114.27 23.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' HB ' ' A' ' 18' ' ' THR . 8.5 mt -91.01 144.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -133.73 8.57 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -157.57 140.83 15.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 111.304 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -153.91 101.08 2.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.941 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -151.33 155.93 34.76 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.479 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.11 149.17 19.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.862 2.375 . . . . 0.0 112.829 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -149.21 93.22 2.05 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.263 -1.299 . . . . 0.0 112.851 -179.869 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.78 0.324 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.71 163.36 13.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.318 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.22 167.79 0.26 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.592 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp -98.11 131.25 26.81 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.06 121.04 6.89 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.831 2.354 . . . . 0.0 112.47 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.08 -173.56 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.745 2.297 . . . . 0.0 112.471 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 t70 63.83 27.39 14.55 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.785 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.5 m -151.55 130.8 12.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.747 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -134.78 -45.56 0.73 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.437 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.4 114.23 53.61 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.528 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.59 121.49 9.96 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.556 2.171 . . . . 0.0 112.517 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 29' ' ' TRP . 61.3 Cg_endo -72.85 -18.93 24.22 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.866 2.378 . . . . 0.0 112.96 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -87.8 146.37 25.65 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 m -134.43 149.84 30.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.56 123.53 50.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.356 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.767 HD12 ' CD1' ' A' ' 25' ' ' LEU . 1.3 mt -106.43 94.01 4.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 109.59 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.546 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 159' ' ' ILE . 31.3 p -118.29 156.83 28.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.632 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.6 t -57.93 -35.06 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.567 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.778 ' HB2' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.873 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.87 -159.4 31.5 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.358 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -125.93 124.48 66.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.922 0.361 . . . . 0.0 111.003 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.603 HG22 ' HA2' ' A' ' 135' ' ' GLY . 24.2 pt -123.74 130.89 73.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.72 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -92.87 121.97 43.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.767 ' CD1' HD12 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -123.23 154.87 38.18 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.303 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 130.32 56.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 92.3 mt -103.79 134.1 47.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.769 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.721 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 82.7 m-85 -77.18 98.46 5.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.613 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 39.9 p-90 -82.26 20.42 1.05 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -100.27 -68.98 0.79 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.5 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.34 18.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.139 179.347 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.76 1.01 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.6 Cg_exo -40.26 -40.02 2.81 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.296 1.998 . . . . 0.0 113.226 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.85 -53.75 54.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.561 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 m -70.81 -35.48 72.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.831 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 68.5 m -56.69 -53.59 56.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.539 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -44.02 96.46 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.369 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -55.47 -44.83 76.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -60.51 -58.05 10.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.239 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.77 96.63 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.609 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.625 ' HG2' HG21 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -56.86 -47.11 81.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.346 -179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -39.02 88.56 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.7 -28.14 36.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.636 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -50.11 55.75 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.557 0.217 . . . . 0.0 111.171 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.457 HH11 HG22 ' A' ' 77' ' ' ILE . 12.7 ptm180 -60.68 -33.78 73.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.31 52.44 0.45 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.667 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.18 -54.27 1.91 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.383 0.135 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -47.26 62.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -60.36 114.71 3.07 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.35 -26.86 3.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.675 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.674 HG23 HD12 ' A' ' 159' ' ' ILE . 14.2 t -72.67 -175.58 1.71 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.558 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -165.75 144.9 6.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.723 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -61.92 112.94 2.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.719 0.295 . . . . 0.0 110.716 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -88.29 -55.07 3.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.357 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 113.43 22.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.219 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.666 ' HA ' HG22 ' A' ' 62' ' ' ILE . 13.2 mm -120.21 84.89 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -91.76 90.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -62.8 153.08 34.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 t0 68.27 26.79 6.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.165 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -163.59 -85.27 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.507 ' HB3' HG23 ' A' ' 115' ' ' THR . 0.0 OUTLIER -160.24 169.59 22.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.421 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.666 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.9 pt -143.12 132.9 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.4 pt20 -118.19 150.46 39.37 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.325 0.583 . . . . 0.0 112.245 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.47 115.9 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.462 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.19 -179.42 34.96 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.293 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t0 70.93 69.81 0.34 Allowed Pre-proline 0 N--CA 1.463 0.193 0 CA-C-O 120.858 0.361 . . . . 0.0 111.146 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -89.23 45.91 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.151 2.568 . . . . 0.0 112.087 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -178.07 -38.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.595 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.12 66.82 1.18 Allowed Glycine 0 C--N 1.338 0.661 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.972 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.2 m -93.04 -24.53 18.29 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.593 0.235 . . . . 0.0 110.944 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.31 -33.62 0.13 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.68 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -69.97 0.39 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.608 0.204 . . . . 0.0 110.99 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.15 165.73 34.91 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.824 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.09 101.48 0.21 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.511 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.64 133.56 36.38 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 t -84.01 -175.69 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.625 HG21 ' HG2' ' A' ' 41' ' ' GLU . 42.2 pt -71.8 -38.43 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.505 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -81.31 -31.22 33.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.196 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.27 -152.79 23.98 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -92.9 -45.52 7.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.324 . . . . 0.0 110.482 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.5 162.7 30.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.734 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.64 164.95 19.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.015 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -68.44 -178.12 1.05 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.434 ' OD1' HG21 ' A' ' 127' ' ' THR . 1.4 t70 -114.28 156.64 24.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.423 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.77 97.09 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.29 145.12 47.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -154.44 122.99 3.02 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.503 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.95 87.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.059 2.506 . . . . 0.0 112.867 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . 1.1 t70 -160.5 33.16 0.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.968 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD22 HG21 ' A' ' 128' ' ' ILE . 1.2 mp -143.02 -176.25 4.83 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.325 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptt -120.16 148.24 43.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.851 0.358 . . . . 0.0 111.512 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.524 ' CE2' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -136.9 79.82 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 179.671 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -31.01 49.19 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.323 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 112.77 -64.75 0.27 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.46 101.96 0.64 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.629 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' N ' HD12 ' A' ' 136' ' ' ILE . . . 83.25 69.92 1.37 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.977 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 96' ' ' GLY . 27.1 mm -132.62 137.09 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.654 0.227 . . . . 0.0 111.149 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.5 HD13 HG22 ' A' ' 132' ' ' VAL . 1.7 tp -112.73 94.93 5.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . 0.774 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -111.58 144.16 41.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.203 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 122.68 26.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.342 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.0 166.08 21.14 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.402 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -146.88 142.28 27.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.324 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.48 -40.99 18.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.394 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.55 179.79 34.9 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.619 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.73 122.57 11.21 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.552 2.168 . . . . 0.0 111.821 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.99 28.77 18.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.937 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.1 m -137.22 80.09 1.79 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 110.632 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -102.71 163.06 12.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.642 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.4 -127.46 2.77 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.6 m -135.71 41.3 2.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.953 0.406 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -108.48 161.31 15.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.74 161.35 42.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.774 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 24.3 p90 -137.52 130.45 30.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 111.298 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.521 HG13 HG21 ' A' ' 132' ' ' VAL . 10.9 t -101.2 107.77 22.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.085 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -79.78 138.94 37.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.522 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 pp -114.77 -17.88 11.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.553 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.602 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -112.99 162.96 19.3 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.483 0.182 . . . . 0.0 111.02 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.602 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 52.5 Cg_endo -68.52 122.64 9.63 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 112.762 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.537 ' CB ' HD12 ' A' ' 122' ' ' LEU . 77.9 p -147.15 70.23 1.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.827 0.346 . . . . 0.0 111.465 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.77 -38.81 92.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.903 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -62.47 -26.62 68.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.399 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.537 HD12 ' CB ' ' A' ' 119' ' ' THR . 2.1 mt -64.53 -16.44 62.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.586 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.89 81.98 0.2 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 110.0 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 169.6 -45.19 0.21 Allowed Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.358 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -70.73 -45.65 64.49 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.512 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -114.6 136.4 53.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.734 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 11.0 t -80.12 162.6 24.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.915 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.585 HG21 HD22 ' A' ' 90' ' ' LEU . 1.1 tt -87.85 -179.44 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.673 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -178.78 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.79 -179.71 27.67 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.76 161.72 33.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.822 0.344 . . . . 0.0 111.062 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.521 HG21 HG13 ' A' ' 114' ' ' VAL . 13.9 t -114.89 87.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.7 t -84.97 -36.4 21.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.52 101.27 3.85 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.016 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 158.81 -21.96 0.31 Allowed Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.343 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.7 tt -50.72 -30.88 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.988 0.394 . . . . 0.0 111.503 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.32 -13.83 63.24 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.471 ' O ' HG23 ' A' ' 142' ' ' VAL . 4.8 ttp -97.35 -32.65 11.77 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.919 0.36 . . . . 0.0 111.077 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.503 HG21 HG11 ' A' ' 114' ' ' VAL . 3.0 m -81.03 -30.74 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -79.29 -33.82 42.98 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.394 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -64.78 -29.56 70.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 145' ' ' VAL . 19.8 t -56.91 -34.94 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.705 0.288 . . . . 0.0 110.895 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.23 -30.82 24.26 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.565 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.1 mtt -61.43 -27.38 68.51 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 145' ' ' VAL . 13.2 p -82.82 33.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 62.38 171.36 0.13 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.018 0.437 . . . . 0.0 111.529 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -147.33 172.4 13.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 1.4 m-20 -85.06 -176.48 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.8 p -90.52 34.46 0.89 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.409 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -164.53 36.83 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.897 0.379 . . . . 0.0 110.774 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.61 57.83 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.088 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.2 OUTLIER -126.66 133.74 25.33 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 133.84 23.28 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.518 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.57 -35.26 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.809 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 -173.4 4.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.6 104.4 13.09 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.228 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' A' ' 20' ' ' MET . 9.2 p -119.8 122.13 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -156.3 162.54 40.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.243 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.68 ' HA ' HG22 ' A' ' 18' ' ' THR . 24.3 mt -97.26 129.36 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.803 0.335 . . . . 0.0 111.245 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 26.7 pt -111.94 -36.53 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.042 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -145.24 150.52 36.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -157.51 88.71 1.01 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.122 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -126.3 153.76 74.63 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.851 0.358 . . . . 0.0 111.621 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.22 140.65 14.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 112.382 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.86 152.78 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.072 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.536 179.584 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo . . . . . 0 CA--C 1.536 0.604 0 N-CA-C 113.446 0.518 . . . . 0.0 113.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.36 145.93 41.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.738 0.304 . . . . 0.0 110.97 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.31 138.18 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.4 ' CE1' HG22 ' A' ' 24' ' ' VAL . 2.2 m-85 -110.93 104.12 12.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.254 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.461 HD12 ' CD1' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -93.29 102.22 14.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.642 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HG2' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -79.9 83.35 5.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.39 148.65 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 t -58.16 -33.92 69.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.519 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.42 -41.27 85.14 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.341 . . . . 0.0 110.569 179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.04 154.45 9.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.145 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.436 HD13 ' HG2' ' A' ' 17' ' ' GLU . 5.7 tp -80.27 136.24 23.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 111.46 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.624 HG22 ' HA2' ' A' ' 135' ' ' GLY . 9.1 pt -144.44 137.06 22.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.442 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 15' ' ' TYR . 16.6 t -94.84 143.08 12.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.84 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.62 HD22 HD22 ' A' ' 98' ' ' LEU . 2.0 mt -124.92 163.68 21.74 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.33 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.11 114.2 20.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.783 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 142.9 27.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.541 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 17.2 m-85 -92.32 97.24 10.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -78.81 14.83 1.21 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -66.51 0.9 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.501 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 2.9 m80 -100.67 -15.38 17.75 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.29 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.45 1.15 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.667 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 61.7 Cg_exo -39.48 -35.63 0.87 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 122.198 1.932 . . . . 0.0 113.33 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -63.26 1.22 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.773 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 129' ' ' PHE . 5.9 t -65.65 -36.1 82.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.684 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.2 t -55.22 -50.97 68.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.469 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -58.98 -40.29 84.37 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -51.22 64.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.845 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -43.1 90.8 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.039 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.79 72.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.85 -50.31 69.34 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.146 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -37.83 71.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.0 -31.98 56.88 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -75.57 -48.06 24.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.264 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -28.78 67.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.823 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.06 45.6 1.46 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -102.03 -45.87 5.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.583 0.23 . . . . 0.0 110.667 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -68.25 -30.65 69.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.221 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -59.31 113.36 2.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.059 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 -18.61 26.5 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.987 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -83.45 175.23 9.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.744 0.307 . . . . 0.0 110.926 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.442 ' H ' HG22 ' A' ' 51' ' ' THR . 33.4 pttt -154.51 173.21 16.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.488 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.49 120.72 26.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.131 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -98.62 -30.48 12.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.498 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.5 123.96 46.39 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.614 0.245 . . . . 0.0 110.627 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.923 HD12 ' HB3' ' A' ' 153' ' ' PRO . 55.5 mt -145.79 100.14 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.0 mt -90.81 118.59 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.586 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -56.46 123.84 16.11 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.191 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 6.5 t70 59.07 50.22 8.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.155 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.73 -84.61 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.78 171.41 18.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.348 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.699 HG22 HG23 ' A' ' 56' ' ' ILE . 1.8 pp -141.02 114.59 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.753 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.6 tt0 -93.75 134.79 35.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 111.617 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 112' ' ' PHE . . . -94.06 152.33 20.65 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.571 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.165 -179.841 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.171 0 CA-C-O 120.878 0.37 . . . . 0.0 111.463 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 t -81.18 157.38 25.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.847 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.9 pt -58.44 -36.64 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.372 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.63 -31.41 57.37 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.48 -155.71 27.22 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.567 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -78.36 -55.48 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.674 0.273 . . . . 0.0 110.792 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -135.18 146.15 48.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.808 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -133.14 179.48 6.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -77.91 134.12 37.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.545 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.89 137.09 33.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.281 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.54 40.58 1.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.59 ' HA ' HG23 ' A' ' 127' ' ' THR . 4.8 tp -80.14 133.69 36.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.614 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.39 118.08 3.53 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.694 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.92 101.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.28 -46.02 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.931 ' HB3' HD13 ' A' ' 128' ' ' ILE . 2.8 mm? -86.74 177.25 7.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 93' ' ' THR . 6.2 tttt -149.79 150.46 32.04 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -112.99 61.34 0.64 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.226 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.412 HG22 ' HG2' ' A' ' 91' ' ' LYS . 15.0 t -126.11 -46.59 1.66 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -61.98 112.3 4.71 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.89 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 136' ' ' ILE . . . -45.32 120.37 2.45 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.561 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 105.64 64.93 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.089 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 114' ' ' VAL . 7.3 mm -133.4 157.05 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.807 0.304 . . . . 0.0 111.382 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.62 HD22 HD22 ' A' ' 25' ' ' LEU . 1.6 tp -118.89 101.16 7.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.784 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.662 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -104.8 141.12 37.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.232 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.46 127.95 32.76 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.854 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -130.48 177.25 7.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -121.83 -51.91 2.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.85 -179.45 34.66 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.473 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -50.96 117.28 3.22 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.643 2.229 . . . . 0.0 112.052 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 61.64 31.13 18.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.993 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -138.26 94.89 2.92 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.458 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.7 150.08 30.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.935 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.08 -146.11 12.15 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 26.45 5.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.671 0.272 . . . . 0.0 111.474 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -90.5 165.44 13.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CE1' ' HA3' ' A' ' 64' ' ' GLY . 9.5 p90 -154.25 127.31 8.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.785 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 26.6 p90 -124.55 135.1 52.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.356 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 97' ' ' ILE . 10.0 p -108.2 121.58 61.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.727 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.7 p -80.43 119.05 22.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 116' ' ' LEU . 4.6 pp -97.94 -7.87 29.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.826 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.65 148.4 65.44 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.465 0.174 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.82 132.61 50.39 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.889 2.393 . . . . 0.0 112.341 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.446 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.0 p -144.98 107.59 4.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 111.418 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -96.67 -30.39 13.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.462 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.446 ' CZ2' HG22 ' A' ' 119' ' ' THR . 22.0 p90 -61.12 -40.87 95.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.687 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.59 0.43 57.43 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.82 81.21 0.02 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 110.885 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.03 -23.68 2.42 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.809 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -57.03 -56.28 23.86 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.58 0.228 . . . . 0.0 111.295 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -98.24 179.14 4.84 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.662 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 25.4 m -107.96 158.67 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.769 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.931 HD13 ' HB3' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -90.29 -179.01 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.511 179.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.483 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -177.45 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.35 179.98 25.7 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.817 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -136.9 158.59 44.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.661 0.267 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.512 ' CG2' HD13 ' A' ' 98' ' ' LEU . 19.5 t -118.18 84.12 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -77.41 -56.66 4.36 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.423 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -109.01 93.1 4.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.888 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 159.57 -22.48 0.28 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.233 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 95' ' ' ALA . 10.5 tt -46.47 -34.41 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.51 -45.52 96.12 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.404 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.588 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -62.31 -33.77 75.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.72 0.295 . . . . 0.0 110.615 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.464 HG11 ' CG1' ' A' ' 114' ' ' VAL . 21.1 t -76.22 -35.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.806 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -55.1 -51.55 66.03 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.84 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.805 ' O ' HG13 ' A' ' 145' ' ' VAL . 16.8 ptp180 -57.64 -37.3 73.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.015 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 145' ' ' VAL . 38.0 t -59.75 -28.45 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.102 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.63 -30.98 13.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.144 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 mtt -76.62 -24.28 53.37 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 141' ' ' ARG . 33.6 m -60.53 176.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.782 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 130.44 37.17 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.5 p -119.83 172.95 7.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 3.8 t-20 -82.97 -171.03 3.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.511 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.1 m -92.17 28.21 1.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.699 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -155.36 -72.14 0.12 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.84 41.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.035 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.418 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -116.18 123.85 30.36 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.443 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.923 ' HB3' HD12 ' A' ' 56' ' ' ILE . 41.8 Cg_endo -69.16 119.65 6.61 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.735 2.29 . . . . 0.0 112.425 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.43 -32.95 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.769 0.319 . . . . 0.0 110.496 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.88 -167.11 1.15 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.552 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.52 112.94 20.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 111.451 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.519 HG13 ' HB2' ' A' ' 20' ' ' MET . 36.9 t -133.55 126.5 51.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.341 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.75 174.05 15.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 111.607 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mt -108.08 135.78 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.0 pt -107.31 -33.32 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.493 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -170.59 159.32 6.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.71 0.29 . . . . 0.0 110.903 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -148.95 135.24 19.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.95 144.68 16.98 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.59 152.56 22.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.364 2.042 . . . . 0.0 112.162 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 m -63.07 150.94 41.36 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.997 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.375 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo . . . . . 0 C--O 1.233 0.23 0 CA-C-O 120.691 0.204 . . . . 0.0 112.406 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -112.16 176.84 4.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.048 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 164' ' ' PRO . 39.2 t -143.44 129.87 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -93.72 101.5 13.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.704 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.566 HD21 ' CE2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -87.91 90.87 8.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.155 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.17 101.39 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.208 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 159' ' ' ILE . 1.2 p -110.0 165.18 11.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -33.01 71.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.666 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.04 -32.75 69.57 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.5 -145.44 8.02 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.447 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -143.22 130.01 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.228 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.511 HG22 ' CA ' ' A' ' 135' ' ' GLY . 33.4 pt -134.26 134.11 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.964 0.412 . . . . 0.0 111.63 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.17 117.22 43.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.504 HD13 HD12 ' A' ' 16' ' ' LEU . 7.1 mp -98.1 148.31 23.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -117.13 100.82 7.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.554 HD13 ' SG ' ' A' ' 36' ' ' CYS . 37.5 mt -83.13 137.54 34.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.493 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 26.3 m-85 -71.08 98.15 1.6 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.961 0.41 . . . . 0.0 110.818 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.431 ' CE3' ' HD2' ' A' ' 30' ' ' LYS . 2.2 p-90 -79.05 11.51 2.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.494 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' CE3' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -100.41 -69.36 0.77 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.683 0.278 . . . . 0.0 110.851 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.516 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -100.75 -17.0 17.14 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.655 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -96.87 1.06 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.8 Cg_exo -42.0 -35.57 3.23 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 121.937 1.758 . . . . 0.0 112.875 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -59.27 -59.54 5.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.686 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 p -64.19 -34.38 77.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.569 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.554 ' SG ' HD13 ' A' ' 27' ' ' LEU . 19.3 t -57.15 -47.61 80.76 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -61.14 -40.82 95.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -61.37 -41.46 97.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -38.6 74.14 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.71 55.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.815 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' HG21 ' A' ' 77' ' ' ILE . 27.4 mt-10 -64.94 -32.62 74.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 42' ' ' LEU . 0.4 OUTLIER -54.79 -43.84 73.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.558 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -81.52 -31.81 32.61 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.199 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -49.14 66.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.558 ' HD2' HG22 ' A' ' 77' ' ' ILE . 36.4 mtp85 -59.58 -31.92 69.9 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.58 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.09 28.61 3.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.759 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -97.67 -31.25 12.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.607 0.241 . . . . 0.0 110.823 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.566 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -81.77 -57.34 3.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.065 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -63.51 124.9 22.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 110.453 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.75 -29.79 6.99 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.542 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.607 ' HB ' HD12 ' A' ' 159' ' ' ILE . 1.6 m -61.94 162.64 8.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.775 0.322 . . . . 0.0 111.256 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -136.54 33.76 2.73 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.069 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.609 ' HE2' HD12 ' A' ' 62' ' ' ILE . 9.2 m-85 59.86 179.09 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.637 0.256 . . . . 0.0 111.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -145.11 -70.96 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.601 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.528 ' O ' HD13 ' A' ' 56' ' ' ILE . 3.8 tpt180 -95.9 130.01 42.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 111.208 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.759 HG21 HG12 ' A' ' 142' ' ' VAL . 27.1 mm -133.07 92.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.961 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.554 HD12 ' HE2' ' A' ' 61' ' ' MET . 7.3 mt -95.3 117.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.149 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -76.05 150.32 37.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 61.89 31.2 18.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -160.41 -88.49 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.088 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.554 ' HE2' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.29 170.13 21.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 111.408 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.655 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -140.82 125.45 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.524 ' HG3' ' HE3' ' A' ' 61' ' ' MET . 3.0 mt-30 -94.1 157.0 16.29 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.052 0.454 . . . . 0.0 111.496 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.63 153.44 19.96 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.55 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.478 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.139 -179.654 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.205 0 CA-C-O 120.593 0.235 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.2 p -104.88 164.96 11.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.076 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.558 HG22 ' HD2' ' A' ' 45' ' ' ARG . 2.5 pp -66.06 -33.02 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.496 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -75.91 -30.66 58.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.38 -140.68 6.41 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.749 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.24 76.28 1.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.98 0.419 . . . . 0.0 110.475 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HB3' HG22 ' A' ' 107' ' ' THR . 54.9 mm-40 70.8 135.63 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.41 -175.36 4.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.181 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.83 -179.62 1.21 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.28 141.63 36.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.863 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -78.19 109.76 12.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.156 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tp -156.33 134.24 11.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.407 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.99 -62.39 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.1 151.95 50.31 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.526 2.151 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.03 89.57 1.46 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.702 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.656 HD13 HG22 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -78.24 -178.29 5.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.149 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.4 155.14 27.95 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.83 83.98 1.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.741 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.5 p -69.52 -34.82 74.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.91 6.17 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.662 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.87 117.23 34.41 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.808 0.304 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.781 ' HA3' HD12 ' A' ' 136' ' ' ILE . . . 67.09 59.89 6.52 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.741 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 96' ' ' GLY . 19.1 mm -140.32 144.73 27.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.565 0.221 . . . . 0.0 110.78 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.747 HD23 HG22 ' A' ' 114' ' ' VAL . 1.1 mt -116.49 127.4 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.798 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -127.64 142.62 51.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.339 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 104.28 10.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.02 179.49 5.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.244 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.86 176.51 12.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.28 14.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.578 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.06 149.94 21.61 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.71 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.67 141.64 34.06 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.883 2.389 . . . . 0.0 112.663 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 63.21 23.22 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 81' ' ' GLN . 0.2 OUTLIER -152.19 80.5 1.25 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 110.673 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.19 113.07 24.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.53 -107.38 0.17 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.241 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.6 m -149.44 25.43 0.87 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -90.64 163.82 14.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.237 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -151.93 175.66 12.26 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.798 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 15.7 p90 -152.7 124.06 7.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 111.43 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.747 HG22 HD23 ' A' ' 98' ' ' LEU . 5.6 t -89.65 111.95 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.058 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.4 ' OG1' ' HB ' ' A' ' 97' ' ' ILE . 81.9 p -79.68 120.67 24.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.416 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.55 -25.29 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.336 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.77 156.4 40.73 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.095 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.4 130.82 30.36 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.016 2.478 . . . . 0.0 113.043 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.3 p -148.41 62.95 1.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -83.4 -14.7 52.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.73 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -90.77 -25.92 19.73 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.68 0.276 . . . . 0.0 111.29 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.22 1.25 29.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.762 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.76 79.52 0.29 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.23 -37.71 0.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.677 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -67.77 -54.9 15.58 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.664 0.268 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -109.86 138.35 46.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.73 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.749 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 3.6 t -84.56 157.74 21.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.95 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.656 HG22 HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -79.72 -179.63 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.724 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.512 ' HE1' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -170.46 -42.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.186 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.72 177.97 25.64 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.728 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.17 153.95 42.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 132' ' ' VAL . 13.8 p -109.71 107.12 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.097 0.475 . . . . 0.0 111.408 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.67 -46.0 7.45 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -123.45 84.27 2.25 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.873 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.511 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 169.62 -23.98 0.1 OUTLIER Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.583 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.781 HD12 ' HA3' ' A' ' 96' ' ' GLY . 15.8 tt -41.34 -37.34 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.16 -43.7 96.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.602 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 ttp -65.67 -39.56 91.48 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.549 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.414 HG11 HG11 ' A' ' 114' ' ' VAL . 21.5 t -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -61.41 -32.21 72.15 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.909 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -33.56 71.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.964 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.759 HG12 HG21 ' A' ' 56' ' ' ILE . 19.8 t -57.85 -30.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.7 -31.88 10.79 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.234 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.5 mmt -58.52 -36.01 73.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.511 0.196 . . . . 0.0 111.358 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 142' ' ' VAL . 30.2 m -64.23 176.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.563 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -81.68 172.24 13.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.057 0.456 . . . . 0.0 111.005 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.22 171.49 15.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.29 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.29 -171.1 1.85 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.84 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 p -95.21 30.28 2.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -152.65 32.07 0.51 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.4 t0 55.47 68.76 0.82 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.816 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -150.72 114.48 3.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.737 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.403 ' HG3' HG13 ' A' ' 56' ' ' ILE . 56.0 Cg_endo -71.3 152.4 61.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.056 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 146' ' ' GLU . 36.2 t -69.89 -37.98 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.41 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.35 80.6 1.52 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.351 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.86 148.25 10.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.59 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.666 HG13 ' HB2' ' A' ' 20' ' ' MET . 8.3 t -82.71 141.24 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.147 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -126.15 152.73 45.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 111.384 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.607 HD12 ' HB ' ' A' ' 51' ' ' THR . 6.7 mt -115.05 140.85 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 25.1 pt -120.14 -37.8 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.051 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.53 165.1 28.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.962 0.41 . . . . 0.0 111.472 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.452 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -156.53 87.31 1.02 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.673 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -100.86 106.53 44.58 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.166 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.615 ' HA ' HG13 ' A' ' 14' ' ' VAL . 72.3 Cg_endo -79.74 93.23 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.656 2.237 . . . . 0.0 112.132 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.5 m -150.65 164.74 35.36 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.206 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.275 -1.291 . . . . 0.0 112.842 179.752 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 CA--C 1.535 0.541 0 N-CA-C 112.841 0.285 . . . . 0.0 112.841 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.43 158.64 16.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.707 0.289 . . . . 0.0 111.213 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 164' ' ' PRO . 23.7 m -141.24 135.9 32.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.981 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -92.54 113.14 25.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.62 HD12 HD13 ' A' ' 25' ' ' LEU . 3.2 mt -97.86 96.14 8.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.647 ' HG2' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.39 113.67 20.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.722 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.755 ' CG2' HG23 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -125.81 156.16 39.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.949 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.5 t -59.07 -33.55 70.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.07 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.628 ' HB2' HG13 ' A' ' 157' ' ' VAL . 8.0 tpt -69.97 -30.86 68.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.191 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.13 -161.54 34.03 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.647 HD12 ' HG2' ' A' ' 17' ' ' GLU . 2.1 tt -122.3 128.13 75.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 117.105 0.452 . . . . 0.0 111.202 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.442 HG22 ' CA ' ' A' ' 135' ' ' GLY . 16.3 pt -129.49 127.59 65.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.047 0.451 . . . . 0.0 111.898 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.49 121.08 51.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.729 HD22 HD22 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -127.9 157.96 39.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.222 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.8 150.61 23.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.73 135.75 54.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.775 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 44.6 m-85 -76.69 95.04 3.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.725 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -78.86 11.35 2.69 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.32 -61.87 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 122.179 -0.325 . . . . 0.0 110.957 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.515 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 21.0 m170 -100.6 -15.02 17.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.775 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.41 1.31 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 58.8 Cg_exo -38.96 -38.15 1.01 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.353 2.036 . . . . 0.0 113.156 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -61.36 -57.97 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.578 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.49 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -67.2 -35.22 79.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.752 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.2 m -55.2 -51.6 66.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.4 89.48 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.547 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.4 -50.77 72.48 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.745 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.75 -47.96 83.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.555 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.35 86.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.073 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -38.79 92.21 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.453 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -60.42 3.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.586 0.232 . . . . 0.0 111.381 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.35 98.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.679 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -48.6 72.28 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.327 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -61.8 -55.54 28.96 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.49 43.16 0.06 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.243 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -45.75 2.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.781 0.324 . . . . 0.0 110.566 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.06 -24.58 59.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.113 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.88 102.47 4.75 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.55 26.95 4.59 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.487 ' OG1' HD12 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -89.4 178.08 6.41 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.04 0.42 . . . . 0.0 110.952 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -157.02 134.8 10.87 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.954 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CD2' HG22 ' A' ' 62' ' ' ILE . 28.3 m-85 -69.3 124.09 22.92 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.11 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -100.73 -32.19 10.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.014 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.457 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -119.31 119.8 35.08 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.81 0.338 . . . . 0.0 111.228 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.609 HG12 HG23 ' A' ' 62' ' ' ILE . 29.0 mt -135.13 94.54 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.668 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.3 mt -83.35 108.8 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -63.99 145.34 56.04 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.36 30.77 20.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.321 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.3 -83.3 0.08 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.247 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.412 ' HB3' ' HA ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -160.45 168.29 25.45 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.471 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.609 HG23 HG12 ' A' ' 56' ' ' ILE . 3.7 mp -131.91 125.95 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.526 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 1.4 pt20 -112.83 138.83 49.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.289 0.566 . . . . 0.0 112.348 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.48 103.86 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.379 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.333 0.391 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.277 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.639 0.257 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.0 p -129.4 172.81 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.62 -35.45 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.501 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -74.25 -33.59 63.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.247 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.72 -151.7 20.47 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.767 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -83.61 -52.09 6.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.727 0.263 . . . . 0.0 110.612 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -154.46 150.74 28.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.31 174.5 10.48 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.513 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.87 173.76 7.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.8 169.45 11.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.636 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -129.74 47.06 2.55 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 tp -68.68 145.51 53.81 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -162.79 86.7 1.38 Allowed Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.985 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.99 100.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.766 2.311 . . . . 0.0 112.26 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.71 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.939 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.762 HD22 HG21 ' A' ' 128' ' ' ILE . 4.9 mp -66.94 175.82 2.33 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.734 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -106.91 165.14 11.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.42 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.86 70.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 97' ' ' ILE . 25.7 p -57.3 -30.34 64.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.703 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 102.69 -48.1 1.07 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.649 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.0 109.64 18.34 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.296 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.553 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 79.03 63.85 2.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.784 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 96' ' ' GLY . 10.5 mm -131.94 152.46 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.751 0.276 . . . . 0.0 111.312 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.729 HD22 HD22 ' A' ' 25' ' ' LEU . 4.7 tp -131.28 101.7 5.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.702 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -110.13 144.38 38.83 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.28 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.49 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.73 106.69 11.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.632 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.33 151.28 23.24 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.548 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -123.09 157.39 32.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.44 63.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.08 179.63 35.49 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.353 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.39 125.95 17.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.582 2.188 . . . . 0.0 112.007 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.1 30.13 19.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.9 m -142.6 91.03 2.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -96.99 155.11 16.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.162 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.32 -151.72 5.48 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.849 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 m -104.16 64.95 0.78 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.521 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -141.42 146.54 36.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -151.08 166.02 32.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.488 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.677 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 30.2 p90 -137.76 142.46 40.94 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.689 HG22 ' CD1' ' A' ' 98' ' ' LEU . 5.3 t -111.23 106.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 3.3 p -80.32 134.78 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.552 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.38 -27.6 8.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.47 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.76 151.56 39.35 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.655 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 66.0 Cg_exo -52.38 130.1 34.5 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.809 2.34 . . . . 0.0 112.484 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.9 t -161.07 77.72 0.57 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 111.197 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.07 -3.73 52.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -89.54 -27.22 20.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.079 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -21.16 66.27 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.286 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -66.82 84.75 0.12 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.203 0.525 . . . . 0.0 110.314 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.15 -47.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.035 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -80.17 -35.36 36.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.467 0.175 . . . . 0.0 110.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -122.31 134.51 54.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.802 0.334 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.702 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 31.8 m -80.88 161.12 24.53 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.762 HG21 HD22 ' A' ' 90' ' ' LEU . 1.5 tt -79.54 -179.24 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.456 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.549 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -176.69 -39.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.26 -179.97 26.51 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.85 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -148.81 148.84 30.4 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 122.78 -0.247 . . . . 0.0 110.654 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.531 HG21 ' HB ' ' A' ' 136' ' ' ILE . 10.4 m -79.13 136.77 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 111.552 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 7.2 t -118.78 -47.06 2.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -142.56 80.93 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.999 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.442 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 176.03 -21.6 0.05 OUTLIER Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.116 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.531 ' HB ' HG21 ' A' ' 132' ' ' VAL . 14.6 tt -40.85 -38.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.19 93.89 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.555 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.424 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.9 ttp -59.78 -41.61 91.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.773 0.32 . . . . 0.0 110.379 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.18 -44.87 84.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.582 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -61.83 -40.84 96.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -56.5 -40.78 75.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 20' ' ' MET . 17.6 t -56.97 -38.29 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.291 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.84 -29.96 16.54 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.625 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 79.1 mmm -66.53 -16.92 64.51 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.456 ' O ' HG21 ' A' ' 154' ' ' VAL . 16.2 m -88.2 19.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 165.22 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.4 p -144.18 174.55 10.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.489 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -172.69 3.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.9 m -93.55 33.74 1.24 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.92 31.94 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.478 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 52.7 51.22 16.45 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -123.3 143.49 41.29 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.822 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.503 ' CB ' HG23 ' A' ' 157' ' ' VAL . 60.6 Cg_endo -73.21 141.78 32.9 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.68 2.254 . . . . 0.0 112.531 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 145' ' ' VAL . 6.4 m -78.89 -35.4 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.888 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.17 11.46 38.25 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.13 138.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.268 0.556 . . . . 0.0 112.295 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 20' ' ' MET . 38.4 t -128.74 132.89 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.693 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' HG2' ' N ' ' A' ' 159' ' ' ILE . 2.5 tttp -144.17 156.68 44.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.795 0.331 . . . . 0.0 111.408 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.755 HG23 ' CG2' ' A' ' 18' ' ' THR . 7.2 mt -110.82 120.46 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.436 HD11 ' CD ' ' A' ' 17' ' ' GLU . 31.8 pt -81.67 -43.47 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -175.21 174.31 2.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.511 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -150.78 133.61 15.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -152.29 157.26 33.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.116 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.437 ' HA ' HG12 ' A' ' 14' ' ' VAL . 72.1 Cg_endo -79.34 148.86 21.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.261 1.974 . . . . 0.0 112.1 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.5 m -61.94 147.47 46.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.695 -1.059 . . . . 0.0 112.857 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.534 0.514 0 CA-C-O 121.005 0.335 . . . . 0.0 112.155 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -126.17 160.16 30.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.7 154.84 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -114.04 111.3 21.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.218 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -92.26 109.08 20.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 2.9 mm-40 -81.15 112.59 18.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.863 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.77 145.09 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.5 t -56.71 -36.31 69.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.027 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.899 ' HB2' HG23 ' A' ' 157' ' ' VAL . 1.2 tpt -65.71 -29.15 69.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.742 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.464 ' HA3' ' HG2' ' A' ' 138' ' ' MET . . . 153.46 150.48 5.46 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.204 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 tt -80.32 139.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.758 0.279 . . . . 0.0 111.031 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.572 HG22 ' CA ' ' A' ' 135' ' ' GLY . 10.8 pt -145.93 133.47 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.753 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.32 137.71 21.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 16' ' ' LEU . 3.2 mt -129.94 147.82 51.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.77 113.19 26.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.776 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 mt -96.87 119.14 34.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.787 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 29.4 m-85 -66.67 102.91 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -80.62 12.34 3.18 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -61.82 1.32 Allowed 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.834 0.35 . . . . 0.0 110.623 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.502 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 62.2 m170 -100.75 -15.5 17.65 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.564 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.66 0.98 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.0 Cg_exo -40.77 -35.31 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.286 1.99 . . . . 0.0 113.137 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -60.02 3.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.628 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.67 HG21 ' HG3' ' A' ' 100' ' ' MET . 26.8 m -67.28 -43.61 81.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.851 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.8 t -54.69 -47.52 73.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -59.17 -48.95 79.73 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.271 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -60.98 -43.41 98.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.125 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.11 -56.42 21.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.999 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.9 94.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.262 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.31 -46.33 83.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -36.8 77.65 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.095 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.58 -48.92 68.06 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.74 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -35.03 79.54 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.974 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -36.81 84.95 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.232 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.5 41.17 1.65 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.401 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -113.34 -47.49 3.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.463 0.173 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.13 -32.33 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.055 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 112.39 8.3 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.686 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.97 -23.76 11.32 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.099 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -68.54 178.48 2.02 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.073 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 157' ' ' VAL . 0.3 OUTLIER -156.91 159.6 38.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.161 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -74.06 129.6 38.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -106.63 -36.56 6.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.441 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 119.1 37.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.574 HG12 HG23 ' A' ' 62' ' ' ILE . 22.1 mt -139.4 130.82 34.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.17 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.452 HD12 ' CE ' ' A' ' 61' ' ' MET . 17.7 mt -114.87 120.53 64.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.039 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.26 142.5 52.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.226 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 29.73 19.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.861 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.39 -85.13 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.877 -0.147 . . . . 0.0 111.306 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.452 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.65 173.32 15.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.429 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.574 HG23 HG12 ' A' ' 56' ' ' ILE . 3.7 mp -133.31 119.97 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.577 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.8 pt20 -106.75 143.96 34.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.83 124.75 2.65 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.71 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.332 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.187 -179.537 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 p -78.26 174.95 10.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.74 -31.4 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -79.67 -69.44 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.451 0.167 . . . . 0.0 110.945 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.08 158.46 30.79 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -33.51 72.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.25 140.96 26.9 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.691 0.282 . . . . 0.0 111.077 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -156.85 172.17 19.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.357 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.13 179.31 0.96 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.443 ' OD1' HD12 ' A' ' 86' ' ' LEU . 2.5 p30 -101.26 179.84 4.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.996 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -129.74 36.54 4.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.443 HD12 ' OD1' ' A' ' 84' ' ' ASP . 6.6 mt -57.52 146.77 28.86 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.511 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.79 145.68 17.99 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 68.57 5.26 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.614 2.209 . . . . 0.0 112.631 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.601 ' HB3' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -165.46 172.98 11.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.104 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 1.042 HD22 HG21 ' A' ' 128' ' ' ILE . 3.9 mp 64.38 172.65 0.19 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.658 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 163.64 10.22 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.993 0.425 . . . . 0.0 112.006 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HE2' ' HB2' ' A' ' 99' ' ' ALA . 1.2 m-85 -116.76 87.43 2.69 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.147 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -127.93 -52.45 1.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.609 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.25 7.35 68.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.147 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.02 -169.6 0.2 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.634 0.373 . . . . 0.0 111.191 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.49 47.58 90.44 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 30.5 mm -120.45 154.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.74 0.305 . . . . 0.0 111.089 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.508 HD13 HD22 ' A' ' 25' ' ' LEU . 1.1 tp -124.42 104.03 8.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.036 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -116.57 140.16 49.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.575 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.67 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.56 121.09 24.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.309 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 113' ' ' PHE . . . -110.9 172.2 7.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.378 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -150.7 152.94 34.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.99 78.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.36 176.05 33.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.183 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.47 125.03 15.84 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.537 2.158 . . . . 0.0 111.948 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.23 36.44 17.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -147.54 83.41 1.54 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.908 0.385 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.38 168.65 10.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.41 46.08 0.46 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.901 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t 55.48 37.01 28.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.294 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 161.61 14.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -160.29 173.47 15.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.638 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 21.7 p90 -148.24 132.15 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.0 111.399 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.618 HG21 HG11 ' A' ' 139' ' ' VAL . 14.1 p -103.06 120.39 52.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.588 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 92' ' ' PHE . 17.5 p -79.49 129.81 34.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.501 ' C ' HD12 ' A' ' 116' ' ' LEU . 4.1 pp -109.61 -10.7 14.83 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.897 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -136.47 164.33 43.49 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 120.509 0.195 . . . . 0.0 111.298 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 36.7 Cg_endo -65.94 119.97 7.07 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.609 2.206 . . . . 0.0 111.434 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 71.9 p -136.43 103.39 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.675 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.536 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -60.09 -41.57 92.79 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.605 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.6 pp -86.89 0.17 55.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.453 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.85 84.04 0.31 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.825 0.345 . . . . 0.0 110.717 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.54 -29.59 2.25 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.076 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -57.9 11.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.605 0.24 . . . . 0.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -95.77 159.19 15.1 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.737 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 6.7 t -93.59 161.3 14.41 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.042 HG21 HD22 ' A' ' 90' ' ' LEU . 3.3 mm -89.04 -178.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.289 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.7 ' H ' HG22 ' A' ' 128' ' ' ILE . 2.4 p90 -178.96 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.485 0.183 . . . . 0.0 111.346 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.66 -179.64 19.62 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.48 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.38 162.22 38.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.614 0.245 . . . . 0.0 110.986 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 25' ' ' LEU . 13.0 t -116.47 121.27 67.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.825 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.3 t -115.35 -63.81 1.4 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.93 91.5 3.68 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.803 0.335 . . . . 0.0 110.311 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.572 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 155.2 -22.16 0.58 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.193 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.519 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -44.88 -36.2 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -53.79 -42.52 68.9 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.707 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.464 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 7.1 tpt -75.17 -43.67 50.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.564 0.221 . . . . 0.0 110.698 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.618 HG11 HG21 ' A' ' 114' ' ' VAL . 15.4 t -54.49 -35.95 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.923 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -61.67 -39.34 91.04 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.911 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HB2' ' HE3' ' A' ' 138' ' ' MET . 0.5 OUTLIER -59.55 -38.21 80.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.015 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.421 HG22 ' HG2' ' A' ' 20' ' ' MET . 19.2 t -58.08 -31.15 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.756 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.466 ' HA3' HD22 ' A' ' 116' ' ' LEU . . . -92.14 -38.49 5.68 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.042 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.2 tpt -53.02 -34.58 57.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.473 0.309 . . . . 0.0 111.692 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 m -59.48 168.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.895 0.379 . . . . 0.0 111.469 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.679 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -104.35 148.01 26.87 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -96.83 165.36 12.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.92 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 6.9 m120 -136.0 146.75 47.52 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.88 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.26 -46.43 0.13 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.004 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -173.47 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -176.84 38.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.6 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 148' ' ' ASN . 6.9 mtt180 -101.09 123.03 46.48 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.718 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 56' ' ' ILE . 29.4 Cg_endo -63.36 132.41 35.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.803 2.335 . . . . 0.0 112.563 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 146' ' ' GLU . 41.3 t -70.23 -42.81 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.709 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.42 115.02 17.84 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.18 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.18 96.17 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.5 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.899 HG23 ' HB2' ' A' ' 20' ' ' MET . 12.5 p -90.41 139.42 17.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.98 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 52' ' ' LYS . 18.2 pttt -154.7 155.64 34.97 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.213 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 mt -96.69 145.99 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.889 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.07 -52.12 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 44.4 mtpt -144.43 171.57 14.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.35 104.79 1.66 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.086 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.06 154.66 77.67 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.311 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.15 172.24 13.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.618 2.212 . . . . 0.0 112.581 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.25 -33.84 11.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.252 -1.304 . . . . 0.0 112.582 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo . . . . . 0 CA--C 1.529 0.245 0 CA-C-O 120.858 0.274 . . . . 0.0 112.327 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.78 99.93 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.25 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 m -94.37 146.97 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.271 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.495 ' HE1' ' HG ' ' A' ' 165' ' ' SER . 6.6 m-85 -121.01 108.72 14.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.242 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.79 104.94 17.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 110.991 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CB ' ' HG2' ' A' ' 161' ' ' LYS . 0.5 OUTLIER -79.94 97.06 6.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.625 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.53 HG22 HG12 ' A' ' 159' ' ' ILE . 1.9 p -106.43 160.18 15.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -63.71 -36.97 85.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.607 179.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.655 ' CB ' HG13 ' A' ' 157' ' ' VAL . 9.4 tpt -64.66 -32.24 73.82 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.09 -163.91 37.47 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.046 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 22' ' ' ILE . 10.8 tt -122.06 118.82 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.003 0.402 . . . . 0.0 111.342 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.478 HG23 ' SD ' ' A' ' 138' ' ' MET . 26.9 pt -116.01 158.19 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 15' ' ' TYR . 18.8 t -122.97 120.64 61.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.931 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 98' ' ' LEU . 5.2 mt -115.01 155.13 27.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -116.21 115.56 26.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD21 ' HE1' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -95.25 120.46 35.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.717 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.825 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 87.1 m-85 -72.62 104.59 3.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -82.98 23.23 0.86 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 -65.46 0.97 Allowed 'General case' 0 C--O 1.231 0.108 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.469 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.4 m-70 -100.93 -11.49 19.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.646 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -100.14 1.05 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.2 Cg_exo -40.77 -36.05 1.82 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 122.117 1.878 . . . . 0.0 113.302 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -68.81 -53.52 21.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.943 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -69.32 -36.71 77.25 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.942 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.3 t -58.84 -50.1 75.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.63 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -59.28 -40.24 85.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.408 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -62.36 -43.06 99.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.89 -52.4 65.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.856 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.33 78.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HB3' HD13 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -60.46 -51.05 71.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.215 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.542 HD22 ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -60.91 -29.95 69.89 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.429 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . . . -70.24 -49.22 52.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -76.63 -29.23 56.36 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.573 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -55.12 -32.13 61.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.34 46.64 0.91 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -125.34 -55.0 1.57 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.408 0.147 . . . . 0.0 111.079 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.542 ' CE1' HD22 ' A' ' 42' ' ' LEU . 13.8 m-85 -60.81 -30.35 70.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.337 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -71.7 121.27 18.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.757 0.313 . . . . 0.0 110.469 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.28 -24.26 23.08 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.682 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.854 ' HB ' HD12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -60.85 158.34 13.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 26.74 2.37 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 63.04 -179.43 0.15 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.015 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.41 -92.88 0.28 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.186 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -79.79 121.77 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.706 0.288 . . . . 0.0 110.513 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.833 HD12 ' HG3' ' A' ' 153' ' ' PRO . 7.8 mt -131.54 125.89 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 mt -129.82 118.0 43.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -56.16 25.53 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.763 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.82 49.46 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.765 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -169.22 -89.02 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.213 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.81 175.73 12.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 0.0 111.407 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.686 HD12 HG11 ' A' ' 142' ' ' VAL . 5.9 tt -139.26 109.55 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.511 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -89.47 156.6 18.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.579 0.704 . . . . 0.0 112.158 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.93 105.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.279 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.572 -179.133 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.618 0.247 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 p -88.58 168.32 12.66 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 41' ' ' GLU . 5.2 pt -60.93 -31.44 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.62 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -75.77 -37.13 59.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.32 -151.19 16.87 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -45.02 92.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 110.699 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -161.51 155.36 21.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.95 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -119.17 170.1 9.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.29 178.21 4.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -132.51 171.51 13.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.203 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.23 110.5 9.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.7 tp -100.79 111.07 23.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -130.59 102.52 16.6 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.957 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.03 -14.86 35.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.068 2.512 . . . . 0.0 113.141 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.78 -45.99 20.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.514 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' HD13 ' A' ' 128' ' ' ILE . 6.2 mt -80.2 138.07 36.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.0 178.17 6.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.61 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.621 ' HE2' ' HB2' ' A' ' 99' ' ' ALA . 10.4 m-85 -137.75 97.64 3.48 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.6 ' OG1' HD11 ' A' ' 97' ' ' ILE . 21.5 p -81.87 -4.32 56.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.7 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.17 -75.06 1.8 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.979 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.84 107.66 0.32 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.851 0.358 . . . . 0.0 111.802 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 69.7 61.13 4.56 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.306 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.6 HD11 ' OG1' ' A' ' 93' ' ' THR . 26.8 mm -137.39 131.69 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.626 0.25 . . . . 0.0 110.852 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.616 HD11 HD22 ' A' ' 25' ' ' LEU . 7.2 mt -101.63 122.16 43.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.949 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.621 ' HB2' ' HE2' ' A' ' 92' ' ' PHE . . . -126.22 134.93 51.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.69 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.467 ' HE3' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -79.94 107.46 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.434 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.476 ' HB3' ' OE1' ' A' ' 111' ' ' GLN . . . -85.99 161.97 18.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.476 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.25 140.79 22.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.49 58.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.435 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.01 175.29 35.26 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.552 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.13 121.21 9.25 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.625 2.216 . . . . 0.0 112.185 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 58.52 30.64 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.326 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.6 m -120.77 85.36 2.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.987 0.422 . . . . 0.0 110.493 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.64 120.98 39.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.988 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.63 51.35 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.409 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.496 ' OG ' HD13 ' A' ' 42' ' ' LEU . 16.7 m 58.89 35.89 24.38 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -97.75 139.7 33.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.669 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.65 174.97 13.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.036 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.8 p90 -159.55 140.18 12.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.218 0.533 . . . . 0.0 111.876 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.574 HG22 ' CD2' ' A' ' 98' ' ' LEU . 4.9 t -98.27 113.77 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.79 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.46 141.94 36.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.91 -28.71 7.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.412 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.74 42.29 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.774 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.09 114.57 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.761 2.307 . . . . 0.0 112.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.3 p -129.37 68.35 1.42 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.065 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -81.11 -39.47 25.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -65.21 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.176 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mt -73.54 -9.31 58.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.664 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.16 84.45 0.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.112 0.482 . . . . 0.0 110.485 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -50.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.465 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.87 -31.58 63.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.635 0.255 . . . . 0.0 111.129 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -119.56 123.22 43.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.084 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.552 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 14.8 t -79.87 163.28 24.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.599 HD12 ' CE1' ' A' ' 92' ' ' PHE . 1.3 tt -80.74 -179.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.946 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.542 ' HE1' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -176.99 -39.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.856 -0.156 . . . . 0.0 111.287 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.93 179.47 22.04 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.549 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.467 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -138.05 160.91 38.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.22 96.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.017 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.3 -41.54 12.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.502 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -144.5 108.6 4.76 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.894 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.39 -19.64 1.18 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.255 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.448 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.0 tt -50.09 -29.24 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.74 -39.14 90.2 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.427 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.478 ' SD ' HG23 ' A' ' 23' ' ' ILE . 3.4 ttp -69.32 -50.51 45.84 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.393 0.14 . . . . 0.0 110.985 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.646 ' O ' HG12 ' A' ' 142' ' ' VAL . 3.6 m -61.89 -20.6 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.418 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.85 -31.72 35.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.593 0.235 . . . . 0.0 110.899 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -56.32 -41.96 76.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.573 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 62' ' ' ILE . 14.5 p -56.7 -30.66 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.705 0.288 . . . . 0.0 111.361 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.28 -34.91 15.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.966 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.2 mtt -62.09 -28.54 69.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.31 163.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.709 0.29 . . . . 0.0 111.236 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.4 tt0 -62.39 123.07 17.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.192 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.6 p -107.35 178.71 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -79.8 -179.01 6.7 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m -90.15 19.13 5.23 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -151.1 -68.35 0.18 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -174.02 73.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.77 0.319 . . . . 0.0 111.275 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -156.4 96.98 2.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.833 ' HG3' HD12 ' A' ' 56' ' ' ILE . 49.5 Cg_endo -69.46 131.15 21.05 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.733 2.289 . . . . 0.0 112.232 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 146' ' ' GLU . 60.5 t -58.64 -44.25 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.647 0.26 . . . . 0.0 110.394 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.62 63.87 0.61 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -52.16 150.5 4.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.648 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.655 HG13 ' CB ' ' A' ' 20' ' ' MET . 3.9 t -79.78 101.9 5.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.791 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' SER . 5.7 tttm -84.69 150.51 25.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.854 HD12 ' HB ' ' A' ' 51' ' ' THR . 17.6 mt -116.77 128.99 74.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.4 pt -109.32 -33.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.424 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -163.14 168.02 21.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.07 107.87 2.76 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -144.26 147.08 35.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.432 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.05 174.39 11.56 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.714 2.276 . . . . 0.0 112.516 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.495 ' HG ' ' HE1' ' A' ' 15' ' ' TYR . 25.0 p -95.2 -37.38 11.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.309 -1.273 . . . . 0.0 112.868 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 CA--C 1.531 0.366 0 CA-C-O 120.61 0.171 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.474 HD22 HG12 ' A' ' 24' ' ' VAL . 2.4 m120 -130.62 160.75 33.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.702 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 27' ' ' LEU . 25.2 m -125.61 141.22 46.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.178 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.31 105.7 15.21 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.764 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.414 ' CD1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -97.12 101.64 13.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.062 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.88 108.05 19.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.305 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -113.2 161.98 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.941 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.409 ' N ' HD11 ' A' ' 160' ' ' ILE . 1.4 m -63.05 -30.0 71.26 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.178 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.85 ' HG2' HG22 ' A' ' 142' ' ' VAL . 8.7 tpt -68.79 -32.03 71.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.094 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.64 -148.65 14.19 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.396 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.51 136.49 59.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.764 0.316 . . . . 0.0 111.446 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.56 HG22 ' CA ' ' A' ' 135' ' ' GLY . 20.7 pt -144.32 128.92 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.519 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.474 HG12 HD22 ' A' ' 13' ' ' ASN . 18.3 t -102.53 98.66 7.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.53 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.69 ' HG ' HD11 ' A' ' 98' ' ' LEU . 9.5 mp -80.83 148.77 29.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.35 140.33 48.12 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 14' ' ' VAL . 3.0 mp -124.11 129.65 51.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.154 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 37.6 m-85 -63.19 99.7 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 110.771 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -78.85 12.63 2.05 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.05 -65.51 0.96 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 110.522 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.503 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.1 m80 -100.73 -15.51 17.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.27 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.75 1.64 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.4 Cg_exo -40.57 -37.74 2.27 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.052 1.835 . . . . 0.0 113.089 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -60.72 -55.8 28.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -34.79 79.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.736 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.6 t -58.35 -45.59 87.89 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.58 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -61.69 -43.53 98.68 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.222 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.42 -39.33 93.63 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -69.07 -43.0 75.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.91 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.02 73.54 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.286 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -48.42 80.52 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.011 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -36.33 78.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.131 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.41 50.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.248 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -76.3 -49.08 17.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -60.08 -40.87 91.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.745 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.93 53.11 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -112.14 -62.84 1.51 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.515 0.198 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.615 ' O ' HG22 ' A' ' 51' ' ' THR . 12.9 m-85 -63.3 -51.71 64.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.65 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -67.23 119.75 12.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 110.47 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.22 8.8 10.09 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.088 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 48' ' ' TYR . 15.1 t -117.74 -172.18 2.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.274 0.537 . . . . 0.0 111.176 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.8 150.19 35.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.759 ' HB3' HD11 ' A' ' 56' ' ' ILE . 59.8 m-85 -64.23 136.9 57.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.187 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -109.44 -36.59 5.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.734 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.472 ' O ' HD13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -113.89 113.65 25.16 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.628 0.251 . . . . 0.0 111.114 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.759 HD11 ' HB3' ' A' ' 53' ' ' PHE . 29.6 mm -132.71 116.66 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.53 88.28 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.039 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HD3' ' HA3' ' A' ' 143' ' ' GLY . 21.8 tptt -58.97 155.53 13.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.09 25.75 4.67 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -166.29 -82.38 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.02 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.605 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -160.53 170.07 21.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 111.516 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -142.66 161.57 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.51 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -146.75 154.59 41.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.924 0.392 . . . . 0.0 111.55 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.68 150.45 17.12 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.562 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.412 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.987 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.0 t -125.4 175.04 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -53.02 -33.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.828 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.403 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 29.1 m-85 -92.23 -35.91 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.016 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.9 -143.49 10.34 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.588 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -134.68 27.52 3.65 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 111.193 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.13 -55.72 0.65 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.119 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 78' ' ' TYR . 15.5 m-85 61.73 -176.79 0.13 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.63 131.51 48.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.59 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.43 146.25 49.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -131.96 98.85 4.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.236 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.72 110.9 10.71 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.649 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -132.12 172.84 6.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 -173.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.742 2.294 . . . . 0.0 112.174 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.82 179.28 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.9 mt 66.82 165.89 0.21 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.739 0.304 . . . . 0.0 110.887 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 160.38 40.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 111.471 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.31 96.63 5.75 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.972 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.426 ' OG1' HD11 ' A' ' 97' ' ' ILE . 17.0 p -71.97 -33.61 68.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.2 -26.67 23.03 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.916 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 116.17 31.46 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.069 0.435 . . . . 0.0 111.654 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 66.35 54.82 21.37 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.213 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 96' ' ' GLY . 19.8 mm -129.23 135.53 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.768 0.284 . . . . 0.0 111.203 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.781 HD23 HG22 ' A' ' 114' ' ' VAL . 1.3 mt -105.64 120.44 41.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.833 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.758 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -117.81 141.16 48.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.369 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.19 120.02 23.11 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.181 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.72 141.8 36.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.43 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -157.16 117.4 3.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.743 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.47 72.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.71 179.83 17.51 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.48 30.27 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.686 2.258 . . . . 0.0 113.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -176.7 38.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 110.697 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.28 81.95 1.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 110.829 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -106.24 91.47 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.223 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.91 -105.16 0.02 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.358 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -157.5 36.48 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.43 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -118.1 160.3 21.76 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.696 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -159.74 165.66 32.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.758 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 6.5 p90 -137.63 136.79 37.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.42 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.781 HG22 HD23 ' A' ' 98' ' ' LEU . 4.8 t -102.72 110.53 29.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.201 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -79.8 130.89 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 61' ' ' MET . 0.6 OUTLIER -114.71 -15.99 11.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.675 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -108.61 152.35 42.12 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.835 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.99 104.41 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.761 2.308 . . . . 0.0 112.343 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.6 p -138.3 67.53 1.41 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -70.4 -32.96 70.82 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -60.55 -29.13 68.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.296 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.419 HD23 ' HD2' ' A' ' 125' ' ' LYS . 4.4 mt -73.17 -11.86 60.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.877 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.24 85.44 0.15 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.219 0.533 . . . . 0.0 110.425 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.79 -40.71 0.11 Allowed Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.279 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.419 ' HD2' HD23 ' A' ' 122' ' ' LEU . 30.7 mttt -74.56 -44.55 50.47 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 110.836 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -112.84 133.9 54.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.651 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 15.3 t -79.91 164.28 23.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.997 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.4 tt -90.4 -179.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.689 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.0 p90 -178.31 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -179.77 23.27 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.779 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.589 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -146.03 150.31 35.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.8 t -106.9 99.75 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.206 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.26 -45.96 5.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -119.84 96.34 5.14 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.829 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.56 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 152.24 -22.23 0.86 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.277 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.2 tt -47.21 -36.41 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.848 0.324 . . . . 0.0 111.807 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.59 96.2 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.482 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 ttp -65.77 -41.99 91.36 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.611 0.243 . . . . 0.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.71 -36.98 63.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.719 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -63.4 -36.15 82.76 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.983 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -60.78 -42.06 96.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.486 0.184 . . . . 0.0 111.028 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.85 HG22 ' HG2' ' A' ' 20' ' ' MET . 12.1 t -58.27 -34.03 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.148 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 58' ' ' LYS . . . -89.62 -36.38 7.41 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.12 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -35.77 61.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.46 0.304 . . . . 0.0 111.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 155' ' ' ASP . 18.9 m -63.76 173.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.612 ' O ' HG12 ' A' ' 154' ' ' VAL . 3.6 mm-40 -72.83 -179.93 3.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.062 0.458 . . . . 0.0 111.266 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.0 177.72 9.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.97 -173.11 4.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.03 27.83 2.32 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -147.26 -71.95 0.22 Allowed 'General case' 0 C--O 1.231 0.122 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 178.74 45.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.008 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.04 116.34 28.78 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.33 129.13 33.12 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.953 2.435 . . . . 0.0 112.849 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 146' ' ' GLU . 11.4 p -69.78 -35.36 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.12 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.567 ' HB2' HG21 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -75.41 -173.03 1.96 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -127.47 90.95 3.21 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 20' ' ' MET . 7.8 p -102.51 123.43 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.036 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -152.82 126.85 9.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.69 0.281 . . . . 0.0 111.711 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.437 ' HA ' ' HB ' ' A' ' 18' ' ' THR . 4.6 mt -81.42 132.95 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.597 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 19' ' ' SER . 0.3 OUTLIER -114.19 -33.64 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.295 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -127.51 146.19 50.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.772 0.32 . . . . 0.0 111.114 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.79 82.67 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.825 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -122.67 143.67 40.62 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.32 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -80.43 150.29 19.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.803 2.335 . . . . 0.0 112.603 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.3 t -171.77 148.72 2.42 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.892 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.036 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.53 0.318 0 N-CA-C 112.658 0.215 . . . . 0.0 112.658 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -107.21 170.56 7.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.021 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.435 HG13 ' HG ' ' A' ' 25' ' ' LEU . 14.2 p -151.89 147.4 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -112.89 135.36 53.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.828 HD12 HD21 ' A' ' 25' ' ' LEU . 18.0 mt -121.63 97.79 5.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 86.28 7.38 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.602 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.7 OUTLIER -98.94 157.47 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.352 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 t -64.63 -36.39 84.1 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.847 ' HB2' HG23 ' A' ' 157' ' ' VAL . 9.8 tpt -65.47 -31.49 72.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.37 151.48 6.15 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.058 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -81.05 142.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.715 0.293 . . . . 0.0 111.483 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.713 HG22 ' HA2' ' A' ' 135' ' ' GLY . 19.5 pt -148.37 146.49 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.786 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.21 130.58 69.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.828 HD21 HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -133.03 162.91 30.46 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.387 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.55 154.11 25.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.907 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.43 134.12 46.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.769 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.769 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 74.3 m-85 -75.15 98.17 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.381 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -82.86 20.4 1.18 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -100.22 -67.29 0.86 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.482 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.81 -13.05 18.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.145 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.14 0.73 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 85.2 Cg_exo -42.77 -34.98 3.87 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.005 1.804 . . . . 0.0 112.789 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -57.72 -62.73 1.59 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.908 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -66.7 -33.65 76.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.41 -51.32 70.39 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.64 84.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.744 0.307 . . . . 0.0 110.468 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.24 -41.42 94.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.755 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.15 -48.35 68.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.89 83.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.387 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.98 -50.1 74.74 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.79 -33.21 66.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.466 0.174 . . . . 0.0 111.441 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.92 24.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.512 0.196 . . . . 0.0 111.479 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -75.85 -36.79 59.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.449 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -30.33 71.15 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 31.0 3.07 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.927 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -105.03 -41.71 5.51 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.565 0.221 . . . . 0.0 110.663 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -65.58 -51.16 61.81 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.02 123.24 20.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.69 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.91 -29.38 5.39 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.315 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.79 -176.42 3.35 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 111.514 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -155.04 154.8 33.04 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.766 ' HB3' HD11 ' A' ' 56' ' ' ILE . 54.8 m-85 -66.86 169.83 7.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.983 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -135.72 -53.36 0.76 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.665 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.625 ' C ' HD12 ' A' ' 56' ' ' ILE . 6.2 mtt-85 -100.53 108.46 20.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.766 HD11 ' HB3' ' A' ' 53' ' ' PHE . 1.7 mp -120.02 99.87 8.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.53 95.54 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.95 -23.29 65.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.602 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 21.3 3.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CD2' ' HG3' ' A' ' 61' ' ' MET . 10.6 t80 -169.98 -81.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.521 -0.112 . . . . 0.0 111.141 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.457 ' HG3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -160.43 175.33 12.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 111.186 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.4 pp -133.97 137.06 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -117.47 143.58 45.9 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.138 0.494 . . . . 0.0 112.18 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 125.59 3.66 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.894 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.332 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.027 -179.563 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p -105.96 -175.5 2.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.182 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -66.4 -28.3 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.228 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -97.33 39.19 1.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.825 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -147.38 25.16 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.016 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 -37.3 5.91 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.462 0.172 . . . . 0.0 111.135 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -143.0 158.87 43.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -167.77 169.97 11.23 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.172 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.95 129.86 42.89 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -64.53 168.19 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.633 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -111.49 38.25 2.65 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.172 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.596 ' HA ' HG23 ' A' ' 127' ' ' THR . 0.1 OUTLIER -64.56 135.82 56.38 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.756 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.25 102.28 1.88 Allowed Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.969 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.9 80.71 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.369 . . . . 0.0 111.984 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.33 -49.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.767 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.466 HD13 HG21 ' A' ' 128' ' ' ILE . 4.8 mp -85.14 145.69 27.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -97.2 154.51 17.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -113.16 89.33 3.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -57.9 -33.83 69.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.214 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.67 -27.44 17.87 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.846 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.69 106.2 16.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.979 0.389 . . . . 0.0 111.086 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.572 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 74.41 58.46 4.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.958 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 96' ' ' GLY . 25.3 mm -133.08 120.41 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.703 0.287 . . . . 0.0 110.817 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.613 HD12 HG13 ' A' ' 132' ' ' VAL . 3.1 mt -96.09 110.02 22.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -117.05 138.69 51.43 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.706 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.419 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.89 118.61 21.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.561 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.16 172.08 9.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -148.75 157.87 43.75 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.71 23.94 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.85 174.52 35.87 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.435 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.78 120.26 7.29 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.557 2.171 . . . . 0.0 111.991 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 56.92 42.18 26.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.024 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.6 m -144.6 88.11 1.9 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -107.78 161.93 14.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.14 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.4 -106.16 1.01 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.168 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -147.52 34.68 0.86 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.03 158.1 23.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -160.4 176.46 11.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -145.96 136.69 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.56 HG22 ' CD2' ' A' ' 98' ' ' LEU . 22.0 t -102.13 109.9 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.129 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.53 132.94 36.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.407 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 pp -114.9 -23.32 9.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.861 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.15 149.03 35.93 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.71 117.3 4.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.862 2.375 . . . . 0.0 112.213 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.842 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 10.2 p -151.91 99.03 2.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.156 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -92.8 -21.89 19.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.842 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.8 p90 -59.06 -26.18 64.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.3 pp -85.03 -4.59 59.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.78 86.95 0.04 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.182 0.515 . . . . 0.0 110.091 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.73 -32.27 1.46 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.642 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.19 -53.92 21.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.662 0.231 . . . . 0.0 111.219 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -104.61 150.03 25.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.269 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.665 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 49.1 m -86.14 155.75 20.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.959 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 90' ' ' LEU . 1.3 tt -86.47 -179.42 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.636 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -175.72 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.62 -179.82 31.89 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.919 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -138.2 166.22 24.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.6 0.238 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.662 HG12 ' HB3' ' A' ' 25' ' ' LEU . 3.0 m -134.44 102.79 4.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 111.782 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.82 -53.74 4.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.9 84.18 1.89 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.955 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.713 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 169.81 -27.84 0.12 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.844 -0.694 . . . . 0.0 113.437 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 96' ' ' GLY . 7.8 tt -46.98 -37.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.73 -38.17 81.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.76 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -70.45 -35.56 73.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.108 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.59 -30.23 41.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -74.82 -38.04 62.16 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.483 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -67.73 -29.56 68.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.685 HG22 ' HG2' ' A' ' 20' ' ' MET . 21.5 t -56.34 -32.71 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.649 0.262 . . . . 0.0 111.015 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 58' ' ' LYS . . . -93.59 -32.19 7.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.506 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 21.2 mmt -60.15 -33.3 71.97 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.524 0.162 . . . . 0.0 111.385 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.1 m -63.75 173.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.18 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 126.07 26.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.976 0.417 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 p -118.58 167.94 11.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -177.29 5.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.83 46.91 1.43 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -174.28 -67.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.56 44.02 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -122.95 104.05 36.15 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.137 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.0 117.06 3.48 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 112.461 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.43 -32.24 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.696 0.284 . . . . 0.0 110.361 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.13 -170.94 1.03 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.382 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.89 114.05 22.65 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.731 0.3 . . . . 0.0 111.617 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 20' ' ' MET . 7.1 p -125.43 113.38 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 174.85 11.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.638 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.435 ' HA ' HG22 ' A' ' 18' ' ' THR . 2.4 mt -115.14 139.49 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.314 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.55 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -116.13 -30.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.602 179.037 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.22 28.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 110.952 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.13 111.14 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.023 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 36.6 p90 -145.05 158.37 52.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 111.707 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.4 Cg_exo -80.09 152.38 21.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.274 2.649 . . . . 0.0 112.482 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 140.29 1.85 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.451 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo . . . . . 0 CA--C 1.533 0.439 0 N-CA-C 112.715 0.237 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -125.0 165.74 17.6 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.004 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.672 HG22 HD11 ' A' ' 27' ' ' LEU . 30.5 m -140.58 154.23 21.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.467 ' CE1' HG22 ' A' ' 24' ' ' VAL . 4.1 m-85 -111.5 104.17 12.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -87.88 96.64 10.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.16 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 161' ' ' LYS . 1.3 tm-20 -80.37 82.48 6.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.187 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.668 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.8 OUTLIER -84.78 161.05 20.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.386 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -64.04 -33.22 75.25 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.054 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.923 ' HB2' HG13 ' A' ' 157' ' ' VAL . 15.3 tpt -67.51 -34.16 76.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.945 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.81 -148.36 12.75 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.221 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.427 HD11 ' CD1' ' A' ' 15' ' ' TYR . 17.2 tt -132.28 126.45 55.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 111.279 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 25' ' ' LEU . 29.7 pt -129.99 133.26 64.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.467 HG22 ' CE1' ' A' ' 15' ' ' TYR . 18.4 t -94.3 109.41 22.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.82 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 132' ' ' VAL . 7.4 mt -105.49 162.42 13.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.28 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -119.89 144.81 47.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.051 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.672 HD11 HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -129.47 134.29 47.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.81 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 28.0 m-85 -64.42 100.6 0.37 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.014 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -80.8 15.31 1.81 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -100.15 -64.9 1.0 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.772 0.32 . . . . 0.0 110.343 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.478 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -100.76 -13.2 18.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.333 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.01 1.2 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 77.8 Cg_exo -41.84 -37.52 4.15 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.011 1.807 . . . . 0.0 112.908 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -49.49 71.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.486 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.1 m -67.07 -36.94 83.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.387 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -54.51 -49.13 70.91 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.358 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -64.6 -38.55 91.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.264 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.409 ' CG ' HD13 ' A' ' 77' ' ' ILE . 1.5 t30 -56.74 -44.09 81.33 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.478 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -67.51 -43.16 81.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.212 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.11 -52.43 55.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.272 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -46.5 89.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -40.73 69.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 -33.77 33.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -47.63 84.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -60.16 -30.23 69.18 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.424 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.87 26.02 5.16 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.908 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -37.13 13.11 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.777 0.288 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -36.39 40.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.179 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -66.99 90.01 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 110.138 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.8 -26.04 2.53 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.772 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.6 p -61.3 151.4 32.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.809 0.305 . . . . 0.0 111.281 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -132.2 159.69 38.29 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.863 0.363 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -74.13 100.46 3.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.638 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -73.02 -50.2 24.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -102.72 131.09 49.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.725 HG23 HG12 ' A' ' 62' ' ' ILE . 27.0 mt -142.16 105.19 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.018 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mt -90.98 115.06 29.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.735 0.302 . . . . 0.0 110.913 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 2.0 tmtt? -63.34 132.2 50.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.188 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 2.5 t70 55.39 52.45 11.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.267 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.449 ' N ' HD11 ' A' ' 116' ' ' LEU . 16.4 t80 -165.82 -83.83 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.482 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.58 163.6 32.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.819 0.343 . . . . 0.0 111.442 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 56' ' ' ILE . 4.0 mp -137.99 130.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.721 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.1 pt20 -117.9 154.58 31.64 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 112.004 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.92 106.09 0.48 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.153 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.941 -179.729 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.668 ' HB2' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -80.35 -84.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.684 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 76' ' ' SER . 4.3 mp -142.55 -50.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.811 0.339 . . . . 0.0 110.534 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 34.76 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.41 -168.54 13.19 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -119.32 21.69 12.1 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.66 ' HB3' HG23 ' A' ' 107' ' ' THR . 0.0 OUTLIER -177.73 92.82 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 110.632 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -107.76 175.61 5.42 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.251 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.74 140.72 46.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.785 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 157.11 11.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.79 37.31 2.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.651 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 149.13 21.74 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.51 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.28 -62.31 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.526 ' HG2' HD13 ' A' ' 90' ' ' LEU . 78.2 Cg_endo -75.73 -174.23 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.758 2.306 . . . . 0.0 112.42 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.94 -61.65 1.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.014 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.577 HD22 HG21 ' A' ' 128' ' ' ILE . 7.6 mp 57.5 -173.85 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.11 173.98 10.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' A' ' 99' ' ' ALA . 8.2 t80 -160.31 38.93 0.17 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.979 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -108.93 -57.74 2.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.811 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.28 122.34 5.26 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.591 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.15 127.21 12.19 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 101.96 62.38 0.75 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 96' ' ' GLY . 14.8 mm -126.67 140.13 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.767 0.283 . . . . 0.0 111.045 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.524 HD22 ' HE1' ' A' ' 129' ' ' PHE . 3.2 mt -112.41 120.8 42.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.676 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -124.52 142.06 51.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.443 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -79.6 114.75 18.76 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.286 179.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.18 26.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.437 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -135.82 157.25 47.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -37.22 14.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.158 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.79 174.46 36.61 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 119.12 5.65 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.579 2.186 . . . . 0.0 112.165 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 59.05 30.75 20.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.185 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 81' ' ' GLN . 10.5 m -139.87 88.3 2.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.709 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.02 165.91 12.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.09 -105.7 1.47 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.93 43.94 0.12 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 111.041 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -126.03 157.46 37.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 100' ' ' MET . 2.4 m-85 -149.73 160.09 43.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.412 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.676 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 7.1 p90 -137.43 130.3 30.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 111.618 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 139' ' ' VAL . 21.4 t -98.54 107.1 19.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.228 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.41 HG21 ' CE2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -79.72 125.84 30.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 60' ' ' PHE . 1.9 pp -109.29 -4.69 16.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.66 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.432 ' N ' HD12 ' A' ' 116' ' ' LEU . . . -119.95 152.28 53.81 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-O 120.527 0.203 . . . . 0.0 110.839 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.26 100.06 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 112.025 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 79.5 p -122.41 110.4 15.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -94.9 -40.48 9.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -61.81 -33.67 74.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 122' ' ' LEU . 12.8 mt -81.91 -3.31 53.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.556 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -82.1 66.56 7.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.004 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.9 -47.38 0.07 OUTLIER Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.651 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -56.08 -47.52 77.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.706 0.289 . . . . 0.0 110.885 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -108.57 139.69 42.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.606 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 11.0 t -79.97 155.8 27.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.788 0.328 . . . . 0.0 111.125 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.577 HG21 HD22 ' A' ' 90' ' ' LEU . 1.2 tt -83.57 -178.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.561 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.524 ' HE1' HD22 ' A' ' 98' ' ' LEU . 1.2 p90 -179.38 -39.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.3 -179.75 17.01 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.113 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -146.85 171.79 14.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.29 . . . . 0.0 110.924 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 25' ' ' LEU . 16.3 t -130.64 119.16 44.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.352 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -56.51 2.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.13 92.33 3.86 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.061 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.84 -17.26 0.95 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.274 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.568 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -45.87 -36.93 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.89 -47.87 76.46 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.638 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.423 ' O ' HG23 ' A' ' 142' ' ' VAL . 7.2 tmm? -58.26 -46.07 86.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 110.403 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 114' ' ' VAL . 19.5 t -59.79 -37.98 73.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -63.79 -44.66 92.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.845 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -56.65 -34.3 67.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.175 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 138' ' ' MET . 21.8 t -58.24 -36.03 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.886 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.38 -38.13 18.8 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.563 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 mtp -55.3 -47.69 75.2 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.7 0.25 . . . . 0.0 111.208 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -50.88 136.89 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.52 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -60.75 120.83 10.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.636 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.6 p -86.48 170.39 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.407 ' CB ' ' HG3' ' A' ' 152' ' ' ARG . 1.4 t-20 -81.96 -166.22 1.18 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.56 34.37 0.76 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -160.12 32.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.627 0.251 . . . . 0.0 110.914 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.34 35.23 13.34 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.088 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.407 ' HG3' ' CB ' ' A' ' 148' ' ' ASN . 2.6 ptp180 -111.71 150.65 42.56 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.943 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.28 120.05 6.84 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.671 2.247 . . . . 0.0 112.495 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.9 t -70.57 -32.22 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.367 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -174.66 4.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.39 79.97 3.14 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.296 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.923 HG13 ' HB2' ' A' ' 20' ' ' MET . 30.3 t -113.93 113.43 43.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.345 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.92 179.81 8.46 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.388 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.668 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.2 mt -102.22 125.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.608 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.1 pt -107.12 -32.45 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.553 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . 3.3 tttt -145.1 143.73 30.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.651 0.262 . . . . 0.0 110.864 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.5 94.83 2.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.725 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -119.1 155.98 52.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.329 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -79.76 167.2 20.79 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.555 2.17 . . . . 0.0 113.003 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . 0.412 ' HG ' ' HE2' ' A' ' 15' ' ' TYR . 3.5 t -105.91 163.17 12.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.26 -1.3 . . . . 0.0 112.93 179.789 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 41.5 Cg_endo . . . . . 0 CA--C 1.532 0.413 0 N-CA-C 112.969 0.334 . . . . 0.0 112.969 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.48 142.83 34.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.706 0.289 . . . . 0.0 110.831 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.71 152.59 25.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -113.85 115.09 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.537 HD21 ' HE2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -101.32 104.62 15.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.126 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.16 87.06 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.395 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.6 OUTLIER -84.96 159.6 20.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.674 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 160' ' ' ILE . 0.3 OUTLIER -60.78 -34.15 74.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.73 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -73.51 -33.44 64.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.394 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.16 -168.19 40.88 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.52 ' C ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -119.06 123.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.182 0.491 . . . . 0.0 111.207 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.645 HG22 ' HA2' ' A' ' 135' ' ' GLY . 23.1 pt -128.1 146.18 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.863 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.0 t -105.2 139.3 26.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.522 HD21 HD12 ' A' ' 23' ' ' ILE . 3.4 mt -136.67 159.29 42.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.494 ' C ' HD22 ' A' ' 27' ' ' LEU . 15.8 pt-20 -121.46 145.29 48.08 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.854 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 ' C ' ' A' ' 26' ' ' GLU . 3.7 mm? -116.36 144.48 44.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.521 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.706 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 49.2 m-85 -86.33 102.49 14.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.753 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 10.9 m95 -76.36 11.99 1.37 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.29 -61.96 1.3 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.546 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.751 ' NE2' HD11 ' A' ' 90' ' ' LEU . 6.7 p80 -100.79 -15.98 17.45 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.18 1.38 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 66.8 Cg_exo -40.05 -37.21 1.65 Allowed 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.131 1.887 . . . . 0.0 113.312 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -55.63 13.7 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.061 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.616 HG21 ' HG3' ' A' ' 100' ' ' MET . 52.5 m -68.45 -39.49 81.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.3 -50.63 72.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -43.78 86.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.403 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.46 -48.03 83.55 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.78 -45.97 81.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.614 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.59 76.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.55 -42.23 98.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.431 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -52.09 67.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.544 0.211 . . . . 0.0 111.236 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.59 68.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -61.22 -42.53 98.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -38.67 92.08 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.279 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.06 38.96 1.09 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.813 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -32.52 6.55 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.481 0.182 . . . . 0.0 111.011 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HE2' HD21 ' A' ' 16' ' ' LEU . 1.5 t80 -68.59 -36.28 78.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.204 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -65.79 108.7 2.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.27 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.74 -23.15 4.24 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.89 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.537 ' HB ' HD12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -64.0 165.46 8.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 111.502 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 158' ' ' LYS . 0.4 OUTLIER -153.8 143.68 21.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.085 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CD1' HG22 ' A' ' 62' ' ' ILE . 42.3 m-85 -66.04 108.48 2.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.88 5.66 47.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.136 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -150.05 114.85 5.31 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.618 0.247 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.862 HG23 HG12 ' A' ' 62' ' ' ILE . 4.0 mp -137.49 107.43 4.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.31 79.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 41.82 -147.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.662 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.08 53.47 2.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.091 0.472 . . . . 0.0 110.311 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -125.13 -66.02 0.99 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.318 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 ptm -156.64 137.3 13.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.747 0.308 . . . . 0.0 111.175 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.862 HG12 HG23 ' A' ' 56' ' ' ILE . 6.4 mt -132.38 115.17 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.0 pt20 -103.08 146.78 27.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.481 . . . . 0.0 112.054 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.78 111.85 0.6 Allowed Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.898 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.945 -179.656 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.662 0.268 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 t -134.94 159.2 42.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.176 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -56.94 -33.6 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.38 -30.81 63.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.94 -160.97 29.12 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.762 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -52.35 60.62 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 110.603 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.65 159.3 38.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -144.41 178.03 8.22 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.97 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.97 130.17 38.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -65.27 161.03 20.29 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.78 139.18 47.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -121.34 127.61 51.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.584 ' HB2' HD12 ' A' ' 90' ' ' LEU . 17.7 p80 -65.63 135.64 95.74 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.313 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.93 -36.96 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.571 2.181 . . . . 0.0 112.429 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -163.42 106.73 1.01 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.737 0.303 . . . . 0.0 110.827 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.751 HD11 ' NE2' ' A' ' 31' ' ' HIS . 11.7 mt -149.85 178.76 8.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.31 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -124.66 160.93 27.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.488 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.414 ' CB ' ' HB2' ' A' ' 123' ' ' ASP . 4.2 t80 -135.83 76.43 1.61 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.38 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.3 m -57.09 -27.47 61.79 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 98.96 -58.52 0.88 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.797 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.26 114.37 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 70.93 64.01 2.96 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.964 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 96' ' ' GLY . 12.7 mm -130.61 158.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.696 0.284 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.821 ' HG ' HG12 ' A' ' 114' ' ' VAL . 1.1 mt -137.52 97.66 3.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.275 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -105.68 136.05 45.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.616 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -79.74 121.46 25.37 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.87 176.83 4.92 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.457 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -139.76 173.61 11.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.296 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.07 -35.73 12.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.44 167.74 32.52 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.531 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.54 124.07 14.32 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.558 2.172 . . . . 0.0 112.159 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.36 29.07 18.58 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.393 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 m -132.03 89.83 2.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.39 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.58 147.17 25.07 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.625 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.23 -110.72 1.48 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.16 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.5 m -151.55 45.66 0.79 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.986 0.422 . . . . 0.0 111.199 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 148.04 32.71 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.167 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -149.7 132.04 15.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 23.9 p90 -110.08 127.11 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 111.497 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.821 HG12 ' HG ' ' A' ' 98' ' ' LEU . 29.2 m -99.85 119.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.558 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 p -88.81 142.54 27.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.802 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.565 ' N ' HD22 ' A' ' 116' ' ' LEU . 1.3 mm? -113.65 -24.88 8.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.138 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -106.58 162.57 19.27 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.031 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 46.4 Cg_endo -67.94 112.31 2.67 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.683 2.255 . . . . 0.0 112.45 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 p -141.34 76.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 92' ' ' PHE . 36.2 mt-30 -76.67 -34.8 58.23 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.153 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -59.69 -28.5 67.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.439 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 122' ' ' LEU . 11.0 mt -81.39 -2.35 49.01 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 92' ' ' PHE . 35.8 t0 -82.89 60.22 5.27 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 110.443 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.23 -52.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.778 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -32.61 74.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -119.03 148.83 42.58 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.623 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 95.2 m -99.28 163.7 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.716 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.694 HG22 ' H ' ' A' ' 129' ' ' PHE . 2.7 mm -79.41 -179.09 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.241 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.694 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -176.97 -34.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.82 170.46 31.26 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.575 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.401 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -126.7 159.07 34.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.7 0.286 . . . . 0.0 110.983 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.84 94.53 3.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 6.2 t -92.0 -61.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.277 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -111.74 98.21 7.25 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.645 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 156.03 -21.59 0.51 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.455 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.2 tt -47.88 -35.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.91 92.14 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.037 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.94 -16.45 55.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.566 0.222 . . . . 0.0 110.879 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.64 HG11 HG21 ' A' ' 114' ' ' VAL . 21.9 t -88.57 -42.28 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.558 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.47 -31.03 68.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -53.71 -32.17 50.92 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.581 HG12 HG21 ' A' ' 56' ' ' ILE . 20.9 t -63.41 -36.46 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.644 0.259 . . . . 0.0 111.145 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.02 -29.05 39.2 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.458 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.6 mtp -74.3 -23.51 59.09 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 145' ' ' VAL . 13.3 p -84.03 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.39 174.59 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.151 0.5 . . . . 0.0 111.427 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 p -150.78 173.74 13.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.275 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -89.73 -176.37 4.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.852 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -91.4 28.98 1.55 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.608 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -150.4 29.31 0.71 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.296 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.5 44.39 21.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.21 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.3 mtp-105 -115.3 144.47 32.33 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.733 ' HB3' HD13 ' A' ' 56' ' ' ILE . 74.1 Cg_endo -76.58 140.57 21.39 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.804 2.336 . . . . 0.0 112.747 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.24 -34.14 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.457 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -171.01 3.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.59 96.64 5.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.275 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 157' ' ' VAL . 10.9 p -117.02 111.36 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 52' ' ' LYS . 5.9 pttt -145.38 173.63 11.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.722 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.1 mt -106.3 126.13 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.678 0.275 . . . . 0.0 111.3 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.411 HG23 ' HB2' ' A' ' 19' ' ' SER . 42.7 pt -108.14 -33.79 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.638 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -138.8 152.11 47.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.774 0.321 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.48 115.41 3.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -153.5 166.12 16.3 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.84 168.78 18.85 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.045 2.497 . . . . 0.0 112.193 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.38 96.73 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.996 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.799 -1.001 . . . . 0.0 113.031 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 CA--C 1.532 0.402 0 N-CA-C 112.739 0.246 . . . . 0.0 112.739 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.23 168.8 8.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.462 HG23 HD13 ' A' ' 27' ' ' LEU . 21.3 t -128.36 126.86 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.019 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.429 ' CE1' HD11 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -90.43 95.37 10.14 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.594 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.01 85.75 3.32 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 89.02 6.37 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.274 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.541 HG22 ' CG1' ' A' ' 159' ' ' ILE . 1.1 p -84.36 162.78 19.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.165 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 160' ' ' ILE . 2.3 t -68.62 -34.07 75.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.46 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.514 ' CB ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -70.06 -33.36 71.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.1 -159.12 27.26 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.387 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.429 HD11 ' CE1' ' A' ' 15' ' ' TYR . 11.6 tt -122.52 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.877 0.339 . . . . 0.0 111.469 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG22 ' CA ' ' A' ' 135' ' ' GLY . 17.3 pt -139.16 137.8 41.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 131.18 61.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.423 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -128.59 144.59 51.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.865 0.365 . . . . 0.0 111.325 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -106.41 116.7 32.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.886 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 14' ' ' VAL . 8.9 mp -94.96 129.26 42.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.229 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.791 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 69.9 m-85 -63.41 101.5 0.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -82.01 18.34 1.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -100.38 -66.16 0.92 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.743 0.306 . . . . 0.0 110.474 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.5 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 3.0 t60 -100.65 -15.38 17.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.983 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.791 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -96.43 0.84 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_exo -42.32 -37.06 4.73 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.987 1.791 . . . . 0.0 112.753 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -54.17 39.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.533 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -35.05 79.81 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 73.9 m -60.11 -47.18 87.0 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.508 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -59.28 -39.71 83.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.495 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -47.24 84.26 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.21 -43.89 98.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.99 63.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.109 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.21 -37.56 87.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.961 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -63.41 -35.73 81.39 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.631 0.253 . . . . 0.0 110.862 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 162' ' ' ALA . . . -83.32 -36.06 24.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.558 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.36 -36.89 63.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.325 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -61.31 -36.58 80.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.525 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.62 30.88 3.37 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.938 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.94 -51.73 3.96 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.599 0.238 . . . . 0.0 110.433 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.422 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 4.0 m-85 -65.55 -29.57 70.2 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.27 101.09 0.88 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.253 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.59 30.02 3.43 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.38 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -111.21 151.33 28.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.976 0.388 . . . . 0.0 110.85 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.57 151.82 48.41 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -60.83 144.3 52.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 63' ' ' GLN . 16.5 p80 -113.71 -38.93 4.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.905 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.442 ' CD ' HD11 ' A' ' 57' ' ' ILE . 5.7 ttt180 -125.11 118.62 26.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.79 0.328 . . . . 0.0 111.257 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.903 HG23 HG12 ' A' ' 62' ' ' ILE . 3.3 mt -130.54 104.35 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.442 HD11 ' CD ' ' A' ' 55' ' ' ARG . 4.1 mp -98.28 115.19 37.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.976 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 137.19 57.14 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.922 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.65 35.43 19.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.652 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -151.09 -88.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.432 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -160.46 157.36 27.49 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.698 0.285 . . . . 0.0 111.041 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.903 HG12 HG23 ' A' ' 56' ' ' ILE . 6.6 mt -130.38 124.93 58.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.346 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.2 pt20 -112.27 148.72 33.55 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.77 109.54 0.59 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.374 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.333 0.394 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.228 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.22 0 CA-C-O 120.658 0.266 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -113.1 167.12 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt -56.99 -39.35 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -80.34 -30.98 38.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.42 -167.05 29.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.848 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -63.07 -54.96 29.86 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.598 0.237 . . . . 0.0 110.678 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.775 ' HG2' HG23 ' A' ' 107' ' ' THR . 8.8 mp0 -135.7 139.26 43.53 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.817 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -123.93 172.02 9.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.83 179.2 1.49 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.196 0.522 . . . . 0.0 111.927 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.15 159.95 22.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.416 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.17 75.42 1.16 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.403 HD12 ' OG1' ' A' ' 127' ' ' THR . 0.4 OUTLIER -119.03 141.07 49.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.05 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.407 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -164.06 -63.28 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.55 ' HG2' HD11 ' A' ' 90' ' ' LEU . 70.9 Cg_endo -74.19 172.55 15.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.695 2.263 . . . . 0.0 112.956 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.51 95.5 5.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.867 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 1.005 HD22 HG21 ' A' ' 128' ' ' ILE . 5.9 mp -91.73 172.68 8.32 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 159.21 30.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.037 0.446 . . . . 0.0 111.382 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.4 41.68 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.17 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 94' ' ' GLY . 11.7 t -148.11 -47.18 0.16 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.854 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 93' ' ' THR . . . -55.28 122.09 24.92 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.757 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.45 126.88 8.62 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.616 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 102.91 63.06 0.71 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.281 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.616 HD13 ' O ' ' A' ' 96' ' ' GLY . 9.5 mm -130.42 137.79 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 117.056 0.428 . . . . 0.0 110.955 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 25' ' ' LEU . 7.7 tp -111.2 101.91 10.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.107 0.479 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -110.02 146.73 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.31 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.28 133.08 36.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.223 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 142.54 35.17 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -143.22 117.72 9.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.31 75.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.394 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.32 179.5 34.88 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.303 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.85 128.67 23.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.494 2.129 . . . . 0.0 111.934 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 58.79 35.31 24.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.775 HG23 ' HG2' ' A' ' 81' ' ' GLN . 85.5 m -143.19 89.33 2.09 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -106.19 155.41 19.49 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.95 -165.63 11.88 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.72 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.31 61.88 1.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.947 0.403 . . . . 0.0 110.888 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.57 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -153.34 155.8 37.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.04 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.16 161.03 43.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.072 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 14.2 p90 -130.79 141.33 50.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.3 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.697 HG11 HG11 ' A' ' 139' ' ' VAL . 11.4 t -102.74 110.6 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.479 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.89 109.15 15.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.032 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 61' ' ' MET . 0.9 OUTLIER -103.53 -6.82 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.917 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 119' ' ' THR . . . -122.81 142.85 38.84 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.387 0.136 . . . . 0.0 110.806 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.39 122.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.905 2.403 . . . . 0.0 112.577 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 117' ' ' ALA . 31.1 p -128.48 112.56 14.48 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.947 0.404 . . . . 0.0 111.279 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -94.92 -42.74 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.438 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 46.7 p90 -67.74 -31.88 72.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.336 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 122' ' ' LEU . 12.4 mt -89.36 -2.25 58.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.739 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -68.85 85.53 0.33 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.348 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.02 -25.6 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.72 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -57.01 -53.81 53.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.712 0.256 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -102.3 156.7 17.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.64 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 47.6 m -90.32 150.9 21.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.001 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 1.005 HG21 HD22 ' A' ' 90' ' ' LEU . 1.1 tt -79.88 -179.62 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.418 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.453 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -177.22 -35.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.88 179.99 29.7 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.828 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 161.9 36.87 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 122.827 -0.219 . . . . 0.0 110.659 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 132' ' ' VAL . 11.6 p -124.51 105.32 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.27 0.557 . . . . 0.0 111.528 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.51 -38.42 9.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.28 88.14 2.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.89 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.475 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 159.46 -22.31 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.351 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 tt -43.33 -38.81 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.4 -37.12 86.97 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.909 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -36.0 59.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.789 0.328 . . . . 0.0 110.124 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.697 HG11 HG11 ' A' ' 114' ' ' VAL . 23.7 t -66.76 -56.74 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.32 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -63.26 -24.43 67.87 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.258 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -58.67 -33.77 70.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.547 0.213 . . . . 0.0 110.816 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.775 HG12 HG21 ' A' ' 56' ' ' ILE . 26.0 t -63.84 -35.64 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.018 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.71 -39.5 60.07 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.312 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 mmt -53.66 -51.5 62.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -52.2 143.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.691 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -64.75 122.21 16.36 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.3 p -93.06 179.15 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -170.04 2.21 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.75 46.02 1.32 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.646 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -174.61 -76.53 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.835 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.58 30.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.31 118.64 60.85 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-O 120.656 0.265 . . . . 0.0 111.682 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HB3' HD13 ' A' ' 56' ' ' ILE . 38.1 Cg_endo -67.51 115.25 3.61 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.044 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.21 -31.48 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -171.04 2.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.619 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.26 97.38 6.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 157' ' ' VAL . 9.1 p -123.48 108.51 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.875 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 175.22 11.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.361 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.541 ' CG1' HG22 ' A' ' 18' ' ' THR . 3.6 mt -103.57 130.48 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.321 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 19' ' ' SER . 17.4 pt -106.73 -29.43 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.914 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.18 108.51 1.9 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.16 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.496 ' O ' ' HB1' ' A' ' 43' ' ' ALA . . . -120.37 114.37 21.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.187 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -154.1 149.22 20.26 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -80.03 161.3 23.73 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.514 2.143 . . . . 0.0 112.6 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.8 t -165.38 -62.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.424 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo . . . . . 0 CA--C 1.531 0.37 0 CA-C-O 121.037 0.349 . . . . 0.0 112.069 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.36 166.32 11.8 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.019 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.26 46.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.03 96.49 8.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.815 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -86.3 94.73 9.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.766 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.554 ' HG2' HD11 ' A' ' 160' ' ' ILE . 4.3 tt0 -83.5 118.77 24.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.54 HG22 HG23 ' A' ' 159' ' ' ILE . 8.1 p -135.25 158.02 45.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.522 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -59.04 -36.72 75.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.747 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.736 ' CB ' HG13 ' A' ' 157' ' ' VAL . 8.0 tpt -67.03 -33.49 75.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.55 143.42 3.67 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.36 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.502 HD12 ' CB ' ' A' ' 17' ' ' GLU . 1.7 tt -82.57 126.83 40.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.471 HG22 ' HA2' ' A' ' 135' ' ' GLY . 2.7 pt -128.56 137.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.403 ' HB ' ' CG ' ' A' ' 134' ' ' GLN . 20.6 t -99.86 135.37 35.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.02 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -135.67 147.56 48.59 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.315 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.24 129.56 38.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.6 HD21 HD12 ' A' ' 25' ' ' LEU . 4.5 mm? -104.78 131.97 51.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.337 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.808 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 22.8 m-85 -76.07 99.65 4.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.0 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -83.03 18.18 1.73 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -67.32 0.86 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.489 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 2.3 m-70 -100.69 -13.28 18.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.59 1.71 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.2 Cg_exo -40.86 -36.4 2.0 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.062 1.841 . . . . 0.0 112.927 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -47.74 79.38 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.688 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.613 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.7 OUTLIER -78.35 -36.76 45.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.906 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.3 t -57.98 -47.63 82.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.655 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -42.97 75.1 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.197 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -58.89 -53.7 55.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -41.46 70.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.997 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.1 54.65 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.27 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -45.44 93.09 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.176 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -35.4 71.19 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.136 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -84.21 -36.48 22.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.298 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -47.23 68.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.232 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -58.22 -25.82 62.11 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.757 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.33 13.0 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.817 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.49 -34.74 18.55 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.643 0.259 . . . . 0.0 110.935 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.429 ' HE2' HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -76.15 -25.42 55.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -65.08 93.62 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 110.245 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.08 -20.11 3.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.106 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.817 ' HB ' HD12 ' A' ' 159' ' ' ILE . 2.2 m -58.12 157.41 8.19 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.906 0.353 . . . . 0.0 111.508 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -138.92 169.39 17.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.482 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' HB3' HD11 ' A' ' 56' ' ' ILE . 9.9 m-85 -96.86 83.47 3.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.96 -45.24 78.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -99.77 120.66 40.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.754 0.311 . . . . 0.0 111.026 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.867 HD12 ' HG2' ' A' ' 153' ' ' PRO . 19.3 mt -145.68 98.54 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.295 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.11 107.09 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -39.09 93.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.538 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.66 41.3 0.89 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.41 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.986 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.51 171.53 18.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 111.115 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.726 HG21 HG23 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -131.77 151.67 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.824 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -134.32 161.77 34.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.587 0.708 . . . . 0.0 112.524 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.81 109.33 0.41 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.331 0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.145 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 t -104.51 158.64 16.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.012 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 78' ' ' TYR . 2.6 pp -57.23 -27.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.298 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.751 ' N ' HD12 ' A' ' 77' ' ' ILE . 19.3 m-85 -82.28 -33.14 29.23 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.904 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.02 -158.53 27.66 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.33 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.71 -72.71 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.874 0.337 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.416 ' HB3' HG23 ' A' ' 107' ' ' THR . 15.8 mm100 -133.1 140.75 47.81 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 108' ' ' ASN . 44.0 p90 -130.03 166.93 19.1 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 111.57 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.25 110.0 21.94 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.345 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.06 178.35 4.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.485 ' HB3' HG21 ' A' ' 127' ' ' THR . 2.0 mm-40 62.9 166.42 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.685 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.38 106.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.587 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.411 ' CB ' ' HD3' ' A' ' 88' ' ' PRO . 1.2 m80 -172.11 -61.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.085 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 87' ' ' HIS . 87.9 Cg_endo -80.84 -173.38 1.82 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.652 2.235 . . . . 0.0 112.616 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.58 95.62 5.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.949 ' HG ' HG21 ' A' ' 128' ' ' ILE . 2.6 mm? -77.03 -176.33 3.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -70.21 0.47 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.72 70.58 0.63 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.38 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -75.75 -39.08 57.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 119.93 -42.06 1.83 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.362 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.55 100.22 11.21 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.735 0.302 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.585 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 89.23 55.22 2.13 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.915 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 96' ' ' GLY . 37.3 mm -130.61 130.75 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.653 0.264 . . . . 0.0 110.867 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 129' ' ' PHE . 2.7 mt -102.92 104.27 14.48 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.738 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -108.63 142.42 39.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.32 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.613 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.5 123.53 27.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.47 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 143.9 32.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.491 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -154.48 136.34 14.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.69 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.56 179.32 32.49 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.926 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 139.61 63.0 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.398 2.065 . . . . 0.0 112.122 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 59.81 44.91 13.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.308 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 81' ' ' GLN . 87.6 m -146.99 85.97 1.63 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 68.3 m-80 -106.56 152.13 24.11 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.51 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 -138.95 3.62 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.808 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.47 60.84 0.73 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.505 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -150.83 146.25 26.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.379 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CD2' ' HG2' ' A' ' 100' ' ' MET . 3.8 m-85 -149.72 160.08 43.82 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.391 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.738 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 31.4 p90 -134.66 134.37 41.07 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.483 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 98' ' ' LEU . 24.1 t -104.04 110.02 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.238 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.498 HG21 HG21 ' A' ' 119' ' ' THR . 45.1 p -80.96 138.27 36.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.977 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 -18.91 11.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.512 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.39 158.29 35.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.464 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 85.4 Cg_exo -44.84 128.74 9.16 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.848 2.366 . . . . 0.0 112.902 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.806 HG22 HD12 ' A' ' 122' ' ' LEU . 22.8 p -131.94 33.79 3.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -61.64 -37.79 85.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.831 0.348 . . . . 0.0 110.58 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -79.6 -27.78 41.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.136 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.806 HD12 HG22 ' A' ' 119' ' ' THR . 19.8 mt -75.52 -5.15 43.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.89 84.69 0.08 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.179 0.514 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 163.3 -41.14 0.33 Allowed Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.415 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -59.12 -57.29 13.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.625 0.25 . . . . 0.0 110.783 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -109.53 173.69 6.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.639 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 28.2 m -106.67 160.14 15.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.949 HG21 ' HG ' ' A' ' 90' ' ' LEU . 2.3 tt -87.51 179.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.226 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.568 ' HE1' HD11 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -176.79 -40.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.08 -179.8 27.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.276 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -144.08 167.26 22.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.494 0.187 . . . . 0.0 110.837 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 132' ' ' VAL . 30.5 m -125.08 107.21 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -43.99 12.14 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.403 ' CG ' ' HB ' ' A' ' 24' ' ' VAL . 7.2 pt20 -132.06 90.59 2.84 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.898 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 168.96 -27.77 0.13 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.341 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.507 HD12 ' CA ' ' A' ' 96' ' ' GLY . 12.3 tt -44.28 -36.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -41.04 75.06 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.694 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.679 ' O ' HG23 ' A' ' 142' ' ' VAL . 11.4 tmm? -68.59 -36.55 78.87 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 110.755 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.449 HG13 HD11 ' A' ' 62' ' ' ILE . 35.1 t -73.62 -35.46 44.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -72.17 -39.39 68.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.192 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 138' ' ' MET . 7.5 ptp180 -62.57 -31.69 72.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.727 HG11 HD13 ' A' ' 56' ' ' ILE . 22.0 t -56.51 -31.0 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.632 0.253 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.85 -22.98 40.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.714 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.5 mmt -76.8 -4.54 44.02 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.27 32.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.646 0.26 . . . . 0.0 111.489 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.79 169.96 0.19 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 111.432 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -152.67 175.84 12.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.399 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 0.6 OUTLIER -79.92 -174.72 4.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.76 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.7 p -89.4 36.59 0.84 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.572 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -166.32 -72.42 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.392 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -174.13 70.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.666 0.269 . . . . 0.0 110.825 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -153.37 99.73 2.65 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.625 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.867 ' HG2' HD12 ' A' ' 56' ' ' ILE . 51.0 Cg_exo -53.6 154.35 16.1 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.988 2.459 . . . . 0.0 113.308 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -76.18 -34.11 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.973 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -170.65 2.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.682 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -127.48 110.83 13.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.976 0.417 . . . . 0.0 111.436 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.736 HG13 ' CB ' ' A' ' 20' ' ' MET . 35.5 t -108.54 121.0 60.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 18' ' ' THR . 3.0 pttt -145.24 152.65 40.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.593 0.235 . . . . 0.0 111.203 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.817 HD12 ' HB ' ' A' ' 51' ' ' THR . 30.4 mt -93.21 138.97 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.086 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 17' ' ' GLU . 9.9 pt -109.76 -35.61 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.938 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.66 146.58 4.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.499 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -132.17 115.85 16.24 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -133.56 156.19 79.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.68 170.93 16.35 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.676 2.251 . . . . 0.0 112.741 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.55 94.76 6.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.361 -1.244 . . . . 0.0 112.288 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 CA-C-O 120.699 0.208 . . . . 0.0 112.441 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -126.36 142.51 51.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 164' ' ' PRO . 27.5 m -126.85 153.64 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.286 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -111.34 100.65 9.22 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.4 110.59 19.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -87.39 108.23 18.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.558 HG22 ' CG1' ' A' ' 159' ' ' ILE . 1.0 OUTLIER -114.02 156.38 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -61.7 -31.58 71.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.362 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.792 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -71.12 -34.64 71.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.68 -156.22 26.33 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.362 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.2 tt -127.53 128.26 69.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.814 0.307 . . . . 0.0 111.142 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.637 HG22 ' HA2' ' A' ' 135' ' ' GLY . 11.6 pt -141.0 138.73 34.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.497 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.502 ' O ' HD23 ' A' ' 25' ' ' LEU . 22.3 m -97.46 148.27 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 24' ' ' VAL . 16.3 mt -123.49 122.83 39.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.367 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.11 94.96 6.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.254 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 36' ' ' CYS . 8.8 mp -82.41 147.26 28.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.976 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.699 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 52.6 m-85 -72.26 102.0 2.99 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -81.16 15.76 1.8 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -69.82 0.75 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 110.277 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.491 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.59 -13.99 18.36 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.164 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.81 1.58 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 72.3 Cg_exo -41.4 -36.75 2.93 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.065 1.844 . . . . 0.0 112.844 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -52.33 63.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.773 0.321 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -64.97 -40.45 95.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.357 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.73 ' HA ' HD23 ' A' ' 27' ' ' LEU . 46.2 t -56.5 -48.38 77.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.467 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -58.79 -42.88 90.09 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.256 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.2 -51.9 67.61 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HE1' ' HH ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -61.24 -41.63 97.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.92 85.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.697 ' HB3' HD13 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -67.05 -42.09 85.36 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.286 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 76' ' ' SER . 0.1 OUTLIER -62.57 -34.01 76.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.646 0.26 . . . . 0.0 111.153 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -83.59 -31.73 26.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -84.22 -38.92 19.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.558 0.218 . . . . 0.0 111.474 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -61.4 -58.44 8.2 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.85 65.17 0.04 OUTLIER Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.75 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.39 -62.08 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.584 0.23 . . . . 0.0 110.827 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' HH ' ' HE1' ' A' ' 39' ' ' PHE . 3.9 m-85 -60.59 -42.63 97.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.174 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -67.47 101.18 0.94 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.681 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.49 -32.99 2.11 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.437 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 65' ' ' GLY . 14.5 t -86.66 -168.59 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.752 0.31 . . . . 0.0 111.391 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -150.31 -174.16 4.66 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.692 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.617 ' HB3' HD11 ' A' ' 56' ' ' ILE . 8.1 m-85 -83.38 122.12 28.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.414 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -103.29 11.88 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.524 ' O ' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -157.62 111.33 2.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.853 HG23 HG22 ' A' ' 62' ' ' ILE . 21.6 mm -134.9 120.07 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.7 mp -109.78 115.23 49.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.493 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -54.78 124.43 16.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.465 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 58.38 57.4 3.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -165.1 -81.68 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.368 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.496 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -160.71 173.33 15.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 111.617 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.853 HG22 HG23 ' A' ' 56' ' ' ILE . 42.3 pt -142.87 140.51 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.942 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -122.17 153.81 38.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.243 0.544 . . . . 0.0 111.969 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.38 146.42 16.48 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.826 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.561 ' O ' HG21 ' A' ' 51' ' ' THR . . . . . . . . 0 C--N 1.332 0.343 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.33 -179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.212 0 CA-C-O 120.57 0.224 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.561 ' HB2' HD11 ' A' ' 42' ' ' LEU . 13.0 p -92.26 -52.4 4.7 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.762 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 41' ' ' GLU . 1.1 tp -172.6 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.954 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.435 ' N ' HG23 ' A' ' 77' ' ' ILE . 25.1 m-85 -102.18 -32.92 9.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.68 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 176.99 179.33 47.33 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.385 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.27 11.42 30.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.1 110.21 0.15 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.606 0.241 . . . . 0.0 110.998 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 34.7 p90 -126.88 161.04 29.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.0 179.78 2.61 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.302 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.3 177.48 5.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -139.17 103.96 4.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.272 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.1 tp -154.17 134.33 13.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.425 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -171.44 -61.3 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.131 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 87' ' ' HIS . 18.4 Cg_endo -60.31 171.33 3.31 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.682 2.255 . . . . 0.0 112.716 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -78.36 107.64 11.13 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.997 0.427 . . . . 0.0 111.195 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.468 ' CD1' HG21 ' A' ' 128' ' ' ILE . 4.0 mm? -109.44 162.32 14.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.932 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -118.31 150.83 38.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.461 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 96.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 15.0 t -175.45 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.627 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.34 120.25 21.11 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.064 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 116' ' ' LEU . . . -49.95 106.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.624 ' CA ' HD13 ' A' ' 136' ' ' ILE . . . 117.33 69.95 0.4 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.014 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 96' ' ' GLY . 10.1 mm -131.74 139.62 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.569 0.224 . . . . 0.0 111.223 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 114' ' ' VAL . 0.8 OUTLIER -106.25 104.94 14.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.622 179.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -109.84 144.09 38.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.49 128.6 33.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.65 167.77 20.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.259 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' A' ' 126' ' ' HIS . 3.5 p-10 -159.53 117.53 2.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.773 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.25 -40.28 52.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.142 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.94 160.72 31.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.9 125.84 20.01 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.66 2.24 . . . . 0.0 112.175 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 58.54 30.93 20.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.6 m -142.61 84.4 1.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.992 0.425 . . . . 0.0 110.25 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.448 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 2.8 m-20 -123.71 165.9 16.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.582 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.76 -103.33 0.92 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 38.0 m -151.23 43.26 0.77 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 111.172 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -105.09 154.18 20.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.323 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -155.39 159.31 39.78 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.664 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 15.1 p90 -138.33 139.61 39.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.449 . . . . 0.0 111.611 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.742 HG22 HD23 ' A' ' 98' ' ' LEU . 16.9 t -115.56 110.95 33.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.54 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.448 HG21 ' OG1' ' A' ' 119' ' ' THR . 0.3 OUTLIER -79.8 113.7 18.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.551 ' O ' ' HB1' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -83.8 -16.21 45.49 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.594 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.84 162.54 51.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.473 0.177 . . . . 0.0 110.885 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 93' ' ' THR . 50.6 Cg_exo -53.85 131.51 44.71 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.901 2.401 . . . . 0.0 112.702 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.448 ' OG1' HG21 ' A' ' 115' ' ' THR . 1.8 p -143.5 105.07 4.31 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 -43.65 6.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -58.61 -31.84 68.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.148 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.6 -17.94 52.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.529 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -65.66 85.25 0.07 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 110.466 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 153.46 -35.43 0.76 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.363 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -50.53 62.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.692 0.282 . . . . 0.0 110.908 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.404 ' HA ' ' OD1' ' A' ' 102' ' ' ASN . 24.9 m-70 -112.44 147.61 36.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.454 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.753 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 12.9 t -79.81 170.11 16.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.828 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.3 tt -99.69 -179.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -171.7 -38.41 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 27' ' ' LEU . . . -151.76 -179.41 27.4 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.082 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.449 ' C ' HD12 ' A' ' 98' ' ' LEU . 1.8 ttm105 -135.74 148.12 48.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.83 102.13 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.113 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.45 -63.5 1.28 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.495 ' O ' HG22 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -114.3 82.71 1.76 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.655 178.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.637 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . -178.75 -24.09 0.04 OUTLIER Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.916 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.624 HD13 ' CA ' ' A' ' 96' ' ' GLY . 9.2 tp -46.75 -34.55 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 117.266 0.533 . . . . 0.0 112.297 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.22 -22.09 54.97 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.868 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.652 ' O ' HG23 ' A' ' 142' ' ' VAL . 8.8 tmm? -93.44 -39.35 10.95 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.644 HG13 HD11 ' A' ' 62' ' ' ILE . 32.3 t -59.43 -54.28 36.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.065 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.401 ' HA ' HD13 ' A' ' 116' ' ' LEU . 28.5 p30 -59.07 -33.25 70.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.675 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -38.52 91.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 138' ' ' MET . 20.7 t -57.47 -36.0 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.685 0.279 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.16 -34.43 69.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.397 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.1 mtt -58.59 -40.83 84.26 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 155' ' ' ASP . 1.6 t -54.01 119.01 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.26 121.74 12.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.596 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.1 t -89.83 168.73 11.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.134 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -81.8 -170.04 2.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.45 31.24 1.04 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.594 0.235 . . . . 0.0 111.442 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.67 30.37 0.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.65 53.73 10.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.488 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.16 134.6 25.27 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.21 116.69 4.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.592 2.195 . . . . 0.0 112.322 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.09 -35.27 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.625 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.43 ' HB2' HG11 ' A' ' 145' ' ' VAL . 0.8 OUTLIER -82.71 -169.26 2.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.567 179.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.42 101.67 11.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 20' ' ' MET . 26.2 t -130.42 108.27 15.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.238 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -179.97 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.621 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.558 ' CG1' HG22 ' A' ' 18' ' ' THR . 1.5 mt -111.57 145.33 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.248 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.494 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -121.64 -35.0 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.898 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.8 149.46 26.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.27 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.428 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -145.48 121.48 10.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.459 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -144.95 155.36 55.54 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.392 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.403 ' HB3' HG12 ' A' ' 14' ' ' VAL . 95.4 Cg_endo -80.21 168.18 18.86 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.691 2.26 . . . . 0.0 112.257 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.7 t -142.46 154.21 44.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.148 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.821 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 CA--C 1.537 0.654 0 N-CA-C 113.275 0.452 . . . . 0.0 113.275 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -89.93 142.95 27.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.649 0.261 . . . . 0.0 111.208 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -131.43 136.59 57.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.164 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.3 108.29 19.85 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.28 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.427 ' HG ' ' HB1' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -107.28 99.53 9.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.99 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -82.16 110.29 17.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.71 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.648 HG22 ' CG1' ' A' ' 159' ' ' ILE . 2.3 p -112.31 161.51 16.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 p -62.81 -37.12 85.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.235 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.741 ' HB2' HG13 ' A' ' 157' ' ' VAL . 1.3 tpt -68.46 -30.01 68.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.27 -154.33 24.54 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.345 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.86 128.76 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.864 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.85 145.06 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.79 119.12 60.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.549 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.511 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -115.04 155.56 26.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -110.76 115.01 28.82 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.757 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 mt -87.0 147.86 25.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.797 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.763 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 35.1 m-85 -84.81 104.58 14.89 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.629 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -82.55 21.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.2 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -69.52 0.77 Allowed 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.505 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.81 18.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.942 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.1 1.27 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.3 Cg_exo -41.43 -38.16 3.68 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.054 1.836 . . . . 0.0 112.819 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -54.15 50.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.321 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.833 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -69.68 -33.62 72.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -55.92 -56.01 25.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -61.24 -39.07 88.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.344 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.97 -38.86 83.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.019 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -46.74 80.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.15 77.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.537 ' HB3' HG21 ' A' ' 77' ' ' ILE . 1.2 mm-40 -61.03 -50.55 72.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.068 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 1.4 mp -57.49 -40.13 77.96 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.992 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.6 67.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.342 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -73.02 -50.83 20.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -60.77 -28.56 68.82 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.847 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.49 28.34 5.47 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.733 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -89.67 -41.32 12.0 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.612 0.206 . . . . 0.0 110.729 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 5.5 m-85 -72.01 -31.13 65.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.281 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.69 102.86 0.21 Allowed 'General case' 0 C--O 1.233 0.202 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.71 11.76 9.13 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.487 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.3 p -95.55 168.46 10.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.392 0.596 . . . . 0.0 110.827 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -157.55 169.54 24.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.678 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.859 ' HB3' HD11 ' A' ' 56' ' ' ILE . 47.3 m-85 -94.86 100.71 12.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.552 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -88.84 -43.64 11.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.819 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.555 ' O ' HD13 ' A' ' 56' ' ' ILE . 7.3 mtt180 -90.97 108.61 19.97 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.694 0.283 . . . . 0.0 110.612 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 1.046 HG23 HG22 ' A' ' 62' ' ' ILE . 36.1 mm -131.99 140.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.264 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.421 HD13 ' HG3' ' A' ' 61' ' ' MET . 4.3 mp -116.75 116.84 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.715 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 122.85 14.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.402 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 61.93 51.05 3.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.331 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.88 -80.15 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.234 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.421 ' HG3' HD13 ' A' ' 57' ' ' ILE . 1.3 ptm -160.6 172.2 17.58 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 111.33 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.046 HG22 HG23 ' A' ' 56' ' ' ILE . 1.2 pp -132.86 115.71 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 16.0 pt20 -104.69 138.28 41.24 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 0.0 111.986 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.32 110.5 1.08 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.962 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.323 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.841 -179.747 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.901 0.381 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -74.55 162.25 28.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.406 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 41' ' ' GLU . 2.8 pt -61.45 -27.24 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.052 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -96.45 30.69 2.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.103 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.18 -146.94 16.68 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.971 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 -25.65 11.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -148.33 139.97 23.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.557 0.217 . . . . 0.0 110.794 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 m-85 -87.38 -174.42 4.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.488 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.17 69.9 1.15 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.733 0.301 . . . . 0.0 111.744 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 66.13 146.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.939 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.616 ' O ' HG21 ' A' ' 127' ' ' THR . 6.4 mt-10 -155.38 36.37 0.38 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.13 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tp -65.91 149.9 49.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 111.526 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 11.5 p80 -99.82 152.03 37.68 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.75 -50.42 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.586 2.191 . . . . 0.0 112.24 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.82 146.97 14.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -171.9 173.84 4.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -90.66 160.91 15.62 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.876 0.369 . . . . 0.0 111.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.52 61.14 0.75 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.978 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.34 -36.06 75.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.88 -20.38 46.02 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.238 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.55 112.66 25.68 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.163 0.482 . . . . 0.0 110.959 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.459 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 72.62 56.86 5.76 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.331 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.0 mm -124.15 161.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.483 0.183 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 132' ' ' VAL . 3.4 mt -142.08 106.35 4.79 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 110.446 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.752 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -114.52 144.04 44.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.833 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.83 110.92 15.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.48 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.71 145.55 31.52 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -124.19 174.75 7.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.26 -45.13 4.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.476 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.96 174.82 36.8 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.778 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.89 141.3 67.04 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.658 2.239 . . . . 0.0 112.152 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 45.2 30.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.914 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -149.93 87.53 1.48 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.78 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.48 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 60.8 m-80 -95.4 172.84 7.84 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.43 -171.43 12.19 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.717 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 m -103.52 45.7 0.95 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.023 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -115.25 168.34 10.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.564 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 24.1 p90 -160.59 171.86 18.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.454 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.752 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 42.0 p90 -152.28 131.56 12.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.851 0.358 . . . . 0.0 111.645 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 139' ' ' VAL . 34.1 t -96.41 116.78 39.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.358 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.482 HG21 ' OG1' ' A' ' 119' ' ' THR . 0.2 OUTLIER -79.59 127.98 32.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.704 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.63 HD22 ' HA ' ' A' ' 140' ' ' ASN . 3.2 mt -113.36 -8.4 13.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.561 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -131.59 161.56 61.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.456 0.17 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 20.3 Cg_endo -59.95 121.77 10.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.873 2.382 . . . . 0.0 112.603 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.482 ' OG1' HG21 ' A' ' 115' ' ' THR . 0.9 OUTLIER -143.09 49.02 1.47 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.078 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -31.84 69.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.124 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -65.84 -28.48 69.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.186 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.552 HD23 ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -75.89 -7.36 54.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.899 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -66.14 85.57 0.09 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.124 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.68 -41.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.351 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB2' HD23 ' A' ' 122' ' ' LEU . 20.5 mttt -67.1 -49.56 64.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.548 0.213 . . . . 0.0 111.036 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.32 140.86 48.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.664 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 97.8 m -85.07 151.4 24.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 129' ' ' PHE . 0.6 OUTLIER -79.46 -178.98 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.275 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.659 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.7 OUTLIER -169.34 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 -179.51 26.17 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.66 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -143.3 155.59 44.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.525 0.203 . . . . 0.0 110.689 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.526 HG13 HD12 ' A' ' 98' ' ' LEU . 16.0 m -114.39 85.08 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.164 0.507 . . . . 0.0 112.24 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.97 -40.01 40.67 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.05 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -127.52 98.33 5.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.65 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.79 -12.3 1.3 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.622 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.452 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 15.5 tt -50.54 -30.35 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 117.255 0.527 . . . . 0.0 111.938 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.79 -12.13 67.13 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.29 -0.481 . . . . 0.0 113.417 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.05 -30.05 12.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.793 0.296 . . . . 0.0 110.814 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 114' ' ' VAL . 2.5 m -84.61 -34.85 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.434 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.63 ' HA ' HD22 ' A' ' 116' ' ' LEU . 53.7 p30 -61.52 -28.21 69.16 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.279 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . 0.635 ' O ' HG13 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -78.55 -30.83 47.11 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.855 -0.157 . . . . 0.0 111.298 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.482 ' HB ' HG21 ' A' ' 62' ' ' ILE . 39.3 t -57.47 -36.88 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.688 0.28 . . . . 0.0 110.738 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.11 -30.27 11.32 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.208 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -65.15 -31.94 73.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 141' ' ' ARG . 27.1 m -61.38 176.38 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.98 0.419 . . . . 0.0 111.569 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.38 172.75 12.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -147.79 166.15 28.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -142.74 159.21 42.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 m 85.49 -40.86 0.05 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.508 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 168.36 -37.63 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -169.62 37.25 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.358 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.22 124.99 36.4 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.85 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.462 ' HG3' HG13 ' A' ' 56' ' ' ILE . 51.9 Cg_exo -54.74 109.49 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.71 2.273 . . . . 0.0 112.478 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.1 p -64.13 -30.85 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.922 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.64 -171.67 3.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.719 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.13 117.84 32.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.741 HG13 ' HB2' ' A' ' 20' ' ' MET . 21.6 t -142.07 121.88 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.21 178.53 10.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.726 0.298 . . . . 0.0 111.732 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.648 ' CG1' HG22 ' A' ' 18' ' ' THR . 3.3 mt -110.84 143.45 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.062 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.38 -40.45 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.38 153.06 17.2 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.669 0.271 . . . . 0.0 111.211 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.427 ' HB1' ' HG ' ' A' ' 16' ' ' LEU . . . -150.88 141.6 22.74 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -154.51 156.45 31.62 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.55 162.94 24.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.448 2.099 . . . . 0.0 112.5 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -85.88 144.51 27.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.076 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 118.684 -1.065 . . . . 0.0 112.954 179.789 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 CA--C 1.529 0.269 0 CA-C-O 120.639 0.183 . . . . 0.0 111.912 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -125.05 174.88 7.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.783 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' A' ' 27' ' ' LEU . 9.5 p -148.16 130.33 6.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.404 ' HB2' ' CB ' ' A' ' 163' ' ' TYR . 10.4 m-85 -105.36 106.3 16.73 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 107.15 18.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.498 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HG2' HD12 ' A' ' 22' ' ' ILE . 11.2 mt-10 -86.61 82.35 7.93 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.354 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.65 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.8 OUTLIER -91.62 165.32 13.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.28 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -67.4 -37.15 82.65 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.729 ' HB2' HG13 ' A' ' 157' ' ' VAL . 12.9 tpt -62.44 -32.97 73.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.82 -148.53 14.4 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.194 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.475 HD12 ' HG2' ' A' ' 17' ' ' GLU . 4.8 tt -134.83 130.14 52.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.861 0.331 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.647 HG22 ' CA ' ' A' ' 135' ' ' GLY . 15.5 pt -137.62 135.58 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.637 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.73 140.24 17.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.599 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 98' ' ' LEU . 2.0 mt -130.87 141.0 50.28 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.588 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.82 107.91 19.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.524 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.433 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -84.49 146.68 27.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.665 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 23.0 m-85 -79.86 92.04 5.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -80.69 19.48 0.82 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.01 -72.44 0.67 Allowed 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.48 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -101.1 -12.1 19.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.017 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.9 1.34 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 71.7 Cg_exo -41.09 -36.38 2.24 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.248 1.966 . . . . 0.0 112.965 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -58.02 -60.37 3.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.353 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -39.31 91.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.337 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 27' ' ' LEU . 14.0 t -55.01 -48.68 73.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.446 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -60.61 -37.29 80.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -58.35 -54.22 49.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.767 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -61.13 -45.84 93.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 110.826 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.39 94.02 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.31 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.5 -44.07 58.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.251 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -37.91 70.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.117 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -80.93 -32.66 34.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.413 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -66.94 -45.95 76.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.124 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -28.42 68.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.736 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.04 36.18 2.79 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.733 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.19 -50.13 5.64 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.637 0.218 . . . . 0.0 110.697 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -62.75 -28.65 70.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.939 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -67.63 113.66 5.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.422 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.6 20.9 7.08 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.359 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.2 p -124.93 154.73 40.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.038 0.419 . . . . 0.0 110.53 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -129.56 169.66 14.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CD1' HG12 ' A' ' 157' ' ' VAL . 34.1 m-85 -85.31 99.07 10.9 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.783 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -76.86 -39.4 51.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.169 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -100.98 117.28 34.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.607 0.241 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.62 HG23 ' CG1' ' A' ' 62' ' ' ILE . 13.2 mt -141.11 120.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.0 111.379 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 mt -116.22 116.56 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.795 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.494 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -56.59 -60.28 3.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.563 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -88.47 62.38 6.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.605 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 178.25 -86.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.272 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.413 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -161.2 170.94 19.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.809 0.337 . . . . 0.0 111.554 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.62 ' CG1' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -127.23 123.09 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.139 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 1.7 pt20 -117.4 155.19 30.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.22 100.63 0.41 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.453 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 111' ' ' GLN . . . . . . . . 0 C--N 1.332 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.58 -179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.365 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 8.5 t -76.69 171.76 14.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.364 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 tt -73.23 -34.09 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.489 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -100.33 36.75 1.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 111.131 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 76' ' ' SER . . . 89.05 169.07 44.32 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.071 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -52.42 63.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.429 0.157 . . . . 0.0 110.786 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -141.61 143.26 33.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.862 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -138.56 173.57 11.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.525 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.18 173.43 11.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.396 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 4.3 p30 -80.19 178.46 8.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -132.21 72.91 1.51 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.467 ' N ' HD22 ' A' ' 86' ' ' LEU . 3.4 mm? -99.17 104.73 16.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.85 -54.23 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HB2' HD21 ' A' ' 90' ' ' LEU . 71.4 Cg_exo -48.72 149.99 6.79 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.78 2.32 . . . . 0.0 112.703 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.54 94.9 2.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.508 HD22 ' CG2' ' A' ' 128' ' ' ILE . 3.0 mt -90.16 -174.94 4.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.721 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -69.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.638 ' HD1' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER 62.06 61.28 1.37 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.113 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.7 p -57.62 -36.86 72.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.413 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 118' ' ' PRO . . . 147.64 -101.52 0.23 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.613 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' A' ' 136' ' ' ILE . . . -71.95 135.17 46.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.974 0.416 . . . . 0.0 111.736 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 77.93 52.65 5.26 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.994 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 96' ' ' GLY . 17.1 mm -135.81 138.67 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.94 HD13 HG22 ' A' ' 114' ' ' VAL . 13.3 tp -115.33 133.75 55.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.8 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -134.13 151.65 51.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 116.35 19.64 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.36 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.92 158.51 26.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.857 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -121.03 173.45 7.25 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.293 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.24 -43.98 3.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.181 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.95 -179.43 33.78 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.65 113.23 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.05 30.54 20.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.12 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -129.82 90.77 3.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -83.21 162.77 21.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.94 -140.94 4.5 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.57 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 m -138.58 58.49 1.66 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.076 0.465 . . . . 0.0 110.802 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 3.3 mt-30 -132.78 178.23 7.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.821 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -160.45 158.02 28.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.057 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.72 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 41.3 p90 -137.36 133.02 34.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.94 HG22 HD13 ' A' ' 98' ' ' LEU . 22.1 t -101.32 114.66 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.2 p -79.94 113.62 18.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.099 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 58' ' ' LYS . 0.8 OUTLIER -86.71 -23.83 25.4 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -119.19 165.01 18.33 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.806 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 18.6 Cg_endo -58.1 124.64 16.39 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.621 2.214 . . . . 0.0 111.994 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 122' ' ' LEU . 2.7 p -141.79 48.17 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.211 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -64.47 -35.35 80.65 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.756 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -65.58 -27.9 68.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 2.5 mt -78.46 0.11 27.19 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.55 79.91 1.07 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.235 0.54 . . . . 0.0 109.942 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.57 -46.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.203 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.45 -43.28 90.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 110.676 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -123.45 135.8 54.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.747 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 63.5 m -80.16 160.83 25.54 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.74 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.638 HD12 ' HD1' ' A' ' 92' ' ' PHE . 1.4 tt -79.39 -179.5 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.934 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.424 ' CE2' ' HG ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -177.13 -38.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.403 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.41 -179.6 17.73 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.848 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 7.6 mtm180 -137.3 168.1 20.29 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 122.819 -0.224 . . . . 0.0 110.778 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.563 HG21 HG13 ' A' ' 114' ' ' VAL . 11.5 t -131.06 91.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.908 0.385 . . . . 0.0 111.345 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.33 -41.66 9.73 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.535 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 103.83 6.83 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.123 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.647 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 147.12 -19.68 1.57 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.422 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' A' ' 95' ' ' ALA . 12.7 tt -48.17 -36.5 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.996 0.398 . . . . 0.0 112.002 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.23 -24.18 67.04 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.289 -0.481 . . . . 0.0 113.133 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ttp -91.07 -32.37 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.236 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.584 HG11 ' CG1' ' A' ' 114' ' ' VAL . 20.2 t -73.92 -48.67 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.33 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -65.0 -31.56 72.86 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.155 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -59.98 -34.46 73.34 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.203 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.617 HG13 HG21 ' A' ' 157' ' ' VAL . 37.1 t -58.01 -38.69 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.8 -42.61 86.3 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.314 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.6 mmt -49.19 -48.62 45.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -52.73 141.8 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 111.503 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.46 112.69 2.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.764 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.2 p -79.86 165.52 22.62 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.107 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.59 -167.29 1.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.598 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.0 p -88.89 32.78 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.568 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -158.52 31.13 0.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.903 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 57.43 41.8 25.64 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.521 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.09 147.51 37.08 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 120.62 0.247 . . . . 0.0 111.551 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 152.32 31.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.904 2.403 . . . . 0.0 112.636 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 154' ' ' VAL . 8.3 p -117.84 23.49 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.283 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.13 24.41 4.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 54.98 85.43 0.06 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 20' ' ' MET . 22.8 t -118.7 111.81 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 175.48 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.65 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.0 mt -105.22 127.81 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.79 0.328 . . . . 0.0 111.048 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 pt -107.13 -33.62 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.765 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.416 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -159.38 167.94 27.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.285 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.426 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -133.25 159.32 40.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.365 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.404 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -129.23 97.08 26.64 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.207 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.9 95.0 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.827 2.352 . . . . 0.0 112.198 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.6 t -84.48 143.89 29.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.273 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.51 -1.161 . . . . 0.0 112.758 179.741 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo . . . . . 0 CA--C 1.534 0.52 0 N-CA-C 112.594 0.19 . . . . 0.0 112.594 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.481 ' HB3' HG12 ' A' ' 24' ' ' VAL . 8.2 m120 -142.31 175.32 9.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.776 0.322 . . . . 0.0 111.627 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -144.8 147.68 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -91.84 120.31 32.42 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 111.139 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.802 HD21 ' HE2' ' A' ' 48' ' ' TYR . 2.2 mt -114.05 102.83 10.55 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.303 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 6.5 mt-10 -92.86 103.16 15.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.27 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 159' ' ' ILE . 2.1 p -113.56 158.19 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.3 t -60.47 -35.9 76.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.813 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.782 ' HB2' HG13 ' A' ' 157' ' ' VAL . 11.4 tpt -68.76 -32.34 72.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.329 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.51 -163.74 37.29 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.35 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 tt -124.12 129.95 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.984 0.392 . . . . 0.0 111.185 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.559 HG22 ' CA ' ' A' ' 135' ' ' GLY . 8.3 pt -136.96 156.83 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.683 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 13' ' ' ASN . 20.3 t -123.32 116.52 48.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.717 HD23 HD12 ' A' ' 16' ' ' LEU . 3.5 mm? -91.51 158.81 16.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.431 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 3.8 tt0 -110.65 105.59 14.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.75 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.97 131.15 37.49 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.392 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.738 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 24.5 m-85 -82.41 113.9 20.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -81.96 14.96 2.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.83 -68.46 0.81 Allowed 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.686 0.279 . . . . 0.0 110.378 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.481 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -100.87 -13.94 18.16 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -97.63 0.66 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 98.7 Cg_exo -43.73 -40.56 11.1 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.071 1.847 . . . . 0.0 112.896 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -54.61 27.08 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.746 HG21 ' HG3' ' A' ' 100' ' ' MET . 4.8 m -64.1 -35.85 82.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.117 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 t -57.01 -51.63 68.48 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.81 -40.47 88.5 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -58.51 -47.23 84.84 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.01 -46.91 78.61 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.739 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 -45.68 70.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.403 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.15 -45.96 91.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.211 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -44.1 93.07 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 110.845 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -70.59 -35.68 73.14 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.143 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.06 -47.15 60.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -57.41 -31.1 65.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.611 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 33.04 2.53 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.103 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.23 -34.86 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.606 0.203 . . . . 0.0 111.058 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.802 ' HE2' HD21 ' A' ' 16' ' ' LEU . 1.4 t80 -73.37 -37.2 66.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.645 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.88 151.84 41.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.27 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 18.31 71.0 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.861 -0.609 . . . . 0.0 113.083 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -109.19 161.67 15.01 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.004 0.402 . . . . 0.0 110.465 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HB3' ' CB ' ' A' ' 158' ' ' LYS . 44.3 pttt -146.54 165.67 28.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -70.64 110.86 5.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -77.18 -45.23 27.34 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.851 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -112.11 130.1 56.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.726 HD12 ' HG3' ' A' ' 153' ' ' PRO . 51.9 mt -143.05 97.48 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.792 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.54 110.11 21.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -62.51 141.06 58.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.187 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.6 45.74 7.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.524 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -168.71 -89.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.942 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 175.23 12.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.651 ' CG2' HG23 ' A' ' 56' ' ' ILE . 1.8 pp -144.04 156.34 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.015 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 6.0 pt20 -132.73 142.53 49.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 111.568 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.03 156.43 16.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.704 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.334 0.441 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.973 -179.997 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.618 0.247 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.26 177.74 8.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 pp -56.19 -31.44 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.747 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.53 40.39 1.11 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.96 179.69 33.37 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.956 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.75 76.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.529 0.204 . . . . 0.0 110.931 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -155.91 146.28 21.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.908 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -126.9 177.21 6.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.22 140.53 38.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.59 157.19 14.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.465 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.63 40.6 3.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.541 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.94 145.98 42.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.695 0.283 . . . . 0.0 110.916 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -164.46 153.51 11.57 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.87 -166.48 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.396 2.064 . . . . 0.0 112.08 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.53 33.46 10.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 111.152 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.658 HD13 ' CG1' ' A' ' 128' ' ' ILE . 84.7 mt -122.03 -178.45 3.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.882 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HE2' ' HB ' ' A' ' 93' ' ' THR . 17.0 tttt -128.08 157.29 41.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.088 0.47 . . . . 0.0 111.659 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.39 48.36 0.89 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.919 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.696 HG23 HD11 ' A' ' 97' ' ' ILE . 1.7 t -58.8 -23.83 60.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.8 -7.31 81.6 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.78 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.64 96.87 5.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.951 0.876 . . . . 0.0 111.383 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.586 ' C ' HD12 ' A' ' 97' ' ' ILE . . . 83.23 61.64 1.89 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.302 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.696 HD11 HG23 ' A' ' 93' ' ' THR . 4.4 mp -138.75 154.46 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.717 0.258 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.756 HD12 ' HE2' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -125.99 111.94 15.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.907 0.384 . . . . 0.0 110.454 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.614 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -108.22 137.04 46.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.34 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.746 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.64 104.88 10.54 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 164.89 22.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.475 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 172.68 12.62 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.32 -36.03 10.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.733 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.74 -179.84 32.93 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.614 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -61.87 124.21 14.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.696 2.264 . . . . 0.0 112.149 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.26 28.49 17.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.051 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.5 m -136.57 84.53 2.08 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.269 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.11 129.41 34.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.769 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.02 -164.06 24.88 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.953 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 m -110.25 68.43 0.67 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.063 0.458 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -148.67 152.47 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -147.17 156.68 43.18 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.755 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.614 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 22.8 p90 -137.77 126.15 23.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.968 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 11.7 p -98.47 120.14 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.356 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 p -84.18 129.36 34.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.761 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.45 -19.47 12.93 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.64 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -122.14 160.34 47.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.61 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 9.5 Cg_endo -51.56 127.82 23.87 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.043 2.495 . . . . 0.0 112.802 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.5 p -147.42 42.9 1.1 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -59.19 -30.99 68.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.426 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 32.6 p90 -60.95 -29.2 69.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.273 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 14.6 mt -81.25 -2.06 47.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.78 85.63 0.21 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.153 0.501 . . . . 0.0 110.386 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.21 -31.58 0.54 Allowed Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.697 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -72.59 -62.94 1.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.708 0.254 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -95.63 172.13 8.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.558 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 13.3 t -114.06 156.73 23.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.522 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 129' ' ' PHE . 4.2 mm -80.01 -179.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.283 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.756 ' HE2' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -178.22 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.393 0.277 . . . . 0.0 110.696 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 26' ' ' GLU . . . -145.44 -179.63 21.86 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.213 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 160.6 42.31 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.577 0.227 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 25' ' ' LEU . 17.8 t -106.73 93.61 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.8 m -84.12 -42.58 15.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.475 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 107.25 8.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 136.09 -10.31 4.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.607 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.417 ' HA ' HG11 ' A' ' 132' ' ' VAL . 13.4 tt -48.78 -33.82 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.55 91.68 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.609 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -66.59 -46.49 75.79 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 0.0 110.471 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.75 -38.1 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.787 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.13 -40.81 77.87 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.62 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -62.09 -37.32 84.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.917 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.648 ' CG1' HD13 ' A' ' 56' ' ' ILE . 38.2 t -57.5 -41.04 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.946 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.09 -13.13 58.05 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.6 tpt -84.11 -35.64 23.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.977 0.388 . . . . 0.0 111.507 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 m -51.85 154.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.985 0.422 . . . . 0.0 111.684 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.17 95.49 0.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.672 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.3 p -79.95 170.52 16.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.371 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.31 179.46 7.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 29.59 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.387 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -156.1 33.52 0.34 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 54.3 61.88 2.83 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.34 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.0 114.38 13.89 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.114 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.726 ' HG3' HD12 ' A' ' 56' ' ' ILE . 32.2 Cg_exo -61.99 117.41 4.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.849 2.366 . . . . 0.0 112.575 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.3 m -68.03 -34.26 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.334 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.3 179.54 7.43 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -105.79 80.66 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 20' ' ' MET . 32.6 t -98.94 115.62 39.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.658 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.415 ' CB ' ' HB3' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -149.96 175.14 11.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.553 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.64 ' HA ' HG22 ' A' ' 18' ' ' THR . 3.9 mt -109.8 148.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.69 -40.93 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.845 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 11.0 mttt -139.25 161.73 36.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.77 0.319 . . . . 0.0 111.298 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.53 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -156.57 110.14 2.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -128.69 166.84 21.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.93 174.71 11.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.905 2.403 . . . . 0.0 111.916 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.2 t -129.18 103.53 7.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.719 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.473 -179.851 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo . . . . . 0 CA--C 1.533 0.449 0 CA-C-O 121.05 0.354 . . . . 0.0 112.178 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.69 161.46 13.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.331 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 27' ' ' LEU . 22.0 t -134.08 131.47 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.104 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -91.25 96.97 10.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.09 98.59 10.18 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.218 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -87.34 122.23 30.83 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.225 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -128.61 163.6 24.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.156 -179.279 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.8 t -68.18 -34.75 76.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.196 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.702 ' HG3' HG22 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.72 -30.81 70.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 18' ' ' THR . . . 168.16 -143.46 8.16 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.253 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.2 mt -140.86 135.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.854 0.327 . . . . 0.0 111.036 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 135' ' ' GLY . 16.6 pt -137.78 147.95 25.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.764 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.1 t -120.04 123.64 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.021 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.4 mm? -116.26 159.14 22.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.217 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -125.71 106.76 9.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 14' ' ' VAL . 5.3 mp -87.05 158.61 19.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.778 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 33.2 m-85 -102.86 102.5 12.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.236 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -81.25 23.25 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.14 -68.07 0.83 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.525 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.65 -14.11 18.27 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 178.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -97.29 1.39 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.7 Cg_exo -40.71 -37.46 2.28 Favored 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 121.952 1.768 . . . . 0.0 112.893 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -55.15 38.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.487 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.456 ' CG2' ' HB1' ' A' ' 32' ' ' ALA . 3.9 t -71.93 -34.97 69.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.797 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 2.1 m -56.97 -50.94 71.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.66 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -42.33 99.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -65.07 -48.23 74.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.206 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.39 -46.38 86.51 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.946 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.15 83.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.562 ' CB ' HD13 ' A' ' 77' ' ' ILE . 3.4 mm-40 -62.42 -43.97 97.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.058 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -58.26 -41.17 83.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.01 77.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.902 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -68.48 -41.22 80.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -28.55 68.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.554 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.25 28.88 4.47 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.775 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -51.14 5.35 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.573 0.225 . . . . 0.0 110.425 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 15.1 m-85 -77.3 -41.52 40.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.444 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -70.3 93.38 0.85 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.96 3.5 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.091 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.576 ' OG1' HD12 ' A' ' 159' ' ' ILE . 74.0 p -61.78 166.55 4.3 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.006 0.403 . . . . 0.0 112.004 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -137.01 25.77 3.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.939 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 159' ' ' ILE . 10.0 m-85 57.23 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 0.0 111.659 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -149.37 -65.84 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 56' ' ' ILE . 2.8 mtt180 -91.34 122.25 33.79 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.399 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.726 ' HA ' HG22 ' A' ' 62' ' ' ILE . 23.9 mm -131.21 84.3 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.102 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.555 HD12 ' CE ' ' A' ' 61' ' ' MET . 26.1 mt -89.86 88.94 2.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -24.23 60.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.744 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -91.43 25.59 2.55 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.85 -77.67 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 O-C-N 122.452 -0.155 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.555 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.32 178.79 9.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.631 0.253 . . . . 0.0 111.123 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 56' ' ' ILE . 4.0 pt -135.46 149.19 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -133.06 154.17 50.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 112.161 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.82 103.43 0.47 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.025 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.334 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.776 -179.673 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.229 0 CA-C-O 120.605 0.241 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p -99.82 172.71 7.08 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.562 HD13 ' CB ' ' A' ' 41' ' ' GLU . 34.4 pt -57.4 -38.22 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.646 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -74.55 -46.19 40.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.6 -153.91 21.95 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.757 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -34.54 7.08 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.455 ' CB ' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER -141.58 109.87 5.92 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.675 0.274 . . . . 0.0 111.037 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -118.34 176.19 5.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.09 -177.91 0.41 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -113.86 176.94 4.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.463 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -130.75 110.31 11.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.369 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.02 129.09 9.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.417 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 0.7 OUTLIER -178.78 -53.51 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 87' ' ' HIS . 27.1 Cg_exo -61.94 171.82 4.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.659 2.239 . . . . 0.0 112.11 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.19 -75.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.75 HD22 HG21 ' A' ' 128' ' ' ILE . 0.4 OUTLIER 65.35 151.43 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -137.4 167.07 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.556 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -133.24 87.83 2.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.053 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.1 p -71.34 -27.78 63.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.82 -67.99 0.89 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.85 104.92 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.7 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.522 ' HA3' HD12 ' A' ' 136' ' ' ILE . . . 76.76 63.05 2.39 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.435 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 96' ' ' GLY . 33.9 mm -142.4 123.34 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.778 0.289 . . . . 0.0 110.559 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.616 HD22 ' HE2' ' A' ' 129' ' ' PHE . 3.0 mt -98.93 117.51 33.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 111.251 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -119.63 143.69 47.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.496 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.65 116.48 19.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.387 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB2' ' HD1' ' A' ' 113' ' ' PHE . . . -80.12 168.28 19.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.477 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -151.95 170.92 18.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -101.71 -49.07 4.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.649 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.02 -179.65 34.95 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.29 122.06 10.54 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.704 2.269 . . . . 0.0 111.908 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.32 31.33 17.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.188 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.455 HG23 ' CB ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -139.12 85.44 2.07 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.731 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -107.49 140.83 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.36 -152.14 16.02 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.781 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 p -117.73 38.78 3.52 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -111.25 150.71 29.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.154 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.12 146.14 42.48 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.675 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.659 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 31.9 p90 -129.27 130.36 46.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 114' ' ' VAL . 12.1 p -109.77 121.2 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.898 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 61' ' ' MET . 1.1 p -79.59 139.38 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.525 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -108.82 -31.16 7.8 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.663 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.1 153.89 37.73 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.036 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.48 122.71 10.71 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.681 2.254 . . . . 0.0 112.029 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.681 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 75.1 p -145.97 92.61 2.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.85 -4.51 52.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.717 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.681 ' CZ2' HG22 ' A' ' 119' ' ' THR . 22.9 p90 -82.18 -32.63 29.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.286 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.4 pp -83.49 0.53 45.98 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -60.32 87.09 0.01 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.354 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.12 -23.3 2.74 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.966 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -61.6 -65.8 0.64 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.917 0.359 . . . . 0.0 110.951 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -97.5 172.61 7.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.795 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.74 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 46.5 m -92.13 155.15 18.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.95 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.75 HG21 HD22 ' A' ' 90' ' ' LEU . 1.4 tt -98.97 -179.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.778 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.616 ' HE2' HD22 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -172.77 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.8 -179.78 19.82 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.928 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -136.17 172.59 12.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.711 0.291 . . . . 0.0 110.969 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.66 121.09 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.218 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 29.1 m -123.25 -59.0 1.6 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -113.91 93.7 4.49 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.532 ' O ' HG22 ' A' ' 23' ' ' ILE . . . 148.44 -17.43 1.3 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.386 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.522 HD12 ' HA3' ' A' ' 96' ' ' GLY . 15.2 tt -44.7 -34.75 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.008 0.404 . . . . 0.0 111.92 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.33 -42.23 82.22 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.769 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.75 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.4 ttp -60.79 -40.23 91.83 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.75 0.309 . . . . 0.0 110.476 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.645 HG13 HD11 ' A' ' 62' ' ' ILE . 22.9 t -70.53 -35.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.0 -46.43 74.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -58.4 -35.31 71.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.524 0.202 . . . . 0.0 111.262 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 138' ' ' MET . 33.4 t -58.42 -40.04 76.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.638 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.68 -37.97 38.46 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.464 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 mmt -60.76 -38.47 85.32 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.554 0.216 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.4 OUTLIER -62.64 166.65 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.366 -0.379 . . . . 0.0 112.015 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 145' ' ' VAL . 1.9 mt-10 -66.68 171.3 5.3 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.283 0.563 . . . . 0.0 110.968 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 154' ' ' VAL . 3.0 p -149.13 174.73 12.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.271 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -95.48 -176.33 3.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.6 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.9 m -92.76 35.09 1.05 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 111.279 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.27 37.12 0.12 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.459 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.16 41.84 31.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.215 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.93 126.06 29.84 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.056 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.534 ' HB3' HG13 ' A' ' 56' ' ' ILE . 33.8 Cg_endo -64.5 154.24 72.88 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.813 2.342 . . . . 0.0 112.776 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 147' ' ' THR . 40.0 t -103.93 -28.24 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.889 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.66 17.65 11.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 33.81 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.702 HG22 ' HG3' ' A' ' 20' ' ' MET . 11.0 t -80.24 97.52 3.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.0 tttp -102.4 130.56 49.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.422 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.576 HD12 ' OG1' ' A' ' 51' ' ' THR . 13.0 mt -104.68 135.59 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.647 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.56 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -134.26 2.48 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 22.3 mttt -154.37 131.99 11.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.643 0.258 . . . . 0.0 111.183 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.43 81.74 1.04 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.063 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -144.67 156.81 56.11 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.368 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.93 177.83 7.91 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.098 2.532 . . . . 0.0 112.195 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.43 119.36 17.4 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.112 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.514 179.841 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo . . . . . 0 CA--C 1.53 0.305 0 CA-C-O 120.631 0.18 . . . . 0.0 112.359 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -128.49 177.47 6.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.786 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.79 129.93 66.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.687 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.83 93.01 9.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.92 89.26 7.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.937 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 89.56 6.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.445 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 159' ' ' ILE . 1.2 p -95.21 164.11 12.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.147 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -66.89 -40.92 87.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.609 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.715 ' HB2' HG23 ' A' ' 157' ' ' VAL . 4.5 tpt -62.11 -30.91 71.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.21 -168.71 41.03 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.951 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.17 129.13 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.932 0.366 . . . . 0.0 111.075 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.605 HG22 ' CA ' ' A' ' 135' ' ' GLY . 11.6 pt -138.52 128.34 33.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.584 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.85 111.28 32.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.391 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.875 HD12 HG12 ' A' ' 132' ' ' VAL . 0.8 OUTLIER -103.4 154.44 19.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.196 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -112.2 133.37 54.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 4.5 mt -97.23 149.84 21.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.408 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.66 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 20.0 m-85 -92.24 90.66 7.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -80.47 23.6 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -100.44 -71.95 0.69 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.536 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.94 -13.67 18.21 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.664 178.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -100.15 1.36 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 43.5 Cg_exo -36.83 -37.39 0.31 Allowed 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.467 2.111 . . . . 0.0 113.375 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -60.67 3.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.781 0.324 . . . . 0.0 110.532 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.2 p -67.0 -34.69 78.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 96.6 m -58.94 -50.57 73.55 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -57.3 -40.31 77.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.284 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.451 ' OD1' HD11 ' A' ' 42' ' ' LEU . 14.9 t-20 -63.25 -53.09 58.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.568 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.725 ' HA ' HD12 ' A' ' 42' ' ' LEU . 20.5 t80 -56.76 -44.04 81.38 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.5 99.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.982 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.664 ' HB3' HG21 ' A' ' 77' ' ' ILE . 1.8 tt0 -64.7 -38.0 89.5 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.933 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 39' ' ' PHE . 9.2 mt -64.02 -39.55 94.34 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.971 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.88 74.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.115 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -72.83 -52.83 13.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.151 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.428 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.29 32.07 3.85 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.591 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -53.08 8.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.629 0.252 . . . . 0.0 110.386 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -64.81 -41.0 96.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.644 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -61.19 127.44 31.54 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.473 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 -32.02 8.03 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.604 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 170.12 15.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HB3' ' CB ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.46 159.23 43.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.925 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.472 ' CD1' HG12 ' A' ' 62' ' ' ILE . 58.6 m-85 -67.45 117.24 9.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.681 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.25 -61.57 1.67 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.289 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -88.97 123.37 33.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.072 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 153' ' ' PRO . 7.1 mt -142.07 112.29 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.297 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -93.89 121.02 44.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.065 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.23 123.7 18.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.13 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 t70 59.17 58.02 3.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.537 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.417 ' H ' HD21 ' A' ' 116' ' ' LEU . 15.6 t80 -166.66 -74.68 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.976 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.402 ' SD ' HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -160.11 177.46 10.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.224 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 62' ' ' ILE . 11.2 tt -151.15 101.91 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.544 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.9 tt0 -87.36 132.54 33.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.13 150.47 17.76 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.419 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.38 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.023 -179.744 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.275 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 p -101.28 169.79 8.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.664 HG21 ' HB3' ' A' ' 41' ' ' GLU . 3.9 pt -67.96 -29.95 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.866 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -81.65 -42.87 19.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.301 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.2 -138.56 2.65 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.725 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -61.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -160.72 161.16 32.13 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.731 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -137.03 177.36 7.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.21 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -87.11 176.94 7.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.092 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -92.74 179.25 5.54 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 127' ' ' THR . 0.4 OUTLIER -136.0 136.02 39.98 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.252 -179.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.05 129.37 9.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -62.48 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.47 ' HB2' HD12 ' A' ' 90' ' ' LEU . 41.1 Cg_endo -66.68 -14.48 44.09 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.755 2.303 . . . . 0.0 113.076 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 72.2 -67.99 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.477 0.311 . . . . 0.0 111.144 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HB3' HD13 ' A' ' 128' ' ' ILE . 1.7 mp 66.27 157.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.855 0.36 . . . . 0.0 111.57 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -58.72 145.67 39.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.379 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.6 29.16 0.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.618 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.5 t -137.43 -46.57 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.5 122.95 30.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.778 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.16 131.6 10.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.636 0.255 . . . . 0.0 111.671 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.582 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 100.81 59.93 0.81 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.868 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.706 HD12 HH11 ' A' ' 131' ' ' ARG . 14.6 mm -128.56 132.56 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.73 0.265 . . . . 0.0 111.039 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 114' ' ' VAL . 2.1 mt -109.67 103.65 12.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -111.48 140.21 46.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.398 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.7 108.72 13.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 113' ' ' PHE . . . -88.81 151.99 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.754 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -130.66 147.5 52.34 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.718 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.05 -73.68 0.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.252 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.61 176.14 19.91 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.435 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.3 135.93 38.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.359 2.04 . . . . 0.0 111.879 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.35 30.41 19.79 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.336 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.78 87.05 2.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.776 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -83.25 129.7 35.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.472 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.43 -116.84 4.25 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.832 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.4 m -154.22 32.06 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 111.463 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -95.33 163.16 13.37 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 2.6 p90 -159.03 124.29 4.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.3 p90 -110.97 135.1 51.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.809 ' CG1' HG11 ' A' ' 139' ' ' VAL . 3.5 t -100.88 105.53 17.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.881 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.39 125.58 31.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.283 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.627 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -116.24 -1.22 12.42 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.695 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.688 ' O ' HG23 ' A' ' 119' ' ' THR . . . -121.16 140.07 30.5 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -52.12 112.53 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.761 2.307 . . . . 0.0 112.212 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' ALA . 69.5 p -128.79 97.73 4.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.92 -32.06 15.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.332 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.6 p90 -60.02 -39.16 84.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.2 pp -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -63.83 85.52 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.42 -32.08 1.99 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.701 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -44.69 96.65 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.634 0.254 . . . . 0.0 111.128 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -104.02 150.15 24.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.625 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 87.2 m -89.37 151.74 21.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 90' ' ' LEU . 1.0 OUTLIER -80.9 -179.33 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.498 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -172.09 -42.26 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.04 173.35 30.55 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.855 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.706 HH11 HD12 ' A' ' 97' ' ' ILE . 7.6 tpp180 -140.84 148.64 40.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.592 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.875 HG12 HD12 ' A' ' 25' ' ' LEU . 17.7 m -89.98 114.01 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.671 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 27.0 m -95.48 -36.2 11.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -150.52 94.91 2.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.634 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.605 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 162.03 -19.24 0.18 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.828 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.532 ' HB ' HG21 ' A' ' 132' ' ' VAL . 10.5 tt -44.39 -34.61 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.457 0.628 . . . . 0.0 111.903 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.9 -25.15 52.35 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.024 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.488 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.6 ttp -86.11 -36.03 19.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.754 0.311 . . . . 0.0 110.329 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.809 HG11 ' CG1' ' A' ' 114' ' ' VAL . 21.9 t -72.42 -54.26 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.437 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -58.56 -30.69 67.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.575 0.226 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.56 -39.23 90.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.532 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.547 ' O ' HG22 ' A' ' 145' ' ' VAL . 17.8 t -65.87 -27.03 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.35 -30.78 24.01 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.158 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.31 -34.56 78.26 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.137 0.175 . . . . 0.0 111.45 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 142' ' ' VAL . 29.6 m -63.4 174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.828 0.347 . . . . 0.0 111.413 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.15 131.16 44.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.5 p -94.61 172.14 8.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.19 142.68 47.5 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.853 0.359 . . . . 0.0 111.646 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.19 -47.76 0.14 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.989 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 176.35 -32.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.593 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -169.54 36.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.478 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 116.05 65.57 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.78 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 56' ' ' ILE . 31.3 Cg_endo -64.82 111.28 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.596 2.197 . . . . 0.0 112.191 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.56 -33.86 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -168.25 1.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.587 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.09 100.04 7.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.748 0.309 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 20' ' ' MET . 9.6 p -118.7 115.17 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.708 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.432 ' CB ' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -154.4 176.21 12.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.318 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.574 ' HA ' HG22 ' A' ' 18' ' ' THR . 3.2 mt -110.45 130.0 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.6 pt -110.41 -34.35 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.506 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -147.04 140.11 25.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.76 0.314 . . . . 0.0 110.767 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.41 117.14 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.83 147.93 31.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.246 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.83 146.44 18.6 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.668 2.245 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.89 174.22 7.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.042 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.545 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo . . . . . 0 CA--C 1.529 0.259 0 CA-C-O 120.654 0.189 . . . . 0.0 112.298 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -118.98 167.3 11.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.1 m -144.28 137.42 23.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.207 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CD2' HG22 ' A' ' 24' ' ' VAL . 18.9 m-85 -118.57 102.26 8.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.777 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mt -84.06 104.9 14.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -87.12 90.66 8.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.474 ' HB ' HG23 ' A' ' 159' ' ' ILE . 1.4 t -114.06 166.55 11.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -35.86 79.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.211 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.931 ' HB2' HG13 ' A' ' 157' ' ' VAL . 7.4 tpt -62.7 -28.23 69.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.115 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 152.45 5.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.954 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 17' ' ' GLU . 1.4 tp -79.64 122.75 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 117.078 0.439 . . . . 0.0 111.358 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -124.62 124.09 67.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 15' ' ' TYR . 20.8 t -98.66 120.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.976 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -110.61 147.73 33.64 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -102.37 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.519 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.548 HD11 ' CE1' ' A' ' 129' ' ' PHE . 3.8 mm? -81.35 132.18 35.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.468 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 79.0 m-85 -68.28 99.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -77.9 11.23 2.3 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 -69.18 0.78 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.701 0.286 . . . . 0.0 110.527 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 14.7 m-70 -100.82 -15.93 17.45 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.652 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.55 1.48 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 81.6 Cg_exo -42.81 -36.5 5.16 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.079 1.853 . . . . 0.0 113.081 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -62.91 -57.13 11.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.853 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -61.92 -36.98 82.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.03 -48.49 73.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -56.37 -39.08 72.35 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.465 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.81 -44.17 64.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -61.76 -45.38 94.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.63 80.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.59 -43.15 97.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.52 -35.39 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.069 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.64 81.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.528 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -92.6 -31.9 15.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.616 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -57.2 -31.69 65.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.6 26.13 4.92 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.982 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.2 -44.82 7.11 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.585 ' O ' HG22 ' A' ' 51' ' ' THR . 10.7 m-85 -82.25 -33.23 29.31 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.922 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.0 105.91 0.37 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.733 0.301 . . . . 0.0 110.501 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 21.96 6.19 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.895 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.69 ' CG2' HD12 ' A' ' 159' ' ' ILE . 7.6 t -98.55 173.44 6.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.144 0.472 . . . . 0.0 111.097 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.66 38.17 0.23 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.713 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.445 ' HB3' HD11 ' A' ' 56' ' ' ILE . 31.0 m-85 56.45 -177.58 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.413 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -151.11 -48.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.706 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.21 111.26 19.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.69 0.281 . . . . 0.0 110.624 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.803 HG23 HG22 ' A' ' 62' ' ' ILE . 32.6 mm -115.7 116.02 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.486 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.47 HD12 ' CE ' ' A' ' 61' ' ' MET . 33.0 mt -122.74 94.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.361 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -56.73 -27.5 59.34 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.517 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.37 31.47 2.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.734 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.74 -78.36 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.47 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.21 178.13 9.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 111.601 -179.345 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.803 HG22 HG23 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -132.81 104.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.311 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 11.1 tt0 -93.44 130.8 39.13 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.643 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.92 145.54 17.84 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.737 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.395 -179.005 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.717 0.294 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.3 p -96.24 -179.24 4.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.527 HD11 ' CZ ' ' A' ' 78' ' ' TYR . 1.2 pt -61.52 -28.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.484 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.527 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 62.8 m-85 -83.97 -43.71 14.92 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.87 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.81 -169.47 42.54 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.745 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -63.52 -45.38 90.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.559 0.219 . . . . 0.0 111.213 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.837 ' CB ' HG23 ' A' ' 107' ' ' THR . 2.9 pt20 -152.17 127.74 10.07 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.79 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -116.37 157.05 25.66 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.936 0.398 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -65.95 179.16 0.94 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -95.64 146.57 24.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.32 102.09 11.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.601 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tp -134.73 144.88 47.99 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.426 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 m-70 -158.3 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HB2' HD12 ' A' ' 90' ' ' LEU . 72.6 Cg_endo -74.43 158.1 44.61 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.676 2.251 . . . . 0.0 112.507 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.66 -49.03 43.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.238 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.665 HD22 HG13 ' A' ' 128' ' ' ILE . 0.2 OUTLIER 56.2 -170.92 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -159.7 35.97 0.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.556 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -126.97 -46.54 1.53 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.79 117.08 9.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.864 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 136' ' ' ILE . . . -45.35 134.24 6.76 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.62 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.523 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 98.38 60.32 0.91 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.726 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 96' ' ' GLY . 11.0 mm -128.36 160.23 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.568 0.184 . . . . 0.0 110.643 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.604 HD21 HG22 ' A' ' 114' ' ' VAL . 10.2 mt -133.96 115.95 14.99 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.947 0.403 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -118.14 139.95 50.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.335 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.431 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.82 113.56 18.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.64 170.37 10.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -142.66 151.44 41.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.82 -33.81 75.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.72 179.99 34.91 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.467 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.99 131.9 44.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.541 2.16 . . . . 0.0 111.72 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 p30 44.15 30.0 0.4 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.688 0.618 . . . . 0.0 112.0 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.837 HG23 ' CB ' ' A' ' 81' ' ' GLN . 50.2 m -136.59 85.81 2.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -83.89 162.17 20.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.63 -105.35 1.15 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.035 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m -155.89 40.55 0.38 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -109.41 161.27 15.46 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.187 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 7.6 p90 -159.98 125.91 4.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 50.5 p90 -112.85 133.76 54.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.281 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.604 HG22 HD21 ' A' ' 98' ' ' LEU . 40.6 t -94.81 111.29 25.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.63 103.42 9.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 58' ' ' LYS . 1.1 pp -95.23 -5.33 44.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.743 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.23 151.01 50.35 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.58 0.228 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 109.21 2.31 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.778 2.319 . . . . 0.0 111.931 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.441 ' OG1' HD21 ' A' ' 122' ' ' LEU . 72.1 p -133.91 100.96 4.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.23 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.1 -27.04 16.47 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.419 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -58.8 -27.33 64.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.54 0.21 . . . . 0.0 111.505 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.497 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.4 pp -98.03 0.2 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.85 84.56 0.03 OUTLIER 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 151.11 -30.95 0.98 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.837 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -67.41 -57.65 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.685 0.279 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -93.88 144.38 25.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.897 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.617 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 12.3 t -88.22 152.69 21.79 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.821 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 129' ' ' PHE . 3.3 mm -80.16 -179.32 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.406 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.71 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -173.26 -44.19 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.445 0.164 . . . . 0.0 111.179 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.0 179.7 20.36 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.729 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.96 153.65 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -101.69 87.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.32 -51.37 8.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.711 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 103.04 7.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 156.18 -23.75 0.52 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.196 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 95' ' ' ALA . 15.0 tt -47.49 -34.77 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -44.44 97.91 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.537 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.8 tpt -76.52 -46.41 26.68 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.555 0.217 . . . . 0.0 110.769 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 135' ' ' GLY . 19.9 t -56.49 -34.8 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.191 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -67.24 -39.64 86.22 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.674 0.273 . . . . 0.0 110.788 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -60.94 -28.64 69.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.198 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.2 t -58.36 -25.42 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.736 0.303 . . . . 0.0 111.03 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.66 -23.3 39.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.804 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -63.57 -27.01 68.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.772 0.286 . . . . 0.0 111.359 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER -64.53 173.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.478 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -86.58 133.72 33.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.57 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -100.81 178.07 4.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.656 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.55 29.03 8.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.376 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.21 24.53 8.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 111.198 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.93 33.83 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.184 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 58.33 44.15 18.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.389 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.52 90.33 37.65 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.458 ' HG3' HG13 ' A' ' 56' ' ' ILE . 36.8 Cg_endo -66.25 139.68 55.93 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.693 2.262 . . . . 0.0 112.437 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.84 -50.42 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.83 67.45 1.98 Allowed 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -51.32 156.31 1.22 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.757 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.931 HG13 ' HB2' ' A' ' 20' ' ' MET . 25.9 t -79.83 138.15 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.096 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.86 119.31 16.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 111.266 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.69 HD12 ' CG2' ' A' ' 51' ' ' THR . 12.0 mt -92.62 148.33 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.206 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -38.33 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.856 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -154.63 170.42 21.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.88 0.371 . . . . 0.0 111.343 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -132.7 134.57 44.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.639 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -107.85 93.72 11.14 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.71 104.74 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.468 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.2 t -71.49 78.94 0.78 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.397 -1.224 . . . . 0.0 112.459 -179.925 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 CA--C 1.53 0.323 0 N-CA-C 112.755 0.252 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -126.77 154.64 43.97 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.998 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.29 143.88 38.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.29 117.36 34.58 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.53 HD12 HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -98.47 99.77 10.97 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 105.24 17.45 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.392 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.56 ' HB ' HG23 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -114.92 167.74 10.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -21.48 52.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.644 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.807 ' HB3' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -95.6 28.2 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.995 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 18' ' ' THR . . . 119.03 -156.59 15.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.284 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -146.43 139.07 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.919 0.36 . . . . 0.0 111.021 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 25' ' ' LEU . 8.4 pt -139.34 133.69 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 111.642 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 t -108.13 113.77 44.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 23' ' ' ILE . 2.2 mp -112.57 138.41 49.38 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -103.64 130.15 51.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.869 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.724 HD12 ' SG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -97.51 131.8 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.593 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.608 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 22.9 m-85 -64.83 99.4 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.788 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -79.46 14.77 1.47 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -70.67 0.73 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.493 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 10.2 m-70 -100.88 -14.46 17.94 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.14 1.12 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.8 Cg_exo -40.79 -37.19 2.24 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.154 1.903 . . . . 0.0 112.974 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -55.3 36.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 110.442 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -64.9 -35.12 80.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.724 ' SG ' HD12 ' A' ' 27' ' ' LEU . 55.8 m -56.15 -50.2 71.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.299 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -61.11 -39.32 89.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -62.4 -59.06 5.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.929 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -40.84 84.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.53 67.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -64.22 -36.12 83.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.11 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -49.49 77.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.656 0.265 . . . . 0.0 110.657 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.95 64.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.23 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -46.09 50.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.312 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -60.14 -54.07 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.51 52.36 0.03 OUTLIER Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.788 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -125.63 -49.67 1.63 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.544 0.211 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.477 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -71.65 -45.29 62.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.177 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -56.17 118.64 4.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.23 32.37 20.27 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.697 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -100.23 -175.27 2.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -163.39 137.27 5.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HB3' HD11 ' A' ' 56' ' ' ILE . 39.9 m-85 -64.93 150.28 48.16 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.852 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -142.76 19.26 2.0 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.619 ' C ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -158.07 104.69 1.91 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.584 0.23 . . . . 0.0 111.155 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.949 HD13 ' HG3' ' A' ' 153' ' ' PRO . 2.7 mp -136.18 113.59 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.26 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.85 100.11 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 1.1 ttmt -59.12 145.23 43.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.68 36.09 2.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.092 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -169.53 -94.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.892 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -160.41 169.61 22.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 56' ' ' ILE . 33.9 pt -137.24 150.33 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.753 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 4.6 pm0 -126.26 145.61 50.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 111.324 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.57 159.79 13.62 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.604 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.333 0.411 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.896 -179.867 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.196 0 CA-C-O 120.698 0.285 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.6 t -108.37 170.92 7.71 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 78' ' ' TYR . 19.5 pt -48.5 -45.05 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CD2' HG13 ' A' ' 77' ' ' ILE . 4.1 p90 -131.07 14.85 5.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.158 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -86.27 -136.57 4.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.372 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.84 -63.49 0.37 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.137 0.494 . . . . 0.0 110.364 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.59 100.91 2.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.508 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD1' ' HA2' ' A' ' 79' ' ' GLY . 27.9 p90 -154.31 179.4 9.02 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -101.87 115.54 30.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.848 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.21 165.92 16.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.136 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.15 128.56 38.04 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.357 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.2 136.68 49.92 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.045 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.419 ' HB3' HD12 ' A' ' 90' ' ' LEU . 25.5 m80 -140.6 99.91 6.87 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.008 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.79 156.16 67.04 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 60.71 76.12 0.38 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -145.24 80.37 1.61 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.754 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.39 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.219 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.59 34.13 2.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.718 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -71.59 -36.27 70.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.344 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.05 160.34 12.74 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.3 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.99 94.74 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.866 0.365 . . . . 0.0 111.689 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 81.06 44.95 7.84 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.781 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 96' ' ' GLY . 33.6 mm -124.57 116.11 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.579 0.228 . . . . 0.0 110.855 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.557 HD22 HD22 ' A' ' 25' ' ' LEU . 25.1 tp -96.51 114.78 26.47 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.933 0.397 . . . . 0.0 111.097 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -114.07 150.38 34.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.319 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.403 ' HG3' ' CG ' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -79.45 125.27 29.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.592 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.54 151.77 28.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.71 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -130.16 146.71 51.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.403 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 107' ' ' THR . . . -91.17 -53.9 4.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.794 0.33 . . . . 0.0 110.592 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.12 179.99 35.29 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.502 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.63 116.85 3.57 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.475 2.117 . . . . 0.0 111.881 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.89 26.82 15.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.31 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 27.5 m -146.23 83.77 1.63 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.834 0.35 . . . . 0.0 110.889 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -101.18 156.29 17.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.354 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.65 -109.78 3.38 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.14 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.0 38.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 111.258 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -100.46 170.92 8.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -150.45 160.03 44.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 25.2 p90 -152.8 138.83 18.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 98' ' ' LEU . 17.6 m -103.69 134.7 44.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 117' ' ' ALA . 3.2 m -79.61 117.94 20.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.858 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -5.48 42.43 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.477 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 119' ' ' THR . . . -155.98 156.8 30.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.356 0.122 . . . . 0.0 111.147 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -51.38 120.23 6.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.911 2.407 . . . . 0.0 112.736 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.63 ' HB ' HD12 ' A' ' 122' ' ' LEU . 45.8 p -135.02 53.44 1.99 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.364 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -59.48 -35.75 74.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -66.62 -24.7 66.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.534 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.63 HD12 ' HB ' ' A' ' 119' ' ' THR . 2.4 mt -76.11 -2.78 32.6 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.55 85.36 0.07 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.095 0.474 . . . . 0.0 110.348 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.39 -44.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.736 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -64.63 -53.56 45.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.678 0.275 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -125.63 131.66 52.62 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.647 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 13.4 t -79.92 167.42 20.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.804 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.676 HG21 HD22 ' A' ' 90' ' ' LEU . 1.4 tt -79.56 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.699 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.581 ' CD1' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -177.8 -44.07 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.16 179.96 16.23 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.801 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.38 165.59 30.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.523 0.202 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.99 103.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.3 t -98.06 -51.24 4.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.798 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -123.3 98.39 5.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 23' ' ' ILE . . . 149.9 -17.72 1.08 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.386 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.9 tt -46.57 -33.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.65 88.66 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.308 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.419 ' HG3' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -60.17 -40.48 90.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.761 0.315 . . . . 0.0 110.274 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 114' ' ' VAL . 25.2 t -64.68 -41.43 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.901 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.92 -41.98 83.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -59.63 -33.89 72.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.128 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.569 HG12 HG12 ' A' ' 56' ' ' ILE . 10.6 t -60.25 -30.85 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.068 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . -89.05 -41.86 5.77 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.355 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.7 mmt -51.78 -34.69 40.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 142' ' ' VAL . 32.4 m -62.26 171.26 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.543 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 154' ' ' VAL . 1.1 tt0 -84.25 177.69 8.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.897 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -133.1 176.46 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -111.22 -165.52 1.0 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.68 36.73 0.9 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.77 29.34 0.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.866 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.43 39.2 23.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -121.77 146.06 44.83 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.785 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.949 ' HG3' HD13 ' A' ' 56' ' ' ILE . 66.6 Cg_endo -73.67 140.14 29.01 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.759 2.306 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 146' ' ' GLU . 4.3 m -58.85 -33.93 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.049 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.4 77.68 1.19 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.263 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.58 138.11 47.51 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.354 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' A' ' 20' ' ' MET . 21.7 t -80.05 126.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 114.27 23.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' HB ' ' A' ' 18' ' ' THR . 8.5 mt -91.01 144.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -133.73 8.57 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -157.57 140.83 15.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 111.304 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -153.91 101.08 2.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.941 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -151.33 155.93 34.76 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.479 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.11 149.17 19.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.862 2.375 . . . . 0.0 112.829 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -149.21 93.22 2.05 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.263 -1.299 . . . . 0.0 112.851 -179.869 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 29' ' ' TRP . 61.3 Cg_endo . . . . . 0 CA--C 1.534 0.499 0 N-CA-C 112.96 0.331 . . . . 0.0 112.96 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -87.8 146.37 25.65 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 m -134.43 149.84 30.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.56 123.53 50.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.356 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.767 HD12 ' CD1' ' A' ' 25' ' ' LEU . 1.3 mt -106.43 94.01 4.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 109.59 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.546 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 159' ' ' ILE . 31.3 p -118.29 156.83 28.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.632 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.6 t -57.93 -35.06 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.567 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.778 ' HB2' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.873 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.87 -159.4 31.5 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.358 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -125.93 124.48 66.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.922 0.361 . . . . 0.0 111.003 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.603 HG22 ' HA2' ' A' ' 135' ' ' GLY . 24.2 pt -123.74 130.89 73.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.72 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -92.87 121.97 43.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.767 ' CD1' HD12 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -123.23 154.87 38.18 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.303 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 130.32 56.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 92.3 mt -103.79 134.1 47.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.769 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.721 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 82.7 m-85 -77.18 98.46 5.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.613 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 39.9 p-90 -82.26 20.42 1.05 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -100.27 -68.98 0.79 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.5 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.34 18.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.139 179.347 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.76 1.01 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.6 Cg_exo -40.26 -40.02 2.81 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.296 1.998 . . . . 0.0 113.226 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.85 -53.75 54.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.561 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 m -70.81 -35.48 72.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.831 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 68.5 m -56.69 -53.59 56.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.539 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -44.02 96.46 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.369 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -55.47 -44.83 76.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -60.51 -58.05 10.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.239 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.77 96.63 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.609 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.625 ' HG2' HG21 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -56.86 -47.11 81.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.346 -179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -39.02 88.56 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.7 -28.14 36.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.636 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -50.11 55.75 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.557 0.217 . . . . 0.0 111.171 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.457 HH11 HG22 ' A' ' 77' ' ' ILE . 12.7 ptm180 -60.68 -33.78 73.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.31 52.44 0.45 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.667 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.18 -54.27 1.91 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.383 0.135 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -47.26 62.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -60.36 114.71 3.07 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.35 -26.86 3.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.675 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.674 HG23 HD12 ' A' ' 159' ' ' ILE . 14.2 t -72.67 -175.58 1.71 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.558 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -165.75 144.9 6.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.723 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -61.92 112.94 2.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.719 0.295 . . . . 0.0 110.716 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -88.29 -55.07 3.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.357 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 113.43 22.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.219 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.666 ' HA ' HG22 ' A' ' 62' ' ' ILE . 13.2 mm -120.21 84.89 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -91.76 90.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -62.8 153.08 34.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 t0 68.27 26.79 6.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.165 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -163.59 -85.27 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.507 ' HB3' HG23 ' A' ' 115' ' ' THR . 0.0 OUTLIER -160.24 169.59 22.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.421 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.666 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.9 pt -143.12 132.9 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 2.7 pt20 -118.19 150.46 39.37 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.325 0.583 . . . . 0.0 112.245 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.47 115.9 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.462 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.359 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.293 -179.115 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 t -84.01 -175.69 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.625 HG21 ' HG2' ' A' ' 41' ' ' GLU . 42.2 pt -71.8 -38.43 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.505 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -81.31 -31.22 33.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.196 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.27 -152.79 23.98 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -92.9 -45.52 7.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.324 . . . . 0.0 110.482 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.5 162.7 30.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.734 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.64 164.95 19.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.015 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -68.44 -178.12 1.05 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.434 ' OD1' HG21 ' A' ' 127' ' ' THR . 1.4 t70 -114.28 156.64 24.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.423 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.77 97.09 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.29 145.12 47.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -154.44 122.99 3.02 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.503 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.95 87.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.059 2.506 . . . . 0.0 112.867 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . 1.1 t70 -160.5 33.16 0.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.968 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD22 HG21 ' A' ' 128' ' ' ILE . 1.2 mp -143.02 -176.25 4.83 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.325 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptt -120.16 148.24 43.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.851 0.358 . . . . 0.0 111.512 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.524 ' CE2' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -136.9 79.82 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 179.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -31.01 49.19 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.323 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 112.77 -64.75 0.27 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.46 101.96 0.64 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.629 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.439 ' N ' HD12 ' A' ' 136' ' ' ILE . . . 83.25 69.92 1.37 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.977 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 96' ' ' GLY . 27.1 mm -132.62 137.09 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.654 0.227 . . . . 0.0 111.149 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.5 HD13 HG22 ' A' ' 132' ' ' VAL . 1.7 tp -112.73 94.93 5.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . 0.774 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -111.58 144.16 41.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.203 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 122.68 26.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.342 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.0 166.08 21.14 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.402 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -146.88 142.28 27.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.324 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.48 -40.99 18.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.394 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.55 179.79 34.9 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.619 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.73 122.57 11.21 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.552 2.168 . . . . 0.0 111.821 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.99 28.77 18.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.937 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.1 m -137.22 80.09 1.79 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 110.632 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -102.71 163.06 12.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.642 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.4 -127.46 2.77 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.6 m -135.71 41.3 2.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.953 0.406 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -108.48 161.31 15.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.74 161.35 42.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.774 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 24.3 p90 -137.52 130.45 30.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 111.298 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.521 HG13 HG21 ' A' ' 132' ' ' VAL . 10.9 t -101.2 107.77 22.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.085 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -79.78 138.94 37.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.522 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 pp -114.77 -17.88 11.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.553 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.602 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -112.99 162.96 19.3 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.483 0.182 . . . . 0.0 111.02 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.602 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 52.5 Cg_endo -68.52 122.64 9.63 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 112.762 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.537 ' CB ' HD12 ' A' ' 122' ' ' LEU . 77.9 p -147.15 70.23 1.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.827 0.346 . . . . 0.0 111.465 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.77 -38.81 92.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.903 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -62.47 -26.62 68.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.399 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.537 HD12 ' CB ' ' A' ' 119' ' ' THR . 2.1 mt -64.53 -16.44 62.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.586 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.89 81.98 0.2 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 110.0 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 169.6 -45.19 0.21 Allowed Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.358 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -70.73 -45.65 64.49 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.512 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -114.6 136.4 53.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.734 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 11.0 t -80.12 162.6 24.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.915 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.585 HG21 HD22 ' A' ' 90' ' ' LEU . 1.1 tt -87.85 -179.44 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.673 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -178.78 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.79 -179.71 27.67 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.76 161.72 33.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.822 0.344 . . . . 0.0 111.062 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.521 HG21 HG13 ' A' ' 114' ' ' VAL . 13.9 t -114.89 87.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.7 t -84.97 -36.4 21.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.52 101.27 3.85 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.016 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 158.81 -21.96 0.31 Allowed Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.343 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.7 tt -50.72 -30.88 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.988 0.394 . . . . 0.0 111.503 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.32 -13.83 63.24 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . 0.471 ' O ' HG23 ' A' ' 142' ' ' VAL . 4.8 ttp -97.35 -32.65 11.77 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.919 0.36 . . . . 0.0 111.077 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.503 HG21 HG11 ' A' ' 114' ' ' VAL . 3.0 m -81.03 -30.74 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -79.29 -33.82 42.98 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.394 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -64.78 -29.56 70.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 145' ' ' VAL . 19.8 t -56.91 -34.94 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.705 0.288 . . . . 0.0 110.895 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.23 -30.82 24.26 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.565 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.1 mtt -61.43 -27.38 68.51 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 145' ' ' VAL . 13.2 p -82.82 33.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 62.38 171.36 0.13 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.018 0.437 . . . . 0.0 111.529 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -147.33 172.4 13.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 1.4 m-20 -85.06 -176.48 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.8 p -90.52 34.46 0.89 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.409 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -164.53 36.83 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.897 0.379 . . . . 0.0 110.774 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.61 57.83 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.088 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.2 OUTLIER -126.66 133.74 25.33 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 133.84 23.28 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.518 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.57 -35.26 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.809 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 -173.4 4.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.6 104.4 13.09 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.228 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' A' ' 20' ' ' MET . 9.2 p -119.8 122.13 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -156.3 162.54 40.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.243 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.68 ' HA ' HG22 ' A' ' 18' ' ' THR . 24.3 mt -97.26 129.36 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.803 0.335 . . . . 0.0 111.245 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 26.7 pt -111.94 -36.53 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.042 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -145.24 150.52 36.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -157.51 88.71 1.01 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.122 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -126.3 153.76 74.63 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.851 0.358 . . . . 0.0 111.621 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.22 140.65 14.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 112.382 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.86 152.78 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.072 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.536 179.584 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.561 0.219 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.72 92.53 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.679 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -110.01 132.02 54.54 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.96 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 5' ' ' PRO . 1.3 pt -94.63 99.41 4.01 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.769 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 4' ' ' ILE . 1.9 Cg_endo -45.06 -55.21 3.58 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.867 2.378 . . . . 0.0 112.849 -179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD3' ' HG2' ' A' ' 5' ' ' PRO . 58.5 Cg_endo -71.07 162.38 42.85 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.185 1.923 . . . . 0.0 112.111 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -145.59 169.03 19.21 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.112 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.2 p -139.16 126.71 21.77 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -99.08 -60.64 1.49 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 63.1 109.21 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.214 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -64.53 110.69 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.622 2.215 . . . . 0.0 112.198 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -85.84 12.78 2.93 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.748 2.298 . . . . 0.0 113.446 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.36 145.93 41.18 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.738 0.304 . . . . 0.0 110.97 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.7 t -122.31 138.18 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.4 ' CE1' HG22 ' A' ' 24' ' ' VAL . 2.2 m-85 -110.93 104.12 12.68 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.254 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.461 HD12 ' CD1' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -93.29 102.22 14.49 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.642 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' HG2' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -79.9 83.35 5.83 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.728 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -91.39 148.65 22.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.977 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.1 t -58.16 -33.92 69.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.954 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.519 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.42 -41.27 85.14 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.815 0.341 . . . . 0.0 110.569 179.298 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.04 154.45 9.04 Favored Glycine 0 C--N 1.334 0.433 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.145 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.436 HD13 ' HG2' ' A' ' 17' ' ' GLU . 5.7 tp -80.27 136.24 23.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 111.46 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.624 HG22 ' HA2' ' A' ' 135' ' ' GLY . 9.1 pt -144.44 137.06 22.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.442 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 15' ' ' TYR . 16.6 t -94.84 143.08 12.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.84 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.62 HD22 HD22 ' A' ' 98' ' ' LEU . 2.0 mt -124.92 163.68 21.74 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.33 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -123.11 114.2 20.01 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.783 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.48 142.9 27.28 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.541 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 17.2 m-85 -92.32 97.24 10.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.798 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -78.81 14.83 1.21 Allowed 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 -66.51 0.9 Allowed 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.847 0.356 . . . . 0.0 110.324 179.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.501 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 2.9 m80 -100.67 -15.38 17.75 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.29 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.697 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.45 1.15 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.333 1.234 . . . . 0.0 114.333 -179.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.667 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 61.7 Cg_exo -39.48 -35.63 0.87 Allowed 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 122.198 1.932 . . . . 0.0 113.33 -179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -63.71 -63.26 1.22 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.773 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.431 HG21 ' HB2' ' A' ' 129' ' ' PHE . 5.9 t -65.65 -36.1 82.7 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.684 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.2 t -55.22 -50.97 68.06 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.469 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.5 mtmt -58.98 -40.29 84.37 Favored 'General case' 0 N--CA 1.461 0.076 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.583 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.33 -51.22 64.5 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.845 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.87 -43.1 90.8 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.039 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.79 72.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.124 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.9 mm-40 -63.85 -50.31 69.34 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.146 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.85 -37.83 71.84 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.0 -31.98 56.88 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.011 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 35.3 ttt-85 -75.57 -48.06 24.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.264 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.72 -28.78 67.64 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.823 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 104.06 45.6 1.46 Allowed Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.887 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -102.03 -45.87 5.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.583 0.23 . . . . 0.0 110.667 179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -68.25 -30.65 69.73 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.221 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -59.31 113.36 2.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.059 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.84 -18.61 26.5 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.987 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 52' ' ' LYS . 0.2 OUTLIER -83.45 175.23 9.97 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.744 0.307 . . . . 0.0 110.926 -179.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.442 ' H ' HG22 ' A' ' 51' ' ' THR . 33.4 pttt -154.51 173.21 16.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.488 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -84.49 120.72 26.65 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.131 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -98.62 -30.48 12.46 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.498 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.5 123.96 46.39 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.614 0.245 . . . . 0.0 110.627 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.923 HD12 ' HB3' ' A' ' 153' ' ' PRO . 55.5 mt -145.79 100.14 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.835 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.0 mt -90.81 118.59 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.586 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 0.2 OUTLIER -56.46 123.84 16.11 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.191 -179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.422 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 6.5 t70 59.07 50.22 8.44 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.155 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -157.73 -84.61 0.05 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.394 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.78 171.41 18.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.848 0.356 . . . . 0.0 111.348 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.699 HG22 HG23 ' A' ' 56' ' ' ILE . 1.8 pp -141.02 114.59 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.753 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.6 tt0 -93.75 134.79 35.71 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.925 0.393 . . . . 0.0 111.617 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.42 ' HA3' ' CE1' ' A' ' 112' ' ' PHE . . . -94.06 152.33 20.65 Favored Glycine 0 C--N 1.334 0.444 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.571 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -80.89 178.54 53.98 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.018 -0.61 . . . . 0.0 113.165 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 5.0 t0 -174.87 -58.54 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 115.734 -0.233 . . . . 0.0 110.995 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 73.6 Cg_endo -76.26 63.72 7.05 Favored 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 122.412 2.074 . . . . 0.0 111.781 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.475 ' O ' HG22 ' A' ' 68' ' ' THR . 12.4 m 65.5 12.62 8.31 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.535 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.418 ' O ' HG23 ' A' ' 70' ' ' THR . . . 57.83 13.75 14.09 Favored Glycine 0 C--N 1.34 0.804 0 C-N-CA 121.209 -0.52 . . . . 0.0 113.777 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 69' ' ' GLY . 5.9 p -156.31 22.24 0.36 Allowed 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 117.196 0.498 . . . . 0.0 111.731 -179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 53.9 30.76 45.91 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.222 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.14 -55.0 4.26 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.692 0.282 . . . . 0.0 110.7 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -141.18 94.43 0.19 Allowed Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.14 -0.552 . . . . 0.0 112.176 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -145.45 132.13 4.49 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.587 -179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.09 142.8 24.62 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.878 0.37 . . . . 0.0 111.463 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.3 t -81.18 157.38 25.28 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.847 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.9 pt -58.44 -36.64 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.372 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -76.63 -31.41 57.37 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.118 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.48 -155.71 27.22 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.567 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -78.36 -55.48 5.2 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.674 0.273 . . . . 0.0 110.792 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -135.18 146.15 48.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.808 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -133.14 179.48 6.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.127 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -77.91 134.12 37.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.545 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -52.89 137.09 33.13 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.281 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -94.54 40.58 1.09 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.262 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.59 ' HA ' HG23 ' A' ' 127' ' ' THR . 4.8 tp -80.14 133.69 36.09 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.614 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -150.39 118.08 3.53 Favored Pre-proline 0 C--N 1.332 -0.169 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.694 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.92 101.61 0.07 OUTLIER 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.659 2.239 . . . . 0.0 112.336 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.28 -46.02 0.02 OUTLIER 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.069 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.931 ' HB3' HD13 ' A' ' 128' ' ' ILE . 2.8 mm? -86.74 177.25 7.38 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.45 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.412 ' HG2' HG22 ' A' ' 93' ' ' THR . 6.2 tttt -149.79 150.46 32.04 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.751 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 92' ' ' PHE . 0.3 OUTLIER -112.99 61.34 0.64 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.226 -179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.412 HG22 ' HG2' ' A' ' 91' ' ' LYS . 15.0 t -126.11 -46.59 1.66 Allowed 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 111.992 0.367 . . . . 0.0 111.992 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -61.98 112.3 4.71 Favored Glycine 0 C--O 1.228 -0.241 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.89 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.441 ' O ' HD12 ' A' ' 136' ' ' ILE . . . -45.32 120.37 2.45 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.561 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 105.64 64.93 0.65 Allowed Glycine 0 C--N 1.334 0.465 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.089 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 114' ' ' VAL . 7.3 mm -133.4 157.05 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.807 0.304 . . . . 0.0 111.382 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.62 HD22 HD22 ' A' ' 25' ' ' LEU . 1.6 tp -118.89 101.16 7.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.784 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.662 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -104.8 141.12 37.07 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.232 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.46 127.95 32.76 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.736 0.303 . . . . 0.0 110.602 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.51 145.95 31.58 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.854 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -130.48 177.25 7.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -121.83 -51.91 2.01 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.383 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.85 -179.45 34.66 Favored Glycine 0 CA--C 1.517 0.2 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.473 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -50.96 117.28 3.22 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.643 2.229 . . . . 0.0 112.052 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 61.64 31.13 18.75 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.993 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -138.26 94.89 2.92 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.458 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -111.7 150.08 30.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.935 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.08 -146.11 12.15 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.52 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.2 m -130.29 26.45 5.13 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.671 0.272 . . . . 0.0 111.474 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -90.5 165.44 13.79 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.745 0.307 . . . . 0.0 110.961 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CE1' ' HA3' ' A' ' 64' ' ' GLY . 9.5 p90 -154.25 127.31 8.33 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.785 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 26.6 p90 -124.55 135.1 52.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.356 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 97' ' ' ILE . 10.0 p -108.2 121.58 61.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.727 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 75.7 p -80.43 119.05 22.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.25 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.488 ' C ' HD12 ' A' ' 116' ' ' LEU . 4.6 pp -97.94 -7.87 29.23 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.826 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -135.65 148.4 65.44 Favored Pre-proline 0 C--O 1.232 0.172 0 CA-C-O 120.465 0.174 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.82 132.61 50.39 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.889 2.393 . . . . 0.0 112.341 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.446 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.0 p -144.98 107.59 4.43 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 120.825 0.345 . . . . 0.0 111.418 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -96.67 -30.39 13.27 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.462 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.446 ' CZ2' HG22 ' A' ' 119' ' ' THR . 22.0 p90 -61.12 -40.87 95.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.687 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 pp -92.59 0.43 57.43 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.82 81.21 0.02 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.967 0.413 . . . . 0.0 110.885 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.03 -23.68 2.42 Favored Glycine 0 CA--C 1.521 0.465 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.809 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -57.03 -56.28 23.86 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.58 0.228 . . . . 0.0 111.295 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -98.24 179.14 4.84 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.889 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.662 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 25.4 m -107.96 158.67 17.16 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.769 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.931 HD13 ' HB3' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -90.29 -179.01 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.511 179.376 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.483 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -177.45 -40.36 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -149.35 179.98 25.7 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.817 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.4 ttt180 -136.9 158.59 44.1 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.661 0.267 . . . . 0.0 111.161 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.512 ' CG2' HD13 ' A' ' 98' ' ' LEU . 19.5 t -118.18 84.12 0.79 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.138 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -77.41 -56.66 4.36 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.423 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -109.01 93.1 4.33 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.068 -0.515 . . . . 0.0 109.888 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.624 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 159.57 -22.48 0.28 Allowed Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.233 -179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.441 HD12 ' O ' ' A' ' 95' ' ' ALA . 10.5 tt -46.47 -34.41 2.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.51 -45.52 96.12 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.404 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.588 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.1 OUTLIER -62.31 -33.77 75.32 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.72 0.295 . . . . 0.0 110.615 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.464 HG11 ' CG1' ' A' ' 114' ' ' VAL . 21.1 t -76.22 -35.08 27.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.806 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -55.1 -51.55 66.03 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.84 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.805 ' O ' HG13 ' A' ' 145' ' ' VAL . 16.8 ptp180 -57.64 -37.3 73.11 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.015 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.598 ' O ' HG22 ' A' ' 145' ' ' VAL . 38.0 t -59.75 -28.45 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.102 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.63 -30.98 13.91 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.144 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.6 mtt -76.62 -24.28 53.37 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 141' ' ' ARG . 33.6 m -60.53 176.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-O 120.866 0.365 . . . . 0.0 111.782 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.31 130.44 37.17 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.889 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.5 p -119.83 172.95 7.34 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.617 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.418 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 3.8 t-20 -82.97 -171.03 3.33 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.511 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.1 m -92.17 28.21 1.96 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.699 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -155.36 -72.14 0.12 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.67 0.271 . . . . 0.0 110.352 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -172.84 41.83 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.035 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.418 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.0 OUTLIER -116.18 123.85 30.36 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.443 -179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.923 ' HB3' HD12 ' A' ' 56' ' ' ILE . 41.8 Cg_endo -69.16 119.65 6.61 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.735 2.29 . . . . 0.0 112.425 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 29.7 t -73.43 -32.95 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 CA-C-O 120.769 0.319 . . . . 0.0 110.496 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -79.88 -167.11 1.15 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.552 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -118.52 112.94 20.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 120.921 0.391 . . . . 0.0 111.451 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.519 HG13 ' HB2' ' A' ' 20' ' ' MET . 36.9 t -133.55 126.5 51.85 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.123 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.341 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -159.75 174.05 15.1 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.795 0.331 . . . . 0.0 111.607 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 7.9 mt -108.08 135.78 45.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 5.0 pt -107.31 -33.32 2.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.493 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -170.59 159.32 6.68 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.71 0.29 . . . . 0.0 110.903 179.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -148.95 135.24 19.31 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.315 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -151.95 144.68 16.98 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.151 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -79.59 152.56 22.95 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.364 2.042 . . . . 0.0 112.162 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.3 m -63.07 150.94 41.36 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.997 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.375 -179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.1 mtt . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 120.594 0.235 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.03 145.73 49.77 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.201 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 62.69 14.51 7.28 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.031 -179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.2 mt -149.13 63.94 7.07 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-O 120.522 0.201 . . . . 0.0 110.666 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.63 107.58 0.22 Allowed 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.659 2.24 . . . . 0.0 112.328 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -81.05 95.65 0.96 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.772 2.315 . . . . 0.0 112.553 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t70 69.47 152.94 0.1 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.324 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.3 m -117.22 134.92 54.22 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.847 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.4 m95 -166.36 118.48 1.02 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.143 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 35.9 mm-40 -135.26 92.82 17.44 Favored Pre-proline 0 C--O 1.233 0.19 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.693 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -47.86 104.3 0.07 OUTLIER 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.914 2.409 . . . . 0.0 112.534 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.45 -51.56 1.0 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.954 2.436 . . . . 0.0 112.406 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -112.16 176.84 4.85 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.048 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.615 HG13 ' HA ' ' A' ' 164' ' ' PRO . 39.2 t -143.44 129.87 16.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -93.72 101.5 13.63 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.704 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.566 HD21 ' CE2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -87.91 90.87 8.55 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.155 -179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.17 101.39 9.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.208 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 159' ' ' ILE . 1.2 p -110.0 165.18 11.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.248 -179.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.84 -33.01 71.72 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.666 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -71.04 -32.75 69.57 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 179.313 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.5 -145.44 8.02 Favored Glycine 0 C--N 1.335 0.514 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.447 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 17.2 tt -143.22 130.01 17.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.697 0.284 . . . . 0.0 111.228 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.511 HG22 ' CA ' ' A' ' 135' ' ' GLY . 33.4 pt -134.26 134.11 55.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.964 0.412 . . . . 0.0 111.63 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.17 117.22 43.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.623 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.504 HD13 HD12 ' A' ' 16' ' ' LEU . 7.1 mp -98.1 148.31 23.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.272 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -117.13 100.82 7.98 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.581 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.554 HD13 ' SG ' ' A' ' 36' ' ' CYS . 37.5 mt -83.13 137.54 34.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.493 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.558 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 26.3 m-85 -71.08 98.15 1.6 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.961 0.41 . . . . 0.0 110.818 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.431 ' CE3' ' HD2' ' A' ' 30' ' ' LYS . 2.2 p-90 -79.05 11.51 2.72 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.494 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.431 ' HD2' ' CE3' ' A' ' 29' ' ' TRP . 0.3 OUTLIER -100.41 -69.36 0.77 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.683 0.278 . . . . 0.0 110.851 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.516 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.3 OUTLIER -100.75 -17.0 17.14 Favored 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 179.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.655 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -96.87 1.06 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.655 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.8 Cg_exo -42.0 -35.57 3.23 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 121.937 1.758 . . . . 0.0 112.875 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -59.27 -59.54 5.29 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.686 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 52.1 p -64.19 -34.38 77.95 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.569 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.554 ' SG ' HD13 ' A' ' 27' ' ' LEU . 19.3 t -57.15 -47.61 80.76 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.547 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.9 ttpp -61.14 -40.82 95.26 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.646 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -61.37 -41.46 97.13 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.748 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.56 -38.6 74.14 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.95 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -58.95 -53.71 55.35 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.815 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.52 ' HB3' HG21 ' A' ' 77' ' ' ILE . 27.4 mt-10 -64.94 -32.62 74.43 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.8 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD12 ' OD1' ' A' ' 66' ' ' ASP . 0.4 OUTLIER -54.79 -43.84 73.2 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.681 0.277 . . . . 0.0 110.558 179.35 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -81.52 -31.81 32.61 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.199 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -49.14 66.65 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.558 ' HD2' HG22 ' A' ' 77' ' ' ILE . 36.4 mtp85 -59.58 -31.92 69.9 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.572 -0.286 . . . . 0.0 111.58 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.09 28.61 3.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.759 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -97.67 -31.25 12.37 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.607 0.241 . . . . 0.0 110.823 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.566 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -81.77 -57.34 3.48 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.065 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -63.51 124.9 22.54 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 120.816 0.341 . . . . 0.0 110.453 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.75 -29.79 6.99 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.542 -179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.607 ' HB ' HD12 ' A' ' 159' ' ' ILE . 1.6 m -61.94 162.64 8.79 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 120.775 0.322 . . . . 0.0 111.256 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.417 ' O ' ' HD2' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -136.54 33.76 2.73 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.069 -179.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.609 ' HE2' HD12 ' A' ' 62' ' ' ILE . 9.2 m-85 59.86 179.09 0.09 Allowed 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.637 0.256 . . . . 0.0 111.203 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -145.11 -70.96 0.27 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.601 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.528 ' O ' HD13 ' A' ' 56' ' ' ILE . 3.8 tpt180 -95.9 130.01 42.99 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.849 0.357 . . . . 0.0 111.208 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.759 HG21 HG12 ' A' ' 142' ' ' VAL . 27.1 mm -133.07 92.15 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.961 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.554 HD12 ' HE2' ' A' ' 61' ' ' MET . 7.3 mt -95.3 117.17 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.149 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -76.05 150.32 37.34 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.142 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 61.89 31.2 18.28 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.404 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -160.41 -88.49 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.088 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.554 ' HE2' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.29 170.13 21.73 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.702 0.287 . . . . 0.0 111.408 -179.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.655 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.0 OUTLIER -140.82 125.45 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.328 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.524 ' HG3' ' HE3' ' A' ' 61' ' ' MET . 3.0 mt-30 -94.1 157.0 16.29 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.052 0.454 . . . . 0.0 111.496 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.63 153.44 19.96 Favored Glycine 0 C--N 1.331 0.263 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.55 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.62 171.07 49.04 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.139 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.491 ' OD1' HD12 ' A' ' 42' ' ' LEU . 0.4 OUTLIER -160.6 -64.71 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 115.651 -0.274 . . . . 0.0 110.714 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.443 ' HD3' ' CB ' ' A' ' 66' ' ' ASP . 86.4 Cg_endo -77.8 163.26 29.02 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.448 2.098 . . . . 0.0 112.888 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.442 HG22 ' HA2' ' A' ' 71' ' ' GLY . 4.6 m 57.29 37.59 28.24 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.244 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.2 -32.91 77.9 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.614 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.8 p -85.68 -34.09 21.38 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.606 0.241 . . . . 0.0 111.233 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.442 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 94.89 60.35 1.08 Allowed Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.328 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -165.21 -52.23 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.485 0.183 . . . . 0.0 111.147 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -111.56 140.79 16.3 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.734 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -127.11 87.16 0.33 Allowed Glycine 0 C--N 1.335 0.508 0 C-N-CA 121.135 -0.555 . . . . 0.0 112.554 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.73 156.7 41.83 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.593 0.235 . . . . 0.0 111.222 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.2 p -104.88 164.96 11.4 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.076 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.558 HG22 ' HD2' ' A' ' 45' ' ' ARG . 2.5 pp -66.06 -33.02 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.496 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -75.91 -30.66 58.86 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.356 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 167.38 -140.68 6.41 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.749 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.24 76.28 1.37 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.98 0.419 . . . . 0.0 110.475 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HB3' HG22 ' A' ' 107' ' ' THR . 54.9 mm-40 70.8 135.63 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.919 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -145.41 -175.36 4.68 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.181 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -67.83 -179.62 1.21 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.867 0.365 . . . . 0.0 110.661 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -105.28 141.63 36.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.863 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -78.19 109.76 12.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.156 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.7 tp -156.33 134.24 11.14 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.407 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -171.99 -62.39 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.296 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.33 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -73.1 151.95 50.31 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.526 2.151 . . . . 0.0 112.355 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -73.03 89.57 1.46 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.702 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.656 HD13 HG22 ' A' ' 128' ' ' ILE . 0.9 OUTLIER -78.24 -178.29 5.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.149 -179.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.6 tptt -115.4 155.14 27.95 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-O 120.931 0.396 . . . . 0.0 111.083 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.83 83.98 1.46 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.741 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.5 p -69.52 -34.82 74.82 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.372 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.91 6.17 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.662 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -101.87 117.23 34.41 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.808 0.304 . . . . 0.0 111.232 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.781 ' HA3' HD12 ' A' ' 136' ' ' ILE . . . 67.09 59.89 6.52 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 121.228 -0.51 . . . . 0.0 112.741 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.587 HD13 ' O ' ' A' ' 96' ' ' GLY . 19.1 mm -140.32 144.73 27.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.565 0.221 . . . . 0.0 110.78 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.747 HD23 HG22 ' A' ' 114' ' ' VAL . 1.1 mt -116.49 127.4 54.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.906 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.798 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -127.64 142.62 51.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.339 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 104.28 10.36 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.493 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.02 179.49 5.31 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.244 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -157.86 176.51 12.48 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.443 -179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.28 14.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.578 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -153.06 149.94 21.61 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.71 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -50.67 141.64 34.06 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.883 2.389 . . . . 0.0 112.663 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 63.21 23.22 13.75 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.408 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.421 HG22 ' HB3' ' A' ' 81' ' ' GLN . 0.2 OUTLIER -152.19 80.5 1.25 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-O 120.948 0.404 . . . . 0.0 110.673 179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -98.19 113.07 24.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.816 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.53 -107.38 0.17 Allowed Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.241 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 66' ' ' ASP . 1.6 m -149.44 25.43 0.87 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -90.64 163.82 14.4 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.812 0.339 . . . . 0.0 111.237 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -151.93 175.66 12.26 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.798 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 15.7 p90 -152.7 124.06 7.67 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.931 0.396 . . . . 0.0 111.43 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.747 HG22 HD23 ' A' ' 98' ' ' LEU . 5.6 t -89.65 111.95 23.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.058 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.4 ' OG1' ' HB ' ' A' ' 97' ' ' ILE . 81.9 p -79.68 120.67 24.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.416 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.55 -25.29 12.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.336 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.77 156.4 40.73 Favored Pre-proline 0 CA--C 1.531 0.248 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.095 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -50.4 130.82 30.36 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.016 2.478 . . . . 0.0 113.043 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.3 p -148.41 62.95 1.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.075 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -83.4 -14.7 52.11 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.73 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.8 p90 -90.77 -25.92 19.73 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 120.68 0.276 . . . . 0.0 111.29 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.0 mt -80.22 1.25 29.12 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.762 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -68.76 79.52 0.29 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.333 0.587 . . . . 0.0 111.381 -179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 173.23 -37.71 0.14 Allowed Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.677 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.0 mttt -67.77 -54.9 15.58 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 120.664 0.268 . . . . 0.0 110.97 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -109.86 138.35 46.36 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.73 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.749 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 3.6 t -84.56 157.74 21.14 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.95 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.656 HG22 HD13 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -79.72 -179.63 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.724 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.512 ' HE1' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -170.46 -42.9 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.186 179.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -147.72 177.97 25.64 Favored Glycine 0 C--N 1.336 0.569 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.728 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.17 153.95 42.64 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.612 0.244 . . . . 0.0 110.885 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 132' ' ' VAL . 13.8 p -109.71 107.12 22.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 121.097 0.475 . . . . 0.0 111.408 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.67 -46.0 7.45 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -123.45 84.27 2.25 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.873 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.511 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 169.62 -23.98 0.1 OUTLIER Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.583 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.781 HD12 ' HA3' ' A' ' 96' ' ' GLY . 15.8 tt -41.34 -37.34 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.16 -43.7 96.91 Favored Glycine 0 C--N 1.336 0.577 0 C-N-CA 121.173 -0.537 . . . . 0.0 112.602 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 2.8 ttp -65.67 -39.56 91.48 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.716 0.293 . . . . 0.0 110.549 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.414 HG11 HG11 ' A' ' 114' ' ' VAL . 21.5 t -65.02 -40.49 89.23 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.888 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -61.41 -32.21 72.15 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.909 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.51 -33.56 71.5 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.964 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.759 HG12 HG21 ' A' ' 56' ' ' ILE . 19.8 t -57.85 -30.56 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.03 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -89.7 -31.88 10.79 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.234 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.5 mmt -58.52 -36.01 73.17 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.511 0.196 . . . . 0.0 111.358 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 142' ' ' VAL . 30.2 m -64.23 176.12 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 111.563 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.414 ' HB3' ' CG2' ' A' ' 154' ' ' VAL . 0.2 OUTLIER -81.68 172.24 13.65 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.057 0.456 . . . . 0.0 111.005 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.22 171.49 15.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.29 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -105.29 -171.1 1.85 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.84 179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.6 p -95.21 30.28 2.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.375 179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -152.65 32.07 0.51 Allowed 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.919 0.39 . . . . 0.0 110.628 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.4 t0 55.47 68.76 0.82 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.816 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -150.72 114.48 3.22 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.737 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.403 ' HG3' HG13 ' A' ' 56' ' ' ILE . 56.0 Cg_endo -71.3 152.4 61.16 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.474 2.116 . . . . 0.0 112.056 179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.414 ' CG2' ' HB3' ' A' ' 146' ' ' GLU . 36.2 t -69.89 -37.98 74.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.41 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -117.35 80.6 1.52 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.351 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -53.86 148.25 10.66 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.59 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.666 HG13 ' HB2' ' A' ' 20' ' ' MET . 8.3 t -82.71 141.24 15.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.147 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -126.15 152.73 45.58 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.741 0.305 . . . . 0.0 111.384 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.607 HD12 ' HB ' ' A' ' 51' ' ' THR . 6.7 mt -115.05 140.85 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 25.1 pt -120.14 -37.8 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 116.292 -0.413 . . . . 0.0 112.051 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -142.53 165.1 28.34 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.962 0.41 . . . . 0.0 111.472 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.452 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -156.53 87.31 1.02 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.673 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -100.86 106.53 44.58 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.166 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.615 ' HA ' HG13 ' A' ' 14' ' ' VAL . 72.3 Cg_endo -79.74 93.23 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.656 2.237 . . . . 0.0 112.132 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.5 m -150.65 164.74 35.36 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.206 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.275 -1.291 . . . . 0.0 112.842 179.752 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.658 0.266 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.03 155.57 21.05 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.14 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.63 62.77 0.72 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.366 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.552 HG23 ' O ' ' A' ' 4' ' ' ILE . 2.2 tt -173.66 87.85 0.37 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-O 120.992 0.425 . . . . 0.0 111.576 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.472 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 44.2 Cg_exo -55.36 -49.0 17.68 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.662 2.241 . . . . 0.0 113.042 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 5' ' ' PRO . 94.9 Cg_endo -79.98 133.05 9.86 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.473 2.115 . . . . 0.0 112.404 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -119.83 169.78 9.83 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.348 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.82 157.06 17.58 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.081 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -129.89 -51.29 1.14 Allowed 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.277 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -115.63 143.54 30.79 Favored Pre-proline 0 N--CA 1.463 0.187 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.719 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.66 109.55 0.44 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.817 2.345 . . . . 0.0 112.569 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.42 -17.23 30.65 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 122.623 2.216 . . . . 0.0 112.841 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.43 158.64 16.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 120.707 0.289 . . . . 0.0 111.213 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 164' ' ' PRO . 23.7 m -141.24 135.9 32.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.981 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -92.54 113.14 25.33 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.62 HD12 HD13 ' A' ' 25' ' ' LEU . 3.2 mt -97.86 96.14 8.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.845 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.647 ' HG2' HD12 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -83.39 113.67 20.9 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.722 179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.755 ' CG2' HG23 ' A' ' 159' ' ' ILE . 0.7 OUTLIER -125.81 156.16 39.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.949 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.5 t -59.07 -33.55 70.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.07 178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.628 ' HB2' HG13 ' A' ' 157' ' ' VAL . 8.0 tpt -69.97 -30.86 68.31 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.191 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 163.13 -161.54 34.03 Favored Glycine 0 C--N 1.335 0.522 0 N-CA-C 111.922 -0.471 . . . . 0.0 111.922 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.647 HD12 ' HG2' ' A' ' 17' ' ' GLU . 2.1 tt -122.3 128.13 75.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 117.105 0.452 . . . . 0.0 111.202 179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.442 HG22 ' CA ' ' A' ' 135' ' ' GLY . 16.3 pt -129.49 127.59 65.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 121.047 0.451 . . . . 0.0 111.898 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 25.5 t -101.49 121.08 51.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.375 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.729 HD22 HD22 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -127.9 157.96 39.09 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.222 -179.415 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -102.8 150.61 23.31 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.847 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.7 mp -118.73 135.75 54.33 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.886 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.775 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 44.6 m-85 -76.69 95.04 3.89 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.725 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 60.4 p-90 -78.86 11.35 2.69 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.32 -61.87 1.31 Allowed 'General case' 0 N--CA 1.463 0.191 0 O-C-N 122.179 -0.325 . . . . 0.0 110.957 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.515 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 21.0 m170 -100.6 -15.02 17.93 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.775 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.41 1.31 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 -179.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.663 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 58.8 Cg_exo -38.96 -38.15 1.01 Allowed 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.353 2.036 . . . . 0.0 113.156 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 11.5 tptm -61.36 -57.97 10.13 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.578 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.49 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -67.2 -35.22 79.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.752 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.2 m -55.2 -51.6 66.02 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.425 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -39.4 89.48 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.547 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -58.4 -50.77 72.48 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.745 179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -60.75 -47.96 83.96 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.555 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -61.32 -47.35 86.33 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.073 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -38.79 92.21 Favored 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.453 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.39 -60.42 3.81 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.586 0.232 . . . . 0.0 111.381 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.54 -41.35 98.45 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.679 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.41 -48.6 72.28 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.327 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 29.6 ttm-85 -61.8 -55.54 28.96 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.199 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 141.49 43.16 0.06 OUTLIER Glycine 0 C--N 1.335 0.473 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.243 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.44 -45.75 2.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.781 0.324 . . . . 0.0 110.566 179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -74.06 -24.58 59.53 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.113 179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -74.88 102.47 4.75 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.55 26.95 4.59 Favored Glycine 0 CA--C 1.522 0.469 0 C-N-CA 120.873 -0.679 . . . . 0.0 113.32 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.487 ' OG1' HD12 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -89.4 178.08 6.41 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 117.04 0.42 . . . . 0.0 110.952 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.1 ttpp -157.02 134.8 10.87 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.954 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' CD2' HG22 ' A' ' 62' ' ' ILE . 28.3 m-85 -69.3 124.09 22.92 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.11 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -100.73 -32.19 10.83 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.014 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.457 ' HB3' ' NE2' ' A' ' 63' ' ' GLN . 0.3 OUTLIER -119.31 119.8 35.08 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 120.81 0.338 . . . . 0.0 111.228 -179.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.609 HG12 HG23 ' A' ' 62' ' ' ILE . 29.0 mt -135.13 94.54 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.668 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 34.3 mt -83.35 108.8 16.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 55.7 tttt -63.99 145.34 56.04 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.961 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 59.36 30.77 20.53 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.321 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -152.3 -83.3 0.08 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.247 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.412 ' HB3' ' HA ' ' A' ' 115' ' ' THR . 0.4 OUTLIER -160.45 168.29 25.45 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.471 -179.482 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.609 HG23 HG12 ' A' ' 56' ' ' ILE . 3.7 mp -131.91 125.95 56.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.526 179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.519 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 1.4 pt20 -112.83 138.83 49.08 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.289 0.566 . . . . 0.0 112.348 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.48 103.86 0.63 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.379 178.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . -129.26 -179.75 16.17 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.895 -0.669 . . . . 0.0 113.277 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -114.85 73.53 3.12 Favored Pre-proline 0 CA--C 1.53 0.2 0 CA-C-O 120.858 0.361 . . . . 0.0 110.815 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.26 -1.44 11.61 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.788 2.325 . . . . 0.0 113.425 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.4 m 60.01 33.18 21.34 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 120.717 0.294 . . . . 0.0 111.148 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 59.41 24.81 59.71 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 121.226 -0.511 . . . . 0.0 113.574 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 34.4 p -125.97 -45.53 1.72 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 117.029 0.414 . . . . 0.0 111.315 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 82.45 38.19 13.0 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.195 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -177.76 -46.42 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.622 0.248 . . . . 0.0 110.881 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -90.67 97.3 2.31 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.545 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -141.69 162.53 27.0 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.698 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -138.41 155.55 48.39 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.639 0.257 . . . . 0.0 111.497 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 87.0 p -129.4 172.81 11.14 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.13 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.1 pp -61.62 -35.45 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.501 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -74.25 -33.59 63.37 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.247 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 165.72 -151.7 20.47 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.767 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -83.61 -52.09 6.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.727 0.263 . . . . 0.0 110.612 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -154.46 150.74 28.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.916 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -141.31 174.5 10.48 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.513 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -71.87 173.76 7.85 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.117 0.484 . . . . 0.0 111.594 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.8 169.45 11.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.636 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -129.74 47.06 2.55 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 11.0 tp -68.68 145.51 53.81 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -162.79 86.7 1.38 Allowed Pre-proline 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.985 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -54.99 100.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.766 2.311 . . . . 0.0 112.26 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -165.71 -44.83 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.939 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.762 HD22 HG21 ' A' ' 128' ' ' ILE . 4.9 mp -66.94 175.82 2.33 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.734 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 tttp -106.91 165.14 11.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.42 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -144.86 70.56 1.28 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.84 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.478 ' OG1' HD11 ' A' ' 97' ' ' ILE . 25.7 p -57.3 -30.34 64.66 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.703 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 102.69 -48.1 1.07 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.649 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -85.0 109.64 18.34 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.765 0.317 . . . . 0.0 111.296 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.553 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 79.03 63.85 2.01 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.784 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.553 HD13 ' O ' ' A' ' 96' ' ' GLY . 10.5 mm -131.94 152.46 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-N 116.751 0.276 . . . . 0.0 111.312 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.729 HD22 HD22 ' A' ' 25' ' ' LEU . 4.7 tp -131.28 101.7 5.67 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.878 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.702 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -110.13 144.38 38.83 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.28 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.49 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.73 106.69 11.94 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.528 179.632 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.33 151.28 23.24 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.548 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -123.09 157.39 32.95 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.165 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.47 -34.44 63.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.08 179.63 35.49 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.098 -0.572 . . . . 0.0 112.353 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.39 125.95 17.4 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.582 2.188 . . . . 0.0 112.007 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.1 30.13 19.26 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.9 m -142.6 91.03 2.27 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.368 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -96.99 155.11 16.92 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.162 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -145.32 -151.72 5.48 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.849 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 11.0 m -104.16 64.95 0.78 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.947 0.403 . . . . 0.0 111.065 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.521 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.8 OUTLIER -141.42 146.54 36.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.451 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -151.08 166.02 32.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.488 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.677 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 30.2 p90 -137.76 142.46 40.94 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 111.601 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.689 HG22 ' CD1' ' A' ' 98' ' ' LEU . 5.3 t -111.23 106.89 21.62 Favored 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.545 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.412 ' HA ' ' HB3' ' A' ' 61' ' ' MET . 3.3 p -80.32 134.78 36.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.552 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.8 pp -111.38 -27.6 8.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.47 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -104.76 151.56 39.35 Favored Pre-proline 0 C--O 1.233 0.216 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.655 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 66.0 Cg_exo -52.38 130.1 34.5 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.809 2.34 . . . . 0.0 112.484 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 4.9 t -161.07 77.72 0.57 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 111.197 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.07 -3.73 52.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.64 179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -89.54 -27.22 20.42 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.719 -0.219 . . . . 0.0 111.079 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.75 -21.16 66.27 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.286 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -66.82 84.75 0.12 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.203 0.525 . . . . 0.0 110.314 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 179.15 -47.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.366 -0.834 . . . . 0.0 112.035 -179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -80.17 -35.36 36.6 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.467 0.175 . . . . 0.0 110.968 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -122.31 134.51 54.66 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.802 0.334 . . . . 0.0 111.149 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.702 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 31.8 m -80.88 161.12 24.53 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.968 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.762 HG21 HD22 ' A' ' 90' ' ' LEU . 1.5 tt -79.54 -179.24 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.456 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.549 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -176.69 -39.82 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.26 -179.97 26.51 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.85 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.3 ttp180 -148.81 148.84 30.4 Favored 'General case' 0 N--CA 1.466 0.343 0 O-C-N 122.78 -0.247 . . . . 0.0 110.654 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.531 HG21 ' HB ' ' A' ' 136' ' ' ILE . 10.4 m -79.13 136.77 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 121.025 0.441 . . . . 0.0 111.552 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 7.2 t -118.78 -47.06 2.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -142.56 80.93 1.72 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.999 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.442 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 176.03 -21.6 0.05 OUTLIER Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.726 -0.749 . . . . 0.0 114.116 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.531 ' HB ' HG21 ' A' ' 132' ' ' VAL . 14.6 tt -40.85 -38.04 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.83 -46.19 93.89 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 121.14 -0.553 . . . . 0.0 112.555 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.424 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.9 ttp -59.78 -41.61 91.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.773 0.32 . . . . 0.0 110.379 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -57.18 -44.87 84.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.582 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -61.83 -40.84 96.7 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.581 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -56.5 -40.78 75.56 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.077 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.593 HG22 ' HG2' ' A' ' 20' ' ' MET . 17.6 t -56.97 -38.29 59.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.291 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -88.84 -29.96 16.54 Favored Glycine 0 CA--C 1.523 0.547 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.625 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 79.1 mmm -66.53 -16.92 64.51 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.456 ' O ' HG21 ' A' ' 154' ' ' VAL . 16.2 m -88.2 19.47 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 69.75 165.22 0.27 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.213 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 16.4 p -144.18 174.55 10.79 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.489 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -172.69 3.85 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.801 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 57.9 m -93.55 33.74 1.24 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-O 120.705 0.288 . . . . 0.0 111.366 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -156.92 31.94 0.3 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.478 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 52.7 51.22 16.45 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.11 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -123.3 143.49 41.29 Favored Pre-proline 0 C--O 1.233 0.209 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.822 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.503 ' CB ' HG23 ' A' ' 157' ' ' VAL . 60.6 Cg_endo -73.21 141.78 32.9 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.68 2.254 . . . . 0.0 112.531 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.456 HG21 ' O ' ' A' ' 145' ' ' VAL . 6.4 m -78.89 -35.4 17.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.888 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -102.17 11.46 38.25 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.13 138.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.268 0.556 . . . . 0.0 112.295 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.628 HG13 ' HB2' ' A' ' 20' ' ' MET . 38.4 t -128.74 132.89 67.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.693 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' HG2' ' N ' ' A' ' 159' ' ' ILE . 2.5 tttp -144.17 156.68 44.42 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.795 0.331 . . . . 0.0 111.408 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.755 HG23 ' CG2' ' A' ' 18' ' ' THR . 7.2 mt -110.82 120.46 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.059 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.436 HD11 ' CD ' ' A' ' 17' ' ' GLU . 31.8 pt -81.67 -43.47 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 9.6 pttt -175.21 174.31 2.43 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 121.072 0.463 . . . . 0.0 111.639 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.511 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -150.78 133.61 15.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.68 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -152.29 157.26 33.92 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.116 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.437 ' HA ' HG12 ' A' ' 14' ' ' VAL . 72.1 Cg_endo -79.34 148.86 21.37 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.261 1.974 . . . . 0.0 112.1 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.5 m -61.94 147.47 46.78 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.695 -1.059 . . . . 0.0 112.857 179.904 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.407 0.146 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.16 -75.33 0.26 Allowed 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.192 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -162.57 131.58 4.21 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.72 0.295 . . . . 0.0 111.253 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.482 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 11.5 mm -79.59 -49.79 1.34 Allowed Pre-proline 0 CA--C 1.532 0.281 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.506 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 97.9 Cg_endo -81.55 128.34 6.07 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.354 2.036 . . . . 0.0 112.784 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.93 -174.12 1.81 Allowed 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.666 2.244 . . . . 0.0 112.494 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.6 104.13 6.77 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.84 0.352 . . . . 0.0 111.344 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 p -74.61 -35.42 62.93 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.3 t-105 69.73 154.06 0.12 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.527 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.25 139.25 84.27 Favored Pre-proline 0 C--O 1.232 0.171 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.975 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -78.37 157.22 29.27 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.551 2.167 . . . . 0.0 112.368 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.41 62.1 3.52 Favored 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.225 2.617 . . . . 0.0 112.155 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -126.17 160.16 30.99 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.138 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.6 m -133.7 154.84 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.17 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -114.04 111.3 21.41 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.218 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -92.26 109.08 20.44 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.817 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.474 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 2.9 mm-40 -81.15 112.59 18.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.863 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.77 145.09 50.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.837 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.5 t -56.71 -36.31 69.54 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.027 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.899 ' HB2' HG23 ' A' ' 157' ' ' VAL . 1.2 tpt -65.71 -29.15 69.64 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.742 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.464 ' HA3' ' HG2' ' A' ' 138' ' ' MET . . . 153.46 150.48 5.46 Favored Glycine 0 C--N 1.338 0.668 0 CA-C-N 116.206 -0.452 . . . . 0.0 112.204 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 tt -80.32 139.83 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.758 0.279 . . . . 0.0 111.031 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.572 HG22 ' CA ' ' A' ' 135' ' ' GLY . 10.8 pt -145.93 133.47 15.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.753 -179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.32 137.71 21.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.917 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD12 HD12 ' A' ' 16' ' ' LEU . 3.2 mt -129.94 147.82 51.74 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.324 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -101.77 113.19 26.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.776 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.8 mt -96.87 119.14 34.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.648 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.787 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 29.4 m-85 -66.67 102.91 0.98 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.728 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -80.62 12.34 3.18 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -100.1 -61.82 1.32 Allowed 'General case' 0 C--O 1.23 0.073 0 CA-C-O 120.834 0.35 . . . . 0.0 110.623 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.502 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 62.2 m170 -100.75 -15.5 17.65 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.564 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.787 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.66 0.98 0.09 OUTLIER Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.0 Cg_exo -40.77 -35.31 1.55 Allowed 'Trans proline' 0 C--N 1.367 1.502 0 C-N-CA 122.286 1.99 . . . . 0.0 113.137 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -60.02 3.79 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.628 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.67 HG21 ' HG3' ' A' ' 100' ' ' MET . 26.8 m -67.28 -43.61 81.35 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.851 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.8 t -54.69 -47.52 73.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 13.0 tptt -59.17 -48.95 79.73 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.271 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -60.98 -43.41 98.87 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.125 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -57.11 -56.42 21.96 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.766 0.317 . . . . 0.0 110.999 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.8 -44.9 94.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 0.0 111.262 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -57.31 -46.33 83.3 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.9 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.86 -36.8 77.65 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.095 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.58 -48.92 68.06 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.74 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -35.03 79.54 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.974 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.41 -36.81 84.95 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.232 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.5 41.17 1.65 Allowed Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.401 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -113.34 -47.49 3.01 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.463 0.173 . . . . 0.0 110.879 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.13 -32.33 68.86 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.055 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -72.26 112.39 8.3 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.686 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 114.97 -23.76 11.32 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.779 -0.724 . . . . 0.0 113.099 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.503 HG21 ' HA ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -68.54 178.48 2.02 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.849 0.357 . . . . 0.0 111.073 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 157' ' ' VAL . 0.3 OUTLIER -156.91 159.6 38.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.161 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -74.06 129.6 38.18 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.151 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -106.63 -36.56 6.7 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.441 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.84 119.1 37.43 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.719 0.295 . . . . 0.0 110.989 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.574 HG12 HG23 ' A' ' 62' ' ' ILE . 22.1 mt -139.4 130.82 34.16 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.17 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.452 HD12 ' CE ' ' A' ' 61' ' ' MET . 17.7 mt -114.87 120.53 64.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.039 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.26 142.5 52.3 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.226 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 60.86 29.73 19.2 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.861 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.39 -85.13 0.1 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.877 -0.147 . . . . 0.0 111.306 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.452 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.65 173.32 15.65 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.81 0.338 . . . . 0.0 111.429 -179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.574 HG23 HG12 ' A' ' 56' ' ' ILE . 3.7 mp -133.31 119.97 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.577 179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.8 pt20 -106.75 143.96 34.09 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.132 0.491 . . . . 0.0 112.022 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -140.83 124.75 2.65 Favored Glycine 0 C--N 1.332 0.322 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.71 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.39 -179.63 35.29 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.464 -0.874 . . . . 0.0 113.187 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.11 55.94 0.56 Allowed Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 111.641 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' HA ' HG21 ' A' ' 51' ' ' THR . 90.1 Cg_endo -79.22 58.76 7.1 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.717 2.278 . . . . 0.0 112.227 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.596 HG21 ' HA2' ' A' ' 74' ' ' GLY . 61.8 p -120.02 -71.44 0.74 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.25 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.97 27.78 69.29 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.215 -0.517 . . . . 0.0 112.823 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.2 p -89.93 -36.3 15.08 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.653 0.227 . . . . 0.0 111.505 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 103.14 -37.57 3.65 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.459 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -62.32 1.44 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.514 0.197 . . . . 0.0 111.128 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.29 173.58 36.91 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.707 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.596 ' HA2' HG21 ' A' ' 68' ' ' THR . . . -138.91 107.8 0.58 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.616 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -143.91 144.4 31.7 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.0 p -78.26 174.95 10.66 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.102 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.9 pp -60.74 -31.4 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.815 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -79.67 -69.44 0.58 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-O 120.451 0.167 . . . . 0.0 110.945 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -163.08 158.46 30.79 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.933 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.54 -33.51 72.77 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 111.598 0.221 . . . . 0.0 111.598 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -146.25 140.96 26.9 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-O 120.691 0.282 . . . . 0.0 111.077 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 12.2 p90 -156.85 172.17 19.13 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.357 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -66.13 179.31 0.96 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.061 0.458 . . . . 0.0 111.446 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.443 ' OD1' HD12 ' A' ' 86' ' ' LEU . 2.5 p30 -101.26 179.84 4.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.996 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -129.74 36.54 4.06 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.214 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.443 HD12 ' OD1' ' A' ' 84' ' ' ASP . 6.6 mt -57.52 146.77 28.86 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.511 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.79 145.68 17.99 Favored Pre-proline 0 C--O 1.232 0.184 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.113 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.47 68.57 5.26 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 122.614 2.209 . . . . 0.0 112.631 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.601 ' HB3' HD12 ' A' ' 90' ' ' LEU . 0.4 OUTLIER -165.46 172.98 11.51 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.104 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 1.042 HD22 HG21 ' A' ' 128' ' ' ILE . 3.9 mp 64.38 172.65 0.19 Allowed 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.658 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.58 163.64 10.22 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.993 0.425 . . . . 0.0 112.006 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.465 ' HE2' ' HB2' ' A' ' 99' ' ' ALA . 1.2 m-85 -116.76 87.43 2.69 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.147 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 71.2 p -127.93 -52.45 1.33 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.609 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -83.25 7.35 68.0 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.147 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.02 -169.6 0.2 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.634 0.373 . . . . 0.0 111.191 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.49 47.58 90.44 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.977 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 30.5 mm -120.45 154.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.74 0.305 . . . . 0.0 111.089 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.508 HD13 HD22 ' A' ' 25' ' ' LEU . 1.1 tp -124.42 104.03 8.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.036 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.737 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -116.57 140.16 49.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.575 -179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.67 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.56 121.09 24.82 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.309 179.629 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 113' ' ' PHE . . . -110.9 172.2 7.01 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.378 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -150.7 152.94 34.68 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.997 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.1 -34.99 78.79 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.161 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -155.36 176.05 33.09 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.183 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -61.47 125.03 15.84 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.537 2.158 . . . . 0.0 111.948 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.23 36.44 17.89 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.248 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.6 m -147.54 83.41 1.54 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.908 0.385 . . . . 0.0 110.997 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.38 168.65 10.76 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.094 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.41 46.08 0.46 Allowed Glycine 0 CA--C 1.521 0.416 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.901 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 t 55.48 37.01 28.3 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 120.807 0.337 . . . . 0.0 111.294 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.28 161.61 14.85 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.777 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -160.29 173.47 15.64 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.455 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.638 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 21.7 p90 -148.24 132.15 17.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.968 0.413 . . . . 0.0 111.399 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.618 HG21 HG11 ' A' ' 139' ' ' VAL . 14.1 p -103.06 120.39 52.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.588 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.417 HG21 ' HB3' ' A' ' 92' ' ' PHE . 17.5 p -79.49 129.81 34.81 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.935 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.501 ' C ' HD12 ' A' ' 116' ' ' LEU . 4.1 pp -109.61 -10.7 14.83 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.897 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.651 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -136.47 164.33 43.49 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-O 120.509 0.195 . . . . 0.0 111.298 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.651 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 36.7 Cg_endo -65.94 119.97 7.07 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.609 2.206 . . . . 0.0 111.434 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 71.9 p -136.43 103.39 5.25 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.932 0.396 . . . . 0.0 111.675 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.02 -32.71 15.81 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.536 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 19.2 p90 -60.09 -41.57 92.79 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.605 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.6 pp -86.89 0.17 55.45 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.453 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.85 84.04 0.31 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.825 0.345 . . . . 0.0 110.717 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 141.54 -29.59 2.25 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.878 -0.677 . . . . 0.0 113.076 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -57.9 11.01 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.605 0.24 . . . . 0.0 111.287 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 -95.77 159.19 15.1 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.737 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 6.7 t -93.59 161.3 14.41 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.952 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.042 HG21 HD22 ' A' ' 90' ' ' LEU . 3.3 mm -89.04 -178.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.289 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.7 ' H ' HG22 ' A' ' 128' ' ' ILE . 2.4 p90 -178.96 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.485 0.183 . . . . 0.0 111.346 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.66 -179.64 19.62 Favored Glycine 0 C--N 1.336 0.578 0 C-N-CA 121.187 -0.53 . . . . 0.0 112.48 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.38 162.22 38.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.614 0.245 . . . . 0.0 110.986 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG22 ' CD2' ' A' ' 25' ' ' LEU . 13.0 t -116.47 121.27 67.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.825 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.3 t -115.35 -63.81 1.4 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.93 91.5 3.68 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.803 0.335 . . . . 0.0 110.311 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.572 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 155.2 -22.16 0.58 Allowed Glycine 0 CA--C 1.522 0.508 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.193 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.519 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -44.88 -36.2 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -53.79 -42.52 68.9 Favored Glycine 0 C--N 1.337 0.638 0 C-N-CA 121.112 -0.566 . . . . 0.0 112.707 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.464 ' HG2' ' HA3' ' A' ' 21' ' ' GLY . 7.1 tpt -75.17 -43.67 50.96 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.564 0.221 . . . . 0.0 110.698 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.618 HG11 HG21 ' A' ' 114' ' ' VAL . 15.4 t -54.49 -35.95 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.923 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -61.67 -39.34 91.04 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.911 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.406 ' HB2' ' HE3' ' A' ' 138' ' ' MET . 0.5 OUTLIER -59.55 -38.21 80.47 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.015 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.421 HG22 ' HG2' ' A' ' 20' ' ' MET . 19.2 t -58.08 -31.15 40.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.756 179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.466 ' HA3' HD22 ' A' ' 116' ' ' LEU . . . -92.14 -38.49 5.68 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.018 -0.611 . . . . 0.0 112.042 179.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.2 tpt -53.02 -34.58 57.03 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.473 0.309 . . . . 0.0 111.692 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 m -59.48 168.64 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.895 0.379 . . . . 0.0 111.469 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.679 ' O ' HG23 ' A' ' 154' ' ' VAL . 0.9 OUTLIER -104.35 148.01 26.87 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.909 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 40.7 p -96.83 165.36 12.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.92 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 6.9 m120 -136.0 146.75 47.52 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.88 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.26 -46.43 0.13 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.004 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -173.47 -37.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.769 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -176.84 38.27 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.6 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 148' ' ' ASN . 6.9 mtt180 -101.09 123.03 46.48 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 116.691 -0.231 . . . . 0.0 110.718 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 56' ' ' ILE . 29.4 Cg_endo -63.36 132.41 35.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.803 2.335 . . . . 0.0 112.563 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.679 HG23 ' O ' ' A' ' 146' ' ' GLU . 41.3 t -70.23 -42.81 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.709 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -78.42 115.02 17.84 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.18 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.18 96.17 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.003 0.43 . . . . 0.0 111.5 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.899 HG23 ' HB2' ' A' ' 20' ' ' MET . 12.5 p -90.41 139.42 17.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.98 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.418 ' HA ' ' HB3' ' A' ' 52' ' ' LYS . 18.2 pttt -154.7 155.64 34.97 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.213 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 13.8 mt -96.69 145.99 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.889 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 1.1 pt -114.07 -52.12 5.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.845 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 44.4 mtpt -144.43 171.57 14.15 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.797 0.332 . . . . 0.0 111.282 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.35 104.79 1.66 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.086 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -136.06 154.66 77.67 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.311 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.15 172.24 13.07 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.618 2.212 . . . . 0.0 112.581 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -96.25 -33.84 11.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.784 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.252 -1.304 . . . . 0.0 112.582 -179.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 120.522 0.201 . . . . 0.0 111.407 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 64.62 92.89 0.07 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.452 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -146.09 -50.66 0.23 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.314 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 mt -111.01 93.0 16.24 Favored Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.03 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -68.17 155.47 69.32 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.695 2.264 . . . . 0.0 112.349 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.43 -31.51 34.25 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.52 2.147 . . . . 0.0 112.247 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -116.7 175.98 5.33 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.909 0.385 . . . . 0.0 110.919 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.39 -55.22 2.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.638 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER 64.67 162.05 0.12 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.28 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -132.29 81.08 61.89 Favored Pre-proline 0 C--O 1.233 0.198 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.218 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.442 ' HB2' ' HD3' ' A' ' 12' ' ' PRO . 45.4 Cg_exo -54.7 -47.84 24.54 Favored 'Trans proline' 0 CA--C 1.535 0.534 0 C-N-CA 122.686 2.257 . . . . 0.0 113.055 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.442 ' HD3' ' HB2' ' A' ' 11' ' ' PRO . 84.7 Cg_endo -81.26 80.99 2.8 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.486 2.124 . . . . 0.0 112.327 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -118.78 99.93 7.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.25 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.2 m -94.37 146.97 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.271 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.495 ' HE1' ' HG ' ' A' ' 165' ' ' SER . 6.6 m-85 -121.01 108.72 14.19 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.242 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.79 104.94 17.46 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 110.991 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.424 ' CB ' ' HG2' ' A' ' 161' ' ' LYS . 0.5 OUTLIER -79.94 97.06 6.58 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.625 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.53 HG22 HG12 ' A' ' 159' ' ' ILE . 1.9 p -106.43 160.18 15.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.036 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.405 ' CB ' ' HB3' ' A' ' 158' ' ' LYS . 0.5 OUTLIER -63.71 -36.97 85.61 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.607 179.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.655 ' CB ' HG13 ' A' ' 157' ' ' VAL . 9.4 tpt -64.66 -32.24 73.82 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.09 -163.91 37.47 Favored Glycine 0 C--N 1.335 0.524 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.046 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.401 HG23 ' O ' ' A' ' 22' ' ' ILE . 10.8 tt -122.06 118.82 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 117.003 0.402 . . . . 0.0 111.342 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.478 HG23 ' SD ' ' A' ' 138' ' ' MET . 26.9 pt -116.01 158.19 16.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.583 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 15' ' ' TYR . 18.8 t -122.97 120.64 61.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.931 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.616 HD22 HD11 ' A' ' 98' ' ' LEU . 5.2 mt -115.01 155.13 27.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -116.21 115.56 26.21 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD21 ' HE1' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -95.25 120.46 35.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.717 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.825 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 87.1 m-85 -72.62 104.59 3.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -82.98 23.23 0.86 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 -65.46 0.97 Allowed 'General case' 0 C--O 1.231 0.108 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.469 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.4 m-70 -100.93 -11.49 19.7 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.646 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.825 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -100.14 1.05 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.659 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.2 Cg_exo -40.77 -36.05 1.82 Allowed 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 122.117 1.878 . . . . 0.0 113.302 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.1 tptp -68.81 -53.52 21.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.943 179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -69.32 -36.71 77.25 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.942 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 17.3 t -58.84 -50.1 75.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.63 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.3 mtmt -59.28 -40.24 85.47 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.408 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -62.36 -43.06 99.71 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -60.89 -52.4 65.2 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.856 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.22 -49.33 78.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.285 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' HB3' HD13 ' A' ' 77' ' ' ILE . 1.0 OUTLIER -60.46 -51.05 71.1 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.215 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.542 HD22 ' CE1' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -60.91 -29.95 69.89 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.429 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.405 ' HB2' ' HD2' ' A' ' 48' ' ' TYR . . . -70.24 -49.22 52.19 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.673 0.273 . . . . 0.0 110.779 179.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -76.63 -29.23 56.36 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.573 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -55.12 -32.13 61.81 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.34 46.64 0.91 Allowed Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.909 -0.663 . . . . 0.0 112.338 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -125.34 -55.0 1.57 Allowed 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.408 0.147 . . . . 0.0 111.079 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.542 ' CE1' HD22 ' A' ' 42' ' ' LEU . 13.8 m-85 -60.81 -30.35 70.02 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-N 116.782 -0.19 . . . . 0.0 111.337 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -71.7 121.27 18.56 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.757 0.313 . . . . 0.0 110.469 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.28 -24.26 23.08 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.682 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.854 ' HB ' HD12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -60.85 158.34 13.28 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.874 0.368 . . . . 0.0 111.229 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.28 26.74 2.37 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.289 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 63.04 -179.43 0.15 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.015 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.41 -92.88 0.28 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.186 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -79.79 121.77 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.706 0.288 . . . . 0.0 110.513 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.833 HD12 ' HG3' ' A' ' 153' ' ' PRO . 7.8 mt -131.54 125.89 57.04 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.399 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 mt -129.82 118.0 43.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.8 -56.16 25.53 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.763 -179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.82 49.46 1.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.765 -179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -169.22 -89.02 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.213 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.81 175.73 12.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.833 0.349 . . . . 0.0 111.407 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.686 HD12 HG11 ' A' ' 142' ' ' VAL . 5.9 tt -139.26 109.55 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.511 179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -89.47 156.6 18.55 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.579 0.704 . . . . 0.0 112.158 -179.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -148.93 105.37 0.3 Allowed Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.279 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -157.81 179.62 33.41 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.614 -0.803 . . . . 0.0 113.572 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 42.94 63.83 7.05 Favored Pre-proline 0 N--CA 1.466 0.351 0 CA-C-O 121.523 0.678 . . . . 0.0 111.247 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.77 56.99 6.13 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.914 2.409 . . . . 0.0 111.866 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 42.7 p -114.74 -68.0 0.96 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.184 -179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.65 22.31 7.78 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.218 -0.515 . . . . 0.0 113.215 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.33 -37.75 4.9 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 117.033 0.417 . . . . 0.0 111.492 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 65.64 30.08 76.57 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.503 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.57 -49.27 0.11 Allowed 'General case' 0 CA--C 1.529 0.165 0 CA-C-O 120.564 0.221 . . . . 0.0 110.881 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -108.06 80.09 0.26 Allowed Glycine 0 C--N 1.336 0.551 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.484 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.39 125.37 5.9 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.579 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -155.1 166.99 31.86 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.618 0.247 . . . . 0.0 111.211 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 34.0 p -88.58 168.32 12.66 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.155 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 41' ' ' GLU . 5.2 pt -60.93 -31.44 49.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.62 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -75.77 -37.13 59.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.033 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 169.32 -151.19 16.87 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.494 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.22 -45.02 92.24 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.675 0.274 . . . . 0.0 110.699 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -161.51 155.36 21.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.95 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -119.17 170.1 9.37 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.012 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -73.29 178.21 4.65 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.329 -179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -132.51 171.51 13.69 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.203 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -134.23 110.5 9.57 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.457 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.7 tp -100.79 111.07 23.22 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.701 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -130.59 102.52 16.6 Favored Pre-proline 0 CA--C 1.531 0.215 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.957 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -61.03 -14.86 35.59 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.068 2.512 . . . . 0.0 113.141 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.78 -45.99 20.27 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.514 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.521 ' HB3' HD13 ' A' ' 128' ' ' ILE . 6.2 mt -80.2 138.07 36.78 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 111.025 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.0 178.17 6.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.61 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.621 ' HE2' ' HB2' ' A' ' 99' ' ' ALA . 10.4 m-85 -137.75 97.64 3.48 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.874 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.6 ' OG1' HD11 ' A' ' 97' ' ' ILE . 21.5 p -81.87 -4.32 56.22 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.7 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.17 -75.06 1.8 Allowed Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.759 -0.734 . . . . 0.0 111.979 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -54.84 107.66 0.32 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.851 0.358 . . . . 0.0 111.802 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.595 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 69.7 61.13 4.56 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.306 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.6 HD11 ' OG1' ' A' ' 93' ' ' THR . 26.8 mm -137.39 131.69 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 CA-C-O 120.626 0.25 . . . . 0.0 110.852 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.616 HD11 HD22 ' A' ' 25' ' ' LEU . 7.2 mt -101.63 122.16 43.36 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.949 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.621 ' HB2' ' HE2' ' A' ' 92' ' ' PHE . . . -126.22 134.93 51.09 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.69 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.467 ' HE3' ' O ' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -79.94 107.46 12.74 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.434 179.185 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.476 ' HB3' ' OE1' ' A' ' 111' ' ' GLN . . . -85.99 161.97 18.73 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.476 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.25 140.79 22.5 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.191 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.39 -33.49 58.88 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.435 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.01 175.29 35.26 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.552 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.13 121.21 9.25 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.625 2.216 . . . . 0.0 112.185 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 58.52 30.64 20.04 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.326 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 70.6 m -120.77 85.36 2.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.987 0.422 . . . . 0.0 110.493 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -118.64 120.98 39.06 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.988 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -116.63 51.35 0.73 Allowed Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.94 -0.647 . . . . 0.0 112.409 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.496 ' OG ' HD13 ' A' ' 42' ' ' LEU . 16.7 m 58.89 35.89 24.38 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.704 0.287 . . . . 0.0 111.169 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.476 ' OE1' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -97.75 139.7 33.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.669 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 12.8 p90 -159.65 174.97 13.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.036 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.536 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 42.8 p90 -159.55 140.18 12.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.218 0.533 . . . . 0.0 111.876 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.574 HG22 ' CD2' ' A' ' 98' ' ' LEU . 4.9 t -98.27 113.77 33.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.79 178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.46 141.94 36.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.834 0.35 . . . . 0.0 110.433 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 mt -113.91 -28.71 7.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.412 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -109.68 154.74 42.29 Favored Pre-proline 0 C--O 1.234 0.259 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.774 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.09 114.57 1.79 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.761 2.307 . . . . 0.0 112.181 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.3 p -129.37 68.35 1.42 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.065 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -81.11 -39.47 25.59 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.938 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 40.3 p90 -65.21 -32.58 74.32 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.176 179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.8 mt -73.54 -9.31 58.54 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.664 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -66.16 84.45 0.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.112 0.482 . . . . 0.0 110.485 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -179.23 -50.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.597 -0.728 . . . . 0.0 112.465 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mtmt -73.87 -31.58 63.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.635 0.255 . . . . 0.0 111.129 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.1 m-70 -119.56 123.22 43.41 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.084 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.552 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 14.8 t -79.87 163.28 24.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.599 HD12 ' CE1' ' A' ' 92' ' ' PHE . 1.3 tt -80.74 -179.43 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.946 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.542 ' HE1' HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -176.99 -39.5 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.856 -0.156 . . . . 0.0 111.287 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -144.93 179.47 22.04 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.549 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.467 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -138.05 160.91 38.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.909 0.385 . . . . 0.0 111.204 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.22 96.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.017 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.8 m -89.3 -41.54 12.1 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.502 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -144.5 108.6 4.76 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.894 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.39 -19.64 1.18 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.58 -0.819 . . . . 0.0 113.255 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.448 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.0 tt -50.09 -29.24 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.74 -39.14 90.2 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.427 179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.478 ' SD ' HG23 ' A' ' 23' ' ' ILE . 3.4 ttp -69.32 -50.51 45.84 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.393 0.14 . . . . 0.0 110.985 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.646 ' O ' HG12 ' A' ' 142' ' ' VAL . 3.6 m -61.89 -20.6 24.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.418 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -80.85 -31.72 35.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.593 0.235 . . . . 0.0 110.899 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -56.32 -41.96 76.86 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.573 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 62' ' ' ILE . 14.5 p -56.7 -30.66 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-O 120.705 0.288 . . . . 0.0 111.361 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -84.28 -34.91 15.87 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.966 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 42.2 mtt -62.09 -28.54 69.69 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 19.5 m -77.31 163.78 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 120.709 0.29 . . . . 0.0 111.236 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.44 ' O ' HG23 ' A' ' 154' ' ' VAL . 3.4 tt0 -62.39 123.07 17.3 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.192 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 7.6 p -107.35 178.71 4.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.124 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -79.8 -179.01 6.7 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.943 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.4 m -90.15 19.13 5.23 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.545 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 -151.1 -68.35 0.18 Allowed 'General case' 0 C--O 1.231 0.13 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -174.02 73.8 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.77 0.319 . . . . 0.0 111.275 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 17.2 mtt85 -156.4 96.98 2.21 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.419 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.833 ' HG3' HD12 ' A' ' 56' ' ' ILE . 49.5 Cg_endo -69.46 131.15 21.05 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.733 2.289 . . . . 0.0 112.232 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 146' ' ' GLU . 60.5 t -58.64 -44.25 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-O 120.647 0.26 . . . . 0.0 110.394 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -108.62 63.87 0.61 Allowed 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -52.16 150.5 4.47 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.648 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.655 HG13 ' CB ' ' A' ' 20' ' ' MET . 3.9 t -79.78 101.9 5.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.791 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.405 ' HB3' ' CB ' ' A' ' 19' ' ' SER . 5.7 tttm -84.69 150.51 25.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.854 HD12 ' HB ' ' A' ' 51' ' ' THR . 17.6 mt -116.77 128.99 74.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.966 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.4 pt -109.32 -33.62 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.385 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.424 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -163.14 168.02 21.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.771 0.32 . . . . 0.0 111.094 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.07 107.87 2.76 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.056 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -144.26 147.08 35.8 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.432 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.05 174.39 11.56 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.714 2.276 . . . . 0.0 112.516 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.495 ' HG ' ' HE1' ' A' ' 15' ' ' TYR . 25.0 p -95.2 -37.38 11.06 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.009 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.309 -1.273 . . . . 0.0 112.868 -179.894 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 ptt? . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.65 146.3 50.9 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.093 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 59.55 81.55 0.17 Allowed 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.138 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.12 134.39 90.45 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.238 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 62.0 Cg_endo -74.18 143.58 32.24 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.656 2.237 . . . . 0.0 112.192 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 50.8 Cg_exo -55.01 111.97 0.9 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.706 2.271 . . . . 0.0 112.432 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -62.62 114.89 3.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.416 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.6 p -69.15 -72.77 0.17 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.585 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -74.48 155.49 37.94 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.972 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.405 ' CB ' ' HD3' ' A' ' 11' ' ' PRO . 1.5 mt-30 -178.53 -61.81 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.406 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 72.2 Cg_endo -77.79 109.71 2.79 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.613 2.209 . . . . 0.0 112.535 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 11' ' ' PRO . 45.3 Cg_endo -69.35 -44.07 2.59 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.545 2.163 . . . . 0.0 112.49 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.474 HD22 HG12 ' A' ' 24' ' ' VAL . 2.4 m120 -130.62 160.75 33.28 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.702 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.4 HG22 HD11 ' A' ' 27' ' ' LEU . 25.2 m -125.61 141.22 46.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.178 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -109.31 105.7 15.21 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.764 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.414 ' CD1' HD22 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -97.12 101.64 13.25 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.062 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.88 108.05 19.33 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.305 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.437 ' HB ' ' HA ' ' A' ' 159' ' ' ILE . 0.0 OUTLIER -113.2 161.98 16.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.941 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.409 ' N ' HD11 ' A' ' 160' ' ' ILE . 1.4 m -63.05 -30.0 71.26 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.178 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.85 ' HG2' HG22 ' A' ' 142' ' ' VAL . 8.7 tpt -68.79 -32.03 71.47 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.094 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.64 -148.65 14.19 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.265 -0.493 . . . . 0.0 112.396 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.2 tt -129.51 136.49 59.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 120.764 0.316 . . . . 0.0 111.446 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.56 HG22 ' CA ' ' A' ' 135' ' ' GLY . 20.7 pt -144.32 128.92 13.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.519 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.474 HG12 HD22 ' A' ' 13' ' ' ASN . 18.3 t -102.53 98.66 7.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.53 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.69 ' HG ' HD11 ' A' ' 98' ' ' LEU . 9.5 mp -80.83 148.77 29.82 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.142 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -113.35 140.33 48.12 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.005 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 14' ' ' VAL . 3.0 mp -124.11 129.65 51.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.154 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 37.6 m-85 -63.19 99.7 0.19 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.954 0.406 . . . . 0.0 110.771 -179.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.0 p-90 -78.85 12.63 2.05 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.05 -65.51 0.96 Allowed 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.778 0.323 . . . . 0.0 110.522 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.503 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.1 m80 -100.73 -15.51 17.66 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.27 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.75 1.64 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.718 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.4 Cg_exo -40.57 -37.74 2.27 Favored 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 122.052 1.835 . . . . 0.0 113.089 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -60.72 -55.8 28.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.736 0.303 . . . . 0.0 110.362 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.61 -34.79 79.06 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.736 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 14.6 t -58.35 -45.59 87.89 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.58 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -61.69 -43.53 98.68 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.222 179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -64.42 -39.33 93.63 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.79 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -69.07 -43.0 75.46 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.91 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.02 73.54 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.286 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.28 -48.42 80.52 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.011 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.52 -36.33 78.15 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.131 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.97 -30.41 50.27 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.248 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.2 ttt-85 -76.3 -49.08 17.9 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.035 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -60.08 -40.87 91.03 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.745 -179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.93 53.11 0.24 Allowed Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.857 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -112.14 -62.84 1.51 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.515 0.198 . . . . 0.0 110.579 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.615 ' O ' HG22 ' A' ' 51' ' ' THR . 12.9 m-85 -63.3 -51.71 64.96 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.65 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -67.23 119.75 12.64 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.896 0.379 . . . . 0.0 110.47 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.22 8.8 10.09 Favored Glycine 0 CA--C 1.524 0.638 0 CA-C-N 115.858 -0.61 . . . . 0.0 113.088 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.615 HG22 ' O ' ' A' ' 48' ' ' TYR . 15.1 t -117.74 -172.18 2.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.274 0.537 . . . . 0.0 111.176 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.8 150.19 35.73 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.129 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.759 ' HB3' HD11 ' A' ' 56' ' ' ILE . 59.8 m-85 -64.23 136.9 57.63 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.187 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -109.44 -36.59 5.95 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.734 -179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.472 ' O ' HD13 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -113.89 113.65 25.16 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.628 0.251 . . . . 0.0 111.114 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.759 HD11 ' HB3' ' A' ' 53' ' ' PHE . 29.6 mm -132.71 116.66 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.97 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 36.7 mt -124.53 88.28 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-O 120.876 0.37 . . . . 0.0 111.039 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HD3' ' HA3' ' A' ' 143' ' ' GLY . 21.8 tptt -58.97 155.53 13.26 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.103 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.09 25.75 4.67 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.217 -179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -166.29 -82.38 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.02 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.605 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -160.53 170.07 21.66 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 120.9 0.381 . . . . 0.0 111.516 -179.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.3 pt -142.66 161.57 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.51 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -146.75 154.59 41.58 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.924 0.392 . . . . 0.0 111.55 179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.68 150.45 17.12 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.562 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.89 -179.55 38.77 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.987 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.676 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 15.1 t70 -156.3 -63.05 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.305 0 CA-C-N 115.942 -0.129 . . . . 0.0 111.198 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 73.6 Cg_endo -76.0 -176.81 3.23 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.279 1.986 . . . . 0.0 112.677 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 70' ' ' THR . 6.7 t -56.69 -35.92 69.03 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.979 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.73 29.59 47.19 Favored Glycine 0 C--N 1.336 0.571 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.431 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.404 ' H ' HG23 ' A' ' 68' ' ' THR . 1.2 p -133.74 -46.19 0.8 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.852 0.326 . . . . 0.0 111.06 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 114.99 31.3 2.1 Favored Glycine 0 C--N 1.332 0.314 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.477 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.3 mtm105 -105.72 -45.04 4.5 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.586 0.232 . . . . 0.0 110.69 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.46 80.15 0.2 Allowed Glycine 0 C--N 1.335 0.49 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.457 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -133.43 80.62 0.32 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.326 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -117.04 155.72 28.74 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.817 0.342 . . . . 0.0 111.149 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 31.0 t -125.4 175.04 7.76 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 30.4 pt -53.02 -33.83 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.828 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.403 ' HB2' ' CE2' ' A' ' 82' ' ' PHE . 29.1 m-85 -92.23 -35.91 13.54 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.724 -0.216 . . . . 0.0 111.016 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.9 -143.49 10.34 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.588 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -134.68 27.52 3.65 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 120.714 0.293 . . . . 0.0 111.193 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -138.13 -55.72 0.65 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.119 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.403 ' CE2' ' HB2' ' A' ' 78' ' ' TYR . 15.5 m-85 61.73 -176.79 0.13 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.053 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -128.63 131.51 48.08 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.59 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -61.43 146.25 49.0 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -131.96 98.85 4.56 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.236 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.0 tp -132.72 110.9 10.71 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.649 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -132.12 172.84 6.68 Favored Pre-proline 0 N--CA 1.463 0.21 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.911 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.06 -173.84 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 122.742 2.294 . . . . 0.0 112.174 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 67.82 179.28 0.23 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.405 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.9 mt 66.82 165.89 0.21 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.739 0.304 . . . . 0.0 110.887 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.17 160.38 40.86 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 111.471 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.31 96.63 5.75 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.972 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.426 ' OG1' HD11 ' A' ' 97' ' ' ILE . 17.0 p -71.97 -33.61 68.29 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.724 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.2 -26.67 23.03 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.916 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -106.52 116.17 31.46 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.069 0.435 . . . . 0.0 111.654 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 66.35 54.82 21.37 Favored Glycine 0 C--N 1.333 0.38 0 CA-C-N 116.049 -0.523 . . . . 0.0 113.213 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 96' ' ' GLY . 19.8 mm -129.23 135.53 61.63 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 116.768 0.284 . . . . 0.0 111.203 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.781 HD23 HG22 ' A' ' 114' ' ' VAL . 1.3 mt -105.64 120.44 41.68 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.833 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.758 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -117.81 141.16 48.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.369 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.19 120.02 23.11 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.181 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.72 141.8 36.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.43 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.4 p-10 -157.16 117.4 3.51 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.743 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.47 72.52 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.504 -0.317 . . . . 0.0 111.102 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.71 179.83 17.51 Favored Glycine 0 C--N 1.333 0.393 0 N-CA-C 111.777 -0.529 . . . . 0.0 111.777 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.48 30.27 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 122.686 2.258 . . . . 0.0 113.203 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -176.7 38.1 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.918 0.389 . . . . 0.0 110.697 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.28 81.95 1.69 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 110.829 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.1 m120 -106.24 91.47 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.223 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -67.91 -105.16 0.02 OUTLIER Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.358 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.466 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . 67.3 m -157.5 36.48 0.27 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.43 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -118.1 160.3 21.76 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.696 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.2 p90 -159.74 165.66 32.05 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.774 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.758 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 6.5 p90 -137.63 136.79 37.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.42 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.781 HG22 HD23 ' A' ' 98' ' ' LEU . 4.8 t -102.72 110.53 29.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.201 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.1 p -79.8 130.89 35.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.602 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.605 HD23 ' HA ' ' A' ' 61' ' ' MET . 0.6 OUTLIER -114.71 -15.99 11.85 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.675 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -108.61 152.35 42.12 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.655 -0.248 . . . . 0.0 110.835 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -63.99 104.41 0.48 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.761 2.308 . . . . 0.0 112.343 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.6 p -138.3 67.53 1.41 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.98 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -70.4 -32.96 70.82 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -60.55 -29.13 68.95 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.296 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.419 HD23 ' HD2' ' A' ' 125' ' ' LYS . 4.4 mt -73.17 -11.86 60.67 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.877 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -67.24 85.44 0.15 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.219 0.533 . . . . 0.0 110.425 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 175.79 -40.71 0.11 Allowed Glycine 0 CA--C 1.518 0.273 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.279 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.419 ' HD2' HD23 ' A' ' 122' ' ' LEU . 30.7 mttt -74.56 -44.55 50.47 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.63 0.252 . . . . 0.0 110.836 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 57.1 m-70 -112.84 133.9 54.61 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.795 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.651 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 15.3 t -79.91 164.28 23.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.997 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.4 tt -90.4 -179.41 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.689 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 98' ' ' LEU . 3.0 p90 -178.31 -33.18 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -146.93 -179.77 23.27 Favored Glycine 0 C--N 1.338 0.651 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.779 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.589 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -146.03 150.31 35.76 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.962 0.41 . . . . 0.0 111.034 179.643 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 17.8 t -106.9 99.75 9.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.206 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.26 -45.96 5.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.224 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -119.84 96.34 5.14 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.829 179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.56 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 152.24 -22.23 0.86 Allowed Glycine 0 CA--C 1.521 0.419 0 C-N-CA 120.709 -0.758 . . . . 0.0 113.277 -179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 13.2 tt -47.21 -36.41 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 116.848 0.324 . . . . 0.0 111.807 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -61.21 -45.59 96.2 Favored Glycine 0 C--N 1.338 0.644 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.482 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.7 ttp -65.77 -41.99 91.36 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.611 0.243 . . . . 0.0 110.601 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.71 -36.98 63.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.719 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -63.4 -36.15 82.76 Favored 'General case' 0 CA--C 1.529 0.141 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.983 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 21.8 mtt180 -60.78 -42.06 96.78 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.486 0.184 . . . . 0.0 111.028 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.85 HG22 ' HG2' ' A' ' 20' ' ' MET . 12.1 t -58.27 -34.03 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.148 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 58' ' ' LYS . . . -89.62 -36.38 7.41 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.12 179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -35.77 61.12 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.46 0.304 . . . . 0.0 111.5 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 155' ' ' ASP . 18.9 m -63.76 173.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.352 0 CA-C-O 120.748 0.309 . . . . 0.0 111.174 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.612 ' O ' HG12 ' A' ' 154' ' ' VAL . 3.6 mm-40 -72.83 -179.93 3.37 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.062 0.458 . . . . 0.0 111.266 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -148.0 177.72 9.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.933 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -86.97 -173.11 4.3 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.606 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.03 27.83 2.32 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -147.26 -71.95 0.22 Allowed 'General case' 0 C--O 1.231 0.122 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 t0 178.74 45.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.008 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.04 116.34 28.78 Favored Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.921 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -56.33 129.13 33.12 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.953 2.435 . . . . 0.0 112.849 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.612 HG12 ' O ' ' A' ' 146' ' ' GLU . 11.4 p -69.78 -35.36 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.12 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.567 ' HB2' HG21 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -75.41 -173.03 1.96 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.669 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -127.47 90.95 3.21 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.814 HG23 ' HB2' ' A' ' 20' ' ' MET . 7.8 p -102.51 123.43 55.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.036 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.2 pttt -152.82 126.85 9.04 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.69 0.281 . . . . 0.0 111.711 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.437 ' HA ' ' HB ' ' A' ' 18' ' ' THR . 4.6 mt -81.42 132.95 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.597 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.409 HD11 ' N ' ' A' ' 19' ' ' SER . 0.3 OUTLIER -114.19 -33.64 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.295 179.835 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 12.2 mttp -127.51 146.19 50.59 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.772 0.32 . . . . 0.0 111.114 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.79 82.67 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.825 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -122.67 143.67 40.62 Favored Pre-proline 0 C--O 1.233 0.234 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.32 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 11' ' ' PRO . 94.6 Cg_endo -80.43 150.29 19.46 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.803 2.335 . . . . 0.0 112.603 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 23.3 t -171.77 148.72 2.42 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.892 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 CA-C-O 118.75 -1.028 . . . . 0.0 113.036 179.822 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.794 0.33 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.97 -36.88 9.23 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.231 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 64.01 82.64 0.18 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.062 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.8 mm 59.56 73.51 0.66 Allowed Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.034 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -57.05 109.37 0.45 Allowed 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.842 2.361 . . . . 0.0 112.645 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.56 163.95 36.18 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.774 2.316 . . . . 0.0 112.957 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -130.0 -49.2 1.12 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.055 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.5 p -164.13 169.19 18.09 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.649 0.261 . . . . 0.0 111.359 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.5 m95 -132.24 -48.32 0.92 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.432 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -99.8 104.22 26.9 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.826 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -69.18 116.24 4.4 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.54 2.16 . . . . 0.0 112.478 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.38 -35.95 17.0 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.644 2.229 . . . . 0.0 112.658 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -107.21 170.56 7.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.847 0.356 . . . . 0.0 111.021 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.435 HG13 ' HG ' ' A' ' 25' ' ' LEU . 14.2 p -151.89 147.4 15.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.376 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -112.89 135.36 53.74 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.202 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.828 HD12 HD21 ' A' ' 25' ' ' LEU . 18.0 mt -121.63 97.79 5.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.82 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.46 86.28 7.38 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.602 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.7 OUTLIER -98.94 157.47 16.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.352 -179.584 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 t -64.63 -36.39 84.1 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.967 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.847 ' HB2' HG23 ' A' ' 157' ' ' VAL . 9.8 tpt -65.47 -31.49 72.6 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.117 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 159.37 151.48 6.15 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.233 -0.508 . . . . 0.0 112.058 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.5 tt -81.05 142.86 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.715 0.293 . . . . 0.0 111.483 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.713 HG22 ' HA2' ' A' ' 135' ' ' GLY . 19.5 pt -148.37 146.49 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.786 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 18.6 t -115.21 130.58 69.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.721 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.828 HD21 HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -133.03 162.91 30.46 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.387 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.55 154.11 25.29 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.907 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.0 mt -130.43 134.12 46.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.769 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.769 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 74.3 m-85 -75.15 98.17 3.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.381 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 46.3 p-90 -82.86 20.4 1.18 Allowed 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -100.22 -67.29 0.86 Allowed 'General case' 0 C--O 1.231 0.11 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.482 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.81 -13.05 18.57 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.145 179.334 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.14 0.73 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -179.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 85.2 Cg_exo -42.77 -34.98 3.87 Favored 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.005 1.804 . . . . 0.0 112.789 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.2 tptt -57.72 -62.73 1.59 Allowed 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.908 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.6 p -66.7 -33.65 76.1 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.761 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -59.41 -51.32 70.39 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.31 -38.64 84.32 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.744 0.307 . . . . 0.0 110.468 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.24 -41.42 94.35 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.755 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -67.15 -48.35 68.28 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.994 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -59.9 -47.89 83.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.387 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.98 -50.1 74.74 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.19 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.424 HD23 ' HG2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -56.79 -33.21 66.44 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 120.466 0.174 . . . . 0.0 111.441 179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.72 -34.92 24.79 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.512 0.196 . . . . 0.0 111.479 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.4 ttt180 -75.85 -36.79 59.47 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.449 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.36 -30.33 71.15 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 31.0 3.07 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.927 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.533 ' CE2' HG22 ' A' ' 68' ' ' THR . 1.1 m-85 -105.03 -41.71 5.51 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.565 0.221 . . . . 0.0 110.663 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -65.58 -51.16 61.81 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.214 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -68.02 123.24 20.08 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.946 0.403 . . . . 0.0 110.69 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 122.91 -29.38 5.39 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.679 -0.691 . . . . 0.0 112.315 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER -75.79 -176.42 3.35 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 120.98 0.419 . . . . 0.0 111.514 -179.791 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -155.04 154.8 33.04 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.915 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.766 ' HB3' HD11 ' A' ' 56' ' ' ILE . 54.8 m-85 -66.86 169.83 7.5 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.983 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -135.72 -53.36 0.76 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.665 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.625 ' C ' HD12 ' A' ' 56' ' ' ILE . 6.2 mtt-85 -100.53 108.46 20.41 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.753 0.311 . . . . 0.0 111.012 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.766 HD11 ' HB3' ' A' ' 53' ' ' PHE . 1.7 mp -120.02 99.87 8.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.58 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.8 mt -107.53 95.54 3.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.612 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HB3' ' HA3' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -60.95 -23.29 65.19 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.602 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.09 21.3 3.79 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.457 ' CD2' ' HG3' ' A' ' 61' ' ' MET . 10.6 t80 -169.98 -81.89 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.399 0 O-C-N 122.521 -0.112 . . . . 0.0 111.141 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.457 ' HG3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -160.43 175.33 12.9 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.719 0.295 . . . . 0.0 111.186 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.4 pp -133.97 137.06 52.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.527 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -117.47 143.58 45.9 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.138 0.494 . . . . 0.0 112.18 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.69 125.59 3.66 Favored Glycine 0 C--N 1.333 0.39 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.894 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.11 -179.9 34.27 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.027 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.4 t70 71.28 56.21 0.41 Allowed Pre-proline 0 N--CA 1.464 0.268 0 C-N-CA 122.564 0.346 . . . . 0.0 111.789 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.53 ' HA ' HG21 ' A' ' 51' ' ' THR . 91.2 Cg_endo -79.18 62.8 8.6 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.564 2.176 . . . . 0.0 111.994 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.533 HG22 ' CE2' ' A' ' 47' ' ' TYR . 70.5 p -134.45 -61.22 0.78 Allowed 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.305 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.69 30.29 62.12 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 121.205 -0.521 . . . . 0.0 112.727 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.4 m -100.97 -47.14 4.87 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.638 0.219 . . . . 0.0 111.203 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.42 -36.42 4.01 Favored Glycine 0 C--N 1.336 0.559 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.228 -179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -110.03 27.2 9.84 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.32 125.14 1.42 Allowed Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.869 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -148.13 80.64 0.21 Allowed Glycine 0 C--N 1.335 0.505 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.613 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -150.34 150.91 32.09 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 120.751 0.31 . . . . 0.0 111.293 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.8 p -105.96 -175.5 2.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.182 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 4.8 pt -66.4 -28.3 43.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.132 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.228 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -97.33 39.19 1.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 120.851 0.357 . . . . 0.0 110.825 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 82.72 -147.38 25.16 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.016 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.81 -37.3 5.91 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.462 0.172 . . . . 0.0 111.135 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -143.0 158.87 43.19 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -167.77 169.97 11.23 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.172 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -61.95 129.86 42.89 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.744 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -64.53 168.19 6.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.633 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -111.49 38.25 2.65 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.172 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.596 ' HA ' HG23 ' A' ' 127' ' ' THR . 0.1 OUTLIER -64.56 135.82 56.38 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.756 179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.25 102.28 1.88 Allowed Pre-proline 0 C--O 1.233 0.206 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.969 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.9 80.71 0.11 Allowed 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.854 2.369 . . . . 0.0 111.984 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -140.33 -49.83 0.46 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.767 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.466 HD13 HG21 ' A' ' 128' ' ' ILE . 4.8 mp -85.14 145.69 27.5 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.891 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.6 tttm -97.2 154.51 17.34 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.239 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -113.16 89.33 3.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 28.7 p -57.9 -33.83 69.16 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.214 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 105.67 -27.44 17.87 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.846 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -104.69 106.2 16.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.979 0.389 . . . . 0.0 111.086 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.572 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 74.41 58.46 4.23 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.958 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.572 HD13 ' O ' ' A' ' 96' ' ' GLY . 25.3 mm -133.08 120.41 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 CA-C-O 120.703 0.287 . . . . 0.0 110.817 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.613 HD12 HG13 ' A' ' 132' ' ' VAL . 3.1 mt -96.09 110.02 22.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.893 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -117.05 138.69 51.43 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.706 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.419 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.89 118.61 21.81 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.561 179.373 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -89.16 172.08 9.34 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.521 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -148.75 157.87 43.75 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.44 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.71 23.94 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.377 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.85 174.52 35.87 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 121.1 -0.571 . . . . 0.0 112.435 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.78 120.26 7.29 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.557 2.171 . . . . 0.0 111.991 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 56.92 42.18 26.71 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.024 -179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.6 m -144.6 88.11 1.9 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -107.78 161.93 14.45 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.14 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.4 -106.16 1.01 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.168 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 50.8 m -147.52 34.68 0.86 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.712 0.291 . . . . 0.0 111.462 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.03 158.1 23.65 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.92 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -160.4 176.46 11.64 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.566 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -145.96 136.69 24.3 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.897 0.379 . . . . 0.0 111.532 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.56 HG22 ' CD2' ' A' ' 98' ' ' LEU . 22.0 t -102.13 109.9 27.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.129 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.53 132.94 36.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.407 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 2.5 pp -114.9 -23.32 9.17 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.861 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -101.15 149.03 35.93 Favored Pre-proline 0 CA--C 1.529 0.149 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.973 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.71 117.3 4.11 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.862 2.375 . . . . 0.0 112.213 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.842 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 10.2 p -151.91 99.03 2.52 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.156 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -92.8 -21.89 19.65 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.842 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.8 p90 -59.06 -26.18 64.39 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.471 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.3 pp -85.03 -4.59 59.21 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -63.78 86.95 0.04 OUTLIER 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.182 0.515 . . . . 0.0 110.091 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 146.73 -32.27 1.46 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.642 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.19 -53.92 21.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.662 0.231 . . . . 0.0 111.219 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -104.61 150.03 25.02 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.269 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.665 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 49.1 m -86.14 155.75 20.64 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.959 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.466 HG21 HD13 ' A' ' 90' ' ' LEU . 1.3 tt -86.47 -179.42 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.636 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -175.72 -38.13 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 111.903 0.335 . . . . 0.0 111.903 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.62 -179.82 31.89 Favored Glycine 0 C--N 1.336 0.562 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.919 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -138.2 166.22 24.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.6 0.238 . . . . 0.0 110.946 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.662 HG12 ' HB3' ' A' ' 25' ' ' LEU . 3.0 m -134.44 102.79 4.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-O 120.819 0.343 . . . . 0.0 111.782 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.3 m -89.82 -53.74 4.37 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.512 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -110.9 84.18 1.89 Allowed 'General case' 0 C--O 1.231 0.123 0 CA-C-N 116.165 -0.471 . . . . 0.0 109.955 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.713 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 169.81 -27.84 0.12 Allowed Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.844 -0.694 . . . . 0.0 113.437 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 96' ' ' GLY . 7.8 tt -46.98 -37.68 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.73 -38.17 81.19 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.101 -0.571 . . . . 0.0 112.76 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.64 ' O ' HG23 ' A' ' 142' ' ' VAL . 0.0 OUTLIER -70.45 -35.56 73.41 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-O 120.703 0.287 . . . . 0.0 111.108 179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.59 -30.23 41.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.382 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 13.2 m-20 -74.82 -38.04 62.16 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.483 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 138' ' ' MET . 0.0 OUTLIER -67.73 -29.56 68.82 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.685 HG22 ' HG2' ' A' ' 20' ' ' MET . 21.5 t -56.34 -32.71 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.649 0.262 . . . . 0.0 111.015 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 58' ' ' LYS . . . -93.59 -32.19 7.83 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.506 179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 21.2 mmt -60.15 -33.3 71.97 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.524 0.162 . . . . 0.0 111.385 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 13.1 m -63.75 173.86 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.793 0.33 . . . . 0.0 111.18 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.86 126.07 26.15 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.976 0.417 . . . . 0.0 111.16 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.8 p -118.58 167.94 11.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.104 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -80.07 -177.29 5.96 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.964 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.83 46.91 1.43 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.228 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -174.28 -67.61 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.822 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.56 44.02 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.935 0.398 . . . . 0.0 110.821 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 1.3 ttt85 -122.95 104.05 36.15 Favored Pre-proline 0 CA--C 1.53 0.181 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.137 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.0 117.06 3.48 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.822 2.348 . . . . 0.0 112.461 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.6 t -62.43 -32.24 54.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.696 0.284 . . . . 0.0 110.361 179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.13 -170.94 1.03 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.382 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -117.89 114.05 22.65 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.731 0.3 . . . . 0.0 111.617 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.847 HG23 ' HB2' ' A' ' 20' ' ' MET . 7.1 p -125.43 113.38 34.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.796 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.19 174.85 11.21 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.638 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.435 ' HA ' HG22 ' A' ' 18' ' ' THR . 2.4 mt -115.14 139.49 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.314 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.55 ' N ' HD13 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -116.13 -30.57 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.602 179.037 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.22 28.59 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.617 0.246 . . . . 0.0 110.952 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.13 111.14 3.15 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.023 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 36.6 p90 -145.05 158.37 52.31 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 120.923 0.392 . . . . 0.0 111.707 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 163' ' ' TYR . 3.4 Cg_exo -80.09 152.38 21.42 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.274 2.649 . . . . 0.0 112.482 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -170.31 140.29 1.85 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.451 179.879 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 120.671 0.272 . . . . 0.0 111.169 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.32 29.75 15.59 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.67 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.91 76.41 0.09 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.888 0.375 . . . . 0.0 110.795 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 28.6 mt -107.04 92.53 7.83 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.749 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.34 145.58 60.03 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.516 2.144 . . . . 0.0 112.118 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.41 ' HB2' ' HA3' ' A' ' 166' ' ' GLY . 92.5 Cg_endo -78.64 58.37 6.77 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.856 2.37 . . . . 0.0 111.929 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 t70 55.03 23.85 5.5 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.869 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.9 m -161.49 163.62 30.21 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.62 0.248 . . . . 0.0 111.0 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 27.5 m95 -108.5 -27.44 9.9 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.5 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.18 76.52 3.58 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-O 120.746 0.308 . . . . 0.0 110.883 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.434 ' HG3' ' CB ' ' A' ' 164' ' ' PRO . 73.7 Cg_endo -76.16 151.0 33.99 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.892 2.394 . . . . 0.0 112.667 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.0 -37.51 3.48 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.745 2.297 . . . . 0.0 112.715 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -125.0 165.74 17.6 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.842 0.353 . . . . 0.0 111.004 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.672 HG22 HD11 ' A' ' 27' ' ' LEU . 30.5 m -140.58 154.23 21.95 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.138 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.467 ' CE1' HG22 ' A' ' 24' ' ' VAL . 4.1 m-85 -111.5 104.17 12.56 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.767 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.521 HD12 HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -87.88 96.64 10.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.16 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' HB3' ' HB3' ' A' ' 161' ' ' LYS . 1.3 tm-20 -80.37 82.48 6.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.187 179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.668 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.8 OUTLIER -84.78 161.05 20.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.386 -179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.4 t -64.04 -33.22 75.25 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.054 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.923 ' HB2' HG13 ' A' ' 157' ' ' VAL . 15.3 tpt -67.51 -34.16 76.55 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.945 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.81 -148.36 12.75 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.18 -0.533 . . . . 0.0 112.221 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.427 HD11 ' CD1' ' A' ' 15' ' ' TYR . 17.2 tt -132.28 126.45 55.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.798 0.332 . . . . 0.0 111.279 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.507 HD12 HD21 ' A' ' 25' ' ' LEU . 29.7 pt -129.99 133.26 64.77 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.467 HG22 ' CE1' ' A' ' 15' ' ' TYR . 18.4 t -94.3 109.41 22.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.82 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.541 HD22 HG22 ' A' ' 132' ' ' VAL . 7.4 mt -105.49 162.42 13.49 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.28 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -119.89 144.81 47.2 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.051 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.672 HD11 HG22 ' A' ' 14' ' ' VAL . 0.6 OUTLIER -129.47 134.29 47.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.22 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.81 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 28.0 m-85 -64.42 100.6 0.37 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.014 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -80.8 15.31 1.81 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.27 0.471 . . . . 0.0 112.27 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.7 mmpt? -100.15 -64.9 1.0 Allowed 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 120.772 0.32 . . . . 0.0 110.343 179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.478 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 1.0 OUTLIER -100.76 -13.2 18.55 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.333 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.81 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.01 1.2 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 77.8 Cg_exo -41.84 -37.52 4.15 Favored 'Trans proline' 0 C--N 1.367 1.534 0 C-N-CA 122.011 1.807 . . . . 0.0 112.908 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.36 -49.49 71.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.486 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 93.1 m -67.07 -36.94 83.09 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.387 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 65.0 m -54.51 -49.13 70.91 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.358 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 4.2 tttm -64.6 -38.55 91.39 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.264 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.409 ' CG ' HD13 ' A' ' 77' ' ' ILE . 1.5 t30 -56.74 -44.09 81.33 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.478 179.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -67.51 -43.16 81.55 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.212 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.11 -52.43 55.42 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.272 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -46.5 89.17 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.093 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.56 -40.73 69.01 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.109 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.08 -33.77 33.13 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.22 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.8 -47.63 84.95 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.213 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -60.16 -30.23 69.18 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.72 -0.218 . . . . 0.0 111.424 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.87 26.02 5.16 Favored Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.908 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.84 -37.13 13.11 Favored 'General case' 0 CA--C 1.528 0.099 0 CA-C-N 116.777 0.288 . . . . 0.0 110.773 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.21 -36.39 40.18 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.179 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -66.99 90.01 0.18 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.999 0.428 . . . . 0.0 110.138 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.8 -26.04 2.53 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 115.747 -0.66 . . . . 0.0 112.772 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.6 p -61.3 151.4 32.05 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.809 0.305 . . . . 0.0 111.281 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -132.2 159.69 38.29 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.863 0.363 . . . . 0.0 111.254 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -74.13 100.46 3.65 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.638 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -73.02 -50.2 24.48 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.226 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.1 mtt-85 -102.72 131.09 49.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.032 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.725 HG23 HG12 ' A' ' 62' ' ' ILE . 27.0 mt -142.16 105.19 1.28 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.018 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 40.9 mt -90.98 115.06 29.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 120.735 0.302 . . . . 0.0 110.913 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.423 ' HD3' ' HB2' ' A' ' 59' ' ' ASP . 2.0 tmtt? -63.34 132.2 50.76 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.188 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.423 ' HB2' ' HD3' ' A' ' 58' ' ' LYS . 2.5 t70 55.39 52.45 11.33 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.267 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.449 ' N ' HD11 ' A' ' 116' ' ' LEU . 16.4 t80 -165.82 -83.83 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.482 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -160.58 163.6 32.57 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.819 0.343 . . . . 0.0 111.442 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.725 HG12 HG23 ' A' ' 56' ' ' ILE . 4.0 mp -137.99 130.46 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.721 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.1 pt20 -117.9 154.58 31.64 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.015 0.436 . . . . 0.0 112.004 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -139.92 106.09 0.48 Allowed Glycine 0 C--N 1.335 0.497 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.153 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.25 -179.99 35.4 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.941 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.0 76.46 0.34 Allowed Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 121.063 0.459 . . . . 0.0 111.068 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.22 -34.02 6.6 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.759 2.306 . . . . 0.0 112.697 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.7 t -87.07 -41.04 14.14 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.304 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.93 52.35 14.85 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.529 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.6 p -112.29 -42.89 3.61 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 115.83 -68.04 0.28 Allowed Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.119 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.82 -33.39 18.62 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 116.656 0.228 . . . . 0.0 111.39 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -84.57 84.09 1.6 Allowed Glycine 0 C--N 1.335 0.493 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.816 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.39 97.69 0.18 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.728 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -120.48 135.13 55.16 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.659 0.266 . . . . 0.0 111.221 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.668 ' HB2' HD12 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -80.35 -84.7 0.09 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.684 179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.668 HD12 ' HB2' ' A' ' 76' ' ' SER . 4.3 mp -142.55 -50.48 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 120.811 0.339 . . . . 0.0 110.534 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -97.44 34.76 1.75 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.865 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 118.41 -168.54 13.19 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.757 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -119.32 21.69 12.1 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.502 0.186 . . . . 0.0 111.502 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.66 ' HB3' HG23 ' A' ' 107' ' ' THR . 0.0 OUTLIER -177.73 92.82 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.871 0.367 . . . . 0.0 110.632 179.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 21.7 p90 -107.76 175.61 5.42 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.251 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -73.74 140.72 46.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.785 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.21 157.11 11.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.44 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -106.79 37.31 2.37 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.651 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -95.46 149.13 21.74 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.51 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -171.28 -62.31 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.801 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.526 ' HG2' HD13 ' A' ' 90' ' ' LEU . 78.2 Cg_endo -75.73 -174.23 1.95 Allowed 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.758 2.306 . . . . 0.0 112.42 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -92.94 -61.65 1.54 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.014 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.577 HD22 HG21 ' A' ' 128' ' ' ILE . 7.6 mp 57.5 -173.85 0.08 Allowed 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 111.781 0.289 . . . . 0.0 111.781 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.11 173.98 10.48 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.158 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.657 ' CE1' ' HB2' ' A' ' 99' ' ' ALA . 8.2 t80 -160.31 38.93 0.17 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.979 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 m -108.93 -57.74 2.11 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.811 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -45.28 122.34 5.26 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.591 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -48.15 127.21 12.19 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 101.96 62.38 0.75 Allowed Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.864 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 96' ' ' GLY . 14.8 mm -126.67 140.13 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.767 0.283 . . . . 0.0 111.045 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.524 HD22 ' HE1' ' A' ' 129' ' ' PHE . 3.2 mt -112.41 120.8 42.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.946 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.676 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -124.52 142.06 51.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.443 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -79.6 114.75 18.76 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.286 179.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 157.18 26.1 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.437 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 34.0 p30 -135.82 157.25 47.31 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.228 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -89.41 -37.22 14.98 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.158 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.79 174.46 36.61 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.293 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.4 119.12 5.65 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.579 2.186 . . . . 0.0 112.165 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 59.05 30.75 20.63 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.185 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.66 HG23 ' HB3' ' A' ' 81' ' ' GLN . 10.5 m -139.87 88.3 2.22 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.709 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -92.02 165.91 12.95 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.781 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.09 -105.7 1.47 Allowed Glycine 0 C--N 1.333 0.4 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.526 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.93 43.94 0.12 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.962 0.41 . . . . 0.0 111.041 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -126.03 157.46 37.86 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.519 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE2' ' HG2' ' A' ' 100' ' ' MET . 2.4 m-85 -149.73 160.09 43.82 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.412 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.676 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 7.1 p90 -137.43 130.3 30.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.068 0.461 . . . . 0.0 111.618 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 139' ' ' VAL . 21.4 t -98.54 107.1 19.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.228 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.41 HG21 ' CE2' ' A' ' 92' ' ' PHE . 0.6 OUTLIER -79.72 125.84 30.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.084 -179.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.449 HD11 ' N ' ' A' ' 60' ' ' PHE . 1.9 pp -109.29 -4.69 16.26 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.66 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.432 ' N ' HD12 ' A' ' 116' ' ' LEU . . . -119.95 152.28 53.81 Favored Pre-proline 0 C--O 1.234 0.24 0 CA-C-O 120.527 0.203 . . . . 0.0 110.839 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -65.26 100.06 0.37 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.866 2.377 . . . . 0.0 112.025 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 79.5 p -122.41 110.4 15.59 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.932 0.396 . . . . 0.0 111.467 -179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -94.9 -40.48 9.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.951 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 36.9 p90 -61.81 -33.67 74.54 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.521 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 122' ' ' LEU . 12.8 mt -81.91 -3.31 53.95 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.698 -0.228 . . . . 0.0 111.556 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -82.1 66.56 7.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.117 0.484 . . . . 0.0 110.004 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.9 -47.38 0.07 OUTLIER Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.651 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -56.08 -47.52 77.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 120.706 0.289 . . . . 0.0 110.885 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 -108.57 139.69 42.99 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.549 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.606 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 11.0 t -79.97 155.8 27.5 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.788 0.328 . . . . 0.0 111.125 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.577 HG21 HD22 ' A' ' 90' ' ' LEU . 1.2 tt -83.57 -178.8 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.561 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.524 ' HE1' HD22 ' A' ' 98' ' ' LEU . 1.2 p90 -179.38 -39.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -136.3 -179.75 17.01 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.873 -0.68 . . . . 0.0 113.113 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.7 ttt180 -146.85 171.79 14.65 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.71 0.29 . . . . 0.0 110.924 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.541 HG22 HD22 ' A' ' 25' ' ' LEU . 16.3 t -130.64 119.16 44.99 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.352 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -56.51 2.38 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.13 92.33 3.86 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.061 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.84 -17.26 0.95 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.736 -0.745 . . . . 0.0 113.274 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.568 ' O ' HD13 ' A' ' 136' ' ' ILE . 0.0 OUTLIER -45.87 -36.93 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.89 -47.87 76.46 Favored Glycine 0 C--N 1.337 0.607 0 C-N-CA 121.262 -0.494 . . . . 0.0 112.638 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.423 ' O ' HG23 ' A' ' 142' ' ' VAL . 7.2 tmm? -58.26 -46.07 86.65 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.699 0.285 . . . . 0.0 110.403 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.483 HG11 HG11 ' A' ' 114' ' ' VAL . 19.5 t -59.79 -37.98 73.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.673 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 30.6 m-20 -63.79 -44.66 92.71 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.845 179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 9.5 mtp180 -56.65 -34.3 67.19 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.175 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 138' ' ' MET . 21.8 t -58.24 -36.03 55.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.886 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -80.38 -38.13 18.8 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.563 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 17.3 mtp -55.3 -47.69 75.2 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.7 0.25 . . . . 0.0 111.208 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -50.88 136.89 9.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.52 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -60.75 120.83 10.85 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.636 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 21.6 p -86.48 170.39 11.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.152 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.407 ' CB ' ' HG3' ' A' ' 152' ' ' ARG . 1.4 t-20 -81.96 -166.22 1.18 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.56 34.37 0.76 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 111.777 0.288 . . . . 0.0 111.777 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -160.12 32.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.627 0.251 . . . . 0.0 110.914 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.34 35.23 13.34 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.088 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.407 ' HG3' ' CB ' ' A' ' 148' ' ' ASN . 2.6 ptp180 -111.71 150.65 42.56 Favored Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.943 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -70.28 120.05 6.84 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.671 2.247 . . . . 0.0 112.495 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 44.9 t -70.57 -32.22 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.367 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -88.93 -174.66 4.57 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.432 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -96.39 79.97 3.14 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 111.296 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.923 HG13 ' HB2' ' A' ' 20' ' ' MET . 30.3 t -113.93 113.43 43.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.345 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.92 179.81 8.46 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.388 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.668 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.2 mt -102.22 125.97 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.13 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.608 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 24.1 pt -107.12 -32.45 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.553 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 17' ' ' GLU . 3.3 tttt -145.1 143.73 30.56 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.651 0.262 . . . . 0.0 110.864 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -143.5 94.83 2.66 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.725 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -119.1 155.98 52.8 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.329 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.434 ' CB ' ' HG3' ' A' ' 11' ' ' PRO . 94.0 Cg_endo -79.76 167.2 20.79 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.555 2.17 . . . . 0.0 113.003 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . 0.412 ' HG ' ' HE2' ' A' ' 15' ' ' TYR . 3.5 t -105.91 163.17 12.95 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.334 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 6' ' ' PRO . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.26 -1.3 . . . . 0.0 112.93 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.42 177.08 4.95 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.614 0.245 . . . . 0.0 110.926 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.45 149.61 50.16 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.41 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.8 mp -126.18 71.43 70.15 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.16 108.7 0.3 Allowed 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.803 2.335 . . . . 0.0 112.331 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.42 147.71 84.17 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.043 2.495 . . . . 0.0 112.962 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -152.48 43.37 0.67 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.135 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.6 p -92.53 90.75 7.29 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.809 0.337 . . . . 0.0 111.097 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -155.64 117.81 4.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.99 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.6 mp0 -84.8 160.11 56.39 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.634 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.412 ' HA ' ' HD2' ' A' ' 12' ' ' PRO . 71.7 Cg_exo -49.09 108.01 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.802 2.335 . . . . 0.0 112.643 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 29' ' ' TRP . 41.5 Cg_endo -67.79 -27.99 37.07 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.732 2.288 . . . . 0.0 112.969 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.48 142.83 34.54 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.706 0.289 . . . . 0.0 110.831 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.4 m -121.71 152.59 25.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.148 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -113.85 115.09 27.19 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.071 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.537 HD21 ' HE2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -101.32 104.62 15.63 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.126 -179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -87.16 87.06 7.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.395 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.722 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.6 OUTLIER -84.96 159.6 20.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.674 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.411 ' HB2' HG23 ' A' ' 160' ' ' ILE . 0.3 OUTLIER -60.78 -34.15 74.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.73 179.417 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.425 ' HB2' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -73.51 -33.44 64.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.394 179.849 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 174.16 -168.19 40.88 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 121.281 -0.485 . . . . 0.0 112.152 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.52 ' C ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -119.06 123.66 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 117.182 0.491 . . . . 0.0 111.207 179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.645 HG22 ' HA2' ' A' ' 135' ' ' GLY . 23.1 pt -128.1 146.18 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.863 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.0 t -105.2 139.3 26.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.864 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.522 HD21 HD12 ' A' ' 23' ' ' ILE . 3.4 mt -136.67 159.29 42.26 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.232 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.494 ' C ' HD22 ' A' ' 27' ' ' LEU . 15.8 pt-20 -121.46 145.29 48.08 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.854 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.494 HD22 ' C ' ' A' ' 26' ' ' GLU . 3.7 mm? -116.36 144.48 44.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.521 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.706 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 49.2 m-85 -86.33 102.49 14.04 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 110.753 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.455 ' CZ2' ' HA ' ' A' ' 12' ' ' PRO . 10.9 m95 -76.36 11.99 1.37 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -100.29 -61.96 1.3 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-O 120.682 0.277 . . . . 0.0 110.546 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.751 ' NE2' HD11 ' A' ' 90' ' ' LEU . 6.7 p80 -100.79 -15.98 17.45 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.706 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.18 1.38 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.639 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 66.8 Cg_exo -40.05 -37.21 1.65 Allowed 'Trans proline' 0 C--N 1.366 1.461 0 C-N-CA 122.131 1.887 . . . . 0.0 113.312 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -55.63 13.7 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.061 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.616 HG21 ' HG3' ' A' ' 100' ' ' MET . 52.5 m -68.45 -39.49 81.44 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.17 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.6 t -58.3 -50.63 72.94 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -43.78 86.27 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.403 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -60.46 -48.03 83.55 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.843 179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -56.78 -45.97 81.78 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.614 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.59 76.98 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.55 -42.23 98.53 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.431 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.25 -52.09 67.14 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.544 0.211 . . . . 0.0 111.236 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.59 68.16 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.646 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -61.22 -42.53 98.76 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.344 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.13 -38.67 92.08 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.279 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.06 38.96 1.09 Allowed Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.813 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.04 -32.52 6.55 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.481 0.182 . . . . 0.0 111.011 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HE2' HD21 ' A' ' 16' ' ' LEU . 1.5 t80 -68.59 -36.28 78.5 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.204 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -65.79 108.7 2.21 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.779 0.323 . . . . 0.0 110.27 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 131.74 -23.15 4.24 Favored Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.89 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.537 ' HB ' HD12 ' A' ' 159' ' ' ILE . 0.2 OUTLIER -64.0 165.46 8.91 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.004 0.431 . . . . 0.0 111.502 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.402 ' CG ' ' HB3' ' A' ' 158' ' ' LYS . 0.4 OUTLIER -153.8 143.68 21.92 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.085 -179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CD1' HG22 ' A' ' 62' ' ' ILE . 42.3 m-85 -66.04 108.48 2.23 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.165 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -98.88 5.66 47.22 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.176 -0.466 . . . . 0.0 112.136 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mmt85 -150.05 114.85 5.31 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.618 0.247 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.862 HG23 HG12 ' A' ' 62' ' ' ILE . 4.0 mp -137.49 107.43 4.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.122 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.31 79.79 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.941 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 41.82 -147.78 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.662 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.08 53.47 2.83 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.091 0.472 . . . . 0.0 110.311 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -125.13 -66.02 0.99 Allowed 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.318 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.8 ptm -156.64 137.3 13.24 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.747 0.308 . . . . 0.0 111.175 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.862 HG12 HG23 ' A' ' 56' ' ' ILE . 6.4 mt -132.38 115.17 25.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.871 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 3.0 pt20 -103.08 146.78 27.86 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.111 0.481 . . . . 0.0 112.054 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.78 111.85 0.6 Allowed Glycine 0 C--N 1.333 0.391 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.898 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.44 -179.93 35.53 Favored Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.945 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.65 65.54 0.75 Allowed Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 120.986 0.422 . . . . 0.0 111.23 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.466 ' HB3' ' OG1' ' A' ' 51' ' ' THR . 90.9 Cg_endo -81.78 58.7 6.87 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.84 2.36 . . . . 0.0 112.063 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.2 m -118.22 -59.42 1.9 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.171 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.4 30.5 5.29 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 121.047 -0.597 . . . . 0.0 112.895 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 1.7 t -114.79 -41.29 3.4 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.716 0.258 . . . . 0.0 111.084 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 128.84 -60.19 0.67 Allowed Glycine 0 C--N 1.337 0.592 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.44 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -123.42 37.17 4.47 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.896 0.379 . . . . 0.0 110.674 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -121.66 97.33 0.61 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.677 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -125.33 99.94 0.59 Allowed Glycine 0 C--N 1.333 0.365 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.425 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.73 159.31 16.09 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.662 0.268 . . . . 0.0 110.886 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 t -134.94 159.2 42.21 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.176 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -56.94 -33.6 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.192 179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 -73.38 -30.81 63.53 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.15 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 151.94 -160.97 29.12 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.762 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.81 -52.35 60.62 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 120.655 0.264 . . . . 0.0 110.603 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -156.65 159.3 38.3 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.7 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -144.41 178.03 8.22 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.97 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.97 130.17 38.91 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.824 0.345 . . . . 0.0 110.875 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -65.27 161.03 20.29 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.326 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.78 139.18 47.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.582 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.5 mt -121.34 127.61 51.44 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.284 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.584 ' HB2' HD12 ' A' ' 90' ' ' LEU . 17.7 p80 -65.63 135.64 95.74 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.313 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.93 -36.96 3.11 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.571 2.181 . . . . 0.0 112.429 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -163.42 106.73 1.01 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.737 0.303 . . . . 0.0 110.827 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.751 HD11 ' NE2' ' A' ' 31' ' ' HIS . 11.7 mt -149.85 178.76 8.61 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.31 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -124.66 160.93 27.39 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.873 0.368 . . . . 0.0 111.488 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.414 ' CB ' ' HB2' ' A' ' 123' ' ' ASP . 4.2 t80 -135.83 76.43 1.61 Allowed 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.38 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 79.3 m -57.09 -27.47 61.79 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.426 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 98.96 -58.52 0.88 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.797 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -73.26 114.37 11.38 Favored 'General case' 0 C--O 1.234 0.244 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 70.93 64.01 2.96 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.179 -0.534 . . . . 0.0 112.964 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.444 HD13 ' O ' ' A' ' 96' ' ' GLY . 12.7 mm -130.61 158.59 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.221 0 CA-C-O 120.696 0.284 . . . . 0.0 111.139 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.821 ' HG ' HG12 ' A' ' 114' ' ' VAL . 1.1 mt -137.52 97.66 3.51 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.275 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.623 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -105.68 136.05 45.99 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.05 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.616 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.1 OUTLIER -79.74 121.46 25.37 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.806 0.336 . . . . 0.0 110.658 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -109.87 176.83 4.92 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.457 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -139.76 173.61 11.35 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.296 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -94.07 -35.73 12.43 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.69 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -154.44 167.74 32.52 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.531 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.54 124.07 14.32 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.558 2.172 . . . . 0.0 112.159 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.36 29.07 18.58 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.393 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.7 m -132.03 89.83 2.73 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-O 120.797 0.332 . . . . 0.0 110.39 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -98.58 147.17 25.07 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.625 -179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.23 -110.72 1.48 Allowed Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.16 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 49.5 m -151.55 45.66 0.79 Allowed 'General case' 0 C--O 1.234 0.254 0 CA-C-O 120.986 0.422 . . . . 0.0 111.199 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.31 148.04 32.71 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.167 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -149.7 132.04 15.58 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.408 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.557 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 23.9 p90 -110.08 127.11 54.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.93 0.395 . . . . 0.0 111.497 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.821 HG12 ' HG ' ' A' ' 98' ' ' LEU . 29.2 m -99.85 119.2 47.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.558 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 3.3 p -88.81 142.54 27.58 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.802 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.565 ' N ' HD22 ' A' ' 116' ' ' LEU . 1.3 mm? -113.65 -24.88 8.96 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.138 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.569 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -106.58 162.57 19.27 Favored Pre-proline 0 CA--C 1.532 0.26 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.031 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.569 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 46.4 Cg_endo -67.94 112.31 2.67 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.683 2.255 . . . . 0.0 112.45 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 25.5 p -141.34 76.89 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.279 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 92' ' ' PHE . 36.2 mt-30 -76.67 -34.8 58.23 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.153 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -59.69 -28.5 67.35 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.439 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 122' ' ' LEU . 11.0 mt -81.39 -2.35 49.01 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.414 ' HB2' ' CB ' ' A' ' 92' ' ' PHE . 35.8 t0 -82.89 60.22 5.27 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.22 0.533 . . . . 0.0 110.443 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -151.23 -52.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.778 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -32.61 74.24 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.557 0.218 . . . . 0.0 110.685 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -119.03 148.83 42.58 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.527 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.623 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 95.2 m -99.28 163.7 12.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.716 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.694 HG22 ' H ' ' A' ' 129' ' ' PHE . 2.7 mm -79.41 -179.09 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.241 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.694 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -176.97 -34.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 111.516 0.191 . . . . 0.0 111.516 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.82 170.46 31.26 Favored Glycine 0 C--N 1.337 0.611 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.575 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.401 ' HB3' ' HG2' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -126.7 159.07 34.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.7 0.286 . . . . 0.0 110.983 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.84 94.53 3.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.194 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 6.2 t -92.0 -61.04 1.71 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.277 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -111.74 98.21 7.25 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.645 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 156.03 -21.59 0.51 Allowed Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.659 -0.781 . . . . 0.0 113.455 -179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.2 tt -47.88 -35.15 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.91 92.14 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 121.3 -0.476 . . . . 0.0 113.037 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.94 -16.45 55.23 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.566 0.222 . . . . 0.0 110.879 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.64 HG11 HG21 ' A' ' 114' ' ' VAL . 21.9 t -88.57 -42.28 14.65 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.678 -0.237 . . . . 0.0 111.558 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -70.47 -31.03 68.0 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -53.71 -32.17 50.92 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 111.597 0.221 . . . . 0.0 111.597 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.581 HG12 HG21 ' A' ' 56' ' ' ILE . 20.9 t -63.41 -36.46 76.3 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-O 120.644 0.259 . . . . 0.0 111.145 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.02 -29.05 39.2 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.458 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.6 mtp -74.3 -23.51 59.09 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 145' ' ' VAL . 13.3 p -84.03 29.72 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 64.39 174.59 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.151 0.5 . . . . 0.0 111.427 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.0 p -150.78 173.74 13.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.275 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -89.73 -176.37 4.95 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.852 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -91.4 28.98 1.55 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.608 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -150.4 29.31 0.71 Allowed 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.807 0.337 . . . . 0.0 110.296 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 57.5 44.39 21.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.21 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 7.3 mtp-105 -115.3 144.47 32.33 Favored Pre-proline 0 C--O 1.233 0.229 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.904 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.733 ' HB3' HD13 ' A' ' 56' ' ' ILE . 74.1 Cg_endo -76.58 140.57 21.39 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.804 2.336 . . . . 0.0 112.747 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 22.0 t -80.24 -34.14 14.67 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.457 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.3 -171.01 3.08 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.682 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.59 96.64 5.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.275 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 157' ' ' VAL . 10.9 p -117.02 111.36 34.71 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.996 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.402 ' HB3' ' CG ' ' A' ' 52' ' ' LYS . 5.9 pttt -145.38 173.63 11.83 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.131 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.722 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.1 mt -106.3 126.13 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-O 120.678 0.275 . . . . 0.0 111.3 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.411 HG23 ' HB2' ' A' ' 19' ' ' SER . 42.7 pt -108.14 -33.79 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.638 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 20.9 mttt -138.8 152.11 47.61 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.774 0.321 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -156.48 115.41 3.42 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.082 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -153.5 166.12 16.3 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.442 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -79.84 168.78 18.85 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.045 2.497 . . . . 0.0 112.193 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.38 96.73 3.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.996 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.799 -1.001 . . . . 0.0 113.031 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.607 0.241 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.0 101.87 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.318 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.751 ' HB1' ' HG2' ' A' ' 6' ' ' PRO . . . -96.09 96.14 8.64 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.396 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.549 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 2.0 mt -83.0 -49.0 0.76 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.525 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 4' ' ' ILE . 52.9 Cg_exo -53.68 -49.83 15.91 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.444 2.096 . . . . 0.0 113.337 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.751 ' HG2' ' HB1' ' A' ' 3' ' ' ALA . 87.6 Cg_endo -81.51 129.33 6.5 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 122.473 2.116 . . . . 0.0 112.432 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -92.77 119.59 32.29 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -137.17 153.12 50.52 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.24 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 62.27 86.75 0.11 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.047 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -120.52 147.88 46.51 Favored Pre-proline 0 C--O 1.232 0.16 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.402 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.44 ' CG ' ' HB2' ' A' ' 164' ' ' PRO . 58.1 Cg_endo -71.84 122.37 8.45 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.776 2.318 . . . . 0.0 112.664 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -70.23 -40.0 5.03 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.73 2.287 . . . . 0.0 112.739 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -103.23 168.8 8.94 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.913 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.462 HG23 HD13 ' A' ' 27' ' ' LEU . 21.3 t -128.36 126.86 66.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.019 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.429 ' CE1' HD11 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -90.43 95.37 10.14 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.594 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -99.01 85.75 3.32 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.882 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.99 89.02 6.37 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.274 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.541 HG22 ' CG1' ' A' ' 159' ' ' ILE . 1.1 p -84.36 162.78 19.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.165 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.508 ' HB2' HG23 ' A' ' 160' ' ' ILE . 2.3 t -68.62 -34.07 75.13 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.46 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.514 ' CB ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -70.06 -33.36 71.84 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.231 179.653 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.1 -159.12 27.26 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 121.129 -0.558 . . . . 0.0 112.387 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.429 HD11 ' CE1' ' A' ' 15' ' ' TYR . 11.6 tt -122.52 136.3 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-N 116.877 0.339 . . . . 0.0 111.469 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG22 ' CA ' ' A' ' 135' ' ' GLY . 17.3 pt -139.16 137.8 41.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.522 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.4 t -110.2 131.18 61.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.423 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -128.59 144.59 51.18 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 120.865 0.365 . . . . 0.0 111.325 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -106.41 116.7 32.39 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.886 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.462 HD13 HG23 ' A' ' 14' ' ' VAL . 8.9 mp -94.96 129.26 42.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.229 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.791 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 69.9 m-85 -63.41 101.5 0.33 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.86 -179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.9 p-90 -82.01 18.34 1.36 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.6 mmtp -100.38 -66.16 0.92 Allowed 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.743 0.306 . . . . 0.0 110.474 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.5 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 3.0 t60 -100.65 -15.38 17.77 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.983 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.791 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -96.43 0.84 0.08 OUTLIER Pre-proline 0 CA--C 1.544 0.733 0 N-CA-C 114.417 1.266 . . . . 0.0 114.417 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 76.3 Cg_exo -42.32 -37.06 4.73 Favored 'Trans proline' 0 C--N 1.366 1.487 0 C-N-CA 121.987 1.791 . . . . 0.0 112.753 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -54.17 39.45 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.533 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -65.29 -35.05 79.81 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.453 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 73.9 m -60.11 -47.18 87.0 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.508 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -59.28 -39.71 83.77 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.495 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.28 -47.24 84.26 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.578 179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -61.21 -43.89 98.16 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.99 63.14 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.109 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -63.21 -37.56 87.73 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.961 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.2 OUTLIER -63.41 -35.73 81.39 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.631 0.253 . . . . 0.0 110.862 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.496 ' HB1' ' O ' ' A' ' 162' ' ' ALA . . . -83.32 -36.06 24.73 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.558 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.36 -36.89 63.6 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.325 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 20.4 ttm105 -61.31 -36.58 80.51 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.525 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.62 30.88 3.37 Favored Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.938 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -97.94 -51.73 3.96 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-O 120.599 0.238 . . . . 0.0 110.433 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.422 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 4.0 m-85 -65.55 -29.57 70.2 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.662 179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.27 101.09 0.88 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.253 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.59 30.02 3.43 Favored Glycine 0 CA--C 1.522 0.477 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.38 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 p -111.21 151.33 28.37 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.976 0.388 . . . . 0.0 110.85 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -127.57 151.82 48.41 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.086 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -60.83 144.3 52.96 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.126 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 63' ' ' GLN . 16.5 p80 -113.71 -38.93 4.14 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.905 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.442 ' CD ' HD11 ' A' ' 57' ' ' ILE . 5.7 ttt180 -125.11 118.62 26.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 120.79 0.328 . . . . 0.0 111.257 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.903 HG23 HG12 ' A' ' 62' ' ' ILE . 3.3 mt -130.54 104.35 9.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.749 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.442 HD11 ' CD ' ' A' ' 55' ' ' ARG . 4.1 mp -98.28 115.19 37.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.976 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.69 137.19 57.14 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.922 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.65 35.43 19.87 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.652 179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -151.09 -88.75 0.06 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.585 -0.28 . . . . 0.0 110.797 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.432 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.8 OUTLIER -160.46 157.36 27.49 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.698 0.285 . . . . 0.0 111.041 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.903 HG12 HG23 ' A' ' 56' ' ' ILE . 6.6 mt -130.38 124.93 58.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.346 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 7.2 pt20 -112.27 148.72 33.55 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.77 109.54 0.59 Allowed Glycine 0 N--CA 1.45 -0.402 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.374 179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.57 ' HA3' ' HB3' ' A' ' 111' ' ' GLN . . . -160.9 -179.63 35.77 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.228 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -119.27 61.21 5.74 Favored Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 120.805 0.335 . . . . 0.0 110.732 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.52 ' O ' HG23 ' A' ' 68' ' ' THR . 29.9 Cg_endo -64.17 -53.71 1.08 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.387 2.058 . . . . 0.0 112.097 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.52 HG23 ' O ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -167.81 41.1 0.04 OUTLIER 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.981 0.42 . . . . 0.0 110.645 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -77.49 64.47 3.23 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.264 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.7 t -175.28 -42.5 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.622 0.248 . . . . 0.0 111.055 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 127.83 91.05 0.71 Allowed Glycine 0 C--N 1.334 0.463 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.069 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 60.86 37.71 18.33 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.753 0.311 . . . . 0.0 111.053 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.37 90.86 0.41 Allowed Glycine 0 C--N 1.336 0.565 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.404 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.32 102.9 0.23 Allowed Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.447 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -140.31 136.17 32.96 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.658 0.266 . . . . 0.0 111.281 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 24.7 t -113.1 167.12 10.8 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.393 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 29.6 pt -56.99 -39.35 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.235 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -80.34 -30.98 38.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.693 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.42 -167.05 29.66 Favored Glycine 0 C--N 1.336 0.576 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.848 179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 17.3 tptt -63.07 -54.96 29.86 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.598 0.237 . . . . 0.0 110.678 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.775 ' HG2' HG23 ' A' ' 107' ' ' THR . 8.8 mp0 -135.7 139.26 43.53 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.817 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 27.7 p90 -123.93 172.02 9.26 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.243 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.83 179.2 1.49 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.196 0.522 . . . . 0.0 111.927 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -118.15 159.95 22.4 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.416 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -121.17 75.42 1.16 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.164 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.403 HD12 ' OG1' ' A' ' 127' ' ' THR . 0.4 OUTLIER -119.03 141.07 49.03 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.05 179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.407 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -164.06 -63.28 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.334 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.868 179.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.55 ' HG2' HD11 ' A' ' 90' ' ' LEU . 70.9 Cg_endo -74.19 172.55 15.79 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.695 2.263 . . . . 0.0 112.956 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -110.51 95.5 5.61 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.867 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 1.005 HD22 HG21 ' A' ' 128' ' ' ILE . 5.9 mp -91.73 172.68 8.32 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.972 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 159.21 30.42 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.037 0.446 . . . . 0.0 111.382 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -162.4 41.68 0.12 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.17 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 94' ' ' GLY . 11.7 t -148.11 -47.18 0.16 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.854 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' N ' HG23 ' A' ' 93' ' ' THR . . . -55.28 122.09 24.92 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.823 -0.703 . . . . 0.0 111.757 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.45 126.88 8.62 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.616 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 102.91 63.06 0.71 Allowed Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.281 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.616 HD13 ' O ' ' A' ' 96' ' ' GLY . 9.5 mm -130.42 137.79 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 117.056 0.428 . . . . 0.0 110.955 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.833 HD22 HD22 ' A' ' 25' ' ' LEU . 7.7 tp -111.2 101.91 10.37 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.107 0.479 . . . . 0.0 110.888 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.64 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -110.02 146.73 34.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.31 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -79.28 133.08 36.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.223 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.84 142.54 35.17 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.551 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -143.22 117.72 9.73 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.086 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -33.31 75.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.394 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.32 179.5 34.88 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.303 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.85 128.67 23.78 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.494 2.129 . . . . 0.0 111.934 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 58.79 35.31 24.24 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.932 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.775 HG23 ' HG2' ' A' ' 81' ' ' GLN . 85.5 m -143.19 89.33 2.09 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.493 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -106.19 155.41 19.49 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.968 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -127.95 -165.63 11.88 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.72 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.31 61.88 1.07 Allowed 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.947 0.403 . . . . 0.0 110.888 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.57 ' HB3' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -153.34 155.8 37.15 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.04 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -151.16 161.03 43.47 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.072 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 14.2 p90 -130.79 141.33 50.35 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.3 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.697 HG11 HG11 ' A' ' 139' ' ' VAL . 11.4 t -102.74 110.6 29.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.479 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.89 109.15 15.99 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.032 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 61' ' ' MET . 0.9 OUTLIER -103.53 -6.82 21.36 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.917 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 119' ' ' THR . . . -122.81 142.85 38.84 Favored Pre-proline 0 CA--C 1.529 0.15 0 CA-C-O 120.387 0.136 . . . . 0.0 110.806 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -54.39 122.65 11.9 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.905 2.403 . . . . 0.0 112.577 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 117' ' ' ALA . 31.1 p -128.48 112.56 14.48 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.947 0.404 . . . . 0.0 111.279 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -94.92 -42.74 8.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.627 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.438 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 46.7 p90 -67.74 -31.88 72.1 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.336 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.459 HD23 ' HA ' ' A' ' 122' ' ' LEU . 12.4 mt -89.36 -2.25 58.36 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.739 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -68.85 85.53 0.33 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.09 0.471 . . . . 0.0 110.348 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.02 -25.6 3.33 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.72 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -57.01 -53.81 53.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.712 0.256 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.9 m-70 -102.3 156.7 17.4 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.827 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.64 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 47.6 m -90.32 150.9 21.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.001 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 1.005 HG21 HD22 ' A' ' 90' ' ' LEU . 1.1 tt -79.88 -179.62 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.418 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.453 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -177.22 -35.98 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -153.88 179.99 29.7 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.828 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.46 161.9 36.87 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 122.827 -0.219 . . . . 0.0 110.659 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 132' ' ' VAL . 11.6 p -124.51 105.32 15.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-O 121.27 0.557 . . . . 0.0 111.528 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.6 m -97.51 -38.42 9.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.493 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -126.28 88.14 2.79 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.89 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.475 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 159.46 -22.31 0.29 Allowed Glycine 0 CA--C 1.523 0.586 0 C-N-CA 120.778 -0.725 . . . . 0.0 113.351 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.2 tt -43.33 -38.81 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.4 -37.12 86.97 Favored Glycine 0 C--N 1.338 0.681 0 C-N-CA 121.236 -0.506 . . . . 0.0 112.909 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.99 -36.0 59.37 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.789 0.328 . . . . 0.0 110.124 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.697 HG11 HG11 ' A' ' 114' ' ' VAL . 23.7 t -66.76 -56.74 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.144 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.32 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -63.26 -24.43 67.87 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 121.215 -0.194 . . . . 0.0 111.258 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.3 mtt180 -58.67 -33.77 70.49 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.547 0.213 . . . . 0.0 110.816 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.775 HG12 HG21 ' A' ' 56' ' ' ILE . 26.0 t -63.84 -35.64 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.018 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -71.71 -39.5 60.07 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.312 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 1.8 mmt -53.66 -51.5 62.96 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.8 OUTLIER -52.2 143.15 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 111.691 -179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -64.75 122.21 16.36 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.821 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 44.3 p -93.06 179.15 5.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.066 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -170.04 2.21 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.894 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.75 46.02 1.32 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.89 0.376 . . . . 0.0 111.646 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -174.61 -76.53 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.835 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -170.58 30.09 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.386 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.31 118.64 60.85 Favored Pre-proline 0 C--O 1.232 0.173 0 CA-C-O 120.656 0.265 . . . . 0.0 111.682 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.692 ' HB3' HD13 ' A' ' 56' ' ' ILE . 38.1 Cg_endo -67.51 115.25 3.61 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.044 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.1 t -64.21 -31.48 53.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.478 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.23 -171.04 2.79 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.619 179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -116.26 97.38 6.01 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.717 0.294 . . . . 0.0 111.446 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.515 ' O ' HG13 ' A' ' 157' ' ' VAL . 9.1 p -123.48 108.51 21.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.875 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.3 175.22 11.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.361 -179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.541 ' CG1' HG22 ' A' ' 18' ' ' THR . 3.6 mt -103.57 130.48 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.321 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.508 HG23 ' HB2' ' A' ' 19' ' ' SER . 17.4 pt -106.73 -29.43 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.914 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.18 108.51 1.9 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.16 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.496 ' O ' ' HB1' ' A' ' 43' ' ' ALA . . . -120.37 114.37 21.74 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.187 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -154.1 149.22 20.26 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.103 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.44 ' HB2' ' CG ' ' A' ' 11' ' ' PRO . 97.5 Cg_endo -80.03 161.3 23.73 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.514 2.143 . . . . 0.0 112.6 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 28.8 t -165.38 -62.34 0.03 OUTLIER 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.034 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.375 -1.236 . . . . 0.0 112.424 -179.909 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 ttm . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.675 0.274 . . . . 0.0 111.319 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.24 73.02 1.34 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.947 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -125.76 86.54 2.55 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.249 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 4' ' ' ILE . 3.5 tt -129.68 54.69 15.16 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.2 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.462 ' HG2' ' HD3' ' A' ' 6' ' ' PRO . 1.6 Cg_endo -46.2 -54.33 4.83 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.78 2.32 . . . . 0.0 112.661 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HD3' ' HG2' ' A' ' 5' ' ' PRO . 62.5 Cg_endo -71.9 -170.18 0.52 Allowed 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 122.206 1.937 . . . . 0.0 112.099 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 68.37 97.03 0.06 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 120.944 0.402 . . . . 0.0 110.87 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 t -123.46 173.42 8.03 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.313 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -145.9 34.87 1.02 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.123 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -70.36 -60.45 3.32 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.323 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.85 112.71 3.34 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.516 2.144 . . . . 0.0 112.522 -179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.18 55.28 4.58 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.829 2.353 . . . . 0.0 112.069 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -114.36 166.32 11.8 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.019 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 21.3 t -127.58 141.26 46.84 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.054 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -96.03 96.49 8.91 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.815 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.531 HD12 HD21 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -86.3 94.73 9.42 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.766 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.554 ' HG2' HD11 ' A' ' 160' ' ' ILE . 4.3 tt0 -83.5 118.77 24.0 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.066 0.46 . . . . 0.0 111.225 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.54 HG22 HG23 ' A' ' 159' ' ' ILE . 8.1 p -135.25 158.02 45.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.522 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.8 p -59.04 -36.72 75.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.747 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.736 ' CB ' HG13 ' A' ' 157' ' ' VAL . 8.0 tpt -67.03 -33.49 75.66 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.929 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.55 143.42 3.67 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.182 -0.532 . . . . 0.0 112.36 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.502 HD12 ' CB ' ' A' ' 17' ' ' GLU . 1.7 tt -82.57 126.83 40.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.15 0 CA-C-O 120.807 0.337 . . . . 0.0 111.174 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.471 HG22 ' HA2' ' A' ' 135' ' ' GLY . 2.7 pt -128.56 137.74 56.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.295 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.403 ' HB ' ' CG ' ' A' ' 134' ' ' GLN . 20.6 t -99.86 135.37 35.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.02 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD12 HD21 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -135.67 147.56 48.59 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.315 -179.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.24 129.56 38.16 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.589 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.6 HD21 HD12 ' A' ' 25' ' ' LEU . 4.5 mm? -104.78 131.97 51.59 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.337 -179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.808 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 22.8 m-85 -76.07 99.65 4.69 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.0 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 39.9 p-90 -83.03 18.18 1.73 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.17 -67.32 0.86 Allowed 'General case' 0 C--O 1.232 0.147 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.489 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 2.3 m-70 -100.69 -13.28 18.57 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.917 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.59 1.71 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.707 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.2 Cg_exo -40.86 -36.4 2.0 Favored 'Trans proline' 0 C--N 1.366 1.499 0 C-N-CA 122.062 1.841 . . . . 0.0 112.927 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -47.74 79.38 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.688 179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.613 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.7 OUTLIER -78.35 -36.76 45.75 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.906 179.352 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.3 t -57.98 -47.63 82.43 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.655 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.19 -42.97 75.1 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.197 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.8 t-20 -58.89 -53.7 55.43 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.87 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -54.68 -41.46 70.21 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.997 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.17 -53.1 54.65 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.27 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -45.44 93.09 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.176 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -35.4 71.19 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.136 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -84.21 -36.48 22.75 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.298 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.23 -47.23 68.38 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.586 -0.279 . . . . 0.0 111.232 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -58.22 -25.82 62.11 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.757 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 101.96 20.33 13.0 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.817 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.49 -34.74 18.55 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 120.643 0.259 . . . . 0.0 110.935 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.429 ' HE2' HD21 ' A' ' 16' ' ' LEU . 0.5 OUTLIER -76.15 -25.42 55.28 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.438 179.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 9.7 m-80 -65.08 93.62 0.13 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.716 0.293 . . . . 0.0 110.245 179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 137.08 -20.11 3.41 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.106 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.817 ' HB ' HD12 ' A' ' 159' ' ' ILE . 2.2 m -58.12 157.41 8.19 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.906 0.353 . . . . 0.0 111.508 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -138.92 169.39 17.88 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.482 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' HB3' HD11 ' A' ' 56' ' ' ILE . 9.9 m-85 -96.86 83.47 3.41 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.801 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.96 -45.24 78.36 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.909 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmt85 -99.77 120.66 40.09 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.754 0.311 . . . . 0.0 111.026 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.867 HD12 ' HG2' ' A' ' 153' ' ' PRO . 19.3 mt -145.68 98.54 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.295 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.4 mt -104.11 107.09 21.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.898 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -62.83 -39.09 93.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.538 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -85.66 41.3 0.89 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 177.41 -85.62 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.986 179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.51 171.53 18.83 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.713 0.292 . . . . 0.0 111.115 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.726 HG21 HG23 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -131.77 151.67 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.824 179.79 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.9 OUTLIER -134.32 161.77 34.03 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.587 0.708 . . . . 0.0 112.524 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.81 109.33 0.41 Allowed Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.834 -1.075 . . . . 0.0 111.142 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 111' ' ' GLN . . . -160.2 -179.25 34.85 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.145 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.4 76.34 3.74 Favored Pre-proline 0 C--O 1.234 0.239 0 CA-C-O 120.814 0.34 . . . . 0.0 110.75 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -78.36 143.49 19.67 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.646 2.231 . . . . 0.0 112.58 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.8 p -98.4 29.5 3.59 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.442 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -75.82 -27.25 63.08 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.454 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -112.38 -30.11 7.28 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 111.495 0.183 . . . . 0.0 111.495 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 112.27 22.87 5.69 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.943 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -118.28 16.67 13.97 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.847 0.324 . . . . 0.0 111.236 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -124.98 150.19 17.12 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.411 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.04 168.82 28.95 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.092 -0.575 . . . . 0.0 113.14 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.09 175.47 8.53 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.723 0.297 . . . . 0.0 111.213 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.7 t -104.51 158.64 16.35 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.012 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.751 HD12 ' N ' ' A' ' 78' ' ' TYR . 2.6 pp -57.23 -27.26 27.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.298 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.751 ' N ' HD12 ' A' ' 77' ' ' ILE . 19.3 m-85 -82.28 -33.14 29.23 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.67 -0.241 . . . . 0.0 110.904 179.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 145.02 -158.53 27.66 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 121.153 -0.546 . . . . 0.0 112.33 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.71 -72.71 0.19 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.874 0.337 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.416 ' HB3' HG23 ' A' ' 107' ' ' THR . 15.8 mm100 -133.1 140.75 47.81 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 110.216 -0.291 . . . . 0.0 110.216 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.425 ' CZ ' ' HB2' ' A' ' 108' ' ' ASN . 44.0 p90 -130.03 166.93 19.1 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.776 0.322 . . . . 0.0 111.57 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -101.25 110.0 21.94 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.345 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -169.06 178.35 4.49 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.806 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.485 ' HB3' HG21 ' A' ' 127' ' ' THR . 2.0 mm-40 62.9 166.42 0.12 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.685 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 65.38 106.49 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.587 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.411 ' CB ' ' HD3' ' A' ' 88' ' ' PRO . 1.2 m80 -172.11 -61.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.085 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 87' ' ' HIS . 87.9 Cg_endo -80.84 -173.38 1.82 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.652 2.235 . . . . 0.0 112.616 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.58 95.62 5.79 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.695 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.949 ' HG ' HG21 ' A' ' 128' ' ' ILE . 2.6 mm? -77.03 -176.33 3.94 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.114 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.88 -70.21 0.47 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 59.72 70.58 0.63 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.938 0.399 . . . . 0.0 111.38 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 3.2 m -75.75 -39.08 57.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 119.93 -42.06 1.83 Allowed Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 116.011 -0.541 . . . . 0.0 112.362 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.55 100.22 11.21 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.735 0.302 . . . . 0.0 111.219 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.585 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 89.23 55.22 2.13 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.915 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.585 HD13 ' O ' ' A' ' 96' ' ' GLY . 37.3 mm -130.61 130.75 64.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.653 0.264 . . . . 0.0 110.867 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 129' ' ' PHE . 2.7 mt -102.92 104.27 14.48 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.619 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.738 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -108.63 142.42 39.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.32 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.613 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.5 123.53 27.65 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.47 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.59 143.9 32.81 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.491 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -154.48 136.34 14.52 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.892 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.69 -31.58 72.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -156.56 179.32 32.49 Favored Glycine 0 C--N 1.332 0.333 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.926 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.87 139.61 63.0 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.398 2.065 . . . . 0.0 112.122 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 59.81 44.91 13.29 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.308 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 81' ' ' GLN . 87.6 m -146.99 85.97 1.63 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.848 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 82' ' ' PHE . 68.3 m-80 -106.56 152.13 24.11 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.819 0.342 . . . . 0.0 111.51 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.09 -138.95 3.62 Favored Glycine 0 C--N 1.336 0.543 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.808 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.47 60.84 0.73 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.001 0.429 . . . . 0.0 110.96 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.505 ' HA ' ' HA3' ' A' ' 65' ' ' GLY . 0.5 OUTLIER -150.83 146.25 26.23 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.379 179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.458 ' CD2' ' HG2' ' A' ' 100' ' ' MET . 3.8 m-85 -149.72 160.08 43.82 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.72 0.295 . . . . 0.0 111.391 -179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.738 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 31.4 p90 -134.66 134.37 41.07 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.483 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.494 HG22 ' CD2' ' A' ' 98' ' ' LEU . 24.1 t -104.04 110.02 29.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.238 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.498 HG21 HG21 ' A' ' 119' ' ' THR . 45.1 p -80.96 138.27 36.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.977 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -114.61 -18.91 11.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.512 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -110.39 158.29 35.76 Favored Pre-proline 0 CA--C 1.53 0.199 0 N-CA-C 110.485 -0.191 . . . . 0.0 110.485 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.464 ' HA ' ' HA3' ' A' ' 94' ' ' GLY . 85.4 Cg_exo -44.84 128.74 9.16 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.848 2.366 . . . . 0.0 112.902 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.806 HG22 HD12 ' A' ' 122' ' ' LEU . 22.8 p -131.94 33.79 3.91 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.208 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -61.64 -37.79 85.3 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.831 0.348 . . . . 0.0 110.58 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 46.6 p90 -79.6 -27.78 41.05 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.136 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.806 HD12 HG22 ' A' ' 119' ' ' THR . 19.8 mt -75.52 -5.15 43.78 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.89 84.69 0.08 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.179 0.514 . . . . 0.0 110.391 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 163.3 -41.14 0.33 Allowed Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.415 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -59.12 -57.29 13.72 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.625 0.25 . . . . 0.0 110.783 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -109.53 173.69 6.21 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.639 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.718 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 28.2 m -106.67 160.14 15.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.97 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.949 HG21 ' HG ' ' A' ' 90' ' ' LEU . 2.3 tt -87.51 179.32 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.226 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.568 ' HE1' HD11 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -176.79 -40.57 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 179.397 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.08 -179.8 27.12 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.276 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -144.08 167.26 22.8 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.494 0.187 . . . . 0.0 110.837 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 132' ' ' VAL . 30.5 m -125.08 107.21 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 CA-C-O 121.038 0.447 . . . . 0.0 111.695 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.73 -43.99 12.14 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.432 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.403 ' CG ' ' HB ' ' A' ' 24' ' ' VAL . 7.2 pt20 -132.06 90.59 2.84 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.815 -0.629 . . . . 0.0 109.898 179.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.471 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 168.96 -27.77 0.13 Allowed Glycine 0 CA--C 1.522 0.471 0 C-N-CA 120.854 -0.688 . . . . 0.0 113.341 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.507 HD12 ' CA ' ' A' ' 96' ' ' GLY . 12.3 tt -44.28 -36.11 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -54.9 -41.04 75.06 Favored Glycine 0 C--N 1.338 0.648 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.694 179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.679 ' O ' HG23 ' A' ' 142' ' ' VAL . 11.4 tmm? -68.59 -36.55 78.87 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.753 0.311 . . . . 0.0 110.755 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.449 HG13 HD11 ' A' ' 62' ' ' ILE . 35.1 t -73.62 -35.46 44.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.087 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -72.17 -39.39 68.71 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.192 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 138' ' ' MET . 7.5 ptp180 -62.57 -31.69 72.55 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.773 -0.194 . . . . 0.0 111.499 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.727 HG11 HD13 ' A' ' 56' ' ' ILE . 22.0 t -56.51 -31.0 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.632 0.253 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.85 -22.98 40.34 Favored Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.714 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 4.5 mmt -76.8 -4.54 44.02 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.27 32.1 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 CA-C-O 120.646 0.26 . . . . 0.0 111.489 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 64.79 169.96 0.19 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.891 0.377 . . . . 0.0 111.432 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -152.67 175.84 12.39 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.399 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 0.6 OUTLIER -79.92 -174.72 4.57 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.76 179.465 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 10.7 p -89.4 36.59 0.84 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.572 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -166.32 -72.42 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.392 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -174.13 70.17 0.03 OUTLIER 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.666 0.269 . . . . 0.0 110.825 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.442 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.1 OUTLIER -153.37 99.73 2.65 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.625 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.867 ' HG2' HD12 ' A' ' 56' ' ' ILE . 51.0 Cg_exo -53.6 154.35 16.1 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 122.988 2.459 . . . . 0.0 113.308 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 18.2 t -76.18 -34.11 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.973 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.12 -170.65 2.99 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.682 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -127.48 110.83 13.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.976 0.417 . . . . 0.0 111.436 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.736 HG13 ' CB ' ' A' ' 20' ' ' MET . 35.5 t -108.54 121.0 60.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.212 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.896 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 18' ' ' THR . 3.0 pttt -145.24 152.65 40.29 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.593 0.235 . . . . 0.0 111.203 179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.817 HD12 ' HB ' ' A' ' 51' ' ' THR . 30.4 mt -93.21 138.97 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.086 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.554 HD11 ' HG2' ' A' ' 17' ' ' GLU . 9.9 pt -109.76 -35.61 2.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.938 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -168.66 146.58 4.01 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.713 0.292 . . . . 0.0 111.271 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.499 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -132.17 115.85 16.24 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.131 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -133.56 156.19 79.85 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.018 -179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -79.68 170.93 16.35 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.676 2.251 . . . . 0.0 112.741 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.55 94.76 6.95 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.361 -1.244 . . . . 0.0 112.288 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.8 ptt? . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -97.93 154.36 17.72 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.513 0.197 . . . . 0.0 111.064 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 71.13 138.16 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.124 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 mp -109.95 98.01 32.2 Favored Pre-proline 0 C--O 1.232 0.181 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.924 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -51.95 160.29 3.14 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.987 2.458 . . . . 0.0 112.536 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -50.74 120.58 6.72 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.903 2.402 . . . . 0.0 112.777 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -125.33 125.94 44.28 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.856 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 m 64.0 174.32 0.18 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.401 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -164.73 159.84 19.15 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.526 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -83.26 135.82 43.94 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.96 116.02 4.14 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.707 2.271 . . . . 0.0 112.358 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -67.4 -33.99 28.04 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 122.689 2.259 . . . . 0.0 112.441 179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -126.36 142.51 51.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.805 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.403 HG12 ' HB3' ' A' ' 164' ' ' PRO . 27.5 m -126.85 153.64 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.286 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -111.34 100.65 9.22 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.994 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.4 110.59 19.81 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.921 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -87.39 108.23 18.9 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.781 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.558 HG22 ' CG1' ' A' ' 159' ' ' ILE . 1.0 OUTLIER -114.02 156.38 24.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.166 -179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -61.7 -31.58 71.74 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.362 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.792 ' HB2' HG13 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -71.12 -34.64 71.25 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.87 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.68 -156.22 26.33 Favored Glycine 0 C--N 1.335 0.483 0 C-N-CA 121.283 -0.484 . . . . 0.0 112.362 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 15.2 tt -127.53 128.26 69.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.814 0.307 . . . . 0.0 111.142 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.637 HG22 ' HA2' ' A' ' 135' ' ' GLY . 11.6 pt -141.0 138.73 34.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.497 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.502 ' O ' HD23 ' A' ' 25' ' ' LEU . 22.3 m -97.46 148.27 5.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.242 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 24' ' ' VAL . 16.3 mt -123.49 122.83 39.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.367 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.11 94.96 6.25 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.254 179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 36' ' ' CYS . 8.8 mp -82.41 147.26 28.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.976 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.699 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 52.6 m-85 -72.26 102.0 2.99 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.699 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -81.16 15.76 1.8 Allowed 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 112.305 0.483 . . . . 0.0 112.305 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.82 -69.82 0.75 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.682 0.277 . . . . 0.0 110.277 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.491 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.59 -13.99 18.36 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.17 -0.468 . . . . 0.0 112.164 179.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.699 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.81 1.58 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 114.425 1.268 . . . . 0.0 114.425 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.66 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 72.3 Cg_exo -41.4 -36.75 2.93 Favored 'Trans proline' 0 C--N 1.367 1.507 0 C-N-CA 122.065 1.844 . . . . 0.0 112.844 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -52.33 63.79 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 120.773 0.321 . . . . 0.0 110.36 179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.3 m -64.97 -40.45 95.0 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.357 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.73 ' HA ' HD23 ' A' ' 27' ' ' LEU . 46.2 t -56.5 -48.38 77.31 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.467 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 17.1 mttt -58.79 -42.88 90.09 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.256 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -60.2 -51.9 67.61 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.615 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.428 ' HE1' ' HH ' ' A' ' 48' ' ' TYR . 0.4 OUTLIER -61.24 -41.63 97.22 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.176 -179.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.23 -43.92 85.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.697 ' HB3' HD13 ' A' ' 77' ' ' ILE . 0.5 OUTLIER -67.05 -42.09 85.36 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.286 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 76' ' ' SER . 0.1 OUTLIER -62.57 -34.01 76.11 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.646 0.26 . . . . 0.0 111.153 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -83.59 -31.73 26.14 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.841 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.0 mtt180 -84.22 -38.92 19.95 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-O 120.558 0.218 . . . . 0.0 111.474 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.1 ttt180 -61.4 -58.44 8.2 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.592 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.85 65.17 0.04 OUTLIER Glycine 0 C--N 1.334 0.452 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.75 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -133.39 -62.08 0.8 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.584 0.23 . . . . 0.0 110.827 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' HH ' ' HE1' ' A' ' 39' ' ' PHE . 3.9 m-85 -60.59 -42.63 97.12 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.174 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -67.47 101.18 0.94 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.053 0.454 . . . . 0.0 110.681 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.49 -32.99 2.11 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.437 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.561 HG21 ' O ' ' A' ' 65' ' ' GLY . 14.5 t -86.66 -168.59 2.29 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.752 0.31 . . . . 0.0 111.391 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 10.6 pttm -150.31 -174.16 4.66 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.692 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.617 ' HB3' HD11 ' A' ' 56' ' ' ILE . 8.1 m-85 -83.38 122.12 28.06 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.414 ' CD2' ' HA3' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -103.29 11.88 36.21 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.524 ' O ' HD13 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -157.62 111.33 2.55 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.613 0.244 . . . . 0.0 111.087 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.853 HG23 HG22 ' A' ' 62' ' ' ILE . 21.6 mm -134.9 120.07 29.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.321 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 57' ' ' ILE . 4.7 mp -109.78 115.23 49.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.493 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.5 tmtt? -54.78 124.43 16.49 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.465 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.6 t0 58.38 57.4 3.9 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.176 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -165.1 -81.68 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.368 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.496 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -160.71 173.33 15.59 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.875 0.369 . . . . 0.0 111.617 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.853 HG22 HG23 ' A' ' 56' ' ' ILE . 42.3 pt -142.87 140.51 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.942 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.0 OUTLIER -122.17 153.81 38.28 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.243 0.544 . . . . 0.0 111.969 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.38 146.42 16.48 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.826 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.561 ' O ' HG21 ' A' ' 51' ' ' THR . . . -110.85 139.32 15.46 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.33 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 110' ' ' SER . 4.9 t70 -158.92 53.52 0.59 Allowed Pre-proline 0 CA--C 1.537 0.48 0 CA-C-O 120.836 0.35 . . . . 0.0 111.079 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 66' ' ' ASP . 60.9 Cg_endo -85.88 -177.84 2.68 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.992 2.461 . . . . 0.0 113.137 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.416 ' HB ' ' O ' ' A' ' 73' ' ' GLY . 1.3 p -155.79 31.17 0.36 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.784 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.32 59.73 1.92 Allowed Glycine 0 C--N 1.333 0.405 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.574 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.3 p -112.32 28.78 8.47 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.701 0.286 . . . . 0.0 111.043 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.42 32.3 83.75 Favored Glycine 0 C--N 1.334 0.433 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.691 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.87 -70.47 0.77 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.471 0.177 . . . . 0.0 110.96 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 68' ' ' THR . . . -160.45 158.83 30.29 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.34 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -137.4 104.53 0.47 Allowed Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.782 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -160.4 121.21 2.97 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.57 0.224 . . . . 0.0 111.395 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.561 ' HB2' HD11 ' A' ' 42' ' ' LEU . 13.0 p -92.26 -52.4 4.7 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.762 179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.697 HD13 ' HB3' ' A' ' 41' ' ' GLU . 1.1 tp -172.6 -46.59 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.954 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.435 ' N ' HG23 ' A' ' 77' ' ' ILE . 25.1 m-85 -102.18 -32.92 9.86 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.68 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 176.99 179.33 47.33 Favored Glycine 0 C--N 1.335 0.521 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.385 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.27 11.42 30.38 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -174.1 110.21 0.15 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.606 0.241 . . . . 0.0 110.998 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE1' ' HB3' ' A' ' 108' ' ' ASN . 34.7 p90 -126.88 161.04 29.21 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.819 0.342 . . . . 0.0 111.355 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.0 179.78 2.61 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.302 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.3 177.48 5.19 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.854 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -139.17 103.96 4.89 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.272 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 15.1 tp -154.17 134.33 13.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.425 ' N ' ' HD2' ' A' ' 88' ' ' PRO . 0.1 OUTLIER -171.44 -61.3 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.131 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 87' ' ' HIS . 18.4 Cg_endo -60.31 171.33 3.31 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 122.682 2.255 . . . . 0.0 112.716 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -78.36 107.64 11.13 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.997 0.427 . . . . 0.0 111.195 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.468 ' CD1' HG21 ' A' ' 128' ' ' ILE . 4.0 mm? -109.44 162.32 14.48 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.932 -179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -118.31 150.83 38.82 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.461 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -151.45 96.05 2.22 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.174 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 15.0 t -175.45 -41.77 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.627 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -58.34 120.25 21.11 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.064 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 116' ' ' LEU . . . -49.95 106.25 0.11 Allowed 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.624 ' CA ' HD13 ' A' ' 136' ' ' ILE . . . 117.33 69.95 0.4 Allowed Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.954 -0.641 . . . . 0.0 113.014 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.516 HD13 ' O ' ' A' ' 96' ' ' GLY . 10.1 mm -131.74 139.62 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 120.569 0.224 . . . . 0.0 111.223 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.742 HD23 HG22 ' A' ' 114' ' ' VAL . 0.8 OUTLIER -106.25 104.94 14.76 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.622 179.245 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.753 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -109.84 144.09 38.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.115 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.49 128.6 33.56 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.192 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.65 167.77 20.24 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.259 -179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' A' ' 126' ' ' HIS . 3.5 p-10 -159.53 117.53 2.75 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.773 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -76.25 -40.28 52.33 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.142 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.94 160.72 31.82 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.477 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.9 125.84 20.01 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.66 2.24 . . . . 0.0 112.175 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 58.54 30.93 20.46 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.34 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 62.6 m -142.61 84.4 1.85 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.992 0.425 . . . . 0.0 110.25 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.448 ' HB3' ' CE1' ' A' ' 82' ' ' PHE . 2.8 m-20 -123.71 165.9 16.45 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.582 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.76 -103.33 0.92 Allowed Glycine 0 C--N 1.334 0.432 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.891 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 66' ' ' ASP . 38.0 m -151.23 43.26 0.77 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.827 0.346 . . . . 0.0 111.172 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -105.09 154.18 20.51 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.323 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -155.39 159.31 39.78 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.664 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.684 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 15.1 p90 -138.33 139.61 39.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.042 0.449 . . . . 0.0 111.611 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.742 HG22 HD23 ' A' ' 98' ' ' LEU . 16.9 t -115.56 110.95 33.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.54 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.448 HG21 ' OG1' ' A' ' 119' ' ' THR . 0.3 OUTLIER -79.8 113.7 18.15 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.074 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.551 ' O ' ' HB1' ' A' ' 95' ' ' ALA . 0.9 OUTLIER -83.8 -16.21 45.49 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.594 179.768 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.84 162.54 51.09 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.473 0.177 . . . . 0.0 110.885 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 93' ' ' THR . 50.6 Cg_exo -53.85 131.51 44.71 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.901 2.401 . . . . 0.0 112.702 -179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.448 ' OG1' HG21 ' A' ' 115' ' ' THR . 1.8 p -143.5 105.07 4.31 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.057 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.27 -43.65 6.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -58.61 -31.84 68.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.148 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.8 mt -79.6 -17.94 52.72 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.529 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -65.66 85.25 0.07 Allowed 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.167 0.508 . . . . 0.0 110.466 179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 153.46 -35.43 0.76 Allowed Glycine 0 CA--C 1.519 0.324 0 CA-C-N 115.476 -0.783 . . . . 0.0 112.363 -179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.55 -50.53 62.86 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.692 0.282 . . . . 0.0 110.908 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' HA ' ' OD1' ' A' ' 102' ' ' ASN . 24.9 m-70 -112.44 147.61 36.11 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.454 179.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.753 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 12.9 t -79.81 170.11 16.97 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.828 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 99' ' ' ALA . 1.3 tt -99.69 -179.32 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.829 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -171.7 -38.41 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.176 0.435 . . . . 0.0 112.176 179.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 27' ' ' LEU . . . -151.76 -179.41 27.4 Favored Glycine 0 C--N 1.337 0.599 0 C-N-CA 120.891 -0.671 . . . . 0.0 113.082 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.449 ' C ' HD12 ' A' ' 98' ' ' LEU . 1.8 ttm105 -135.74 148.12 48.7 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.852 0.358 . . . . 0.0 110.946 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.1 t -95.83 102.13 13.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.113 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -89.45 -63.5 1.28 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.077 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.495 ' O ' HG22 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -114.3 82.71 1.76 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.655 178.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.637 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . -178.75 -24.09 0.04 OUTLIER Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.916 -179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.624 HD13 ' CA ' ' A' ' 96' ' ' GLY . 9.2 tp -46.75 -34.55 2.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 117.266 0.533 . . . . 0.0 112.297 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -59.22 -22.09 54.97 Favored Glycine 0 C--N 1.34 0.783 0 C-N-CA 121.054 -0.594 . . . . 0.0 112.868 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.652 ' O ' HG23 ' A' ' 142' ' ' VAL . 8.8 tmm? -93.44 -39.35 10.95 Favored 'General case' 0 C--N 1.334 -0.087 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.644 HG13 HD11 ' A' ' 62' ' ' ILE . 32.3 t -59.43 -54.28 36.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.065 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.401 ' HA ' HD13 ' A' ' 116' ' ' LEU . 28.5 p30 -59.07 -33.25 70.59 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.675 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -38.52 91.04 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.039 179.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 138' ' ' MET . 20.7 t -57.47 -36.0 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.685 0.279 . . . . 0.0 110.98 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -70.16 -34.43 69.9 Favored Glycine 0 CA--C 1.521 0.412 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.397 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 5.1 mtt -58.59 -40.83 84.26 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 155' ' ' ASP . 1.6 t -54.01 119.01 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -59.26 121.74 12.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.596 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 5.1 t -89.83 168.73 11.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.134 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -81.8 -170.04 2.64 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.45 31.24 1.04 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.594 0.235 . . . . 0.0 111.442 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -154.67 30.37 0.42 Allowed 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.757 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 54.65 53.73 10.21 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.488 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -132.16 134.6 25.27 Favored Pre-proline 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.133 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -66.21 116.69 4.16 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 122.592 2.195 . . . . 0.0 112.322 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 45.4 t -68.09 -35.27 70.97 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.625 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.43 ' HB2' HG11 ' A' ' 145' ' ' VAL . 0.8 OUTLIER -82.71 -169.26 2.39 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.567 179.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.42 101.67 11.35 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 20' ' ' MET . 26.2 t -130.42 108.27 15.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.238 179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -154.97 -179.97 8.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.621 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.558 ' CG1' HG22 ' A' ' 18' ' ' THR . 1.5 mt -111.57 145.33 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.248 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.494 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -121.64 -35.0 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.898 179.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.8 149.46 26.47 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.666 0.27 . . . . 0.0 111.019 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.428 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -145.48 121.48 10.7 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.459 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -144.95 155.36 55.54 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.392 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.403 ' HB3' HG12 ' A' ' 14' ' ' VAL . 95.4 Cg_endo -80.21 168.18 18.86 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.691 2.26 . . . . 0.0 112.257 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.7 t -142.46 154.21 44.35 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.148 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.254 -1.303 . . . . 0.0 112.821 179.788 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 120.458 0.17 . . . . 0.0 111.188 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.4 -59.2 1.96 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.962 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -111.97 132.28 54.87 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.951 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.521 HG23 ' O ' ' A' ' 4' ' ' ILE . 5.9 tp -118.77 70.04 9.38 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-O 121.349 0.595 . . . . 0.0 110.692 179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -73.33 173.58 13.53 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.75 2.3 . . . . 0.0 111.856 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.61 -26.36 36.98 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.644 2.229 . . . . 0.0 112.741 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 61.45 58.61 2.06 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.844 0.354 . . . . 0.0 111.131 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 71.66 137.16 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.47 179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -160.69 129.28 4.66 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.595 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -169.83 -62.0 0.0 OUTLIER Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.859 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.85 118.36 5.65 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.494 2.13 . . . . 0.0 112.56 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -77.31 -2.48 12.68 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 122.808 2.339 . . . . 0.0 113.275 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -89.93 142.95 27.21 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.649 0.261 . . . . 0.0 111.208 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 10.0 m -131.43 136.59 57.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.164 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -92.3 108.29 19.85 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.28 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.427 ' HG ' ' HB1' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -107.28 99.53 9.06 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.99 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -82.16 110.29 17.23 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.71 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.648 HG22 ' CG1' ' A' ' 159' ' ' ILE . 2.3 p -112.31 161.51 16.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.015 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 43.3 p -62.81 -37.12 85.46 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.235 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.741 ' HB2' HG13 ' A' ' 157' ' ' VAL . 1.3 tpt -68.46 -30.01 68.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.338 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 167.27 -154.33 24.54 Favored Glycine 0 C--N 1.339 0.698 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.345 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.4 tt -130.86 128.76 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 CA-C-O 120.865 0.364 . . . . 0.0 110.864 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.4 pt -133.85 145.06 33.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.625 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.2 t -117.79 119.12 60.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.549 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD13 HD13 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -115.04 155.56 26.78 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.268 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -110.76 115.01 28.82 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.757 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 6.0 mt -87.0 147.86 25.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.797 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.763 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 35.1 m-85 -84.81 104.58 14.89 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.629 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -82.55 21.83 0.93 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.2 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.09 -69.52 0.77 Allowed 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.505 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.81 18.2 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.942 179.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.763 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -98.1 1.27 0.08 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 75.3 Cg_exo -41.43 -38.16 3.68 Favored 'Trans proline' 0 C--N 1.368 1.556 0 C-N-CA 122.054 1.836 . . . . 0.0 112.819 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.69 -54.15 50.35 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.321 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.833 HG21 ' HG3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -69.68 -33.62 72.8 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.032 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.4 t -55.92 -56.01 25.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.674 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -61.24 -39.07 88.92 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.795 0.331 . . . . 0.0 110.344 179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -59.97 -38.86 83.76 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.019 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.97 -46.74 80.22 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.71 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.15 -41.15 77.67 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.259 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.537 ' HB3' HG21 ' A' ' 77' ' ' ILE . 1.2 mm-40 -61.03 -50.55 72.88 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.068 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 1.4 mp -57.49 -40.13 77.96 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.681 -0.236 . . . . 0.0 110.992 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.71 -34.6 67.24 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.342 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -73.02 -50.83 20.86 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.144 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -60.77 -28.56 68.82 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.847 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.49 28.34 5.47 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.733 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -89.67 -41.32 12.0 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.612 0.206 . . . . 0.0 110.729 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.421 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 5.5 m-85 -72.01 -31.13 65.91 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.281 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -60.69 102.86 0.21 Allowed 'General case' 0 C--O 1.233 0.202 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 116.71 11.76 9.13 Favored Glycine 0 CA--C 1.526 0.781 0 C-N-CA 120.841 -0.695 . . . . 0.0 113.487 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.473 ' CG2' ' HB3' ' A' ' 67' ' ' PRO . 20.3 p -95.55 168.46 10.68 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 117.392 0.596 . . . . 0.0 110.827 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.6 pttp -157.55 169.54 24.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 111.678 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.859 ' HB3' HD11 ' A' ' 56' ' ' ILE . 47.3 m-85 -94.86 100.71 12.54 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.552 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -88.84 -43.64 11.07 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.819 -179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.555 ' O ' HD13 ' A' ' 56' ' ' ILE . 7.3 mtt180 -90.97 108.61 19.97 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 120.694 0.283 . . . . 0.0 110.612 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 1.046 HG23 HG22 ' A' ' 62' ' ' ILE . 36.1 mm -131.99 140.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.264 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.421 HD13 ' HG3' ' A' ' 61' ' ' MET . 4.3 mp -116.75 116.84 53.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.715 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.24 122.85 14.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.402 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 3.2 t70 61.93 51.05 3.87 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.331 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -157.88 -80.15 0.07 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.234 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.421 ' HG3' HD13 ' A' ' 57' ' ' ILE . 1.3 ptm -160.6 172.2 17.58 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.735 0.303 . . . . 0.0 111.33 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.046 HG22 HG23 ' A' ' 56' ' ' ILE . 1.2 pp -132.86 115.71 25.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.757 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 16.0 pt20 -104.69 138.28 41.24 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.107 0.48 . . . . 0.0 111.986 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.32 110.5 1.08 Allowed Glycine 0 C--N 1.333 0.41 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.962 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.36 179.44 35.87 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.841 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 65.68 69.53 0.61 Allowed Pre-proline 0 C--O 1.233 0.196 0 CA-C-O 121.144 0.497 . . . . 0.0 110.628 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.473 ' HB3' ' CG2' ' A' ' 51' ' ' THR . 25.4 Cg_endo -62.56 -71.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.909 2.406 . . . . 0.0 112.542 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.478 HG22 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER 46.04 47.2 12.83 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.751 0.278 . . . . 0.0 111.751 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -57.94 -32.27 66.18 Favored Glycine 0 C--N 1.336 0.575 0 C-N-CA 120.959 -0.639 . . . . 0.0 112.775 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.6 t -83.28 -31.43 26.93 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.508 0.194 . . . . 0.0 111.258 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.478 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 80.18 32.49 35.22 Favored Glycine 0 C--N 1.335 0.474 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.465 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.2 mtp180 -150.54 -62.71 0.2 Allowed 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.678 0.275 . . . . 0.0 110.834 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.43 121.14 3.94 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.485 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.08 79.67 0.21 Allowed Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.266 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -109.82 158.87 17.71 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.901 0.381 . . . . 0.0 111.119 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.0 t -74.55 162.25 28.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.406 -179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.537 HG21 ' HB3' ' A' ' 41' ' ' GLU . 2.8 pt -61.45 -27.24 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.052 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -96.45 30.69 2.47 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.103 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 103.18 -146.94 16.68 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.971 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.12 -25.65 11.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -148.33 139.97 23.67 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.557 0.217 . . . . 0.0 110.794 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.48 ' CD2' ' HB2' ' A' ' 108' ' ' ASN . 2.1 m-85 -87.38 -174.42 4.82 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.488 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -125.17 69.9 1.15 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.733 0.301 . . . . 0.0 111.744 -179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 t70 66.13 146.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.939 179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.616 ' O ' HG21 ' A' ' 127' ' ' THR . 6.4 mt-10 -155.38 36.37 0.38 Allowed 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.13 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.6 tp -65.91 149.9 49.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 111.526 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.446 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 11.5 p80 -99.82 152.03 37.68 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.114 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -67.75 -50.42 0.88 Allowed 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.586 2.191 . . . . 0.0 112.24 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -160.82 146.97 14.91 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.77 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 87' ' ' HIS . 0.2 OUTLIER -171.9 173.84 4.35 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.952 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -90.66 160.91 15.62 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.876 0.369 . . . . 0.0 111.057 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.52 61.14 0.75 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.978 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.34 -36.06 75.0 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 101.88 -20.38 46.02 Favored Glycine 0 CA--C 1.522 0.501 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.238 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -103.55 112.66 25.68 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 117.163 0.482 . . . . 0.0 110.959 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.459 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 72.62 56.86 5.76 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.331 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 114' ' ' VAL . 7.0 mm -124.15 161.57 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-O 120.483 0.183 . . . . 0.0 110.736 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 132' ' ' VAL . 3.4 mt -142.08 106.35 4.79 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-O 120.759 0.314 . . . . 0.0 110.446 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.752 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -114.52 144.04 44.0 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.935 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.833 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.83 110.92 15.64 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.48 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.71 145.55 31.52 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -124.19 174.75 7.47 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.203 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -106.26 -45.13 4.37 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.476 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.96 174.82 36.8 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.778 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.89 141.3 67.04 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.658 2.239 . . . . 0.0 112.152 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 p30 45.2 30.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.914 -179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 23.9 m -149.93 87.53 1.48 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.78 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.48 ' HB2' ' CD2' ' A' ' 82' ' ' PHE . 60.8 m-80 -95.4 172.84 7.84 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.43 -171.43 12.19 Favored Glycine 0 C--N 1.335 0.5 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.717 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.6 m -103.52 45.7 0.95 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.921 0.391 . . . . 0.0 111.023 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -115.25 168.34 10.04 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.564 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 24.1 p90 -160.59 171.86 18.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.454 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.752 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 42.0 p90 -152.28 131.56 12.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.851 0.358 . . . . 0.0 111.645 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 139' ' ' VAL . 34.1 t -96.41 116.78 39.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.358 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.482 HG21 ' OG1' ' A' ' 119' ' ' THR . 0.2 OUTLIER -79.59 127.98 32.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.704 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.63 HD22 ' HA ' ' A' ' 140' ' ' ASN . 3.2 mt -113.36 -8.4 13.45 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.561 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -131.59 161.56 61.51 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-O 120.456 0.17 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.558 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 20.3 Cg_endo -59.95 121.77 10.34 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.873 2.382 . . . . 0.0 112.603 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.482 ' OG1' HG21 ' A' ' 115' ' ' THR . 0.9 OUTLIER -143.09 49.02 1.47 Allowed 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.078 179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -31.84 69.01 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.124 179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 25.1 p90 -65.84 -28.48 69.01 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.186 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.552 HD23 ' HB2' ' A' ' 125' ' ' LYS . 0.3 OUTLIER -75.89 -7.36 54.34 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.899 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -66.14 85.57 0.09 Allowed 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.155 0.502 . . . . 0.0 110.124 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.68 -41.05 0.53 Allowed Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.351 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB2' HD23 ' A' ' 122' ' ' LEU . 20.5 mttt -67.1 -49.56 64.52 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.548 0.213 . . . . 0.0 111.036 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.32 140.86 48.28 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.732 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.664 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 97.8 m -85.07 151.4 24.17 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.56 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.659 HG22 ' H ' ' A' ' 129' ' ' PHE . 0.6 OUTLIER -79.46 -178.98 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.275 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.659 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.7 OUTLIER -169.34 -36.45 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.33 -179.51 26.17 Favored Glycine 0 C--N 1.338 0.653 0 C-N-CA 121.137 -0.554 . . . . 0.0 112.66 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 13.2 ttt-85 -143.3 155.59 44.5 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.525 0.203 . . . . 0.0 110.689 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.526 HG13 HD12 ' A' ' 98' ' ' LEU . 16.0 m -114.39 85.08 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.164 0.507 . . . . 0.0 112.24 -179.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.97 -40.01 40.67 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.05 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -127.52 98.33 5.19 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.65 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 147.79 -12.3 1.3 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.622 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.452 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 15.5 tt -50.54 -30.35 7.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 117.255 0.527 . . . . 0.0 111.938 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -69.79 -12.13 67.13 Favored Glycine 0 C--N 1.339 0.731 0 C-N-CA 121.29 -0.481 . . . . 0.0 113.417 179.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -98.05 -30.05 12.91 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.793 0.296 . . . . 0.0 110.814 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 114' ' ' VAL . 2.5 m -84.61 -34.85 9.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.434 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.63 ' HA ' HD22 ' A' ' 116' ' ' LEU . 53.7 p30 -61.52 -28.21 69.16 Favored 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 121.219 -0.192 . . . . 0.0 111.279 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.635 ' O ' HG13 ' A' ' 145' ' ' VAL . 0.2 OUTLIER -78.55 -30.83 47.11 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.855 -0.157 . . . . 0.0 111.298 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.482 ' HB ' HG21 ' A' ' 62' ' ' ILE . 39.3 t -57.47 -36.88 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.688 0.28 . . . . 0.0 110.738 179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -91.11 -30.27 11.32 Favored Glycine 0 CA--C 1.522 0.472 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.208 179.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.1 tpt -65.15 -31.94 73.37 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 141' ' ' ARG . 27.1 m -61.38 176.38 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-O 120.98 0.419 . . . . 0.0 111.569 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -82.38 172.75 12.71 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 2.7 p -147.79 166.15 28.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.08 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -142.74 159.21 42.68 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.44 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.0 m 85.49 -40.86 0.05 Allowed 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.508 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 168.36 -37.63 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.073 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -169.62 37.25 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.358 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.22 124.99 36.4 Favored Pre-proline 0 N--CA 1.461 0.114 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.85 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.462 ' HG3' HG13 ' A' ' 56' ' ' ILE . 51.9 Cg_exo -54.74 109.49 0.4 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.71 2.273 . . . . 0.0 112.478 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 14.1 p -64.13 -30.85 51.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.922 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.64 -171.67 3.45 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.719 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.13 117.84 32.36 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 111.626 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.741 HG13 ' HB2' ' A' ' 20' ' ' MET . 21.6 t -142.07 121.88 10.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.732 179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.21 178.53 10.09 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 120.726 0.298 . . . . 0.0 111.732 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.648 ' CG1' HG22 ' A' ' 18' ' ' THR . 3.3 mt -110.84 143.45 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.062 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.9 pt -113.38 -40.45 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.135 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.38 153.06 17.2 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.669 0.271 . . . . 0.0 111.211 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.427 ' HB1' ' HG ' ' A' ' 16' ' ' LEU . . . -150.88 141.6 22.74 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.506 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -154.51 156.45 31.62 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.126 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -79.55 162.94 24.53 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.448 2.099 . . . . 0.0 112.5 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -85.88 144.51 27.64 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.076 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 118.684 -1.065 . . . . 0.0 112.954 179.789 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtm . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.901 0.381 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -172.01 111.28 0.28 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.108 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -131.54 -60.21 0.94 Allowed 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.262 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pt -65.35 130.1 94.61 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.996 179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.53 112.8 3.61 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.733 2.289 . . . . 0.0 112.468 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.66 161.02 29.94 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.944 2.429 . . . . 0.0 112.97 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -142.2 33.54 1.52 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.287 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -159.81 134.74 7.94 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.684 0.278 . . . . 0.0 111.168 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -111.21 128.29 55.87 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.52 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -110.07 81.56 2.19 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.361 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.78 107.85 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.882 2.388 . . . . 0.0 112.823 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.57 -42.87 2.27 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.951 2.434 . . . . 0.0 111.912 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.0 m-20 -125.05 174.88 7.72 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.783 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.426 ' HB ' HD11 ' A' ' 27' ' ' LEU . 9.5 p -148.16 130.33 6.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.004 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.404 ' HB2' ' CB ' ' A' ' 163' ' ' TYR . 10.4 m-85 -105.36 106.3 16.73 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.1 107.15 18.61 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.498 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.475 ' HG2' HD12 ' A' ' 22' ' ' ILE . 11.2 mt-10 -86.61 82.35 7.93 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.354 179.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.65 HG22 ' HA ' ' A' ' 159' ' ' ILE . 0.8 OUTLIER -91.62 165.32 13.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.28 -179.491 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.5 m -67.4 -37.15 82.65 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.258 178.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.729 ' HB2' HG13 ' A' ' 157' ' ' VAL . 12.9 tpt -62.44 -32.97 73.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.038 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 164.82 -148.53 14.4 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 121.292 -0.48 . . . . 0.0 112.194 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.475 HD12 ' HG2' ' A' ' 17' ' ' GLU . 4.8 tt -134.83 130.14 52.23 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-N 116.861 0.331 . . . . 0.0 111.385 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.647 HG22 ' CA ' ' A' ' 135' ' ' GLY . 15.5 pt -137.62 135.58 46.22 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.637 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 26.0 t -96.73 140.24 17.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.599 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 98' ' ' LEU . 2.0 mt -130.87 141.0 50.28 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.588 -179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -101.82 107.91 19.24 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.524 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.433 HD13 ' SG ' ' A' ' 36' ' ' CYS . 0.5 OUTLIER -84.49 146.68 27.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.893 -179.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.665 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 23.0 m-85 -79.86 92.04 5.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.693 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 56.1 p-90 -80.69 19.48 0.82 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -100.01 -72.44 0.67 Allowed 'General case' 0 C--O 1.231 0.079 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.48 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -101.1 -12.1 19.08 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.017 178.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.9 1.34 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.665 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 71.7 Cg_exo -41.09 -36.38 2.24 Favored 'Trans proline' 0 C--N 1.369 1.653 0 C-N-CA 122.248 1.966 . . . . 0.0 112.965 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tptt -58.02 -60.37 3.83 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.596 -0.274 . . . . 0.0 110.353 179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.93 -39.31 91.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.337 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.433 ' SG ' HD13 ' A' ' 27' ' ' LEU . 14.0 t -55.01 -48.68 73.05 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.446 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 1.8 mtpm? -60.61 -37.29 80.95 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -58.35 -54.22 49.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.767 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -61.13 -45.84 93.03 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.738 0.304 . . . . 0.0 110.826 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -60.46 -41.39 94.02 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.31 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -73.5 -44.07 58.63 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.466 -0.333 . . . . 0.0 111.251 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.37 -37.91 70.72 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.653 -0.249 . . . . 0.0 111.117 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -80.93 -32.66 34.55 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.413 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.5 mtt-85 -66.94 -45.95 76.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.777 -0.192 . . . . 0.0 111.124 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.49 -28.42 68.56 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.736 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.04 36.18 2.79 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 121.003 -0.618 . . . . 0.0 112.733 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -93.19 -50.13 5.64 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.637 0.218 . . . . 0.0 110.697 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -62.75 -28.65 70.12 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.939 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -67.63 113.66 5.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.633 0.254 . . . . 0.0 110.422 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.6 20.9 7.08 Favored Glycine 0 CA--C 1.523 0.559 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.359 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 82.2 p -124.93 154.73 40.69 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 117.038 0.419 . . . . 0.0 110.53 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 18.1 pttt -129.56 169.66 14.73 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CD1' HG12 ' A' ' 157' ' ' VAL . 34.1 m-85 -85.31 99.07 10.9 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.783 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -76.86 -39.4 51.25 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.169 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -100.98 117.28 34.72 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.607 0.241 . . . . 0.0 110.805 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.62 HG23 ' CG1' ' A' ' 62' ' ' ILE . 13.2 mt -141.11 120.04 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.0 111.379 -179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.3 mt -116.22 116.56 52.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.795 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.494 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -56.59 -60.28 3.77 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.563 -179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -88.47 62.38 6.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.605 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 178.25 -86.42 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.272 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.413 ' HA ' HD23 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -161.2 170.94 19.32 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 120.809 0.337 . . . . 0.0 111.554 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.62 ' CG1' HG23 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -127.23 123.09 61.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.139 179.089 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.481 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 1.7 pt20 -117.4 155.19 30.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -178.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.22 100.63 0.41 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.453 179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.487 ' HA2' ' HB3' ' A' ' 111' ' ' GLN . . . -107.22 175.89 20.73 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.58 -179.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 41.2 t0 -143.6 67.33 16.15 Favored Pre-proline 0 C--O 1.234 0.246 0 CA-C-O 120.952 0.406 . . . . 0.0 110.57 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.17 163.61 22.42 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.79 2.327 . . . . 0.0 112.715 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.747 HG23 ' HA3' ' A' ' 73' ' ' GLY . 2.9 m -114.61 43.85 1.85 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.921 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.44 23.41 30.24 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.613 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.75 -30.89 9.62 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-O 120.438 0.161 . . . . 0.0 111.395 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.85 28.99 7.94 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.585 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.12 32.65 0.21 Allowed 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.747 ' HA3' HG23 ' A' ' 68' ' ' THR . . . -108.19 157.62 15.23 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.544 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -99.04 174.13 27.28 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.117 -0.563 . . . . 0.0 113.131 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -88.04 157.08 18.99 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.817 0.341 . . . . 0.0 111.365 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 79' ' ' GLY . 8.5 t -76.69 171.76 14.16 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.364 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.8 tt -73.23 -34.09 43.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.489 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 42.8 m-85 -100.33 36.75 1.81 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.745 0.307 . . . . 0.0 111.131 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 76' ' ' SER . . . 89.05 169.07 44.32 Favored Glycine 0 C--N 1.337 0.586 0 C-N-CA 121.068 -0.587 . . . . 0.0 113.071 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.9 -52.42 63.12 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.429 0.157 . . . . 0.0 110.786 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -141.61 143.26 33.59 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.862 179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.4 p90 -138.56 173.57 11.45 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.525 -179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -76.18 173.43 11.36 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.396 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.408 ' HB2' ' CD2' ' A' ' 86' ' ' LEU . 4.3 p30 -80.19 178.46 8.25 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.387 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -132.21 72.91 1.51 Allowed 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.253 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.467 ' N ' HD22 ' A' ' 86' ' ' LEU . 3.4 mm? -99.17 104.73 16.73 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.949 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -179.85 -54.23 0.0 OUTLIER Pre-proline 0 N--CA 1.467 0.397 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.299 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.427 ' HB2' HD21 ' A' ' 90' ' ' LEU . 71.4 Cg_exo -48.72 149.99 6.79 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.78 2.32 . . . . 0.0 112.703 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.54 94.9 2.69 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.813 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.508 HD22 ' CG2' ' A' ' 128' ' ' ILE . 3.0 mt -90.16 -174.94 4.38 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.721 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.37 -69.9 0.37 Allowed 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.638 ' HD1' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER 62.06 61.28 1.37 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 120.992 0.425 . . . . 0.0 111.113 -179.419 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.7 p -57.62 -36.86 72.36 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.413 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.411 ' CA ' ' HA ' ' A' ' 118' ' ' PRO . . . 147.64 -101.52 0.23 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.613 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.502 ' HB1' HD11 ' A' ' 136' ' ' ILE . . . -71.95 135.17 46.37 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.974 0.416 . . . . 0.0 111.736 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 77.93 52.65 5.26 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.994 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.462 HD13 ' O ' ' A' ' 96' ' ' GLY . 17.1 mm -135.81 138.67 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.876 0.338 . . . . 0.0 110.868 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.94 HD13 HG22 ' A' ' 114' ' ' VAL . 13.3 tp -115.33 133.75 55.75 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.8 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -134.13 151.65 51.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.222 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 116.35 19.64 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.36 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -79.92 158.51 26.63 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.857 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -121.03 173.45 7.25 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.293 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -111.24 -43.98 3.63 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.181 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -158.95 -179.43 33.78 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.266 -0.493 . . . . 0.0 112.451 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.65 113.23 1.06 Allowed 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.646 2.231 . . . . 0.0 111.926 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 59.05 30.54 20.37 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.12 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.2 m -129.82 90.77 3.03 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -83.21 162.77 21.12 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.026 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.94 -140.94 4.5 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.57 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.0 m -138.58 58.49 1.66 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.076 0.465 . . . . 0.0 110.802 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.487 ' HB3' ' HA2' ' A' ' 65' ' ' GLY . 3.3 mt-30 -132.78 178.23 7.02 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.821 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -160.45 158.02 28.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.057 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.72 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 41.3 p90 -137.36 133.02 34.39 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.006 0.431 . . . . 0.0 111.544 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.94 HG22 HD13 ' A' ' 98' ' ' LEU . 22.1 t -101.32 114.66 41.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.248 179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 35.2 p -79.94 113.62 18.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.099 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 58' ' ' LYS . 0.8 OUTLIER -86.71 -23.83 25.4 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.426 179.794 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -119.19 165.01 18.33 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.806 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 18.6 Cg_endo -58.1 124.64 16.39 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.621 2.214 . . . . 0.0 111.994 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 122' ' ' LEU . 2.7 p -141.79 48.17 1.62 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.211 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -64.47 -35.35 80.65 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.756 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -65.58 -27.9 68.75 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.228 179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HB2' ' HB ' ' A' ' 119' ' ' THR . 2.5 mt -78.46 0.11 27.19 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.55 79.91 1.07 Allowed 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.235 0.54 . . . . 0.0 109.942 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.57 -46.38 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.503 -0.772 . . . . 0.0 112.203 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -65.45 -43.28 90.86 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.634 0.254 . . . . 0.0 110.676 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 -123.45 135.8 54.27 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.941 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.747 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 63.5 m -80.16 160.83 25.54 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.74 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.638 HD12 ' HD1' ' A' ' 92' ' ' PHE . 1.4 tt -79.39 -179.5 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.934 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.424 ' CE2' ' HG ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -177.13 -38.2 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.403 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.41 -179.6 17.73 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.848 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 25' ' ' LEU . 7.6 mtm180 -137.3 168.1 20.29 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 122.819 -0.224 . . . . 0.0 110.778 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.563 HG21 HG13 ' A' ' 114' ' ' VAL . 11.5 t -131.06 91.94 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-O 120.908 0.385 . . . . 0.0 111.345 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -93.33 -41.66 9.73 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.535 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -130.72 103.83 6.83 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.123 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.647 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 147.12 -19.68 1.57 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.705 -0.76 . . . . 0.0 113.422 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.502 HD11 ' HB1' ' A' ' 95' ' ' ALA . 12.7 tt -48.17 -36.5 6.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 116.996 0.398 . . . . 0.0 112.002 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -63.23 -24.18 67.04 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.289 -0.481 . . . . 0.0 113.133 179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 1.2 ttp -91.07 -32.37 15.9 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.882 0.372 . . . . 0.0 110.236 179.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.584 HG11 ' CG1' ' A' ' 114' ' ' VAL . 20.2 t -73.92 -48.67 37.86 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.33 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.2 p-10 -65.0 -31.56 72.86 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.155 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -59.98 -34.46 73.34 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.203 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.617 HG13 HG21 ' A' ' 157' ' ' VAL . 37.1 t -58.01 -38.69 68.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.692 0.282 . . . . 0.0 110.927 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -67.8 -42.61 86.3 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.314 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 8.6 mmt -49.19 -48.62 45.07 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.556 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.7 OUTLIER -52.73 141.8 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-O 120.797 0.332 . . . . 0.0 111.503 -179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -63.46 112.69 2.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.764 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 70.2 p -79.86 165.52 22.62 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.107 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -80.59 -167.29 1.31 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.598 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 13.0 p -88.89 32.78 0.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.568 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -158.52 31.13 0.23 Allowed 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 120.719 0.295 . . . . 0.0 110.903 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 57.43 41.8 25.64 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.521 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.09 147.51 37.08 Favored Pre-proline 0 N--CA 1.464 0.233 0 CA-C-O 120.62 0.247 . . . . 0.0 111.551 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.15 152.32 31.03 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.904 2.403 . . . . 0.0 112.636 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.497 ' O ' HG22 ' A' ' 154' ' ' VAL . 8.3 p -117.84 23.49 5.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.283 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -133.13 24.41 4.2 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 54.98 85.43 0.06 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.729 HG13 ' HB2' ' A' ' 20' ' ' MET . 22.8 t -118.7 111.81 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.27 175.48 13.97 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.453 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.65 ' HA ' HG22 ' A' ' 18' ' ' THR . 4.0 mt -105.22 127.81 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-O 120.79 0.328 . . . . 0.0 111.048 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.9 pt -107.13 -33.62 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.765 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.416 ' HG2' ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -159.38 167.94 27.55 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.705 0.288 . . . . 0.0 111.285 179.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.426 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -133.25 159.32 40.55 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.365 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.404 ' CB ' ' HB2' ' A' ' 15' ' ' TYR . 1.0 OUTLIER -129.23 97.08 26.64 Favored Pre-proline 0 C--O 1.234 0.267 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.207 -179.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.9 95.0 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.827 2.352 . . . . 0.0 112.198 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.6 t -84.48 143.89 29.07 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.273 -179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.51 -1.161 . . . . 0.0 112.758 179.741 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtp . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 120.775 0.322 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -167.02 80.79 0.22 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.156 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.08 -25.77 66.39 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.551 179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 27.6 mm -116.51 83.2 13.17 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.757 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.29 149.69 63.05 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.705 2.27 . . . . 0.0 112.48 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.92 143.41 36.62 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.779 2.319 . . . . 0.0 112.662 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -143.62 131.99 22.12 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.39 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.28 92.78 0.06 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.614 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -179.87 1.42 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.441 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -132.67 88.71 37.54 Favored Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.044 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.417 ' CD ' ' HD3' ' A' ' 12' ' ' PRO . 52.7 Cg_exo -53.1 -44.11 51.58 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.08 2.52 . . . . 0.0 113.728 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.417 ' HD3' ' CD ' ' A' ' 11' ' ' PRO . 13.8 Cg_exo -70.27 54.74 1.41 Allowed 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 122.548 2.165 . . . . 0.0 112.594 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.481 ' HB3' HG12 ' A' ' 24' ' ' VAL . 8.2 m120 -142.31 175.32 9.86 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.776 0.322 . . . . 0.0 111.627 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 31.5 m -144.8 147.68 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -91.84 120.31 32.42 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.855 0.359 . . . . 0.0 111.139 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.802 HD21 ' HE2' ' A' ' 48' ' ' TYR . 2.2 mt -114.05 102.83 10.55 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.303 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.444 ' HB2' ' HB2' ' A' ' 161' ' ' LYS . 6.5 mt-10 -92.86 103.16 15.53 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.27 179.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 159' ' ' ILE . 2.1 p -113.56 158.19 21.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.851 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.3 t -60.47 -35.9 76.98 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.813 179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.782 ' HB2' HG13 ' A' ' 157' ' ' VAL . 11.4 tpt -68.76 -32.34 72.02 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.484 -0.325 . . . . 0.0 111.329 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.51 -163.74 37.29 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.35 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.6 tt -124.12 129.95 73.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.984 0.392 . . . . 0.0 111.185 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.559 HG22 ' CA ' ' A' ' 135' ' ' GLY . 8.3 pt -136.96 156.83 35.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.683 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.481 HG12 ' HB3' ' A' ' 13' ' ' ASN . 20.3 t -123.32 116.52 48.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.986 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.717 HD23 HD12 ' A' ' 16' ' ' LEU . 3.5 mm? -91.51 158.81 16.26 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.191 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.431 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 3.8 tt0 -110.65 105.59 14.54 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.75 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -91.97 131.15 37.49 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.392 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.738 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 24.5 m-85 -82.41 113.9 20.49 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.994 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -81.96 14.96 2.48 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.83 -68.46 0.81 Allowed 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 120.686 0.279 . . . . 0.0 110.378 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.481 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.9 OUTLIER -100.87 -13.94 18.16 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 179.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.738 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -97.63 0.66 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 98.7 Cg_exo -43.73 -40.56 11.1 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.071 1.847 . . . . 0.0 112.896 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.16 -54.61 27.08 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.595 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.746 HG21 ' HG3' ' A' ' 100' ' ' MET . 4.8 m -64.1 -35.85 82.1 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.117 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.6 t -57.01 -51.63 68.48 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.579 179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -59.81 -40.47 88.5 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.512 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -58.51 -47.23 84.84 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.978 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -56.01 -46.91 78.61 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.739 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.85 -45.68 70.47 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.403 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -60.15 -45.96 91.3 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.211 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.46 -44.1 93.07 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-O 120.625 0.25 . . . . 0.0 110.845 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 162' ' ' ALA . . . -70.59 -35.68 73.14 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.143 179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.06 -47.15 60.09 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.133 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.0 mtt180 -57.41 -31.1 65.52 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.611 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.7 33.04 2.53 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.103 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.23 -34.86 7.36 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 116.606 0.203 . . . . 0.0 111.058 179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.802 ' HE2' HD21 ' A' ' 16' ' ' LEU . 1.4 t80 -73.37 -37.2 66.12 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.617 -0.265 . . . . 0.0 111.645 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.0 p30 -63.88 151.84 41.36 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.928 0.394 . . . . 0.0 111.27 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.18 18.31 71.0 Favored Glycine 0 CA--C 1.523 0.538 0 CA-C-N 115.861 -0.609 . . . . 0.0 113.083 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.0 m -109.19 161.67 15.01 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 117.004 0.402 . . . . 0.0 110.465 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HB3' ' CB ' ' A' ' 158' ' ' LYS . 44.3 pttt -146.54 165.67 28.77 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.617 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -70.64 110.86 5.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.863 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -77.18 -45.23 27.34 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.851 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -112.11 130.1 56.01 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 120.845 0.355 . . . . 0.0 111.299 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.726 HD12 ' HG3' ' A' ' 153' ' ' PRO . 51.9 mt -143.05 97.48 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.792 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.54 110.11 21.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.928 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 7.8 tttp -62.51 141.06 58.6 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.187 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 61.6 45.74 7.87 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.524 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.8 t80 -168.71 -89.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.942 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.55 175.23 12.95 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 120.645 0.26 . . . . 0.0 111.111 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.651 ' CG2' HG23 ' A' ' 56' ' ' ILE . 1.8 pp -144.04 156.34 15.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.015 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 6.0 pt20 -132.73 142.53 49.08 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 111.568 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.03 156.43 16.41 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.704 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.98 -179.65 47.26 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.308 -0.472 . . . . 0.0 112.973 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.419 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -155.76 -64.54 0.02 OUTLIER Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.94 -0.13 . . . . 0.0 111.128 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 66' ' ' ASP . 71.6 Cg_endo -76.46 -161.78 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 122.445 2.097 . . . . 0.0 111.832 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.684 HG22 ' HA2' ' A' ' 73' ' ' GLY . 9.6 t -51.95 -34.57 42.58 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.404 0.145 . . . . 0.0 111.285 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 66.06 47.53 72.66 Favored Glycine 0 C--N 1.337 0.63 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.771 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.8 p -136.32 40.52 2.64 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.812 0.339 . . . . 0.0 111.074 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 61.16 24.01 62.66 Favored Glycine 0 CA--C 1.522 0.491 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.827 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.9 ttt-85 -175.06 77.45 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.867 0.365 . . . . 0.0 110.722 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.684 ' HA2' HG22 ' A' ' 68' ' ' THR . . . -84.31 158.85 34.76 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 121.161 -0.542 . . . . 0.0 113.008 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.8 178.39 53.8 Favored Glycine 0 C--N 1.334 0.453 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.804 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.85 131.68 35.26 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.618 0.247 . . . . 0.0 111.152 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -83.26 177.74 8.39 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 2.4 pp -56.19 -31.44 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.747 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -95.53 40.39 1.11 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.879 0.371 . . . . 0.0 110.381 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.96 179.69 33.37 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.097 -0.573 . . . . 0.0 112.956 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -33.75 76.16 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.529 0.204 . . . . 0.0 110.931 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -155.91 146.28 21.73 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.908 179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 16.3 p90 -126.9 177.21 6.75 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.064 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -78.22 140.53 38.91 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.9 0.381 . . . . 0.0 111.024 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.59 157.19 14.89 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.465 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -129.63 40.6 3.56 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.541 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 8.6 tt -74.94 145.98 42.16 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.695 0.283 . . . . 0.0 110.916 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -164.46 153.51 11.57 Favored Pre-proline 0 N--CA 1.464 0.231 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.128 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.87 -166.48 0.29 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.396 2.064 . . . . 0.0 112.08 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.53 33.46 10.89 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 120.868 0.366 . . . . 0.0 111.152 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.658 HD13 ' CG1' ' A' ' 128' ' ' ILE . 84.7 mt -122.03 -178.45 3.86 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.882 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HE2' ' HB ' ' A' ' 93' ' ' THR . 17.0 tttt -128.08 157.29 41.13 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.088 0.47 . . . . 0.0 111.659 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -150.39 48.36 0.89 Allowed 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.919 179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.696 HG23 HD11 ' A' ' 97' ' ' ILE . 1.7 t -58.8 -23.83 60.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 179.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 87.8 -7.31 81.6 Favored Glycine 0 CA--C 1.523 0.572 0 CA-C-O 119.641 -0.533 . . . . 0.0 113.78 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -114.64 96.87 5.96 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 117.951 0.876 . . . . 0.0 111.383 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.586 ' C ' HD12 ' A' ' 97' ' ' ILE . . . 83.23 61.64 1.89 Allowed Glycine 0 CA--C 1.521 0.463 0 C-N-CA 121.153 -0.546 . . . . 0.0 113.302 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.696 HD11 HG23 ' A' ' 93' ' ' THR . 4.4 mp -138.75 154.46 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 116.717 0.258 . . . . 0.0 110.735 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.756 HD12 ' HE2' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -125.99 111.94 15.32 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 120.907 0.384 . . . . 0.0 110.454 179.142 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.614 ' HB3' ' CE1' ' A' ' 113' ' ' PHE . . . -108.22 137.04 46.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.34 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.746 ' HG3' HG21 ' A' ' 35' ' ' THR . 0.0 OUTLIER -79.64 104.88 10.54 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.426 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.37 164.89 22.77 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.475 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -144.48 172.68 12.62 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -97.32 -36.03 10.52 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.733 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -157.74 -179.84 32.93 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.614 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -61.87 124.21 14.07 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.696 2.264 . . . . 0.0 112.149 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.26 28.49 17.02 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.051 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 27.5 m -136.57 84.53 2.08 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.269 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.11 129.41 34.81 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.769 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -104.02 -164.06 24.88 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.953 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.0 m -110.25 68.43 0.67 Allowed 'General case' 0 C--O 1.232 0.159 0 CA-C-O 121.063 0.458 . . . . 0.0 110.774 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -148.67 152.47 36.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.724 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -147.17 156.68 43.18 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.755 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.614 ' CE1' ' HB3' ' A' ' 99' ' ' ALA . 22.8 p90 -137.77 126.15 23.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.968 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 97' ' ' ILE . 11.7 p -98.47 120.14 47.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.356 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 4.4 p -84.18 129.36 34.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.761 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -110.45 -19.47 12.93 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.64 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.5 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -122.14 160.34 47.99 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.61 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.5 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 9.5 Cg_endo -51.56 127.82 23.87 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 123.043 2.495 . . . . 0.0 112.802 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 70.5 p -147.42 42.9 1.1 Allowed 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.033 179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -59.19 -30.99 68.61 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.426 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 32.6 p90 -60.95 -29.2 69.49 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.701 -0.227 . . . . 0.0 111.273 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.426 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 14.6 mt -81.25 -2.06 47.36 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.849 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.78 85.63 0.21 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 121.153 0.501 . . . . 0.0 110.386 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 157.21 -31.58 0.54 Allowed Glycine 0 CA--C 1.519 0.335 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.697 -179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 mtpt -72.59 -62.94 1.27 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.708 0.254 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -95.63 172.13 8.25 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.81 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.558 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 13.3 t -114.06 156.73 23.6 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.522 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.738 HG22 ' H ' ' A' ' 129' ' ' PHE . 4.2 mm -80.01 -179.23 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.283 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.756 ' HE2' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -178.22 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 122.393 0.277 . . . . 0.0 110.696 -179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 26' ' ' GLU . . . -145.44 -179.63 21.86 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.213 179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 160.6 42.31 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-O 120.577 0.227 . . . . 0.0 110.841 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 25' ' ' LEU . 17.8 t -106.73 93.61 2.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.887 0.375 . . . . 0.0 111.118 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.8 m -84.12 -42.58 15.89 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.475 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.47 107.25 8.36 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.155 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.559 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 136.09 -10.31 4.17 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.607 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.417 ' HA ' HG11 ' A' ' 132' ' ' VAL . 13.4 tt -48.78 -33.82 5.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -57.83 -39.55 91.68 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.609 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 3.9 tmm? -66.59 -46.49 75.79 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.64 0.257 . . . . 0.0 110.471 179.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.75 -38.1 74.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.787 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -57.13 -40.81 77.87 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.62 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 54.6 mtp85 -62.09 -37.32 84.6 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.917 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.648 ' CG1' HD13 ' A' ' 56' ' ' ILE . 38.2 t -57.5 -41.04 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.946 179.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -92.09 -13.13 58.05 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.928 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 12.6 tpt -84.11 -35.64 23.52 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.977 0.388 . . . . 0.0 111.507 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 7.5 m -51.85 154.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.985 0.422 . . . . 0.0 111.684 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -70.17 95.49 0.99 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.672 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 19.3 p -79.95 170.52 16.36 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.371 -179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.31 179.46 7.45 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.946 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.8 m -90.69 29.59 1.3 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.387 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -156.1 33.52 0.34 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 120.808 0.337 . . . . 0.0 110.474 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 54.3 61.88 2.83 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.34 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -133.0 114.38 13.89 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.114 -179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.726 ' HG3' HD12 ' A' ' 56' ' ' ILE . 32.2 Cg_exo -61.99 117.41 4.25 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 122.849 2.366 . . . . 0.0 112.575 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 10.3 m -68.03 -34.26 65.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.334 179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -84.3 179.54 7.43 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.689 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -105.79 80.66 1.57 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 120.972 0.415 . . . . 0.0 111.13 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.782 HG13 ' HB2' ' A' ' 20' ' ' MET . 32.6 t -98.94 115.62 39.93 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.658 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.415 ' CB ' ' HB3' ' A' ' 52' ' ' LYS . 0.6 OUTLIER -149.96 175.14 11.95 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.553 -179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.64 ' HA ' HG22 ' A' ' 18' ' ' THR . 3.9 mt -109.8 148.36 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.113 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 9.0 pt -124.69 -40.93 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.845 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 17' ' ' GLU . 11.0 mttt -139.25 161.73 36.72 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.77 0.319 . . . . 0.0 111.298 -179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.53 ' HB3' ' HB1' ' A' ' 43' ' ' ALA . . . -156.57 110.14 2.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.136 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -128.69 166.84 21.97 Favored Pre-proline 0 N--CA 1.464 0.262 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.046 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.93 174.71 11.26 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.905 2.403 . . . . 0.0 111.916 179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.2 t -129.18 103.53 7.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.719 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.349 -1.251 . . . . 0.0 112.473 -179.851 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptm . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.708 0.29 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -118.46 171.4 8.19 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.382 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -67.43 -55.81 12.16 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.968 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 22.3 mt -134.01 94.2 18.81 Favored Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.95 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.12 163.47 3.28 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.04 2.494 . . . . 0.0 112.793 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.49 125.2 13.01 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.755 2.304 . . . . 0.0 112.683 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -118.54 153.0 34.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.753 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -80.4 58.3 3.09 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.079 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 67.37 143.84 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.378 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -129.74 123.82 21.36 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.06 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 12' ' ' PRO . 27.2 Cg_endo -62.57 109.83 0.96 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.543 2.162 . . . . 0.0 111.769 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 11' ' ' PRO . 6.6 Cg_exo -74.43 63.0 5.43 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.093 2.528 . . . . 0.0 112.178 -179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -96.69 161.46 13.87 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.331 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 27' ' ' LEU . 22.0 t -134.08 131.47 55.62 Favored 'Isoleucine or valine' 0 C--O 1.232 0.139 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.104 -179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -91.25 96.97 10.84 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.615 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.09 98.59 10.18 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.218 -179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.447 ' CB ' ' HB2' ' A' ' 161' ' ' LYS . 0.0 OUTLIER -87.34 122.23 30.83 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.225 179.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -128.61 163.6 24.69 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.156 -179.279 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.8 t -68.18 -34.75 76.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.196 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.702 ' HG3' HG22 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.72 -30.81 70.4 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.62 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 18' ' ' THR . . . 168.16 -143.46 8.16 Favored Glycine 0 C--N 1.335 0.525 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.253 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.2 mt -140.86 135.23 33.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.854 0.327 . . . . 0.0 111.036 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 135' ' ' GLY . 16.6 pt -137.78 147.95 25.83 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.764 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.1 t -120.04 123.64 71.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.021 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.578 ' N ' HD22 ' A' ' 25' ' ' LEU . 1.4 mm? -116.26 159.14 22.28 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.217 -178.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -125.71 106.76 9.95 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.818 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' CD1' HG21 ' A' ' 14' ' ' VAL . 5.3 mp -87.05 158.61 19.18 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.838 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.778 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 33.2 m-85 -102.86 102.5 12.61 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.236 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 8.6 m95 -81.25 23.25 0.61 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -100.14 -68.07 0.83 Allowed 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.525 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.65 -14.11 18.27 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.654 178.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -97.29 1.39 0.08 OUTLIER Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 114.33 1.233 . . . . 0.0 114.33 -179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 68.7 Cg_exo -40.71 -37.46 2.28 Favored 'Trans proline' 0 C--N 1.366 1.45 0 C-N-CA 121.952 1.768 . . . . 0.0 112.893 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.92 -55.15 38.19 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.487 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.456 ' CG2' ' HB1' ' A' ' 32' ' ' ALA . 3.9 t -71.93 -34.97 69.48 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.797 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 33' ' ' PRO . 2.1 m -56.97 -50.94 71.12 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.66 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.15 -42.33 99.44 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.737 179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -65.07 -48.23 74.47 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.206 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -58.39 -46.38 86.51 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.946 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.15 83.25 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.042 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.562 ' CB ' HD13 ' A' ' 77' ' ' ILE . 3.4 mm-40 -62.42 -43.97 97.54 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.058 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -58.26 -41.17 83.67 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.79 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.99 -36.01 77.36 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.902 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 49.4 mtt85 -68.48 -41.22 80.44 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.059 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -28.55 68.84 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.554 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.25 28.88 4.47 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 121.131 -0.557 . . . . 0.0 112.775 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -91.92 -51.14 5.35 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-O 120.573 0.225 . . . . 0.0 110.425 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.405 ' CD2' ' HB3' ' A' ' 42' ' ' LEU . 15.1 m-85 -77.3 -41.52 40.37 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.444 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -70.3 93.38 0.85 Allowed 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.42 -12.96 3.5 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.091 -179.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.851 HG22 ' HB3' ' A' ' 67' ' ' PRO . 74.0 p -61.78 166.55 4.3 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 117.006 0.403 . . . . 0.0 112.004 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -137.01 25.77 3.0 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.939 -179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 159' ' ' ILE . 10.0 m-85 57.23 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.714 0.292 . . . . 0.0 111.659 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 49.5 m-70 -149.37 -65.84 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 56' ' ' ILE . 2.8 mtt180 -91.34 122.25 33.79 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.399 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.726 ' HA ' HG22 ' A' ' 62' ' ' ILE . 23.9 mm -131.21 84.3 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.102 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.555 HD12 ' CE ' ' A' ' 61' ' ' MET . 26.1 mt -89.86 88.94 2.98 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.905 0.383 . . . . 0.0 110.373 179.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.56 -24.23 60.26 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.744 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -91.43 25.59 2.55 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.759 0.281 . . . . 0.0 111.759 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -172.85 -77.67 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 O-C-N 122.452 -0.155 . . . . 0.0 111.35 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.555 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.32 178.79 9.25 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 120.631 0.253 . . . . 0.0 111.123 -179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.726 HG22 ' HA ' ' A' ' 56' ' ' ILE . 4.0 pt -135.46 149.19 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.001 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 0.3 OUTLIER -133.06 154.17 50.8 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.166 0.508 . . . . 0.0 112.161 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -134.82 103.43 0.47 Allowed Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.025 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.06 167.74 35.53 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.776 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.7 t70 63.04 70.68 0.72 Allowed Pre-proline 0 CA--C 1.531 0.237 0 CA-C-O 120.944 0.402 . . . . 0.0 111.078 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.851 ' HB3' HG22 ' A' ' 51' ' ' THR . 57.1 Cg_endo -72.09 -40.72 2.34 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.703 2.269 . . . . 0.0 112.322 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 55.8 59.27 3.9 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.426 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.32 -29.59 73.62 Favored Glycine 0 C--N 1.335 0.486 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.706 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.7 p -88.28 -30.0 19.97 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.75 0.275 . . . . 0.0 111.349 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 105.35 0.38 40.67 Favored Glycine 0 CA--C 1.523 0.564 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.805 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -166.88 41.75 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.915 0.358 . . . . 0.0 111.127 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.78 123.72 1.77 Allowed Glycine 0 C--N 1.337 0.615 0 C-N-CA 121.02 -0.609 . . . . 0.0 112.66 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.33 87.46 0.17 Allowed Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.521 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -153.72 152.71 31.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.605 0.241 . . . . 0.0 111.311 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 55.8 p -99.82 172.71 7.08 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.053 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.562 HD13 ' CB ' ' A' ' 41' ' ' GLU . 34.4 pt -57.4 -38.22 61.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.646 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -74.55 -46.19 40.59 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.758 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 170.6 -153.91 21.95 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.757 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.23 -34.54 7.08 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.599 0.222 . . . . 0.0 111.599 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.455 ' CB ' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER -141.58 109.87 5.92 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.675 0.274 . . . . 0.0 111.037 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -118.34 176.19 5.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.264 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -65.09 -177.91 0.41 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.362 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -113.86 176.94 4.82 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.463 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -130.75 110.31 11.25 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.369 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -154.02 129.09 9.6 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.121 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.417 ' HB3' ' HD3' ' A' ' 88' ' ' PRO . 0.7 OUTLIER -178.78 -53.51 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.259 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 87' ' ' HIS . 27.1 Cg_exo -61.94 171.82 4.52 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.659 2.239 . . . . 0.0 112.11 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -62.19 -75.81 0.07 Allowed 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.683 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.75 HD22 HG21 ' A' ' 128' ' ' ILE . 0.4 OUTLIER 65.35 151.43 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.453 179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 ptmt -137.4 167.07 22.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.556 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -133.24 87.83 2.43 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.053 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 34.1 p -71.34 -27.78 63.61 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.161 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 96.82 -67.99 0.89 Allowed Glycine 0 C--N 1.335 0.473 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.339 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.85 104.92 1.81 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.703 0.287 . . . . 0.0 111.7 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.522 ' HA3' HD12 ' A' ' 136' ' ' ILE . . . 76.76 63.05 2.39 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.052 -0.594 . . . . 0.0 113.435 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.511 HD13 ' O ' ' A' ' 96' ' ' GLY . 33.9 mm -142.4 123.34 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.778 0.289 . . . . 0.0 110.559 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.616 HD22 ' HE2' ' A' ' 129' ' ' PHE . 3.0 mt -98.93 117.51 33.59 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.942 0.401 . . . . 0.0 111.251 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.74 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -119.63 143.69 47.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.496 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -79.65 116.48 19.86 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.387 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB2' ' HD1' ' A' ' 113' ' ' PHE . . . -80.12 168.28 19.33 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.477 -179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.9 p-10 -151.95 170.92 18.68 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.195 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -101.71 -49.07 4.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.649 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.02 -179.65 34.95 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.739 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.29 122.06 10.54 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.704 2.269 . . . . 0.0 111.908 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 62.32 31.33 17.42 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.188 -179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.455 HG23 ' CB ' ' A' ' 81' ' ' GLN . 0.4 OUTLIER -139.12 85.44 2.07 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.731 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -107.49 140.83 39.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.723 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -108.36 -152.14 16.02 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.781 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.7 p -117.73 38.78 3.52 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.91 0.386 . . . . 0.0 111.142 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -111.25 150.71 29.22 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.154 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -138.12 146.14 42.48 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.675 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.659 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 31.9 p90 -129.27 130.36 46.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 111.388 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.413 ' O ' HG13 ' A' ' 114' ' ' VAL . 12.1 p -109.77 121.2 62.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.898 179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 61' ' ' MET . 1.1 p -79.59 139.38 37.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.525 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 pp -108.82 -31.16 7.8 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.663 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -102.1 153.89 37.73 Favored Pre-proline 0 C--O 1.234 0.256 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.036 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.48 122.71 10.71 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.681 2.254 . . . . 0.0 112.029 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.681 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 75.1 p -145.97 92.61 2.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.247 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -92.85 -4.51 52.79 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.717 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.681 ' CZ2' HG22 ' A' ' 119' ' ' THR . 22.9 p90 -82.18 -32.63 29.84 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.754 -0.203 . . . . 0.0 111.286 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.472 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.4 pp -83.49 0.53 45.98 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -60.32 87.09 0.01 OUTLIER 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.354 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 140.12 -23.3 2.74 Favored Glycine 0 CA--C 1.522 0.481 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.966 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -61.6 -65.8 0.64 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.917 0.359 . . . . 0.0 110.951 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 82.5 m-70 -97.5 172.61 7.64 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.795 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.74 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 46.5 m -92.13 155.15 18.24 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.95 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.75 HG21 HD22 ' A' ' 90' ' ' LEU . 1.4 tt -98.97 -179.57 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.778 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.616 ' HE2' HD22 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -172.77 -41.13 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -142.8 -179.78 19.82 Favored Glycine 0 C--N 1.336 0.563 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.928 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -136.17 172.59 12.78 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.711 0.291 . . . . 0.0 110.969 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.0 t -125.66 121.09 59.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.218 -179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 29.1 m -123.25 -59.0 1.6 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.634 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -113.91 93.7 4.49 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.978 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.532 ' O ' HG22 ' A' ' 23' ' ' ILE . . . 148.44 -17.43 1.3 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.386 -179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.522 HD12 ' HA3' ' A' ' 96' ' ' GLY . 15.2 tt -44.7 -34.75 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 117.008 0.404 . . . . 0.0 111.92 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -55.33 -42.23 82.22 Favored Glycine 0 C--N 1.338 0.692 0 C-N-CA 121.304 -0.474 . . . . 0.0 112.769 179.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.75 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.4 ttp -60.79 -40.23 91.83 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.75 0.309 . . . . 0.0 110.476 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.645 HG13 HD11 ' A' ' 62' ' ' ILE . 22.9 t -70.53 -35.33 61.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.572 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -67.0 -46.43 74.57 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -58.4 -35.31 71.83 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.524 0.202 . . . . 0.0 111.262 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.75 HG23 ' O ' ' A' ' 138' ' ' MET . 33.4 t -58.42 -40.04 76.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.638 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -75.68 -37.97 38.46 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.464 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 11.1 mmt -60.76 -38.47 85.32 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 120.554 0.216 . . . . 0.0 111.204 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 142' ' ' VAL . 0.4 OUTLIER -62.64 166.65 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.366 -0.379 . . . . 0.0 112.015 -179.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 145' ' ' VAL . 1.9 mt-10 -66.68 171.3 5.3 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.283 0.563 . . . . 0.0 110.968 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.508 ' HA ' HG23 ' A' ' 154' ' ' VAL . 3.0 p -149.13 174.73 12.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.271 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -95.48 -176.33 3.74 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.6 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.9 m -92.76 35.09 1.05 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 120.745 0.307 . . . . 0.0 111.279 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.27 37.12 0.12 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.873 0.368 . . . . 0.0 110.459 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 55.16 41.84 31.18 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.215 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.93 126.06 29.84 Favored Pre-proline 0 CA--C 1.53 0.203 0 CA-C-N 116.515 -0.312 . . . . 0.0 111.056 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.534 ' HB3' HG13 ' A' ' 56' ' ' ILE . 33.8 Cg_endo -64.5 154.24 72.88 Favored 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 122.813 2.342 . . . . 0.0 112.776 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.508 HG23 ' HA ' ' A' ' 147' ' ' THR . 40.0 t -103.93 -28.24 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.889 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.66 17.65 11.44 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.8 t0 33.81 93.23 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.702 HG22 ' HG3' ' A' ' 20' ' ' MET . 11.0 t -80.24 97.52 3.05 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 10.0 tttp -102.4 130.56 49.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.422 -179.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.576 HD12 ' OG1' ' A' ' 51' ' ' THR . 13.0 mt -104.68 135.59 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.647 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.56 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -134.26 2.48 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.447 ' HB2' ' CB ' ' A' ' 17' ' ' GLU . 22.3 mttt -154.37 131.99 11.39 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.643 0.258 . . . . 0.0 111.183 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -155.43 81.74 1.04 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.063 179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -144.67 156.81 56.11 Favored Pre-proline 0 N--CA 1.465 0.29 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.368 -179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -79.93 177.83 7.91 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.098 2.532 . . . . 0.0 112.195 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -135.43 119.36 17.4 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.112 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.088 0 CA-C-O 118.383 -1.232 . . . . 0.0 112.514 179.841 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 mtm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 120.668 0.271 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.82 159.04 40.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.35 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.02 158.06 15.91 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.127 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.495 HD12 ' HD2' ' A' ' 6' ' ' PRO . 1.1 pt -61.96 144.53 93.76 Favored Pre-proline 0 CA--C 1.531 0.225 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.294 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.52 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 43.8 Cg_exo -54.99 -49.49 16.46 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.597 2.198 . . . . 0.0 112.572 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' A' ' 5' ' ' PRO . 35.6 Cg_exo -58.87 161.74 14.78 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.216 1.944 . . . . 0.0 112.512 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.7 t0 62.04 98.09 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.606 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 60.0 p -155.94 -73.22 0.11 Allowed 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.87 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 64.85 118.78 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.046 0.45 . . . . 0.0 111.5 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.03 164.37 42.73 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.575 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -49.93 106.4 0.12 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.014 2.476 . . . . 0.0 112.248 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.94 -47.9 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.276 1.984 . . . . 0.0 112.359 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -128.49 177.47 6.97 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.786 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.6 p -129.79 129.93 66.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.687 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -86.83 93.01 9.17 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.905 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.92 89.26 7.91 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.937 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.16 89.56 6.01 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.445 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 159' ' ' ILE . 1.2 p -95.21 164.11 12.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.147 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -66.89 -40.92 87.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.609 179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.715 ' HB2' HG23 ' A' ' 157' ' ' VAL . 4.5 tpt -62.11 -30.91 71.34 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.936 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 168.21 -168.71 41.03 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.951 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.0 tt -117.17 129.13 74.2 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 116.932 0.366 . . . . 0.0 111.075 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.605 HG22 ' CA ' ' A' ' 135' ' ' GLY . 11.6 pt -138.52 128.34 33.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.584 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 21.9 t -103.85 111.28 32.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.391 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.875 HD12 HG12 ' A' ' 132' ' ' VAL . 0.8 OUTLIER -103.4 154.44 19.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.196 -179.405 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -112.2 133.37 54.37 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.933 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 4.5 mt -97.23 149.84 21.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.408 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.66 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 20.0 m-85 -92.24 90.66 7.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.85 0.357 . . . . 0.0 110.776 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 6.4 m95 -80.47 23.6 0.5 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 mmpt? -100.44 -71.95 0.69 Allowed 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 178.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.536 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -100.94 -13.67 18.21 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.664 178.81 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -100.15 1.36 0.09 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 43.5 Cg_exo -36.83 -37.39 0.31 Allowed 'Trans proline' 0 C--N 1.366 1.477 0 C-N-CA 122.467 2.111 . . . . 0.0 113.375 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -60.67 3.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.781 0.324 . . . . 0.0 110.532 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 49.2 p -67.0 -34.69 78.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.888 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.461 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 96.6 m -58.94 -50.57 73.55 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.551 179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 6.6 mtmt -57.3 -40.31 77.58 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.284 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.451 ' OD1' HD11 ' A' ' 42' ' ' LEU . 14.9 t-20 -63.25 -53.09 58.46 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.568 179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.725 ' HA ' HD12 ' A' ' 42' ' ' LEU . 20.5 t80 -56.76 -44.04 81.38 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.738 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.55 -42.5 99.57 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.982 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.664 ' HB3' HG21 ' A' ' 77' ' ' ILE . 1.8 tt0 -64.7 -38.0 89.5 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.933 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 39' ' ' PHE . 9.2 mt -64.02 -39.55 94.34 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.971 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -70.5 -36.88 74.05 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.115 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.8 mtt180 -72.83 -52.83 13.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.151 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -59.36 -33.84 71.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.428 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.29 32.07 3.85 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.591 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -76.63 -53.08 8.51 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-O 120.629 0.252 . . . . 0.0 110.386 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -64.81 -41.0 96.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.644 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.8 m-20 -61.19 127.44 31.54 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.473 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.79 -32.02 8.03 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.604 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 170.12 15.28 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.865 0.364 . . . . 0.0 110.896 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.432 ' HB3' ' CB ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -145.46 159.23 43.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.925 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.472 ' CD1' HG12 ' A' ' 62' ' ' ILE . 58.6 m-85 -67.45 117.24 9.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.681 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.5 m80 -89.25 -61.57 1.67 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.289 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -88.97 123.37 33.24 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.072 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 153' ' ' PRO . 7.1 mt -142.07 112.29 2.88 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.297 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.544 ' N ' HD12 ' A' ' 57' ' ' ILE . 3.8 mp -93.89 121.02 44.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.065 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.23 123.7 18.89 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.13 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 23.1 t70 59.17 58.02 3.24 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.537 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.417 ' H ' HD21 ' A' ' 116' ' ' LEU . 15.6 t80 -166.66 -74.68 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.976 179.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.402 ' SD ' HD13 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -160.11 177.46 10.68 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.224 179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 62' ' ' ILE . 11.2 tt -151.15 101.91 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.082 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.544 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 13.9 tt0 -87.36 132.54 33.92 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.883 0.373 . . . . 0.0 111.731 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.13 150.47 17.76 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.419 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.79 171.24 52.38 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.023 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.503 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 2.8 t0 179.21 -55.02 0.0 OUTLIER Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 111.591 0.219 . . . . 0.0 111.591 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.503 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 96.7 Cg_endo -80.45 47.12 2.45 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.601 2.201 . . . . 0.0 112.978 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.3 40.9 0.36 Allowed 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.803 0.335 . . . . 0.0 110.976 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -115.42 31.28 6.26 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.952 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 t -128.39 -41.5 1.55 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.709 0.255 . . . . 0.0 111.455 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.51 40.66 2.71 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.629 -179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -169.23 -58.95 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.45 0.167 . . . . 0.0 111.097 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.26 149.79 19.44 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.765 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.28 101.74 2.78 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.763 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.34 160.96 14.14 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.78 0.324 . . . . 0.0 111.275 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.0 p -101.28 169.79 8.66 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.367 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.664 HG21 ' HB3' ' A' ' 41' ' ' GLU . 3.9 pt -67.96 -29.95 46.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.866 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -81.65 -42.87 19.36 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.708 -0.223 . . . . 0.0 111.301 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.2 -138.56 2.65 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.725 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.2 -61.92 1.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.676 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -160.72 161.16 32.13 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.731 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -137.03 177.36 7.92 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.21 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -87.11 176.94 7.36 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-O 120.97 0.414 . . . . 0.0 111.092 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -92.74 179.25 5.54 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.152 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 127' ' ' THR . 0.4 OUTLIER -136.0 136.02 39.98 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.252 -179.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.05 129.37 9.77 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.945 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -172.21 -62.48 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.47 ' HB2' HD12 ' A' ' 90' ' ' LEU . 41.1 Cg_endo -66.68 -14.48 44.09 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.755 2.303 . . . . 0.0 113.076 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER 72.2 -67.99 0.24 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.477 0.311 . . . . 0.0 111.144 179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.669 ' HB3' HD13 ' A' ' 128' ' ' ILE . 1.7 mp 66.27 157.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.855 0.36 . . . . 0.0 111.57 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -58.72 145.67 39.39 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.379 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -148.6 29.16 0.85 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.618 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.5 t -137.43 -46.57 0.56 Allowed 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -56.5 122.95 30.05 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.778 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -46.16 131.6 10.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.636 0.255 . . . . 0.0 111.671 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.582 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 100.81 59.93 0.81 Allowed Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.868 179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.706 HD12 HH11 ' A' ' 131' ' ' ARG . 14.6 mm -128.56 132.56 67.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.73 0.265 . . . . 0.0 111.039 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG22 ' A' ' 114' ' ' VAL . 2.1 mt -109.67 103.65 12.53 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.749 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.625 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -111.48 140.21 46.27 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.398 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -79.7 108.72 13.47 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.688 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 113' ' ' PHE . . . -88.81 151.99 22.03 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.754 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.5 m-20 -130.66 147.5 52.34 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.718 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.05 -73.68 0.11 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.252 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -108.61 176.14 19.91 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.435 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.3 135.93 38.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.359 2.04 . . . . 0.0 111.879 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 60.35 30.41 19.79 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.336 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -138.78 87.05 2.19 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.961 0.41 . . . . 0.0 110.776 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -83.25 129.7 35.03 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.472 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -105.43 -116.84 4.25 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.832 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.406 ' HB2' ' CD ' ' A' ' 67' ' ' PRO . 67.4 m -154.22 32.06 0.43 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 120.681 0.277 . . . . 0.0 111.463 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -95.33 163.16 13.37 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.828 0.347 . . . . 0.0 111.069 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 2.6 p90 -159.03 124.29 4.23 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.042 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 52.3 p90 -110.97 135.1 51.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.051 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.809 ' CG1' HG11 ' A' ' 139' ' ' VAL . 3.5 t -100.88 105.53 17.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.881 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.39 125.58 31.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.283 -179.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.627 ' N ' HD13 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -116.24 -1.22 12.42 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.695 179.446 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.688 ' O ' HG23 ' A' ' 119' ' ' THR . . . -121.16 140.07 30.5 Favored Pre-proline 0 C--O 1.233 0.198 0 N-CA-C 110.609 -0.145 . . . . 0.0 110.609 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -52.12 112.53 0.88 Allowed 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 122.761 2.307 . . . . 0.0 112.212 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 117' ' ' ALA . 69.5 p -128.79 97.73 4.75 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -91.92 -32.06 15.42 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.332 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 24.6 p90 -60.02 -39.16 84.88 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.58 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.2 pp -93.42 -0.59 56.44 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.729 -0.214 . . . . 0.0 111.474 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -63.83 85.52 0.03 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-O 120.971 0.415 . . . . 0.0 110.204 179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 142.42 -32.08 1.99 Allowed Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.701 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 -44.69 96.65 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.634 0.254 . . . . 0.0 111.128 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -104.02 150.15 24.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.625 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 87.2 m -89.37 151.74 21.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.055 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.669 HD13 ' HB3' ' A' ' 90' ' ' LEU . 1.0 OUTLIER -80.9 -179.33 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.498 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.486 ' CE2' ' HB3' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -172.09 -42.26 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.04 173.35 30.55 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.855 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.706 HH11 HD12 ' A' ' 97' ' ' ILE . 7.6 tpp180 -140.84 148.64 40.87 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.834 0.35 . . . . 0.0 110.592 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.875 HG12 HD12 ' A' ' 25' ' ' LEU . 17.7 m -89.98 114.01 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.671 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 27.0 m -95.48 -36.2 11.4 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.048 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -150.52 94.91 2.17 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.634 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.605 ' CA ' HG22 ' A' ' 23' ' ' ILE . . . 162.03 -19.24 0.18 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.828 -179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.532 ' HB ' HG21 ' A' ' 132' ' ' VAL . 10.5 tt -44.39 -34.61 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 CA-C-N 117.457 0.628 . . . . 0.0 111.903 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -56.9 -25.15 52.35 Favored Glycine 0 C--N 1.34 0.757 0 C-N-CA 121.279 -0.486 . . . . 0.0 113.024 179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.488 ' O ' HG23 ' A' ' 142' ' ' VAL . 1.6 ttp -86.11 -36.03 19.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.754 0.311 . . . . 0.0 110.329 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.809 HG11 ' CG1' ' A' ' 114' ' ' VAL . 21.9 t -72.42 -54.26 16.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.437 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -58.56 -30.69 67.33 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.575 0.226 . . . . 0.0 110.85 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 33.3 ttm180 -61.56 -39.23 90.35 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.532 179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.547 ' O ' HG22 ' A' ' 145' ' ' VAL . 17.8 t -65.87 -27.03 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.788 179.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.35 -30.78 24.01 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.158 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 26.1 mmt -66.31 -34.56 78.26 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.137 0.175 . . . . 0.0 111.45 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 142' ' ' VAL . 29.6 m -63.4 174.92 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-O 120.828 0.347 . . . . 0.0 111.413 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -98.15 131.16 44.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.384 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 77.5 p -94.61 172.14 8.36 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.798 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.19 142.68 47.5 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-O 120.853 0.359 . . . . 0.0 111.646 -179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 83.19 -47.76 0.14 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.989 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 176.35 -32.81 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.593 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 39.9 p30 -169.54 36.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.478 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.5 116.05 65.57 Favored Pre-proline 0 C--O 1.233 0.212 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.78 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.523 ' HB3' HD12 ' A' ' 56' ' ' ILE . 31.3 Cg_endo -64.82 111.28 1.66 Allowed 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.596 2.197 . . . . 0.0 112.191 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 30.3 t -63.56 -33.86 64.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.609 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.98 -168.25 1.21 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.587 179.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -117.09 100.04 7.46 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.748 0.309 . . . . 0.0 111.398 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.715 HG23 ' HB2' ' A' ' 20' ' ' MET . 9.6 p -118.7 115.17 47.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.708 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.432 ' CB ' ' HB3' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -154.4 176.21 12.62 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.318 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.574 ' HA ' HG22 ' A' ' 18' ' ' THR . 3.2 mt -110.45 130.0 64.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 CA-C-O 120.795 0.331 . . . . 0.0 111.5 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 18.6 pt -110.41 -34.35 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.506 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.7 tttp -147.04 140.11 25.25 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.76 0.314 . . . . 0.0 110.767 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -159.41 117.14 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.784 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 4.7 p90 -146.83 147.93 31.36 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.246 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -79.83 146.44 18.6 Favored 'Trans proline' 0 C--N 1.347 0.447 0 C-N-CA 122.668 2.245 . . . . 0.0 112.464 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.89 174.22 7.28 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.042 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.364 -1.242 . . . . 0.0 112.545 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.086 0.47 . . . . 0.0 111.226 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.37 104.13 15.98 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.233 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -141.36 125.6 17.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.91 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 4' ' ' ILE . 3.7 mt 59.99 56.08 4.44 Favored Pre-proline 0 CA--C 1.537 0.464 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.159 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 73.4 Cg_endo -75.22 145.29 30.53 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.71 2.273 . . . . 0.0 112.378 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 5' ' ' PRO . 33.1 Cg_exo -57.95 170.86 1.85 Allowed 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.825 2.35 . . . . 0.0 112.659 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 m-20 64.14 72.63 0.45 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.579 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.6 m -120.44 166.64 13.3 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.506 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.536 ' O ' ' HB3' ' A' ' 10' ' ' GLN . 18.9 m95 -68.63 177.81 2.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.473 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.536 ' HB3' ' O ' ' A' ' 9' ' ' TRP . 1.1 tm0? 74.58 131.1 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.429 0 O-C-N 123.254 0.346 . . . . 0.0 110.623 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' A' ' 10' ' ' GLN . 35.1 Cg_endo -65.36 108.73 1.23 Allowed 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.579 2.186 . . . . 0.0 111.936 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.0 -41.08 72.03 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.673 2.249 . . . . 0.0 112.298 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -118.98 167.3 11.88 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.1 m -144.28 137.42 23.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.207 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.422 ' CD2' HG22 ' A' ' 24' ' ' VAL . 18.9 m-85 -118.57 102.26 8.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.777 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 mt -84.06 104.9 14.5 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.497 ' HA ' HD12 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -87.12 90.66 8.44 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 179.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.474 ' HB ' HG23 ' A' ' 159' ' ' ILE . 1.4 t -114.06 166.55 11.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.816 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.67 -35.86 79.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.211 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.931 ' HB2' HG13 ' A' ' 157' ' ' VAL . 7.4 tpt -62.7 -28.23 69.8 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.115 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 146.89 152.45 5.65 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 121.324 -0.465 . . . . 0.0 111.954 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 17' ' ' GLU . 1.4 tp -79.64 122.75 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 CA-C-N 117.078 0.439 . . . . 0.0 111.358 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.472 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -124.62 124.09 67.41 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 15' ' ' TYR . 20.8 t -98.66 120.88 48.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.976 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -110.61 147.73 33.64 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.048 -179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -102.37 107.37 18.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.519 179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.548 HD11 ' CE1' ' A' ' 129' ' ' PHE . 3.8 mm? -81.35 132.18 35.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.468 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.565 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 79.0 m-85 -68.28 99.03 0.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.053 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 25.0 p-90 -77.9 11.23 2.3 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.29 -69.18 0.78 Allowed 'General case' 0 N--CA 1.462 0.128 0 CA-C-O 120.701 0.286 . . . . 0.0 110.527 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 14.7 m-70 -100.82 -15.93 17.45 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.652 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -98.55 1.48 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.772 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.652 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 81.6 Cg_exo -42.81 -36.5 5.16 Favored 'Trans proline' 0 C--N 1.364 1.376 0 C-N-CA 122.079 1.853 . . . . 0.0 113.081 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.7 tptt -62.91 -57.13 11.84 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.853 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.1 p -61.92 -36.98 82.96 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.267 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.03 -48.49 73.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.599 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 11.4 ttpp -56.37 -39.08 72.35 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.465 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -71.81 -44.17 64.37 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.882 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -61.76 -45.38 94.13 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.78 0.324 . . . . 0.0 110.892 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.63 80.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.248 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.59 -43.15 97.72 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.52 -35.39 80.8 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 116.73 -0.214 . . . . 0.0 111.069 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.64 81.47 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.528 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptp180 -92.6 -31.9 15.0 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.616 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 9.8 ttm-85 -57.2 -31.69 65.73 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.6 26.13 4.92 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.982 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -96.2 -44.82 7.11 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.585 ' O ' HG22 ' A' ' 51' ' ' THR . 10.7 m-85 -82.25 -33.23 29.31 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.922 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -59.0 105.91 0.37 Allowed 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.733 0.301 . . . . 0.0 110.501 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 111.81 21.96 6.19 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.895 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.69 ' CG2' HD12 ' A' ' 159' ' ' ILE . 7.6 t -98.55 173.44 6.93 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 117.144 0.472 . . . . 0.0 111.097 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.66 38.17 0.23 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.713 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.445 ' HB3' HD11 ' A' ' 56' ' ' ILE . 31.0 m-85 56.45 -177.58 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.413 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -151.11 -48.05 0.12 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.706 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -117.21 111.26 19.19 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.69 0.281 . . . . 0.0 110.624 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.803 HG23 HG22 ' A' ' 62' ' ' ILE . 32.6 mm -115.7 116.02 51.1 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.486 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.47 HD12 ' CE ' ' A' ' 61' ' ' MET . 33.0 mt -122.74 94.78 3.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.361 179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' O ' HD11 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -56.73 -27.5 59.34 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.517 -179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.37 31.47 2.22 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.734 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -169.74 -78.36 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.68 0.252 . . . . 0.0 111.68 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.47 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -160.21 178.13 9.96 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.854 0.359 . . . . 0.0 111.601 -179.345 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.803 HG22 HG23 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -132.81 104.2 6.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.311 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.542 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 11.1 tt0 -93.44 130.8 39.13 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.848 0.356 . . . . 0.0 111.643 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -97.92 145.54 17.84 Favored Glycine 0 C--N 1.331 0.305 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.737 179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.48 168.46 29.45 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.395 -179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -152.88 68.38 6.77 Favored Pre-proline 0 C--O 1.235 0.302 0 CA-C-O 120.893 0.378 . . . . 0.0 111.08 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.67 -177.07 0.28 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.716 2.278 . . . . 0.0 112.234 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.69 -50.5 1.73 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.566 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.53 44.39 0.32 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.45 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -149.38 -44.88 0.14 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.504 0.192 . . . . 0.0 111.263 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.9 28.66 17.71 Favored Glycine 0 C--N 1.334 0.444 0 C-N-CA 121.021 -0.609 . . . . 0.0 112.551 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -177.27 -42.43 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.57 0.224 . . . . 0.0 111.165 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.28 101.39 1.98 Allowed Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.647 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -126.41 110.06 1.21 Allowed Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.433 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.29 138.9 22.87 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.717 0.294 . . . . 0.0 111.207 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 97.3 p -96.24 -179.24 4.59 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.028 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.527 HD11 ' CZ ' ' A' ' 78' ' ' TYR . 1.2 pt -61.52 -28.94 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.484 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.527 ' CZ ' HD11 ' A' ' 77' ' ' ILE . 62.8 m-85 -83.97 -43.71 14.92 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.87 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 171.81 -169.47 42.54 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.745 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -63.52 -45.38 90.92 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.559 0.219 . . . . 0.0 111.213 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.837 ' CB ' HG23 ' A' ' 107' ' ' THR . 2.9 pt20 -152.17 127.74 10.07 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.79 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.9 p90 -116.37 157.05 25.66 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.936 0.398 . . . . 0.0 111.115 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -65.95 179.16 0.94 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.053 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -95.64 146.57 24.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -105.32 102.09 11.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.601 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 4.4 tp -134.73 144.88 47.99 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.862 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.426 ' CB ' ' CD ' ' A' ' 88' ' ' PRO . 2.4 m-70 -158.3 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.465 0.3 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.82 179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.452 ' HB2' HD12 ' A' ' 90' ' ' LEU . 72.6 Cg_endo -74.43 158.1 44.61 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.676 2.251 . . . . 0.0 112.507 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -71.66 -49.03 43.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.238 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.665 HD22 HG13 ' A' ' 128' ' ' ILE . 0.2 OUTLIER 56.2 -170.92 0.08 Allowed 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 120.921 0.391 . . . . 0.0 111.948 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.52 167.88 13.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.225 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.468 ' CD1' HD11 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -159.7 35.97 0.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.556 -179.872 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -126.97 -46.54 1.53 Allowed 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -57.79 117.08 9.21 Favored Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.641 -0.79 . . . . 0.0 111.864 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.427 ' O ' HD12 ' A' ' 136' ' ' ILE . . . -45.35 134.24 6.76 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.699 0.285 . . . . 0.0 111.62 -179.296 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.523 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 98.38 60.32 0.91 Allowed Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.726 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 96' ' ' GLY . 11.0 mm -128.36 160.23 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.568 0.184 . . . . 0.0 110.643 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.604 HD21 HG22 ' A' ' 114' ' ' VAL . 10.2 mt -133.96 115.95 14.99 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-O 120.947 0.403 . . . . 0.0 111.163 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -118.14 139.95 50.5 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.335 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.431 ' HB2' ' HB3' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -79.82 113.56 18.07 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.497 179.406 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -88.64 170.37 10.89 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.366 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.6 p30 -142.66 151.44 41.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.087 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.82 -33.81 75.51 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.932 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.72 179.99 34.91 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.467 179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -52.99 131.9 44.91 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.541 2.16 . . . . 0.0 111.72 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.0 p30 44.15 30.0 0.4 Allowed 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.688 0.618 . . . . 0.0 112.0 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.837 HG23 ' CB ' ' A' ' 81' ' ' GLN . 50.2 m -136.59 85.81 2.17 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.593 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -83.89 162.17 20.61 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.09 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -129.63 -105.35 1.15 Allowed Glycine 0 C--N 1.331 0.282 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.035 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 33.7 m -155.89 40.55 0.38 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.944 0.402 . . . . 0.0 111.174 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -109.41 161.27 15.46 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.187 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' O ' ' HA ' ' A' ' 63' ' ' GLN . 7.6 p90 -159.98 125.91 4.19 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.522 -179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 63' ' ' GLN . 50.5 p90 -112.85 133.76 54.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.281 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.604 HG22 HD21 ' A' ' 98' ' ' LEU . 40.6 t -94.81 111.29 25.26 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.234 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.63 103.42 9.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.023 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 58' ' ' LYS . 1.1 pp -95.23 -5.33 44.05 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.743 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -119.23 151.01 50.35 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 120.58 0.228 . . . . 0.0 111.219 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.07 109.21 2.31 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 122.778 2.319 . . . . 0.0 111.931 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.441 ' OG1' HD21 ' A' ' 122' ' ' LEU . 72.1 p -133.91 100.96 4.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.23 -179.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -94.1 -27.04 16.47 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.419 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -58.8 -27.33 64.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.54 0.21 . . . . 0.0 111.505 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.497 ' C ' HD12 ' A' ' 122' ' ' LEU . 4.4 pp -98.03 0.2 45.8 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.85 84.56 0.03 OUTLIER 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.966 0.412 . . . . 0.0 110.403 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 151.11 -30.95 0.98 Allowed Glycine 0 CA--C 1.52 0.366 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.837 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -67.41 -57.65 6.19 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.685 0.279 . . . . 0.0 111.224 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 30.0 m-70 -93.88 144.38 25.5 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.897 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.617 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 12.3 t -88.22 152.69 21.79 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.821 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.71 HG22 ' H ' ' A' ' 129' ' ' PHE . 3.3 mm -80.16 -179.32 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.406 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.71 ' H ' HG22 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -173.26 -44.19 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.445 0.164 . . . . 0.0 111.179 179.693 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -143.0 179.7 20.36 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.729 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.96 153.65 50.64 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.726 0.298 . . . . 0.0 110.93 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.8 t -101.69 87.81 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.769 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.5 m -81.32 -51.37 8.44 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.711 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -127.81 103.04 7.06 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.223 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 139' ' ' VAL . . . 156.18 -23.75 0.52 Allowed Glycine 0 CA--C 1.52 0.406 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.196 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.427 HD12 ' O ' ' A' ' 95' ' ' ALA . 15.0 tt -47.49 -34.77 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 N-CA-C 111.826 0.306 . . . . 0.0 111.826 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -60.7 -44.44 97.91 Favored Glycine 0 C--N 1.338 0.668 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.537 179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 7.8 tpt -76.52 -46.41 26.68 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.555 0.217 . . . . 0.0 110.769 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 135' ' ' GLY . 19.9 t -56.49 -34.8 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.191 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -67.24 -39.64 86.22 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-O 120.674 0.273 . . . . 0.0 110.788 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 78.8 mtt-85 -60.94 -28.64 69.1 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.198 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . . . . . . . . . 17.2 t -58.36 -25.42 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.736 0.303 . . . . 0.0 111.03 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.66 -23.3 39.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.804 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 16.0 mmt -63.57 -27.01 68.95 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.772 0.286 . . . . 0.0 111.359 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.412 HG23 ' H ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER -64.53 173.13 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.478 -179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -86.58 133.72 33.7 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.57 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 11.7 p -100.81 178.07 4.8 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.656 179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -110.55 29.03 8.09 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.727 -0.215 . . . . 0.0 111.376 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 56.21 24.53 8.2 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 120.728 0.299 . . . . 0.0 111.198 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.93 33.83 0.25 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.184 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 58.33 44.15 18.92 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.389 -179.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -131.52 90.33 37.65 Favored Pre-proline 0 CA--C 1.533 0.291 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.757 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.458 ' HG3' HG13 ' A' ' 56' ' ' ILE . 36.8 Cg_endo -66.25 139.68 55.93 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.693 2.262 . . . . 0.0 112.437 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.84 -50.42 77.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.83 67.45 1.98 Allowed 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -51.32 156.31 1.22 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.757 -178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.931 HG13 ' HB2' ' A' ' 20' ' ' MET . 25.9 t -79.83 138.15 20.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.096 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.86 119.31 16.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.77 0.319 . . . . 0.0 111.266 -179.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.69 HD12 ' CG2' ' A' ' 51' ' ' THR . 12.0 mt -92.62 148.33 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.206 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.78 -38.33 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.856 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -154.63 170.42 21.56 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.88 0.371 . . . . 0.0 111.343 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -132.7 134.57 44.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.639 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.41 ' HB3' ' HB2' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -107.85 93.72 11.14 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.184 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_endo -79.71 104.74 1.74 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.579 2.186 . . . . 0.0 111.468 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.2 t -71.49 78.94 0.78 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.397 -1.224 . . . . 0.0 112.459 -179.925 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.548 0.213 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.5 -53.62 0.1 Allowed 'General case' 0 CA--C 1.528 0.111 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.32 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.84 -65.78 0.54 Allowed 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.293 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.9 pt -143.32 101.43 5.18 Favored Pre-proline 0 C--N 1.333 -0.149 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.416 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HB2' ' HD3' ' A' ' 6' ' ' PRO . 50.3 Cg_exo -52.97 -48.39 22.41 Favored 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 122.381 2.054 . . . . 0.0 112.797 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 5' ' ' PRO . 97.8 Cg_endo -78.26 139.04 16.43 Favored 'Trans proline' 0 C--N 1.358 1.038 0 C-N-CA 122.426 2.084 . . . . 0.0 113.014 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -132.93 127.64 34.74 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.249 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.3 t 61.58 -169.81 0.17 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.816 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -81.46 179.47 7.83 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -108.44 101.13 41.35 Favored Pre-proline 0 C--O 1.232 0.139 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.71 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.48 110.36 2.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.806 2.338 . . . . 0.0 112.414 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.98 -32.78 17.02 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.661 2.241 . . . . 0.0 112.755 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -126.77 154.64 43.97 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.998 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.1 p -132.29 143.88 38.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.448 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.29 117.36 34.58 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.096 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.53 HD12 HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -98.47 99.77 10.97 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.103 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.5 105.24 17.45 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.392 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.56 ' HB ' HG23 ' A' ' 159' ' ' ILE . 0.6 OUTLIER -114.92 167.74 10.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.127 -179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.53 -21.48 52.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.644 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.807 ' HB3' HG13 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -95.6 28.2 3.1 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.995 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.456 ' O ' HG23 ' A' ' 18' ' ' THR . . . 119.03 -156.59 15.62 Favored Glycine 0 C--N 1.337 0.626 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.284 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.0 mt -146.43 139.07 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 CA-C-N 116.919 0.36 . . . . 0.0 111.021 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.696 HD12 HD11 ' A' ' 25' ' ' LEU . 8.4 pt -139.34 133.69 39.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.02 0.438 . . . . 0.0 111.642 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.5 t -108.13 113.77 44.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.598 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.696 HD11 HD12 ' A' ' 23' ' ' ILE . 2.2 mp -112.57 138.41 49.38 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.149 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -103.64 130.15 51.05 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.869 179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.724 HD12 ' SG ' ' A' ' 36' ' ' CYS . 0.4 OUTLIER -97.51 131.8 43.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.593 179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.608 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 22.9 m-85 -64.83 99.4 0.33 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.788 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . . . . . . . . . 47.2 p-90 -79.46 14.77 1.47 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.95 -70.67 0.73 Allowed 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.493 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 10.2 m-70 -100.88 -14.46 17.94 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.65 ' N ' ' CD ' ' A' ' 33' ' ' PRO . . . -99.14 1.12 0.09 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.65 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 69.8 Cg_exo -40.79 -37.19 2.24 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 122.154 1.903 . . . . 0.0 112.974 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -55.3 36.57 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 120.794 0.33 . . . . 0.0 110.442 179.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 23.5 m -64.9 -35.12 80.11 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.883 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.724 ' SG ' HD12 ' A' ' 27' ' ' LEU . 55.8 m -56.15 -50.2 71.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.299 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -61.11 -39.32 89.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.622 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -62.4 -59.06 5.53 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.929 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.52 -40.84 84.03 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.2 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.87 -49.53 67.78 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 -64.22 -36.12 83.04 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.11 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.81 -49.49 77.5 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 120.656 0.265 . . . . 0.0 110.657 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.95 64.23 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.23 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.39 -46.09 50.94 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.312 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.0 ttt-85 -60.14 -54.07 50.28 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.532 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.51 52.36 0.03 OUTLIER Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.788 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -125.63 -49.67 1.63 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.544 0.211 . . . . 0.0 110.909 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.477 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -71.65 -45.29 62.47 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.177 179.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -56.17 118.64 4.89 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.824 0.345 . . . . 0.0 110.866 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.23 32.37 20.27 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.697 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.2 t -100.23 -175.27 2.89 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 111.166 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.5 ttmt -163.39 137.27 5.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.003 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HB3' HD11 ' A' ' 56' ' ' ILE . 39.9 m-85 -64.93 150.28 48.16 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.852 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -142.76 19.26 2.0 Allowed 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.619 ' C ' HD12 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -158.07 104.69 1.91 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.584 0.23 . . . . 0.0 111.155 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.949 HD13 ' HG3' ' A' ' 153' ' ' PRO . 2.7 mp -136.18 113.59 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.26 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.85 100.11 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.638 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 143' ' ' GLY . 1.1 ttmt -59.12 145.23 43.12 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.038 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 69.68 36.09 2.23 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.092 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -169.53 -94.35 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.892 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.4 ' SD ' ' CD2' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -160.41 169.61 22.7 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 56' ' ' ILE . 33.9 pt -137.24 150.33 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.753 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 4.6 pm0 -126.26 145.61 50.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.968 0.413 . . . . 0.0 111.324 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.57 159.79 13.62 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.604 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -89.9 160.22 28.47 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.896 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.529 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -148.29 -65.07 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.28 0 CA-C-N 115.957 -0.121 . . . . 0.0 111.214 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 66' ' ' ASP . 71.8 Cg_endo -77.27 97.82 1.17 Allowed 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 122.433 2.089 . . . . 0.0 112.208 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.473 HG22 ' HA2' ' A' ' 71' ' ' GLY . 0.2 OUTLIER -153.7 67.78 0.76 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.981 0.42 . . . . 0.0 110.759 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.24 -11.52 75.57 Favored Glycine 0 CA--C 1.523 0.566 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.168 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 73' ' ' GLY . 2.3 t -130.67 -43.27 1.12 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.884 0.342 . . . . 0.0 111.362 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.473 ' HA2' HG22 ' A' ' 68' ' ' THR . . . 135.69 -35.46 2.15 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.501 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -107.32 -20.14 13.37 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.412 ' H ' HG23 ' A' ' 70' ' ' THR . . . -123.79 131.61 8.1 Favored Glycine 0 C--N 1.337 0.637 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.835 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -118.56 125.49 6.44 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.813 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.43 146.15 28.31 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.698 0.285 . . . . 0.0 111.135 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.6 t -108.37 170.92 7.71 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.045 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.425 HG13 ' CD2' ' A' ' 78' ' ' TYR . 19.5 pt -48.5 -45.05 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.338 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.425 ' CD2' HG13 ' A' ' 77' ' ' ILE . 4.1 p90 -131.07 14.85 5.19 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.158 178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' ' CD1' ' A' ' 82' ' ' PHE . . . -86.27 -136.57 4.37 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.372 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 76.84 -63.49 0.37 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.137 0.494 . . . . 0.0 110.364 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -150.59 100.91 2.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.508 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.471 ' CD1' ' HA2' ' A' ' 79' ' ' GLY . 27.9 p90 -154.31 179.4 9.02 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.166 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -101.87 115.54 30.76 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.848 179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -85.21 165.92 16.98 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.136 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -92.15 128.56 38.04 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.357 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.2 136.68 49.92 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.045 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.419 ' HB3' HD12 ' A' ' 90' ' ' LEU . 25.5 m80 -140.6 99.91 6.87 Favored Pre-proline 0 C--O 1.233 0.191 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.008 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.79 156.16 67.04 Favored 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.652 2.235 . . . . 0.0 112.382 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 60.71 76.12 0.38 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.917 -179.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.676 HD22 HG21 ' A' ' 128' ' ' ILE . 0.1 OUTLIER -145.24 80.37 1.61 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.754 -179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.39 -90.94 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.219 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 46.59 34.13 2.31 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.718 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.5 t -71.59 -36.27 70.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.344 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 115.05 160.34 12.74 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.3 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . 65.99 94.74 0.06 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.866 0.365 . . . . 0.0 111.689 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.44 ' O ' HD13 ' A' ' 97' ' ' ILE . . . 81.06 44.95 7.84 Favored Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.781 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 96' ' ' GLY . 33.6 mm -124.57 116.11 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-O 120.579 0.228 . . . . 0.0 110.855 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.557 HD22 HD22 ' A' ' 25' ' ' LEU . 25.1 tp -96.51 114.78 26.47 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.933 0.397 . . . . 0.0 111.097 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.647 ' HB1' ' O ' ' A' ' 127' ' ' THR . . . -114.07 150.38 34.11 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.319 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.403 ' HG3' ' CG ' ' A' ' 129' ' ' PHE . 0.7 OUTLIER -79.45 125.27 29.33 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.592 179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -80.54 151.77 28.99 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.71 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -130.16 146.71 51.82 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.403 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 107' ' ' THR . . . -91.17 -53.9 4.16 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.794 0.33 . . . . 0.0 110.592 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -160.12 179.99 35.29 Favored Glycine 0 CA--C 1.518 0.227 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.502 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.63 116.85 3.57 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.475 2.117 . . . . 0.0 111.881 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 62.89 26.82 15.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.31 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.57 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 27.5 m -146.23 83.77 1.63 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.834 0.35 . . . . 0.0 110.889 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 41.6 m-80 -101.18 156.29 17.52 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.354 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -107.65 -109.78 3.38 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.14 179.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.411 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -169.0 38.71 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.744 0.307 . . . . 0.0 111.258 179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -100.46 170.92 8.07 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 120.822 0.344 . . . . 0.0 111.112 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -150.45 160.03 44.05 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.905 -179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 25.2 p90 -152.8 138.83 18.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.365 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.433 ' CG1' HD13 ' A' ' 98' ' ' LEU . 17.6 m -103.69 134.7 44.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.547 179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.495 HG22 ' O ' ' A' ' 117' ' ' ALA . 3.2 m -79.61 117.94 20.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.858 -179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.6 -5.48 42.43 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.477 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.62 ' O ' HG23 ' A' ' 119' ' ' THR . . . -155.98 156.8 30.91 Favored Pre-proline 0 CA--C 1.53 0.21 0 CA-C-O 120.356 0.122 . . . . 0.0 111.147 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -51.38 120.23 6.59 Favored 'Trans proline' 0 C--N 1.352 0.724 0 C-N-CA 122.911 2.407 . . . . 0.0 112.736 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.63 ' HB ' HD12 ' A' ' 122' ' ' LEU . 45.8 p -135.02 53.44 1.99 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.364 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -59.48 -35.75 74.7 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.087 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 35.7 p90 -66.62 -24.7 66.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.534 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.63 HD12 ' HB ' ' A' ' 119' ' ' THR . 2.4 mt -76.11 -2.78 32.6 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.049 0.389 . . . . 0.0 112.049 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.55 85.36 0.07 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.095 0.474 . . . . 0.0 110.348 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 165.39 -44.26 0.28 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.601 -0.727 . . . . 0.0 112.736 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 34.9 mttt -64.63 -53.56 45.71 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.678 0.275 . . . . 0.0 110.884 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 -125.63 131.66 52.62 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.549 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.647 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 13.4 t -79.92 167.42 20.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.804 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.676 HG21 HD22 ' A' ' 90' ' ' LEU . 1.4 tt -79.56 -179.77 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.649 -0.251 . . . . 0.0 110.699 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.581 ' CD1' HD11 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -177.8 -44.07 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 111.381 0.141 . . . . 0.0 111.381 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.16 179.96 16.23 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.801 179.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.38 165.59 30.64 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 120.523 0.202 . . . . 0.0 110.938 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.99 103.87 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-O 120.78 0.324 . . . . 0.0 111.461 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 4.3 t -98.06 -51.24 4.1 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.798 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -123.3 98.39 5.84 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.163 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.422 ' O ' HG22 ' A' ' 23' ' ' ILE . . . 149.9 -17.72 1.08 Allowed Glycine 0 CA--C 1.524 0.637 0 C-N-CA 120.753 -0.737 . . . . 0.0 113.386 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 12.9 tt -46.57 -33.88 2.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -58.47 -47.65 88.66 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.308 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.419 ' HG3' ' HA3' ' A' ' 21' ' ' GLY . 0.0 OUTLIER -60.17 -40.48 90.09 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.761 0.315 . . . . 0.0 110.274 179.263 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.429 HG11 HG21 ' A' ' 114' ' ' VAL . 25.2 t -64.68 -41.43 92.21 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.901 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -57.92 -41.98 83.84 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.887 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 3.0 mtt-85 -59.63 -33.89 72.1 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.128 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.569 HG12 HG12 ' A' ' 56' ' ' ILE . 10.6 t -60.25 -30.85 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.068 179.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.444 ' O ' ' HG3' ' A' ' 58' ' ' LYS . . . -89.05 -41.86 5.77 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.355 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 9.7 mmt -51.78 -34.69 40.77 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 142' ' ' VAL . 32.4 m -62.26 171.26 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 120.96 0.409 . . . . 0.0 111.543 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.522 ' O ' HG22 ' A' ' 154' ' ' VAL . 1.1 tt0 -84.25 177.69 8.09 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.897 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 1.3 p -133.1 176.46 8.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.162 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -111.22 -165.52 1.0 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.853 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.68 36.73 0.9 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 120.734 0.302 . . . . 0.0 111.179 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -152.77 29.34 0.52 Allowed 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.866 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.43 39.2 23.88 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.656 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -121.77 146.06 44.83 Favored Pre-proline 0 CA--C 1.53 0.179 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.785 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.949 ' HG3' HD13 ' A' ' 56' ' ' ILE . 66.6 Cg_endo -73.67 140.14 29.01 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.759 2.306 . . . . 0.0 112.397 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 146' ' ' GLU . 4.3 m -58.85 -33.93 50.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.049 179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -118.4 77.68 1.19 Allowed 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.263 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.58 138.11 47.51 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.354 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.807 HG13 ' HB3' ' A' ' 20' ' ' MET . 21.7 t -80.05 126.2 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.72 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.87 114.27 23.66 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.119 -179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.56 HG23 ' HB ' ' A' ' 18' ' ' THR . 8.5 mt -91.01 144.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.456 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.621 ' H ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -133.73 8.57 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 179.77 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -157.57 140.83 15.37 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.593 0.235 . . . . 0.0 111.304 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -153.91 101.08 2.41 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.941 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -151.33 155.93 34.76 Favored Pre-proline 0 N--CA 1.464 0.267 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.479 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -80.11 149.17 19.68 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.862 2.375 . . . . 0.0 112.829 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 1.4 m -149.21 93.22 2.05 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.566 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.263 -1.299 . . . . 0.0 112.851 -179.869 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ptt? . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 120.78 0.324 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.71 163.36 13.78 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.318 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 68.22 167.79 0.26 Allowed 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.592 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.1 tp -98.11 131.25 26.81 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -50.06 121.04 6.89 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.831 2.354 . . . . 0.0 112.47 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.08 -173.56 0.53 Allowed 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.745 2.297 . . . . 0.0 112.471 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 t70 63.83 27.39 14.55 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.785 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.5 m -151.55 130.8 12.78 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.747 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -134.78 -45.56 0.73 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.437 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -84.4 114.23 53.61 Favored Pre-proline 0 C--O 1.233 0.2 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.528 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.59 121.49 9.96 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.556 2.171 . . . . 0.0 112.517 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.467 ' HB3' ' CD1' ' A' ' 29' ' ' TRP . 61.3 Cg_endo -72.85 -18.93 24.22 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.866 2.378 . . . . 0.0 112.96 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -87.8 146.37 25.65 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.799 0.333 . . . . 0.0 110.859 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.2 m -134.43 149.84 30.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.207 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -112.56 123.53 50.49 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.356 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.767 HD12 ' CD1' ' A' ' 25' ' ' LEU . 1.3 mt -106.43 94.01 4.91 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.828 179.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.43 109.59 15.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.546 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.68 HG22 ' HA ' ' A' ' 159' ' ' ILE . 31.3 p -118.29 156.83 28.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.632 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.6 t -57.93 -35.06 70.56 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.567 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.778 ' HB2' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -67.56 -36.48 81.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.873 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 170.87 -159.4 31.5 Favored Glycine 0 C--N 1.338 0.689 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.358 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.7 tt -125.93 124.48 66.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.922 0.361 . . . . 0.0 111.003 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.603 HG22 ' HA2' ' A' ' 135' ' ' GLY . 24.2 pt -123.74 130.89 73.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.72 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 17.3 t -92.87 121.97 43.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.023 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.767 ' CD1' HD12 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -123.23 154.87 38.18 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.303 -179.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -112.95 130.32 56.16 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.84 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.481 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 92.3 mt -103.79 134.1 47.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.769 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.721 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 82.7 m-85 -77.18 98.46 5.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.613 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 12' ' ' PRO . 39.9 p-90 -82.26 20.42 1.05 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -100.27 -68.98 0.79 Allowed 'General case' 0 C--O 1.231 0.123 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.5 ' C ' ' HD2' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -100.88 -13.34 18.39 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.139 179.347 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 28' ' ' TYR . . . -99.76 1.01 0.09 OUTLIER Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.661 ' CD ' ' N ' ' A' ' 32' ' ' ALA . 67.6 Cg_exo -40.26 -40.02 2.81 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 122.296 1.998 . . . . 0.0 113.226 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.1 tptt -58.85 -53.75 54.86 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.561 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.4 m -70.81 -35.48 72.53 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.831 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 68.5 m -56.69 -53.59 56.01 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.539 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -44.02 96.46 Favored 'General case' 0 C--N 1.334 -0.07 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.369 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -55.47 -44.83 76.82 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.149 179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -60.51 -58.05 10.14 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.239 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.15 -42.77 96.63 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.609 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.625 ' HG2' HG21 ' A' ' 77' ' ' ILE . 0.6 OUTLIER -56.86 -47.11 81.17 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.346 -179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -39.02 88.56 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.605 -0.27 . . . . 0.0 111.166 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.7 -28.14 36.77 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.636 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.31 -50.11 55.75 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.557 0.217 . . . . 0.0 111.171 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.457 HH11 HG22 ' A' ' 77' ' ' ILE . 12.7 ptm180 -60.68 -33.78 73.35 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.457 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 114.31 52.44 0.45 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.667 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.18 -54.27 1.91 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.383 0.135 . . . . 0.0 111.079 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.14 -47.26 62.09 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.192 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.7 m-20 -60.36 114.71 3.07 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.687 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 134.35 -26.86 3.32 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.675 -179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.674 HG23 HD12 ' A' ' 159' ' ' ILE . 14.2 t -72.67 -175.58 1.71 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.181 0.515 . . . . 0.0 111.558 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 158' ' ' LYS . 0.0 OUTLIER -165.75 144.9 6.23 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.723 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -61.92 112.94 2.52 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.719 0.295 . . . . 0.0 110.716 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.0 m80 -88.29 -55.07 3.89 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.357 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.94 113.43 22.05 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.219 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.666 ' HA ' HG22 ' A' ' 62' ' ' ILE . 13.2 mm -120.21 84.89 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.863 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 31.4 mt -91.76 90.7 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.297 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -62.8 153.08 34.08 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.035 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 1.7 t0 68.27 26.79 6.81 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.165 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 41.9 t80 -163.59 -85.27 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.077 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.507 ' HB3' HG23 ' A' ' 115' ' ' THR . 0.0 OUTLIER -160.24 169.59 22.89 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 111.421 -179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.666 HG22 ' HA ' ' A' ' 56' ' ' ILE . 1.9 pt -143.12 132.9 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.594 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' PHE . 2.7 pt20 -118.19 150.46 39.37 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.325 0.583 . . . . 0.0 112.245 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.47 115.9 0.83 Allowed Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.462 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.19 -179.42 34.96 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.293 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.2 t0 70.93 69.81 0.34 Allowed Pre-proline 0 N--CA 1.463 0.193 0 CA-C-O 120.858 0.361 . . . . 0.0 111.146 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -89.23 45.91 0.88 Allowed 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.151 2.568 . . . . 0.0 112.087 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -178.07 -38.81 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.595 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -72.12 66.82 1.18 Allowed Glycine 0 C--N 1.338 0.661 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.972 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 22.2 m -93.04 -24.53 18.29 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.593 0.235 . . . . 0.0 110.944 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 172.31 -33.62 0.13 Allowed Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.255 -0.498 . . . . 0.0 112.68 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.19 -69.97 0.39 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.608 0.204 . . . . 0.0 110.99 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.15 165.73 34.91 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.824 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -152.09 101.48 0.21 Allowed Glycine 0 C--N 1.333 0.392 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.511 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.64 133.56 36.38 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.687 0.28 . . . . 0.0 111.282 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 7.8 t -84.01 -175.69 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.148 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.625 HG21 ' HG2' ' A' ' 41' ' ' GLU . 42.2 pt -71.8 -38.43 65.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.505 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -81.31 -31.22 33.65 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.561 -0.29 . . . . 0.0 111.196 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.27 -152.79 23.98 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.83 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 8.1 mmtp -92.9 -45.52 7.93 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-O 120.779 0.324 . . . . 0.0 110.482 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -132.5 162.7 30.56 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.734 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.64 164.95 19.05 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.015 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -68.44 -178.12 1.05 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.434 ' OD1' HG21 ' A' ' 127' ' ' THR . 1.4 t70 -114.28 156.64 24.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.423 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -128.77 97.09 4.56 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.882 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.6 tp -135.29 145.12 47.22 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.002 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -154.44 122.99 3.02 Favored Pre-proline 0 CA--C 1.529 0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.503 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.95 87.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 123.059 2.506 . . . . 0.0 112.867 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.549 ' O ' HD12 ' A' ' 90' ' ' LEU . 1.1 t70 -160.5 33.16 0.16 Allowed 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.968 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD22 HG21 ' A' ' 128' ' ' ILE . 1.2 mp -143.02 -176.25 4.83 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.325 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.9 tptt -120.16 148.24 43.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.851 0.358 . . . . 0.0 111.512 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.524 ' CE2' HD12 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -136.9 79.82 1.78 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.991 179.671 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -78.21 -31.01 49.19 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.323 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.452 ' HA3' ' HA ' ' A' ' 118' ' ' PRO . . . 112.77 -64.75 0.27 Allowed Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.486 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.46 101.96 0.64 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.774 0.321 . . . . 0.0 111.629 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.439 ' N ' HD12 ' A' ' 136' ' ' ILE . . . 83.25 69.92 1.37 Allowed Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.2 -0.524 . . . . 0.0 112.977 179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.4 HD13 ' O ' ' A' ' 96' ' ' GLY . 27.1 mm -132.62 137.09 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.654 0.227 . . . . 0.0 111.149 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.5 HD13 HG22 ' A' ' 132' ' ' VAL . 1.7 tp -112.73 94.93 5.14 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 110.881 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . 0.774 ' HB3' ' CZ ' ' A' ' 113' ' ' PHE . . . -111.58 144.16 41.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.203 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.47 122.68 26.74 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.342 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -81.0 166.08 21.14 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.402 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -146.88 142.28 27.47 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.324 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -83.48 -40.99 18.52 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.394 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.55 179.79 34.9 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.619 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -61.73 122.57 11.21 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.552 2.168 . . . . 0.0 111.821 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 60.99 28.77 18.54 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.937 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 31.1 m -137.22 80.09 1.79 Allowed 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.001 0.429 . . . . 0.0 110.632 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 49.9 m-80 -102.71 163.06 12.44 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.642 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.4 -127.46 2.77 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.473 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.6 m -135.71 41.3 2.72 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.953 0.406 . . . . 0.0 110.896 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -108.48 161.31 15.17 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.56 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -151.74 161.35 42.81 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.522 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.774 ' CZ ' ' HB3' ' A' ' 99' ' ' ALA . 24.3 p90 -137.52 130.45 30.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 111.298 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.521 HG13 HG21 ' A' ' 132' ' ' VAL . 10.9 t -101.2 107.77 22.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.085 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.507 HG23 ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -79.78 138.94 37.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.522 -179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 pp -114.77 -17.88 11.49 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.553 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.602 ' HB1' ' HD2' ' A' ' 118' ' ' PRO . . . -112.99 162.96 19.3 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-O 120.483 0.182 . . . . 0.0 111.02 179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.602 ' HD2' ' HB1' ' A' ' 117' ' ' ALA . 52.5 Cg_endo -68.52 122.64 9.63 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.042 2.495 . . . . 0.0 112.762 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.537 ' CB ' HD12 ' A' ' 122' ' ' LEU . 77.9 p -147.15 70.23 1.18 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.827 0.346 . . . . 0.0 111.465 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -64.77 -38.81 92.24 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.903 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.8 p90 -62.47 -26.62 68.62 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.399 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.537 HD12 ' CB ' ' A' ' 119' ' ' THR . 2.1 mt -64.53 -16.44 62.59 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.586 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -67.89 81.98 0.2 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.107 0.48 . . . . 0.0 110.0 179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 169.6 -45.19 0.21 Allowed Glycine 0 C--N 1.332 0.319 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.358 -179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -70.73 -45.65 64.49 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.512 179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -114.6 136.4 53.08 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.398 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.734 ' O ' ' HB1' ' A' ' 99' ' ' ALA . 11.0 t -80.12 162.6 24.68 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.915 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.585 HG21 HD22 ' A' ' 90' ' ' LEU . 1.1 tt -87.85 -179.44 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.673 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.427 ' CZ ' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -178.78 -35.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -151.79 -179.71 27.67 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.266 -0.492 . . . . 0.0 112.536 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.76 161.72 33.33 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.822 0.344 . . . . 0.0 111.062 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.521 HG21 HG13 ' A' ' 114' ' ' VAL . 13.9 t -114.89 87.21 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.022 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 1.7 t -84.97 -36.4 21.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.617 179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.52 101.27 3.85 Favored 'General case' 0 N--CA 1.46 0.059 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.016 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA2' HG22 ' A' ' 23' ' ' ILE . . . 158.81 -21.96 0.31 Allowed Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.343 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.447 ' HA ' ' CG2' ' A' ' 139' ' ' VAL . 12.7 tt -50.72 -30.88 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 CA-C-N 116.988 0.394 . . . . 0.0 111.503 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -67.32 -13.83 63.24 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.354 -0.45 . . . . 0.0 113.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.471 ' O ' HG23 ' A' ' 142' ' ' VAL . 4.8 ttp -97.35 -32.65 11.77 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-N 116.919 0.36 . . . . 0.0 111.077 179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.503 HG21 HG11 ' A' ' 114' ' ' VAL . 3.0 m -81.03 -30.74 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -79.29 -33.82 42.98 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 121.285 -0.166 . . . . 0.0 111.394 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -64.78 -29.56 70.53 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 111.75 0.278 . . . . 0.0 111.75 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 145' ' ' VAL . 19.8 t -56.91 -34.94 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-O 120.705 0.288 . . . . 0.0 110.895 179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.23 -30.82 24.26 Favored Glycine 0 CA--C 1.522 0.527 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.565 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' MET . . . . . . . . . . . . . 6.1 mtt -61.43 -27.38 68.51 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 145' ' ' VAL . 13.2 p -82.82 33.52 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.692 0 N-CA-C 111.752 0.278 . . . . 0.0 111.752 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 62.38 171.36 0.13 Allowed 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.018 0.437 . . . . 0.0 111.529 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 3.6 p -147.33 172.4 13.94 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.444 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 152' ' ' ARG . 1.4 m-20 -85.06 -176.48 6.21 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.8 p -90.52 34.46 0.89 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.409 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -164.53 36.83 0.07 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-O 120.897 0.379 . . . . 0.0 110.774 179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 54.61 57.83 5.4 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.088 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.454 ' HB3' ' HB2' ' A' ' 148' ' ' ASN . 0.2 OUTLIER -126.66 133.74 25.33 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.991 -179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.46 133.84 23.28 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 122.61 2.206 . . . . 0.0 112.518 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.57 -35.26 50.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.809 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.41 -173.4 4.35 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.394 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -110.6 104.4 13.09 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.228 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.778 HG23 ' HB2' ' A' ' 20' ' ' MET . 9.2 p -119.8 122.13 67.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.836 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -156.3 162.54 40.1 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.243 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.68 ' HA ' HG22 ' A' ' 18' ' ' THR . 24.3 mt -97.26 129.36 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-O 120.803 0.335 . . . . 0.0 111.245 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 26.7 pt -111.94 -36.53 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.041 -0.527 . . . . 0.0 112.042 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -145.24 150.52 36.83 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.709 0.29 . . . . 0.0 110.809 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.405 ' HB2' HD23 ' A' ' 16' ' ' LEU . . . -157.51 88.71 1.01 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.122 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -126.3 153.76 74.63 Favored Pre-proline 0 CA--C 1.531 0.228 0 CA-C-O 120.851 0.358 . . . . 0.0 111.621 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -80.22 140.65 14.01 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 123.008 2.472 . . . . 0.0 112.382 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.86 152.78 2.04 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.072 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.536 179.584 . . . . . . . . 0 0 . 1 stop_ save_